[
  {
    "clause_id": "1",
    "change_type": "modified",
    "old_text": "1\t Scope\nThis document specifies a framework for the identification, and if necessary, quantification of\nconstituents of a medical device, allowing the identification of biological hazards and the estimation\nand control of biological risks from material constituents, using a generally stepwise approach to the\nchemical characterization which can include one or more of the following:\n\u2014\t the identification of its materials of construction (medical device configuration);\n\u2014\t the characterization of the materials of construction via the identification and quantification of\ntheir chemical constituents (material composition);\n\u2014\t the characterization of the medical device for chemical substances that were introduced during\nmanufacturing (e.g. mould release agents, process contaminants, sterilization residues);\n\u2014\t the estimation (using laboratory extraction conditions) of the potential of the medical device,\nor its materials of construction, to release chemical substances under clinical use conditions\n(extractables);\n\u2014\t the measurement of chemical substances released from a medical device under its clinical conditions\nof use (leachables).\nThis document can also be used for chemical characterization (e.g. the identification and/or\nquantification) of degradation products. Information on other aspects of degradation assessment are\ncovered in ISO\u00a010993-9, ISO\u00a010993-13, ISO\u00a010993-14 and ISO\u00a010993-15.\nThe ISO\u00a010993 series is applicable when the material or medical device has direct or indirect body\ncontact (see ISO\u00a010993-1 for categorization by nature of body contact).\nThis document is intended for suppliers of materials and manufacturers of medical devices, to support\na biological evaluation.",
    "new_text": "1\t Scope\nThis document specifies the process and requirements for the toxicological risk assessment of medical\ndevice constituents. The methods and criteria used to assess whether exposure to a constituent\nis without appreciable harm are also specified. The toxicological risk assessment can be part of the\nbiological evaluation of the final product, as described in ISO 10993-1.\nThe process described in this document applies to chemical characterization information obtained in\nline with ISO\u00a010993-18. When a toxicological risk assessment of either the compositional information or\nanalytical chemistry data (e.g. extractable data or leachable data) are required to determine whether\nthe toxicological risks related to the constituents are negligible or tolerable.\nThe process described in this document is not intended to apply to circumstances where the\ntoxicological risk has been estimated by other means, such as:\n\u2014\t constituents, excluding cohort of concern or excluded chemicals, that are present in or extracted from\na medical device at an amount representative of patient exposure below a relevant, toxicologically-\nbased reporting threshold (see applicable requirements in ISO\u00a0 10993-18:2020, Annex\u00a0 E and\nISO/TS\u00a021726);\n\u2014\t a new or changed medical device for which chemical or biological equivalence has been established\nwith an existing biocompatible or clinically established medical device (see applicable requirements\nin ISO\u00a010993-18:2020, Annex\u00a0C).\nThe process described in this document is also not applicable to:\n\u2014\t medical device constituents that do not contact the body (e.g. in vitro diagnostics);\n\u2014\t biological risks associated with physical interactions of the medical device with the body (i.e.\napplication of mechanical forces, energy or surface morphology, etc.), provided that the chemical\nexposure is not changed;\n\u2014\t active pharmaceutical ingredients of device-drug combination products or biologic components of\ndevice-biologic combination products as additional regulatory considerations can apply;\n\u2014\t exposure to a particular constituent that arises from sources other than the device, such as food,\nwater or air.",
    "change_text": "1\t Scope\nThis document specifies the process and requirements for the toxicological risk assessment of medical\ndevice constituents. The methods and criteria used to assess whether exposure to a constituent\nis without appreciable harm are also specified. The toxicological risk assessment can be part of the\nbiological evaluation of the final product, as described in ISO 10993-1.\nThe process described in this document applies to chemical characterization information obtained in\nline with ISO\u00a010993-18. When a toxicological risk assessment of either the compositional information or\nanalytical chemistry data (e.g. extractable data or leachable data) are required to determine whether\nthe toxicological risks related to the constituents are negligible or tolerable.\nThe process described in this document is not intended to apply to circumstances where the\ntoxicological risk has been estimated by other means, such as:\n\u2014\t constituents, excluding cohort of concern or excluded chemicals, that are present in or extracted from\na medical device at an amount representative of patient exposure below a relevant, toxicologically-\nbased reporting threshold (see applicable requirements in ISO\u00a0 10993-18:2020, Annex\u00a0 E and\nISO/TS\u00a021726);\n\u2014\t a new or changed medical device for which chemical or biological equivalence has been established\nwith an existing biocompatible or clinically established medical device (see applicable requirements\nin ISO\u00a010993-18:2020, Annex\u00a0C).\nThe process described in this document is also not applicable to:\n\u2014\t medical device constituents that do not contact the body (e.g. in vitro diagnostics);\n\u2014\t biological risks associated with physical interactions of the medical device with the body (i.e.\napplication of mechanical forces, energy or surface morphology, etc.), provided that the chemical\nexposure is not changed;\n\u2014\t active pharmaceutical ingredients of device-drug combination products or biologic components of\ndevice-biologic combination products as additional regulatory considerations can apply;\n\u2014\t exposure to a particular constituent that arises from sources other than the device, such as food,\nwater or air.",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to11__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to11__0\"><a href=\"#difflib_chg_to11__0\">f</a></td><td class=\"diff_header\" id=\"from11_1\">1</td><td nowrap=\"nowrap\">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scope</td><td class=\"diff_next\"><a href=\"#difflib_chg_to11__0\">f</a></td><td class=\"diff_header\" id=\"to11_1\">1</td><td nowrap=\"nowrap\">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scope</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to11__top\">t</a></td><td class=\"diff_header\" id=\"from11_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;document&nbsp;specifies&nbsp;a&nbsp;framework&nbsp;for&nbsp;the&nbsp;identification,&nbsp;and&nbsp;if&nbsp;necessary,&nbsp;quantification&nbsp;of</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to11__top\">t</a></td><td class=\"diff_header\" id=\"to11_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;document&nbsp;specifies&nbsp;the&nbsp;process&nbsp;and&nbsp;requirements&nbsp;for&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;medical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">constituents&nbsp;of&nbsp;a&nbsp;medical&nbsp;device,&nbsp;allowing&nbsp;the&nbsp;identification&nbsp;of&nbsp;biological&nbsp;hazards&nbsp;and&nbsp;the&nbsp;estimation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">device&nbsp;constituents.&nbsp;The&nbsp;methods&nbsp;and&nbsp;criteria&nbsp;used&nbsp;to&nbsp;assess&nbsp;whether&nbsp;exposure&nbsp;to&nbsp;a&nbsp;constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;control&nbsp;of&nbsp;biological&nbsp;risks&nbsp;from&nbsp;material&nbsp;constituents,&nbsp;using&nbsp;a&nbsp;generally&nbsp;stepwise&nbsp;approach&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_add\">is&nbsp;without&nbsp;appreciable&nbsp;harm&nbsp;are&nbsp;also&nbsp;specified.&nbsp;The&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;can&nbsp;be&nbsp;part&nbsp;of&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization&nbsp;which&nbsp;can&nbsp;include&nbsp;one&nbsp;or&nbsp;more&nbsp;of&nbsp;the&nbsp;following:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">biological&nbsp;evaluation&nbsp;of&nbsp;the&nbsp;final&nbsp;product,&nbsp;as&nbsp;described&nbsp;in&nbsp;ISO&nbsp;10993-1.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;identification&nbsp;of&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction&nbsp;(medical&nbsp;device&nbsp;configuration);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;process&nbsp;described&nbsp;in&nbsp;this&nbsp;document&nbsp;applies&nbsp;to&nbsp;chemical&nbsp;characterization&nbsp;information&nbsp;obtained&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;characterization&nbsp;of&nbsp;the&nbsp;materials&nbsp;of&nbsp;construction&nbsp;via&nbsp;the&nbsp;identification&nbsp;and&nbsp;quantification&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">line&nbsp;with&nbsp;ISO\u00a010993-18.&nbsp;When&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;either&nbsp;the&nbsp;compositional&nbsp;information&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">their&nbsp;chemical&nbsp;constituents&nbsp;(material&nbsp;composition);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">analytical&nbsp;chemistry&nbsp;data&nbsp;(e.g.&nbsp;extractable&nbsp;data&nbsp;or&nbsp;leachable&nbsp;data)&nbsp;are&nbsp;required&nbsp;to&nbsp;determine&nbsp;whether</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;characterization&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;for&nbsp;chemical&nbsp;substances&nbsp;that&nbsp;were&nbsp;introduced&nbsp;during</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;toxicological&nbsp;risks&nbsp;related&nbsp;to&nbsp;the&nbsp;constituents&nbsp;are&nbsp;negligible&nbsp;or&nbsp;tolerable.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manufacturing&nbsp;(e.g.&nbsp;mould&nbsp;release&nbsp;agents,&nbsp;process&nbsp;contaminants,&nbsp;sterilization&nbsp;residues);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;process&nbsp;described&nbsp;in&nbsp;this&nbsp;document&nbsp;is&nbsp;not&nbsp;intended&nbsp;to&nbsp;apply&nbsp;to&nbsp;circumstances&nbsp;where&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;estimation&nbsp;(using&nbsp;laboratory&nbsp;extraction&nbsp;conditions)&nbsp;of&nbsp;the&nbsp;potential&nbsp;of&nbsp;the&nbsp;medical&nbsp;device,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;risk&nbsp;has&nbsp;been&nbsp;estimated&nbsp;by&nbsp;other&nbsp;means,&nbsp;such&nbsp;as:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;to&nbsp;release&nbsp;chemical&nbsp;substances&nbsp;under&nbsp;clinical&nbsp;use&nbsp;conditions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;constituents,&nbsp;excluding&nbsp;cohort&nbsp;of&nbsp;concern&nbsp;or&nbsp;excluded&nbsp;chemicals,&nbsp;that&nbsp;are&nbsp;present&nbsp;in&nbsp;or&nbsp;extracted&nbsp;from</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(extractables);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a&nbsp;medical&nbsp;device&nbsp;at&nbsp;an&nbsp;amount&nbsp;representative&nbsp;of&nbsp;patient&nbsp;exposure&nbsp;below&nbsp;a&nbsp;relevant,&nbsp;toxicologically-</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;measurement&nbsp;of&nbsp;chemical&nbsp;substances&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;under&nbsp;its&nbsp;clinical&nbsp;conditions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">based&nbsp;reporting&nbsp;threshold&nbsp;(see&nbsp;applicable&nbsp;requirements&nbsp;in&nbsp;ISO\u00a0&nbsp;10993-18:2020,&nbsp;Annex\u00a0&nbsp;E&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;use&nbsp;(leachables).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO/TS\u00a021726);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;document&nbsp;can&nbsp;also&nbsp;be&nbsp;used&nbsp;for&nbsp;chemical&nbsp;characterization&nbsp;(e.g.&nbsp;the&nbsp;identification&nbsp;and/or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;new&nbsp;or&nbsp;changed&nbsp;medical&nbsp;device&nbsp;for&nbsp;which&nbsp;chemical&nbsp;or&nbsp;biological&nbsp;equivalence&nbsp;has&nbsp;been&nbsp;established</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantification)&nbsp;of&nbsp;degradation&nbsp;products.&nbsp;Information&nbsp;on&nbsp;other&nbsp;aspects&nbsp;of&nbsp;degradation&nbsp;assessment&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">with&nbsp;an&nbsp;existing&nbsp;biocompatible&nbsp;or&nbsp;clinically&nbsp;established&nbsp;medical&nbsp;device&nbsp;(see&nbsp;applicable&nbsp;requirements</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">covered&nbsp;in&nbsp;ISO\u00a010993-9,&nbsp;ISO\u00a010993-13,&nbsp;ISO\u00a010993-14&nbsp;and&nbsp;ISO\u00a010993-15.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">in&nbsp;ISO\u00a010993-18:2020,&nbsp;Annex\u00a0C).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;ISO\u00a010993&nbsp;series&nbsp;is&nbsp;applicable&nbsp;when&nbsp;the&nbsp;material&nbsp;or&nbsp;medical&nbsp;device&nbsp;has&nbsp;direct&nbsp;or&nbsp;indirect&nbsp;body</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;process&nbsp;described&nbsp;in&nbsp;this&nbsp;document&nbsp;is&nbsp;also&nbsp;not&nbsp;applicable&nbsp;to:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contact&nbsp;(see&nbsp;ISO\u00a010993-1&nbsp;for&nbsp;categorization&nbsp;by&nbsp;nature&nbsp;of&nbsp;body&nbsp;contact).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;medical&nbsp;device&nbsp;constituents&nbsp;that&nbsp;do&nbsp;not&nbsp;contact&nbsp;the&nbsp;body&nbsp;(e.g.&nbsp;in&nbsp;vitro&nbsp;diagnostics);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;document&nbsp;is&nbsp;intended&nbsp;for&nbsp;suppliers&nbsp;of&nbsp;materials&nbsp;and&nbsp;manufacturers&nbsp;of&nbsp;medical&nbsp;devices,&nbsp;to&nbsp;support</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;biological&nbsp;risks&nbsp;associated&nbsp;with&nbsp;physical&nbsp;interactions&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;with&nbsp;the&nbsp;body&nbsp;(i.e.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from11_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;biological&nbsp;evaluation.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">application&nbsp;of&nbsp;mechanical&nbsp;forces,&nbsp;energy&nbsp;or&nbsp;surface&nbsp;morphology,&nbsp;etc.),&nbsp;provided&nbsp;that&nbsp;the&nbsp;chemical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;is&nbsp;not&nbsp;changed;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;active&nbsp;pharmaceutical&nbsp;ingredients&nbsp;of&nbsp;device-drug&nbsp;combination&nbsp;products&nbsp;or&nbsp;biologic&nbsp;components&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">device-biologic&nbsp;combination&nbsp;products&nbsp;as&nbsp;additional&nbsp;regulatory&nbsp;considerations&nbsp;can&nbsp;apply;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exposure&nbsp;to&nbsp;a&nbsp;particular&nbsp;constituent&nbsp;that&nbsp;arises&nbsp;from&nbsp;sources&nbsp;other&nbsp;than&nbsp;the&nbsp;device,&nbsp;such&nbsp;as&nbsp;food,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to11_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">water&nbsp;or&nbsp;air.</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "10",
    "change_type": "added",
    "old_text": "",
    "new_text": "10\tToxicological risk acceptance criteria",
    "change_text": "10\tToxicological risk acceptance criteria"
  },
  {
    "clause_id": "10.1",
    "change_type": "added",
    "old_text": "",
    "new_text": "10.1\tGeneral\nAn exposure dose of a constituent is without appreciable harm to health (i.e. tolerable toxicological\nrisk) when the following apply:\n\u2014\t MoS exceeds 1;\n\u2014\t contributing values to the MoS are demonstrated to be conservative.\nNOTE\u00a01\nConservative means the estimation of toxicological risk is deliberately higher (i.e. lower MoS) than\nthe probable true risk.\nExamples when the values contributing to the MoS are conservative include, but not limited to:\n\u2014\t The method used in the calculation of EEDmax represents an overestimate of the probable true\nworst-case estimated exposure dose;\n\u2014\t For each uncertainty factor used in the derivation of the TI (C.2.2 or C.3.2) or TCL (C.4.3), the default\nvalue is used.\nWhen the TCL, TI or EEDmax are not demonstrated to be conservative, the evaluation of the MoS shall be\naddressed in accordance with 10.2.\nWhen the TCL, TI or EEDmax are demonstrated to be conservative and when the MoS does not exceed\n1 (i.e. a possible toxicological risk), the toxicological risk shall be further evaluated in accordance with\n10.2.\nMoS values shall be assessed based on expert judgement when exposure dose is based on assumed\nrelease as described in Clause E.3 (i.e. release kinetics data are not available).\nFor a toxicological risk to be judged acceptable, it shall be supported by evidence that assumed release\nis conservative in relation to the intended use of the medical device.\nNOTE\u00a02\nExpert judgement can include assessment of the nature of the harm to health as described in Clause\u00a05\nand Clause\u00a06.\nMoS values, including how each was calculated, and the conclusion of each exposure dose evaluation\nshall be justified and documented, in accordance with Clause\u00a011.",
    "change_text": "10.1\tGeneral\nAn exposure dose of a constituent is without appreciable harm to health (i.e. tolerable toxicological\nrisk) when the following apply:\n\u2014\t MoS exceeds 1;\n\u2014\t contributing values to the MoS are demonstrated to be conservative.\nNOTE\u00a01\nConservative means the estimation of toxicological risk is deliberately higher (i.e. lower MoS) than\nthe probable true risk.\nExamples when the values contributing to the MoS are conservative include, but not limited to:\n\u2014\t The method used in the calculation of EEDmax represents an overestimate of the probable true\nworst-case estimated exposure dose;\n\u2014\t For each uncertainty factor used in the derivation of the TI (C.2.2 or C.3.2) or TCL (C.4.3), the default\nvalue is used.\nWhen the TCL, TI or EEDmax are not demonstrated to be conservative, the evaluation of the MoS shall be\naddressed in accordance with 10.2.\nWhen the TCL, TI or EEDmax are demonstrated to be conservative and when the MoS does not exceed\n1 (i.e. a possible toxicological risk), the toxicological risk shall be further evaluated in accordance with\n10.2.\nMoS values shall be assessed based on expert judgement when exposure dose is based on assumed\nrelease as described in Clause E.3 (i.e. release kinetics data are not available).\nFor a toxicological risk to be judged acceptable, it shall be supported by evidence that assumed release\nis conservative in relation to the intended use of the medical device.\nNOTE\u00a02\nExpert judgement can include assessment of the nature of the harm to health as described in Clause\u00a05\nand Clause\u00a06.\nMoS values, including how each was calculated, and the conclusion of each exposure dose evaluation\nshall be justified and documented, in accordance with Clause\u00a011."
  },
  {
    "clause_id": "10.2",
    "change_type": "added",
    "old_text": "",
    "new_text": "10.2\tFurther risk analysis or risk evaluation or risk control\nToxicological risk shall be further addressed by other means in accordance with ISO\u00a0 10993-1 and\nISO\u00a014971 when any of the following apply:\n\u2014\t the MoS is below 1 based on release kinetics in Clause E.2, and TI or TCL are used,\n\u2014\t the cancer risk of a human carcinogen or suspected human carcinogen exceeds 1 in 100\u00a0000, or\n\u2014\t the MoS is judged to represent possible toxicological risk.\nNOTE\u00a01\nWhen constituent exposure is understood, an MoS below 1 generally indicates a possible or probable\ntoxicological risk.\nFurther risk analysis, risk evaluation or risk control can consider information that addresses:\n\u2014\t the dose of a constituent that will elicit harm (e.g. LOAEL),\n\u2014\t the relevance of the exposure dose to the intended use of the medical device (e.g. refinement of the\nEEDmax), or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n23\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t if risk control is not practical and information is available that demonstrates the expected benefit of\nthe medical device outweighs the toxicological risk.\nFor example, exposure is reduced as low as reasonably practicable and cancer risk is actively managed\nusing risk management procedures as described in ISO 14971.\nOutcomes of further risk analysis or risk evaluation or risk control shall be documented in accordance\nwith ISO\u00a010993-1 and ISO\u00a014971.",
    "change_text": "10.2\tFurther risk analysis or risk evaluation or risk control\nToxicological risk shall be further addressed by other means in accordance with ISO\u00a0 10993-1 and\nISO\u00a014971 when any of the following apply:\n\u2014\t the MoS is below 1 based on release kinetics in Clause E.2, and TI or TCL are used,\n\u2014\t the cancer risk of a human carcinogen or suspected human carcinogen exceeds 1 in 100\u00a0000, or\n\u2014\t the MoS is judged to represent possible toxicological risk.\nNOTE\u00a01\nWhen constituent exposure is understood, an MoS below 1 generally indicates a possible or probable\ntoxicological risk.\nFurther risk analysis, risk evaluation or risk control can consider information that addresses:\n\u2014\t the dose of a constituent that will elicit harm (e.g. LOAEL),\n\u2014\t the relevance of the exposure dose to the intended use of the medical device (e.g. refinement of the\nEEDmax), or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n23\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t if risk control is not practical and information is available that demonstrates the expected benefit of\nthe medical device outweighs the toxicological risk.\nFor example, exposure is reduced as low as reasonably practicable and cancer risk is actively managed\nusing risk management procedures as described in ISO 14971.\nOutcomes of further risk analysis or risk evaluation or risk control shall be documented in accordance\nwith ISO\u00a010993-1 and ISO\u00a014971."
  },
  {
    "clause_id": "11",
    "change_type": "added",
    "old_text": "",
    "new_text": "11\tReporting requirements\nConstituent specific toxicological data, justifications and methods used to apply TSL, TTC, the derivation\nof TCL or TI values, the estimation of exposure dose, the derivation of MoS values and the evaluations of\nworst-case exposure shall be documented and reported (see examples in Annex\u00a0F).\nCompliance with the requirements in this document, which includes Clause\u00a0 6 to Clause\u00a0 9, and\nAnnexes\u00a0B,\u00a0C\u00a0and\u00a0E, is verified by inspection of the report.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n24\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0A\n(normative)\n\nEvaluation of toxicological data quality when selecting a point of\ndeparture\nAccording to 7.1 and C.2.2.4.3, it is essential that relevant toxicological data are used to evaluate the\nnature of harm, and to establish the POD value. POD values that can be used in the derivation of a TI\nvalue include, but are not limited to, BMDL, NOAEL or LOAEL.\nToxicological data should be systematically collected and critically assessed for quality. Quality\nassessment addresses the study design, conduct or data analysis and reporting that can introduce\nselection, performance, detection, attrition and reporting biases.[51]to[61] Reporting bias can be assessed\nby confirming that all key information is included in collected studies. Ideally, studies should present\nsufficient information to allow a knowledgeable reader to understand:\n\u2014\t the toxicological relevance of the study to the constituent;\n\u2014\t that the reported methodological information is adequate for the experiment to be repeated and the\ndose-response data are reproducible;\n\u2014\t the reliability and validity of the findings based on the data generated.\nEvaluation of reporting bias should address whether the quality of the underlying methods used or the\ngenerated data can be adversely impacted. Reporting bias can be evaluated when toxicological data are\nobtained from a secondary health effect source based on expertise of the source (e.g. source is authored\nby experts in toxicology).\nThe adequacy of available evidence to support the conclusions of the toxicological risk assessment shall\nbe confirmed.\nNOTE\nTools for assessing quality are categorized into:\na)\nchecklists of questions that identify sources of bias, or\nb)\nscoring systems that produce a numerical reliability rating for each study (e.g. ToxRTool, ARRIVE Guidelines).\nReducing uncertainty in scores can be addressed by weighing each source of bias[62]to[72].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n25\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0B\n(normative)\n\nDerivation of toxicological screening limits\nB.1\t General\nThe total quantity (in \u00b5g) of a constituent can be used to assess whether exposure for one or more days\ncan result in a cumulative exposure dose that is at a negligible toxicological risk level (i.e. too low to\npresent a toxicological risk for the applicable harms) and no additional toxicological risk estimation is\nrecommended.\nNOTE\u00a01\nWhen TSL is applied, TQ represents the cumulative exposure dose [e.g. the summation of the exposure\ndose (daily) over the number of exposure days of contact with the device][73].\nThe TSLs according to this document apply to systemic toxicity (acute, subacute, subchronic and\nchronic), genotoxicity, carcinogenicity, reproductive or developmental toxicity for oral or parenteral\nroutes, as well as adults, paediatrics (6 months of age or older) and pregnant women[74].\nWhen the TSL approach is used for any medical device, the 120\u00a0\u00b5g TSL \u226430 d value shall be used for\neach constituent to address applicable biological endpoints that can result from short-term (i.e.\u00a0\u226430\u00a0d)\nexposure, see Table\u00a0B.2.\nFor long-term body contacting medical devices, the 600\u00a0\u00b5g TSL\u00a0>30 d value should be used for each\nconstituent, in addition to the TSL \u226430 d value, to address TQ values that exceed the TSL \u226430 d value and\napplicable biological endpoints that can result from long-term (i.e.\u00a0>30\u00a0d) exposure, see Table\u00a0B.2.\nTSL shall not be applied to harms that the TTC values are not protective in accordance with\nISO/TS\u00a021726:2019, Clause\u00a01.\nToxicological screening limits shall apply to the following:\n\u2014\t identified constituent, and\n\u2014\t total quantity of each constituent present in or on or released from the medical device.\nNOTE\u00a02\nISO\u00a0 10993-18 describes information gathering or an extraction study method that results in an\nestimate of the total quantity of a constituent present in, on or extracted from the medical device.\nToxicological screening limits shall not apply to medical devices used long-term in very young infants\nor neonates, including preterm, or to the following types of constituents:\n\u2014\t the nature of harm is irritation,\n\u2014\t the cohort of concern substances or excluded compounds, or\n\u2014\t substances that are not identified constituents (i.e. unknown or incomplete chemical identity).\nNOTE\u00a03\nTSL does not apply to preterm or very young infants (i.e.\u00a06 months of age or younger) because these\nindividuals have unique susceptibilities (Clause\u00a08 and C.2.2.2).\nA TSL shall not be applied to volatile compounds from gas pathway devices because inhalation specific\nTTC values are established in ISO\u00a018562-1 for these constituents.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n26\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nB.2\t Calculation of the TSL\nToxicological screening limits are based on mutagenic TTC values applicable to\u00a0the duration of exposure\nto the constituent. The toxicological screening limit can be calculated using Formula\u00a0(B.1).\nTSL = TTC \u00d7 D\n(B.1)\nwhere\n\nTSL\nis the toxicological screening limit expressed as the cumulative quantity of exposure, in \u00b5g, to\na constituent over a specified time period;\n\nD\nis the duration of exposure, in d, according to ISO\u00a010993-1:2018, 5.3.\nWhen a toxicological screening limit is used, default TTC and D values in Table\u00a0B.1 below shall be used\nto calculate the applicable TSL value and applied in accordance with Clause B.3.\nTable\u00a0B.1\u00a0\u2014 Default toxicological screening limit TTC and D for TSL calculations\nPeriod of assumed exposure\nto the constituent\nd\nTTC\ng/d\nD\nd\nTSL\n\u00b5g\n\u226430\n120\n1\n120 (i.e. 120\u00a0\u00b5g/d \u00d7 1\u00a0d)\n>30\n20\n30\n600 (i.e. 20\u00a0\u00b5g/d \u00d7 30\u00a0d)\nNOTE\u00a01\nFor long-term contact, the duration of exposure is rounded down to 30\u00a0d, instead of 31\u00a0d.\nNOTE\u00a02\nThe TTC and D values in Table\u00a0B.1 are conservative (i.e. lowest values) for dose and time dependent\nharms (e.g. genotoxicity, cancer, systemic toxicity, reproductive/developmental toxicity, see ISO/TS 21726:2019,\n5.1).\nB.3\t Application of toxicological screening limits\nWhen the TSL approach is used for any medical device, TSL\u00a0\u226430\u00a0d\u00a0=\u00a0120\u00a0\u00b5g for short-term exposure\nduration shall be used for each constituent in accordance with Table\u00a0B.2.\nFor medical devices in long-term contact with the body, TSL\u00a0 >30 d\u00a0=\u00a0 600\u00a0 \u00b5g for long-term exposure\nduration may be used for each constituent in addition to the TSL\u00a0\u226430 d value, see Table\u00a0B.2.\nTable\u00a0B.2\u00a0\u2014 Application of toxicological screening limits for TQ\nMedical device contact duration\nPeriods of assumed exposure to the constituent\n1\u00a0d\n\u226430\u00a0d\n>30\u00a0d\nLimited (\u22641\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nNot applicable\nNot applicable\nProlonged (\u226430\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nNot applicable\nLong-term (>30\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0>30 d\u00a0=\u00a0600\u00a0\u00b5g\nNOTE\nToxicological screening limits are not intended to replace the analytical evaluation threshold (AET)\ndescribed in ISO\u00a010993-18.\nThe toxicological screening limit can be used to evaluate the safety of extractables that exceed the AET\nconsidering the restrictions defined in Clause\u00a0B.1.\nWhen the TSL approach is used, the total quantity of each identified chemical constituent to which an\nindividual can be exposed shall be compared to the relevant TSLs in accordance with Table\u00a0B.2.\nFor single-use (disposable) medical devices that are repeatedly used and when cumulative duration\nof body contact is prolonged, the TSL\u00a0\u226430\u00a0d may be used to screen constituents that present negligible\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n27\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\ntoxicological risk for short-term exposure (see EXAMPLE\u00a06). For single-use (disposable) medical devices\nthat are repeatedly used and cumulative duration of body contact is long-term, toxicological risk for\neach constituent should be assessed in accordance with Clauses\u00a07, 8, 9 and 10.\nWhen the number or quantity of medical devices that contact the body differs from the number or\nquantity of medical devices used in the extraction study, the total quantity of each identified chemical\nconstituent extracted shall be adjusted by application of a SF using Formula\u00a0(B.2), unless justified with\nsupporting evidence that the reported total quantity represents a cumulative exposure dose.\nTQmax = TQ \u00d7 SF\n(B.2)\nwhere\n\nTQmax is the maximum total quantity, in \u00b5g, to which an individual can be exposed (i.e. cumulative\nexposure dose);\n\nTQ\nis the total quantity, in \u00b5g, present in or on, or extracted from the medical device (e.g. from\nan exaggerated or exhaustive extraction study);\n\nSF\nis the ratio of the quantity (e.g. cm2, g or ml) of medical devices that are in contact with the\nbody divided by the quantity of medical device(s) used in the extraction study.\nWhen the number of medical devices applies to the intended use (e.g. a hip implant), the maximum\nnumber of medical devices that contacts the body and the number of medical devices used in the\nextractions study shall be used to calculate the SF using Formula\u00a0(B.3), unless justified with supporting\nevidence that the reported total quantity represents the cumulative exposure dose.\nWhen the number of medical devices does not apply (e.g. the largest surface area of the medical device\nthat can contact the body is not the same as the surface area of the device which is in contact with the\nsolution during extraction), the maximum quantity (e.g. cm2, g or ml) of the medical device that is in\ncontact with the body and the quantity of the medical device used in the extraction study shall be used\nto calculate the SF using Formula\u00a0(B.3).\nSF = MDb.c. / MDa.r.s.\n(B.3)\nwhere\n\nMDb.c.\nis the maximum quantity (e.g. cm2, g or ml) of medical devices that are simultaneously in\ncontact with the body;\n\nMDa.r.s. is the quantity of medical devices used in the extraction study.\nEXAMPLES 1 to 6 are applications of toxicological screening limits.\nEXAMPLE\u00a01\nLimited or prolonged contact: When 100\u00a0 \u00b5g of an identified constituent is extracted from a\nsingle medical device and a single medical device is in contact with the body for less than or equal to 30\u00a0d (not\nrepeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430 d of 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 100\u00a0\u00d7 1 = 100\u00a0\u00b5g\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n28\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\n100\nis the reported total quantity in the extraction solvent (i.e. TQext), in\u00a0\u00b5g;\n\n1\nis the SF where 1 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by the single medical device extracted.\nShort-term exposure to the constituent is a negligible toxicological risk because TQmax is less than the\nTSL\u226430 d.\nEXAMPLE\u00a02\nLimited or prolonged contact: When 100\u00a0\u00b5g of an identified constituent is extracted from a single\nmedical device and two medical devices are in contact with the body for less than or equal to 30\u00a0d (not repeatedly\nused), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 100\u00a0\u00d7 2 = 200\u00a0\u00b5g\nwhere\n\n100\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n2\nis the SF where 2 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by\u00a0the single medical device extracted.\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL\u226430 d.\nEXAMPLE\u00a03\nLong-term contact: When 300\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice and a single medical device is in contact with the body for long-term (i.e. greater than 30\u00a0d) (not repeatedly\nused), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g and a TSL>30 d of 600\u00a0\u00b5g.\nTSL \u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTSL>30 d =\u00a020\u00a0\u00d7 30 =\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n29\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\nTQmax = 300\u00a0\u00d7 1 = 300\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n1\nis the SF where 1 is the maximum number of medical devices that are in contact with the body\ndivided by\u00a0the single medical device extracted.\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL\u00a0\u226430 d; whereas, long-term exposure to the constituent is a negligible toxicological risk because\nTQmax is less than the TSL>30 d.\nEXAMPLE\u00a04\nLong-term contact: When 320\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice and two of the same medical devices are in contact with the body at the same time for more than 30\u00a0d (not\nrepeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g and a TSL>30 d of\n600\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1)\n\nTSL >30 d\u00a0=\u00a020\u00a0\u00d7 30\u00a0=\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 320\u00a0\u00b5g \u00d7 2 = 640\u00a0\u00b5g\nwhere\n\n320\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n2\nis the SF where 2 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by the single medical device extracted.\nShort-term and long-term exposure to the constituent can present a toxicological risk because TQmax is\ngreater than the TSL \u226430 d and TSL\u00a0>30 d, respectively.\nEXAMPLE\u00a05\nLong-term contact: When 300\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice (50\u00a0cm2) and two of the same medical devices (200\u00a0cm2 each) are in contact with the body at the same\ntime (i.e. the total device surface area is equal to two devices multiplied by 200\u00a0cm2/device\u00a0which is \u00a0400\u00a0cm2)\nfor more than 30\u00a0d (not repeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430\u00a0d of\n120\u00a0\u00b5g and a TSL\u00a0>30\u00a0d of 600\u00a0\u00b5g.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n30\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTSL\u226430 d =\u00a0120\u00a0\u00d7 1\u00a0=\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTSL>30 d =\u00a020\u00a0\u00d7 30\u00a0=\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 300 \u00d7 8 = 2\u00a0400\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n8\nis the SF where 400\u00a0cm2 is the maximum device surface area, in cm2, that is in contact with\nthe body\u00a0divided by the\u00a050\u00a0cm2 device surface area extracted.\nShort-term and long-term exposure to the constituent can present a toxicological risk because TQmax is\ngreater than the TSL \u226430 d and TSL\u00a0>30 d, respectively.\nEXAMPLE\u00a06\nCumulative prolonged contact:  When 300\u00a0 \u00b5g of an identified constituent is extracted from a\nsingle medical device (50\u00a0cm2) that is in contact with the body for less than one day, and a new device is used\nevery day for up to 10 days (i.e. repeat use), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430 d\nof 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120 \u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days of contact of a single medical device.\n\nTQmax = 300 \u00d7 10 = 3\u00a0000\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n10\nis the SF where 50\u00a0cm2 is the maximum device surface area, in cm2, that is in contact with the\nbody\u00a0divided by the\u00a050\u00a0cm2 device surface area extracted.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n31\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL \u226430 d.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n32\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0C\n(normative)\n\nDerivation of constituent TI or TCL for select endpoints\nC.1\t General\nThe method to derive a non-cancer TI (see Clause C.2), cancer TI (see Clause C.3), or TCL (see Clause C.4)\nis described in this annex. The methods to derive a TI or TCL shall be applied when toxicological data\nfor a constituent are available, as described in Clause\u00a06 and 7.1.\nWhen toxicological data of a constituent are not available to derive a TI, then TTC shall be applied in\naccordance with 7.2.\nNOTE\nIn this annex, an uncertainty factor approach is described based on References [75] to [85].\nC.2\t Setting of TI for non-cancer endpoints\nC.2.1\t General\nFor each relevant anticipated route and duration of exposure, a TI is calculated from the NOAEL,\nLOAEL, BMDL or other value determined to be the POD (see 7.1). Each TI calculation shall account for\nuncertainty of the data and its extrapolation to intended human exposure.\nThe TI shall provide protection to the most sensitive individuals with which the medical device is in\ncontact.\nNOTE\nWhere a relevant dose-based threshold has been determined by an expert committee or regulatory\nagency for non-medical device use, it can be adapted for medical device use by applying uncertainty factors to\naddress differences in the circumstances of exposure relevant to the medical device intended use (see C.2.2 for\ntypes of uncertainties to consider for medical device uses).\nC.2.2\t Determination of uncertainty factors\nC.2.2.1\nGeneral\nSources of uncertainty shall be identified and used in the derivation of the TI. The selection of\nuncertainty factors that account for sources of uncertainty encompasses many different considerations\nto meet the requirements in 10.1. These factors consider the uncertainties inherent in estimating the\npotential effects of a constituent on exposed individual(s) (see Table\u00a0C.1).\nThe value of each uncertainty factor shall be documented, with justification for its selection. Some\nconsiderations in the selection of the appropriate uncertainty factors include variation among humans,\nspecies extrapolations and other uncertainties as described in C.2.2.2 to C.2.2.4[86]to[89].\nC.2.2.2\nUncertainty for intraspecies variation, UF(TI)1\nIntraspecies variation among humans applies to pre-term, paediatric and adults [including elderly or\npregnant women, (i.e. including the woman or foetus)] that differ in absorption, metabolism, tissue\ndistribution, excretion, elimination or biological response to constituents of toxicological concern. In\nthe absence of human data to characterize variability among adults or paediatrics (6\u00a0months of age or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n33\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nolder), a default 10-fold uncertainty factor shall be applied unless otherwise justified with supporting\nevidence.\nNOTE\u00a01\nPreterm, neonate, very young infants (i.e. 6 months or younger) and pregnant women (including the\nwoman or foetus) are potentially more vulnerable to constituents of toxicological concern due to differences\nin developmental (e.g. neurological, immunological, skeletal, reproductive or endocrine) or toxicokinetics (i.e.\nabsorption, metabolism, tissue distribution and excretion)[92]to[95].\nWhen preterm, neonate and very young infants (i.e. 6 months or younger) are exposed to chemical\nconstituents whose main elimination route is hepatic metabolism or renal excretion, an additional\nthreefold uncertainty factor shall be applied to address the immaturity of the metabolic capacity and\nrenal function[90][91].\nFor infants older than 6\u00a0months, a justification of an additional uncertainty factor can be required.\nThe uncertainty factor that accounts for intraspecies variation shall be justified and documented. An\nidiosyncratic response shall not serve as the basis for a TI value because justification of an uncertainty\nfactor protective for these individuals is generally not feasible.\nNOTE\u00a02\nIdiosyncratic means the response is specific to an individual and not the general population[96].\nNOTE\u00a03\nIn some cases, the uncertainty factor for intraspecies variation can be less than 10. For example, when\nhuman data indicate intraspecies variation is negligible or when the POD is based on the most sensitive human\nsub-population.\nC.2.2.3\nUncertainty for interspecies differences, UF(TI)2\nInterspecies uncertainty accounts for extrapolation from data derived in a species other than humans.\nIn the absence of detailed knowledge of interspecies differences in toxicity, a default 10-fold uncertainty\nfactor shall be applied unless otherwise justified with supporting evidence.\nWhen toxicity and toxicokinetics of the constituent are established and similar between human and\nthe experimental model, a smaller uncertainty factor for interspecies differences can be justified with\nsupporting evidence. The uncertainty factor that accounts for interspecies variation shall be justified\nand documented[89].\nC.2.2.4\nUncertainty from the quality and relevance of the experimental data, UF(TI)n\nUF(TI)n is used in the MF calculation (see C.2.3) when additional uncertainties related to the following\napply, which include, but are not limited to:\n\u2014\t use of short-term studies for extrapolation to longer-term exposures or effects (see C.2.2.4.2);\n\u2014\t use of LOAEL data instead of NOAEL data (see C.2.2.4.3);\n\u2014\t use of animal models of uncertain or limited relevance to the medical device user or its intended use\n(see C.2.2.4.3);\n\u2014\t use of data from different route of exposure (see C.2.2.4.1);\n\u2014\t data quality (see C.2.2.4.3).\nTable\u00a0C.1 provides types of additional uncertainties and ranges to be considered for UF(TI)n. Sources\nand numerical level of uncertainty shall be justified and documented in the report.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n34\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0C.1\u00a0\u2014 Additional uncertainty factors for consideration in the derivation of a TI\nSources of additional\nuncertainty\nTypes of additional uncertainty\nUF(TI)n\nSubclause\nRoute-to-route\nOral data to dermal application or inhalation to dermal\napplication\n1\nC.2.2.4.1\nInhalation to parenteral or inhalation to oral application\n1 to 10\nOral data to parenteral\n1 to 100\nExposure duration\nSubchronic to chronic extrapolation\n2 to 6\nC.2.2.4.2\nSubacute to chronic extrapolation\n6 to 10\nPoint-of-departure\nLOAEL to NOAEL\n3 to 10\nC.2.2.4.3\nData applicability\nUse of an analogue, state of matter (e.g. gas to solid dose)\n1 to 10\nData quality\nReliability and relevance\n1 to 10\nNOTE\nAccounting for multiple additional uncertainties each at the maximum value (i.e. 10) can result in an\nexcessively high modifying factor, see C.2.3.\nC.2.2.4.1\nRoute-to-route extrapolation\nC.2.2.4.1.1\t Oral to dermal application or inhalation data to dermal application\nWhen extrapolating a systemic toxicity POD from oral-to-dermal or inhalation-to-dermal exposure\nroutes, a default value of 1 can be justified when absorption and systemic dose by oral or inhalation\nroutes is equivalent or greater than the dermal route. Otherwise, a higher uncertainty factor shall be\napplied unless justified with supporting evidence[97]to[99].\nNOTE\nFor absorbable chemicals, time to Cmax (i.e. highest concentration) in the systemic circulation is\ntypically shorter for oral exposure compared to dermal exposure[100]to[103].\nC.2.2.4.1.2\t Inhalation data to parenteral application or inhalation data to oral application\nFor extrapolation from inhalation to parenteral routes, a default 10-fold uncertainty factor shall be\nused unless otherwise justified with supporting evidence.\nLower or higher uncertainty factors can be applied when the extent of absorption is known. For volatile\nand semi-volatile organic constituents, the rate of absorption can be higher than for non-volatile organic\nconstituents and metals. For extrapolation from inhalation to oral routes, an uncertainty factor of 1 can\nbe applied, since lower thresholds derived for inhalation compared to the oral route are due to the lack\nof a first-pass effect in inhalation studies[104].\nC.2.2.4.1.3\t Oral data to parenteral application\nOral bioavailability UFs adjust the quantity of constituent in the gastrointestinal tract that is absorbed.\nWhen extrapolating an oral POD of a constituent to parenteral exposure route (e.g. intravenous) based\non its bioavailability, the impact of pre-systemic metabolism on the systemic dose and nature of harm\n(e.g. an ingested constituent that is metabolized by the liver to lesser toxic products) shall be justified\nand documented.\nWhen a POD from an oral toxicity study is extrapolated to parenteral exposure routes (e.g. intravenous),\nthe following uncertainty factors based on oral bioavailability data (if available) can be used[105]:\n\u2014\t UF(TI)n\u00a0=\u00a0100 if oral bioavailability is\u00a0<1\u00a0%,\n\u2014\t UF(TI)n\u00a0=\u00a010 if oral bioavailability is\u00a0\u22651\u00a0% and\u00a0<50\u00a0%,\n\u2014\t UF(TI)n\u00a0=\u00a02 if oral bioavailability is\u00a0\u226550\u00a0% and\u00a0<90\u00a0%, or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n35\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t UF(TI)n\u00a0=\u00a01 if oral bioavailability is\u00a0\u226590\u00a0%.\nAlternatively, an oral POD can be extrapolated by multiplying by the percent of oral bioavailability.\nWhen a range of oral bioavailability data are reported, the lower limit shall be used.\nExtrapolation of a POD from an oral toxicity study to parenteral exposure routes based on the above oral\nbioavailability UF or percent oral bioavailability shall be justified with supporting oral bioavailability\ndata.\nIf oral bioavailability is not known, a default value of 10 can be used[106]to[108].\nC.2.2.4.2\nExposure duration\nWhen short-term repeat exposure studies are used for extrapolation to longer-term exposures, time-\ndependent toxicities, or accumulation of the constituent in the body can occur. For extrapolation from\na subchronic study to chronic exposure, a default sixfold uncertainty factor shall be applied unless\notherwise justified with supporting evidence.\nFor extrapolation from subacute studies to chronic exposure, a default 10-fold uncertainty factor shall\nbe applied unless otherwise justified with supporting evidence.\nAn uncertainty factor of 10 should be applied when the dose-response curve is shallow or unknown.\nNOTE\nIn general, a shallow dose-response curve applies when the magnitude of the harm is only slightly\nhigher at a higher dose compared to the same harm that occurs at a lower dose of the same constituent. A BMDL\nvalue near the origin of the dose-response curve indicates the dose-response curve is shallow.\nHigher uncertainty factors may be considered when toxicity increases over time and constituents\naccumulate in the body[88][89][94][109][110][111][112][113].\nC.2.2.4.3\nPoint of departure, data applicability and data quality\nUncertainty in the applicability of toxicological data from an analogue should also be considered. The\nmagnitude of this UF should account for the extent of structural and biological similarity between\nthe analogue and the extracted compound of interest. When accounting for the quality of constituent\nspecific or analogue toxicological data used to derive the TI, for studies judged to be well designed\nfor their intended purposes and executed properly, a default uncertainty factor of 1 can be selected.\nA default 10-fold uncertainty factor shall be applied when the selected POD is obtained from a\ntoxicological study with reduced reliability or relevance[114][115].\nExamples of when a 10-fold default UF for data quality or relevance can be applied include:\n\u2014\t to account for the absence of clinically relevant toxicity data pertaining to the patient population\n(e.g. reproductive or developmental toxicity for a device used in pregnant women), or\n\u2014\t when the POD is obtained from an underpowered study (low numbers of animals or only in one sex)\nor limited number of organs collected for evaluating potential harm.\nC.2.3\t Determination of the modifying factor\nThe modifying factor shall be calculated as the product of all uncertainty factors identified in\naccordance with C.2.2.2 to C.2.2.4, as shown in Formula\u00a0(C.1).\nMF\u00a0=\u00a0UF(TI)1 \u00d7 UF(TI)2 \u00d7 UF(TI)n\n(C.1)\nwhere MF is the modifying factor.\nThe application of a large MF (e.g.\u00a0>10\u00a0000 for the general population) can overestimate a toxicological\nrisk. In these cases, toxicological risk shall be assessed by applying TTC in accordance with 7.2, or\nfurther analyse or control the toxicological risk, see 10.2.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n36\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.2.4\t Derivation of the non-cancer TI value\nAfter the POD (NOAEL, LOAEL, etc.) and the modifying factor are determined, the TI shall be calculated\nin amount (mg or \u00b5g) per kilogram body mass per day, as shown in Formula\u00a0(C.2).\nTI\u00a0=\u00a0POD\u00a0/\u00a0MF\n(C.2)\nC.3\t Setting of TI for cancer endpoints\nC.3.1\t General\nWhen human data are inadequate, the determination that a constituent can be a suspected human\ncarcinogen shall be based on the weight of evidence. Types of data used in weight of evidence include:\n\u2014\t carcinogenicity data from long-term in vivo animal studies (e.g. pre-neoplastic lesions or tumour\nfindings in animal studies);\n\u2014\t mechanistic data (e.g. genotoxicity or other modes of action involving other key characteristics).\nFor constituents that are not human carcinogens or suspected human carcinogens, the approach in\nClause\u00a07 shall be applied.\nNOTE\u00a01\nMechanistic data can be useful in a weight of evidence assessment to establish whether cancer can be\nassociated with a specified exposure dose (e.g. non-linear)[116][117][118].\nNOTE\u00a02\nKey characteristics include chemical properties and biological activities that are important elements\nof the constituent\u2019s carcinogenic mode of action. Reported key characteristics include\na)\nelectrophilic or metabolically activated,\nb)\ngenotoxic,\nc)\nalters DNA repair or makes the genome unstable,\nd)\ninduces of epigenetic changes,\ne)\ninduces oxidative stress,\nf)\ninduces chronic inflammation,\ng)\nimmunosuppressive,\nh)\nmodulates receptor-mediated effects,\ni)\ncauses cell immortalization, and\nj)\ncauses cellular proliferation or cell death, or impairs the supply of nutrients[119].\nC.3.2\t Cancer risk estimation\nC.3.2.1\nGeneral\nWhen a chemical constituent is a human carcinogen or suspected human carcinogen, cancer risk\nshall assess whether an exposure to a human carcinogen or suspected human carcinogen dose is at a\ntolerable cancer risk level.\nWhen the constituent TI is based on a cancer risk estimate, the MoS calculation shall apply a cancer risk\nthreshold that is protective for a lifetime of exposure (e.g. 70\u00a0years), unless otherwise justified.\nOther approaches used to evaluate the cancer risk of a constituent shall be justified and documented.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n37\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.3.2.2\nSlope-factor approach\nCancer risk can be estimated based on a constituent specific slope factor (if available). The slope factor,\nwhich is used to calculate [see Formula\u00a0(C.3)] the dose that corresponds to a default lifetime cancer\nrisk level of 1 in 100\u00a0000 (i.e. cancer risk specific dose), shall be used as the TI value for cancer, unless\notherwise justified with supporting evidence[120].\nCRSD\u00a0=\u00a0CRL\u00a0/\u00a0SlF\n(C.3)\nwhere\n\nCRSD is the cancer risk specific dose, in mg/kg/d;\n\nCRL\nis the cancer risk level;\n\nSlF\nis the slope factor, in (mg/kg/d)\u22121.\nNOTE\nApplication of a slope factor means the dose-response relationship at low doses is linear (i.e. non-\nthreshold mode of action). When a slope factor is used to estimate cancer risk, additional uncertainty factors are\nnot applied to derive the cancer risk specific dose.\nEXAMPLE\nThe lifetime oral cancer risk specific dose for benzene is:\n\u2014\t SlF\u00a0=\u00a00,015 (mg/kg/d)\u22121[121];\n\u2014\t CRL\u00a0=\u00a01 in 100\u00a0000 (i.e. 1 \u00d7 10\u22125);\n\u2014\t CRSD\u00a0=\u00a01 \u00d7 10\u22125\u00a0/\u00a00,015\u00a0=\u00a06,667 \u00d7 10\u22124\u00a0mg/kg/d.\nC.3.2.3\nTD50 approach\nWhen a slope factor for a human carcinogen or suspected human carcinogen is not available, an\nalternative cancer risk approach can be based on a constituent specific TD50 value (if available) as\nshown in Formula\u00a0(C.4)[74].\nCRSD\u00a0=\u00a0TD50\u00a0/\u00a050\u00a0000\n(C.4)\nwhere\n\nTD50\nis the daily dose-rate, in \u00b5g/kg body mass/d, for life, to induce tumours in half of test animals\nthat would have remained tumour-free at zero dose;\n\n50\u00a0000\nis an assumed value for estimating lifetime cancer risk level of 1 in 100\u00a0000.\nNOTE\nWhen a TD50 is used to estimate cancer risk, additional uncertainty factors are not applied to derive\nthe cancer risk specific dose.\nOther approaches used to evaluate cancer risk of a constituent shall be justified and documented.\nC.4\t Establishment of tolerable contact levels\nC.4.1\t General\nA review of constituent irritation data provides the information necessary to decide whether estimation\nof the irritation risk needs to be assessed according to this document. If constituent specific irritation\ninformation is available and applicable to the intended use of the medical device, a modifying-factor\napproach can be used to derive a constituent specific TCL that represents acceptable irritation risk[19]\n[20][84][91][103].\nNOTE\nTCLs are considered in addition to tolerable intakes unless justified and documented.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n38\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThis approach is not intended for the derivation of TCL values based on allergic contact dermatitis or\nlocal effects, except for irritation in anatomically or pharmacokinetically isolated organs (e.g. brain,\neye).\nC.4.2\t Setting of TCL for the irritation endpoint\nFor each relevant contact tissue, a TCL shall be calculated from the NIL.\nEach TCL calculation shall consider the degree of irritation from increasing concentrations of non-\nirritating doses whenever these data are available.\nA modifying-factor approach shall be used to calculate the TCL. This approach incorporates the use of a\nmodifying factor as described in C.4.4. Formula\u00a0(C.5) calculates the TCL, in \u00b5g/cm2, using the modifying-\nfactor approach.\nTCL =\u00a0NIL\u00a0/\u00a0MFTCL\n(C.5)\nwhere\n\nNIL\nis the non-irritating level from the study where the threshold was experimentally identified\nand reported, in \u00b5g/cm2;\n\nMFTCL\nis the modifying factor.\nNOTE\nWhen a NIL is absent, a MIL can be used, see C.4.3.4.\nIrritation limits should be established based upon the broadest segment of exposed individuals. When\nthe TCL is intended for specific subpopulations, the applicable data (e.g. clinical data) should be used for\nthe specific individuals for which the device is intended.\nC.4.3\t Determination of TCL uncertainty factors\nC.4.3.1\nGeneral\nThe methods used to determine the biological risk of irritation are different from those used to\ndetermine the biological risk of systemic toxicity. The chief difference is the degree of uncertainty.\nNormally, when irritation is not observed in an appropriate test model, irritation is less probable for\nhumans. Hence, there is a more limited use of multiple uncertainty factors and large margins of safety.\nNevertheless, the choice of uncertainty factors should encompass several considerations described in\nC.4.3.2, C.4.3.3 and C.4.3.4.\nC.4.3.2\nUncertainty for intraspecies variation, UF(TCL)1\nUncertainty among humans shall be addressed when deriving a TCL value. It is always preferable to\nhave actual data to assess human variation.\nIn the absence of experimental data to characterize individual variability in human response to an\nirritating leachable substance, a default 10-fold uncertainty factor, UF(TCL)1, shall be applied, unless\notherwise justified with supporting evidence. For example, other uncertainty factors, UF(TCL)1, ranging\nfrom 3 to 9 can be used if justified when the MIL or NIL is based on animal studies.\nC.4.3.3\nUncertainty for interspecies differences, UF(TCL)2\nUncertainty resulting from inherent differences between other species and humans shall be addressed.\nIt is always preferable to have data and detailed knowledge of the relationship between humans and\nthe test species.\nIn the absence of such information, a default 10-fold uncertainty factor, UF(TCL)2, shall be used unless\notherwise justified with supporting evidence.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n39\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.4.3.4\nUncertainty from the quality and relevance of experimental data, UF(TCL)n\nUncertainty resulting from the quality and relevance of the experimental data shall be addressed.\nWhen a MIL is used, a default threefold uncertainty factor, UF(TCL)n, shall be applied unless otherwise\njustified with supporting evidence.\nA UF of 9 shall be applied when conclusions are drawn based upon a poorly designed or executed study,\nor when the amount of relevant constituent specific irritation data is limited.\nC.4.4\t Determination of the TCL modifying factor\nThe TCL modifying factor, MFTCL, shall be calculated as a product of the uncertainty from C.4.3 as given\nin Formula\u00a0(C.6).\nMFTCL = UF(TCL)1 \u00d7 UF(TCL)2 \u00d7 UF(TCL)n\n(C.6)\nFormula\u00a0(C.5) shall serve as the basis for the TCL. In most cases, an overall modifying factor of 30 or less\nshould be sufficient but can be larger when non-irritating concentrations have not been established.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n40\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0D\n(informative)\n\nTypical assumptions for biological parameters\nD.1\t General\nThis annex provides parameters for use in assessing risk. It specifies the lifespan, daily intake of water,\ndaily intake of air, body mass and gestation period for the human, rat, mouse, hamster, guinea pig, dog\nand rabbit. These are the most common species for which data are available. This data can serve as\nthe basis for interspecies comparisons unless other data can be shown to be more appropriate. Actual\nspecies data vary somewhat in the real world.\nD.2\t Assumptions\nD.2.1\t Human\nThe parameters for humans:\n\u2014\t 70-year lifespan;\n\u2014\t 2\u00a0l/d intake of drinking water;\n\u2014\t 20\u00a0m3/24\u00a0h day air intake (adult); 10\u00a0m3/d in 8\u00a0h workday (adult)[122];\n\u2014\t 70\u00a0kg body mass for adult men; 60\u00a0kg for adult women, which is also representative of all adults in a\nworst-case assumption;\n\u2014\t 10\u00a0kg for children (>1\u00a0year to\u00a0\u226416\u00a0years of age); 3,5\u00a0kg for infants (<1\u00a0year); 1,5\u00a0kg for very low\nbirthweight infants; or 0,5\u00a0kg for very low birthweight neonates (e.g. preterm neonate);\n\u2014\t 9-month (normally 40\u00a0weeks) gestation period;\n\u2014\t 5\u00a0l blood volume (adult).\nNOTE\u00a01\nBody mass of 70\u00a0 kg and 60\u00a0 kg for an adult male, and adult female or unisex, respectively, are\nconservative for exposure dose estimation because these values are below the average for these sex-based\ngroups (e.g. a medical device use that is intended for all adults)[123]. A body mass of 50\u00a0kg, or lower, for adults\ncan be used when a more conservative approach is judged to be necessary (e.g. patients with below average body\nmass, such as: individuals of low stature or malnutrition due to an eating disorder, cancer or AIDS).\nNOTE\u00a02\nWhen the medical devices intended use is for a wide range of general patients, the use of infant body\nmass (3,5\u00a0kg) is sufficiently conservative to calculate the EEDmax for infants and the general population. When\nthe medical device intended to use is for low birthweight neonates, the use of 0,5\u00a0kg is sufficiently conservative\nto calculate the EEDmax for this subpopulation.\nD.2.2\t Rat\nThe parameters for rats are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,025\u00a0l/d of drinking water for males; 0,020\u00a0l/d for females;\n\u2014\t 0,29\u00a0m3/24\u00a0h day air intake;\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n41\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t 0,25\u00a0kg or 0,5\u00a0kg body mass for young and older adult males, respectively; 0,2\u00a0kg or 0,35\u00a0kg for\nyoung and older adult females, respectively[124];\n\u2014\t 22\u00a0d gestation period.\nD.2.3\t Mouse\nThe parameters for mice are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,005\u00a0l/d of drinking water;\n\u2014\t 0,043\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,03\u00a0kg body mass for adult males, 0,025\u00a0kg for adult females;\n\u2014\t 20\u00a0d gestation period.\nD.2.4\t Hamster\nThe parameters for hamsters are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,015\u00a0l/d of drinking water;\n\u2014\t 0,086\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,125\u00a0kg body mass for adult males; 0,110\u00a0kg for adult females;\n\u2014\t 15\u00a0d gestation period.\nD.2.5\t Guinea pig\nThe parameters for guinea pigs are:\n\u2014\t 3-year lifespan;\n\u2014\t 0,085\u00a0l/d of drinking water;\n\u2014\t 0,43\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,5\u00a0kg body mass;\n\u2014\t 68\u00a0d gestation period.\nD.2.6\t Dog\nThe parameters for dogs are:\n\u2014\t 11-year lifespan;\n\u2014\t 0,5\u00a0l/d of drinking water;\n\u2014\t 7,5\u00a0m3/24\u00a0h day air intake;\n\u2014\t 16\u00a0kg body mass;\n\u2014\t 63\u00a0d gestation period.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n42\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nD.2.7\t Rabbit\nThe parameters for rabbits are:\n\u2014\t 7-year lifespan;\n\u2014\t 0,33\u00a0l/d drinking water;\n\u2014\t 1,44\u00a0m3/24\u00a0h day air intake;\n\u2014\t 3\u00a0kg body mass;\n\u2014\t 31\u00a0d gestation period.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n43\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0E\n(normative)\n\nEstimation of an exposure dose\nE.1\t General\nA worst-case estimated exposure dose, EEDmax, for each reportable constitutent shall be estimated in\naccordance with this annex, based on ISO\u00a010993-18 constituent data, unless otherwise justified with\nsupporting evidence.\nNOTE\u00a01\nInformation gathering of constituents intentionally used in the manufacture of the medical device or\nits materials of construction can be used to represent the total quantity of a constituent present in, on or can be\nextracted from the medical device. Exaggerated, exhaustive or simulated-use extractions that are conservative\nrelative to the medical device intended use can be assumed to represent a total quantity that can be extracted.\nSimulated-use extraction or leachable studies, during which data are collected at multiple time-points, can\nprovide (when appropriately justified) release kinetics information for limited, prolonged or long-term contact\nmedical devices.\nNOTE\u00a02\nISO\u00a010993-18 describes approaches for obtaining constituent exposure information, which includes\nwhen to consider conducting a simulated-use, leachable or other type of extraction study.\nNOTE\u00a03\nConstituent information from the literature can be used for exposure dose estimation when\nappropriately justified, see ISO 10993-18:2020, 5.2.2.\nNOTE\u00a04\nThe quantity of a constituent extracted from a medical device and suitable for calculating a worst-\ncase estimated exposure dose is dependent on extraction and analytical parameters, such as the number of\nmedical devices used as the test article, the method used in the preparation of the test article, the solvent(s) type\nand volume, the temperature, the duration of extraction, the number of extraction cycles (if applicable) and the\nreference standard used for quantification[23].\nWhen calculating a worst-case estimated exposure dose of a medical device constituent, the following\ncriteria shall be applied.\na)\t When TSL is not used, worst-case estimated exposure doses shall be estimated for the following\ntime periods and medical device contact categories, unless otherwise justified:\n\u2014\t <1\u00a0d for limited, prolonged and long-term contacting medical devices,\n\u2014\t 2\u00a0d to 30\u00a0d for prolonged and long-term contacting medical devices,\n\u2014\t 31\u00a0d to 365\u00a0d for long-term contacting medical devices that contact the body for\u00a0<1 year, and\n\u2014\t >366\u00a0d for long-term contacting medical devices that contact the body for\u00a0>1 year.\nb)\t When TSL is used in accordance with 6.2.1 and the total quantity of a chemical constituent that\nis present or can be extracted from medical device exceeds the TSL\u226430\u00a0d value but is less than the\nTSL>30\u00a0d value, then a worst-case estimated exposure dose shall be estimated for the following time\nperiods and applicable medical device contact categories, unless otherwise justified:\n\u2014\t <1\u00a0d for limited, prolonged or long-term contacting medical devices, and\n\u2014\t 2\u00a0d to 30\u00a0d for prolonged or long-term contacting medical devices.\nc)\nWhen TSL is used in accordance with 6.2.1 and the total quantity of a chemical constituent that is\npresent or can be extracted from a long-term contacting medical device is above the TSL>30 d value,\nthen the worst-case estimated exposure dose shall be estimated for all four time periods, unless\notherwise justified.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n44\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nWhen two or more constituents elicit the same harm at the same target organ or system and have\nthe same TI, the individual estimated exposure doses for each of the applicable constituents shall be\nsummed.\nE.2\t Exposure dose estimation based on release kinetics information\nExposure dose estimation based on release kinetics information shall be applied to identified\nconstituents using a reference standard suitable for accurate quantification and targeted chemical\nanalysis.\nWhen the medical device is categorized as limited contact with the body, or release kinetics data are\navailable for a prolonged or long-term contact medical device, the exposure dose shall be calculated\nusing Formula\u00a0(E.1).\nEEDmax\u00a0=\u00a0(HQr.k. \u00d7 SFr.k.)\u00a0/\u00a0BWL\n(E.1)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nHQr.k.\nis the highest measured quantity, in \u00b5g/d, released in a day during a release kinetics study\nthat includes data collection for the time periods from Table\u00a0E.1;\n\nSFr.k.\nis the ratio of the number or quantity (in cm2, g or ml) of medical devices that are in contact\nwith the body divided by the number or quantity of medical devices used in the extraction\nstudy;\n\nBWL\nis the lowest body mass, in kg, of an individual in contact with the medical device.\nWhen the number of medical devices that contacts the body differs from the number of medical device(s)\nused in the release-kinetics study, the reported HQr.k. does not represent the worst-case estimated\nexposure dose. To account for the difference between medical device intended use and the release\nkinetics study, the reported HQr.k. of each constituent assessed shall be adjusted by the application of a\nscaling factor, SFr.k., using Formula\u00a0(E.2).\nWhen the number of medical devices does not apply (e.g. the largest surface area of device which can\nbe in contact with the body is not the same as the surface area of the device which is in contact with\nthe solution during extraction), the maximum quantity (in cm2, g or ml) of the medical device that is in\ncontact with the body and the quantity of the medical device used in the extraction study shall be used\nto calculate the SFr.k. using Formula\u00a0(E.2).\nSFr.k.\u00a0=\u00a0MDb.c. / MDr.k.s\n(E.2)\nwhere\n\nMDb.c.\nis the maximum number or quantity (in cm2, g or ml) of medical devices that are simulta\u00ad\nneously in contact with the body;\n\nMDr.k.s.\nis the number or quantity of medical devices used in the release kinetic study.\nWhen the quantity of the medical device used varies, the worst-case (highest) SFr.k. to BWL ratio shall\nbe used, unless otherwise justified with supporting evidence.\nThe selection of specific time periods used for HQr.k. evaluation shall be documented and justified with\nthe medical device category and applicable time periods in accordance with Table\u00a0E.1, unless otherwise\njustified with supporting evidence. Selection of specific days for analysis within a Table\u00a0E.1 time period\nshould consider the constituent\u2019s expected rate of release, duration of release and quantity extracted at\neach time point [i.e. above or below a TCL, TI, TTC (if applicable) or analytical limit (if applicable)].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n45\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.1\u00a0\u2014 Selection of time periods for the evaluation of HQr.k.\nMedical device category\nTime period for obtaining release kinetics data\n\u22641\u00a0d\n2\u00a0d to 30\u00a0d\n31\u00a0d to 365\u00a0d\n\u2265366\u00a0d\nLimited (\u22641\u00a0d)\nX\nNot applicable\nNot applicable\nNot applicable\nProlonged (2\u00a0d to 30\u00a0d)\nX\nX\nNot applicable\nNot applicable\nLong-term (31\u00a0d\u00a0to\u00a0365\u00a0d)\nX\nX\nX\nNot applicable\nLong-term (\u2265366\u00a0d)\nX\nX\nX\nX\nX indicates that release data is required, or a justification for excluding it, for this medical device category and time period.\nNOTE\u00a01\nExpected rate and duration of release can be based on the constituent\u2019s physicochemical\ncharacteristics (e.g. solubility, polarity, lipophilicity, and molecular weight), feasibility of release (e.g. diffusivity\nof an additive embedded in the medical device versus impurity present on device surface), temperature and TQ\nwhen such data are available.\nThe number of time points within an exposure period shall be sufficient to address late bolus release of\nthe constituent(s), unless justified with supporting evidence that late bolus release will not occur.\nNOTE\u00a02\nLate bolus release of a chemical constituent is the release of a higher quantity after the initial or\nsteady-state release. For example, late bolus release of a chemical constituent can occur when the medical device\ndegrades (e.g. wear/corrosion of a material of construction) over multiple days (e.g. prolonged or long-term).\nWhen the HQ of a constituent is obtained by extraction and quantification methods that are conservative\nrelative to the medical device intended use, the HQ of each constituent may be assumed to be adequate\nto calculate a worst-case estimated exposure dose, EEDmax.\nWhen the HQ of a reportable constituent does not represent the highest measured quantity released in\na day based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed by other means according to ISO 10993-1 and ISO 14971.\nEXAMPLES 1 and 2 give exposure dose estimation based on release kinetics information.\nEXAMPLE 1\nConstituent release is quantified for multiple days (i.e. same device is repeatedly extracted for\n24\u00a0h using fresh solvent). The medical device intended use information includes the following:\n\u2014\t externally communicating and prolonged contact;\n\u2014\t body contact is daily for 25\u00a0d;\n\u2014\t a single medical device is in contact with the body of a patient;\n\u2014\t the test article extracted is a single final medical device of largest configuration;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t SFr.k.\u00a0=\u00a01 (i.e. 1 device is used per patient and 1 device was used in the extract).\nThe quantities extracted each day and calculated daily worst-case exposures, per Formula\u00a0(E.1), are presented in\nTable\u00a0E.2.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n46\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.2\u00a0\u2014 Clause E.2, EXAMPLE 1 \u2014 EEDmax values for a constituent per Formula\u00a0(E.1)\nTime period\nd\nExtraction\nday\nHQr.k.\n\u00b5g\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.1)\n\u22641\n1\n12\u00a0000\n200\n200\u00a0\u00b5g/kg/d\u00a0=\u00a0(12\u00a0000\u00a0\u00d7\u00a01)\u00a0/\u00a060\n2\u00a0to 25\n2\n1\u00a0500\n25\n25\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0500\u00a0\u00d7\u00a01)\u00a0/\u00a060\n3\n200\n3,3\n3,3\u00a0\u00b5g/kg/d\u00a0=\u00a0(200\u00a0\u00d7\u00a01)\u00a0/\u00a060\n4\n<LOD\nNot applicable\nNot applicable\nExtraction duration\u00a0is\u00a024\u00a0h at 37\u00a0\u00b0C.\nSFr.k.\u00a0=\u00a01\nBWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 200\u00a0\u00b5g/kg/d and 25\u00a0\u00b5g/kg/d (i.e. highest in each time period) are used to assess\ntoxicological risk of the constituent for the two time periods (i.e.\u00a0\u22641\u00a0d and 2\u00a0d to 25\u00a0d, respectively).\nEXAMPLE 2\nConstituent release is quantified for multiple days (i.e. same device is repeatedly extracted for\n24\u00a0h using fresh solvent). Device intended use information is the following:\n\u2014\t externally communicating and prolonged contact;\n\u2014\t body contact is daily for 10\u00a0d (maximum);\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t up to 5 devices are in contact with the body of a patient;\n\u2014\t the medical device configuration with the largest surface area is 150\u00a0cm2;\n\u2014\t the test article extracted is representative of the final device with a surface area of 100\u00a0cm2;\n\u2014\t SFr.k. is 7,5 (i.e. 5\u00a0\u00d7\u00a0150\u00a0cm2\u00a0/\u00a0100\u00a0cm2).\nThe quantities extracted each day and calculated daily worst-case exposures, per Formula\u00a0(E.1), are presented in\nTable\u00a0E.3.\nTable\u00a0E.3\u00a0\u2014 Clause E.2, EXAMPLE 2 \u2014 EEDmax values for a constituent per Formula\u00a0(E.1)\nTime period\nd\nExtraction\nday\nHQr.k.\n\u00b5g\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.1)\n\u22641\n1\n12\u00a0000\n1\u00a0500\n1\u00a0500\u00a0\u00b5g/kg/d\u00a0=\u00a0(12\u00a0000\u00a0\u00d7 7,5) / 60\n2 to 10\n\n2\n1\u00a0500\n187\n187\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0500 \u00d7 7,5) / 60\n3\n500\n62,5\n62,5\u00a0\u00b5g/kg/d\u00a0=\u00a0(500 \u00d7 7,5) / 60\n4\n200\n25\n25\u00a0\u00b5g/kg/d\u00a0=\u00a0(200 \u00d7 7,5) / 60\n5\n<LOD\nNot applicable\nNot applicable\nExtraction duration\u00a0is\u00a024\u00a0h at 37\u00a0\u00b0C.\nSFr.k.\u00a0=\u00a07,5\nBWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 1\u00a0500\u00a0\u00b5g/kg/d and 187\u00a0\u00b5g/kg/d are used to assess toxicological risk for the two time\nperiods (i.e.\u00a0\u22641\u00a0d and 2\u00a0d to 10\u00a0d, respectively).\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n47\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nE.3\t Worst-case exposure dose estimation based on maximum release\nE.3.1\t General\nWhen the medical device contact is categorized as prolonged or long-term contact and release\nkinetics data are not available, the exposure dose can be calculated using Formula\u00a0(E.3). For limited\ncontact medical devices, calculation of the worst-case estimated exposure dose shall be performed in\naccordance with Clause E.2.\nEEDmax\u00a0=\u00a0(TQ \u00d7 SFa.r.)\u00a0/\u00a0BWL\u00a0/\u00a0Rd\n(E.3)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nTQ\nis the total quantity, in \u00b5g, present in or on, or extracted from the medical device (e.g. from\nan exaggerated or exhaustive extraction study);\n\nSFa.r.\nis the scaling factor applied when the assumed release is used;\n\nBWL\nis the lowest body mass, in kg, of an individual in contact with the medical device;\n\nRd\nis the assumed release duration, in d, (i.e. lowest number of medical device exposure days),\nconsidering the ISO\u00a010993-1 exposure category applicable to the medical device.\nAssumed (i.e. default) release durations, Rd, shall be applied based on the shortest duration of\nconstituent exposure of each period of assumed exposure as presented in Table\u00a0E.4, unless otherwise\njustified with supporting evidence.\nTable\u00a0E.4\u00a0\u2014 Selection of default Rd values\nMedical device contact\nduration category\nRd for each time period of assumed constituent exposure\nd\n\u22641\u00a0d\n2\u00a0d\u00a0to\u00a030\u00a0d\n31\u00a0d\u00a0to\u00a0365\u00a0d\n\u2265366\u00a0d\nProlonged (\u226430\u00a0d)\n1\n2\nNot applicable\nNot applicable\nLong-term (31\u00a0d\u00a0to\u00a0365\u00a0d)\n1\n2\n31\nNot applicable\nLong-term (\u2265366\u00a0d)\n1\n2\n31\n366\nRd value indicates when it is used to calculate a worst-case estimated exposure dose unless otherwise justified.\nNOTE\u00a01\nConservatively, chronic exposure for humans ranges from 365\u00a0d to a lifetime.\nNOTE\u00a02\nSelecting the fewest number of days that the medical device contacts the body in each medical device\ncontact category is a conservative approach for exposure dose estimation.\nWhen the number of medical devices that contacts the body differs from the number of medical\ndevice(s) used in the extraction study, then the reported TQa.r. will not represent the worst-case\nestimated exposure dose. To account for the difference between medical device intended use and the\nextraction study, the reported TQa.r. of each constituent assessed shall be adjusted by application of a\nscaling factor, SFa.r., using Formula\u00a0(E.4).\nWhen the number of medical devices does not apply (e.g. the largest surface area of device which can\nbe in contact with the body is not the same as the surface area of the device which is in contact with the\nsolution during extraction), the maximum quantity (in cm2, g, or ml) of the medical device that contacts\nthe body and the quantity of the medical device used in the extraction study shall be used to calculate\nthe SFa.r.\nSFa.r.\u00a0=\u00a0MDb.c. / MDa.r.s\n(E.4)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n48\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\nMDb.c.\nis the maximum number or quantity (in cm2, g, or ml) of medical devices that simultane\u00ad\nously contact the body;\n\nMDa.r.s.\nis the number or quantity of medical devices used in the extraction study.\nWhen the TQ of a constituent is obtained by extraction and quantification methods that are conservative\nrelative to the medical device intended use, the TQ of each reportable constituent may be assumed to\nrepresent a cumulative exposure dose and adequate for calculating a worst-case estimated exposure\ndose, EEDmax.\nWhen the TQ of a reportable constituent that can be extracted does not represent a cumulative exposure\ndose based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed by other means according to ISO 10993-1 and ISO 14971.\nFor single-use (disposable) medical devices where the cumulative exposure duration can exceed 30\u00a0d,\nthe default Rd value in Table\u00a0E.4 that applies to the contact duration of a new single-use medical device\nshall be used for each time period of assumed constituent exposure greater than 1\u00a0d, unless otherwise\njustified with supporting exposure information (i.e. the design of the extraction study and the worst-\ncase exposure scenario), see EXAMPLES 2, 3, and 4.\nNOTE\u00a03\nThe toxicological risk of a medical device constituent can be underestimated when an Rd higher than\n2 is used for a repeatedly used single-use (disposable) limited or prolonged contacting medical device where the\ncumulative exposure duration can exceed 30\u00a0d.\nWhen the size or the quantity of the medical devices used varies depends on individual size, the worst-\ncase (highest) SFa.r. to BWL ratio should be used.\nEXAMPLE 1 to 4 give the exposure dose estimation based on the assumed maximum release.\nEXAMPLE 1\nConstituent TQ is obtained from formulation and manufacturing process data or by exhaustively\nextracting the medical device using analytically expedient solvents. The medical device intended use information\nincludes the following:\n\u2014\t implanted, tissue or bone, and long-term contact;\n\u2014\t body contact is daily for more than 10\u00a0years;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t up to 2 medical devices can be implanted during a patient\u2019s life;\n\u2014\t the medical device configuration with the largest surface area is 150\u00a0cm2;\n\u2014\t the test article extracted is representative of the final device with a surface area of 100\u00a0cm2;\n\u2014\t SFa.r. . is 3 (i.e. 3\u00a0=\u00a02\u00a0\u00d7\u00a0150\u00a0/\u00a0100);\n\u2014\t TQ present or extracted is 10\u00a0000\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.5.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n49\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.5\u00a0\u2014 Clause E.3, EXAMPLE 1 \u2014 EEDmax values per Formula\u00a0(E.3) for long-term tissue/\nbone implant\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n10\u00a0000\n1\n500\n500\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060/\u00a01\n2\u00a0to\u00a030\n10\u00a0000\n2\n250\n250\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n10\u00a0000\n31\n16\n16\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a031\n\u2265366\n10\u00a0000\n366\n1,4\n1,4\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a0366\nSFa.r.\u00a0=\u00a03\nThe EEDmax values of 500\u00a0\u00b5g/kg/d, 250\u00a0\u00b5g/kg/d, 16\u00a0\u00b5g/kg/d, and 1,4\u00a0\u00b5g/kg/d are used to assess toxicological\nrisk for each time period, respectively, of assumed constituent exposure.\nEXAMPLE 2\nConstituent TQ is obtained from formulation and manufacturing process data or by exaggerated\nextraction of five single-use (disposable) medical devices using analytically expedient solvents. The medical\ndevice intended use information includes the following:\n\u2014\t body contact is in a breached or compromised surface;\n\u2014\t body contact duration of a new medical device is limited (\u226424\u00a0h);\n\u2014\t cumulative exposure duration from repeat use is more than 30 days (i.e. long-term);\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t five new medical devices are used each day;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 5, is equal to the number of medical devices that are\nin contact with the body, 5);\n\u2014\t TQ of a constituent present or extracted from the five medical devices is 900\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.6.\nTable\u00a0E.6\u00a0\u2014 Clause E.3, EXAMPLE\u00a02 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 24\u00a0h\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n2 to\u00a030\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n31\u00a0to\u00a0365\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n\u2265366\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\nExaggerated extraction at 50\u00a0\u00b0C; SFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 15\u00a0\u00b5g/kg/d, 15\u00a0\u00b5g/kg/d, 15\u00a0\u00b5g/kg/d and 15\u00a0\u00b5g/kg/d are used to assess the toxicological\nrisk of the constituent for each time period, respectively, of assumed constituent exposure.\nEXAMPLE 3\nConstituent TQ is obtained from formulation and manufacturing process data or by exaggerated\nextraction of the medical device using analytically expedient solvents. The medical device intended use\ninformation includes the following:\n\u2014\t single-use (disposable) medical device in a breached or compromised surface;\n\u2014\t contact duration of a new medical device is 3\u00a0d;\n\u2014\t cumulative exposure duration from repeat use is more than 30\u00a0days (i.e. long-term);\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n50\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t 1 new medical device is used per procedure;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 1, is equal to the number of medical devices that are\nin contact with the body, 1);\n\u2014\t TQ of a constituent present or extracted is 1\u00a0200\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.7.\nTable\u00a0E.7\u00a0\u2014 Clause E.3, EXAMPLE 3 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 3\u00a0d\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n1\u00a0200\n1\n20\n20\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n2\u00a0to\u00a030\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n\u2265366\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\nExaggerated extraction for 3 d at 50\u00a0\u00b0C; SFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg.\nThe EEDmax values of 20\u00a0\u00b5g/kg/d, 10\u00a0\u00b5g/kg/d, 10\u00a0\u00b5g/kg/d, and 10\u00a0\u00b5g/kg/d are used to assess toxicological risk of\nthe constituent for each of the time periods, respectively, of assumed constituent exposure.\nEXAMPLE 4\nConstituent TQ is obtained from formulation and manufacturing process data or by exhaustive\nextraction of the medical device using analytically expedient solvents. The medical device intended use\ninformation includes the following:\n\u2014\t single-use (disposable) medical device in a breached or compromised surface;\n\u2014\t contact duration of a new medical device is 60\u00a0days (i.e. long-term);\n\u2014\t cumulative exposure duration from repeat use is more than 2\u00a0years;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t 1 new medical device is used per procedure;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 1, is equal to the number of medical devices that are\nin contact with the body, 1);\n\u2014\t TQ of a constituent present or extracted is 10\u00a0400\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ\nrepresents the cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.8.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n51\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.8\u00a0\u2014 Clause E.3, EXAMPLE 4 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 60\u00a0d\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n10\u00a0400\n1\n173\n173\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060 /\u00a01\n2\u00a0to\u00a030\n10\u00a0400\n2\n87\n87\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n10\u00a0400\n31\n5,6\n5,6\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a031\n\u2265366\n10\u00a0400\n31\n5,6\n5,6\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a031\nSFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 173\u00a0 \u00b5g/kg/d, 87\u00a0 \u00b5g/kg/d, 5,6\u00a0 \u00b5g/kg/d and 5,6\u00a0 \u00b5g/kg/d are used to assess\ntoxicological risk of the constituent for each of the time periods, respectively, of assumed constituent\nexposure.\nE.3.2\t Alternative method to calculating an EEDmax based on maximum release\nAn alternative method to calculating an EEDmax is to apply Formula\u00a0(E.3) with a single Rd value of 1\u00a0d,\nregardless of medical device contact category. This worst-case assumption is generally protective;\nhowever, this assumption can result in overestimation of an EEDmax.\nNOTE\nAssuming that the release duration, Rd, is one day regardless of medical device contact category\npresumes the total extractable quantity, TQ, of the constituent is released each day for the entire exposure\nduration. This assumption is more representative of release kinetics when a new medical device is in contact\nwith the body every day for the entire exposure duration. This assumption is generally not representative of\nrelease kinetics for a long-term implant.\nE.4\t Exposure dose estimation of an irritant\nWhen estimating an exposure dose of an irritant, the exposure dose, in \u00b5g/cm2, shall be calculated\nusing Formula\u00a0(E.5).\nEEDmax\u00a0=\u00a0HQi\u00a0/\u00a0SAext\n(E.5)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nHQi\nis the highest quantity, in \u00b5g, of an irritant, i, released during a day when release kinetics\ndata are available or assuming release occurs in one day;\n\nSAext\nis the body contacting surface area, in cm2, of the medical device used in the extraction or\nin the release kinetics study.\nNOTE\nFor more information on the highest quantity based on release kinetics data, see Formula\u00a0 (E.1)\n(e.g.\u00a0HQr.k.).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n52\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0F\n(informative)\n\nReporting of toxicological risk assessment information\nF.1\t General\nToxicological data for each constituent, justifications and methods used in the derivation and evaluation\nof a constituent exposure dose for documenting in the report are summarized in this annex. This\ninformation can facilitate a review process; however, reporting the information specified in this annex\nalone does not establish conformance to all of the requirements in this document.\nF.2 Required justifications\nKey justifications that can be included in the report are summarized in Table\u00a0 F.1. The types of\nrequirements and their applicability are summarized in Table\u00a0F.1.\nTable\u00a0F.1\u00a0\u2014 Summary of justifications to include in the report\nType of requirement and applicability\nSpecific clause\u00a0and subclauses\nWhenever the TRA is conducted\nClause 5 and Clause\u00a011\nWhen to apply 6.2.1, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010\nand Clause\u00a011\n6.1\nHarms other than genotoxicity, cancer, systemic toxicity,\nreproductive or developmental toxicity, or irritation\n6.1\nIdentification of hazardous constituents that are relevant to\nmedical device intended use\n6.2.1 to 6.2.3 and Annex\u00a0A\nApplication of TSL\n6.2.2 and B.1 to B.3\nIdentification of human carcinogen or suspected human\ncarcinogen\n6.2.3\nIdentification and selection of the POD from a constituent\nspecific toxicity study b\n6.2.4\nDerivation of TCL or TI value a,b\n7.1 and Annex C\nApplication of TTC a,b\n7.2\nWhenever the TRA is conducted a,b\nClause\u00a08 and Annex E\nCalculation of constituent MoS b,c\nClause 9\nApplication of acceptance criteria b,c\nClause 10\na\nSee 7.1, 7.2 and Clause 8, when requirements specific to TCL, TI, TTC (if applicable) and EEDmax,\nrespectively, apply.\nb\nRequirement applies when constituent specific harm is relevant and either TSL is not used or constituent\nTQ exceeds TSL.\nc\nToxicological risk evaluation of constituents does not address all applicable medical device risks.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n53\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nF.3 Constituent, medical device use and constituent specific toxicological risk\nassessments\nThe following data can be important to address in the report:\n\u2014\t constituent information:\n\u2014\t constituent name;\n\u2014\t CAS RN;\n\u2014\t InchlKey or SMILES code (i.e. constituent molecular structure);\n\u2014\t TQ extracted, in \u00b5g;\n\u2014\t description of the medical device;\n\u2014\t description of the medical device intended use;\n\u2014\t medical device name;\n\u2014\t part(s) name(s) (if applicable);\n\u2014\t number of devices that contact body;\n\u2014\t frequency and duration of body contact;\n\u2014\t demographics of individual(s) exposed to the device (e.g. age, sex, mass, disease state);\n\u2014\t use of device in infants less than 6 months of age, if applicable;\n\u2014\t constituent specific toxicological data (see Clause\u00a06);\n\u2014\t harm, including type (e.g. genotoxicity, cancer, systemic toxicity, reproductive or developmental\ntoxicity, or irritation), magnitude of the response (e.g. continuous data) and frequency of occurrence\n(e.g. discrete data);\n\u2014\t test specific methodology information:\n\u2014\t test species, strain, sex, age and number;\n\u2014\t route and method;\n\u2014\t vehicle;\n\u2014\t number and range of doses administered;\n\u2014\t POD for the reported critical harm (i.e. harm with the lowest POD where same units and same\nexposure duration apply);\n\u2014\t frequency and duration of dosing;\n\u2014\t information source;\n\u2014\t toxicological screening limit data (see 6.2.2);\n\u2014\t cohort of concern or excluded status;\n\u2014\t comparison of TQ to TSL\u226430 d or TSL>30 d (if used);\n\u2014\t tolerable contact level and tolerable intake data (see Clause\u00a07);\n\u2014\t POD, in \u00b5g/kg/d;\n\u2014\t UF (TI/TCL)1;\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n54\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t UF (TI/TCL)2;\n\u2014\t UF (TI/TCL)n;\n\u2014\t MF;\n\u2014\t TI, in \u00b5g/kg/d;\n\u2014\t TCL, in \u00b5g/cm2;\n\u2014\t exposure dose estimate, EEDmax, data (see Clause\u00a08), in \u00b5g/cm2 or \u00b5g/kg/d, based on\n\u2014\t HQr.k., TQa.r., or HQi (for irritation), see Clauses E.2, E.3 or E.4, respectively,\n\u2014\t SFr.k. or SFa.r., or SAext (for irritation), see Clauses E.2, E.3 or E.4, respectively,\n\u2014\t BWL (kg), see Clauses E.3 or E.4, and\n\u2014\t Rd value if SFa.r. is used (see Clauses E.4 for application of a single or multiple Rd values);\n\u2014\t MoS values (see Clause\u00a09).\nF.4\t Examples of tabulating toxicological risk assessments\nTables\u00a0F.2 to F.9 are examples of how the toxicological risk information can be summarized.\nTable\u00a0F.2\u00a0\u2014 Medical device specific information\nDevice information\nDescription\nDevice name\n\nDevice part(s) with body contact (if applicable)a\nNumber or quantity of devices contacting body\n\nFrequency and duration of body contactb\n\nIndividual(s) exposed to the devicec\n\na\nApplicable when some, but not all, surfaces of the device that contacts the body.\nb\nExamples of frequency are continuous, discontinuous, or single-use (disposable) repeated. Examples of contact\nduration are:\u00a0\u226430 d, >30 d but\u00a0\u2264365 d, or\u00a0>365 d.\nc\nFor example: men (70\u00a0kg), women or unisex (60\u00a0kg or lower), children (>1 year to\u00a0\u226416 years of age; 10\u00a0kg), infants\n(<1\u00a0year; 3,5\u00a0kg) and very low birthweight infants (1,5\u00a0kg), see D.2.1.\nTable\u00a0F.3\u00a0\u2014 TSL information\nConstituent name\nCAS RNa\nTQ extracted\n\u00b5g\nIs constituent\nexcluded from TSLb?\nIs TQ less than\nTSL \u226430 dc?\nIs TQ less than\nTSL\u00a0>30 dc?\nChemical 1\n\n\nY/N\nY/N/NA\nY/N/NA\nChemical 2\n\n\nY/N\nY/N/NA\nY/N/NA\nChemical X\n\n\nY/N\nY/N/NA\nY/N/NA\na\nCAS RN, InchlKey or SMILES code.\nb\nYes (Y) means constituent is a cohort of concern or excluded chemical; No (N) means constituent is not a cohort of\nconcern or excluded chemical.\nc\nYes (Y) means total quantity is too low to present a short-term or long-term toxicological risk (i.e. negligible\ntoxicological risk); No (N) means toxicological risk assessment for short-term, long-term, or both is recommended; Not\napplied (NA) means TSL is not used to assess negligible toxicological risk.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n55\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0F.4\u00a0\u2014 Constituent specific toxicological information\n[Constituent name / chemical abstract service number]\nTest species /\nstrain /sex /\nage / number\nExposure determinants\nToxicological information\nInformation\nsource\nRoutea /\nmethodb\nVehiclec\nFrequency /\ndurationd\nType of harm\nreportede\nType of\nPODf\nPOD valueg\n\n\n\n\n\n\n\n\na\nFor example: oral, subcutaneous, intravenous.\nb\nFor example: gavage, injection and instillation.\nc\nFor example: water, feed and normal saline.\nd\nFor example: every x number of hour(s), day(s) and week(s).\ne\nFor example: genotoxicity, cancer, non-organ specific systemic toxicity, organ specific systemic toxicity (specify organ\nand system), reproductive toxicity and developmental toxicity.\nf\nFor example: NOAEL, LOAEL, BMDL, slope-factor, TD50, NIL or MIL.\ng\nEither \u00b5g/cm2 (NIL or MIL) or \u00b5g/kg/d (NOAEL, LOAEL, BMDL, or slope-factor or, TD50).\nTable\u00a0F.5\u00a0\u2014 Tolerable contact level and tolerable intake information\nConstituent\nname\nCAS RN\nHarma\nPODb\n\u00b5g/kg/day\nUF(TI/TCL)1\nUF(TI/TCL)2\nUF(TI/TCL)n\nMF\nTIc or TCLd\nChemical 1\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\na\nHarm includes irritation, systemic toxicity (acute, subacute, subchronic, chronic), genotoxicity, carcinogenicity,\nreproductive or developmental toxicity.\nb\nAlternately, POD is expressed in \u00b5g/cm2 for TCL derivation.\nc\nTI is expressed in \u00b5g/kg/d.\nd\nTCL is expressed in \u00b5g/cm2.\nTable\u00a0F.6\u00a0\u2014 Threshold of toxicological concern information\nConstituent name\nCAS RNa\nQuantity extracted\n\u00b5g\nIs constituent excluded\nfrom TTC?b\nIs the quantity less than\nTTC?c\nChemical 1\n\n\nY/N\nY/N/NA\nChemical 2\n\n\nY/N\nY/N/NA\nChemical X\n\n\nY/N\nY/N/NA\na\nCAS RN, or InchlKey or SMILES code.\nb\nYes (Y) means constituent is a cohort of concern or excluded chemical; no (N) means constituent is not a cohort of\nconcern or excluded chemical.\nc\nYes (Y) means quantity extracted is negligible toxicological risk; no (N) means toxicological risk assessment for either\nshort-term, long-term, or both, is recommended; not applied (NA) means TTC is not used to assess toxicological risk.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n56\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0F.7\u00a0\u2014 Estimated exposure dose\nConstituent\nname\nCAS RN\nHQ or TQ\nextracted\nSFr.k.\nor\nSFa.r.\nBWL\nkg\nEEDmax\n(\u22641\u00a0d)a\nEEDmax\n(2\u00a0d\u00a0to\u00a030\u00a0d)b\nEEDmax\n(31\u00a0d\u00a0to\u00a0365\u00a0d)c\nEEDmax\n(\u2265366\u00a0d)c\n\u00b5g\nRdd\nd\nEED\n\u00b5g/kg/d\nRdd\nd\nEED\n\u00b5g/\nkg/d\nRdd\nd\nEED\n\u00b5g/kg/d\nRdd\nd\nEED\n\u00b5g/kg/d\nChemical 1\n1\n2\n31\n366\nChemical 2\n1\n2\n31\n366\nChemical X\n1\n2\n31\n366\na\nApplicable for medical devices with limited, prolonged and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nFor TQ data, Rd is the default value in Table\u00a0E.4. For HQ data, 1 d applies, see Clause\u00a0E.2. For Rd applicable to single use (disposable) devices with\nprolonged or long-term cumulative exposure, see Clause\u00a0E.4.\nTable\u00a0F.8\u00a0\u2014 Calculations of the margin of safety values\nConstituent\nname\nCAS RN\nMoS (\u22641\u00a0d)a\nMoS (2\u00a0d\u00a0to 30\u00a0d)b\nMoS (31\u00a0d\u00a0to\u00a0365\u00a0d)c\nMoS (\u2265366\u00a0d)c\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nChemical 1\n\n\n\n\n\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\n\n\n\n\n\na\nApplicable for medical devices with limited, prolonged, and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nTI is expressed in \u00b5g/kg/d.\ne\nTCL is expressed in \u00b5g/cm2.\nf\nEEDmax is expressed in \u00b5g/kg/d when a TI is used, or \u00b5g/cm2 when a TCL is used.\nTable\u00a0F.9\u00a0\u2014 Summary of margin of safety evaluation\nConstituent\nname\nCAS RN\nMoS (\u22641\u00a0d)a\nMoS (2\u00a0d\u00a0to 30\u00a0d)b\nMoS (31\u00a0d\u00a0to\u00a0365\u00a0d)c\nMoS (\u2265366\u00a0d)c\nMoS\nConclusiond\nMoS\nConclusiond\nMoS\nConclusiond\nMoS\nConclusiond\nChemical 1\n\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\n\na\nApplicable for medical devices with limited, prolonged and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nConclusions can include:\n\u2014\ntoxicological risk is tolerable (i.e. EEDmax is without appreciable harm to health), or\n\u2014\npossible toxicological risk (i.e. EEDmax is, or can be, with appreciable harm to health), see 10.2.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n57\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nBibliography\n[1]\nCRUMP, K. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984,\n4 pp.\u00a0854\u2013871\n[2]\nUS EPA, Benchmark dose technical guidance. 2012. https://\u200bwww\u200b.epa\u200b.gov/\u200bsites/\u200bproduction/\u200b\nfiles/\u200b2015\u200b-01/\u200bdocuments/\u200bbenchmark\u200b_dose\u200b_guidance\u200b.pdf\n[3]\nInternational Agency for Research on Cancer. Agents classified by the IARC monographs.\n2013, 1\u2013108. Lyon, France. Available at https://\u200bwiki\u200b.cancer\u200b.org\u200b.au/\u200bpolicy/\u200bIARC\u200b_classifications\n[4]\nNational Cancer Institute. Environmental Carcinogens and Cancer Risk. 2019. U.S. National\nInstitute of Health. Bethesda, Maryland. Available at https://\u200bwww\u200b.cancer\u200b.gov/\u200babout\u200b-cancer/\u200b\ncauses\u200b-prevention/\u200brisk/\u200bsubstances/\u200bcarcinogens\n[5]\nWATSON W. On byproducts and side products. Org. Process. Res. Dev. 2012, 16 p. 1877 URL:\nhttps://\u200bdoi\u200b.org/\u200b10\u200b.1021/\u200bop300317g\n[6]\nIARC, IARC Monographs Preamble. International Agency for Research on Cancer (IARC). 2019.\nURL:\nhttps://\u200bmonographs\u200b.iarc\u200b.who\u200b.int/\u200biarc\u200b-monographs\u200b-preamble\u200b-preamble\u200b-to\u200b-the\u200b-iarc\u200b\n-monographs/\u200b\n[7]\nNTP, Report on Carcinogens Process & Listing Criteria. National Toxicology Program (NTP).\nU.S. Department of Health and Human Services. URL: https://\u200bntp\u200b.niehs\u200b.nih\u200b.gov/\u200bwhatwestudy/\u200b\nassessments/\u200bcancer/\u200bcriteria/\u200bindex\u200b.html\n[8]\nEPA\u2019s Integrated Risk Information System (IRIS). URL: http://\u200bwww\u200b.epa\u200b.gov/\u200biris\n[9]\nChandrasekar  V. et al., Conservative Exposure Predictions for Rapid Risk Assessment of\nPhase-Separated Additives in Medical Device Polymers. Ann. Biomed. Eng. 2018,  46 pp.\u00a014\u201324\n[10]\nLiu  J.-M. et al., Assessment of migration regularity of phthalates from food packaging materials.\nFood Science & Nutrition. 2020,  8 pp.\u00a05738\u20135747\n[11]\nSaylor  D.M. et al., Advances in predicting patient exposure to medical device leachables.\nMEDICAL DEVICES & SENSORS. 2020, e10063. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.1002/\u200bmds3\u200b.10063\n[12]\nFood and Agriculture Organization of the United Nations, World Health Organization (FAO/\nWHO). Environ. Health Criteria. 2009, p.\u00a0240 [Principles and Methods for the Risk Assessment of\nChemicals in Food.]\n[13]\nUnited States Environmental Protection Agency (EPA). Framework for Human Health Risk\nAssessment to Inform Decision Making. 2014. URL: https://\u200bwww\u200b.epa\u200b.gov/\u200brisk/\u200bframework\u200b\n-human\u200b-health\u200b-risk\u200b-assessment\u200b-inform\u200b-decision\u200b-making\n[14]\nEuropean Chemicals Agency (ECHA), Guidance on Information Requirements and Chemical\nSafety Assessment. URL: https://\u200becha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b\n-requirements\u200b-and\u200b-chemical\u200b-safety\u200b-assessment\n[15]\nJohansen  J. D., Mahler  V., Lepoittevin  J.P., Frosch  P. J., Eds. Contact Dermatitis,  6th ed.\n2021.  Springer Cham.  New York, NY\n[16]\nBormann  J. L.,  Maibach  H. I., Draize Human Repeat Insult Patch Test (HRIPT): Seven Decades\nof Pitfalls and Progress. Regulatory Toxicology and Pharmacology. 2021,  121, p. 104867\n[17]\nBernard  L. J., Hostynek  J. J., Maibach  H. I., Chapter 12 Allergic Contact Dermatitis: Elicitation\nThresholds of Potent Allergens in Humans. In Dermatotoxicology (Wilhelm  K. P., Zhai  H.,\nMaibach  H. I., Eds.). 2012, pp. 108-118,  CRC Press,  Boca Raton, FL\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n58\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[18]\nBos  J.D.,  Meinardi  M.M.H.M., The 500 Dalton rule for the skin penetration of chemical\ncompounds and drugs. Exp. Dermatol. 2000,  9 pp.\u00a0165\u2013169\n[19]\nPotts  R.O.,  Guy  R.H., Predicting Skin Permeability. Pharm. Res. 1992,  9 pp.\u00a0663\u2013669\n[20]\nKroes  R. et al., Application of the threshold of toxicological concern (TTC) to the safety\nevaluation of cosmetic ingredients. Food Chem. Toxicol. 2007,  45 pp.\u00a02533\u20132562\n[21]\nOECD, Guidance document on the validation of quantitative structure\u2013activity relationship\n[QSAR] models. OECD Environment Health and Safety Publication, Paris. 2007. (Series on\ntesting and assessment no. 69, ENV/JM/MONO (2007)2) Retrieved from http://\u200bwww\u200b.oecd\u200b\n.org/\u200bofficialdocuments/\u200bpubli\u200bcdisplaydo\u200bcumentpdf/\u200b?cote\u200b=\u200benv/\u200bjm/\u200bmono\u200b%282007\u200b%292\u200b&\u200b\ndoclanguage\u200b=\u200ben. Access date: May 25, 2014)\n[22]\nSteinbach  T.S., Gad-McDonald  S., Kruhlak  N. et al., (Q)SAR: A Tool for the Toxicologist. Int. J.\nToxicol. 2015,  34\u00a0(4) pp.\u00a0352\u2013354\n[23]\nSussman  E.M., Oktem  B., Isayeva  I.S. et al., Chemical Characterization and Non-targeted\nAnalysis of Medical Device Extracts: A Review of Current Approaches, Gaps, and Emerging\nPractices. ACS Biomaterials Science & Engineering. 2022. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.1021/\u200b\nacsbiomaterials\u200b.1c01119\n[24]\nBecker  R.A., Dellarco  V., Seed  J. et al., Quantitative weight of evidence to assess confidence in\npotential modes of action. Regulatory Toxicology and Pharmacology. 2017,  86 pp. 205\u201320.\n[25]\nDekant  W.,  Bridges  J., A quantitative weight of evidence methodology for the assessment\nof reproductive and developmental toxicity and its application for classification and labeling of\nchemicals. Regul Toxicol Pharmacol. 2016,  82 pp. 173\u201385\n[26]\nEastmond  D.A., Recommendations for the evaluation of complex genetic toxicity data sets when\nassessing carcinogenic risks to humans. Environmental and Molecular Mutagenesis. 2017,  58\npp. 380\u20135\n[27]\nMartin  P., Bladier  C., Meek  B. et al., Weight of Evidence for Hazard Identification: A Critical\nReview of the Literature. Environmental Health Perspectives. 2018,  126 pp. 076001\n[28]\nMeek  M.E.(Bette), Palermo C.M., Bachman A.N. et al. , Mode of action human relevance (species\nconcordance) framework: Evolution of the Bradford Hill considerations and comparative\nanalysis of weight of evidence. Journal of Applied Toxicology. 2014,  34 pp. 595\u2013606\n[29]\nUS-EPA Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001B. Environmental\nProtection Agency (EPA). 2005. URL: https://\u200bwww\u200b.epa\u200b.gov/\u200bsites/\u200bdefault/\u200bfiles/\u200b2013\u200b-09/\u200b\ndocuments/\u200bcancer\u200b_guidelines\u200b_final\u200b_3\u200b-25\u200b-05\u200b.pdf\n[30]\nPradeep  P., Povinelli  R.J., White  S. et al., An ensemble model of QSAR tools for regulatory risk\nassessment. J Cheminform. 2016,  8 p.\u00a048\n[31]\nRaies  A.B.,  Bajic  V.B., In silico toxicology: computational methods for the prediction of chemical\ntoxicity. Wiley Interdiscp Reve Comput Mol Sci. 2016,  6\u00a0(2) pp.\u00a0147\u2013172\n[32]\nGray  G., Steven  B., Gail  C., Joshua  C. et al., The Annapolis Accords on the use of toxicology in\nrisk assessment and decision-making: an Annapolis Center workshop report. Toxicol. Methods.\n2001,  11 pp.\u00a0225\u2013231\n[33]\nEuropean Chemicals Agency (ECHA). Read-Across Framework. RAAF, 2017. URL: https://\u200becha\u200b\n.europa\u200b.eu/\u200bdocuments/\u200b10162/\u200b13628/\u200braaf\u200b_en\u200b.pdf/\u200b614e5d61\u200b-891d\u200b-4154\u200b-8a47\u200b-87efebd1851a\n[34]\nHelman  George et al., Generalized Read-Across (GenRA): A workflow implemented into the EPA\nCompTox Chemicals Dashboard. ALTEX - Alternatives to animal experimentation. 2019,  36, pp.\n462\u2013465.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n59\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[35]\nHelman  G. et al., Quantitative prediction of repeat dose toxicity values using GenRA. Regul.\nToxicol. Pharmacol. 2019,  109 p.\u00a0104480\n[36]\nECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter\nR.6: QSARs and grouping of chemicals. European Chemicals Agency (ECHA). 2019. URL: https://\u200b\necha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b\n-safety\u200b-assessment\n[37]\nGovernment of Canada, [Environment and Climate Change Canada - Evaluating Existing\nSubstances - Screening Assessment - Aromatic Azo and Benzidine-based Substance Grouping\n- Certain Azo Solvent Dyes.] 2016. URL: https://\u200bwww\u200b.ec\u200b.gc\u200b.ca/\u200bese\u200b-ees/\u200bdefault\u200b.asp\u200b?lang\u200b=\u200bEn\u200b&\u200bn\u200b=\u200b\nAB88B1AB\u200b-1\n[38]\nOECD OECD: Guidance on grouping of chemicals. Series on Testing & Assessment. No. 194.\nEnvironment Directorate Joint Meeting of the Chemicals Committee and the Working party on\nChemicals, Pesticides and Biotechnology. Organisation for Economic Co-operation and Development.\nOECD, 2nd Edition. 2017. URL: https://\u200bwww\u200b.oecd\u200b.org/\u200bpublications/\u200bguidance\u200b-on\u200b-grouping\u200b-of\u200b\n-chemicals\u200b-second\u200b-edition\u200b-9789264274679\u200b-en\u200b.htm\n[39]\nYang  C., Rathman  J.F., Magdziarz  T. et al., Do Similar Structures Have Similar No Observed\nAdverse Effect Level (NOAEL) Values? Exploring Chemoinformatics Approaches for Estimating\nNOAEL Bounds and Uncertainties. Chem. Res. Toxicol. 2021,  34 pp. 616\u2013633\n[40]\nMellor  C.L., Marchese Robinson  R.L., Benigni  R. et al., Molecular fingerprint-derived\nsimilarity measures for toxicological read-across: Recommendations for optimal use. Regulatory\nToxicology and Pharmacology. 2019,  101 pp. 121-134\n[41]\nMore  S.J. et al., Guidance on the use of the Threshold of Toxicological Concern approach in food\nsafety assessment. EFSA Journal, 2019, 17, e05708. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.2903/\u200bj\u200b.efsa\u200b.2019\u200b\n.5708\n[42]\nATSDR, Framework for Assessing Health Impacts of Multiple Chemicals and Other Stressors\n(Update).  Agency for Toxic Substances and Disease Registry. Division of Toxicology. U.S.\nDepartment of Health and Human Services,  Atlanta, Georgia. 2018, 154\u00a0p.\n[43]\nEuropean Commission. Toxicity and Assessment of Chemical Mixtures. Scientific Committees.\nDirectorate General for Health & Consumers.  European Commission,  Brussels, Belgium. 2012,\n50\u00a0p\n[44]\nGoumenou  M.,  Tsatsakis  A., Proposing new approaches for the risk characterisation of single\nchemicals and chemical mixtures: The source related Hazard Quotient (HQS) and Hazard Index\n(HIS) and the adversity specific Hazard Index (HIA). Toxicology Reports. 2019, 6 pp.632\u2013636.\nhttps://\u200bdoi\u200b.org/\u200b10\u200b.1016/\u200bj\u200b.toxrep\u200b.2019\u200b.06\u200b.010\n[45]\nIPCS, Assessment of Combined Exposures to Multiple Chemicals: Report of a WHO/IPCS\nInternational Workshop. International Programme on Chemical Safety. World Health\nOrganization.\nGeneva.\n2009,\n83\npp.\nURL:\nhttps://\u200bwww\u200b.who\u200b.int/\u200bpublications/\u200bi/\u200bitem/\u200b\n9789241563833\n[46]\nKortenkamp  A., Backhaus  T., Faust  M., State of the Art Report on Mixture Toxicity. European\nCommission. Study contract No. 070307/2007/485103/ETU/D.1. 2009, 391 pp. URL: https://\u200bec\u200b\n.europa\u200b.eu/\u200benvironment/\u200bchemicals/\u200beffects/\u200bpdf/\u200breport\u200b_mixture\u200b_toxicity\u200b.pdf\n[47]\nSvendsgaard  D.J.,  Hertzberg  R.C., Statistical methods for the toxicological evaluation of the\nadditivity assumption as used in the EPA chemical mixture risk assessment guidelines. In: Toxicology\nof chemical mixtures: case studies, mechanisms, and novel approaches, (Yang  R.S.H., ed.).\nAcademic Press,  New York, 1994, pp.\u00a0599\u2013642\n[48]\nTeuschler  L.K.,  Hertzberg  R.C., Current and future risk assessment guidelines, policy, and\nmethods development for chemical mixtures. Toxicology. 1995,  105 pp.\u00a0137\u2013144\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n60\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[49]\nU.S. EPA. Concepts, Methods, And Data Sources For Cumulative Health Risk Assessment Of\nMultiple Chemicals, Exposures And Effects: A Resource Document (Final Report, 2008). U.S.\nEnvironmental Protection Agency (EPA), Washington, DC, EPA/600/R-06/013F, 2008. URL:\nhttps://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b190187\n[50]\nU.S. EPA Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures.\nEPA/630/R-00/002. U.S. Environmental Protection Agency. EPA, Washington, DC, 2000, 209\u00a0 p.\nURL: https://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b20533\n[51]\nHiggins  J.P.T., Thomas  J., Chandler  J., Cumpston  M., Li  T., Page  M.J. et al., eds. Cochrane\nHandbook for Systematic Reviews of Interventions version 6.3 (updated February 2022).\nCochrane, 2022. URL: https://\u200bwww\u200b.training\u200b.cochrane\u200b.org/\u200bhandbook\n[52]\nGreek  R.,  Menache  A., Systematic Reviews of Animal Models: Methodology versus\nEpistemology. Int. J. Med. Sci. 2013,  10 pp.\u00a0206\u2013221\n[53]\nLeenaars  M., Hooijmans  C.R., van Veggel  N. et al., A step-by-step guide to systematically\nidentify all relevant animal studies. Lab. Anim. 2012,  46 pp.\u00a024\u201331\n[54]\nLynch  H.N., Goodman  J.E., Tabony  J.A., Rhomberg  L.R., Systematic comparison of study\nquality criteria. Regul. Toxicol. Pharmacol. 2016,  76 pp.\u00a0187\u2013198\n[55]\nPease  C., Rooney  A., Sapiets  A. et al., Implementing systematic review techniques in chemical\nrisk assessment: Challenges, opportunities and recommendations. Environ. Int. 2016,  92\u201393\npp.\u00a0556\u2013564\n[56]\nRooney  A.A., Boyles  A.L., Wolfe  M.S. et al., Systematic review and evidence integration for\nliterature-based environmental health science assessments. Environ. Health Perspect. 2014,\n122\u00a0(7) pp.\u00a0711\u2013718\n[57]\nSamuel  G.O., Hoffmann  S., Wright  R.A. et al., Guidance on assessing the methodological and\nreporting quality of toxicologically relevant studies: A scoping review. Environ. Int. 2016,  92-93\npp.\u00a0630\u2013646\n[58]\nThe National Institute for Health and Care Excellence. The Guidelines Manual. Process\nand Methods. Appendix B: Methodology checklist: systematic reviews and meta-analyses\nAppendices B\u2013I. 2012. URL: https://\u200bwww\u200b.nice\u200b.org\u200b.uk/\u200bprocess/\u200bpmg6/\u200bresources/\u200bthe\u200b-guidelines\u200b\n-manual\u200b-appendices\u200b-bi\u200b-2549703709/\u200bchapter/\u200bappendix\u200b-b\u200b-methodology\u200b-checklist\u200b-systematic\u200b\n-reviews\u200b-and\u200b-meta\u200b-analyses\n[59]\nViswanathan  M., Ansari  M.T., Berkman  N.D. et al., Assessing the risk of bias of individual\nstudies in systematic reviews of health care interventions. Methods Guide for Effectiveness and\nComparative Effectiveness Reviews. Agency for Healthcare Research and Quality (US), Rockville\n(MD). 2008. URL: https://\u200bwww\u200b.ncbi\u200b.nlm\u200b.nih\u200b.gov/\u200bbooks/\u200bNBK91433\n[60]\nFenner-Crisp  P.A.,  Dellarco  V.L., Key Elements for Judging the Quality of a Risk Assessment.\nEnviron. Health Perspect. 2016,  124\u00a0(8) pp.\u00a01127\u20131135\n[61]\nFesting  M.F.W.,  Altman  D.G., Guidelines for the design and statistical analysis of experiments\nusing laboratory animals. ILAR J. Nat. Res. Counc. Inst. Lab. Anim. Resour. 2002,  43\u00a0(4) pp.\u00a0244\u2013\n258\n[62]\nSanderson  S., Tatt  I.D., Higgins  J.P., Tools for assessing quality and susceptibility to bias in\nobservational studies in epidemiology: a systematic review and annotated bibliography. Int. J.\nEpidemiol. 2007,  36 pp.\u00a0666\u2013676\n[63]\nKlimisch  H.J., Andreae  M., Tillmann  U., A systematic approach for evaluating the quality\nof experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997,  25\u00a0(1)\npp.\u00a01\u20135\n[64]\nSchneider  K. et al., \u201cToxRTool\u201d, a new tool to assess the reliability of toxicological data. Toxicol.\nLett. 2009,  189 pp.\u00a0138\u2013144\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n61\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[65]\nKilkenny  C., Parsons  N., Kadyszewski  E. et al., Survey of the Quality of Experimental Design,\nStatistical Analysis and Reporting of Research Using Animals. PLoS ONE. 2009,  4 p.\u00a0e7824.\n[66]\nKilkenny  C.,  Browne  W.Cuthill, et al., , Improving bioscience research reporting: the ARRIVE\nguidelines for reporting animal research. J. Pharmacol. Pharmacother.  2010,  1 p. 94.\n[67]\nSegal  D. et al., Evaluation of the ToxRTool\u2019s ability to rate the reliability of toxicological data for\nhuman health hazard assessments. Regul. Toxicol. Pharmacol. 2015,  72 pp.\u00a094\u2013101\n[68]\nSchneider  K. et al., Quality Criteria for Primary Literature in Toxicology. In: Regulatory\nToxicology, (Reichl  F.-X.,  Schwenk  M., eds.).  Springer,  Berlin, Heidelberg. 2020, pp.\u00a01\u20136.\n[69]\nPennell  C.P., Hirst  A., Sedrakyan  A., McCulloch  P.G., Adapting the IDEAL Framework and\nRecommendations for medical device evaluation: A modified Delphi survey. Int. J. Surg. 2016,  28\npp.\u00a0141\u2013148\n[70]\nRice  A.S.C., Morland  R., Huang  W. et al., Transparency in the reporting of in vivo pre-clinical\npain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In\nVivo Experiments) guidelines. Scandinavian Journal of Pain. 2013,  4 pp.\u00a058\u201362\n[71]\nSchwarz  F., Iglhaut  G., Becker  J., Quality assessment of reporting of animal studies on\npathogenesis and treatment of peri-implant mucositis and peri-implantitis. A systematic review\nusing the ARRIVE guidelines. J. Clin. Periodontol. 2012,  39\u00a0(Suppl 12) pp.\u00a063\u201372\n[72]\nvon Elm  E., Altman  D.G., Egger  M. et al., Initiative, S.T.R.O.B.E., 2007. Strengthening the\nReporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for\nreporting observational studies. BMJ. 2007,  335\u00a0(7624) pp.\u00a0806\u2013808\n[73]\nPaustenbach  D.J. et al., Benzene toxicity and risk assessment, 1972-1992: implications for\nfuture regulation. Environ. Health Perspect. 1993,  101 pp.\u00a0177\u2013200\n[74]\nICH, Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to\nlimit potential carcinogenic risk M7(R1). ICH Harmonised Tripartite Guideline. International\nConference on Harmonisation (ICH) of Technical Requirements for Registration of\nPharmaceuticals for Human Use Geneva, Switzerland. 2017. URL: http://\u200bwww\u200b.ich\u200b.org\n[75]\nLEHMAN, A.J. and FITZHUGH, O.G. 100-Fold margin of safety. Association of Food and Drug\nOfficials. U.S.Q. Bull. 1954, 18 pp. 33-35\n[76]\nMUMTAZ. M.M. and HERTZBERG, R.C. The status of interactions data in risk assessment of\nchemical mixtures. In J. Saxena, ed. Hazard Assessment of Chemicals. Hemisphere, Washington,\nD.C. 1993, 8 pp. 47-79\n[77]\nMUMTAZ, M.M., SIPES, I.G., CLEWELL, H.J. and YANG, R.S.H. Risk assessment of chemical\nmixtures: Biologic and toxicologic issues (symposium overview). Fundam. Appl. Toxicol. 1993,\n21 pp.\u00a0258\u2013269\n[78]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with methylene chloride as an example of the process. Committee on Rational\nSpecification for Impurities in Bulk Drug Substances. PMA, Washington, DC. Pharmacop. Forum.\n1989,  15\u00a0(6) pp.\u00a05748\u20135759\n[79]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with chloroform, 1,4-dioxane, ethylene oxide and trichloroethylene as examples\nof the process. Committee on Rational Specification for Impurities in Bulk Drug Substances.\nPMA, Washington, DC. Pharmacop. Forum. 1990,  16\u00a0(3) pp.\u00a0541\u2013582\n[80]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with benzene as an example of the process. Committee on Rational Specification\nfor Impurities in Bulk Drug Substances. PMA, Washington, DC. Pharmacop. Forum. 1991,  17\u00a0(1)\npp.\u00a01441\u20131458\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n62\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[81]\nUnited States Pharmacopeial Convention (USP), <467> Organic volatile impurities. USP, Rockville,\nMaryland, Vol.  24, 2000, pp.\u00a01877\u20138\n[82]\nBASKETTER, D.A. Individual ethnic and seasonal variability in irritant susceptibility of skin:\nThe implications for a predictive human patch test. Contact Dermat. 1996,  35 pp.\u00a0208\u2013213\n[83]\nCONINE, D., NAUMANN, B. and HECKER, L. Setting Health-Based Residue Limits For\nContaminants in Pharmaceuticals and Medical Devices. Quality Assurance: Good Practice,\nRegulation, and the Law. 1992, 1(3) pp. 171-180\n[84]\nCommittee on Carcinogenicity of Chemicals in Food. Consumer Products and the Environment,\nGuidelines for the evaluation of chemicals for carcinogenicity, Department of Health Report on\nHealth and Social Subjects No. 42. HMSO, London, 1991. URL: https://\u200bassets\u200b.publishing\u200b.service\u200b\n.gov\u200b.uk/\u200bgovernment/\u200buploads/\u200bsystem/\u200buploads/\u200battachment\u200b_data/\u200bfile/\u200b743785/\u200bGuidelines\u200b_for\u200b\n_the\u200b_evaluation\u200b_of\u200b_Chemicals\u200b_for\u200b_Carcinogenicity\u200b_\u200b_1991\u200b_\u200b.pdf\n[85]\nIPCS Environmental Health Criteria 170. Assessing Human Health Risks of Chemicals: Derivation of\nGuidance Values for Health-Based Exposure Limits. INTERNATIONAL PROGRAMME ON CHEMICAL\nSAFETY (IPCS), World Health Organization, Geneva, Switzerland. 1994. URL: https://\u200binchem\u200b\n.org/\u200bdocuments/\u200behc/\u200behc/\u200behc170\u200b.htm\n[86]\nDOURSON, M. and STARA, J. Regulatory history and experimental support for uncertainty\n(safety) factors. Regul. Toxicol. Pharmacol. 1983,  3 pp.\u00a0224\u2013238\n[87]\nDourson  M., Uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 1996,\n24 p.\u00a0107\n[88]\nDourson  M.L. et al., Evolution of Science-Based Uncertainty Factors in Noncancer Risk\nAssessment. Regul. Toxicol. Pharmacol. 1996,  24 pp.\u00a0108\u2013120\n[89]\nJUDGE, M.R.,  Variation in response of human skin to irritant challenge. Contact Dermat. 1996,\n34 pp.\u00a0115\u2013117\n[90]\nMore  S.J. et al., Guidance on the use of the Threshold of Toxicological Concern approach in food\nsafety assessment. EFSA Journal. 2019,  17 p.\u00a0e05708\n[91]\nIPCS Harmonization Project Document No. 2. CHEMICAL-SPECIFIC ADJUSTMENT FACTORS FOR\nINTERSPECIES DIFFERENCES AND HUMAN VARIABILITY: GUIDANCE DOCUMENT FOR USE OF\nDATA IN DOSE/CONCENTRATION\u2013RESPONSE ASSESSMENT. INTERNATIONAL PROGRAMME ON\nCHEMICAL SAFETY (IPCS), World Health Organization, Geneva, Switzerland. 2005. URL: https://\u200b\napps\u200b.who\u200b.int/\u200biris/\u200bhandle/\u200b10665/\u200b43294\n[92]\nRenwick  A.G. et al., An Analysis of the Need for an Additional Uncertainty Factor for Infants and\nChildren. Regul. Toxicol. Pharmacol. 2000,  31 pp.\u00a0286\u2013296\n[93]\nLandrigan Philip  J. et al., Children\u2019s health and the environment: public health issues and\nchallenges for risk assessment. Environ. Health Perspect. 2004,  112 pp.\u00a0257\u2013265\n[94]\nDorne  J.L.C.M., Metabolism, variability and risk assessment. Toxicology. 2010,  268 pp.\u00a0156\u2013164\n[95]\nHardy  A. et al., Guidance on the risk assessment of substances present in food intended for\ninfants below 16 weeks of age. EFSA Journal. 2017,  15 p.\u00a0e04849\n[96]\nPazeto  C.L., Nascimento  F.J., Santiago  L.H.S., Glina  S., Idiosyncratic reaction after injection\nof polyacrylate - polyalcohol copolymer. Int Braz J Urol. 2018,  44 pp. 831\u2013834\n[97]\nClewell  H.J.,  Andersen  M.E., Risk Assessment Extrapolations and Physiological Modeling.\nToxicol. Ind. Health. 1985,  1 pp.\u00a0111\u2013134\n[98]\nPepelko  W.E., Feasibility of route extrapolation in risk assessment. Br. J. Ind. Med. 1987,  44\npp.\u00a0649\u2013651\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n63\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[99]\nGeraets  L. et al., Human risk assessment of dermal and inhalation exposures to chemicals\nassessed by route-to-route extrapolation: The necessity of kinetic data. Regul. Toxicol.\nPharmacol. 2014,  70 pp.\u00a054\u201364\n[100]\t Mattie  D.R., Grabau  J.H., McDougal  J.N., Significance of the dermal route of exposure to risk\nassessment. Risk Anal. 1994,  14\u00a0(3) pp.\u00a0277\u2013284\n[101]\t Poet  T.S.,  McDougal  J.N., Skin absorption and human risk assessment. Chem. Biol. Interact.\n2002,  140\u00a0(1) pp.\u00a019\u201334\n[102]\t Kroes  R. et al., Application of the threshold of toxicological concern (TTC) to the safety\nevaluation of cosmetic ingredients. Food Chem. Toxicol. 2007,  45 pp.\u00a02533\u20132562\n[103]\t McDougal  J.N.,  Boeniger  M.F., Methods for Assessing Risks of Dermal Exposures in the\nWorkplace. Crit. Rev. Toxicol. 2002,  32 pp.\u00a0291\u2013327\n[104]\t Escher  S. et al., Evaluation of inhalation TTC values with the database RepDose. Regul. Toxicol.\nPharmacol. 2010,  58 pp.\u00a0259\u2013274\n[105]\t https://\u200bdatabase\u200b.ich\u200b.org/\u200bsites/\u200bdefault/\u200bfiles/\u200bQ3D\u200b-R2\u200b_Guideline\u200b_Step4\u200b_2022\u200b_0308\u200b.pdf\n[106]\t Schneider  K., Dilger  M., Kaiser  E., Kalberlah  F., Wosniok  W., Derivation of occupational\nexposure limits for airborne chemicals \u2013 Comparison of methods and protection levels. Federal\nInstitute for Occupational Safety and Health (BAuA) Dortmund. 2022. URL: https://\u200bwww\u200b.baua\u200b\n.de/\u200bDE/\u200bAngebote/\u200bPublikationen/\u200bBerichte/\u200bF2437\u200b.pdf\u200b?\u200b_\u200b_blob\u200b=\u200bpublicationFile\u200b&\u200bv\u200b=\u200b7\n[107]\t ECHA Guidance on information requirements and chemical safety assessment, Chapter R.8:\nCharacterisation of dose [concentration]-response for human health. 2012. URL: https://\u200becha\u200b\n.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b-safety\u200b\n-assessment\n[108]\t IGHRC, Guidelines, Interdepartmental Group on Health Risks from Chemicals, Guidelines\non route-to-route extrapolation of toxicity data when assessing health risks of chemicals.\n2006.\nURL:\nhttp://\u200bwww\u200b.iehconsulting\u200b.co\u200b.uk/\u200bIEH\u200b_Consulting/\u200bighrc\u200b%20web\u200b%20files/\u200bIGHRC\u200b\n_publications1\u200b.html\n[109]\t Venman  B.C.,  Flaga  C., Development of an acceptable factor to estimate chronic end points\nfrom acute toxicity data. Toxicol. Ind. Health. 1985,  1\u00a0(4) pp.\u00a0261\u2013269\n[110]\t Pieters  M.N. et al., Evaluation of the Uncertainty Factor for Subchronic-to-Chronic\nExtrapolation: Statistical Analysis of Toxicity Data. Regul. Toxicol. Pharmacol. 1998,  27 pp.\u00a0108\u2013\n111\n[111]\t Xue  J. et al., Introduction of risk size in the determination of uncertainty factor UFL in risk\nassessment. Environ. Res. Lett. 2012,  7 p.\u00a0034036\n[112]\t Rezvani  N. et al., Uncertainty Factors. In: Encyclopedia of Toxicology, (Wexler  P., ed.).  Academic\nPress,  Oxford,  Third Edition, 2014, pp.\u00a0870\u20137.\n[113]\t Sussman  R.G. et al., A harmonization effort for acceptable daily exposure derivation \u2013\nConsiderations for application of adjustment factors. Regul. Toxicol. Pharmacol. 2016,\n79\u00a0(Supplement 1) pp.\u00a0S57\u2013S66\n[114]\t Renwick  A.G., Data\u2010derived safety factors for the evaluation of food additives and environmental\ncontaminants. Food Addit. Contam. 1993,  10 pp.\u00a0275\u2013305\n[115]\t Schultz  T.W. et al., A strategy for structuring and reporting a read-across prediction of toxicity.\nRegul. Toxicol. Pharmacol. 2015,  72 pp.\u00a0586\u2013601\n[116]\t Weed  D.L., Weight of Evidence: A Review of Concept and Methods. Risk Anal. 2005,  25\u00a0(6)\npp.\u00a01545\u20131557\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n64\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[117]\t Swaen  G.,  van Amelsvoort  L., A weight of evidence approach to causal inference. J. Clin.\nEpidemiol. 2009,  62 pp.\u00a0270\u2013277\n[118]\t Smith  M.T., Guyton  K.Z., Gibbons  C.F. et al., Key Characteristics of Carcinogens as a Basis\nfor Organizing Data on Mechanisms of Carcinogenesis. Environ. Health Perspect. 2016,  124\u00a0(6)\npp.\u00a0713\u2013721\n[119]\t Guyton  K.Z., Rusyn  I., Chiu  W.A. et al., Application of the key characteristics of carcinogens in\ncancer hazard identification. Carcinogenesis. 2018,  39\u00a0(4) pp.\u00a0614\u2013622\n[120]\t EPA, Guidelines for Carcinogen Risk Assessment. Report No. 630-P-03-001F. 2005. URL: https://\u200b\nwww\u200b.epa\u200b.gov/\u200brisk/\u200bguidelines\u200b-carcinogen\u200b-risk\u200b-assessment.\n[121]\t Benzene  E.P.A., CASRN\u00a071\u201143\u20112. Chemical Assessment Summary. Integrated Risk Information\nSystem (IRIS). U.S. Environmental Protection Agency. 2000. URL: https://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200b\niris/\u200biris\u200b_documents/\u200bdocuments/\u200bsubst/\u200b0276\u200b_summary\u200b.pdf\n[122]\t ECHA Guidance on information requirements and chemical safety assessment Chapter R.8:\nCharacterisation of dose [concentration]-response for human health. Version 2.1. 2012. https://\u200b\necha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b\n-safety\u200b-assessment\n[123]\t Portier  K. et al., Body Weight Distributions for Risk Assessment. Risk Anal. 2007,  27 pp.\u00a011\u201326\n[124]\t US EPA\u00a0600/6-87/008, Recommendations for and Documentation of Biological Values for Use in\nRisk Assessment. United States Environmental Protection Agency (EPA). URL: https://\u200bcfpub\u200b.epa\u200b\n.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b34855\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n65\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nICS\u200211.100.20\nPrice based on 65 pages\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.",
    "change_text": "11\tReporting requirements\nConstituent specific toxicological data, justifications and methods used to apply TSL, TTC, the derivation\nof TCL or TI values, the estimation of exposure dose, the derivation of MoS values and the evaluations of\nworst-case exposure shall be documented and reported (see examples in Annex\u00a0F).\nCompliance with the requirements in this document, which includes Clause\u00a0 6 to Clause\u00a0 9, and\nAnnexes\u00a0B,\u00a0C\u00a0and\u00a0E, is verified by inspection of the report.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n24\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0A\n(normative)\n\nEvaluation of toxicological data quality when selecting a point of\ndeparture\nAccording to 7.1 and C.2.2.4.3, it is essential that relevant toxicological data are used to evaluate the\nnature of harm, and to establish the POD value. POD values that can be used in the derivation of a TI\nvalue include, but are not limited to, BMDL, NOAEL or LOAEL.\nToxicological data should be systematically collected and critically assessed for quality. Quality\nassessment addresses the study design, conduct or data analysis and reporting that can introduce\nselection, performance, detection, attrition and reporting biases.[51]to[61] Reporting bias can be assessed\nby confirming that all key information is included in collected studies. Ideally, studies should present\nsufficient information to allow a knowledgeable reader to understand:\n\u2014\t the toxicological relevance of the study to the constituent;\n\u2014\t that the reported methodological information is adequate for the experiment to be repeated and the\ndose-response data are reproducible;\n\u2014\t the reliability and validity of the findings based on the data generated.\nEvaluation of reporting bias should address whether the quality of the underlying methods used or the\ngenerated data can be adversely impacted. Reporting bias can be evaluated when toxicological data are\nobtained from a secondary health effect source based on expertise of the source (e.g. source is authored\nby experts in toxicology).\nThe adequacy of available evidence to support the conclusions of the toxicological risk assessment shall\nbe confirmed.\nNOTE\nTools for assessing quality are categorized into:\na)\nchecklists of questions that identify sources of bias, or\nb)\nscoring systems that produce a numerical reliability rating for each study (e.g. ToxRTool, ARRIVE Guidelines).\nReducing uncertainty in scores can be addressed by weighing each source of bias[62]to[72].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n25\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0B\n(normative)\n\nDerivation of toxicological screening limits\nB.1\t General\nThe total quantity (in \u00b5g) of a constituent can be used to assess whether exposure for one or more days\ncan result in a cumulative exposure dose that is at a negligible toxicological risk level (i.e. too low to\npresent a toxicological risk for the applicable harms) and no additional toxicological risk estimation is\nrecommended.\nNOTE\u00a01\nWhen TSL is applied, TQ represents the cumulative exposure dose [e.g. the summation of the exposure\ndose (daily) over the number of exposure days of contact with the device][73].\nThe TSLs according to this document apply to systemic toxicity (acute, subacute, subchronic and\nchronic), genotoxicity, carcinogenicity, reproductive or developmental toxicity for oral or parenteral\nroutes, as well as adults, paediatrics (6 months of age or older) and pregnant women[74].\nWhen the TSL approach is used for any medical device, the 120\u00a0\u00b5g TSL \u226430 d value shall be used for\neach constituent to address applicable biological endpoints that can result from short-term (i.e.\u00a0\u226430\u00a0d)\nexposure, see Table\u00a0B.2.\nFor long-term body contacting medical devices, the 600\u00a0\u00b5g TSL\u00a0>30 d value should be used for each\nconstituent, in addition to the TSL \u226430 d value, to address TQ values that exceed the TSL \u226430 d value and\napplicable biological endpoints that can result from long-term (i.e.\u00a0>30\u00a0d) exposure, see Table\u00a0B.2.\nTSL shall not be applied to harms that the TTC values are not protective in accordance with\nISO/TS\u00a021726:2019, Clause\u00a01.\nToxicological screening limits shall apply to the following:\n\u2014\t identified constituent, and\n\u2014\t total quantity of each constituent present in or on or released from the medical device.\nNOTE\u00a02\nISO\u00a0 10993-18 describes information gathering or an extraction study method that results in an\nestimate of the total quantity of a constituent present in, on or extracted from the medical device.\nToxicological screening limits shall not apply to medical devices used long-term in very young infants\nor neonates, including preterm, or to the following types of constituents:\n\u2014\t the nature of harm is irritation,\n\u2014\t the cohort of concern substances or excluded compounds, or\n\u2014\t substances that are not identified constituents (i.e. unknown or incomplete chemical identity).\nNOTE\u00a03\nTSL does not apply to preterm or very young infants (i.e.\u00a06 months of age or younger) because these\nindividuals have unique susceptibilities (Clause\u00a08 and C.2.2.2).\nA TSL shall not be applied to volatile compounds from gas pathway devices because inhalation specific\nTTC values are established in ISO\u00a018562-1 for these constituents.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n26\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nB.2\t Calculation of the TSL\nToxicological screening limits are based on mutagenic TTC values applicable to\u00a0the duration of exposure\nto the constituent. The toxicological screening limit can be calculated using Formula\u00a0(B.1).\nTSL = TTC \u00d7 D\n(B.1)\nwhere\n\nTSL\nis the toxicological screening limit expressed as the cumulative quantity of exposure, in \u00b5g, to\na constituent over a specified time period;\n\nD\nis the duration of exposure, in d, according to ISO\u00a010993-1:2018, 5.3.\nWhen a toxicological screening limit is used, default TTC and D values in Table\u00a0B.1 below shall be used\nto calculate the applicable TSL value and applied in accordance with Clause B.3.\nTable\u00a0B.1\u00a0\u2014 Default toxicological screening limit TTC and D for TSL calculations\nPeriod of assumed exposure\nto the constituent\nd\nTTC\ng/d\nD\nd\nTSL\n\u00b5g\n\u226430\n120\n1\n120 (i.e. 120\u00a0\u00b5g/d \u00d7 1\u00a0d)\n>30\n20\n30\n600 (i.e. 20\u00a0\u00b5g/d \u00d7 30\u00a0d)\nNOTE\u00a01\nFor long-term contact, the duration of exposure is rounded down to 30\u00a0d, instead of 31\u00a0d.\nNOTE\u00a02\nThe TTC and D values in Table\u00a0B.1 are conservative (i.e. lowest values) for dose and time dependent\nharms (e.g. genotoxicity, cancer, systemic toxicity, reproductive/developmental toxicity, see ISO/TS 21726:2019,\n5.1).\nB.3\t Application of toxicological screening limits\nWhen the TSL approach is used for any medical device, TSL\u00a0\u226430\u00a0d\u00a0=\u00a0120\u00a0\u00b5g for short-term exposure\nduration shall be used for each constituent in accordance with Table\u00a0B.2.\nFor medical devices in long-term contact with the body, TSL\u00a0 >30 d\u00a0=\u00a0 600\u00a0 \u00b5g for long-term exposure\nduration may be used for each constituent in addition to the TSL\u00a0\u226430 d value, see Table\u00a0B.2.\nTable\u00a0B.2\u00a0\u2014 Application of toxicological screening limits for TQ\nMedical device contact duration\nPeriods of assumed exposure to the constituent\n1\u00a0d\n\u226430\u00a0d\n>30\u00a0d\nLimited (\u22641\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nNot applicable\nNot applicable\nProlonged (\u226430\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nNot applicable\nLong-term (>30\u00a0d)\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0\u226430 d\u00a0=\u00a0120\u00a0\u00b5g\nTSL\u00a0>30 d\u00a0=\u00a0600\u00a0\u00b5g\nNOTE\nToxicological screening limits are not intended to replace the analytical evaluation threshold (AET)\ndescribed in ISO\u00a010993-18.\nThe toxicological screening limit can be used to evaluate the safety of extractables that exceed the AET\nconsidering the restrictions defined in Clause\u00a0B.1.\nWhen the TSL approach is used, the total quantity of each identified chemical constituent to which an\nindividual can be exposed shall be compared to the relevant TSLs in accordance with Table\u00a0B.2.\nFor single-use (disposable) medical devices that are repeatedly used and when cumulative duration\nof body contact is prolonged, the TSL\u00a0\u226430\u00a0d may be used to screen constituents that present negligible\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n27\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\ntoxicological risk for short-term exposure (see EXAMPLE\u00a06). For single-use (disposable) medical devices\nthat are repeatedly used and cumulative duration of body contact is long-term, toxicological risk for\neach constituent should be assessed in accordance with Clauses\u00a07, 8, 9 and 10.\nWhen the number or quantity of medical devices that contact the body differs from the number or\nquantity of medical devices used in the extraction study, the total quantity of each identified chemical\nconstituent extracted shall be adjusted by application of a SF using Formula\u00a0(B.2), unless justified with\nsupporting evidence that the reported total quantity represents a cumulative exposure dose.\nTQmax = TQ \u00d7 SF\n(B.2)\nwhere\n\nTQmax is the maximum total quantity, in \u00b5g, to which an individual can be exposed (i.e. cumulative\nexposure dose);\n\nTQ\nis the total quantity, in \u00b5g, present in or on, or extracted from the medical device (e.g. from\nan exaggerated or exhaustive extraction study);\n\nSF\nis the ratio of the quantity (e.g. cm2, g or ml) of medical devices that are in contact with the\nbody divided by the quantity of medical device(s) used in the extraction study.\nWhen the number of medical devices applies to the intended use (e.g. a hip implant), the maximum\nnumber of medical devices that contacts the body and the number of medical devices used in the\nextractions study shall be used to calculate the SF using Formula\u00a0(B.3), unless justified with supporting\nevidence that the reported total quantity represents the cumulative exposure dose.\nWhen the number of medical devices does not apply (e.g. the largest surface area of the medical device\nthat can contact the body is not the same as the surface area of the device which is in contact with the\nsolution during extraction), the maximum quantity (e.g. cm2, g or ml) of the medical device that is in\ncontact with the body and the quantity of the medical device used in the extraction study shall be used\nto calculate the SF using Formula\u00a0(B.3).\nSF = MDb.c. / MDa.r.s.\n(B.3)\nwhere\n\nMDb.c.\nis the maximum quantity (e.g. cm2, g or ml) of medical devices that are simultaneously in\ncontact with the body;\n\nMDa.r.s. is the quantity of medical devices used in the extraction study.\nEXAMPLES 1 to 6 are applications of toxicological screening limits.\nEXAMPLE\u00a01\nLimited or prolonged contact: When 100\u00a0 \u00b5g of an identified constituent is extracted from a\nsingle medical device and a single medical device is in contact with the body for less than or equal to 30\u00a0d (not\nrepeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430 d of 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 100\u00a0\u00d7 1 = 100\u00a0\u00b5g\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n28\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\n100\nis the reported total quantity in the extraction solvent (i.e. TQext), in\u00a0\u00b5g;\n\n1\nis the SF where 1 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by the single medical device extracted.\nShort-term exposure to the constituent is a negligible toxicological risk because TQmax is less than the\nTSL\u226430 d.\nEXAMPLE\u00a02\nLimited or prolonged contact: When 100\u00a0\u00b5g of an identified constituent is extracted from a single\nmedical device and two medical devices are in contact with the body for less than or equal to 30\u00a0d (not repeatedly\nused), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 100\u00a0\u00d7 2 = 200\u00a0\u00b5g\nwhere\n\n100\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n2\nis the SF where 2 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by\u00a0the single medical device extracted.\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL\u226430 d.\nEXAMPLE\u00a03\nLong-term contact: When 300\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice and a single medical device is in contact with the body for long-term (i.e. greater than 30\u00a0d) (not repeatedly\nused), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g and a TSL>30 d of 600\u00a0\u00b5g.\nTSL \u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTSL>30 d =\u00a020\u00a0\u00d7 30 =\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n29\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\nTQmax = 300\u00a0\u00d7 1 = 300\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n1\nis the SF where 1 is the maximum number of medical devices that are in contact with the body\ndivided by\u00a0the single medical device extracted.\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL\u00a0\u226430 d; whereas, long-term exposure to the constituent is a negligible toxicological risk because\nTQmax is less than the TSL>30 d.\nEXAMPLE\u00a04\nLong-term contact: When 320\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice and two of the same medical devices are in contact with the body at the same time for more than 30\u00a0d (not\nrepeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u226430 d of 120\u00a0\u00b5g and a TSL>30 d of\n600\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120\u00a0\u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1)\n\nTSL >30 d\u00a0=\u00a020\u00a0\u00d7 30\u00a0=\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 320\u00a0\u00b5g \u00d7 2 = 640\u00a0\u00b5g\nwhere\n\n320\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n2\nis the SF where 2 is the maximum number of medical devices that are in contact with the\nbody\u00a0divided by the single medical device extracted.\nShort-term and long-term exposure to the constituent can present a toxicological risk because TQmax is\ngreater than the TSL \u226430 d and TSL\u00a0>30 d, respectively.\nEXAMPLE\u00a05\nLong-term contact: When 300\u00a0\u00b5g of an identified constituent is extracted from a single medical\ndevice (50\u00a0cm2) and two of the same medical devices (200\u00a0cm2 each) are in contact with the body at the same\ntime (i.e. the total device surface area is equal to two devices multiplied by 200\u00a0cm2/device\u00a0which is \u00a0400\u00a0cm2)\nfor more than 30\u00a0d (not repeatedly used), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430\u00a0d of\n120\u00a0\u00b5g and a TSL\u00a0>30\u00a0d of 600\u00a0\u00b5g.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n30\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTSL\u226430 d =\u00a0120\u00a0\u00d7 1\u00a0=\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days for the\u00a0\u226430\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTSL>30 d =\u00a020\u00a0\u00d7 30\u00a0=\u00a0600\u00a0\u00b5g\nwhere\n\n20\nis the TTC for\u00a0>30\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n30\nis the number of days for the\u00a0>30\u00a0d assumed exposure time period (see Table\u00a0B.1).\n\nTQmax = 300 \u00d7 8 = 2\u00a0400\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n8\nis the SF where 400\u00a0cm2 is the maximum device surface area, in cm2, that is in contact with\nthe body\u00a0divided by the\u00a050\u00a0cm2 device surface area extracted.\nShort-term and long-term exposure to the constituent can present a toxicological risk because TQmax is\ngreater than the TSL \u226430 d and TSL\u00a0>30 d, respectively.\nEXAMPLE\u00a06\nCumulative prolonged contact:  When 300\u00a0 \u00b5g of an identified constituent is extracted from a\nsingle medical device (50\u00a0cm2) that is in contact with the body for less than one day, and a new device is used\nevery day for up to 10 days (i.e. repeat use), the application of Formulae\u00a0(B.1), (B.2) and (B.3) results in a TSL\u00a0\u226430 d\nof 120\u00a0\u00b5g.\nTSL\u226430 d\u00a0=\u00a0120 \u00d7 1 =\u00a0120\u00a0\u00b5g\nwhere\n\n120\nis the TTC for\u00a0\u226430\u00a0d (see Table\u00a0B.1), in \u00b5g/d;\n\n1\nis the number of days of contact of a single medical device.\n\nTQmax = 300 \u00d7 10 = 3\u00a0000\u00a0\u00b5g\nwhere\n\n300\nis the reported total quantity in the extraction solvent (i.e. TQext), in \u00b5g;\n\n10\nis the SF where 50\u00a0cm2 is the maximum device surface area, in cm2, that is in contact with the\nbody\u00a0divided by the\u00a050\u00a0cm2 device surface area extracted.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n31\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nShort-term exposure to the constituent can present a toxicological risk because TQmax is greater than\nthe TSL \u226430 d.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n32\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0C\n(normative)\n\nDerivation of constituent TI or TCL for select endpoints\nC.1\t General\nThe method to derive a non-cancer TI (see Clause C.2), cancer TI (see Clause C.3), or TCL (see Clause C.4)\nis described in this annex. The methods to derive a TI or TCL shall be applied when toxicological data\nfor a constituent are available, as described in Clause\u00a06 and 7.1.\nWhen toxicological data of a constituent are not available to derive a TI, then TTC shall be applied in\naccordance with 7.2.\nNOTE\nIn this annex, an uncertainty factor approach is described based on References [75] to [85].\nC.2\t Setting of TI for non-cancer endpoints\nC.2.1\t General\nFor each relevant anticipated route and duration of exposure, a TI is calculated from the NOAEL,\nLOAEL, BMDL or other value determined to be the POD (see 7.1). Each TI calculation shall account for\nuncertainty of the data and its extrapolation to intended human exposure.\nThe TI shall provide protection to the most sensitive individuals with which the medical device is in\ncontact.\nNOTE\nWhere a relevant dose-based threshold has been determined by an expert committee or regulatory\nagency for non-medical device use, it can be adapted for medical device use by applying uncertainty factors to\naddress differences in the circumstances of exposure relevant to the medical device intended use (see C.2.2 for\ntypes of uncertainties to consider for medical device uses).\nC.2.2\t Determination of uncertainty factors\nC.2.2.1\nGeneral\nSources of uncertainty shall be identified and used in the derivation of the TI. The selection of\nuncertainty factors that account for sources of uncertainty encompasses many different considerations\nto meet the requirements in 10.1. These factors consider the uncertainties inherent in estimating the\npotential effects of a constituent on exposed individual(s) (see Table\u00a0C.1).\nThe value of each uncertainty factor shall be documented, with justification for its selection. Some\nconsiderations in the selection of the appropriate uncertainty factors include variation among humans,\nspecies extrapolations and other uncertainties as described in C.2.2.2 to C.2.2.4[86]to[89].\nC.2.2.2\nUncertainty for intraspecies variation, UF(TI)1\nIntraspecies variation among humans applies to pre-term, paediatric and adults [including elderly or\npregnant women, (i.e. including the woman or foetus)] that differ in absorption, metabolism, tissue\ndistribution, excretion, elimination or biological response to constituents of toxicological concern. In\nthe absence of human data to characterize variability among adults or paediatrics (6\u00a0months of age or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n33\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nolder), a default 10-fold uncertainty factor shall be applied unless otherwise justified with supporting\nevidence.\nNOTE\u00a01\nPreterm, neonate, very young infants (i.e. 6 months or younger) and pregnant women (including the\nwoman or foetus) are potentially more vulnerable to constituents of toxicological concern due to differences\nin developmental (e.g. neurological, immunological, skeletal, reproductive or endocrine) or toxicokinetics (i.e.\nabsorption, metabolism, tissue distribution and excretion)[92]to[95].\nWhen preterm, neonate and very young infants (i.e. 6 months or younger) are exposed to chemical\nconstituents whose main elimination route is hepatic metabolism or renal excretion, an additional\nthreefold uncertainty factor shall be applied to address the immaturity of the metabolic capacity and\nrenal function[90][91].\nFor infants older than 6\u00a0months, a justification of an additional uncertainty factor can be required.\nThe uncertainty factor that accounts for intraspecies variation shall be justified and documented. An\nidiosyncratic response shall not serve as the basis for a TI value because justification of an uncertainty\nfactor protective for these individuals is generally not feasible.\nNOTE\u00a02\nIdiosyncratic means the response is specific to an individual and not the general population[96].\nNOTE\u00a03\nIn some cases, the uncertainty factor for intraspecies variation can be less than 10. For example, when\nhuman data indicate intraspecies variation is negligible or when the POD is based on the most sensitive human\nsub-population.\nC.2.2.3\nUncertainty for interspecies differences, UF(TI)2\nInterspecies uncertainty accounts for extrapolation from data derived in a species other than humans.\nIn the absence of detailed knowledge of interspecies differences in toxicity, a default 10-fold uncertainty\nfactor shall be applied unless otherwise justified with supporting evidence.\nWhen toxicity and toxicokinetics of the constituent are established and similar between human and\nthe experimental model, a smaller uncertainty factor for interspecies differences can be justified with\nsupporting evidence. The uncertainty factor that accounts for interspecies variation shall be justified\nand documented[89].\nC.2.2.4\nUncertainty from the quality and relevance of the experimental data, UF(TI)n\nUF(TI)n is used in the MF calculation (see C.2.3) when additional uncertainties related to the following\napply, which include, but are not limited to:\n\u2014\t use of short-term studies for extrapolation to longer-term exposures or effects (see C.2.2.4.2);\n\u2014\t use of LOAEL data instead of NOAEL data (see C.2.2.4.3);\n\u2014\t use of animal models of uncertain or limited relevance to the medical device user or its intended use\n(see C.2.2.4.3);\n\u2014\t use of data from different route of exposure (see C.2.2.4.1);\n\u2014\t data quality (see C.2.2.4.3).\nTable\u00a0C.1 provides types of additional uncertainties and ranges to be considered for UF(TI)n. Sources\nand numerical level of uncertainty shall be justified and documented in the report.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n34\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0C.1\u00a0\u2014 Additional uncertainty factors for consideration in the derivation of a TI\nSources of additional\nuncertainty\nTypes of additional uncertainty\nUF(TI)n\nSubclause\nRoute-to-route\nOral data to dermal application or inhalation to dermal\napplication\n1\nC.2.2.4.1\nInhalation to parenteral or inhalation to oral application\n1 to 10\nOral data to parenteral\n1 to 100\nExposure duration\nSubchronic to chronic extrapolation\n2 to 6\nC.2.2.4.2\nSubacute to chronic extrapolation\n6 to 10\nPoint-of-departure\nLOAEL to NOAEL\n3 to 10\nC.2.2.4.3\nData applicability\nUse of an analogue, state of matter (e.g. gas to solid dose)\n1 to 10\nData quality\nReliability and relevance\n1 to 10\nNOTE\nAccounting for multiple additional uncertainties each at the maximum value (i.e. 10) can result in an\nexcessively high modifying factor, see C.2.3.\nC.2.2.4.1\nRoute-to-route extrapolation\nC.2.2.4.1.1\t Oral to dermal application or inhalation data to dermal application\nWhen extrapolating a systemic toxicity POD from oral-to-dermal or inhalation-to-dermal exposure\nroutes, a default value of 1 can be justified when absorption and systemic dose by oral or inhalation\nroutes is equivalent or greater than the dermal route. Otherwise, a higher uncertainty factor shall be\napplied unless justified with supporting evidence[97]to[99].\nNOTE\nFor absorbable chemicals, time to Cmax (i.e. highest concentration) in the systemic circulation is\ntypically shorter for oral exposure compared to dermal exposure[100]to[103].\nC.2.2.4.1.2\t Inhalation data to parenteral application or inhalation data to oral application\nFor extrapolation from inhalation to parenteral routes, a default 10-fold uncertainty factor shall be\nused unless otherwise justified with supporting evidence.\nLower or higher uncertainty factors can be applied when the extent of absorption is known. For volatile\nand semi-volatile organic constituents, the rate of absorption can be higher than for non-volatile organic\nconstituents and metals. For extrapolation from inhalation to oral routes, an uncertainty factor of 1 can\nbe applied, since lower thresholds derived for inhalation compared to the oral route are due to the lack\nof a first-pass effect in inhalation studies[104].\nC.2.2.4.1.3\t Oral data to parenteral application\nOral bioavailability UFs adjust the quantity of constituent in the gastrointestinal tract that is absorbed.\nWhen extrapolating an oral POD of a constituent to parenteral exposure route (e.g. intravenous) based\non its bioavailability, the impact of pre-systemic metabolism on the systemic dose and nature of harm\n(e.g. an ingested constituent that is metabolized by the liver to lesser toxic products) shall be justified\nand documented.\nWhen a POD from an oral toxicity study is extrapolated to parenteral exposure routes (e.g. intravenous),\nthe following uncertainty factors based on oral bioavailability data (if available) can be used[105]:\n\u2014\t UF(TI)n\u00a0=\u00a0100 if oral bioavailability is\u00a0<1\u00a0%,\n\u2014\t UF(TI)n\u00a0=\u00a010 if oral bioavailability is\u00a0\u22651\u00a0% and\u00a0<50\u00a0%,\n\u2014\t UF(TI)n\u00a0=\u00a02 if oral bioavailability is\u00a0\u226550\u00a0% and\u00a0<90\u00a0%, or\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n35\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t UF(TI)n\u00a0=\u00a01 if oral bioavailability is\u00a0\u226590\u00a0%.\nAlternatively, an oral POD can be extrapolated by multiplying by the percent of oral bioavailability.\nWhen a range of oral bioavailability data are reported, the lower limit shall be used.\nExtrapolation of a POD from an oral toxicity study to parenteral exposure routes based on the above oral\nbioavailability UF or percent oral bioavailability shall be justified with supporting oral bioavailability\ndata.\nIf oral bioavailability is not known, a default value of 10 can be used[106]to[108].\nC.2.2.4.2\nExposure duration\nWhen short-term repeat exposure studies are used for extrapolation to longer-term exposures, time-\ndependent toxicities, or accumulation of the constituent in the body can occur. For extrapolation from\na subchronic study to chronic exposure, a default sixfold uncertainty factor shall be applied unless\notherwise justified with supporting evidence.\nFor extrapolation from subacute studies to chronic exposure, a default 10-fold uncertainty factor shall\nbe applied unless otherwise justified with supporting evidence.\nAn uncertainty factor of 10 should be applied when the dose-response curve is shallow or unknown.\nNOTE\nIn general, a shallow dose-response curve applies when the magnitude of the harm is only slightly\nhigher at a higher dose compared to the same harm that occurs at a lower dose of the same constituent. A BMDL\nvalue near the origin of the dose-response curve indicates the dose-response curve is shallow.\nHigher uncertainty factors may be considered when toxicity increases over time and constituents\naccumulate in the body[88][89][94][109][110][111][112][113].\nC.2.2.4.3\nPoint of departure, data applicability and data quality\nUncertainty in the applicability of toxicological data from an analogue should also be considered. The\nmagnitude of this UF should account for the extent of structural and biological similarity between\nthe analogue and the extracted compound of interest. When accounting for the quality of constituent\nspecific or analogue toxicological data used to derive the TI, for studies judged to be well designed\nfor their intended purposes and executed properly, a default uncertainty factor of 1 can be selected.\nA default 10-fold uncertainty factor shall be applied when the selected POD is obtained from a\ntoxicological study with reduced reliability or relevance[114][115].\nExamples of when a 10-fold default UF for data quality or relevance can be applied include:\n\u2014\t to account for the absence of clinically relevant toxicity data pertaining to the patient population\n(e.g. reproductive or developmental toxicity for a device used in pregnant women), or\n\u2014\t when the POD is obtained from an underpowered study (low numbers of animals or only in one sex)\nor limited number of organs collected for evaluating potential harm.\nC.2.3\t Determination of the modifying factor\nThe modifying factor shall be calculated as the product of all uncertainty factors identified in\naccordance with C.2.2.2 to C.2.2.4, as shown in Formula\u00a0(C.1).\nMF\u00a0=\u00a0UF(TI)1 \u00d7 UF(TI)2 \u00d7 UF(TI)n\n(C.1)\nwhere MF is the modifying factor.\nThe application of a large MF (e.g.\u00a0>10\u00a0000 for the general population) can overestimate a toxicological\nrisk. In these cases, toxicological risk shall be assessed by applying TTC in accordance with 7.2, or\nfurther analyse or control the toxicological risk, see 10.2.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n36\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.2.4\t Derivation of the non-cancer TI value\nAfter the POD (NOAEL, LOAEL, etc.) and the modifying factor are determined, the TI shall be calculated\nin amount (mg or \u00b5g) per kilogram body mass per day, as shown in Formula\u00a0(C.2).\nTI\u00a0=\u00a0POD\u00a0/\u00a0MF\n(C.2)\nC.3\t Setting of TI for cancer endpoints\nC.3.1\t General\nWhen human data are inadequate, the determination that a constituent can be a suspected human\ncarcinogen shall be based on the weight of evidence. Types of data used in weight of evidence include:\n\u2014\t carcinogenicity data from long-term in vivo animal studies (e.g. pre-neoplastic lesions or tumour\nfindings in animal studies);\n\u2014\t mechanistic data (e.g. genotoxicity or other modes of action involving other key characteristics).\nFor constituents that are not human carcinogens or suspected human carcinogens, the approach in\nClause\u00a07 shall be applied.\nNOTE\u00a01\nMechanistic data can be useful in a weight of evidence assessment to establish whether cancer can be\nassociated with a specified exposure dose (e.g. non-linear)[116][117][118].\nNOTE\u00a02\nKey characteristics include chemical properties and biological activities that are important elements\nof the constituent\u2019s carcinogenic mode of action. Reported key characteristics include\na)\nelectrophilic or metabolically activated,\nb)\ngenotoxic,\nc)\nalters DNA repair or makes the genome unstable,\nd)\ninduces of epigenetic changes,\ne)\ninduces oxidative stress,\nf)\ninduces chronic inflammation,\ng)\nimmunosuppressive,\nh)\nmodulates receptor-mediated effects,\ni)\ncauses cell immortalization, and\nj)\ncauses cellular proliferation or cell death, or impairs the supply of nutrients[119].\nC.3.2\t Cancer risk estimation\nC.3.2.1\nGeneral\nWhen a chemical constituent is a human carcinogen or suspected human carcinogen, cancer risk\nshall assess whether an exposure to a human carcinogen or suspected human carcinogen dose is at a\ntolerable cancer risk level.\nWhen the constituent TI is based on a cancer risk estimate, the MoS calculation shall apply a cancer risk\nthreshold that is protective for a lifetime of exposure (e.g. 70\u00a0years), unless otherwise justified.\nOther approaches used to evaluate the cancer risk of a constituent shall be justified and documented.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n37\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.3.2.2\nSlope-factor approach\nCancer risk can be estimated based on a constituent specific slope factor (if available). The slope factor,\nwhich is used to calculate [see Formula\u00a0(C.3)] the dose that corresponds to a default lifetime cancer\nrisk level of 1 in 100\u00a0000 (i.e. cancer risk specific dose), shall be used as the TI value for cancer, unless\notherwise justified with supporting evidence[120].\nCRSD\u00a0=\u00a0CRL\u00a0/\u00a0SlF\n(C.3)\nwhere\n\nCRSD is the cancer risk specific dose, in mg/kg/d;\n\nCRL\nis the cancer risk level;\n\nSlF\nis the slope factor, in (mg/kg/d)\u22121.\nNOTE\nApplication of a slope factor means the dose-response relationship at low doses is linear (i.e. non-\nthreshold mode of action). When a slope factor is used to estimate cancer risk, additional uncertainty factors are\nnot applied to derive the cancer risk specific dose.\nEXAMPLE\nThe lifetime oral cancer risk specific dose for benzene is:\n\u2014\t SlF\u00a0=\u00a00,015 (mg/kg/d)\u22121[121];\n\u2014\t CRL\u00a0=\u00a01 in 100\u00a0000 (i.e. 1 \u00d7 10\u22125);\n\u2014\t CRSD\u00a0=\u00a01 \u00d7 10\u22125\u00a0/\u00a00,015\u00a0=\u00a06,667 \u00d7 10\u22124\u00a0mg/kg/d.\nC.3.2.3\nTD50 approach\nWhen a slope factor for a human carcinogen or suspected human carcinogen is not available, an\nalternative cancer risk approach can be based on a constituent specific TD50 value (if available) as\nshown in Formula\u00a0(C.4)[74].\nCRSD\u00a0=\u00a0TD50\u00a0/\u00a050\u00a0000\n(C.4)\nwhere\n\nTD50\nis the daily dose-rate, in \u00b5g/kg body mass/d, for life, to induce tumours in half of test animals\nthat would have remained tumour-free at zero dose;\n\n50\u00a0000\nis an assumed value for estimating lifetime cancer risk level of 1 in 100\u00a0000.\nNOTE\nWhen a TD50 is used to estimate cancer risk, additional uncertainty factors are not applied to derive\nthe cancer risk specific dose.\nOther approaches used to evaluate cancer risk of a constituent shall be justified and documented.\nC.4\t Establishment of tolerable contact levels\nC.4.1\t General\nA review of constituent irritation data provides the information necessary to decide whether estimation\nof the irritation risk needs to be assessed according to this document. If constituent specific irritation\ninformation is available and applicable to the intended use of the medical device, a modifying-factor\napproach can be used to derive a constituent specific TCL that represents acceptable irritation risk[19]\n[20][84][91][103].\nNOTE\nTCLs are considered in addition to tolerable intakes unless justified and documented.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n38\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThis approach is not intended for the derivation of TCL values based on allergic contact dermatitis or\nlocal effects, except for irritation in anatomically or pharmacokinetically isolated organs (e.g. brain,\neye).\nC.4.2\t Setting of TCL for the irritation endpoint\nFor each relevant contact tissue, a TCL shall be calculated from the NIL.\nEach TCL calculation shall consider the degree of irritation from increasing concentrations of non-\nirritating doses whenever these data are available.\nA modifying-factor approach shall be used to calculate the TCL. This approach incorporates the use of a\nmodifying factor as described in C.4.4. Formula\u00a0(C.5) calculates the TCL, in \u00b5g/cm2, using the modifying-\nfactor approach.\nTCL =\u00a0NIL\u00a0/\u00a0MFTCL\n(C.5)\nwhere\n\nNIL\nis the non-irritating level from the study where the threshold was experimentally identified\nand reported, in \u00b5g/cm2;\n\nMFTCL\nis the modifying factor.\nNOTE\nWhen a NIL is absent, a MIL can be used, see C.4.3.4.\nIrritation limits should be established based upon the broadest segment of exposed individuals. When\nthe TCL is intended for specific subpopulations, the applicable data (e.g. clinical data) should be used for\nthe specific individuals for which the device is intended.\nC.4.3\t Determination of TCL uncertainty factors\nC.4.3.1\nGeneral\nThe methods used to determine the biological risk of irritation are different from those used to\ndetermine the biological risk of systemic toxicity. The chief difference is the degree of uncertainty.\nNormally, when irritation is not observed in an appropriate test model, irritation is less probable for\nhumans. Hence, there is a more limited use of multiple uncertainty factors and large margins of safety.\nNevertheless, the choice of uncertainty factors should encompass several considerations described in\nC.4.3.2, C.4.3.3 and C.4.3.4.\nC.4.3.2\nUncertainty for intraspecies variation, UF(TCL)1\nUncertainty among humans shall be addressed when deriving a TCL value. It is always preferable to\nhave actual data to assess human variation.\nIn the absence of experimental data to characterize individual variability in human response to an\nirritating leachable substance, a default 10-fold uncertainty factor, UF(TCL)1, shall be applied, unless\notherwise justified with supporting evidence. For example, other uncertainty factors, UF(TCL)1, ranging\nfrom 3 to 9 can be used if justified when the MIL or NIL is based on animal studies.\nC.4.3.3\nUncertainty for interspecies differences, UF(TCL)2\nUncertainty resulting from inherent differences between other species and humans shall be addressed.\nIt is always preferable to have data and detailed knowledge of the relationship between humans and\nthe test species.\nIn the absence of such information, a default 10-fold uncertainty factor, UF(TCL)2, shall be used unless\notherwise justified with supporting evidence.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n39\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nC.4.3.4\nUncertainty from the quality and relevance of experimental data, UF(TCL)n\nUncertainty resulting from the quality and relevance of the experimental data shall be addressed.\nWhen a MIL is used, a default threefold uncertainty factor, UF(TCL)n, shall be applied unless otherwise\njustified with supporting evidence.\nA UF of 9 shall be applied when conclusions are drawn based upon a poorly designed or executed study,\nor when the amount of relevant constituent specific irritation data is limited.\nC.4.4\t Determination of the TCL modifying factor\nThe TCL modifying factor, MFTCL, shall be calculated as a product of the uncertainty from C.4.3 as given\nin Formula\u00a0(C.6).\nMFTCL = UF(TCL)1 \u00d7 UF(TCL)2 \u00d7 UF(TCL)n\n(C.6)\nFormula\u00a0(C.5) shall serve as the basis for the TCL. In most cases, an overall modifying factor of 30 or less\nshould be sufficient but can be larger when non-irritating concentrations have not been established.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n40\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0D\n(informative)\n\nTypical assumptions for biological parameters\nD.1\t General\nThis annex provides parameters for use in assessing risk. It specifies the lifespan, daily intake of water,\ndaily intake of air, body mass and gestation period for the human, rat, mouse, hamster, guinea pig, dog\nand rabbit. These are the most common species for which data are available. This data can serve as\nthe basis for interspecies comparisons unless other data can be shown to be more appropriate. Actual\nspecies data vary somewhat in the real world.\nD.2\t Assumptions\nD.2.1\t Human\nThe parameters for humans:\n\u2014\t 70-year lifespan;\n\u2014\t 2\u00a0l/d intake of drinking water;\n\u2014\t 20\u00a0m3/24\u00a0h day air intake (adult); 10\u00a0m3/d in 8\u00a0h workday (adult)[122];\n\u2014\t 70\u00a0kg body mass for adult men; 60\u00a0kg for adult women, which is also representative of all adults in a\nworst-case assumption;\n\u2014\t 10\u00a0kg for children (>1\u00a0year to\u00a0\u226416\u00a0years of age); 3,5\u00a0kg for infants (<1\u00a0year); 1,5\u00a0kg for very low\nbirthweight infants; or 0,5\u00a0kg for very low birthweight neonates (e.g. preterm neonate);\n\u2014\t 9-month (normally 40\u00a0weeks) gestation period;\n\u2014\t 5\u00a0l blood volume (adult).\nNOTE\u00a01\nBody mass of 70\u00a0 kg and 60\u00a0 kg for an adult male, and adult female or unisex, respectively, are\nconservative for exposure dose estimation because these values are below the average for these sex-based\ngroups (e.g. a medical device use that is intended for all adults)[123]. A body mass of 50\u00a0kg, or lower, for adults\ncan be used when a more conservative approach is judged to be necessary (e.g. patients with below average body\nmass, such as: individuals of low stature or malnutrition due to an eating disorder, cancer or AIDS).\nNOTE\u00a02\nWhen the medical devices intended use is for a wide range of general patients, the use of infant body\nmass (3,5\u00a0kg) is sufficiently conservative to calculate the EEDmax for infants and the general population. When\nthe medical device intended to use is for low birthweight neonates, the use of 0,5\u00a0kg is sufficiently conservative\nto calculate the EEDmax for this subpopulation.\nD.2.2\t Rat\nThe parameters for rats are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,025\u00a0l/d of drinking water for males; 0,020\u00a0l/d for females;\n\u2014\t 0,29\u00a0m3/24\u00a0h day air intake;\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n41\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t 0,25\u00a0kg or 0,5\u00a0kg body mass for young and older adult males, respectively; 0,2\u00a0kg or 0,35\u00a0kg for\nyoung and older adult females, respectively[124];\n\u2014\t 22\u00a0d gestation period.\nD.2.3\t Mouse\nThe parameters for mice are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,005\u00a0l/d of drinking water;\n\u2014\t 0,043\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,03\u00a0kg body mass for adult males, 0,025\u00a0kg for adult females;\n\u2014\t 20\u00a0d gestation period.\nD.2.4\t Hamster\nThe parameters for hamsters are:\n\u2014\t 2-year lifespan;\n\u2014\t 0,015\u00a0l/d of drinking water;\n\u2014\t 0,086\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,125\u00a0kg body mass for adult males; 0,110\u00a0kg for adult females;\n\u2014\t 15\u00a0d gestation period.\nD.2.5\t Guinea pig\nThe parameters for guinea pigs are:\n\u2014\t 3-year lifespan;\n\u2014\t 0,085\u00a0l/d of drinking water;\n\u2014\t 0,43\u00a0m3/24\u00a0h day air intake;\n\u2014\t 0,5\u00a0kg body mass;\n\u2014\t 68\u00a0d gestation period.\nD.2.6\t Dog\nThe parameters for dogs are:\n\u2014\t 11-year lifespan;\n\u2014\t 0,5\u00a0l/d of drinking water;\n\u2014\t 7,5\u00a0m3/24\u00a0h day air intake;\n\u2014\t 16\u00a0kg body mass;\n\u2014\t 63\u00a0d gestation period.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n42\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nD.2.7\t Rabbit\nThe parameters for rabbits are:\n\u2014\t 7-year lifespan;\n\u2014\t 0,33\u00a0l/d drinking water;\n\u2014\t 1,44\u00a0m3/24\u00a0h day air intake;\n\u2014\t 3\u00a0kg body mass;\n\u2014\t 31\u00a0d gestation period.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n43\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0E\n(normative)\n\nEstimation of an exposure dose\nE.1\t General\nA worst-case estimated exposure dose, EEDmax, for each reportable constitutent shall be estimated in\naccordance with this annex, based on ISO\u00a010993-18 constituent data, unless otherwise justified with\nsupporting evidence.\nNOTE\u00a01\nInformation gathering of constituents intentionally used in the manufacture of the medical device or\nits materials of construction can be used to represent the total quantity of a constituent present in, on or can be\nextracted from the medical device. Exaggerated, exhaustive or simulated-use extractions that are conservative\nrelative to the medical device intended use can be assumed to represent a total quantity that can be extracted.\nSimulated-use extraction or leachable studies, during which data are collected at multiple time-points, can\nprovide (when appropriately justified) release kinetics information for limited, prolonged or long-term contact\nmedical devices.\nNOTE\u00a02\nISO\u00a010993-18 describes approaches for obtaining constituent exposure information, which includes\nwhen to consider conducting a simulated-use, leachable or other type of extraction study.\nNOTE\u00a03\nConstituent information from the literature can be used for exposure dose estimation when\nappropriately justified, see ISO 10993-18:2020, 5.2.2.\nNOTE\u00a04\nThe quantity of a constituent extracted from a medical device and suitable for calculating a worst-\ncase estimated exposure dose is dependent on extraction and analytical parameters, such as the number of\nmedical devices used as the test article, the method used in the preparation of the test article, the solvent(s) type\nand volume, the temperature, the duration of extraction, the number of extraction cycles (if applicable) and the\nreference standard used for quantification[23].\nWhen calculating a worst-case estimated exposure dose of a medical device constituent, the following\ncriteria shall be applied.\na)\t When TSL is not used, worst-case estimated exposure doses shall be estimated for the following\ntime periods and medical device contact categories, unless otherwise justified:\n\u2014\t <1\u00a0d for limited, prolonged and long-term contacting medical devices,\n\u2014\t 2\u00a0d to 30\u00a0d for prolonged and long-term contacting medical devices,\n\u2014\t 31\u00a0d to 365\u00a0d for long-term contacting medical devices that contact the body for\u00a0<1 year, and\n\u2014\t >366\u00a0d for long-term contacting medical devices that contact the body for\u00a0>1 year.\nb)\t When TSL is used in accordance with 6.2.1 and the total quantity of a chemical constituent that\nis present or can be extracted from medical device exceeds the TSL\u226430\u00a0d value but is less than the\nTSL>30\u00a0d value, then a worst-case estimated exposure dose shall be estimated for the following time\nperiods and applicable medical device contact categories, unless otherwise justified:\n\u2014\t <1\u00a0d for limited, prolonged or long-term contacting medical devices, and\n\u2014\t 2\u00a0d to 30\u00a0d for prolonged or long-term contacting medical devices.\nc)\nWhen TSL is used in accordance with 6.2.1 and the total quantity of a chemical constituent that is\npresent or can be extracted from a long-term contacting medical device is above the TSL>30 d value,\nthen the worst-case estimated exposure dose shall be estimated for all four time periods, unless\notherwise justified.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n44\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nWhen two or more constituents elicit the same harm at the same target organ or system and have\nthe same TI, the individual estimated exposure doses for each of the applicable constituents shall be\nsummed.\nE.2\t Exposure dose estimation based on release kinetics information\nExposure dose estimation based on release kinetics information shall be applied to identified\nconstituents using a reference standard suitable for accurate quantification and targeted chemical\nanalysis.\nWhen the medical device is categorized as limited contact with the body, or release kinetics data are\navailable for a prolonged or long-term contact medical device, the exposure dose shall be calculated\nusing Formula\u00a0(E.1).\nEEDmax\u00a0=\u00a0(HQr.k. \u00d7 SFr.k.)\u00a0/\u00a0BWL\n(E.1)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nHQr.k.\nis the highest measured quantity, in \u00b5g/d, released in a day during a release kinetics study\nthat includes data collection for the time periods from Table\u00a0E.1;\n\nSFr.k.\nis the ratio of the number or quantity (in cm2, g or ml) of medical devices that are in contact\nwith the body divided by the number or quantity of medical devices used in the extraction\nstudy;\n\nBWL\nis the lowest body mass, in kg, of an individual in contact with the medical device.\nWhen the number of medical devices that contacts the body differs from the number of medical device(s)\nused in the release-kinetics study, the reported HQr.k. does not represent the worst-case estimated\nexposure dose. To account for the difference between medical device intended use and the release\nkinetics study, the reported HQr.k. of each constituent assessed shall be adjusted by the application of a\nscaling factor, SFr.k., using Formula\u00a0(E.2).\nWhen the number of medical devices does not apply (e.g. the largest surface area of device which can\nbe in contact with the body is not the same as the surface area of the device which is in contact with\nthe solution during extraction), the maximum quantity (in cm2, g or ml) of the medical device that is in\ncontact with the body and the quantity of the medical device used in the extraction study shall be used\nto calculate the SFr.k. using Formula\u00a0(E.2).\nSFr.k.\u00a0=\u00a0MDb.c. / MDr.k.s\n(E.2)\nwhere\n\nMDb.c.\nis the maximum number or quantity (in cm2, g or ml) of medical devices that are simulta\u00ad\nneously in contact with the body;\n\nMDr.k.s.\nis the number or quantity of medical devices used in the release kinetic study.\nWhen the quantity of the medical device used varies, the worst-case (highest) SFr.k. to BWL ratio shall\nbe used, unless otherwise justified with supporting evidence.\nThe selection of specific time periods used for HQr.k. evaluation shall be documented and justified with\nthe medical device category and applicable time periods in accordance with Table\u00a0E.1, unless otherwise\njustified with supporting evidence. Selection of specific days for analysis within a Table\u00a0E.1 time period\nshould consider the constituent\u2019s expected rate of release, duration of release and quantity extracted at\neach time point [i.e. above or below a TCL, TI, TTC (if applicable) or analytical limit (if applicable)].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n45\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.1\u00a0\u2014 Selection of time periods for the evaluation of HQr.k.\nMedical device category\nTime period for obtaining release kinetics data\n\u22641\u00a0d\n2\u00a0d to 30\u00a0d\n31\u00a0d to 365\u00a0d\n\u2265366\u00a0d\nLimited (\u22641\u00a0d)\nX\nNot applicable\nNot applicable\nNot applicable\nProlonged (2\u00a0d to 30\u00a0d)\nX\nX\nNot applicable\nNot applicable\nLong-term (31\u00a0d\u00a0to\u00a0365\u00a0d)\nX\nX\nX\nNot applicable\nLong-term (\u2265366\u00a0d)\nX\nX\nX\nX\nX indicates that release data is required, or a justification for excluding it, for this medical device category and time period.\nNOTE\u00a01\nExpected rate and duration of release can be based on the constituent\u2019s physicochemical\ncharacteristics (e.g. solubility, polarity, lipophilicity, and molecular weight), feasibility of release (e.g. diffusivity\nof an additive embedded in the medical device versus impurity present on device surface), temperature and TQ\nwhen such data are available.\nThe number of time points within an exposure period shall be sufficient to address late bolus release of\nthe constituent(s), unless justified with supporting evidence that late bolus release will not occur.\nNOTE\u00a02\nLate bolus release of a chemical constituent is the release of a higher quantity after the initial or\nsteady-state release. For example, late bolus release of a chemical constituent can occur when the medical device\ndegrades (e.g. wear/corrosion of a material of construction) over multiple days (e.g. prolonged or long-term).\nWhen the HQ of a constituent is obtained by extraction and quantification methods that are conservative\nrelative to the medical device intended use, the HQ of each constituent may be assumed to be adequate\nto calculate a worst-case estimated exposure dose, EEDmax.\nWhen the HQ of a reportable constituent does not represent the highest measured quantity released in\na day based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed by other means according to ISO 10993-1 and ISO 14971.\nEXAMPLES 1 and 2 give exposure dose estimation based on release kinetics information.\nEXAMPLE 1\nConstituent release is quantified for multiple days (i.e. same device is repeatedly extracted for\n24\u00a0h using fresh solvent). The medical device intended use information includes the following:\n\u2014\t externally communicating and prolonged contact;\n\u2014\t body contact is daily for 25\u00a0d;\n\u2014\t a single medical device is in contact with the body of a patient;\n\u2014\t the test article extracted is a single final medical device of largest configuration;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t SFr.k.\u00a0=\u00a01 (i.e. 1 device is used per patient and 1 device was used in the extract).\nThe quantities extracted each day and calculated daily worst-case exposures, per Formula\u00a0(E.1), are presented in\nTable\u00a0E.2.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n46\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.2\u00a0\u2014 Clause E.2, EXAMPLE 1 \u2014 EEDmax values for a constituent per Formula\u00a0(E.1)\nTime period\nd\nExtraction\nday\nHQr.k.\n\u00b5g\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.1)\n\u22641\n1\n12\u00a0000\n200\n200\u00a0\u00b5g/kg/d\u00a0=\u00a0(12\u00a0000\u00a0\u00d7\u00a01)\u00a0/\u00a060\n2\u00a0to 25\n2\n1\u00a0500\n25\n25\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0500\u00a0\u00d7\u00a01)\u00a0/\u00a060\n3\n200\n3,3\n3,3\u00a0\u00b5g/kg/d\u00a0=\u00a0(200\u00a0\u00d7\u00a01)\u00a0/\u00a060\n4\n<LOD\nNot applicable\nNot applicable\nExtraction duration\u00a0is\u00a024\u00a0h at 37\u00a0\u00b0C.\nSFr.k.\u00a0=\u00a01\nBWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 200\u00a0\u00b5g/kg/d and 25\u00a0\u00b5g/kg/d (i.e. highest in each time period) are used to assess\ntoxicological risk of the constituent for the two time periods (i.e.\u00a0\u22641\u00a0d and 2\u00a0d to 25\u00a0d, respectively).\nEXAMPLE 2\nConstituent release is quantified for multiple days (i.e. same device is repeatedly extracted for\n24\u00a0h using fresh solvent). Device intended use information is the following:\n\u2014\t externally communicating and prolonged contact;\n\u2014\t body contact is daily for 10\u00a0d (maximum);\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t up to 5 devices are in contact with the body of a patient;\n\u2014\t the medical device configuration with the largest surface area is 150\u00a0cm2;\n\u2014\t the test article extracted is representative of the final device with a surface area of 100\u00a0cm2;\n\u2014\t SFr.k. is 7,5 (i.e. 5\u00a0\u00d7\u00a0150\u00a0cm2\u00a0/\u00a0100\u00a0cm2).\nThe quantities extracted each day and calculated daily worst-case exposures, per Formula\u00a0(E.1), are presented in\nTable\u00a0E.3.\nTable\u00a0E.3\u00a0\u2014 Clause E.2, EXAMPLE 2 \u2014 EEDmax values for a constituent per Formula\u00a0(E.1)\nTime period\nd\nExtraction\nday\nHQr.k.\n\u00b5g\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.1)\n\u22641\n1\n12\u00a0000\n1\u00a0500\n1\u00a0500\u00a0\u00b5g/kg/d\u00a0=\u00a0(12\u00a0000\u00a0\u00d7 7,5) / 60\n2 to 10\n\n2\n1\u00a0500\n187\n187\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0500 \u00d7 7,5) / 60\n3\n500\n62,5\n62,5\u00a0\u00b5g/kg/d\u00a0=\u00a0(500 \u00d7 7,5) / 60\n4\n200\n25\n25\u00a0\u00b5g/kg/d\u00a0=\u00a0(200 \u00d7 7,5) / 60\n5\n<LOD\nNot applicable\nNot applicable\nExtraction duration\u00a0is\u00a024\u00a0h at 37\u00a0\u00b0C.\nSFr.k.\u00a0=\u00a07,5\nBWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 1\u00a0500\u00a0\u00b5g/kg/d and 187\u00a0\u00b5g/kg/d are used to assess toxicological risk for the two time\nperiods (i.e.\u00a0\u22641\u00a0d and 2\u00a0d to 10\u00a0d, respectively).\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n47\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nE.3\t Worst-case exposure dose estimation based on maximum release\nE.3.1\t General\nWhen the medical device contact is categorized as prolonged or long-term contact and release\nkinetics data are not available, the exposure dose can be calculated using Formula\u00a0(E.3). For limited\ncontact medical devices, calculation of the worst-case estimated exposure dose shall be performed in\naccordance with Clause E.2.\nEEDmax\u00a0=\u00a0(TQ \u00d7 SFa.r.)\u00a0/\u00a0BWL\u00a0/\u00a0Rd\n(E.3)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nTQ\nis the total quantity, in \u00b5g, present in or on, or extracted from the medical device (e.g. from\nan exaggerated or exhaustive extraction study);\n\nSFa.r.\nis the scaling factor applied when the assumed release is used;\n\nBWL\nis the lowest body mass, in kg, of an individual in contact with the medical device;\n\nRd\nis the assumed release duration, in d, (i.e. lowest number of medical device exposure days),\nconsidering the ISO\u00a010993-1 exposure category applicable to the medical device.\nAssumed (i.e. default) release durations, Rd, shall be applied based on the shortest duration of\nconstituent exposure of each period of assumed exposure as presented in Table\u00a0E.4, unless otherwise\njustified with supporting evidence.\nTable\u00a0E.4\u00a0\u2014 Selection of default Rd values\nMedical device contact\nduration category\nRd for each time period of assumed constituent exposure\nd\n\u22641\u00a0d\n2\u00a0d\u00a0to\u00a030\u00a0d\n31\u00a0d\u00a0to\u00a0365\u00a0d\n\u2265366\u00a0d\nProlonged (\u226430\u00a0d)\n1\n2\nNot applicable\nNot applicable\nLong-term (31\u00a0d\u00a0to\u00a0365\u00a0d)\n1\n2\n31\nNot applicable\nLong-term (\u2265366\u00a0d)\n1\n2\n31\n366\nRd value indicates when it is used to calculate a worst-case estimated exposure dose unless otherwise justified.\nNOTE\u00a01\nConservatively, chronic exposure for humans ranges from 365\u00a0d to a lifetime.\nNOTE\u00a02\nSelecting the fewest number of days that the medical device contacts the body in each medical device\ncontact category is a conservative approach for exposure dose estimation.\nWhen the number of medical devices that contacts the body differs from the number of medical\ndevice(s) used in the extraction study, then the reported TQa.r. will not represent the worst-case\nestimated exposure dose. To account for the difference between medical device intended use and the\nextraction study, the reported TQa.r. of each constituent assessed shall be adjusted by application of a\nscaling factor, SFa.r., using Formula\u00a0(E.4).\nWhen the number of medical devices does not apply (e.g. the largest surface area of device which can\nbe in contact with the body is not the same as the surface area of the device which is in contact with the\nsolution during extraction), the maximum quantity (in cm2, g, or ml) of the medical device that contacts\nthe body and the quantity of the medical device used in the extraction study shall be used to calculate\nthe SFa.r.\nSFa.r.\u00a0=\u00a0MDb.c. / MDa.r.s\n(E.4)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n48\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\nMDb.c.\nis the maximum number or quantity (in cm2, g, or ml) of medical devices that simultane\u00ad\nously contact the body;\n\nMDa.r.s.\nis the number or quantity of medical devices used in the extraction study.\nWhen the TQ of a constituent is obtained by extraction and quantification methods that are conservative\nrelative to the medical device intended use, the TQ of each reportable constituent may be assumed to\nrepresent a cumulative exposure dose and adequate for calculating a worst-case estimated exposure\ndose, EEDmax.\nWhen the TQ of a reportable constituent that can be extracted does not represent a cumulative exposure\ndose based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed by other means according to ISO 10993-1 and ISO 14971.\nFor single-use (disposable) medical devices where the cumulative exposure duration can exceed 30\u00a0d,\nthe default Rd value in Table\u00a0E.4 that applies to the contact duration of a new single-use medical device\nshall be used for each time period of assumed constituent exposure greater than 1\u00a0d, unless otherwise\njustified with supporting exposure information (i.e. the design of the extraction study and the worst-\ncase exposure scenario), see EXAMPLES 2, 3, and 4.\nNOTE\u00a03\nThe toxicological risk of a medical device constituent can be underestimated when an Rd higher than\n2 is used for a repeatedly used single-use (disposable) limited or prolonged contacting medical device where the\ncumulative exposure duration can exceed 30\u00a0d.\nWhen the size or the quantity of the medical devices used varies depends on individual size, the worst-\ncase (highest) SFa.r. to BWL ratio should be used.\nEXAMPLE 1 to 4 give the exposure dose estimation based on the assumed maximum release.\nEXAMPLE 1\nConstituent TQ is obtained from formulation and manufacturing process data or by exhaustively\nextracting the medical device using analytically expedient solvents. The medical device intended use information\nincludes the following:\n\u2014\t implanted, tissue or bone, and long-term contact;\n\u2014\t body contact is daily for more than 10\u00a0years;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t up to 2 medical devices can be implanted during a patient\u2019s life;\n\u2014\t the medical device configuration with the largest surface area is 150\u00a0cm2;\n\u2014\t the test article extracted is representative of the final device with a surface area of 100\u00a0cm2;\n\u2014\t SFa.r. . is 3 (i.e. 3\u00a0=\u00a02\u00a0\u00d7\u00a0150\u00a0/\u00a0100);\n\u2014\t TQ present or extracted is 10\u00a0000\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.5.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n49\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.5\u00a0\u2014 Clause E.3, EXAMPLE 1 \u2014 EEDmax values per Formula\u00a0(E.3) for long-term tissue/\nbone implant\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n10\u00a0000\n1\n500\n500\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060/\u00a01\n2\u00a0to\u00a030\n10\u00a0000\n2\n250\n250\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n10\u00a0000\n31\n16\n16\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a031\n\u2265366\n10\u00a0000\n366\n1,4\n1,4\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0000 \u00d7 3)\u00a0/\u00a060\u00a0/\u00a0366\nSFa.r.\u00a0=\u00a03\nThe EEDmax values of 500\u00a0\u00b5g/kg/d, 250\u00a0\u00b5g/kg/d, 16\u00a0\u00b5g/kg/d, and 1,4\u00a0\u00b5g/kg/d are used to assess toxicological\nrisk for each time period, respectively, of assumed constituent exposure.\nEXAMPLE 2\nConstituent TQ is obtained from formulation and manufacturing process data or by exaggerated\nextraction of five single-use (disposable) medical devices using analytically expedient solvents. The medical\ndevice intended use information includes the following:\n\u2014\t body contact is in a breached or compromised surface;\n\u2014\t body contact duration of a new medical device is limited (\u226424\u00a0h);\n\u2014\t cumulative exposure duration from repeat use is more than 30 days (i.e. long-term);\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t five new medical devices are used each day;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 5, is equal to the number of medical devices that are\nin contact with the body, 5);\n\u2014\t TQ of a constituent present or extracted from the five medical devices is 900\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.6.\nTable\u00a0E.6\u00a0\u2014 Clause E.3, EXAMPLE\u00a02 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 24\u00a0h\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n2 to\u00a030\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n31\u00a0to\u00a0365\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n\u2265366\n900\n1\n15\n15\u00a0\u00b5g/kg/d\u00a0=\u00a0(900 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\nExaggerated extraction at 50\u00a0\u00b0C; SFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 15\u00a0\u00b5g/kg/d, 15\u00a0\u00b5g/kg/d, 15\u00a0\u00b5g/kg/d and 15\u00a0\u00b5g/kg/d are used to assess the toxicological\nrisk of the constituent for each time period, respectively, of assumed constituent exposure.\nEXAMPLE 3\nConstituent TQ is obtained from formulation and manufacturing process data or by exaggerated\nextraction of the medical device using analytically expedient solvents. The medical device intended use\ninformation includes the following:\n\u2014\t single-use (disposable) medical device in a breached or compromised surface;\n\u2014\t contact duration of a new medical device is 3\u00a0d;\n\u2014\t cumulative exposure duration from repeat use is more than 30\u00a0days (i.e. long-term);\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n50\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t 1 new medical device is used per procedure;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 1, is equal to the number of medical devices that are\nin contact with the body, 1);\n\u2014\t TQ of a constituent present or extracted is 1\u00a0200\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ represents\nthe cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.7.\nTable\u00a0E.7\u00a0\u2014 Clause E.3, EXAMPLE 3 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 3\u00a0d\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n1\u00a0200\n1\n20\n20\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200\u00a0\u00d7 1)\u00a0/\u00a060\u00a0/\u00a01\n2\u00a0to\u00a030\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n\u2265366\n1\u00a0200\n2\n10\n10\u00a0\u00b5g/kg/d\u00a0=\u00a0(1\u00a0200 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\nExaggerated extraction for 3 d at 50\u00a0\u00b0C; SFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg.\nThe EEDmax values of 20\u00a0\u00b5g/kg/d, 10\u00a0\u00b5g/kg/d, 10\u00a0\u00b5g/kg/d, and 10\u00a0\u00b5g/kg/d are used to assess toxicological risk of\nthe constituent for each of the time periods, respectively, of assumed constituent exposure.\nEXAMPLE 4\nConstituent TQ is obtained from formulation and manufacturing process data or by exhaustive\nextraction of the medical device using analytically expedient solvents. The medical device intended use\ninformation includes the following:\n\u2014\t single-use (disposable) medical device in a breached or compromised surface;\n\u2014\t contact duration of a new medical device is 60\u00a0days (i.e. long-term);\n\u2014\t cumulative exposure duration from repeat use is more than 2\u00a0years;\n\u2014\t used in adults only (BWL\u00a0=\u00a060\u00a0kg, unisex);\n\u2014\t 1 new medical device is used per procedure;\n\u2014\t the test article extracted is representative of the final device;\n\u2014\t SFa.r. is 1 (i.e. the number of medical devices extracted, 1, is equal to the number of medical devices that are\nin contact with the body, 1);\n\u2014\t TQ of a constituent present or extracted is 10\u00a0400\u00a0\u00b5g.\nThe calculated daily worst-case estimated exposure doses, per Formula\u00a0(E.3), and considering that TQ\nrepresents the cumulative quantity released daily for all exposure periods, are presented in Table\u00a0E.8.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n51\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0E.8\u00a0\u2014 Clause E.3, EXAMPLE 4 \u2014 EEDmax values per Formula\u00a0(E.3) for a single-use\n(disposable) device with cumulative long-term exposure from repeat use every 60\u00a0d\nTime period\nd\nTQ\n\u00b5g\nRd\nd\nEEDmax\n\u00b5g/kg/d\nFormula\u00a0(E.3)\n\u22641\n10\u00a0400\n1\n173\n173\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060 /\u00a01\n2\u00a0to\u00a030\n10\u00a0400\n2\n87\n87\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a02\n31\u00a0to\u00a0365\n10\u00a0400\n31\n5,6\n5,6\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a031\n\u2265366\n10\u00a0400\n31\n5,6\n5,6\u00a0\u00b5g/kg/d\u00a0=\u00a0(10\u00a0400 \u00d7 1)\u00a0/\u00a060\u00a0/\u00a031\nSFa.r.\u00a0=\u00a01; BWL\u00a0=\u00a060\u00a0kg\nThe EEDmax values of 173\u00a0 \u00b5g/kg/d, 87\u00a0 \u00b5g/kg/d, 5,6\u00a0 \u00b5g/kg/d and 5,6\u00a0 \u00b5g/kg/d are used to assess\ntoxicological risk of the constituent for each of the time periods, respectively, of assumed constituent\nexposure.\nE.3.2\t Alternative method to calculating an EEDmax based on maximum release\nAn alternative method to calculating an EEDmax is to apply Formula\u00a0(E.3) with a single Rd value of 1\u00a0d,\nregardless of medical device contact category. This worst-case assumption is generally protective;\nhowever, this assumption can result in overestimation of an EEDmax.\nNOTE\nAssuming that the release duration, Rd, is one day regardless of medical device contact category\npresumes the total extractable quantity, TQ, of the constituent is released each day for the entire exposure\nduration. This assumption is more representative of release kinetics when a new medical device is in contact\nwith the body every day for the entire exposure duration. This assumption is generally not representative of\nrelease kinetics for a long-term implant.\nE.4\t Exposure dose estimation of an irritant\nWhen estimating an exposure dose of an irritant, the exposure dose, in \u00b5g/cm2, shall be calculated\nusing Formula\u00a0(E.5).\nEEDmax\u00a0=\u00a0HQi\u00a0/\u00a0SAext\n(E.5)\nwhere\n\nEEDmax\nis the estimated exposure dose that represents worst-case exposure of a constituent;\n\nHQi\nis the highest quantity, in \u00b5g, of an irritant, i, released during a day when release kinetics\ndata are available or assuming release occurs in one day;\n\nSAext\nis the body contacting surface area, in cm2, of the medical device used in the extraction or\nin the release kinetics study.\nNOTE\nFor more information on the highest quantity based on release kinetics data, see Formula\u00a0 (E.1)\n(e.g.\u00a0HQr.k.).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n52\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nAnnex\u00a0F\n(informative)\n\nReporting of toxicological risk assessment information\nF.1\t General\nToxicological data for each constituent, justifications and methods used in the derivation and evaluation\nof a constituent exposure dose for documenting in the report are summarized in this annex. This\ninformation can facilitate a review process; however, reporting the information specified in this annex\nalone does not establish conformance to all of the requirements in this document.\nF.2 Required justifications\nKey justifications that can be included in the report are summarized in Table\u00a0 F.1. The types of\nrequirements and their applicability are summarized in Table\u00a0F.1.\nTable\u00a0F.1\u00a0\u2014 Summary of justifications to include in the report\nType of requirement and applicability\nSpecific clause\u00a0and subclauses\nWhenever the TRA is conducted\nClause 5 and Clause\u00a011\nWhen to apply 6.2.1, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010\nand Clause\u00a011\n6.1\nHarms other than genotoxicity, cancer, systemic toxicity,\nreproductive or developmental toxicity, or irritation\n6.1\nIdentification of hazardous constituents that are relevant to\nmedical device intended use\n6.2.1 to 6.2.3 and Annex\u00a0A\nApplication of TSL\n6.2.2 and B.1 to B.3\nIdentification of human carcinogen or suspected human\ncarcinogen\n6.2.3\nIdentification and selection of the POD from a constituent\nspecific toxicity study b\n6.2.4\nDerivation of TCL or TI value a,b\n7.1 and Annex C\nApplication of TTC a,b\n7.2\nWhenever the TRA is conducted a,b\nClause\u00a08 and Annex E\nCalculation of constituent MoS b,c\nClause 9\nApplication of acceptance criteria b,c\nClause 10\na\nSee 7.1, 7.2 and Clause 8, when requirements specific to TCL, TI, TTC (if applicable) and EEDmax,\nrespectively, apply.\nb\nRequirement applies when constituent specific harm is relevant and either TSL is not used or constituent\nTQ exceeds TSL.\nc\nToxicological risk evaluation of constituents does not address all applicable medical device risks.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n53\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nF.3 Constituent, medical device use and constituent specific toxicological risk\nassessments\nThe following data can be important to address in the report:\n\u2014\t constituent information:\n\u2014\t constituent name;\n\u2014\t CAS RN;\n\u2014\t InchlKey or SMILES code (i.e. constituent molecular structure);\n\u2014\t TQ extracted, in \u00b5g;\n\u2014\t description of the medical device;\n\u2014\t description of the medical device intended use;\n\u2014\t medical device name;\n\u2014\t part(s) name(s) (if applicable);\n\u2014\t number of devices that contact body;\n\u2014\t frequency and duration of body contact;\n\u2014\t demographics of individual(s) exposed to the device (e.g. age, sex, mass, disease state);\n\u2014\t use of device in infants less than 6 months of age, if applicable;\n\u2014\t constituent specific toxicological data (see Clause\u00a06);\n\u2014\t harm, including type (e.g. genotoxicity, cancer, systemic toxicity, reproductive or developmental\ntoxicity, or irritation), magnitude of the response (e.g. continuous data) and frequency of occurrence\n(e.g. discrete data);\n\u2014\t test specific methodology information:\n\u2014\t test species, strain, sex, age and number;\n\u2014\t route and method;\n\u2014\t vehicle;\n\u2014\t number and range of doses administered;\n\u2014\t POD for the reported critical harm (i.e. harm with the lowest POD where same units and same\nexposure duration apply);\n\u2014\t frequency and duration of dosing;\n\u2014\t information source;\n\u2014\t toxicological screening limit data (see 6.2.2);\n\u2014\t cohort of concern or excluded status;\n\u2014\t comparison of TQ to TSL\u226430 d or TSL>30 d (if used);\n\u2014\t tolerable contact level and tolerable intake data (see Clause\u00a07);\n\u2014\t POD, in \u00b5g/kg/d;\n\u2014\t UF (TI/TCL)1;\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n54\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n\u2014\t UF (TI/TCL)2;\n\u2014\t UF (TI/TCL)n;\n\u2014\t MF;\n\u2014\t TI, in \u00b5g/kg/d;\n\u2014\t TCL, in \u00b5g/cm2;\n\u2014\t exposure dose estimate, EEDmax, data (see Clause\u00a08), in \u00b5g/cm2 or \u00b5g/kg/d, based on\n\u2014\t HQr.k., TQa.r., or HQi (for irritation), see Clauses E.2, E.3 or E.4, respectively,\n\u2014\t SFr.k. or SFa.r., or SAext (for irritation), see Clauses E.2, E.3 or E.4, respectively,\n\u2014\t BWL (kg), see Clauses E.3 or E.4, and\n\u2014\t Rd value if SFa.r. is used (see Clauses E.4 for application of a single or multiple Rd values);\n\u2014\t MoS values (see Clause\u00a09).\nF.4\t Examples of tabulating toxicological risk assessments\nTables\u00a0F.2 to F.9 are examples of how the toxicological risk information can be summarized.\nTable\u00a0F.2\u00a0\u2014 Medical device specific information\nDevice information\nDescription\nDevice name\n\nDevice part(s) with body contact (if applicable)a\nNumber or quantity of devices contacting body\n\nFrequency and duration of body contactb\n\nIndividual(s) exposed to the devicec\n\na\nApplicable when some, but not all, surfaces of the device that contacts the body.\nb\nExamples of frequency are continuous, discontinuous, or single-use (disposable) repeated. Examples of contact\nduration are:\u00a0\u226430 d, >30 d but\u00a0\u2264365 d, or\u00a0>365 d.\nc\nFor example: men (70\u00a0kg), women or unisex (60\u00a0kg or lower), children (>1 year to\u00a0\u226416 years of age; 10\u00a0kg), infants\n(<1\u00a0year; 3,5\u00a0kg) and very low birthweight infants (1,5\u00a0kg), see D.2.1.\nTable\u00a0F.3\u00a0\u2014 TSL information\nConstituent name\nCAS RNa\nTQ extracted\n\u00b5g\nIs constituent\nexcluded from TSLb?\nIs TQ less than\nTSL \u226430 dc?\nIs TQ less than\nTSL\u00a0>30 dc?\nChemical 1\n\n\nY/N\nY/N/NA\nY/N/NA\nChemical 2\n\n\nY/N\nY/N/NA\nY/N/NA\nChemical X\n\n\nY/N\nY/N/NA\nY/N/NA\na\nCAS RN, InchlKey or SMILES code.\nb\nYes (Y) means constituent is a cohort of concern or excluded chemical; No (N) means constituent is not a cohort of\nconcern or excluded chemical.\nc\nYes (Y) means total quantity is too low to present a short-term or long-term toxicological risk (i.e. negligible\ntoxicological risk); No (N) means toxicological risk assessment for short-term, long-term, or both is recommended; Not\napplied (NA) means TSL is not used to assess negligible toxicological risk.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n55\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0F.4\u00a0\u2014 Constituent specific toxicological information\n[Constituent name / chemical abstract service number]\nTest species /\nstrain /sex /\nage / number\nExposure determinants\nToxicological information\nInformation\nsource\nRoutea /\nmethodb\nVehiclec\nFrequency /\ndurationd\nType of harm\nreportede\nType of\nPODf\nPOD valueg\n\n\n\n\n\n\n\n\na\nFor example: oral, subcutaneous, intravenous.\nb\nFor example: gavage, injection and instillation.\nc\nFor example: water, feed and normal saline.\nd\nFor example: every x number of hour(s), day(s) and week(s).\ne\nFor example: genotoxicity, cancer, non-organ specific systemic toxicity, organ specific systemic toxicity (specify organ\nand system), reproductive toxicity and developmental toxicity.\nf\nFor example: NOAEL, LOAEL, BMDL, slope-factor, TD50, NIL or MIL.\ng\nEither \u00b5g/cm2 (NIL or MIL) or \u00b5g/kg/d (NOAEL, LOAEL, BMDL, or slope-factor or, TD50).\nTable\u00a0F.5\u00a0\u2014 Tolerable contact level and tolerable intake information\nConstituent\nname\nCAS RN\nHarma\nPODb\n\u00b5g/kg/day\nUF(TI/TCL)1\nUF(TI/TCL)2\nUF(TI/TCL)n\nMF\nTIc or TCLd\nChemical 1\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\na\nHarm includes irritation, systemic toxicity (acute, subacute, subchronic, chronic), genotoxicity, carcinogenicity,\nreproductive or developmental toxicity.\nb\nAlternately, POD is expressed in \u00b5g/cm2 for TCL derivation.\nc\nTI is expressed in \u00b5g/kg/d.\nd\nTCL is expressed in \u00b5g/cm2.\nTable\u00a0F.6\u00a0\u2014 Threshold of toxicological concern information\nConstituent name\nCAS RNa\nQuantity extracted\n\u00b5g\nIs constituent excluded\nfrom TTC?b\nIs the quantity less than\nTTC?c\nChemical 1\n\n\nY/N\nY/N/NA\nChemical 2\n\n\nY/N\nY/N/NA\nChemical X\n\n\nY/N\nY/N/NA\na\nCAS RN, or InchlKey or SMILES code.\nb\nYes (Y) means constituent is a cohort of concern or excluded chemical; no (N) means constituent is not a cohort of\nconcern or excluded chemical.\nc\nYes (Y) means quantity extracted is negligible toxicological risk; no (N) means toxicological risk assessment for either\nshort-term, long-term, or both, is recommended; not applied (NA) means TTC is not used to assess toxicological risk.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n56\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a0F.7\u00a0\u2014 Estimated exposure dose\nConstituent\nname\nCAS RN\nHQ or TQ\nextracted\nSFr.k.\nor\nSFa.r.\nBWL\nkg\nEEDmax\n(\u22641\u00a0d)a\nEEDmax\n(2\u00a0d\u00a0to\u00a030\u00a0d)b\nEEDmax\n(31\u00a0d\u00a0to\u00a0365\u00a0d)c\nEEDmax\n(\u2265366\u00a0d)c\n\u00b5g\nRdd\nd\nEED\n\u00b5g/kg/d\nRdd\nd\nEED\n\u00b5g/\nkg/d\nRdd\nd\nEED\n\u00b5g/kg/d\nRdd\nd\nEED\n\u00b5g/kg/d\nChemical 1\n1\n2\n31\n366\nChemical 2\n1\n2\n31\n366\nChemical X\n1\n2\n31\n366\na\nApplicable for medical devices with limited, prolonged and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nFor TQ data, Rd is the default value in Table\u00a0E.4. For HQ data, 1 d applies, see Clause\u00a0E.2. For Rd applicable to single use (disposable) devices with\nprolonged or long-term cumulative exposure, see Clause\u00a0E.4.\nTable\u00a0F.8\u00a0\u2014 Calculations of the margin of safety values\nConstituent\nname\nCAS RN\nMoS (\u22641\u00a0d)a\nMoS (2\u00a0d\u00a0to 30\u00a0d)b\nMoS (31\u00a0d\u00a0to\u00a0365\u00a0d)c\nMoS (\u2265366\u00a0d)c\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nTId/TCLe\nEEDmaxf\nMoS\nChemical 1\n\n\n\n\n\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\n\n\n\n\n\na\nApplicable for medical devices with limited, prolonged, and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nTI is expressed in \u00b5g/kg/d.\ne\nTCL is expressed in \u00b5g/cm2.\nf\nEEDmax is expressed in \u00b5g/kg/d when a TI is used, or \u00b5g/cm2 when a TCL is used.\nTable\u00a0F.9\u00a0\u2014 Summary of margin of safety evaluation\nConstituent\nname\nCAS RN\nMoS (\u22641\u00a0d)a\nMoS (2\u00a0d\u00a0to 30\u00a0d)b\nMoS (31\u00a0d\u00a0to\u00a0365\u00a0d)c\nMoS (\u2265366\u00a0d)c\nMoS\nConclusiond\nMoS\nConclusiond\nMoS\nConclusiond\nMoS\nConclusiond\nChemical 1\n\n\n\n\n\n\n\n\n\nChemical 2\n\n\n\n\n\n\n\n\n\nChemical X\n\n\n\n\n\n\n\n\n\na\nApplicable for medical devices with limited, prolonged and long-term contact duration.\nb\nApplicable for medical devices with prolonged and long-term contact duration.\nc\nApplicable for medical devices with long-term contact duration.\nd\nConclusions can include:\n\u2014\ntoxicological risk is tolerable (i.e. EEDmax is without appreciable harm to health), or\n\u2014\npossible toxicological risk (i.e. EEDmax is, or can be, with appreciable harm to health), see 10.2.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n57\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nBibliography\n[1]\nCRUMP, K. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984,\n4 pp.\u00a0854\u2013871\n[2]\nUS EPA, Benchmark dose technical guidance. 2012. https://\u200bwww\u200b.epa\u200b.gov/\u200bsites/\u200bproduction/\u200b\nfiles/\u200b2015\u200b-01/\u200bdocuments/\u200bbenchmark\u200b_dose\u200b_guidance\u200b.pdf\n[3]\nInternational Agency for Research on Cancer. Agents classified by the IARC monographs.\n2013, 1\u2013108. Lyon, France. Available at https://\u200bwiki\u200b.cancer\u200b.org\u200b.au/\u200bpolicy/\u200bIARC\u200b_classifications\n[4]\nNational Cancer Institute. Environmental Carcinogens and Cancer Risk. 2019. U.S. National\nInstitute of Health. Bethesda, Maryland. Available at https://\u200bwww\u200b.cancer\u200b.gov/\u200babout\u200b-cancer/\u200b\ncauses\u200b-prevention/\u200brisk/\u200bsubstances/\u200bcarcinogens\n[5]\nWATSON W. On byproducts and side products. Org. Process. Res. Dev. 2012, 16 p. 1877 URL:\nhttps://\u200bdoi\u200b.org/\u200b10\u200b.1021/\u200bop300317g\n[6]\nIARC, IARC Monographs Preamble. International Agency for Research on Cancer (IARC). 2019.\nURL:\nhttps://\u200bmonographs\u200b.iarc\u200b.who\u200b.int/\u200biarc\u200b-monographs\u200b-preamble\u200b-preamble\u200b-to\u200b-the\u200b-iarc\u200b\n-monographs/\u200b\n[7]\nNTP, Report on Carcinogens Process & Listing Criteria. National Toxicology Program (NTP).\nU.S. Department of Health and Human Services. URL: https://\u200bntp\u200b.niehs\u200b.nih\u200b.gov/\u200bwhatwestudy/\u200b\nassessments/\u200bcancer/\u200bcriteria/\u200bindex\u200b.html\n[8]\nEPA\u2019s Integrated Risk Information System (IRIS). URL: http://\u200bwww\u200b.epa\u200b.gov/\u200biris\n[9]\nChandrasekar  V. et al., Conservative Exposure Predictions for Rapid Risk Assessment of\nPhase-Separated Additives in Medical Device Polymers. Ann. Biomed. Eng. 2018,  46 pp.\u00a014\u201324\n[10]\nLiu  J.-M. et al., Assessment of migration regularity of phthalates from food packaging materials.\nFood Science & Nutrition. 2020,  8 pp.\u00a05738\u20135747\n[11]\nSaylor  D.M. et al., Advances in predicting patient exposure to medical device leachables.\nMEDICAL DEVICES & SENSORS. 2020, e10063. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.1002/\u200bmds3\u200b.10063\n[12]\nFood and Agriculture Organization of the United Nations, World Health Organization (FAO/\nWHO). Environ. Health Criteria. 2009, p.\u00a0240 [Principles and Methods for the Risk Assessment of\nChemicals in Food.]\n[13]\nUnited States Environmental Protection Agency (EPA). Framework for Human Health Risk\nAssessment to Inform Decision Making. 2014. URL: https://\u200bwww\u200b.epa\u200b.gov/\u200brisk/\u200bframework\u200b\n-human\u200b-health\u200b-risk\u200b-assessment\u200b-inform\u200b-decision\u200b-making\n[14]\nEuropean Chemicals Agency (ECHA), Guidance on Information Requirements and Chemical\nSafety Assessment. URL: https://\u200becha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b\n-requirements\u200b-and\u200b-chemical\u200b-safety\u200b-assessment\n[15]\nJohansen  J. D., Mahler  V., Lepoittevin  J.P., Frosch  P. J., Eds. Contact Dermatitis,  6th ed.\n2021.  Springer Cham.  New York, NY\n[16]\nBormann  J. L.,  Maibach  H. I., Draize Human Repeat Insult Patch Test (HRIPT): Seven Decades\nof Pitfalls and Progress. Regulatory Toxicology and Pharmacology. 2021,  121, p. 104867\n[17]\nBernard  L. J., Hostynek  J. J., Maibach  H. I., Chapter 12 Allergic Contact Dermatitis: Elicitation\nThresholds of Potent Allergens in Humans. In Dermatotoxicology (Wilhelm  K. P., Zhai  H.,\nMaibach  H. I., Eds.). 2012, pp. 108-118,  CRC Press,  Boca Raton, FL\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n58\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[18]\nBos  J.D.,  Meinardi  M.M.H.M., The 500 Dalton rule for the skin penetration of chemical\ncompounds and drugs. Exp. Dermatol. 2000,  9 pp.\u00a0165\u2013169\n[19]\nPotts  R.O.,  Guy  R.H., Predicting Skin Permeability. Pharm. Res. 1992,  9 pp.\u00a0663\u2013669\n[20]\nKroes  R. et al., Application of the threshold of toxicological concern (TTC) to the safety\nevaluation of cosmetic ingredients. Food Chem. Toxicol. 2007,  45 pp.\u00a02533\u20132562\n[21]\nOECD, Guidance document on the validation of quantitative structure\u2013activity relationship\n[QSAR] models. OECD Environment Health and Safety Publication, Paris. 2007. (Series on\ntesting and assessment no. 69, ENV/JM/MONO (2007)2) Retrieved from http://\u200bwww\u200b.oecd\u200b\n.org/\u200bofficialdocuments/\u200bpubli\u200bcdisplaydo\u200bcumentpdf/\u200b?cote\u200b=\u200benv/\u200bjm/\u200bmono\u200b%282007\u200b%292\u200b&\u200b\ndoclanguage\u200b=\u200ben. Access date: May 25, 2014)\n[22]\nSteinbach  T.S., Gad-McDonald  S., Kruhlak  N. et al., (Q)SAR: A Tool for the Toxicologist. Int. J.\nToxicol. 2015,  34\u00a0(4) pp.\u00a0352\u2013354\n[23]\nSussman  E.M., Oktem  B., Isayeva  I.S. et al., Chemical Characterization and Non-targeted\nAnalysis of Medical Device Extracts: A Review of Current Approaches, Gaps, and Emerging\nPractices. ACS Biomaterials Science & Engineering. 2022. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.1021/\u200b\nacsbiomaterials\u200b.1c01119\n[24]\nBecker  R.A., Dellarco  V., Seed  J. et al., Quantitative weight of evidence to assess confidence in\npotential modes of action. Regulatory Toxicology and Pharmacology. 2017,  86 pp. 205\u201320.\n[25]\nDekant  W.,  Bridges  J., A quantitative weight of evidence methodology for the assessment\nof reproductive and developmental toxicity and its application for classification and labeling of\nchemicals. Regul Toxicol Pharmacol. 2016,  82 pp. 173\u201385\n[26]\nEastmond  D.A., Recommendations for the evaluation of complex genetic toxicity data sets when\nassessing carcinogenic risks to humans. Environmental and Molecular Mutagenesis. 2017,  58\npp. 380\u20135\n[27]\nMartin  P., Bladier  C., Meek  B. et al., Weight of Evidence for Hazard Identification: A Critical\nReview of the Literature. Environmental Health Perspectives. 2018,  126 pp. 076001\n[28]\nMeek  M.E.(Bette), Palermo C.M., Bachman A.N. et al. , Mode of action human relevance (species\nconcordance) framework: Evolution of the Bradford Hill considerations and comparative\nanalysis of weight of evidence. Journal of Applied Toxicology. 2014,  34 pp. 595\u2013606\n[29]\nUS-EPA Guidelines for Carcinogen Risk Assessment, EPA/630/P-03/001B. Environmental\nProtection Agency (EPA). 2005. URL: https://\u200bwww\u200b.epa\u200b.gov/\u200bsites/\u200bdefault/\u200bfiles/\u200b2013\u200b-09/\u200b\ndocuments/\u200bcancer\u200b_guidelines\u200b_final\u200b_3\u200b-25\u200b-05\u200b.pdf\n[30]\nPradeep  P., Povinelli  R.J., White  S. et al., An ensemble model of QSAR tools for regulatory risk\nassessment. J Cheminform. 2016,  8 p.\u00a048\n[31]\nRaies  A.B.,  Bajic  V.B., In silico toxicology: computational methods for the prediction of chemical\ntoxicity. Wiley Interdiscp Reve Comput Mol Sci. 2016,  6\u00a0(2) pp.\u00a0147\u2013172\n[32]\nGray  G., Steven  B., Gail  C., Joshua  C. et al., The Annapolis Accords on the use of toxicology in\nrisk assessment and decision-making: an Annapolis Center workshop report. Toxicol. Methods.\n2001,  11 pp.\u00a0225\u2013231\n[33]\nEuropean Chemicals Agency (ECHA). Read-Across Framework. RAAF, 2017. URL: https://\u200becha\u200b\n.europa\u200b.eu/\u200bdocuments/\u200b10162/\u200b13628/\u200braaf\u200b_en\u200b.pdf/\u200b614e5d61\u200b-891d\u200b-4154\u200b-8a47\u200b-87efebd1851a\n[34]\nHelman  George et al., Generalized Read-Across (GenRA): A workflow implemented into the EPA\nCompTox Chemicals Dashboard. ALTEX - Alternatives to animal experimentation. 2019,  36, pp.\n462\u2013465.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n59\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[35]\nHelman  G. et al., Quantitative prediction of repeat dose toxicity values using GenRA. Regul.\nToxicol. Pharmacol. 2019,  109 p.\u00a0104480\n[36]\nECHA Guidance on Information Requirements and Chemical Safety Assessment, Chapter\nR.6: QSARs and grouping of chemicals. European Chemicals Agency (ECHA). 2019. URL: https://\u200b\necha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b\n-safety\u200b-assessment\n[37]\nGovernment of Canada, [Environment and Climate Change Canada - Evaluating Existing\nSubstances - Screening Assessment - Aromatic Azo and Benzidine-based Substance Grouping\n- Certain Azo Solvent Dyes.] 2016. URL: https://\u200bwww\u200b.ec\u200b.gc\u200b.ca/\u200bese\u200b-ees/\u200bdefault\u200b.asp\u200b?lang\u200b=\u200bEn\u200b&\u200bn\u200b=\u200b\nAB88B1AB\u200b-1\n[38]\nOECD OECD: Guidance on grouping of chemicals. Series on Testing & Assessment. No. 194.\nEnvironment Directorate Joint Meeting of the Chemicals Committee and the Working party on\nChemicals, Pesticides and Biotechnology. Organisation for Economic Co-operation and Development.\nOECD, 2nd Edition. 2017. URL: https://\u200bwww\u200b.oecd\u200b.org/\u200bpublications/\u200bguidance\u200b-on\u200b-grouping\u200b-of\u200b\n-chemicals\u200b-second\u200b-edition\u200b-9789264274679\u200b-en\u200b.htm\n[39]\nYang  C., Rathman  J.F., Magdziarz  T. et al., Do Similar Structures Have Similar No Observed\nAdverse Effect Level (NOAEL) Values? Exploring Chemoinformatics Approaches for Estimating\nNOAEL Bounds and Uncertainties. Chem. Res. Toxicol. 2021,  34 pp. 616\u2013633\n[40]\nMellor  C.L., Marchese Robinson  R.L., Benigni  R. et al., Molecular fingerprint-derived\nsimilarity measures for toxicological read-across: Recommendations for optimal use. Regulatory\nToxicology and Pharmacology. 2019,  101 pp. 121-134\n[41]\nMore  S.J. et al., Guidance on the use of the Threshold of Toxicological Concern approach in food\nsafety assessment. EFSA Journal, 2019, 17, e05708. URL: https://\u200bdoi\u200b.org/\u200b10\u200b.2903/\u200bj\u200b.efsa\u200b.2019\u200b\n.5708\n[42]\nATSDR, Framework for Assessing Health Impacts of Multiple Chemicals and Other Stressors\n(Update).  Agency for Toxic Substances and Disease Registry. Division of Toxicology. U.S.\nDepartment of Health and Human Services,  Atlanta, Georgia. 2018, 154\u00a0p.\n[43]\nEuropean Commission. Toxicity and Assessment of Chemical Mixtures. Scientific Committees.\nDirectorate General for Health & Consumers.  European Commission,  Brussels, Belgium. 2012,\n50\u00a0p\n[44]\nGoumenou  M.,  Tsatsakis  A., Proposing new approaches for the risk characterisation of single\nchemicals and chemical mixtures: The source related Hazard Quotient (HQS) and Hazard Index\n(HIS) and the adversity specific Hazard Index (HIA). Toxicology Reports. 2019, 6 pp.632\u2013636.\nhttps://\u200bdoi\u200b.org/\u200b10\u200b.1016/\u200bj\u200b.toxrep\u200b.2019\u200b.06\u200b.010\n[45]\nIPCS, Assessment of Combined Exposures to Multiple Chemicals: Report of a WHO/IPCS\nInternational Workshop. International Programme on Chemical Safety. World Health\nOrganization.\nGeneva.\n2009,\n83\npp.\nURL:\nhttps://\u200bwww\u200b.who\u200b.int/\u200bpublications/\u200bi/\u200bitem/\u200b\n9789241563833\n[46]\nKortenkamp  A., Backhaus  T., Faust  M., State of the Art Report on Mixture Toxicity. European\nCommission. Study contract No. 070307/2007/485103/ETU/D.1. 2009, 391 pp. URL: https://\u200bec\u200b\n.europa\u200b.eu/\u200benvironment/\u200bchemicals/\u200beffects/\u200bpdf/\u200breport\u200b_mixture\u200b_toxicity\u200b.pdf\n[47]\nSvendsgaard  D.J.,  Hertzberg  R.C., Statistical methods for the toxicological evaluation of the\nadditivity assumption as used in the EPA chemical mixture risk assessment guidelines. In: Toxicology\nof chemical mixtures: case studies, mechanisms, and novel approaches, (Yang  R.S.H., ed.).\nAcademic Press,  New York, 1994, pp.\u00a0599\u2013642\n[48]\nTeuschler  L.K.,  Hertzberg  R.C., Current and future risk assessment guidelines, policy, and\nmethods development for chemical mixtures. Toxicology. 1995,  105 pp.\u00a0137\u2013144\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n60\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[49]\nU.S. EPA. Concepts, Methods, And Data Sources For Cumulative Health Risk Assessment Of\nMultiple Chemicals, Exposures And Effects: A Resource Document (Final Report, 2008). U.S.\nEnvironmental Protection Agency (EPA), Washington, DC, EPA/600/R-06/013F, 2008. URL:\nhttps://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b190187\n[50]\nU.S. EPA Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures.\nEPA/630/R-00/002. U.S. Environmental Protection Agency. EPA, Washington, DC, 2000, 209\u00a0 p.\nURL: https://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b20533\n[51]\nHiggins  J.P.T., Thomas  J., Chandler  J., Cumpston  M., Li  T., Page  M.J. et al., eds. Cochrane\nHandbook for Systematic Reviews of Interventions version 6.3 (updated February 2022).\nCochrane, 2022. URL: https://\u200bwww\u200b.training\u200b.cochrane\u200b.org/\u200bhandbook\n[52]\nGreek  R.,  Menache  A., Systematic Reviews of Animal Models: Methodology versus\nEpistemology. Int. J. Med. Sci. 2013,  10 pp.\u00a0206\u2013221\n[53]\nLeenaars  M., Hooijmans  C.R., van Veggel  N. et al., A step-by-step guide to systematically\nidentify all relevant animal studies. Lab. Anim. 2012,  46 pp.\u00a024\u201331\n[54]\nLynch  H.N., Goodman  J.E., Tabony  J.A., Rhomberg  L.R., Systematic comparison of study\nquality criteria. Regul. Toxicol. Pharmacol. 2016,  76 pp.\u00a0187\u2013198\n[55]\nPease  C., Rooney  A., Sapiets  A. et al., Implementing systematic review techniques in chemical\nrisk assessment: Challenges, opportunities and recommendations. Environ. Int. 2016,  92\u201393\npp.\u00a0556\u2013564\n[56]\nRooney  A.A., Boyles  A.L., Wolfe  M.S. et al., Systematic review and evidence integration for\nliterature-based environmental health science assessments. Environ. Health Perspect. 2014,\n122\u00a0(7) pp.\u00a0711\u2013718\n[57]\nSamuel  G.O., Hoffmann  S., Wright  R.A. et al., Guidance on assessing the methodological and\nreporting quality of toxicologically relevant studies: A scoping review. Environ. Int. 2016,  92-93\npp.\u00a0630\u2013646\n[58]\nThe National Institute for Health and Care Excellence. The Guidelines Manual. Process\nand Methods. Appendix B: Methodology checklist: systematic reviews and meta-analyses\nAppendices B\u2013I. 2012. URL: https://\u200bwww\u200b.nice\u200b.org\u200b.uk/\u200bprocess/\u200bpmg6/\u200bresources/\u200bthe\u200b-guidelines\u200b\n-manual\u200b-appendices\u200b-bi\u200b-2549703709/\u200bchapter/\u200bappendix\u200b-b\u200b-methodology\u200b-checklist\u200b-systematic\u200b\n-reviews\u200b-and\u200b-meta\u200b-analyses\n[59]\nViswanathan  M., Ansari  M.T., Berkman  N.D. et al., Assessing the risk of bias of individual\nstudies in systematic reviews of health care interventions. Methods Guide for Effectiveness and\nComparative Effectiveness Reviews. Agency for Healthcare Research and Quality (US), Rockville\n(MD). 2008. URL: https://\u200bwww\u200b.ncbi\u200b.nlm\u200b.nih\u200b.gov/\u200bbooks/\u200bNBK91433\n[60]\nFenner-Crisp  P.A.,  Dellarco  V.L., Key Elements for Judging the Quality of a Risk Assessment.\nEnviron. Health Perspect. 2016,  124\u00a0(8) pp.\u00a01127\u20131135\n[61]\nFesting  M.F.W.,  Altman  D.G., Guidelines for the design and statistical analysis of experiments\nusing laboratory animals. ILAR J. Nat. Res. Counc. Inst. Lab. Anim. Resour. 2002,  43\u00a0(4) pp.\u00a0244\u2013\n258\n[62]\nSanderson  S., Tatt  I.D., Higgins  J.P., Tools for assessing quality and susceptibility to bias in\nobservational studies in epidemiology: a systematic review and annotated bibliography. Int. J.\nEpidemiol. 2007,  36 pp.\u00a0666\u2013676\n[63]\nKlimisch  H.J., Andreae  M., Tillmann  U., A systematic approach for evaluating the quality\nof experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 1997,  25\u00a0(1)\npp.\u00a01\u20135\n[64]\nSchneider  K. et al., \u201cToxRTool\u201d, a new tool to assess the reliability of toxicological data. Toxicol.\nLett. 2009,  189 pp.\u00a0138\u2013144\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n61\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[65]\nKilkenny  C., Parsons  N., Kadyszewski  E. et al., Survey of the Quality of Experimental Design,\nStatistical Analysis and Reporting of Research Using Animals. PLoS ONE. 2009,  4 p.\u00a0e7824.\n[66]\nKilkenny  C.,  Browne  W.Cuthill, et al., , Improving bioscience research reporting: the ARRIVE\nguidelines for reporting animal research. J. Pharmacol. Pharmacother.  2010,  1 p. 94.\n[67]\nSegal  D. et al., Evaluation of the ToxRTool\u2019s ability to rate the reliability of toxicological data for\nhuman health hazard assessments. Regul. Toxicol. Pharmacol. 2015,  72 pp.\u00a094\u2013101\n[68]\nSchneider  K. et al., Quality Criteria for Primary Literature in Toxicology. In: Regulatory\nToxicology, (Reichl  F.-X.,  Schwenk  M., eds.).  Springer,  Berlin, Heidelberg. 2020, pp.\u00a01\u20136.\n[69]\nPennell  C.P., Hirst  A., Sedrakyan  A., McCulloch  P.G., Adapting the IDEAL Framework and\nRecommendations for medical device evaluation: A modified Delphi survey. Int. J. Surg. 2016,  28\npp.\u00a0141\u2013148\n[70]\nRice  A.S.C., Morland  R., Huang  W. et al., Transparency in the reporting of in vivo pre-clinical\npain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In\nVivo Experiments) guidelines. Scandinavian Journal of Pain. 2013,  4 pp.\u00a058\u201362\n[71]\nSchwarz  F., Iglhaut  G., Becker  J., Quality assessment of reporting of animal studies on\npathogenesis and treatment of peri-implant mucositis and peri-implantitis. A systematic review\nusing the ARRIVE guidelines. J. Clin. Periodontol. 2012,  39\u00a0(Suppl 12) pp.\u00a063\u201372\n[72]\nvon Elm  E., Altman  D.G., Egger  M. et al., Initiative, S.T.R.O.B.E., 2007. Strengthening the\nReporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for\nreporting observational studies. BMJ. 2007,  335\u00a0(7624) pp.\u00a0806\u2013808\n[73]\nPaustenbach  D.J. et al., Benzene toxicity and risk assessment, 1972-1992: implications for\nfuture regulation. Environ. Health Perspect. 1993,  101 pp.\u00a0177\u2013200\n[74]\nICH, Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to\nlimit potential carcinogenic risk M7(R1). ICH Harmonised Tripartite Guideline. International\nConference on Harmonisation (ICH) of Technical Requirements for Registration of\nPharmaceuticals for Human Use Geneva, Switzerland. 2017. URL: http://\u200bwww\u200b.ich\u200b.org\n[75]\nLEHMAN, A.J. and FITZHUGH, O.G. 100-Fold margin of safety. Association of Food and Drug\nOfficials. U.S.Q. Bull. 1954, 18 pp. 33-35\n[76]\nMUMTAZ. M.M. and HERTZBERG, R.C. The status of interactions data in risk assessment of\nchemical mixtures. In J. Saxena, ed. Hazard Assessment of Chemicals. Hemisphere, Washington,\nD.C. 1993, 8 pp. 47-79\n[77]\nMUMTAZ, M.M., SIPES, I.G., CLEWELL, H.J. and YANG, R.S.H. Risk assessment of chemical\nmixtures: Biologic and toxicologic issues (symposium overview). Fundam. Appl. Toxicol. 1993,\n21 pp.\u00a0258\u2013269\n[78]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with methylene chloride as an example of the process. Committee on Rational\nSpecification for Impurities in Bulk Drug Substances. PMA, Washington, DC. Pharmacop. Forum.\n1989,  15\u00a0(6) pp.\u00a05748\u20135759\n[79]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with chloroform, 1,4-dioxane, ethylene oxide and trichloroethylene as examples\nof the process. Committee on Rational Specification for Impurities in Bulk Drug Substances.\nPMA, Washington, DC. Pharmacop. Forum. 1990,  16\u00a0(3) pp.\u00a0541\u2013582\n[80]\nPharmaceutical Manufacturers Association (PMA), Procedures for setting limits for volatile\norganic solvents with benzene as an example of the process. Committee on Rational Specification\nfor Impurities in Bulk Drug Substances. PMA, Washington, DC. Pharmacop. Forum. 1991,  17\u00a0(1)\npp.\u00a01441\u20131458\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n62\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[81]\nUnited States Pharmacopeial Convention (USP), <467> Organic volatile impurities. USP, Rockville,\nMaryland, Vol.  24, 2000, pp.\u00a01877\u20138\n[82]\nBASKETTER, D.A. Individual ethnic and seasonal variability in irritant susceptibility of skin:\nThe implications for a predictive human patch test. Contact Dermat. 1996,  35 pp.\u00a0208\u2013213\n[83]\nCONINE, D., NAUMANN, B. and HECKER, L. Setting Health-Based Residue Limits For\nContaminants in Pharmaceuticals and Medical Devices. Quality Assurance: Good Practice,\nRegulation, and the Law. 1992, 1(3) pp. 171-180\n[84]\nCommittee on Carcinogenicity of Chemicals in Food. Consumer Products and the Environment,\nGuidelines for the evaluation of chemicals for carcinogenicity, Department of Health Report on\nHealth and Social Subjects No. 42. HMSO, London, 1991. URL: https://\u200bassets\u200b.publishing\u200b.service\u200b\n.gov\u200b.uk/\u200bgovernment/\u200buploads/\u200bsystem/\u200buploads/\u200battachment\u200b_data/\u200bfile/\u200b743785/\u200bGuidelines\u200b_for\u200b\n_the\u200b_evaluation\u200b_of\u200b_Chemicals\u200b_for\u200b_Carcinogenicity\u200b_\u200b_1991\u200b_\u200b.pdf\n[85]\nIPCS Environmental Health Criteria 170. Assessing Human Health Risks of Chemicals: Derivation of\nGuidance Values for Health-Based Exposure Limits. INTERNATIONAL PROGRAMME ON CHEMICAL\nSAFETY (IPCS), World Health Organization, Geneva, Switzerland. 1994. URL: https://\u200binchem\u200b\n.org/\u200bdocuments/\u200behc/\u200behc/\u200behc170\u200b.htm\n[86]\nDOURSON, M. and STARA, J. Regulatory history and experimental support for uncertainty\n(safety) factors. Regul. Toxicol. Pharmacol. 1983,  3 pp.\u00a0224\u2013238\n[87]\nDourson  M., Uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 1996,\n24 p.\u00a0107\n[88]\nDourson  M.L. et al., Evolution of Science-Based Uncertainty Factors in Noncancer Risk\nAssessment. Regul. Toxicol. Pharmacol. 1996,  24 pp.\u00a0108\u2013120\n[89]\nJUDGE, M.R.,  Variation in response of human skin to irritant challenge. Contact Dermat. 1996,\n34 pp.\u00a0115\u2013117\n[90]\nMore  S.J. et al., Guidance on the use of the Threshold of Toxicological Concern approach in food\nsafety assessment. EFSA Journal. 2019,  17 p.\u00a0e05708\n[91]\nIPCS Harmonization Project Document No. 2. CHEMICAL-SPECIFIC ADJUSTMENT FACTORS FOR\nINTERSPECIES DIFFERENCES AND HUMAN VARIABILITY: GUIDANCE DOCUMENT FOR USE OF\nDATA IN DOSE/CONCENTRATION\u2013RESPONSE ASSESSMENT. INTERNATIONAL PROGRAMME ON\nCHEMICAL SAFETY (IPCS), World Health Organization, Geneva, Switzerland. 2005. URL: https://\u200b\napps\u200b.who\u200b.int/\u200biris/\u200bhandle/\u200b10665/\u200b43294\n[92]\nRenwick  A.G. et al., An Analysis of the Need for an Additional Uncertainty Factor for Infants and\nChildren. Regul. Toxicol. Pharmacol. 2000,  31 pp.\u00a0286\u2013296\n[93]\nLandrigan Philip  J. et al., Children\u2019s health and the environment: public health issues and\nchallenges for risk assessment. Environ. Health Perspect. 2004,  112 pp.\u00a0257\u2013265\n[94]\nDorne  J.L.C.M., Metabolism, variability and risk assessment. Toxicology. 2010,  268 pp.\u00a0156\u2013164\n[95]\nHardy  A. et al., Guidance on the risk assessment of substances present in food intended for\ninfants below 16 weeks of age. EFSA Journal. 2017,  15 p.\u00a0e04849\n[96]\nPazeto  C.L., Nascimento  F.J., Santiago  L.H.S., Glina  S., Idiosyncratic reaction after injection\nof polyacrylate - polyalcohol copolymer. Int Braz J Urol. 2018,  44 pp. 831\u2013834\n[97]\nClewell  H.J.,  Andersen  M.E., Risk Assessment Extrapolations and Physiological Modeling.\nToxicol. Ind. Health. 1985,  1 pp.\u00a0111\u2013134\n[98]\nPepelko  W.E., Feasibility of route extrapolation in risk assessment. Br. J. Ind. Med. 1987,  44\npp.\u00a0649\u2013651\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n63\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[99]\nGeraets  L. et al., Human risk assessment of dermal and inhalation exposures to chemicals\nassessed by route-to-route extrapolation: The necessity of kinetic data. Regul. Toxicol.\nPharmacol. 2014,  70 pp.\u00a054\u201364\n[100]\t Mattie  D.R., Grabau  J.H., McDougal  J.N., Significance of the dermal route of exposure to risk\nassessment. Risk Anal. 1994,  14\u00a0(3) pp.\u00a0277\u2013284\n[101]\t Poet  T.S.,  McDougal  J.N., Skin absorption and human risk assessment. Chem. Biol. Interact.\n2002,  140\u00a0(1) pp.\u00a019\u201334\n[102]\t Kroes  R. et al., Application of the threshold of toxicological concern (TTC) to the safety\nevaluation of cosmetic ingredients. Food Chem. Toxicol. 2007,  45 pp.\u00a02533\u20132562\n[103]\t McDougal  J.N.,  Boeniger  M.F., Methods for Assessing Risks of Dermal Exposures in the\nWorkplace. Crit. Rev. Toxicol. 2002,  32 pp.\u00a0291\u2013327\n[104]\t Escher  S. et al., Evaluation of inhalation TTC values with the database RepDose. Regul. Toxicol.\nPharmacol. 2010,  58 pp.\u00a0259\u2013274\n[105]\t https://\u200bdatabase\u200b.ich\u200b.org/\u200bsites/\u200bdefault/\u200bfiles/\u200bQ3D\u200b-R2\u200b_Guideline\u200b_Step4\u200b_2022\u200b_0308\u200b.pdf\n[106]\t Schneider  K., Dilger  M., Kaiser  E., Kalberlah  F., Wosniok  W., Derivation of occupational\nexposure limits for airborne chemicals \u2013 Comparison of methods and protection levels. Federal\nInstitute for Occupational Safety and Health (BAuA) Dortmund. 2022. URL: https://\u200bwww\u200b.baua\u200b\n.de/\u200bDE/\u200bAngebote/\u200bPublikationen/\u200bBerichte/\u200bF2437\u200b.pdf\u200b?\u200b_\u200b_blob\u200b=\u200bpublicationFile\u200b&\u200bv\u200b=\u200b7\n[107]\t ECHA Guidance on information requirements and chemical safety assessment, Chapter R.8:\nCharacterisation of dose [concentration]-response for human health. 2012. URL: https://\u200becha\u200b\n.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b-safety\u200b\n-assessment\n[108]\t IGHRC, Guidelines, Interdepartmental Group on Health Risks from Chemicals, Guidelines\non route-to-route extrapolation of toxicity data when assessing health risks of chemicals.\n2006.\nURL:\nhttp://\u200bwww\u200b.iehconsulting\u200b.co\u200b.uk/\u200bIEH\u200b_Consulting/\u200bighrc\u200b%20web\u200b%20files/\u200bIGHRC\u200b\n_publications1\u200b.html\n[109]\t Venman  B.C.,  Flaga  C., Development of an acceptable factor to estimate chronic end points\nfrom acute toxicity data. Toxicol. Ind. Health. 1985,  1\u00a0(4) pp.\u00a0261\u2013269\n[110]\t Pieters  M.N. et al., Evaluation of the Uncertainty Factor for Subchronic-to-Chronic\nExtrapolation: Statistical Analysis of Toxicity Data. Regul. Toxicol. Pharmacol. 1998,  27 pp.\u00a0108\u2013\n111\n[111]\t Xue  J. et al., Introduction of risk size in the determination of uncertainty factor UFL in risk\nassessment. Environ. Res. Lett. 2012,  7 p.\u00a0034036\n[112]\t Rezvani  N. et al., Uncertainty Factors. In: Encyclopedia of Toxicology, (Wexler  P., ed.).  Academic\nPress,  Oxford,  Third Edition, 2014, pp.\u00a0870\u20137.\n[113]\t Sussman  R.G. et al., A harmonization effort for acceptable daily exposure derivation \u2013\nConsiderations for application of adjustment factors. Regul. Toxicol. Pharmacol. 2016,\n79\u00a0(Supplement 1) pp.\u00a0S57\u2013S66\n[114]\t Renwick  A.G., Data\u2010derived safety factors for the evaluation of food additives and environmental\ncontaminants. Food Addit. Contam. 1993,  10 pp.\u00a0275\u2013305\n[115]\t Schultz  T.W. et al., A strategy for structuring and reporting a read-across prediction of toxicity.\nRegul. Toxicol. Pharmacol. 2015,  72 pp.\u00a0586\u2013601\n[116]\t Weed  D.L., Weight of Evidence: A Review of Concept and Methods. Risk Anal. 2005,  25\u00a0(6)\npp.\u00a01545\u20131557\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n64\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n[117]\t Swaen  G.,  van Amelsvoort  L., A weight of evidence approach to causal inference. J. Clin.\nEpidemiol. 2009,  62 pp.\u00a0270\u2013277\n[118]\t Smith  M.T., Guyton  K.Z., Gibbons  C.F. et al., Key Characteristics of Carcinogens as a Basis\nfor Organizing Data on Mechanisms of Carcinogenesis. Environ. Health Perspect. 2016,  124\u00a0(6)\npp.\u00a0713\u2013721\n[119]\t Guyton  K.Z., Rusyn  I., Chiu  W.A. et al., Application of the key characteristics of carcinogens in\ncancer hazard identification. Carcinogenesis. 2018,  39\u00a0(4) pp.\u00a0614\u2013622\n[120]\t EPA, Guidelines for Carcinogen Risk Assessment. Report No. 630-P-03-001F. 2005. URL: https://\u200b\nwww\u200b.epa\u200b.gov/\u200brisk/\u200bguidelines\u200b-carcinogen\u200b-risk\u200b-assessment.\n[121]\t Benzene  E.P.A., CASRN\u00a071\u201143\u20112. Chemical Assessment Summary. Integrated Risk Information\nSystem (IRIS). U.S. Environmental Protection Agency. 2000. URL: https://\u200bcfpub\u200b.epa\u200b.gov/\u200bncea/\u200b\niris/\u200biris\u200b_documents/\u200bdocuments/\u200bsubst/\u200b0276\u200b_summary\u200b.pdf\n[122]\t ECHA Guidance on information requirements and chemical safety assessment Chapter R.8:\nCharacterisation of dose [concentration]-response for human health. Version 2.1. 2012. https://\u200b\necha\u200b.europa\u200b.eu/\u200bguidance\u200b-documents/\u200bguidance\u200b-on\u200b-information\u200b-requirements\u200b-and\u200b-chemical\u200b\n-safety\u200b-assessment\n[123]\t Portier  K. et al., Body Weight Distributions for Risk Assessment. Risk Anal. 2007,  27 pp.\u00a011\u201326\n[124]\t US EPA\u00a0600/6-87/008, Recommendations for and Documentation of Biological Values for Use in\nRisk Assessment. United States Environmental Protection Agency (EPA). URL: https://\u200bcfpub\u200b.epa\u200b\n.gov/\u200bncea/\u200brisk/\u200brecordisplay\u200b.cfm\u200b?deid\u200b=\u200b34855\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n65\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nICS\u200211.100.20\nPrice based on 65 pages\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited."
  },
  {
    "clause_id": "2",
    "change_type": "modified",
    "old_text": "2\t Normative references\nThe following documents are referred to in the text in such a way that some or all of their content\nconstitutes requirements of this document. For dated references, only the edition cited applies. For\nundated references, the latest edition of the referenced document (including any amendments) applies.\nISO\u00a0 10993-1, Biological evaluation of medical devices \u2014 Part 1: Evaluation and testing within a risk\nmanagement process\nISO\u00a010993-17, Biological evaluation of medical devices \u2014 Part 17: Establishment of allowable limits for\nleachable substances\nISO\u00a014971, Medical devices\u00a0\u2014 Application of risk management to medical devices\nINTERNATIONAL STANDARD\b\nISO 10993-18:2020(E)\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n1\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)",
    "new_text": "2\t Normative references\nThe following documents are referred to in the text in such a way that some or all of their content\nconstitutes requirements of this document. For dated references, only the edition cited applies. For\nundated references, the latest edition of the referenced document (including any amendments) applies.\nISO\u00a010993-1:2018, Biological evaluation of medical devices \u2014 Part 1: Evaluation and testing within a risk\nmanagement process\n1\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nISO\u00a0 10993-18:2020, Biological evaluation of medical devices \u2014 Part 18: Chemical characterization of\nmedical device materials within a risk management process\nISO/TS\u00a021726:2019, Biological evaluation of medical devices \u2014 Application of the threshold of toxicological\nconcern (TTC) for assessing biocompatibility of medical device constituents\nISO\u00a014971:2019, Medical devices \u2014 Application of risk management to medical devices",
    "change_text": "2\t Normative references\nThe following documents are referred to in the text in such a way that some or all of their content\nconstitutes requirements of this document. For dated references, only the edition cited applies. For\nundated references, the latest edition of the referenced document (including any amendments) applies.\nISO\u00a010993-1:2018, Biological evaluation of medical devices \u2014 Part 1: Evaluation and testing within a risk\nmanagement process\n1\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nISO\u00a0 10993-18:2020, Biological evaluation of medical devices \u2014 Part 18: Chemical characterization of\nmedical device materials within a risk management process\nISO/TS\u00a021726:2019, Biological evaluation of medical devices \u2014 Application of the threshold of toxicological\nconcern (TTC) for assessing biocompatibility of medical device constituents\nISO\u00a014971:2019, Medical devices \u2014 Application of risk management to medical devices",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to12__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to12__0\"><a href=\"#difflib_chg_to12__0\">f</a></td><td class=\"diff_header\" id=\"from12_1\">1</td><td nowrap=\"nowrap\">2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Normative&nbsp;references</td><td class=\"diff_next\"><a href=\"#difflib_chg_to12__0\">f</a></td><td class=\"diff_header\" id=\"to12_1\">1</td><td nowrap=\"nowrap\">2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Normative&nbsp;references</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to12__1\"></td><td class=\"diff_header\" id=\"from12_2\">2</td><td nowrap=\"nowrap\">The&nbsp;following&nbsp;documents&nbsp;are&nbsp;referred&nbsp;to&nbsp;in&nbsp;the&nbsp;text&nbsp;in&nbsp;such&nbsp;a&nbsp;way&nbsp;that&nbsp;some&nbsp;or&nbsp;all&nbsp;of&nbsp;their&nbsp;content</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_2\">2</td><td nowrap=\"nowrap\">The&nbsp;following&nbsp;documents&nbsp;are&nbsp;referred&nbsp;to&nbsp;in&nbsp;the&nbsp;text&nbsp;in&nbsp;such&nbsp;a&nbsp;way&nbsp;that&nbsp;some&nbsp;or&nbsp;all&nbsp;of&nbsp;their&nbsp;content</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_3\">3</td><td nowrap=\"nowrap\">constitutes&nbsp;requirements&nbsp;of&nbsp;this&nbsp;document.&nbsp;For&nbsp;dated&nbsp;references,&nbsp;only&nbsp;the&nbsp;edition&nbsp;cited&nbsp;applies.&nbsp;For</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_3\">3</td><td nowrap=\"nowrap\">constitutes&nbsp;requirements&nbsp;of&nbsp;this&nbsp;document.&nbsp;For&nbsp;dated&nbsp;references,&nbsp;only&nbsp;the&nbsp;edition&nbsp;cited&nbsp;applies.&nbsp;For</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_4\">4</td><td nowrap=\"nowrap\">undated&nbsp;references,&nbsp;the&nbsp;latest&nbsp;edition&nbsp;of&nbsp;the&nbsp;referenced&nbsp;document&nbsp;(including&nbsp;any&nbsp;amendments)&nbsp;applies.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_4\">4</td><td nowrap=\"nowrap\">undated&nbsp;references,&nbsp;the&nbsp;latest&nbsp;edition&nbsp;of&nbsp;the&nbsp;referenced&nbsp;document&nbsp;(including&nbsp;any&nbsp;amendments)&nbsp;applies.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to12__1\">n</a></td><td class=\"diff_header\" id=\"from12_5\">5</td><td nowrap=\"nowrap\">ISO\u00a0<span class=\"diff_sub\">&nbsp;</span>10993-1,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;1:&nbsp;Evaluation&nbsp;and&nbsp;testing&nbsp;within&nbsp;a&nbsp;risk</td><td class=\"diff_next\"><a href=\"#difflib_chg_to12__1\">n</a></td><td class=\"diff_header\" id=\"to12_5\">5</td><td nowrap=\"nowrap\">ISO\u00a010993-1<span class=\"diff_add\">:2018</span>,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;1:&nbsp;Evaluation&nbsp;and&nbsp;testing&nbsp;within&nbsp;a&nbsp;risk</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_6\">6</td><td nowrap=\"nowrap\">management&nbsp;process</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_6\">6</td><td nowrap=\"nowrap\">management&nbsp;process</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to12__2\">n</a></td><td class=\"diff_header\" id=\"from12_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-17,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;17:&nbsp;Establishment&nbsp;of&nbsp;allowable&nbsp;limits&nbsp;for</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to12__2\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachable&nbsp;substances</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to12__2\"></td><td class=\"diff_header\" id=\"from12_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a014971,&nbsp;Medical&nbsp;devices\u00a0\u2014&nbsp;Application&nbsp;of&nbsp;risk&nbsp;management&nbsp;to&nbsp;medical&nbsp;devices</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">INTERNATIONAL&nbsp;STANDARD\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_13\">13</td><td nowrap=\"nowrap\">1</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_7\">7</td><td nowrap=\"nowrap\">1</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to12__3\"><a href=\"#difflib_chg_to12__3\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to12__3\">n</a></td><td class=\"diff_header\" id=\"to12_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_14\">14</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_10\">10</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_15\">15</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_11\">11</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_16\">16</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_12\">12</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to12__top\">t</a></td><td class=\"diff_header\" id=\"from12_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to12__top\">t</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from12_18\">18</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">8</span>:202<span class=\"diff_chg\">0</span>(E)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_13\">13</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">7</span>:202<span class=\"diff_chg\">3</span>(E)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO\u00a0&nbsp;10993-18:2020,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;18:&nbsp;Chemical&nbsp;characterization&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">medical&nbsp;device&nbsp;materials&nbsp;within&nbsp;a&nbsp;risk&nbsp;management&nbsp;process</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO/TS\u00a021726:2019,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Application&nbsp;of&nbsp;the&nbsp;threshold&nbsp;of&nbsp;toxicological</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">concern&nbsp;(TTC)&nbsp;for&nbsp;assessing&nbsp;biocompatibility&nbsp;of&nbsp;medical&nbsp;device&nbsp;constituents</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to12_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO\u00a014971:2019,&nbsp;Medical&nbsp;devices&nbsp;\u2014&nbsp;Application&nbsp;of&nbsp;risk&nbsp;management&nbsp;to&nbsp;medical&nbsp;devices</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "3",
    "change_type": "modified",
    "old_text": "3 Terms and definitions\nFor the purposes of this document, the definitions in ISO\u00a010993-1 and the following apply.\nISO and IEC maintain terminological databases for use in standardization at the following addresses:\n\u2014\t ISO Online browsing platform: available from https://\u200bwww\u200b.iso\u200b.org/\u200bobp\n\u2014\t IEC Electropedia: available from http://\u200bwww\u200b.electropedia\u200b.org/\u200b\n3.1\naccelerated extraction\nextraction whose duration is shorter than the duration of clinical use but whose conditions do not result\nin a chemical change to the substances being extracted\nNote\u00a01\u00a0to\u00a0entry:\u00a0See also Annex\u00a0D.\n3.2\nanalytical evaluation threshold\nAET\nthreshold below which the analyst need not identify or quantify leachables or extractables or report\nthem for potential toxicological assessment\nNote\u00a01\u00a0to\u00a0entry:\u00a0See Annex\u00a0E.\n3.3\nanalytically expedient\nsituation where an extraction vehicle can be directly evaluated with generally available analytical\nmethods with the sensitivity and selectivity necessary to achieve a designated reporting threshold\nsuch as the AET\n3.4\nanalytical screening method\nmethod whose purpose is to discover, identify and semi-quantitatively estimate the concentration of all\nrelevant analytes in a test sample above an established reporting threshold (such as the AET)\n3.5\nanalytical targeting method\nmethod whose purpose is to quantify, with an appropriately high degree of accuracy and precision,\nspecified analytes in a specified test sample over a specified concentration range\n3.6\nchemical characterization\nprocess of obtaining chemical information, accomplished either by information gathering or by\ninformation generation, for example, by literature review or chemical testing\n3.7\nchemical information\nqualitative and quantitative, if applicable, knowledge related to the configuration, composition and\nproduction of the medical device and/or its materials of construction, thereby establishing the identities\nand amounts of constituents present in the materials and device\nNote\u00a01\u00a0to entry:\u00a0See also 5.2.1, 5.2.2, 5.2.3, and Annex\u00a0B.\nNote\u00a02\u00a0to entry:\u00a0Chemical information can be used to establish the hypothetical worst-case release of chemicals\nfrom a medical device, predicated on the circumstance that all chemicals present in the device are released from\nthe device under its clinical conditions of use.\n3.8\nclinically established\nmedical device, component, or material of construction which has been used extensively for specified\nand established clinical uses for which biocompatibility has been established\n\ufeff\n2\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n3.9\ncomponent\nitem which forms one part of a medical device, but is not itself a medical device\n3.10\nconstituent\nchemical that is present in a finished medical device or its materials of construction\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 Constituents may be intentionally present (e.g. an additive such as an antioxidant) or\nunintentionally present (e.g. an impurity or degradant).\n3.11\nconvertor\nperson or company who converts or fabricates a basic raw material into a semi-finished product (e.g. a\nformer of lengths of rod, tubing, or plastic components)\n3.12\ndigestion\nprocess of completely solubilizing a medical device, one or more of its components or one or more of\nits materials of construction by breaking it down into its fundamental structural units, including its\nelemental constituents or monomeric units\n3.13\ndissolution\nprocess of completely solubilizing a medical device, one or more of its components or one or more of its\nmaterials of construction, generally preserving the molecular structures of its constituents\n3.14\nexaggerated extraction\nextraction that is intended to result in a greater number or amount of chemical constituents being\nreleased as compared to the amount generated under the clinical conditions of use\nNote\u00a01\u00a0to\u00a0entry:\u00a0It is important to ensure that the exaggerated extraction does not result in a chemical change of\nthe material or the substances being extracted.\n3.15\nexhaustive extraction\nmulti-step extraction conducted until the amount of material extracted in a subsequent extraction step\nis less than 10\u00a0% by gravimetric analysis (or achieved by other means) of that determined in the initial\nextraction step\n3.16\nextractable\nsubstance that is released from a medical device or material of construction when the medical device or\nmaterial is extracted using laboratory extraction conditions and vehicles\n3.17\nextraction power\nability of an extraction vehicle to extract (or leach) substances from a medical device, component or\nmaterial of construction\nNote\u00a01\u00a0to\u00a0entry:\u00a0The extraction power of an extraction vehicle is impacted by its physicochemical properties,\nincluding, but not limited to, its polarity, pH and dielectric constant.\n3.18\nextraction vehicle\nmedium (solution or solvent) which is used to extract (or leach) a test article for the purpose of\nestablishing the test article\u2019s extractables or leachables profile\nNote\u00a01\u00a0to entry:\u00a0It is preferred that extraction vehicles be analytically expedient.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n3\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nNote\u00a02\u00a0to entry:\u00a0For some medical devices (e.g. infusion systems) that are labelled for use with a drug, the most\nappropriate extraction medium may be the drug product or drug product vehicle.\n3.19\nidentification\nprocess of assigning a molecular structure and chemical name to an organic compound or assigning\nconstituent elements or molecular structure as appropriate, and a chemical name to an inorganic\ncompound\n3.20\ninformation gathering\nprocess of collecting existing chemical information, including available test results, that is relevant to\nchemical characterization\n3.21\ninformation generation\nprocess of producing chemical information via laboratory testing\n3.22\nleachable\nsubstance that is released from a medical device or material during its clinical use\nNote\u00a01\u00a0to\u00a0entry:\u00a0For many medical devices, a leachables study is not practical due to challenges with reproducing\nactual clinical conditions, so simulated-use extraction studies are often performed instead. See definition for\nsimulated-use extraction.\n3.23\nmanufacturer\nnatural or legal person who manufactures or fully refurbishes a medical device, or has a device designed,\nmanufactured, or fully refurbished, and markets that medical device under its name or trademark\n3.24\nmaterial composition\nlisting of the constituents that are contained in a material (qualitative) and the amount of each\nsubstance in the material (quantitative)\nNote\u00a01\u00a0to\u00a0entry:\u00a0A material\u2019s composition establishes the hypothetical situation in which the total amount of all\nsubstances present in a medical device are released during clinical use. These amounts can be derived directly\nfrom known composition; experimentally, they can be derived from digestion, dissolution, and, in many cases,\nexhaustive extraction studies.\n3.25\nmaterial of construction\nindividual raw material that is used to produce a component\nEXAMPLE\nPolymer resins.\n3.26\nmedical device configuration\nlisting of a medical device\u2019s components (qualitative), including a listing of the component\u2019s materials of\nconstruction (qualitative) and the proportion of each material in each component (quantitative)\nNote\u00a01\u00a0to\u00a0entry:\u00a0Device configuration should also take into account the shape and relative arrangement of the\nparts in the medical device and surface properties (topography and chemistry).\n3.27\npotentially affected individual\nperson having direct or indirect body contact with the medical device\nNote\u00a01\u00a0to\u00a0entry:\u00a0See ISO\u00a010993-1 for categorization by nature of body contact.\n\ufeff\n4\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n3.28\nqualification\nprocess of establishing that an analytical method is suitable for its intended use\n3.29\nqualitative analysis\nanalytical approach which estimates an analyte's concentration by using the response from a surrogate\nsubstance (or substances) chosen without specifically addressing or considering the relative responses\nof the analyte and the surrogate(s)\n3.30\nquantification\nprocess of assigning a concentration to an analyte present in a sample\nNote\u00a01\u00a0to\u00a0entry:\u00a0There are several possible levels as shown in 3.31, 3.32 and 3.33.\n3.31\nestimated quantitative analysis\nanalytical approach which estimates an analyte's concentration by using the response from a surrogate\nsubstance chosen without specifically addressing or considering the relative responses of the analyte\nand the surrogate\n3.32\nsemi-quantitative analysis\nanalytical approach which provides an analyte\u2019s concentration by using the response from a surrogate\nsubstance (or substances), specifically accounting for the relative responses of the analyte and the\nsurrogate\n3.33\nquantitative analysis\nanalytical approach which establishes the most accurate estimate of an analyte's concentration by\nusing a response function (calibration curve) generated specifically for the analyte via the use of a\nreference standard\nNote\u00a01\u00a0to\u00a0entry:\u00a0Estimated quantitative analysis is generally less accurate than semi-quantitative analysis, which\nis generally less accurate than quantitative analysis.\n3.34\nsafety concern threshold\nSCT\nthreshold below which a leachable (or an extractable as a probable leachable) has a dose so low that it\npresents a negligible safety concern from carcinogenic and non-carcinogenic toxic effects\nNote\u00a01\u00a0to\u00a0entry:\u00a0See Reference\u00a0[27].\n3.35\nsimulated-use extraction\nextraction using a method that simulates clinical use\nNote\u00a01\u00a0to\u00a0entry:\u00a0A simulated-use extraction is performed to estimate the type and amount of substances that\nare expected to be released from a medical device during its clinical use. A simulated-use extraction is designed\nto produce an extractables profile that represents the worst-case leachables profile, meaning that all leachables\nare also extractables and the levels of all individual extractables are at least equal to the level of all individual\nleachables.\n3.36\nsolubilisation\naction or process of using a vehicle to dissolve part or all of a test article\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 Leaching, extraction, dissolution, and digestion are (progressively more complete) sub-\ncategories of solubilisation.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n5\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n3.37\nsponsor\nindividual or organization that plans, commissions, and takes responsibility for testing of a medical device\n3.38\nsupplier\nperson or company who manufactures or provides the materials of construction or components to be\nused in the manufacture of a medical device\n3.39\nthreshold of toxicological concern\nTTC\nlevel of exposure for constituents, below which there would be no appreciable risk to human health\nNote\u00a01\u00a0to\u00a0entry:\u00a0See ISO/TS\u00a021726 for full context.\n3.40\ntoxicological risk assessment\nact of determining the potential of a chemical to elicit an adverse effect based on a specified level of\nexposure",
    "new_text": "3 Terms and definitions\nFor the purposes of this document, the terms and definitions given in ISO\u00a010993-1 and the following\napply.\nISO and IEC maintain terminology databases for use in standardization at the following addresses:\n\u2014\t ISO Online browsing platform: available at https://\u200bwww\u200b.iso\u200b.org/\u200bobp\n\u2014\t IEC Electropedia: available at https://\u200bwww\u200b.electropedia\u200b.org/\u200b\n3.1\nanalogue\nsubstance with similar molecular, physical, chemical or toxicological properties\n3.2\nbenchmark dose low\nBMDL\nlower one-sided confidence limit of a dose derived from dose-response (3.6) modelling that is associated\nwith a specified change (e.g. 5\u00a0% or 10\u00a0%) in the dose-response relationship\nNote\u00a01\u00a0to\u00a0entry:\u00a0A specified change of 5\u00a0% is applied when a reported harm applies to individual animals. A\nspecified change of 10\u00a0% is applied when a reported harm applies to a fraction of animals in a population.\n[SOURCE: EPA\u00a02012[2]]\n3.3\ncarcinogen\nconstituent (3.4) that causes cancer in humans or experimental animals as determined by valid\nexperimental or observational evidence\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 Carcinogens are either genotoxic carcinogens or non-genotoxic carcinogens. A genotoxic\ncarcinogen is a constituent capable of causing cancer by a mechanism that involves direct alteration of the genetic\nmaterial of target cells, as a key event at an early stage in tumour development. A non-genotoxic carcinogen is\na constituent capable of producing cancer by a mechanism where direct gene damage is not the key event in\ntumour development (C.3.1).\n[SOURCE: International Agency for Research on Cancer[3]]\n3.4\nconstituent\nchemical that is present in or on the finished medical device or its materials of construction\nNote\u00a01\u00a0to\u00a0entry:\u00a0Constituents can be intentionally or unintentionally added chemicals or compounds, such as:\nadditives (e.g. plasticizers, lubricants, stabilizers, anti-oxidants, colouring agents, fillers), manufacturing process\nresidues (e.g. monomers, catalysts, solvents, sterilant and cleaning agents), degradation products or impurities\n(e.g. byproducts or side products) or contaminants[5].\n[SOURCE: ISO 10993-18:2020, 3.10, modified \u2014 \"or on\" has been added to the definition and Note 1 to\nentry has been replaced.]\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n2\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.5\ndefault value\nvalue or factor used in the derivation of a worst-case exposure dose (3.32), tolerable contact level (3.25)\nor tolerable intake (3.26), in the absence of specific data [e.g. an uncertainty factor (3.31)]\n3.6\ndose-response\nrelationship of dosage to observable harm\nNote\u00a01\u00a0to\u00a0entry:\u00a0In general, there are two types of dose-response relationships. The first type is the change in\nthe response of an individual to a range of doses. The second type is the distribution of the response among\nindividuals to a range of doses.\n3.7\nexposure dose\nquantity of a constituent (3.4) that does or can contact the body by an exposure route over a specified\ntime period\nNote\u00a01\u00a0to entry:\u00a0The exposure dose is expressed in microgram per kilogram of body mass per day (\u00b5g/kg/d) or in\nmicrogram per centimetre squared (\u00b5g/cm2).\nNote\u00a02\u00a0to entry:\u00a0The exposure dose is different from the absorbed dose. The absorbed dose is the quantity of the\nconstituent that traverses the portal of entry, which is dependent on the absorption rate of the constituent.\n3.8\nharm to health\nadverse reaction, such as altered morphology, physiology, growth, development, reproduction or\nlifespan that\na)\t impairs function of an organ or system, organism, or (sub)population,\nb)\t reduces capacity to tolerate an impaired function, or\nc)\nincreases susceptibility to other influences that impair function\nNote\u00a01\u00a0to\u00a0entry:\u00a0Examples of (sub)population include, but are not limited to, male, female, preterm neonates,\nadults.\n3.9\nharmful dose\ndose capable of eliciting appreciable harm to health (3.8)\n3.10\nhuman carcinogen\ncarcinogen (3.3) for which human data demonstrates a causal association between exposure to the\nconstituent (3.4) and occurrence of cancer\nEXAMPLE\nHuman carcinogens include, but are not limited to, International Agency for Research on Cancer\n(IARC) Group I carcinogens or US National Toxicology Program (NTP) \"known to be a human carcinogen\".[6][7]\n3.11\nidentified constituent\nconstituent (3.4) for which molecular structure information is complete\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 The identity of a constituent can be obtained by information gathering or non-targeted or\ntargeted analytical approaches as described in ISO\u00a010993-18.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n3\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nEXAMPLE\nExamples of molecular structure information include molecular structure illustration or\nsimplified molecular input line entry system (SMILES) code, molecular formula, and Chemical Abstract Service\nRegistry Number (CAS RN\u00ae1)). Molecular structure information includes its atomic elements (type, number,\narrangement) and bond information.\n3.12\nirritation\nlocalized non-specific inflammatory response to single, repeated or continuous application of a\nsubstance/material\nNote\u00a01\u00a0to\u00a0entry:\u00a0Skin irritation is a reversible reaction and is mainly characterized by local erythema (redness)\nand swelling (oedema) of the skin.\n[SOURCE: ISO\u00a010993-23:2021, 3.7]\n3.13\nlowest observed adverse effect level\nLOAEL\nlowest concentration or amount of an identified constituent (3.11) found by experiment or observation\nwhich causes detectable harm to health (3.8) to the target organism under defined conditions of\nexposure\nNote\u00a01\u00a0to\u00a0entry:\u00a0The lowest observed adverse effect level is expressed in microgram per kilogram of body mass\nper day (\u00b5g/kg/d).\n3.14\nmargin of safety\nMoS\nratio of the constituent\u2019s tolerable contact level (3.25) (numerator), tolerable intake (3.26) (numerator)\nand its exposure dose (3.7) (denominator)\nNote\u00a01\u00a0to\u00a0entry:\u00a0Margin of safety addresses irritation (3.12), genotoxicity, systemic toxicity (3.23), carcinogenicity\nor reproductive or developmental endpoints.\n3.15\nminimally irritating level\nMIL\nlowest amount per surface area of an identified constituent (3.4) that is irritating to the tissue at the\ncontact site as determined by valid experimental or observational evidence\nNote\u00a01\u00a0to\u00a0entry:\u00a0The minimally irritating level is expressed in microgram per centimetre squared (\u00b5g/cm2).\n3.16\nmodifying factor\nMF\nmathematical product of uncertainty factors (3.31)\n3.17\nnon-irritating level\nNIL\ngreatest amount per surface area of an identified constituent (3.4) that does not elicit irritation to the\ntissue at the contact site as determined by valid experimental or observational evidence\nNote\u00a01\u00a0to\u00a0entry:\u00a0The non-irritating level is expressed in microgram per centimetre squared (\u00b5g/cm2).\n1)\t  Chemical Abstracts Service (CAS) Registry Number\u00ae is a trademark of the American Chemical Society (ACS).\nThis information is given for the convenience of users of this document and does not constitute an endorsement by\nISO of the product named. Equivalent products may be used if they can be shown to lead to the same results.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n4\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.18\nno observed adverse effect level\nNOAEL\ngreatest concentration or amount of an identified constituent (3.11) found by experiment or observation\nwhich causes no detectable harm to health (3.8) to the target organism under defined conditions of\nexposure\nNote\u00a01\u00a0to\u00a0entry:\u00a0The no observed adverse effect level is expressed in microgram per kilogram of body mass per\nday (\u00b5g/kg/d).\n3.19\npoint of departure\nPOD\nlow point on a toxicological dose-response curve established from experimental or observational data\nthat corresponds to the benchmark dose low (3.2), or a lowest observed adverse effect level (3.13), or a\nminimally irritating level (3.15), or a non-irritating level (3.17), or a no observed adverse effect level (3.18)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The POD is used to derive a tolerable contact level (3.25) or a tolerable intake (3.26).\n[SOURCE: EPA Integrated Risk Information System (IRIS)[8]]\n3.20\nrelease kinetics\nquantity of a constituent (3.4) that is released from a medical device as a function of time\nNote\u00a01\u00a0to entry:\u00a0Release kinetics data can be obtained experimentally (e.g. simulated use study, leachables study\nor other type of extractables study). Alternatively, if supporting chemical and material data are available, a\nqualified or validated release model can be used. Examples of experimental release kinetics test methods and\nrelease models have been published in scientific literature for phthalates and colour additives[9][10].\nNote\u00a0 2\u00a0 to entry:\u00a0 Factors that impact release (e.g. linear versus non-linear) include, but are not limited\nto, physicochemical properties of the constituent (e.g. molecular size, solubility and thermal stability),\nphysicochemical properties of the extracting solvent (e.g. solubility and thermal stability) and the impact of the\nextraction temperature on the device material in the test sample (e.g. increased free volume of a polymer system\nat elevated temperature).\n3.21\nslope factor\nupper-bound estimate of the lifetime cancer risk per increment of dose that can be used to estimate risk\nprobabilities for different exposure levels\nNote\u00a01\u00a0to\u00a0entry:\u00a0The slope factor is expressed in a pre-determined frequency of occurrence (i.e. the number of\nindividuals in which the response is expected to occur) per unit exposure dose (3.7). For example, a slope factor\nfor cancer risk that represents a frequency of occurrence in a specified population is expressed as x in 100\u00a0000\nfor every 1\u00a0\u00b5g/kg/d increase in exposure to the constituent.\n3.22\nsuspected human carcinogen\ncarcinogen (3.3) for which non-human experimental evidence indicates a probable association between\nexposure to the constituent (3.4) and cancer in humans\nNote\u00a01\u00a0to entry:\u00a0Suspected human carcinogen applies when human data are inadequate to establish an association\nbetween exposure to the constituent and cancer. Suspected human carcinogens can be established by non-human\nin vivo or in vitro evidence based on a weight of evidence assessment (see C.3.1).\nNote\u00a02\u00a0to entry:\u00a0Suspected human carcinogens include, but are not limited to, IARC Group 2A or 2B carcinogens\nor NTP \u201creasonably anticipated to be human carcinogen\u201d.[6][7]\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n5\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.23\nsystemic toxicity\nharm that occurs in an organ or system other than at the contact site\nNote\u00a01\u00a0to entry:\u00a0Systemic toxicity can occur after a one-time exposure (i.e. acutely) or after repeated or ongoing\nexposure (e.g. subacute or subchronic or chronic) to a harmful dose (3.9) of a constituent released from a single\nmedical device or from use of multiple medical devices.\nNote\u00a02\u00a0to entry:\u00a0The contact site is the specific location at which the medical device interfaces or interacts with\nthe tissue.\n3.24\nthreshold of toxicological concern\nTTC\nlevel of exposure for constituents, below which there would be no appreciable risk to human health\n[SOURCE: ISO/TS 21726:2019, 3.5]\n3.25\ntolerable contact level\nTCL\nestimate of the surface-contact exposure to an identified constituent (3.11) that is without appreciable\nirritation (3.12)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The tolerable contact level is expressed in microgram per centimetre squared (\u00b5g/cm2) of tissue\nat the contact site.\n3.26\ntolerable intake\nTI\nestimate of the daily exposure of an identified constituent (3.11) over a specified time period (e.g. acute,\nsubacute, subchronic or chronic), on the basis of body mass, that is considered to be without appreciable\nharm to health (3.8)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The tolerable intake is expressed in microgram per kilogram of body mass per day (\u00b5g/kg/d). It\nis derived to establish a toxicological exposure limit for a medical device constituent (3.4).\n3.27\ntotal quantity\nTQ\namount of a constituent (3.4) present in, or that can be extracted from, the medical device\nNote\u00a01\u00a0to entry:\u00a0The total quantity is expressed in microgram (\u00b5g).\nNote\u00a02\u00a0to entry:\u00a0The constituent\u2019s total quantity and its release rate (or kinetics) influence the maximum duration\nthat an individual can be exposed to the constituent (3.4)[11].\n3.28\ntoxicological risk\nprobability of a specified degree of an adverse reaction occurring in response to a specified level of\nexposure\n[SOURCE: ISO 10993-1:2018, 3.24]\n3.29\ntoxicological risk assessment\ndetermination of whether an exposure dose (3.7) to a constituent (3.4) can or cannot elicit appreciable\nharm to health (3.8)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n6\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.30\ntoxicological screening limit\nTSL\ncumulative exposure dose (3.7) to an identified constituent (3.11) over a specified time period that is\nwithout appreciable harm to health (3.8)\nNote\u00a01\u00a0to\u00a0entry:\u00a0TSL is expressed in microgram per individual exposed.\n3.31\nuncertainty factor\nUF\nnumerical value that accounts for uncertainties when extrapolating a point of departure (3.19) to\nindividuals that can be exposed to a constituent (3.4) of toxicological concern\nEXAMPLE\nExtrapolation types include, but are not limited to: intraspecies (see C.2.2.2), interspecies (see\nC.2.2.3), dose route (see C.2.2.4) and study duration (see C.2.2.4).\n3.32\nworst-case estimated exposure dose\nEEDmax\nexposure dose (3.7) that is a maximum value for a specified intended clinical-use scenario\nNote\u00a01\u00a0to entry:\u00a0EEDmax is based on the selection of the full range of intended clinical use scenarios, specific\nclinical use condition or assumption related to the intended clinical scenario (see Annex\u00a0 E for additional\ninformation).\nNote\u00a02\u00a0to entry:\u00a0Specific clinical use conditions or assumptions used to establish worst-case estimated exposure\ndose do not include deliberate misuse of a medical device that is not reasonably foreseeable or that results in\ndifferent harm to health (3.8).",
    "change_text": "3 Terms and definitions\nFor the purposes of this document, the terms and definitions given in ISO\u00a010993-1 and the following\napply.\nISO and IEC maintain terminology databases for use in standardization at the following addresses:\n\u2014\t ISO Online browsing platform: available at https://\u200bwww\u200b.iso\u200b.org/\u200bobp\n\u2014\t IEC Electropedia: available at https://\u200bwww\u200b.electropedia\u200b.org/\u200b\n3.1\nanalogue\nsubstance with similar molecular, physical, chemical or toxicological properties\n3.2\nbenchmark dose low\nBMDL\nlower one-sided confidence limit of a dose derived from dose-response (3.6) modelling that is associated\nwith a specified change (e.g. 5\u00a0% or 10\u00a0%) in the dose-response relationship\nNote\u00a01\u00a0to\u00a0entry:\u00a0A specified change of 5\u00a0% is applied when a reported harm applies to individual animals. A\nspecified change of 10\u00a0% is applied when a reported harm applies to a fraction of animals in a population.\n[SOURCE: EPA\u00a02012[2]]\n3.3\ncarcinogen\nconstituent (3.4) that causes cancer in humans or experimental animals as determined by valid\nexperimental or observational evidence\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 Carcinogens are either genotoxic carcinogens or non-genotoxic carcinogens. A genotoxic\ncarcinogen is a constituent capable of causing cancer by a mechanism that involves direct alteration of the genetic\nmaterial of target cells, as a key event at an early stage in tumour development. A non-genotoxic carcinogen is\na constituent capable of producing cancer by a mechanism where direct gene damage is not the key event in\ntumour development (C.3.1).\n[SOURCE: International Agency for Research on Cancer[3]]\n3.4\nconstituent\nchemical that is present in or on the finished medical device or its materials of construction\nNote\u00a01\u00a0to\u00a0entry:\u00a0Constituents can be intentionally or unintentionally added chemicals or compounds, such as:\nadditives (e.g. plasticizers, lubricants, stabilizers, anti-oxidants, colouring agents, fillers), manufacturing process\nresidues (e.g. monomers, catalysts, solvents, sterilant and cleaning agents), degradation products or impurities\n(e.g. byproducts or side products) or contaminants[5].\n[SOURCE: ISO 10993-18:2020, 3.10, modified \u2014 \"or on\" has been added to the definition and Note 1 to\nentry has been replaced.]\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n2\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.5\ndefault value\nvalue or factor used in the derivation of a worst-case exposure dose (3.32), tolerable contact level (3.25)\nor tolerable intake (3.26), in the absence of specific data [e.g. an uncertainty factor (3.31)]\n3.6\ndose-response\nrelationship of dosage to observable harm\nNote\u00a01\u00a0to\u00a0entry:\u00a0In general, there are two types of dose-response relationships. The first type is the change in\nthe response of an individual to a range of doses. The second type is the distribution of the response among\nindividuals to a range of doses.\n3.7\nexposure dose\nquantity of a constituent (3.4) that does or can contact the body by an exposure route over a specified\ntime period\nNote\u00a01\u00a0to entry:\u00a0The exposure dose is expressed in microgram per kilogram of body mass per day (\u00b5g/kg/d) or in\nmicrogram per centimetre squared (\u00b5g/cm2).\nNote\u00a02\u00a0to entry:\u00a0The exposure dose is different from the absorbed dose. The absorbed dose is the quantity of the\nconstituent that traverses the portal of entry, which is dependent on the absorption rate of the constituent.\n3.8\nharm to health\nadverse reaction, such as altered morphology, physiology, growth, development, reproduction or\nlifespan that\na)\t impairs function of an organ or system, organism, or (sub)population,\nb)\t reduces capacity to tolerate an impaired function, or\nc)\nincreases susceptibility to other influences that impair function\nNote\u00a01\u00a0to\u00a0entry:\u00a0Examples of (sub)population include, but are not limited to, male, female, preterm neonates,\nadults.\n3.9\nharmful dose\ndose capable of eliciting appreciable harm to health (3.8)\n3.10\nhuman carcinogen\ncarcinogen (3.3) for which human data demonstrates a causal association between exposure to the\nconstituent (3.4) and occurrence of cancer\nEXAMPLE\nHuman carcinogens include, but are not limited to, International Agency for Research on Cancer\n(IARC) Group I carcinogens or US National Toxicology Program (NTP) \"known to be a human carcinogen\".[6][7]\n3.11\nidentified constituent\nconstituent (3.4) for which molecular structure information is complete\nNote\u00a0 1\u00a0 to\u00a0 entry:\u00a0 The identity of a constituent can be obtained by information gathering or non-targeted or\ntargeted analytical approaches as described in ISO\u00a010993-18.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n3\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nEXAMPLE\nExamples of molecular structure information include molecular structure illustration or\nsimplified molecular input line entry system (SMILES) code, molecular formula, and Chemical Abstract Service\nRegistry Number (CAS RN\u00ae1)). Molecular structure information includes its atomic elements (type, number,\narrangement) and bond information.\n3.12\nirritation\nlocalized non-specific inflammatory response to single, repeated or continuous application of a\nsubstance/material\nNote\u00a01\u00a0to\u00a0entry:\u00a0Skin irritation is a reversible reaction and is mainly characterized by local erythema (redness)\nand swelling (oedema) of the skin.\n[SOURCE: ISO\u00a010993-23:2021, 3.7]\n3.13\nlowest observed adverse effect level\nLOAEL\nlowest concentration or amount of an identified constituent (3.11) found by experiment or observation\nwhich causes detectable harm to health (3.8) to the target organism under defined conditions of\nexposure\nNote\u00a01\u00a0to\u00a0entry:\u00a0The lowest observed adverse effect level is expressed in microgram per kilogram of body mass\nper day (\u00b5g/kg/d).\n3.14\nmargin of safety\nMoS\nratio of the constituent\u2019s tolerable contact level (3.25) (numerator), tolerable intake (3.26) (numerator)\nand its exposure dose (3.7) (denominator)\nNote\u00a01\u00a0to\u00a0entry:\u00a0Margin of safety addresses irritation (3.12), genotoxicity, systemic toxicity (3.23), carcinogenicity\nor reproductive or developmental endpoints.\n3.15\nminimally irritating level\nMIL\nlowest amount per surface area of an identified constituent (3.4) that is irritating to the tissue at the\ncontact site as determined by valid experimental or observational evidence\nNote\u00a01\u00a0to\u00a0entry:\u00a0The minimally irritating level is expressed in microgram per centimetre squared (\u00b5g/cm2).\n3.16\nmodifying factor\nMF\nmathematical product of uncertainty factors (3.31)\n3.17\nnon-irritating level\nNIL\ngreatest amount per surface area of an identified constituent (3.4) that does not elicit irritation to the\ntissue at the contact site as determined by valid experimental or observational evidence\nNote\u00a01\u00a0to\u00a0entry:\u00a0The non-irritating level is expressed in microgram per centimetre squared (\u00b5g/cm2).\n1)\t  Chemical Abstracts Service (CAS) Registry Number\u00ae is a trademark of the American Chemical Society (ACS).\nThis information is given for the convenience of users of this document and does not constitute an endorsement by\nISO of the product named. Equivalent products may be used if they can be shown to lead to the same results.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n4\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.18\nno observed adverse effect level\nNOAEL\ngreatest concentration or amount of an identified constituent (3.11) found by experiment or observation\nwhich causes no detectable harm to health (3.8) to the target organism under defined conditions of\nexposure\nNote\u00a01\u00a0to\u00a0entry:\u00a0The no observed adverse effect level is expressed in microgram per kilogram of body mass per\nday (\u00b5g/kg/d).\n3.19\npoint of departure\nPOD\nlow point on a toxicological dose-response curve established from experimental or observational data\nthat corresponds to the benchmark dose low (3.2), or a lowest observed adverse effect level (3.13), or a\nminimally irritating level (3.15), or a non-irritating level (3.17), or a no observed adverse effect level (3.18)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The POD is used to derive a tolerable contact level (3.25) or a tolerable intake (3.26).\n[SOURCE: EPA Integrated Risk Information System (IRIS)[8]]\n3.20\nrelease kinetics\nquantity of a constituent (3.4) that is released from a medical device as a function of time\nNote\u00a01\u00a0to entry:\u00a0Release kinetics data can be obtained experimentally (e.g. simulated use study, leachables study\nor other type of extractables study). Alternatively, if supporting chemical and material data are available, a\nqualified or validated release model can be used. Examples of experimental release kinetics test methods and\nrelease models have been published in scientific literature for phthalates and colour additives[9][10].\nNote\u00a0 2\u00a0 to entry:\u00a0 Factors that impact release (e.g. linear versus non-linear) include, but are not limited\nto, physicochemical properties of the constituent (e.g. molecular size, solubility and thermal stability),\nphysicochemical properties of the extracting solvent (e.g. solubility and thermal stability) and the impact of the\nextraction temperature on the device material in the test sample (e.g. increased free volume of a polymer system\nat elevated temperature).\n3.21\nslope factor\nupper-bound estimate of the lifetime cancer risk per increment of dose that can be used to estimate risk\nprobabilities for different exposure levels\nNote\u00a01\u00a0to\u00a0entry:\u00a0The slope factor is expressed in a pre-determined frequency of occurrence (i.e. the number of\nindividuals in which the response is expected to occur) per unit exposure dose (3.7). For example, a slope factor\nfor cancer risk that represents a frequency of occurrence in a specified population is expressed as x in 100\u00a0000\nfor every 1\u00a0\u00b5g/kg/d increase in exposure to the constituent.\n3.22\nsuspected human carcinogen\ncarcinogen (3.3) for which non-human experimental evidence indicates a probable association between\nexposure to the constituent (3.4) and cancer in humans\nNote\u00a01\u00a0to entry:\u00a0Suspected human carcinogen applies when human data are inadequate to establish an association\nbetween exposure to the constituent and cancer. Suspected human carcinogens can be established by non-human\nin vivo or in vitro evidence based on a weight of evidence assessment (see C.3.1).\nNote\u00a02\u00a0to entry:\u00a0Suspected human carcinogens include, but are not limited to, IARC Group 2A or 2B carcinogens\nor NTP \u201creasonably anticipated to be human carcinogen\u201d.[6][7]\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n5\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.23\nsystemic toxicity\nharm that occurs in an organ or system other than at the contact site\nNote\u00a01\u00a0to entry:\u00a0Systemic toxicity can occur after a one-time exposure (i.e. acutely) or after repeated or ongoing\nexposure (e.g. subacute or subchronic or chronic) to a harmful dose (3.9) of a constituent released from a single\nmedical device or from use of multiple medical devices.\nNote\u00a02\u00a0to entry:\u00a0The contact site is the specific location at which the medical device interfaces or interacts with\nthe tissue.\n3.24\nthreshold of toxicological concern\nTTC\nlevel of exposure for constituents, below which there would be no appreciable risk to human health\n[SOURCE: ISO/TS 21726:2019, 3.5]\n3.25\ntolerable contact level\nTCL\nestimate of the surface-contact exposure to an identified constituent (3.11) that is without appreciable\nirritation (3.12)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The tolerable contact level is expressed in microgram per centimetre squared (\u00b5g/cm2) of tissue\nat the contact site.\n3.26\ntolerable intake\nTI\nestimate of the daily exposure of an identified constituent (3.11) over a specified time period (e.g. acute,\nsubacute, subchronic or chronic), on the basis of body mass, that is considered to be without appreciable\nharm to health (3.8)\nNote\u00a01\u00a0to\u00a0entry:\u00a0The tolerable intake is expressed in microgram per kilogram of body mass per day (\u00b5g/kg/d). It\nis derived to establish a toxicological exposure limit for a medical device constituent (3.4).\n3.27\ntotal quantity\nTQ\namount of a constituent (3.4) present in, or that can be extracted from, the medical device\nNote\u00a01\u00a0to entry:\u00a0The total quantity is expressed in microgram (\u00b5g).\nNote\u00a02\u00a0to entry:\u00a0The constituent\u2019s total quantity and its release rate (or kinetics) influence the maximum duration\nthat an individual can be exposed to the constituent (3.4)[11].\n3.28\ntoxicological risk\nprobability of a specified degree of an adverse reaction occurring in response to a specified level of\nexposure\n[SOURCE: ISO 10993-1:2018, 3.24]\n3.29\ntoxicological risk assessment\ndetermination of whether an exposure dose (3.7) to a constituent (3.4) can or cannot elicit appreciable\nharm to health (3.8)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n6\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\n3.30\ntoxicological screening limit\nTSL\ncumulative exposure dose (3.7) to an identified constituent (3.11) over a specified time period that is\nwithout appreciable harm to health (3.8)\nNote\u00a01\u00a0to\u00a0entry:\u00a0TSL is expressed in microgram per individual exposed.\n3.31\nuncertainty factor\nUF\nnumerical value that accounts for uncertainties when extrapolating a point of departure (3.19) to\nindividuals that can be exposed to a constituent (3.4) of toxicological concern\nEXAMPLE\nExtrapolation types include, but are not limited to: intraspecies (see C.2.2.2), interspecies (see\nC.2.2.3), dose route (see C.2.2.4) and study duration (see C.2.2.4).\n3.32\nworst-case estimated exposure dose\nEEDmax\nexposure dose (3.7) that is a maximum value for a specified intended clinical-use scenario\nNote\u00a01\u00a0to entry:\u00a0EEDmax is based on the selection of the full range of intended clinical use scenarios, specific\nclinical use condition or assumption related to the intended clinical scenario (see Annex\u00a0 E for additional\ninformation).\nNote\u00a02\u00a0to entry:\u00a0Specific clinical use conditions or assumptions used to establish worst-case estimated exposure\ndose do not include deliberate misuse of a medical device that is not reasonably foreseeable or that results in\ndifferent harm to health (3.8).",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to13__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__0\"><a href=\"#difflib_chg_to13__0\">f</a></td><td class=\"diff_header\" id=\"from13_1\">1</td><td nowrap=\"nowrap\">3&nbsp;Terms&nbsp;and&nbsp;definitions</td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__0\">f</a></td><td class=\"diff_header\" id=\"to13_1\">1</td><td nowrap=\"nowrap\">3&nbsp;Terms&nbsp;and&nbsp;definitions</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__1\">n</a></td><td class=\"diff_header\" id=\"from13_2\">2</td><td nowrap=\"nowrap\">For&nbsp;the&nbsp;purposes&nbsp;of&nbsp;this&nbsp;document,&nbsp;the&nbsp;definitions&nbsp;in&nbsp;ISO\u00a010993-1&nbsp;and&nbsp;the&nbsp;following<span class=\"diff_sub\">&nbsp;apply.</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__1\">n</a></td><td class=\"diff_header\" id=\"to13_2\">2</td><td nowrap=\"nowrap\">For&nbsp;the&nbsp;purposes&nbsp;of&nbsp;this&nbsp;document,&nbsp;the<span class=\"diff_add\">&nbsp;terms&nbsp;and</span>&nbsp;definitions&nbsp;<span class=\"diff_add\">given&nbsp;</span>in&nbsp;ISO\u00a010993-1&nbsp;and&nbsp;the&nbsp;following</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__1\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">apply.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_3\">3</td><td nowrap=\"nowrap\">ISO&nbsp;and&nbsp;IEC&nbsp;maintain&nbsp;terminolog<span class=\"diff_chg\">ical</span>&nbsp;databases&nbsp;for&nbsp;use&nbsp;in&nbsp;standardization&nbsp;at&nbsp;the&nbsp;following&nbsp;addresses:</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_4\">4</td><td nowrap=\"nowrap\">ISO&nbsp;and&nbsp;IEC&nbsp;maintain&nbsp;terminolog<span class=\"diff_chg\">y</span>&nbsp;databases&nbsp;for&nbsp;use&nbsp;in&nbsp;standardization&nbsp;at&nbsp;the&nbsp;following&nbsp;addresses:</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_4\">4</td><td nowrap=\"nowrap\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISO&nbsp;Online&nbsp;browsing&nbsp;platform:&nbsp;available&nbsp;<span class=\"diff_chg\">from</span>&nbsp;https://\u200bwww\u200b.iso\u200b.org/\u200bobp</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_5\">5</td><td nowrap=\"nowrap\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISO&nbsp;Online&nbsp;browsing&nbsp;platform:&nbsp;available&nbsp;<span class=\"diff_chg\">at</span>&nbsp;https://\u200bwww\u200b.iso\u200b.org/\u200bobp</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_5\">5</td><td nowrap=\"nowrap\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IEC&nbsp;Electropedia:&nbsp;available&nbsp;<span class=\"diff_chg\">from</span>&nbsp;http://\u200bwww\u200b.electropedia\u200b.org/\u200b</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_6\">6</td><td nowrap=\"nowrap\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IEC&nbsp;Electropedia:&nbsp;available&nbsp;<span class=\"diff_chg\">at</span>&nbsp;http<span class=\"diff_add\">s</span>://\u200bwww\u200b.electropedia\u200b.org/\u200b</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_6\">6</td><td nowrap=\"nowrap\">3.1</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_7\">7</td><td nowrap=\"nowrap\">3.1</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__2\"><a href=\"#difflib_chg_to13__2\">n</a></td><td class=\"diff_header\" id=\"from13_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">accelerated&nbsp;extraction</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__2\">n</a></td><td class=\"diff_header\" id=\"to13_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">analogue</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;whose&nbsp;duration&nbsp;is&nbsp;shorter&nbsp;than&nbsp;the&nbsp;duration&nbsp;of&nbsp;clinical&nbsp;use&nbsp;but&nbsp;whose&nbsp;conditions&nbsp;do&nbsp;not&nbsp;result</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">substance&nbsp;with&nbsp;similar&nbsp;molecular,&nbsp;physical,&nbsp;chemical&nbsp;or&nbsp;toxicological&nbsp;properties</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;a&nbsp;chemical&nbsp;change&nbsp;to&nbsp;the&nbsp;substances&nbsp;being&nbsp;extracted</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0See&nbsp;also&nbsp;Annex\u00a0D.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_11\">11</td><td nowrap=\"nowrap\">3.2</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_10\">10</td><td nowrap=\"nowrap\">3.2</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__3\">n</a></td><td class=\"diff_header\" id=\"from13_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;evaluation&nbsp;threshold</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__3\">n</a></td><td class=\"diff_header\" id=\"to13_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">benchmark&nbsp;dose&nbsp;low</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">BMDL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">threshold&nbsp;below&nbsp;which&nbsp;the&nbsp;analyst&nbsp;need&nbsp;not&nbsp;identify&nbsp;or&nbsp;quantify&nbsp;leachables&nbsp;or&nbsp;extractables&nbsp;or&nbsp;report</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">lower&nbsp;one-sided&nbsp;confidence&nbsp;limit&nbsp;of&nbsp;a&nbsp;dose&nbsp;derived&nbsp;from&nbsp;dose-response&nbsp;(3.6)&nbsp;modelling&nbsp;that&nbsp;is&nbsp;associated</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__3\"></td><td class=\"diff_header\" id=\"from13_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">them&nbsp;for&nbsp;potential&nbsp;toxicological&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">with&nbsp;a&nbsp;specified&nbsp;change&nbsp;(e.g.&nbsp;5\u00a0%&nbsp;or&nbsp;10\u00a0%)&nbsp;in&nbsp;the&nbsp;dose-response&nbsp;relationship</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0See&nbsp;Annex\u00a0E.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0A&nbsp;specified&nbsp;change&nbsp;of&nbsp;5\u00a0%&nbsp;is&nbsp;applied&nbsp;when&nbsp;a&nbsp;reported&nbsp;harm&nbsp;applies&nbsp;to&nbsp;individual&nbsp;animals.&nbsp;A</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">specified&nbsp;change&nbsp;of&nbsp;10\u00a0%&nbsp;is&nbsp;applied&nbsp;when&nbsp;a&nbsp;reported&nbsp;harm&nbsp;applies&nbsp;to&nbsp;a&nbsp;fraction&nbsp;of&nbsp;animals&nbsp;in&nbsp;a&nbsp;population.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;EPA\u00a02012[2]]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_17\">17</td><td nowrap=\"nowrap\">3.3</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_18\">18</td><td nowrap=\"nowrap\">3.3</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__4\">n</a></td><td class=\"diff_header\" id=\"from13_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytically&nbsp;expedient</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__4\">n</a></td><td class=\"diff_header\" id=\"to13_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">carcinogen</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">situation&nbsp;where&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;can&nbsp;be&nbsp;directly&nbsp;evaluated&nbsp;with&nbsp;generally&nbsp;available&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;(3.4)&nbsp;that&nbsp;causes&nbsp;cancer&nbsp;in&nbsp;humans&nbsp;or&nbsp;experimental&nbsp;animals&nbsp;as&nbsp;determined&nbsp;by&nbsp;valid</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">methods&nbsp;with&nbsp;the&nbsp;sensitivity&nbsp;and&nbsp;selectivity&nbsp;necessary&nbsp;to&nbsp;achieve&nbsp;a&nbsp;designated&nbsp;reporting&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">experimental&nbsp;or&nbsp;observational&nbsp;evidence</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;as&nbsp;the&nbsp;AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a0&nbsp;1\u00a0&nbsp;to\u00a0&nbsp;entry:\u00a0&nbsp;Carcinogens&nbsp;are&nbsp;either&nbsp;genotoxic&nbsp;carcinogens&nbsp;or&nbsp;non-genotoxic&nbsp;carcinogens.&nbsp;A&nbsp;genotoxic</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">carcinogen&nbsp;is&nbsp;a&nbsp;constituent&nbsp;capable&nbsp;of&nbsp;causing&nbsp;cancer&nbsp;by&nbsp;a&nbsp;mechanism&nbsp;that&nbsp;involves&nbsp;direct&nbsp;alteration&nbsp;of&nbsp;the&nbsp;genetic</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__4\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">material&nbsp;of&nbsp;target&nbsp;cells,&nbsp;as&nbsp;a&nbsp;key&nbsp;event&nbsp;at&nbsp;an&nbsp;early&nbsp;stage&nbsp;in&nbsp;tumour&nbsp;development.&nbsp;A&nbsp;non-genotoxic&nbsp;carcinogen&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a&nbsp;constituent&nbsp;capable&nbsp;of&nbsp;producing&nbsp;cancer&nbsp;by&nbsp;a&nbsp;mechanism&nbsp;where&nbsp;direct&nbsp;gene&nbsp;damage&nbsp;is&nbsp;not&nbsp;the&nbsp;key&nbsp;event&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">tumour&nbsp;development&nbsp;(C.3.1).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;International&nbsp;Agency&nbsp;for&nbsp;Research&nbsp;on&nbsp;Cancer[3]]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_22\">22</td><td nowrap=\"nowrap\">3.4</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_28\">28</td><td nowrap=\"nowrap\">3.4</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__5\">n</a></td><td class=\"diff_header\" id=\"from13_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;screening&nbsp;method</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__5\">n</a></td><td class=\"diff_header\" id=\"to13_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">method&nbsp;whose&nbsp;purpose&nbsp;is&nbsp;to&nbsp;discover,&nbsp;identify&nbsp;and&nbsp;semi-quantitatively&nbsp;estimate&nbsp;the&nbsp;concentration&nbsp;of&nbsp;all</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">chemical&nbsp;that&nbsp;is&nbsp;present&nbsp;in&nbsp;or&nbsp;on&nbsp;the&nbsp;finished&nbsp;medical&nbsp;device&nbsp;or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relevant&nbsp;analytes&nbsp;in&nbsp;a&nbsp;test&nbsp;sample&nbsp;above&nbsp;an&nbsp;established&nbsp;reporting&nbsp;threshold&nbsp;(such&nbsp;as&nbsp;the&nbsp;AET)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0Constituents&nbsp;can&nbsp;be&nbsp;intentionally&nbsp;or&nbsp;unintentionally&nbsp;added&nbsp;chemicals&nbsp;or&nbsp;compounds,&nbsp;such&nbsp;as:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_add\">additives&nbsp;(e.g.&nbsp;plasticizers,&nbsp;lubricants,&nbsp;stabilizers,&nbsp;anti-oxidants,&nbsp;colouring&nbsp;agents,&nbsp;fillers),&nbsp;manufacturing&nbsp;process</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_add\">residues&nbsp;(e.g.&nbsp;monomers,&nbsp;catalysts,&nbsp;solvents,&nbsp;sterilant&nbsp;and&nbsp;cleaning&nbsp;agents),&nbsp;degradation&nbsp;products&nbsp;or&nbsp;impurities</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">(e.g.&nbsp;byproducts&nbsp;or&nbsp;side&nbsp;products)&nbsp;or&nbsp;contaminants[5].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;ISO&nbsp;10993-18:2020,&nbsp;3.10,&nbsp;modified&nbsp;\u2014&nbsp;\"or&nbsp;on\"&nbsp;has&nbsp;been&nbsp;added&nbsp;to&nbsp;the&nbsp;definition&nbsp;and&nbsp;Note&nbsp;1&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_add\">entry&nbsp;has&nbsp;been&nbsp;replaced.]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_add\">2</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__5\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__6\"></td><td class=\"diff_header\" id=\"from13_26\">26</td><td nowrap=\"nowrap\">3.5</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_47\">47</td><td nowrap=\"nowrap\">3.5</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__6\">n</a></td><td class=\"diff_header\" id=\"from13_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;targeting&nbsp;method</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__6\">n</a></td><td class=\"diff_header\" id=\"to13_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_add\">default&nbsp;value</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">method&nbsp;whose&nbsp;purpose&nbsp;is&nbsp;to&nbsp;quantify,&nbsp;with&nbsp;an&nbsp;appropriately&nbsp;high&nbsp;degree&nbsp;of&nbsp;accuracy&nbsp;and&nbsp;precision,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_add\">value&nbsp;or&nbsp;factor&nbsp;used&nbsp;in&nbsp;the&nbsp;derivation&nbsp;of&nbsp;a&nbsp;worst-case&nbsp;exposure&nbsp;dose&nbsp;(3.32),&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;(3.25)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specified&nbsp;analytes&nbsp;in&nbsp;a&nbsp;specified&nbsp;test&nbsp;sample&nbsp;over&nbsp;a&nbsp;specified&nbsp;concentration&nbsp;range</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;tolerable&nbsp;intake&nbsp;(3.26),&nbsp;in&nbsp;the&nbsp;absence&nbsp;of&nbsp;specific&nbsp;data&nbsp;[e.g.&nbsp;an&nbsp;uncertainty&nbsp;factor&nbsp;(3.31)]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_30\">30</td><td nowrap=\"nowrap\">3.6</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_51\">51</td><td nowrap=\"nowrap\">3.6</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__7\">n</a></td><td class=\"diff_header\" id=\"from13_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__7\">n</a></td><td class=\"diff_header\" id=\"to13_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_add\">dose-response</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__7\"></td><td class=\"diff_header\" id=\"from13_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;obtaining&nbsp;chemical&nbsp;information,&nbsp;accomplished&nbsp;either&nbsp;by&nbsp;information&nbsp;gathering&nbsp;or&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_add\">relationship&nbsp;of&nbsp;dosage&nbsp;to&nbsp;observable&nbsp;harm</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;generation,&nbsp;for&nbsp;example,&nbsp;by&nbsp;literature&nbsp;review&nbsp;or&nbsp;chemical&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0In&nbsp;general,&nbsp;there&nbsp;are&nbsp;two&nbsp;types&nbsp;of&nbsp;dose-response&nbsp;relationships.&nbsp;The&nbsp;first&nbsp;type&nbsp;is&nbsp;the&nbsp;change&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;response&nbsp;of&nbsp;an&nbsp;individual&nbsp;to&nbsp;a&nbsp;range&nbsp;of&nbsp;doses.&nbsp;The&nbsp;second&nbsp;type&nbsp;is&nbsp;the&nbsp;distribution&nbsp;of&nbsp;the&nbsp;response&nbsp;among</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_add\">individuals&nbsp;to&nbsp;a&nbsp;range&nbsp;of&nbsp;doses.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_34\">34</td><td nowrap=\"nowrap\">3.7</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_57\">57</td><td nowrap=\"nowrap\">3.7</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__8\">n</a></td><td class=\"diff_header\" id=\"from13_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;information</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__8\">n</a></td><td class=\"diff_header\" id=\"to13_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;dose</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualitative&nbsp;and&nbsp;quantitative,&nbsp;if&nbsp;applicable,&nbsp;knowledge&nbsp;related&nbsp;to&nbsp;the&nbsp;configuration,&nbsp;composition&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_add\">quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;(3.4)&nbsp;that&nbsp;does&nbsp;or&nbsp;can&nbsp;contact&nbsp;the&nbsp;body&nbsp;by&nbsp;an&nbsp;exposure&nbsp;route&nbsp;over&nbsp;a&nbsp;specified</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">production&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and/or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;thereby&nbsp;establishing&nbsp;the&nbsp;identities</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_add\">time&nbsp;period</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;amounts&nbsp;of&nbsp;constituents&nbsp;present&nbsp;in&nbsp;the&nbsp;materials&nbsp;and&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0The&nbsp;exposure&nbsp;dose&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;kilogram&nbsp;of&nbsp;body&nbsp;mass&nbsp;per&nbsp;day&nbsp;(\u00b5g/kg/d)&nbsp;or&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__8\"></td><td class=\"diff_header\" id=\"from13_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to&nbsp;entry:\u00a0See&nbsp;also&nbsp;5.2.1,&nbsp;5.2.2,&nbsp;5.2.3,&nbsp;and&nbsp;Annex\u00a0B.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_add\">microgram&nbsp;per&nbsp;centimetre&nbsp;squared&nbsp;(\u00b5g/cm2).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a02\u00a0to&nbsp;entry:\u00a0Chemical&nbsp;information&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;establish&nbsp;the&nbsp;hypothetical&nbsp;worst-case&nbsp;release&nbsp;of&nbsp;chemicals</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a02\u00a0to&nbsp;entry:\u00a0The&nbsp;exposure&nbsp;dose&nbsp;is&nbsp;different&nbsp;from&nbsp;the&nbsp;absorbed&nbsp;dose.&nbsp;The&nbsp;absorbed&nbsp;dose&nbsp;is&nbsp;the&nbsp;quantity&nbsp;of&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;a&nbsp;medical&nbsp;device,&nbsp;predicated&nbsp;on&nbsp;the&nbsp;circumstance&nbsp;that&nbsp;all&nbsp;chemicals&nbsp;present&nbsp;in&nbsp;the&nbsp;device&nbsp;are&nbsp;released&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;that&nbsp;traverses&nbsp;the&nbsp;portal&nbsp;of&nbsp;entry,&nbsp;which&nbsp;is&nbsp;dependent&nbsp;on&nbsp;the&nbsp;absorption&nbsp;rate&nbsp;of&nbsp;the&nbsp;constituent.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;device&nbsp;under&nbsp;its&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_43\">43</td><td nowrap=\"nowrap\">3.8</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_65\">65</td><td nowrap=\"nowrap\">3.8</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__9\">n</a></td><td class=\"diff_header\" id=\"from13_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinically&nbsp;established</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__9\">n</a></td><td class=\"diff_header\" id=\"to13_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_add\">harm&nbsp;to&nbsp;health</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medical&nbsp;device,&nbsp;component,&nbsp;or&nbsp;material&nbsp;of&nbsp;construction&nbsp;which&nbsp;has&nbsp;been&nbsp;used&nbsp;extensively&nbsp;for&nbsp;specified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_add\">adverse&nbsp;reaction,&nbsp;such&nbsp;as&nbsp;altered&nbsp;morphology,&nbsp;physiology,&nbsp;growth,&nbsp;development,&nbsp;reproduction&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;established&nbsp;clinical&nbsp;uses&nbsp;for&nbsp;which&nbsp;biocompatibility&nbsp;has&nbsp;been&nbsp;established</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_add\">lifespan&nbsp;that</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;impairs&nbsp;function&nbsp;of&nbsp;an&nbsp;organ&nbsp;or&nbsp;system,&nbsp;organism,&nbsp;or&nbsp;(sub)population,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_add\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reduces&nbsp;capacity&nbsp;to&nbsp;tolerate&nbsp;an&nbsp;impaired&nbsp;function,&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_add\">c)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_add\">increases&nbsp;susceptibility&nbsp;to&nbsp;other&nbsp;influences&nbsp;that&nbsp;impair&nbsp;function</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__9\"></td><td class=\"diff_header\" id=\"from13_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0Examples&nbsp;of&nbsp;(sub)population&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;male,&nbsp;female,&nbsp;preterm&nbsp;neonates,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_add\">adults.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__10\"></td><td class=\"diff_header\" id=\"from13_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_55\">55</td><td nowrap=\"nowrap\">3.9</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_75\">75</td><td nowrap=\"nowrap\">3.9</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__10\">n</a></td><td class=\"diff_header\" id=\"from13_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">component</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__10\">n</a></td><td class=\"diff_header\" id=\"to13_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_add\">harmful&nbsp;dose</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">item&nbsp;which&nbsp;forms&nbsp;one&nbsp;part&nbsp;of&nbsp;a&nbsp;medical&nbsp;device,&nbsp;but&nbsp;is&nbsp;not&nbsp;itself&nbsp;a&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_add\">dose&nbsp;capable&nbsp;of&nbsp;eliciting&nbsp;appreciable&nbsp;harm&nbsp;to&nbsp;health&nbsp;(3.8)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_58\">58</td><td nowrap=\"nowrap\">3.10</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_78\">78</td><td nowrap=\"nowrap\">3.10</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__11\">n</a></td><td class=\"diff_header\" id=\"from13_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">constituent</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__11\">n</a></td><td class=\"diff_header\" id=\"to13_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_add\">human&nbsp;carcinogen</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;that&nbsp;is&nbsp;present&nbsp;in&nbsp;a&nbsp;finished&nbsp;medical&nbsp;device&nbsp;or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_add\">carcinogen&nbsp;(3.3)&nbsp;for&nbsp;which&nbsp;human&nbsp;data&nbsp;demonstrates&nbsp;a&nbsp;causal&nbsp;association&nbsp;between&nbsp;exposure&nbsp;to&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__11\"></td><td class=\"diff_header\" id=\"from13_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a0&nbsp;1\u00a0&nbsp;to\u00a0&nbsp;entry:\u00a0&nbsp;Constituents&nbsp;may&nbsp;be&nbsp;intentionally&nbsp;present&nbsp;(e.g.&nbsp;an&nbsp;additive&nbsp;such&nbsp;as&nbsp;an&nbsp;antioxidant)&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;(3.4)&nbsp;and&nbsp;occurrence&nbsp;of&nbsp;cancer</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">unintentionally&nbsp;present&nbsp;(e.g.&nbsp;an&nbsp;impurity&nbsp;or&nbsp;degradant).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Human&nbsp;carcinogens&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;International&nbsp;Agency&nbsp;for&nbsp;Research&nbsp;on&nbsp;Cancer</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_add\">(IARC)&nbsp;Group&nbsp;I&nbsp;carcinogens&nbsp;or&nbsp;US&nbsp;National&nbsp;Toxicology&nbsp;Program&nbsp;(NTP)&nbsp;\"known&nbsp;to&nbsp;be&nbsp;a&nbsp;human&nbsp;carcinogen\".[6][7]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_63\">63</td><td nowrap=\"nowrap\">3.11</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_85\">85</td><td nowrap=\"nowrap\">3.11</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__12\">n</a></td><td class=\"diff_header\" id=\"from13_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">convertor</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__12\">n</a></td><td class=\"diff_header\" id=\"to13_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_add\">identified&nbsp;constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">person&nbsp;or&nbsp;company&nbsp;who&nbsp;converts&nbsp;or&nbsp;fabricates&nbsp;a&nbsp;basic&nbsp;raw&nbsp;material&nbsp;into&nbsp;a&nbsp;semi-finished&nbsp;product&nbsp;(e.g.&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;(3.4)&nbsp;for&nbsp;which&nbsp;molecular&nbsp;structure&nbsp;information&nbsp;is&nbsp;complete</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">former&nbsp;of&nbsp;lengths&nbsp;of&nbsp;rod,&nbsp;tubing,&nbsp;or&nbsp;plastic&nbsp;components)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a0&nbsp;1\u00a0&nbsp;to\u00a0&nbsp;entry:\u00a0&nbsp;The&nbsp;identity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;can&nbsp;be&nbsp;obtained&nbsp;by&nbsp;information&nbsp;gathering&nbsp;or&nbsp;non-targeted&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_add\">targeted&nbsp;analytical&nbsp;approaches&nbsp;as&nbsp;described&nbsp;in&nbsp;ISO\u00a010993-18.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__12\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Examples&nbsp;of&nbsp;molecular&nbsp;structure&nbsp;information&nbsp;include&nbsp;molecular&nbsp;structure&nbsp;illustration&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_add\">simplified&nbsp;molecular&nbsp;input&nbsp;line&nbsp;entry&nbsp;system&nbsp;(SMILES)&nbsp;code,&nbsp;molecular&nbsp;formula,&nbsp;and&nbsp;Chemical&nbsp;Abstract&nbsp;Service</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Registry&nbsp;Number&nbsp;(CAS&nbsp;RN\u00ae1)).&nbsp;Molecular&nbsp;structure&nbsp;information&nbsp;includes&nbsp;its&nbsp;atomic&nbsp;elements&nbsp;(type,&nbsp;number,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_add\">arrangement)&nbsp;and&nbsp;bond&nbsp;information.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_67\">67</td><td nowrap=\"nowrap\">3.12</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_103\">103</td><td nowrap=\"nowrap\">3.12</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__13\">n</a></td><td class=\"diff_header\" id=\"from13_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">digestion</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__13\">n</a></td><td class=\"diff_header\" id=\"to13_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_add\">irritation</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;completely&nbsp;solubilizing&nbsp;a&nbsp;medical&nbsp;device,&nbsp;one&nbsp;or&nbsp;more&nbsp;of&nbsp;its&nbsp;components&nbsp;or&nbsp;one&nbsp;or&nbsp;more&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_add\">localized&nbsp;non-specific&nbsp;inflammatory&nbsp;response&nbsp;to&nbsp;single,&nbsp;repeated&nbsp;or&nbsp;continuous&nbsp;application&nbsp;of&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__13\"></td><td class=\"diff_header\" id=\"from13_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">its&nbsp;materials&nbsp;of&nbsp;construction&nbsp;by&nbsp;breaking&nbsp;it&nbsp;down&nbsp;into&nbsp;its&nbsp;fundamental&nbsp;structural&nbsp;units,&nbsp;including&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_add\">substance/material</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">elemental&nbsp;constituents&nbsp;or&nbsp;monomeric&nbsp;units</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0Skin&nbsp;irritation&nbsp;is&nbsp;a&nbsp;reversible&nbsp;reaction&nbsp;and&nbsp;is&nbsp;mainly&nbsp;characterized&nbsp;by&nbsp;local&nbsp;erythema&nbsp;(redness)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_add\">and&nbsp;swelling&nbsp;(oedema)&nbsp;of&nbsp;the&nbsp;skin.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;ISO\u00a010993-23:2021,&nbsp;3.7]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_72\">72</td><td nowrap=\"nowrap\">3.13</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_110\">110</td><td nowrap=\"nowrap\">3.13</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__14\">n</a></td><td class=\"diff_header\" id=\"from13_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">dissolution</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__14\">n</a></td><td class=\"diff_header\" id=\"to13_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_add\">lowest&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;completely&nbsp;solubilizing&nbsp;a&nbsp;medical&nbsp;device,&nbsp;one&nbsp;or&nbsp;more&nbsp;of&nbsp;its&nbsp;components&nbsp;or&nbsp;one&nbsp;or&nbsp;more&nbsp;of&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_add\">LOAEL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">materials&nbsp;of&nbsp;construction,&nbsp;generally&nbsp;preserving&nbsp;the&nbsp;molecular&nbsp;structures&nbsp;of&nbsp;its&nbsp;constituents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_add\">lowest&nbsp;concentration&nbsp;or&nbsp;amount&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.11)&nbsp;found&nbsp;by&nbsp;experiment&nbsp;or&nbsp;observation</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__14\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_add\">which&nbsp;causes&nbsp;detectable&nbsp;harm&nbsp;to&nbsp;health&nbsp;(3.8)&nbsp;to&nbsp;the&nbsp;target&nbsp;organism&nbsp;under&nbsp;defined&nbsp;conditions&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;lowest&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;kilogram&nbsp;of&nbsp;body&nbsp;mass</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_add\">per&nbsp;day&nbsp;(\u00b5g/kg/d).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_76\">76</td><td nowrap=\"nowrap\">3.14</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_118\">118</td><td nowrap=\"nowrap\">3.14</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__15\">n</a></td><td class=\"diff_header\" id=\"from13_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exaggerated&nbsp;extraction</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__15\">n</a></td><td class=\"diff_header\" id=\"to13_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_add\">margin&nbsp;of&nbsp;safety</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;that&nbsp;is&nbsp;intended&nbsp;to&nbsp;result&nbsp;in&nbsp;a&nbsp;greater&nbsp;number&nbsp;or&nbsp;amount&nbsp;of&nbsp;chemical&nbsp;constituents&nbsp;being</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MoS</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__15\"></td><td class=\"diff_header\" id=\"from13_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">released&nbsp;as&nbsp;compared&nbsp;to&nbsp;the&nbsp;amount&nbsp;generated&nbsp;under&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ratio&nbsp;of&nbsp;the&nbsp;constituent\u2019s&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;(3.25)&nbsp;(numerator),&nbsp;tolerable&nbsp;intake&nbsp;(3.26)&nbsp;(numerator)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0It&nbsp;is&nbsp;important&nbsp;to&nbsp;ensure&nbsp;that&nbsp;the&nbsp;exaggerated&nbsp;extraction&nbsp;does&nbsp;not&nbsp;result&nbsp;in&nbsp;a&nbsp;chemical&nbsp;change&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_add\">and&nbsp;its&nbsp;exposure&nbsp;dose&nbsp;(3.7)&nbsp;(denominator)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;material&nbsp;or&nbsp;the&nbsp;substances&nbsp;being&nbsp;extracted.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0Margin&nbsp;of&nbsp;safety&nbsp;addresses&nbsp;irritation&nbsp;(3.12),&nbsp;genotoxicity,&nbsp;systemic&nbsp;toxicity&nbsp;(3.23),&nbsp;carcinogenicity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;reproductive&nbsp;or&nbsp;developmental&nbsp;endpoints.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_82\">82</td><td nowrap=\"nowrap\">3.15</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_125\">125</td><td nowrap=\"nowrap\">3.15</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__16\">n</a></td><td class=\"diff_header\" id=\"from13_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive&nbsp;extraction</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__16\">n</a></td><td class=\"diff_header\" id=\"to13_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_add\">minimally&nbsp;irritating&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__16\"></td><td class=\"diff_header\" id=\"from13_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">multi-step&nbsp;extraction&nbsp;conducted&nbsp;until&nbsp;the&nbsp;amount&nbsp;of&nbsp;material&nbsp;extracted&nbsp;in&nbsp;a&nbsp;subsequent&nbsp;extraction&nbsp;step</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MIL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;less&nbsp;than&nbsp;10\u00a0%&nbsp;by&nbsp;gravimetric&nbsp;analysis&nbsp;(or&nbsp;achieved&nbsp;by&nbsp;other&nbsp;means)&nbsp;of&nbsp;that&nbsp;determined&nbsp;in&nbsp;the&nbsp;initial</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_add\">lowest&nbsp;amount&nbsp;per&nbsp;surface&nbsp;area&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.4)&nbsp;that&nbsp;is&nbsp;irritating&nbsp;to&nbsp;the&nbsp;tissue&nbsp;at&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;step</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_129\">129</td><td nowrap=\"nowrap\"><span class=\"diff_add\">contact&nbsp;site&nbsp;as&nbsp;determined&nbsp;by&nbsp;valid&nbsp;experimental&nbsp;or&nbsp;observational&nbsp;evidence</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_130\">130</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;minimally&nbsp;irritating&nbsp;level&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;centimetre&nbsp;squared&nbsp;(\u00b5g/cm2).</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__17\"></td><td class=\"diff_header\" id=\"from13_87\">87</td><td nowrap=\"nowrap\">3.16</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_131\">131</td><td nowrap=\"nowrap\">3.16</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__17\">n</a></td><td class=\"diff_header\" id=\"from13_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractable</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__17\">n</a></td><td class=\"diff_header\" id=\"to13_132\">132</td><td nowrap=\"nowrap\"><span class=\"diff_add\">modifying&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;that&nbsp;is&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;of&nbsp;construction&nbsp;when&nbsp;the&nbsp;medical&nbsp;device&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_133\">133</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;is&nbsp;extracted&nbsp;using&nbsp;laboratory&nbsp;extraction&nbsp;conditions&nbsp;and&nbsp;vehicles</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_134\">134</td><td nowrap=\"nowrap\"><span class=\"diff_add\">mathematical&nbsp;product&nbsp;of&nbsp;uncertainty&nbsp;factors&nbsp;(3.31)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_91\">91</td><td nowrap=\"nowrap\">3.17</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_135\">135</td><td nowrap=\"nowrap\">3.17</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__18\">n</a></td><td class=\"diff_header\" id=\"from13_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;power</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__18\">n</a></td><td class=\"diff_header\" id=\"to13_136\">136</td><td nowrap=\"nowrap\"><span class=\"diff_add\">non-irritating&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ability&nbsp;of&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;to&nbsp;extract&nbsp;(or&nbsp;leach)&nbsp;substances&nbsp;from&nbsp;a&nbsp;medical&nbsp;device,&nbsp;component&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_137\">137</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NIL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;of&nbsp;construction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_138\">138</td><td nowrap=\"nowrap\"><span class=\"diff_add\">greatest&nbsp;amount&nbsp;per&nbsp;surface&nbsp;area&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.4)&nbsp;that&nbsp;does&nbsp;not&nbsp;elicit&nbsp;irritation&nbsp;to&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;extraction&nbsp;power&nbsp;of&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;is&nbsp;impacted&nbsp;by&nbsp;its&nbsp;physicochemical&nbsp;properties,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_139\">139</td><td nowrap=\"nowrap\"><span class=\"diff_add\">tissue&nbsp;at&nbsp;the&nbsp;contact&nbsp;site&nbsp;as&nbsp;determined&nbsp;by&nbsp;valid&nbsp;experimental&nbsp;or&nbsp;observational&nbsp;evidence</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">including,&nbsp;but&nbsp;not&nbsp;limited&nbsp;to,&nbsp;its&nbsp;polarity,&nbsp;pH&nbsp;and&nbsp;dielectric&nbsp;constant.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_140\">140</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;non-irritating&nbsp;level&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;centimetre&nbsp;squared&nbsp;(\u00b5g/cm2).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_141\">141</td><td nowrap=\"nowrap\"><span class=\"diff_add\">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical&nbsp;Abstracts&nbsp;Service&nbsp;(CAS)&nbsp;Registry&nbsp;Number\u00ae&nbsp;is&nbsp;a&nbsp;trademark&nbsp;of&nbsp;the&nbsp;American&nbsp;Chemical&nbsp;Society&nbsp;(ACS).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_142\">142</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;information&nbsp;is&nbsp;given&nbsp;for&nbsp;the&nbsp;convenience&nbsp;of&nbsp;users&nbsp;of&nbsp;this&nbsp;document&nbsp;and&nbsp;does&nbsp;not&nbsp;constitute&nbsp;an&nbsp;endorsement&nbsp;by</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_143\">143</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;of&nbsp;the&nbsp;product&nbsp;named.&nbsp;Equivalent&nbsp;products&nbsp;may&nbsp;be&nbsp;used&nbsp;if&nbsp;they&nbsp;can&nbsp;be&nbsp;shown&nbsp;to&nbsp;lead&nbsp;to&nbsp;the&nbsp;same&nbsp;results.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_144\">144</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_145\">145</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_146\">146</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_147\">147</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_148\">148</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_149\">149</td><td nowrap=\"nowrap\"><span class=\"diff_add\">4</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__18\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_150\">150</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_151\">151</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_152\">152</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_153\">153</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_97\">97</td><td nowrap=\"nowrap\">3.18</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_154\">154</td><td nowrap=\"nowrap\">3.18</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__19\">n</a></td><td class=\"diff_header\" id=\"from13_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;vehicle</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__19\">n</a></td><td class=\"diff_header\" id=\"to13_155\">155</td><td nowrap=\"nowrap\"><span class=\"diff_add\">no&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medium&nbsp;(solution&nbsp;or&nbsp;solvent)&nbsp;which&nbsp;is&nbsp;used&nbsp;to&nbsp;extract&nbsp;(or&nbsp;leach)&nbsp;a&nbsp;test&nbsp;article&nbsp;for&nbsp;the&nbsp;purpose&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_156\">156</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOAEL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establishing&nbsp;the&nbsp;test&nbsp;article\u2019s&nbsp;extractables&nbsp;or&nbsp;leachables&nbsp;profile</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_157\">157</td><td nowrap=\"nowrap\"><span class=\"diff_add\">greatest&nbsp;concentration&nbsp;or&nbsp;amount&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.11)&nbsp;found&nbsp;by&nbsp;experiment&nbsp;or&nbsp;observation</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to&nbsp;entry:\u00a0It&nbsp;is&nbsp;preferred&nbsp;that&nbsp;extraction&nbsp;vehicles&nbsp;be&nbsp;analytically&nbsp;expedient.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_158\">158</td><td nowrap=\"nowrap\"><span class=\"diff_add\">which&nbsp;causes&nbsp;no&nbsp;detectable&nbsp;harm&nbsp;to&nbsp;health&nbsp;(3.8)&nbsp;to&nbsp;the&nbsp;target&nbsp;organism&nbsp;under&nbsp;defined&nbsp;conditions&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_159\">159</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_160\">160</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;no&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;kilogram&nbsp;of&nbsp;body&nbsp;mass&nbsp;per</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_161\">161</td><td nowrap=\"nowrap\"><span class=\"diff_add\">day&nbsp;(\u00b5g/kg/d).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__19\"></td><td class=\"diff_header\" id=\"from13_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_110\">110</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a02\u00a0to&nbsp;entry:\u00a0For&nbsp;some&nbsp;medical&nbsp;devices&nbsp;(e.g.&nbsp;infusion&nbsp;systems)&nbsp;that&nbsp;are&nbsp;labelled&nbsp;for&nbsp;use&nbsp;with&nbsp;a&nbsp;drug,&nbsp;the&nbsp;most</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;extraction&nbsp;medium&nbsp;may&nbsp;be&nbsp;the&nbsp;drug&nbsp;product&nbsp;or&nbsp;drug&nbsp;product&nbsp;vehicle.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_112\">112</td><td nowrap=\"nowrap\">3.19</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_162\">162</td><td nowrap=\"nowrap\">3.19</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__20\">n</a></td><td class=\"diff_header\" id=\"from13_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identification</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__20\">n</a></td><td class=\"diff_header\" id=\"to13_163\">163</td><td nowrap=\"nowrap\"><span class=\"diff_add\">point&nbsp;of&nbsp;departure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;assigning&nbsp;a&nbsp;molecular&nbsp;structure&nbsp;and&nbsp;chemical&nbsp;name&nbsp;to&nbsp;an&nbsp;organic&nbsp;compound&nbsp;or&nbsp;assigning</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_164\">164</td><td nowrap=\"nowrap\"><span class=\"diff_add\">POD</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">constituent&nbsp;elements&nbsp;or&nbsp;molecular&nbsp;structure&nbsp;as&nbsp;appropriate,&nbsp;and&nbsp;a&nbsp;chemical&nbsp;name&nbsp;to&nbsp;an&nbsp;inorganic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_165\">165</td><td nowrap=\"nowrap\"><span class=\"diff_add\">low&nbsp;point&nbsp;on&nbsp;a&nbsp;toxicological&nbsp;dose-response&nbsp;curve&nbsp;established&nbsp;from&nbsp;experimental&nbsp;or&nbsp;observational&nbsp;data</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__20\"></td><td class=\"diff_header\" id=\"from13_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compound</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_166\">166</td><td nowrap=\"nowrap\"><span class=\"diff_add\">that&nbsp;corresponds&nbsp;to&nbsp;the&nbsp;benchmark&nbsp;dose&nbsp;low&nbsp;(3.2),&nbsp;or&nbsp;a&nbsp;lowest&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level&nbsp;(3.13),&nbsp;or&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_167\">167</td><td nowrap=\"nowrap\"><span class=\"diff_add\">minimally&nbsp;irritating&nbsp;level&nbsp;(3.15),&nbsp;or&nbsp;a&nbsp;non-irritating&nbsp;level&nbsp;(3.17),&nbsp;or&nbsp;a&nbsp;no&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level&nbsp;(3.18)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_168\">168</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;POD&nbsp;is&nbsp;used&nbsp;to&nbsp;derive&nbsp;a&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;(3.25)&nbsp;or&nbsp;a&nbsp;tolerable&nbsp;intake&nbsp;(3.26).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_169\">169</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;EPA&nbsp;Integrated&nbsp;Risk&nbsp;Information&nbsp;System&nbsp;(IRIS)[8]]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_117\">117</td><td nowrap=\"nowrap\">3.20</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_170\">170</td><td nowrap=\"nowrap\">3.20</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__21\">n</a></td><td class=\"diff_header\" id=\"from13_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;gathering</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__21\">n</a></td><td class=\"diff_header\" id=\"to13_171\">171</td><td nowrap=\"nowrap\"><span class=\"diff_add\">release&nbsp;kinetics</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;collecting&nbsp;existing&nbsp;chemical&nbsp;information,&nbsp;including&nbsp;available&nbsp;test&nbsp;results,&nbsp;that&nbsp;is&nbsp;relevant&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_172\">172</td><td nowrap=\"nowrap\"><span class=\"diff_add\">quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;(3.4)&nbsp;that&nbsp;is&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;as&nbsp;a&nbsp;function&nbsp;of&nbsp;time</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_173\">173</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0Release&nbsp;kinetics&nbsp;data&nbsp;can&nbsp;be&nbsp;obtained&nbsp;experimentally&nbsp;(e.g.&nbsp;simulated&nbsp;use&nbsp;study,&nbsp;leachables&nbsp;study</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_174\">174</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;other&nbsp;type&nbsp;of&nbsp;extractables&nbsp;study).&nbsp;Alternatively,&nbsp;if&nbsp;supporting&nbsp;chemical&nbsp;and&nbsp;material&nbsp;data&nbsp;are&nbsp;available,&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_175\">175</td><td nowrap=\"nowrap\"><span class=\"diff_add\">qualified&nbsp;or&nbsp;validated&nbsp;release&nbsp;model&nbsp;can&nbsp;be&nbsp;used.&nbsp;Examples&nbsp;of&nbsp;experimental&nbsp;release&nbsp;kinetics&nbsp;test&nbsp;methods&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_176\">176</td><td nowrap=\"nowrap\"><span class=\"diff_add\">release&nbsp;models&nbsp;have&nbsp;been&nbsp;published&nbsp;in&nbsp;scientific&nbsp;literature&nbsp;for&nbsp;phthalates&nbsp;and&nbsp;colour&nbsp;additives[9][10].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_177\">177</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a0&nbsp;2\u00a0&nbsp;to&nbsp;entry:\u00a0&nbsp;Factors&nbsp;that&nbsp;impact&nbsp;release&nbsp;(e.g.&nbsp;linear&nbsp;versus&nbsp;non-linear)&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__21\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_178\">178</td><td nowrap=\"nowrap\"><span class=\"diff_add\">to,&nbsp;physicochemical&nbsp;properties&nbsp;of&nbsp;the&nbsp;constituent&nbsp;(e.g.&nbsp;molecular&nbsp;size,&nbsp;solubility&nbsp;and&nbsp;thermal&nbsp;stability),</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_179\">179</td><td nowrap=\"nowrap\"><span class=\"diff_add\">physicochemical&nbsp;properties&nbsp;of&nbsp;the&nbsp;extracting&nbsp;solvent&nbsp;(e.g.&nbsp;solubility&nbsp;and&nbsp;thermal&nbsp;stability)&nbsp;and&nbsp;the&nbsp;impact&nbsp;of&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_180\">180</td><td nowrap=\"nowrap\"><span class=\"diff_add\">extraction&nbsp;temperature&nbsp;on&nbsp;the&nbsp;device&nbsp;material&nbsp;in&nbsp;the&nbsp;test&nbsp;sample&nbsp;(e.g.&nbsp;increased&nbsp;free&nbsp;volume&nbsp;of&nbsp;a&nbsp;polymer&nbsp;system</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_181\">181</td><td nowrap=\"nowrap\"><span class=\"diff_add\">at&nbsp;elevated&nbsp;temperature).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_121\">121</td><td nowrap=\"nowrap\">3.21</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_182\">182</td><td nowrap=\"nowrap\">3.21</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__22\">n</a></td><td class=\"diff_header\" id=\"from13_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;generation</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__22\">n</a></td><td class=\"diff_header\" id=\"to13_183\">183</td><td nowrap=\"nowrap\"><span class=\"diff_add\">slope&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;producing&nbsp;chemical&nbsp;information&nbsp;via&nbsp;laboratory&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_184\">184</td><td nowrap=\"nowrap\"><span class=\"diff_add\">upper-bound&nbsp;estimate&nbsp;of&nbsp;the&nbsp;lifetime&nbsp;cancer&nbsp;risk&nbsp;per&nbsp;increment&nbsp;of&nbsp;dose&nbsp;that&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;estimate&nbsp;risk</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_185\">185</td><td nowrap=\"nowrap\"><span class=\"diff_add\">probabilities&nbsp;for&nbsp;different&nbsp;exposure&nbsp;levels</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__22\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_186\">186</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;slope&nbsp;factor&nbsp;is&nbsp;expressed&nbsp;in&nbsp;a&nbsp;pre-determined&nbsp;frequency&nbsp;of&nbsp;occurrence&nbsp;(i.e.&nbsp;the&nbsp;number&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_187\">187</td><td nowrap=\"nowrap\"><span class=\"diff_add\">individuals&nbsp;in&nbsp;which&nbsp;the&nbsp;response&nbsp;is&nbsp;expected&nbsp;to&nbsp;occur)&nbsp;per&nbsp;unit&nbsp;exposure&nbsp;dose&nbsp;(3.7).&nbsp;For&nbsp;example,&nbsp;a&nbsp;slope&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_188\">188</td><td nowrap=\"nowrap\"><span class=\"diff_add\">for&nbsp;cancer&nbsp;risk&nbsp;that&nbsp;represents&nbsp;a&nbsp;frequency&nbsp;of&nbsp;occurrence&nbsp;in&nbsp;a&nbsp;specified&nbsp;population&nbsp;is&nbsp;expressed&nbsp;as&nbsp;x&nbsp;in&nbsp;100\u00a0000</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_189\">189</td><td nowrap=\"nowrap\"><span class=\"diff_add\">for&nbsp;every&nbsp;1\u00a0\u00b5g/kg/d&nbsp;increase&nbsp;in&nbsp;exposure&nbsp;to&nbsp;the&nbsp;constituent.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_124\">124</td><td nowrap=\"nowrap\">3.22</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_190\">190</td><td nowrap=\"nowrap\">3.22</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__23\">n</a></td><td class=\"diff_header\" id=\"from13_125\">125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachable</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__23\">n</a></td><td class=\"diff_header\" id=\"to13_191\">191</td><td nowrap=\"nowrap\"><span class=\"diff_add\">suspected&nbsp;human&nbsp;carcinogen</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;that&nbsp;is&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;during&nbsp;its&nbsp;clinical&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_192\">192</td><td nowrap=\"nowrap\"><span class=\"diff_add\">carcinogen&nbsp;(3.3)&nbsp;for&nbsp;which&nbsp;non-human&nbsp;experimental&nbsp;evidence&nbsp;indicates&nbsp;a&nbsp;probable&nbsp;association&nbsp;between</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0For&nbsp;many&nbsp;medical&nbsp;devices,&nbsp;a&nbsp;leachables&nbsp;study&nbsp;is&nbsp;not&nbsp;practical&nbsp;due&nbsp;to&nbsp;challenges&nbsp;with&nbsp;reproducing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_193\">193</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;to&nbsp;the&nbsp;constituent&nbsp;(3.4)&nbsp;and&nbsp;cancer&nbsp;in&nbsp;humans</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">actual&nbsp;clinical&nbsp;conditions,&nbsp;so&nbsp;simulated-use&nbsp;extraction&nbsp;studies&nbsp;are&nbsp;often&nbsp;performed&nbsp;instead.&nbsp;See&nbsp;definition&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_194\">194</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0Suspected&nbsp;human&nbsp;carcinogen&nbsp;applies&nbsp;when&nbsp;human&nbsp;data&nbsp;are&nbsp;inadequate&nbsp;to&nbsp;establish&nbsp;an&nbsp;association</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_129\">129</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">simulated-use&nbsp;extraction.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_195\">195</td><td nowrap=\"nowrap\"><span class=\"diff_add\">between&nbsp;exposure&nbsp;to&nbsp;the&nbsp;constituent&nbsp;and&nbsp;cancer.&nbsp;Suspected&nbsp;human&nbsp;carcinogens&nbsp;can&nbsp;be&nbsp;established&nbsp;by&nbsp;non-human</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_196\">196</td><td nowrap=\"nowrap\"><span class=\"diff_add\">in&nbsp;vivo&nbsp;or&nbsp;in&nbsp;vitro&nbsp;evidence&nbsp;based&nbsp;on&nbsp;a&nbsp;weight&nbsp;of&nbsp;evidence&nbsp;assessment&nbsp;(see&nbsp;C.3.1).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_197\">197</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a02\u00a0to&nbsp;entry:\u00a0Suspected&nbsp;human&nbsp;carcinogens&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;IARC&nbsp;Group&nbsp;2A&nbsp;or&nbsp;2B&nbsp;carcinogens</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_198\">198</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;NTP&nbsp;\u201creasonably&nbsp;anticipated&nbsp;to&nbsp;be&nbsp;human&nbsp;carcinogen\u201d.[6][7]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_199\">199</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_200\">200</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_201\">201</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_202\">202</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__23\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_203\">203</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_204\">204</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_205\">205</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_206\">206</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_130\">130</td><td nowrap=\"nowrap\">3.23</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_207\">207</td><td nowrap=\"nowrap\">3.23</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__24\">n</a></td><td class=\"diff_header\" id=\"from13_131\">131</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manufacturer</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__24\">n</a></td><td class=\"diff_header\" id=\"to13_208\">208</td><td nowrap=\"nowrap\"><span class=\"diff_add\">systemic&nbsp;toxicity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_132\">132</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">natural&nbsp;or&nbsp;legal&nbsp;person&nbsp;who&nbsp;manufactures&nbsp;or&nbsp;fully&nbsp;refurbishes&nbsp;a&nbsp;medical&nbsp;device,&nbsp;or&nbsp;has&nbsp;a&nbsp;device&nbsp;designed,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_209\">209</td><td nowrap=\"nowrap\"><span class=\"diff_add\">harm&nbsp;that&nbsp;occurs&nbsp;in&nbsp;an&nbsp;organ&nbsp;or&nbsp;system&nbsp;other&nbsp;than&nbsp;at&nbsp;the&nbsp;contact&nbsp;site</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_133\">133</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manufactured,&nbsp;or&nbsp;fully&nbsp;refurbished,&nbsp;and&nbsp;markets&nbsp;that&nbsp;medical&nbsp;device&nbsp;under&nbsp;its&nbsp;name&nbsp;or&nbsp;trademark</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_210\">210</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0Systemic&nbsp;toxicity&nbsp;can&nbsp;occur&nbsp;after&nbsp;a&nbsp;one-time&nbsp;exposure&nbsp;(i.e.&nbsp;acutely)&nbsp;or&nbsp;after&nbsp;repeated&nbsp;or&nbsp;ongoing</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__24\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_211\">211</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;(e.g.&nbsp;subacute&nbsp;or&nbsp;subchronic&nbsp;or&nbsp;chronic)&nbsp;to&nbsp;a&nbsp;harmful&nbsp;dose&nbsp;(3.9)&nbsp;of&nbsp;a&nbsp;constituent&nbsp;released&nbsp;from&nbsp;a&nbsp;single</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_212\">212</td><td nowrap=\"nowrap\"><span class=\"diff_add\">medical&nbsp;device&nbsp;or&nbsp;from&nbsp;use&nbsp;of&nbsp;multiple&nbsp;medical&nbsp;devices.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_213\">213</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a02\u00a0to&nbsp;entry:\u00a0The&nbsp;contact&nbsp;site&nbsp;is&nbsp;the&nbsp;specific&nbsp;location&nbsp;at&nbsp;which&nbsp;the&nbsp;medical&nbsp;device&nbsp;interfaces&nbsp;or&nbsp;interacts&nbsp;with</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_214\">214</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;tissue.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_134\">134</td><td nowrap=\"nowrap\">3.24</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_215\">215</td><td nowrap=\"nowrap\">3.24</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__25\">n</a></td><td class=\"diff_header\" id=\"from13_135\">135</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;composition</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__25\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_136\">136</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">listing&nbsp;of&nbsp;the&nbsp;constituents&nbsp;that&nbsp;are&nbsp;contained&nbsp;in&nbsp;a&nbsp;material&nbsp;(qualitative)&nbsp;and&nbsp;the&nbsp;amount&nbsp;of&nbsp;each</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_137\">137</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;in&nbsp;the&nbsp;material&nbsp;(quantitative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_138\">138</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0A&nbsp;material\u2019s&nbsp;composition&nbsp;establishes&nbsp;the&nbsp;hypothetical&nbsp;situation&nbsp;in&nbsp;which&nbsp;the&nbsp;total&nbsp;amount&nbsp;of&nbsp;all</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_139\">139</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substances&nbsp;present&nbsp;in&nbsp;a&nbsp;medical&nbsp;device&nbsp;are&nbsp;released&nbsp;during&nbsp;clinical&nbsp;use.&nbsp;These&nbsp;amounts&nbsp;can&nbsp;be&nbsp;derived&nbsp;directly</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_140\">140</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;known&nbsp;composition;&nbsp;experimentally,&nbsp;they&nbsp;can&nbsp;be&nbsp;derived&nbsp;from&nbsp;digestion,&nbsp;dissolution,&nbsp;and,&nbsp;in&nbsp;many&nbsp;cases,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_141\">141</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive&nbsp;extraction&nbsp;studies.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_142\">142</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.25</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_143\">143</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;of&nbsp;construction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_144\">144</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">individual&nbsp;raw&nbsp;material&nbsp;that&nbsp;is&nbsp;used&nbsp;to&nbsp;produce&nbsp;a&nbsp;component</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_145\">145</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_146\">146</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polymer&nbsp;resins.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_147\">147</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.26</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_148\">148</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medical&nbsp;device&nbsp;configuration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_149\">149</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">listing&nbsp;of&nbsp;a&nbsp;medical&nbsp;device\u2019s&nbsp;components&nbsp;(qualitative),&nbsp;including&nbsp;a&nbsp;listing&nbsp;of&nbsp;the&nbsp;component\u2019s&nbsp;materials&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_150\">150</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;(qualitative)&nbsp;and&nbsp;the&nbsp;proportion&nbsp;of&nbsp;each&nbsp;material&nbsp;in&nbsp;each&nbsp;component&nbsp;(quantitative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_151\">151</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0Device&nbsp;configuration&nbsp;should&nbsp;also&nbsp;take&nbsp;into&nbsp;account&nbsp;the&nbsp;shape&nbsp;and&nbsp;relative&nbsp;arrangement&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_152\">152</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parts&nbsp;in&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;surface&nbsp;properties&nbsp;(topography&nbsp;and&nbsp;chemistry).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_153\">153</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.27</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_154\">154</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">potentially&nbsp;affected&nbsp;individual</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_155\">155</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">person&nbsp;having&nbsp;direct&nbsp;or&nbsp;indirect&nbsp;body&nbsp;contact&nbsp;with&nbsp;the&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_156\">156</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0See&nbsp;ISO\u00a010993-1&nbsp;for&nbsp;categorization&nbsp;by&nbsp;nature&nbsp;of&nbsp;body&nbsp;contact.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_157\">157</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_158\">158</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_159\">159</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_160\">160</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_161\">161</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_162\">162</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_163\">163</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_164\">164</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_165\">165</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.28</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_166\">166</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_167\">167</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;establishing&nbsp;that&nbsp;an&nbsp;analytical&nbsp;method&nbsp;is&nbsp;suitable&nbsp;for&nbsp;its&nbsp;intended&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_168\">168</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.29</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_169\">169</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualitative&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_170\">170</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;approach&nbsp;which&nbsp;estimates&nbsp;an&nbsp;analyte's&nbsp;concentration&nbsp;by&nbsp;using&nbsp;the&nbsp;response&nbsp;from&nbsp;a&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_171\">171</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;(or&nbsp;substances)&nbsp;chosen&nbsp;without&nbsp;specifically&nbsp;addressing&nbsp;or&nbsp;considering&nbsp;the&nbsp;relative&nbsp;responses</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_172\">172</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;analyte&nbsp;and&nbsp;the&nbsp;surrogate(s)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_173\">173</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.30</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_174\">174</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_175\">175</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;of&nbsp;assigning&nbsp;a&nbsp;concentration&nbsp;to&nbsp;an&nbsp;analyte&nbsp;present&nbsp;in&nbsp;a&nbsp;sample</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_176\">176</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0There&nbsp;are&nbsp;several&nbsp;possible&nbsp;levels&nbsp;as&nbsp;shown&nbsp;in&nbsp;3.31,&nbsp;3.32&nbsp;and&nbsp;3.33.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_177\">177</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.31</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_178\">178</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">estimated&nbsp;quantitative&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_179\">179</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;approach&nbsp;which&nbsp;estimates&nbsp;an&nbsp;analyte's&nbsp;concentration&nbsp;by&nbsp;using&nbsp;the&nbsp;response&nbsp;from&nbsp;a&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_180\">180</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;chosen&nbsp;without&nbsp;specifically&nbsp;addressing&nbsp;or&nbsp;considering&nbsp;the&nbsp;relative&nbsp;responses&nbsp;of&nbsp;the&nbsp;analyte</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_181\">181</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_182\">182</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.32</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_183\">183</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">semi-quantitative&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_184\">184</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;approach&nbsp;which&nbsp;provides&nbsp;an&nbsp;analyte\u2019s&nbsp;concentration&nbsp;by&nbsp;using&nbsp;the&nbsp;response&nbsp;from&nbsp;a&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_185\">185</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;(or&nbsp;substances),&nbsp;specifically&nbsp;accounting&nbsp;for&nbsp;the&nbsp;relative&nbsp;responses&nbsp;of&nbsp;the&nbsp;analyte&nbsp;and&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_186\">186</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_187\">187</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.33</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_188\">188</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_189\">189</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;approach&nbsp;which&nbsp;establishes&nbsp;the&nbsp;most&nbsp;accurate&nbsp;estimate&nbsp;of&nbsp;an&nbsp;analyte's&nbsp;concentration&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_190\">190</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">using&nbsp;a&nbsp;response&nbsp;function&nbsp;(calibration&nbsp;curve)&nbsp;generated&nbsp;specifically&nbsp;for&nbsp;the&nbsp;analyte&nbsp;via&nbsp;the&nbsp;use&nbsp;of&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_191\">191</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">reference&nbsp;standard</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_192\">192</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0Estimated&nbsp;quantitative&nbsp;analysis&nbsp;is&nbsp;generally&nbsp;less&nbsp;accurate&nbsp;than&nbsp;semi-quantitative&nbsp;analysis,&nbsp;which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_193\">193</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;generally&nbsp;less&nbsp;accurate&nbsp;than&nbsp;quantitative&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_194\">194</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.34</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_195\">195</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">safety&nbsp;concern&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_196\">196</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">SCT</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_197\">197</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">threshold&nbsp;below&nbsp;which&nbsp;a&nbsp;leachable&nbsp;(or&nbsp;an&nbsp;extractable&nbsp;as&nbsp;a&nbsp;probable&nbsp;leachable)&nbsp;has&nbsp;a&nbsp;dose&nbsp;so&nbsp;low&nbsp;that&nbsp;it</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_198\">198</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">presents&nbsp;a&nbsp;negligible&nbsp;safety&nbsp;concern&nbsp;from&nbsp;carcinogenic&nbsp;and&nbsp;non-carcinogenic&nbsp;toxic&nbsp;effects</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_199\">199</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0See&nbsp;Reference\u00a0[27].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_200\">200</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.35</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_201\">201</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">simulated-use&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_202\">202</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;using&nbsp;a&nbsp;method&nbsp;that&nbsp;simulates&nbsp;clinical&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_203\">203</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0A&nbsp;simulated-use&nbsp;extraction&nbsp;is&nbsp;performed&nbsp;to&nbsp;estimate&nbsp;the&nbsp;type&nbsp;and&nbsp;amount&nbsp;of&nbsp;substances&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_204\">204</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;expected&nbsp;to&nbsp;be&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;during&nbsp;its&nbsp;clinical&nbsp;use.&nbsp;A&nbsp;simulated-use&nbsp;extraction&nbsp;is&nbsp;designed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_205\">205</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;produce&nbsp;an&nbsp;extractables&nbsp;profile&nbsp;that&nbsp;represents&nbsp;the&nbsp;worst-case&nbsp;leachables&nbsp;profile,&nbsp;meaning&nbsp;that&nbsp;all&nbsp;leachables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_206\">206</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;also&nbsp;extractables&nbsp;and&nbsp;the&nbsp;levels&nbsp;of&nbsp;all&nbsp;individual&nbsp;extractables&nbsp;are&nbsp;at&nbsp;least&nbsp;equal&nbsp;to&nbsp;the&nbsp;level&nbsp;of&nbsp;all&nbsp;individual</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_207\">207</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachables.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_208\">208</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.36</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_209\">209</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solubilisation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_210\">210</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">action&nbsp;or&nbsp;process&nbsp;of&nbsp;using&nbsp;a&nbsp;vehicle&nbsp;to&nbsp;dissolve&nbsp;part&nbsp;or&nbsp;all&nbsp;of&nbsp;a&nbsp;test&nbsp;article</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_211\">211</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a0&nbsp;1\u00a0&nbsp;to\u00a0&nbsp;entry:\u00a0&nbsp;Leaching,&nbsp;extraction,&nbsp;dissolution,&nbsp;and&nbsp;digestion&nbsp;are&nbsp;(progressively&nbsp;more&nbsp;complete)&nbsp;sub-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_212\">212</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">categories&nbsp;of&nbsp;solubilisation.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_213\">213</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_214\">214</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_215\">215</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_216\">216</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_217\">217</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_218\">218</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_219\">219</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_220\">220</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_221\">221</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.37</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_222\">222</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sponsor</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_223\">223</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">individual&nbsp;or&nbsp;organization&nbsp;that&nbsp;plans,&nbsp;commissions,&nbsp;and&nbsp;takes&nbsp;responsibility&nbsp;for&nbsp;testing&nbsp;of&nbsp;a&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_224\">224</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.38</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_225\">225</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">supplier</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_226\">226</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">person&nbsp;or&nbsp;company&nbsp;who&nbsp;manufactures&nbsp;or&nbsp;provides&nbsp;the&nbsp;materials&nbsp;of&nbsp;construction&nbsp;or&nbsp;components&nbsp;to&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__25\"></td><td class=\"diff_header\" id=\"from13_227\">227</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">used&nbsp;in&nbsp;the&nbsp;manufacture&nbsp;of&nbsp;a&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_228\">228</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.39</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_229\">229</td><td nowrap=\"nowrap\">threshold&nbsp;of&nbsp;toxicological&nbsp;concern</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_216\">216</td><td nowrap=\"nowrap\">threshold&nbsp;of&nbsp;toxicological&nbsp;concern</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_230\">230</td><td nowrap=\"nowrap\">TTC</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_217\">217</td><td nowrap=\"nowrap\">TTC</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_231\">231</td><td nowrap=\"nowrap\">level&nbsp;of&nbsp;exposure&nbsp;for&nbsp;constituents,&nbsp;below&nbsp;which&nbsp;there&nbsp;would&nbsp;be&nbsp;no&nbsp;appreciable&nbsp;risk&nbsp;to&nbsp;human&nbsp;health</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_218\">218</td><td nowrap=\"nowrap\">level&nbsp;of&nbsp;exposure&nbsp;for&nbsp;constituents,&nbsp;below&nbsp;which&nbsp;there&nbsp;would&nbsp;be&nbsp;no&nbsp;appreciable&nbsp;risk&nbsp;to&nbsp;human&nbsp;health</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__26\">n</a></td><td class=\"diff_header\" id=\"from13_232\">232</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note\u00a01\u00a0to\u00a0entry:\u00a0See&nbsp;ISO/TS\u00a021726&nbsp;for&nbsp;full&nbsp;context.</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__26\">n</a></td><td class=\"diff_header\" id=\"to13_219\">219</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;ISO/TS&nbsp;21726:2019,&nbsp;3.5]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_233\">233</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3.40</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_220\">220</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.25</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_221\">221</td><td nowrap=\"nowrap\"><span class=\"diff_add\">tolerable&nbsp;contact&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_222\">222</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TCL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_223\">223</td><td nowrap=\"nowrap\"><span class=\"diff_add\">estimate&nbsp;of&nbsp;the&nbsp;surface-contact&nbsp;exposure&nbsp;to&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.11)&nbsp;that&nbsp;is&nbsp;without&nbsp;appreciable</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_224\">224</td><td nowrap=\"nowrap\"><span class=\"diff_add\">irritation&nbsp;(3.12)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_225\">225</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;centimetre&nbsp;squared&nbsp;(\u00b5g/cm2)&nbsp;of&nbsp;tissue</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_226\">226</td><td nowrap=\"nowrap\"><span class=\"diff_add\">at&nbsp;the&nbsp;contact&nbsp;site.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_227\">227</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.26</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_228\">228</td><td nowrap=\"nowrap\"><span class=\"diff_add\">tolerable&nbsp;intake</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_229\">229</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TI</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_230\">230</td><td nowrap=\"nowrap\"><span class=\"diff_add\">estimate&nbsp;of&nbsp;the&nbsp;daily&nbsp;exposure&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.11)&nbsp;over&nbsp;a&nbsp;specified&nbsp;time&nbsp;period&nbsp;(e.g.&nbsp;acute,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_231\">231</td><td nowrap=\"nowrap\"><span class=\"diff_add\">subacute,&nbsp;subchronic&nbsp;or&nbsp;chronic),&nbsp;on&nbsp;the&nbsp;basis&nbsp;of&nbsp;body&nbsp;mass,&nbsp;that&nbsp;is&nbsp;considered&nbsp;to&nbsp;be&nbsp;without&nbsp;appreciable</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_232\">232</td><td nowrap=\"nowrap\"><span class=\"diff_add\">harm&nbsp;to&nbsp;health&nbsp;(3.8)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_233\">233</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0The&nbsp;tolerable&nbsp;intake&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;kilogram&nbsp;of&nbsp;body&nbsp;mass&nbsp;per&nbsp;day&nbsp;(\u00b5g/kg/d).&nbsp;It</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_234\">234</td><td nowrap=\"nowrap\"><span class=\"diff_add\">is&nbsp;derived&nbsp;to&nbsp;establish&nbsp;a&nbsp;toxicological&nbsp;exposure&nbsp;limit&nbsp;for&nbsp;a&nbsp;medical&nbsp;device&nbsp;constituent&nbsp;(3.4).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_235\">235</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.27</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_236\">236</td><td nowrap=\"nowrap\"><span class=\"diff_add\">total&nbsp;quantity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_237\">237</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TQ</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_238\">238</td><td nowrap=\"nowrap\"><span class=\"diff_add\">amount&nbsp;of&nbsp;a&nbsp;constituent&nbsp;(3.4)&nbsp;present&nbsp;in,&nbsp;or&nbsp;that&nbsp;can&nbsp;be&nbsp;extracted&nbsp;from,&nbsp;the&nbsp;medical&nbsp;device</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_239\">239</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0The&nbsp;total&nbsp;quantity&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;(\u00b5g).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_240\">240</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a02\u00a0to&nbsp;entry:\u00a0The&nbsp;constituent\u2019s&nbsp;total&nbsp;quantity&nbsp;and&nbsp;its&nbsp;release&nbsp;rate&nbsp;(or&nbsp;kinetics)&nbsp;influence&nbsp;the&nbsp;maximum&nbsp;duration</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_241\">241</td><td nowrap=\"nowrap\"><span class=\"diff_add\">that&nbsp;an&nbsp;individual&nbsp;can&nbsp;be&nbsp;exposed&nbsp;to&nbsp;the&nbsp;constituent&nbsp;(3.4)[11].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_242\">242</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.28</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_243\">243</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;risk</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to13__26\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_244\">244</td><td nowrap=\"nowrap\"><span class=\"diff_add\">probability&nbsp;of&nbsp;a&nbsp;specified&nbsp;degree&nbsp;of&nbsp;an&nbsp;adverse&nbsp;reaction&nbsp;occurring&nbsp;in&nbsp;response&nbsp;to&nbsp;a&nbsp;specified&nbsp;level&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_245\">245</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_246\">246</td><td nowrap=\"nowrap\"><span class=\"diff_add\">[SOURCE:&nbsp;ISO&nbsp;10993-1:2018,&nbsp;3.24]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_247\">247</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.29</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_234\">234</td><td nowrap=\"nowrap\">toxicological&nbsp;risk&nbsp;assessment</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_248\">248</td><td nowrap=\"nowrap\">toxicological&nbsp;risk&nbsp;assessment</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to13__top\">t</a></td><td class=\"diff_header\" id=\"from13_235\">235</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">act&nbsp;of&nbsp;determining&nbsp;the&nbsp;potential&nbsp;of&nbsp;a&nbsp;chemical&nbsp;to&nbsp;elicit&nbsp;an&nbsp;adverse&nbsp;effect&nbsp;based&nbsp;on&nbsp;a&nbsp;specified&nbsp;level&nbsp;of</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to13__top\">t</a></td><td class=\"diff_header\" id=\"to13_249\">249</td><td nowrap=\"nowrap\"><span class=\"diff_add\">determination&nbsp;of&nbsp;whether&nbsp;an&nbsp;exposure&nbsp;dose&nbsp;(3.7)&nbsp;to&nbsp;a&nbsp;constituent&nbsp;(3.4)&nbsp;can&nbsp;or&nbsp;cannot&nbsp;elicit&nbsp;appreciable</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from13_236\">236</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exposure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_250\">250</td><td nowrap=\"nowrap\"><span class=\"diff_add\">harm&nbsp;to&nbsp;health&nbsp;(3.8)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_251\">251</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_252\">252</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_253\">253</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_254\">254</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_255\">255</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_256\">256</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_257\">257</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_258\">258</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_259\">259</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_260\">260</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_261\">261</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.30</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_262\">262</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;screening&nbsp;limit</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_263\">263</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_264\">264</td><td nowrap=\"nowrap\"><span class=\"diff_add\">cumulative&nbsp;exposure&nbsp;dose&nbsp;(3.7)&nbsp;to&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;(3.11)&nbsp;over&nbsp;a&nbsp;specified&nbsp;time&nbsp;period&nbsp;that&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_265\">265</td><td nowrap=\"nowrap\"><span class=\"diff_add\">without&nbsp;appreciable&nbsp;harm&nbsp;to&nbsp;health&nbsp;(3.8)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_266\">266</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to\u00a0entry:\u00a0TSL&nbsp;is&nbsp;expressed&nbsp;in&nbsp;microgram&nbsp;per&nbsp;individual&nbsp;exposed.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_267\">267</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.31</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_268\">268</td><td nowrap=\"nowrap\"><span class=\"diff_add\">uncertainty&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_269\">269</td><td nowrap=\"nowrap\"><span class=\"diff_add\">UF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_270\">270</td><td nowrap=\"nowrap\"><span class=\"diff_add\">numerical&nbsp;value&nbsp;that&nbsp;accounts&nbsp;for&nbsp;uncertainties&nbsp;when&nbsp;extrapolating&nbsp;a&nbsp;point&nbsp;of&nbsp;departure&nbsp;(3.19)&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_271\">271</td><td nowrap=\"nowrap\"><span class=\"diff_add\">individuals&nbsp;that&nbsp;can&nbsp;be&nbsp;exposed&nbsp;to&nbsp;a&nbsp;constituent&nbsp;(3.4)&nbsp;of&nbsp;toxicological&nbsp;concern</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_272\">272</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_273\">273</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Extrapolation&nbsp;types&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to:&nbsp;intraspecies&nbsp;(see&nbsp;C.2.2.2),&nbsp;interspecies&nbsp;(see</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_274\">274</td><td nowrap=\"nowrap\"><span class=\"diff_add\">C.2.2.3),&nbsp;dose&nbsp;route&nbsp;(see&nbsp;C.2.2.4)&nbsp;and&nbsp;study&nbsp;duration&nbsp;(see&nbsp;C.2.2.4).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_275\">275</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.32</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_276\">276</td><td nowrap=\"nowrap\"><span class=\"diff_add\">worst-case&nbsp;estimated&nbsp;exposure&nbsp;dose</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_277\">277</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EEDmax</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_278\">278</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;dose&nbsp;(3.7)&nbsp;that&nbsp;is&nbsp;a&nbsp;maximum&nbsp;value&nbsp;for&nbsp;a&nbsp;specified&nbsp;intended&nbsp;clinical-use&nbsp;scenario</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_279\">279</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a01\u00a0to&nbsp;entry:\u00a0EEDmax&nbsp;is&nbsp;based&nbsp;on&nbsp;the&nbsp;selection&nbsp;of&nbsp;the&nbsp;full&nbsp;range&nbsp;of&nbsp;intended&nbsp;clinical&nbsp;use&nbsp;scenarios,&nbsp;specific</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_280\">280</td><td nowrap=\"nowrap\"><span class=\"diff_add\">clinical&nbsp;use&nbsp;condition&nbsp;or&nbsp;assumption&nbsp;related&nbsp;to&nbsp;the&nbsp;intended&nbsp;clinical&nbsp;scenario&nbsp;(see&nbsp;Annex\u00a0&nbsp;E&nbsp;for&nbsp;additional</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_281\">281</td><td nowrap=\"nowrap\"><span class=\"diff_add\">information).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_282\">282</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Note\u00a02\u00a0to&nbsp;entry:\u00a0Specific&nbsp;clinical&nbsp;use&nbsp;conditions&nbsp;or&nbsp;assumptions&nbsp;used&nbsp;to&nbsp;establish&nbsp;worst-case&nbsp;estimated&nbsp;exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_283\">283</td><td nowrap=\"nowrap\"><span class=\"diff_add\">dose&nbsp;do&nbsp;not&nbsp;include&nbsp;deliberate&nbsp;misuse&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;that&nbsp;is&nbsp;not&nbsp;reasonably&nbsp;foreseeable&nbsp;or&nbsp;that&nbsp;results&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to13_284\">284</td><td nowrap=\"nowrap\"><span class=\"diff_add\">different&nbsp;harm&nbsp;to&nbsp;health&nbsp;(3.8).</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "4",
    "change_type": "modified",
    "old_text": "4\t Symbols and abbreviated terms\nThe abbreviated terms given in Table\u00a01 are used in this document.\nTable\u00a01\u00a0\u2014 Methodology abbreviations\nAbbreviated term\nAnalytical method\n2D PAGE\nTwo-dimensional polyacrylamide gel electrophoresis\nAES\nAtomic emission spectroscopy\nAET\nAnalytical evaluation threshold\nDMTA\nDynamic mechanical thermal analysis\nDSC\nDifferential scanning calorimetry\nFID\nFlame ionization detection\nFTIR\nFourier transform infrared spectroscopy\nGC\nGas chromatography\nGPC/SEC\nGel permeation chromatography/size exclusion chromatography\nHPLC (or LC)\nHigh performance liquid chromatography (or liquid chromatography)\nHS\nHeadspace sampling\nIC\nIon chromatography\nICP\nInductively coupled plasma\nIR\nInfrared spectroscopy\nMSa\nMass spectrometry\nNMR\nNuclear magnetic resonance spectroscopy\nNVOC\nNon-volatile organic compound\nNVR\nNon-volatile residue\nSEM-EDS (or SEM-EDX)\nScanning electron microscopy-energy dispersive X-ray spectroscopy\nSVOC\nSemi-volatile organic compound\nTOC\nTotal organic carbon\nUV\nUltraviolet spectroscopy\na\nMass spectrometry is frequently combined with other techniques (especially chromatographic) in coupled methods\nsuch as GC-MS, LC-MS and MS-MS.\n\ufeff\n6\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAbbreviated term\nAnalytical method\nVOC\nVolatile organic compound\nXPS\nX-ray photoelectron spectroscopy\nXRF\nX-ray fluorescence\na\nMass spectrometry is frequently combined with other techniques (especially chromatographic) in coupled methods\nsuch as GC-MS, LC-MS and MS-MS.",
    "new_text": "4\t Abbreviated terms and symbols\nThe following abbreviated terms and symbols apply in this document.\nAET\nAnalytical evaluation threshold\nBMDL\nBenchmark dose low\nBWL\nBody mass (low)\nCoC\nCohort of concern\nCmax\nHighest concentration\nCRL\nCancer risk level\nCRSD\nCancer risk specific dose\nCRSDE\nCancer risk specific dose estimate\nEEDmax\nEstimated exposure dose (maximum)\nHQ\nHighest quantity\nHQi\nHighest quantity (irritant)\nHQr.k.\nHighest quantity (release kinetics)\nLOAEL\nLowest observed adverse effect level\nLOD\nLimit of detection\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n7\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nMD\nMedical device\nMDa.r.s.\nMedical device (extraction (i.e. assumed release) study)\nMDb.c.\nMedical device (body contact)\nMDr.k.s.\nMedical device (release kinetic study)\nMF\nModifying factor\nMFTCL\nModifying factor (tolerable contact level)\nMIL\nMinimally irritating level\nMoS\nMargin of safety\nMoScom\nMargin of safety (combined)\nMoSi\nMargin of safety (individual or each)\nNIL\nNon-irritating level\nNOAEL\nNo observed adverse effect level\nPOD\nPoint of departure\nRd\nRelease duration\nSAext\nSurface area (extraction)\nSIF\nSlope factor\nSVOC\nSemi volatile organic compound\nSF\nScaling factor\nSFa.r.\nScaling factor (assumed release)\nSFr.k.\nScaling factor (release kinetics)\nTCL\nTolerable contact level\nTD50\nToxic dose (50 %)\nTI\nTolerable intake\nTQ\nTotal quantity (i.e. present or extracted)\nTQa.r.\nTotal quantity (assumed release)\nTQext\nTotal quantity (extracted)\nTQmax\nTotal quantity (maximum)\nTRA\nToxicological risk assessment\nTSL\nToxicological screening limit\nTSL \u226430 d\nToxicological screening limit (less or equal to 30 days)\nTSL\u00a0>30 d\nToxicological screening limit (greater than 30 days)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n8\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTTC\nThreshold of toxicological concern\nUF\nUncertainty factor\nVOC\nVolatile organic compound",
    "change_text": "4\t Abbreviated terms and symbols\nThe following abbreviated terms and symbols apply in this document.\nAET\nAnalytical evaluation threshold\nBMDL\nBenchmark dose low\nBWL\nBody mass (low)\nCoC\nCohort of concern\nCmax\nHighest concentration\nCRL\nCancer risk level\nCRSD\nCancer risk specific dose\nCRSDE\nCancer risk specific dose estimate\nEEDmax\nEstimated exposure dose (maximum)\nHQ\nHighest quantity\nHQi\nHighest quantity (irritant)\nHQr.k.\nHighest quantity (release kinetics)\nLOAEL\nLowest observed adverse effect level\nLOD\nLimit of detection\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n7\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nMD\nMedical device\nMDa.r.s.\nMedical device (extraction (i.e. assumed release) study)\nMDb.c.\nMedical device (body contact)\nMDr.k.s.\nMedical device (release kinetic study)\nMF\nModifying factor\nMFTCL\nModifying factor (tolerable contact level)\nMIL\nMinimally irritating level\nMoS\nMargin of safety\nMoScom\nMargin of safety (combined)\nMoSi\nMargin of safety (individual or each)\nNIL\nNon-irritating level\nNOAEL\nNo observed adverse effect level\nPOD\nPoint of departure\nRd\nRelease duration\nSAext\nSurface area (extraction)\nSIF\nSlope factor\nSVOC\nSemi volatile organic compound\nSF\nScaling factor\nSFa.r.\nScaling factor (assumed release)\nSFr.k.\nScaling factor (release kinetics)\nTCL\nTolerable contact level\nTD50\nToxic dose (50 %)\nTI\nTolerable intake\nTQ\nTotal quantity (i.e. present or extracted)\nTQa.r.\nTotal quantity (assumed release)\nTQext\nTotal quantity (extracted)\nTQmax\nTotal quantity (maximum)\nTRA\nToxicological risk assessment\nTSL\nToxicological screening limit\nTSL \u226430 d\nToxicological screening limit (less or equal to 30 days)\nTSL\u00a0>30 d\nToxicological screening limit (greater than 30 days)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n8\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTTC\nThreshold of toxicological concern\nUF\nUncertainty factor\nVOC\nVolatile organic compound",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to14__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__0\"><a href=\"#difflib_chg_to14__1\">n</a></td><td class=\"diff_header\" id=\"from14_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Symbols&nbsp;and&nbsp;abbreviated&nbsp;terms</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__1\">n</a></td><td class=\"diff_header\" id=\"to14_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbreviated&nbsp;terms&nbsp;and&nbsp;symbols</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;abbreviated&nbsp;terms&nbsp;given&nbsp;in&nbsp;Table\u00a01&nbsp;are&nbsp;used&nbsp;in&nbsp;this&nbsp;document.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;following&nbsp;abbreviated&nbsp;terms&nbsp;and&nbsp;symbols&nbsp;apply&nbsp;in&nbsp;this&nbsp;document.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a01\u00a0\u2014&nbsp;Methodology&nbsp;abbreviations</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Abbreviated&nbsp;term</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Analytical&nbsp;method</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2D&nbsp;PAGE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__1\"></td><td class=\"diff_header\" id=\"from14_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Two-dimensional&nbsp;polyacrylamide&nbsp;gel&nbsp;electrophoresis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AES</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Atomic&nbsp;emission&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_10\">10</td><td nowrap=\"nowrap\">AET</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_3\">3</td><td nowrap=\"nowrap\">AET</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_11\">11</td><td nowrap=\"nowrap\">Analytical&nbsp;evaluation&nbsp;threshold</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_4\">4</td><td nowrap=\"nowrap\">Analytical&nbsp;evaluation&nbsp;threshold</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to14__2\">n</a></td><td class=\"diff_header\" id=\"from14_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DMTA</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__2\">n</a></td><td class=\"diff_header\" id=\"to14_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">BMDL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dynamic&nbsp;mechanical&nbsp;thermal&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Benchmark&nbsp;dose&nbsp;low</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DSC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">BWL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Differential&nbsp;scanning&nbsp;calorimetry</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Body&nbsp;mass&nbsp;(low)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">FID</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">CoC</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Flame&nbsp;ionization&nbsp;detection</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cohort&nbsp;of&nbsp;concern</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">FTIR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cmax</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Fourier&nbsp;transform&nbsp;infrared&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Highest&nbsp;concentration</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">CRL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gas&nbsp;chromatography</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cancer&nbsp;risk&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GPC/SEC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">CRSD</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gel&nbsp;permeation&nbsp;chromatography/size&nbsp;exclusion&nbsp;chromatography</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cancer&nbsp;risk&nbsp;specific&nbsp;dose</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">HPLC&nbsp;(or&nbsp;LC)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">CRSDE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">High&nbsp;performance&nbsp;liquid&nbsp;chromatography&nbsp;(or&nbsp;liquid&nbsp;chromatography)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cancer&nbsp;risk&nbsp;specific&nbsp;dose&nbsp;estimate</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">HS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EEDmax</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Headspace&nbsp;sampling</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Estimated&nbsp;exposure&nbsp;dose&nbsp;(maximum)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">IC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">HQ</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ion&nbsp;chromatography</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Highest&nbsp;quantity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ICP</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">HQi</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Inductively&nbsp;coupled&nbsp;plasma</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Highest&nbsp;quantity&nbsp;(irritant)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">IR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">HQr.k.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Infrared&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Highest&nbsp;quantity&nbsp;(release&nbsp;kinetics)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MSa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">LOAEL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Mass&nbsp;spectrometry</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Lowest&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NMR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">LOD</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Nuclear&nbsp;magnetic&nbsp;resonance&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Limit&nbsp;of&nbsp;detection</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NVOC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Non-volatile&nbsp;organic&nbsp;compound</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NVR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Non-volatile&nbsp;residue</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">SEM-EDS&nbsp;(or&nbsp;SEM-EDX)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Scanning&nbsp;electron&nbsp;microscopy-energy&nbsp;dispersive&nbsp;X-ray&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">SVOC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Semi-volatile&nbsp;organic&nbsp;compound</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">TOC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Total&nbsp;organic&nbsp;carbon</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">UV</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__2\"></td><td class=\"diff_header\" id=\"from14_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ultraviolet&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Mass&nbsp;spectrometry&nbsp;is&nbsp;frequently&nbsp;combined&nbsp;with&nbsp;other&nbsp;techniques&nbsp;(especially&nbsp;chromatographic)&nbsp;in&nbsp;coupled&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;as&nbsp;GC-MS,&nbsp;LC-MS&nbsp;and&nbsp;MS-MS.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_53\">53</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_32\">32</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__3\"><a href=\"#difflib_chg_to14__3\">n</a></td><td class=\"diff_header\" id=\"from14_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">6\b</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__3\">n</a></td><td class=\"diff_header\" id=\"to14_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">7</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_56\">56</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_35\">35</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_57\">57</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_36\">36</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_58\">58</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_37\">37</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to14__4\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__4\">n</a></td><td class=\"diff_header\" id=\"to14_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MD</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Medical&nbsp;device</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MDa.r.s.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Medical&nbsp;device&nbsp;(extraction&nbsp;(i.e.&nbsp;assumed&nbsp;release)&nbsp;study)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MDb.c.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Medical&nbsp;device&nbsp;(body&nbsp;contact)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MDr.k.s.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Medical&nbsp;device&nbsp;(release&nbsp;kinetic&nbsp;study)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Modifying&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MFTCL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Modifying&nbsp;factor&nbsp;(tolerable&nbsp;contact&nbsp;level)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MIL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Minimally&nbsp;irritating&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MoS</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Margin&nbsp;of&nbsp;safety</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MoScom</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Margin&nbsp;of&nbsp;safety&nbsp;(combined)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_add\">MoSi</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Margin&nbsp;of&nbsp;safety&nbsp;(individual&nbsp;or&nbsp;each)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NIL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Non-irritating&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOAEL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_add\">No&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_add\">POD</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Point&nbsp;of&nbsp;departure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Rd</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Release&nbsp;duration</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SAext</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Surface&nbsp;area&nbsp;(extraction)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SIF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Slope&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SVOC</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Semi&nbsp;volatile&nbsp;organic&nbsp;compound</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Scaling&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SFa.r.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Scaling&nbsp;factor&nbsp;(assumed&nbsp;release)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_add\">SFr.k.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Scaling&nbsp;factor&nbsp;(release&nbsp;kinetics)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TCL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Tolerable&nbsp;contact&nbsp;level</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TD50</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxic&nbsp;dose&nbsp;(50&nbsp;%)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TI</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Tolerable&nbsp;intake</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TQ</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Total&nbsp;quantity&nbsp;(i.e.&nbsp;present&nbsp;or&nbsp;extracted)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TQa.r.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Total&nbsp;quantity&nbsp;(assumed&nbsp;release)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TQext</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Total&nbsp;quantity&nbsp;(extracted)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TQmax</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Total&nbsp;quantity&nbsp;(maximum)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TRA</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;risk&nbsp;assessment</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;screening&nbsp;limit</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL&nbsp;\u226430&nbsp;d</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;screening&nbsp;limit&nbsp;(less&nbsp;or&nbsp;equal&nbsp;to&nbsp;30&nbsp;days)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL\u00a0&gt;30&nbsp;d</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;screening&nbsp;limit&nbsp;(greater&nbsp;than&nbsp;30&nbsp;days)</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__4\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_59\">59</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_105\">105</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to14__5\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__5\">n</a></td><td class=\"diff_header\" id=\"to14_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_add\">8</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_60\">60</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">8</span>:202<span class=\"diff_chg\">0</span>(E)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_110\">110</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">7</span>:202<span class=\"diff_chg\">3</span>(E)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Abbreviated&nbsp;term</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TTC</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to14__5\"></td><td class=\"diff_header\" id=\"from14_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Analytical&nbsp;method</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Threshold&nbsp;of&nbsp;toxicological&nbsp;concern</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_add\">UF</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Uncertainty&nbsp;factor</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_63\">63</td><td nowrap=\"nowrap\">VOC</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_115\">115</td><td nowrap=\"nowrap\">VOC</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_64\">64</td><td nowrap=\"nowrap\">Volatile&nbsp;organic&nbsp;compound</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to14_116\">116</td><td nowrap=\"nowrap\">Volatile&nbsp;organic&nbsp;compound</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to14__top\">t</a></td><td class=\"diff_header\" id=\"from14_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">XPS</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to14__top\">t</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;photoelectron&nbsp;spectroscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">XRF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;fluorescence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Mass&nbsp;spectrometry&nbsp;is&nbsp;frequently&nbsp;combined&nbsp;with&nbsp;other&nbsp;techniques&nbsp;(especially&nbsp;chromatographic)&nbsp;in&nbsp;coupled&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from14_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;as&nbsp;GC-MS,&nbsp;LC-MS&nbsp;and&nbsp;MS-MS.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "5",
    "change_type": "modified",
    "old_text": "5\t Characterization procedure",
    "new_text": "5\t Toxicological risk assessment within the biological evaluation process",
    "change_text": "5\t Toxicological risk assessment within the biological evaluation process",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to15__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to15__0\"><a href=\"#difflib_chg_to15__top\">t</a></td><td class=\"diff_header\" id=\"from15_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Characterization&nbsp;procedure</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to15__top\">t</a></td><td class=\"diff_header\" id=\"to15_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Toxicological&nbsp;risk&nbsp;assessment&nbsp;within&nbsp;the&nbsp;biological&nbsp;evaluation&nbsp;process</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "5.1",
    "change_type": "modified",
    "old_text": "5.1\t General\nThe chemical characterization information, either collected or generated, and augmented with\nadditional supporting information as appropriate, can be used for a range of important applications, for\nexample:\n\u2014\t supporting the overall biological safety of a medical device (ISO\u00a010993-1 and ISO\u00a014971);\n\u2014\t supporting the biological safety of a reprocessed medical device;\n\u2014\t determining the amount of chemical substances that might be leached from a medical device\nunder the conditions of its clinical use, to support performing a toxicological risk assessment\n(ISO\u00a010993-17);\n\u2014\t supporting equivalence of a proposed medical device to a clinically established device, used for the\nsame type of clinical exposure, with regards to either the device\u2019s configuration or its extractables/\nleachables profiles and any subsequent relevant evaluations;\n\u2014\t supporting equivalence of a clinically established medical device, used for the same type of clinical\nexposure, after changes in the manufacturing process, (including, but not limited, to changes in the\nsterilization process), manufacturing sites, suppliers of materials or components, etc.;\n\u2014\t supporting equivalence of a proposed material of construction to a clinically established material of\nconstruction with regards to either the material\u2019s composition or its extractables profiles and any\nsubsequent relevant evaluations;\n\u2014\t supporting equivalence of a final medical device to a prototype device with regards to the use of\ndata secured on the prototype to support the assessment of the final device, specifically considering\nrelevant information such as composition, device configuration and extractable profile obtained for\neither the device or its materials of construction; or\n\u2014\t screening of potential new materials for chemical suitability in a medical device for a proposed\nclinical application.\nThese important applications notwithstanding, chemical characterization alone can be insufficient to\nestablish the equivalence or biocompatibility of materials and medical devices, and cannot unilaterally\nsubstitute for biological testing. However, chemical characterization in combination with risk\nassessment can be a necessary part of judging chemical equivalence and assessing biocompatibility,\nand if appropriately conducted can be used in lieu of certain biological tests.\nChemical characterization of a medical device provides the necessary input into the device\u2019s biological\nevaluation and toxicological risk assessment (see ISO\u00a010993-1 and ISO\u00a010993-17). A flowchart describing\nthe general chemical characterization process is given in Figure\u00a0 1. This flowchart represents the\nchemical characterization portion of the overall biological evaluation flow as discussed in ISO\u00a010993-1\nand is meant to illustrate the characterization process that is described in this clause. This general\nflowchart is supplemented with additional flowcharts (see Figures\u00a02 to 4) that provide greater detail to\nspecific steps in the general process.\n\ufeff\nTable 1 (continued)\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n7\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nThe requirements and guidance for each step of the chemical characterization process are specified\nin\u00a05.2 to 5.10. When specified in the applicable flowchart, knowledgeable and experienced individuals\nshall compile existing information relevant to the chemical characterization (information gathering)\nand assess its adequacy as the basis for a toxicological risk assessment of the material/medical device.\nIf the existing information is insufficient to complete the assessment, additional information shall be\ngathered or produced by testing (information generation) to enable the toxicological risk assessment.\nThis procedure should consider each of the direct and indirect contact materials of construction used\nin a medical device in addition to the requirement for chemical characterization of the finished medical\ndevice. Since the chemical nature of a medical device can be affected by its processing during its\nconstruction (e.g. sterilization), the effect of this processing on the device shall be taken into account in\nthe design and interpretation of the chemical characterization.\nAt each step of the characterization procedure, the adequacy of the available data as the basis for\nperforming the risk assessment shall be established. The available data can be considered adequate\nif it reflects or exceeds the conditions of clinical use and a risk assessment based on the available data\ncan be completed. Inadequacies in the data can be addressed by filling gaps in such data (e.g. literature\nreview) and/or supplementing the data via analytical testing.\nThe flowcharts have the following types of process steps; start/stop, decision points, information\ngathering and evaluation, and analytical testing. Each type of step is represented by a geometric shape.\nStart/stop steps are identified as ovals, a decision step is identified as a diamond, an information\ngathering/evaluation step is represented as a parallelogram, and a step that involves analytical testing\nis represented as a rectangle.\nThe steps and actions defined in 5.4.2, 5.7 and 5.9 are part of the risk assessment process and represent\nthe points at which chemical information is provided for assessment. As such, they are for the most\npart, outside the scope of chemical characterization, which is the focus of this document. These steps\nare included to indicate the important link between chemical characterization and risk assessment (see\nISO 10993-1, ISO\u00a010993-17, and ISO\u00a014971).\nThe characterization procedure and its associated flowchart system is based on the principles in\nISO\u00a0 10993-1; specifically, that the biological evaluation and toxicological risk assessment process\nis most efficient and effective if it is based on the appropriate (minimum) amount of acceptable and\nnecessary chemical information that can establish that a medical device presents an acceptable health\nrisk. Thus, the first step of the procedure is to establish the configuration of the medical device and\nthe composition of the device\u2019s materials of construction so that it can be compared to a clinically\nestablished device or assessed based on hypothetical worst-case chemical release (i.e. \u201cit all comes\nout\u201d). This assessment should include potential contaminants, degradants, processing aids and\nadditives which could be introduced by the manufacturing process. If an assessment based on the\nhypothetical worst-case chemical release leads to the conclusion that there is an acceptable risk, then\nthe process can be completed with the collection or generation of a minimum amount of information.\nOn the other hand, if the conclusion of acceptable health risk cannot be supported, then additional data\nshall be collected, following a step-wise process from determining and evaluating the medical device\u2019s\nhypothetical worst-case chemical release to the actual chemical release under clinical conditions of use.\nIn any and all cases, the information collected shall reflect (or exceed) and be assessed according to the\nclinical conditions of use.\nIn using the flowcharts, it is not always necessary to complete all steps in the entire sequence; thus, the\nflowchart system has multiple points of exit. For example, if one can demonstrate that a hypothetical\nexposure to all of the chemical constituents of a medical device presents an acceptable health risk,\nadditional chemical testing is not necessary, the characterization is complete and the flowcharts are\nexited and biological evaluation continued according to ISO\u00a010993-1.\n\ufeff\n8\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nNOTE\nThe flowchart can be entered and exited at multiple points.\nFigure\u00a01\u00a0\u2014 General chemical characterization process\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n9\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nIn addition to multiple possible exit points, the flowchart system also has multiple points of entry.\nWhile the first actions taken in the flowcharts can facilitate the later actions in the flowcharts, they\nare not necessarily prerequisites for those further actions. For example, although knowing a device\u2019s\nconfiguration and material composition (including potential impurities) might facilitate establishing\nits leachables profile, the leachables profile can be delineated without configuration and composition\ninformation. Thus, if a sponsor has reason to believe that a leachables assessment will be necessary or\nmost relevant (e.g. for certain indirect contact medical devices) to properly and completely establish\nthe medical device\u2019s toxicological risk, then compositional profiling and extractables studies need not\nbe conducted. Likewise, available knowledge of the medical device\u2019s composition can make it clear that\nan extractables study is likely to produce an extracted substance above an acceptable threshold; in this\ncase, it can be appropriate to skip the extractables study and proceed directly to a leachables study.\nThis multiple entry and exit approach is proper and justifiable as the flowchart system is constructed\nsuch that each successive step gets closer to establishing the actual clinical exposure to leachables and\nthus gets closer to establishing the actual risk. Entering the process at an intermediate point can still\nassure that the most accurate estimate of exposure is produced for toxicological risk assessment. If an\nalternative entry to the flow chart (i.e. other than \u201cstart at the beginning\u201d) is taken, it shall be justified.\nAdditional general guidance on chemical characterization is provided in Annex\u00a0A.",
    "new_text": "5.1\t General\n5.1.1\nRisk assessment principles\nThis document describes an approach for identifying, estimating and evaluating toxicological risks\nthat can arise from exposure to medical device constituents. According to ISO 14971, risk assessment\ncomprises risk analysis and risk evaluation. Risk analysis is the systematic use of available information\nto identify hazards (potential sources of harm) and to estimate the risk. The process of risk estimation\nassigns values to the probability of occurrence of harm and the severity of that harm. Risk evaluation is\nthe process of comparing risk estimates to acceptability criteria to determine the acceptability of risk.\nISO\u00a010993-1 states that the likelihood that harm will occur can be estimated from the knowledge of the\nactual availability of toxic components and the known dose response in relevant tissue.\nNOTE 1\nFor information on relevant risk management concepts and requirements, see ISO 14971:2019, 3.19,\n3.20, 4.4, 5.4, 5.5 and Clause\u00a06. For information on application of these concepts to biological evaluation, see\nISO 10993-1:2018, B.3.1.\nThis document describes a systematic approach to toxicological risk assessment based on:\n\u2014\t toxicological information on constituents that describes potential harms and the circumstances in\nwhich harm can occur (see Clause\u00a06);\n\u2014\t the derivation of a tolerable contact level or tolerable intake, or the selection of a threshold of\ntoxicological concern (see Clause\u00a07);\n\u2014\t exposure dose estimation (see Clause\u00a08);\n\u2014\t the derivation of a MoS, where appropriate (see Clause\u00a09).\nThis process is illustrated in Figure\u00a01.\nToxicological risk assessment shall be conducted by experienced individuals, knowledgeable in\ntoxicology, medical devices (i.e. clinical use conditions, materials, manufacturing process, etc.) and\nexposure dose estimation.\nNOTE\u00a02\nAssessment of toxicological risk typically involves close collaboration of experts in medical device\nmanufacturing or clinical use or design, material science, analytical chemistry and toxicology.\nThis document shall not be used for commercially marketed medical devices to mandate a reassessment\nof historical ISO 10993-18 chemical constituent data assessed previously using the appropriate edition\nof this document at the time of the assessment. Compliance with this document (i.e. ISO 10993-17:2023)\nmay be shown by providing a justification for the adequacy of the historical toxicological risk\nassessment. This includes confirmation that none of the issues identified in ISO 10993-1:2018, 4.9 have\noccurred; otherwise, a new toxicological risk assessment is needed for any of the relevant endpoints in\n6.1 of this document.\n5.1.2\nHazard identification\nA hazard is identified when a medical device constituent that is capable of causing a harm that is\nrelevant to the circumstances of exposure to the medical device is found to be present in or on, or\nreleased from a medical device.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n9\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe relevance of the harm shall be determined from information on the intended use of the medical\ndevice, based on its categorization in accordance with ISO 10993-1:2018, Clause\u00a0 5 and 6.2, taking\ninto account its exposure scenario (see 6.2.1) and reasonably foreseeable sequences or combinations\nof events related to medical device use that can result in harm to health (refer to the applicable\nrequirements in ISO 14971).\nEXAMPLE\nTypes of exposure or contact include, but are not limited to, topical, dermal, oral, gastrointestinal,\ninhalation, respiratory, subcutaneous, intramuscular, bone, intravenous or blood, neural tissues.\nNOTE\nReasonably foreseeable means sequences or combinations of events related to medical device use that\ncan result in harm to health (when TTC is applied).\nIf the harm is not relevant to the intended use of the medical device, the toxicological risk is negligible,\nand can be evaluated as acceptable.\n5.1.3\nRisk estimation\nThe toxicological risk shall be estimated when exposure to a constituent can exceed a pre-determined\nlevel that can result in a relevant harm under the anticipated worst-case conditions of medical device\nuse.\nThe toxicological risk is negligible when the total quantity of a constituent that is present in, on or\nextracted from the medical device is at or below the toxicological screening limit (see 6.2.2), or worst-\ncase estimated exposure dose is below the applicable TTC value (see 7.2), or the worst-case estimated\nexposure dose is below the tolerable contact level or tolerable intake (see Clauses\u00a08, 9 and\u00a010).\nToxicological risk estimation includes the following activities:\n\u2014\t a constituent-specific TCL or TI is derived based on conservative assumptions (see 7.1) or, if a\nconstituent-specific POD is not available, a TTC (if applicable) is applied (see 7.2);\n\u2014\t the calculation of the worst-case estimated exposure dose for the constituent (see Clause\u00a08);\n\u2014\t the calculation of the MoS, where appropriate (see Clause\u00a09).\nNOTE\nRisk estimation is a process used to assign values to the probability of occurrence of harm and the\nseverity of that harm (see ISO 14971:2019, 3.22 and A.2.5.5). For medical devices for which any harm due to\ntoxicity is considered unacceptable, assigning a value for severity is not necessary.\nRisk acceptability shall be based on pre-determined risk acceptability criteria in accordance with\nISO 14971:2019, 4.4 d) and ISO 10993-1:2018, 7 b).\nThe MoS can be used to evaluate whether the toxicological risk acceptability criteria are met (see\nClause\u00a09 and Clause\u00a010).\nWhen exposure to a constituent does not meet the acceptability criteria, the toxicological risk shall be\nfurther addressed (see 10.2).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n10\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nKey\nTox.\ntoxicological\nNOTE\nTSL or TTC are not applicable to cohort of concern, excluded compounds, irritation or other endpoints (see\nISO/TS 21726).\na\nAdequacy of constituent identity for toxicological risk assessment is informed by the experts involved in the\ntoxicological risk assessment.\nb\nHarms specified in this document may be addressed by other approaches described in ISO\u00a010993-1 and other\napplicable parts of the ISO\u00a010993 series.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n11\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nc\nWhen the identity of a reportable constituent cannot be adequately elucidated and its worst-case exposure\ndose cannot be estimated, biological testing may be necessary to address the applicable biological risk(s).\nd\nThe determination that toxicological risk assessment criteria are met is specific to the constituent and\nendpoint(s) addressed per this document and does not infer that all biological risks associated with a medical device\nare acceptable.\nFigure\u00a01\u00a0\u2014 Toxicological risk assessment within the biological evaluation process",
    "change_text": "5.1\t General\n5.1.1\nRisk assessment principles\nThis document describes an approach for identifying, estimating and evaluating toxicological risks\nthat can arise from exposure to medical device constituents. According to ISO 14971, risk assessment\ncomprises risk analysis and risk evaluation. Risk analysis is the systematic use of available information\nto identify hazards (potential sources of harm) and to estimate the risk. The process of risk estimation\nassigns values to the probability of occurrence of harm and the severity of that harm. Risk evaluation is\nthe process of comparing risk estimates to acceptability criteria to determine the acceptability of risk.\nISO\u00a010993-1 states that the likelihood that harm will occur can be estimated from the knowledge of the\nactual availability of toxic components and the known dose response in relevant tissue.\nNOTE 1\nFor information on relevant risk management concepts and requirements, see ISO 14971:2019, 3.19,\n3.20, 4.4, 5.4, 5.5 and Clause\u00a06. For information on application of these concepts to biological evaluation, see\nISO 10993-1:2018, B.3.1.\nThis document describes a systematic approach to toxicological risk assessment based on:\n\u2014\t toxicological information on constituents that describes potential harms and the circumstances in\nwhich harm can occur (see Clause\u00a06);\n\u2014\t the derivation of a tolerable contact level or tolerable intake, or the selection of a threshold of\ntoxicological concern (see Clause\u00a07);\n\u2014\t exposure dose estimation (see Clause\u00a08);\n\u2014\t the derivation of a MoS, where appropriate (see Clause\u00a09).\nThis process is illustrated in Figure\u00a01.\nToxicological risk assessment shall be conducted by experienced individuals, knowledgeable in\ntoxicology, medical devices (i.e. clinical use conditions, materials, manufacturing process, etc.) and\nexposure dose estimation.\nNOTE\u00a02\nAssessment of toxicological risk typically involves close collaboration of experts in medical device\nmanufacturing or clinical use or design, material science, analytical chemistry and toxicology.\nThis document shall not be used for commercially marketed medical devices to mandate a reassessment\nof historical ISO 10993-18 chemical constituent data assessed previously using the appropriate edition\nof this document at the time of the assessment. Compliance with this document (i.e. ISO 10993-17:2023)\nmay be shown by providing a justification for the adequacy of the historical toxicological risk\nassessment. This includes confirmation that none of the issues identified in ISO 10993-1:2018, 4.9 have\noccurred; otherwise, a new toxicological risk assessment is needed for any of the relevant endpoints in\n6.1 of this document.\n5.1.2\nHazard identification\nA hazard is identified when a medical device constituent that is capable of causing a harm that is\nrelevant to the circumstances of exposure to the medical device is found to be present in or on, or\nreleased from a medical device.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n9\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe relevance of the harm shall be determined from information on the intended use of the medical\ndevice, based on its categorization in accordance with ISO 10993-1:2018, Clause\u00a0 5 and 6.2, taking\ninto account its exposure scenario (see 6.2.1) and reasonably foreseeable sequences or combinations\nof events related to medical device use that can result in harm to health (refer to the applicable\nrequirements in ISO 14971).\nEXAMPLE\nTypes of exposure or contact include, but are not limited to, topical, dermal, oral, gastrointestinal,\ninhalation, respiratory, subcutaneous, intramuscular, bone, intravenous or blood, neural tissues.\nNOTE\nReasonably foreseeable means sequences or combinations of events related to medical device use that\ncan result in harm to health (when TTC is applied).\nIf the harm is not relevant to the intended use of the medical device, the toxicological risk is negligible,\nand can be evaluated as acceptable.\n5.1.3\nRisk estimation\nThe toxicological risk shall be estimated when exposure to a constituent can exceed a pre-determined\nlevel that can result in a relevant harm under the anticipated worst-case conditions of medical device\nuse.\nThe toxicological risk is negligible when the total quantity of a constituent that is present in, on or\nextracted from the medical device is at or below the toxicological screening limit (see 6.2.2), or worst-\ncase estimated exposure dose is below the applicable TTC value (see 7.2), or the worst-case estimated\nexposure dose is below the tolerable contact level or tolerable intake (see Clauses\u00a08, 9 and\u00a010).\nToxicological risk estimation includes the following activities:\n\u2014\t a constituent-specific TCL or TI is derived based on conservative assumptions (see 7.1) or, if a\nconstituent-specific POD is not available, a TTC (if applicable) is applied (see 7.2);\n\u2014\t the calculation of the worst-case estimated exposure dose for the constituent (see Clause\u00a08);\n\u2014\t the calculation of the MoS, where appropriate (see Clause\u00a09).\nNOTE\nRisk estimation is a process used to assign values to the probability of occurrence of harm and the\nseverity of that harm (see ISO 14971:2019, 3.22 and A.2.5.5). For medical devices for which any harm due to\ntoxicity is considered unacceptable, assigning a value for severity is not necessary.\nRisk acceptability shall be based on pre-determined risk acceptability criteria in accordance with\nISO 14971:2019, 4.4 d) and ISO 10993-1:2018, 7 b).\nThe MoS can be used to evaluate whether the toxicological risk acceptability criteria are met (see\nClause\u00a09 and Clause\u00a010).\nWhen exposure to a constituent does not meet the acceptability criteria, the toxicological risk shall be\nfurther addressed (see 10.2).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n10\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nKey\nTox.\ntoxicological\nNOTE\nTSL or TTC are not applicable to cohort of concern, excluded compounds, irritation or other endpoints (see\nISO/TS 21726).\na\nAdequacy of constituent identity for toxicological risk assessment is informed by the experts involved in the\ntoxicological risk assessment.\nb\nHarms specified in this document may be addressed by other approaches described in ISO\u00a010993-1 and other\napplicable parts of the ISO\u00a010993 series.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n11\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nc\nWhen the identity of a reportable constituent cannot be adequately elucidated and its worst-case exposure\ndose cannot be estimated, biological testing may be necessary to address the applicable biological risk(s).\nd\nThe determination that toxicological risk assessment criteria are met is specific to the constituent and\nendpoint(s) addressed per this document and does not infer that all biological risks associated with a medical device\nare acceptable.\nFigure\u00a01\u00a0\u2014 Toxicological risk assessment within the biological evaluation process",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to16__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to16__0\"><a href=\"#difflib_chg_to16__0\">f</a></td><td class=\"diff_header\" id=\"from16_1\">1</td><td nowrap=\"nowrap\">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__0\">f</a></td><td class=\"diff_header\" id=\"to16_1\">1</td><td nowrap=\"nowrap\">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to16__1\">n</a></td><td class=\"diff_header\" id=\"from16_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;chemical&nbsp;characterization&nbsp;information,&nbsp;either&nbsp;collected&nbsp;or&nbsp;generated,&nbsp;and&nbsp;augmented&nbsp;with</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__1\">n</a></td><td class=\"diff_header\" id=\"to16_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5.1.1</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additional&nbsp;supporting&nbsp;information&nbsp;as&nbsp;appropriate,&nbsp;can&nbsp;be&nbsp;used&nbsp;for&nbsp;a&nbsp;range&nbsp;of&nbsp;important&nbsp;applications,&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Risk&nbsp;assessment&nbsp;principles</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">example:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;document&nbsp;describes&nbsp;an&nbsp;approach&nbsp;for&nbsp;identifying,&nbsp;estimating&nbsp;and&nbsp;evaluating&nbsp;toxicological&nbsp;risks</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;the&nbsp;overall&nbsp;biological&nbsp;safety&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;(ISO\u00a010993-1&nbsp;and&nbsp;ISO\u00a014971);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">that&nbsp;can&nbsp;arise&nbsp;from&nbsp;exposure&nbsp;to&nbsp;medical&nbsp;device&nbsp;constituents.&nbsp;According&nbsp;to&nbsp;ISO&nbsp;14971,&nbsp;risk&nbsp;assessment</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of&nbsp;a&nbsp;reprocessed&nbsp;medical&nbsp;device;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">comprises&nbsp;risk&nbsp;analysis&nbsp;and&nbsp;risk&nbsp;evaluation.&nbsp;Risk&nbsp;analysis&nbsp;is&nbsp;the&nbsp;systematic&nbsp;use&nbsp;of&nbsp;available&nbsp;information</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining&nbsp;the&nbsp;amount&nbsp;of&nbsp;chemical&nbsp;substances&nbsp;that&nbsp;might&nbsp;be&nbsp;leached&nbsp;from&nbsp;a&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">to&nbsp;identify&nbsp;hazards&nbsp;(potential&nbsp;sources&nbsp;of&nbsp;harm)&nbsp;and&nbsp;to&nbsp;estimate&nbsp;the&nbsp;risk.&nbsp;The&nbsp;process&nbsp;of&nbsp;risk&nbsp;estimation</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">under&nbsp;the&nbsp;conditions&nbsp;of&nbsp;its&nbsp;clinical&nbsp;use,&nbsp;to&nbsp;support&nbsp;performing&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">assigns&nbsp;values&nbsp;to&nbsp;the&nbsp;probability&nbsp;of&nbsp;occurrence&nbsp;of&nbsp;harm&nbsp;and&nbsp;the&nbsp;severity&nbsp;of&nbsp;that&nbsp;harm.&nbsp;Risk&nbsp;evaluation&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(ISO\u00a010993-17);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;process&nbsp;of&nbsp;comparing&nbsp;risk&nbsp;estimates&nbsp;to&nbsp;acceptability&nbsp;criteria&nbsp;to&nbsp;determine&nbsp;the&nbsp;acceptability&nbsp;of&nbsp;risk.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;equivalence&nbsp;of&nbsp;a&nbsp;proposed&nbsp;medical&nbsp;device&nbsp;to&nbsp;a&nbsp;clinically&nbsp;established&nbsp;device,&nbsp;used&nbsp;for&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO\u00a010993-1&nbsp;states&nbsp;that&nbsp;the&nbsp;likelihood&nbsp;that&nbsp;harm&nbsp;will&nbsp;occur&nbsp;can&nbsp;be&nbsp;estimated&nbsp;from&nbsp;the&nbsp;knowledge&nbsp;of&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">same&nbsp;type&nbsp;of&nbsp;clinical&nbsp;exposure,&nbsp;with&nbsp;regards&nbsp;to&nbsp;either&nbsp;the&nbsp;device\u2019s&nbsp;configuration&nbsp;or&nbsp;its&nbsp;extractables/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">actual&nbsp;availability&nbsp;of&nbsp;toxic&nbsp;components&nbsp;and&nbsp;the&nbsp;known&nbsp;dose&nbsp;response&nbsp;in&nbsp;relevant&nbsp;tissue.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachables&nbsp;profiles&nbsp;and&nbsp;any&nbsp;subsequent&nbsp;relevant&nbsp;evaluations;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE&nbsp;1</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;equivalence&nbsp;of&nbsp;a&nbsp;clinically&nbsp;established&nbsp;medical&nbsp;device,&nbsp;used&nbsp;for&nbsp;the&nbsp;same&nbsp;type&nbsp;of&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">For&nbsp;information&nbsp;on&nbsp;relevant&nbsp;risk&nbsp;management&nbsp;concepts&nbsp;and&nbsp;requirements,&nbsp;see&nbsp;ISO&nbsp;14971:2019,&nbsp;3.19,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exposure,&nbsp;after&nbsp;changes&nbsp;in&nbsp;the&nbsp;manufacturing&nbsp;process,&nbsp;(including,&nbsp;but&nbsp;not&nbsp;limited,&nbsp;to&nbsp;changes&nbsp;in&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">3.20,&nbsp;4.4,&nbsp;5.4,&nbsp;5.5&nbsp;and&nbsp;Clause\u00a06.&nbsp;For&nbsp;information&nbsp;on&nbsp;application&nbsp;of&nbsp;these&nbsp;concepts&nbsp;to&nbsp;biological&nbsp;evaluation,&nbsp;see</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sterilization&nbsp;process),&nbsp;manufacturing&nbsp;sites,&nbsp;suppliers&nbsp;of&nbsp;materials&nbsp;or&nbsp;components,&nbsp;etc.;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-1:2018,&nbsp;B.3.1.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;equivalence&nbsp;of&nbsp;a&nbsp;proposed&nbsp;material&nbsp;of&nbsp;construction&nbsp;to&nbsp;a&nbsp;clinically&nbsp;established&nbsp;material&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;document&nbsp;describes&nbsp;a&nbsp;systematic&nbsp;approach&nbsp;to&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;based&nbsp;on:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;with&nbsp;regards&nbsp;to&nbsp;either&nbsp;the&nbsp;material\u2019s&nbsp;composition&nbsp;or&nbsp;its&nbsp;extractables&nbsp;profiles&nbsp;and&nbsp;any</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;toxicological&nbsp;information&nbsp;on&nbsp;constituents&nbsp;that&nbsp;describes&nbsp;potential&nbsp;harms&nbsp;and&nbsp;the&nbsp;circumstances&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">subsequent&nbsp;relevant&nbsp;evaluations;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">which&nbsp;harm&nbsp;can&nbsp;occur&nbsp;(see&nbsp;Clause\u00a06);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;supporting&nbsp;equivalence&nbsp;of&nbsp;a&nbsp;final&nbsp;medical&nbsp;device&nbsp;to&nbsp;a&nbsp;prototype&nbsp;device&nbsp;with&nbsp;regards&nbsp;to&nbsp;the&nbsp;use&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;derivation&nbsp;of&nbsp;a&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;or&nbsp;tolerable&nbsp;intake,&nbsp;or&nbsp;the&nbsp;selection&nbsp;of&nbsp;a&nbsp;threshold&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">data&nbsp;secured&nbsp;on&nbsp;the&nbsp;prototype&nbsp;to&nbsp;support&nbsp;the&nbsp;assessment&nbsp;of&nbsp;the&nbsp;final&nbsp;device,&nbsp;specifically&nbsp;considering</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;concern&nbsp;(see&nbsp;Clause\u00a07);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relevant&nbsp;information&nbsp;such&nbsp;as&nbsp;composition,&nbsp;device&nbsp;configuration&nbsp;and&nbsp;extractable&nbsp;profile&nbsp;obtained&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exposure&nbsp;dose&nbsp;estimation&nbsp;(see&nbsp;Clause\u00a08);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">either&nbsp;the&nbsp;device&nbsp;or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction;&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;derivation&nbsp;of&nbsp;a&nbsp;MoS,&nbsp;where&nbsp;appropriate&nbsp;(see&nbsp;Clause\u00a09).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;screening&nbsp;of&nbsp;potential&nbsp;new&nbsp;materials&nbsp;for&nbsp;chemical&nbsp;suitability&nbsp;in&nbsp;a&nbsp;medical&nbsp;device&nbsp;for&nbsp;a&nbsp;proposed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;process&nbsp;is&nbsp;illustrated&nbsp;in&nbsp;Figure\u00a01.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;application.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;risk&nbsp;assessment&nbsp;shall&nbsp;be&nbsp;conducted&nbsp;by&nbsp;experienced&nbsp;individuals,&nbsp;knowledgeable&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">These&nbsp;important&nbsp;applications&nbsp;notwithstanding,&nbsp;chemical&nbsp;characterization&nbsp;alone&nbsp;can&nbsp;be&nbsp;insufficient&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicology,&nbsp;medical&nbsp;devices&nbsp;(i.e.&nbsp;clinical&nbsp;use&nbsp;conditions,&nbsp;materials,&nbsp;manufacturing&nbsp;process,&nbsp;etc.)&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establish&nbsp;the&nbsp;equivalence&nbsp;or&nbsp;biocompatibility&nbsp;of&nbsp;materials&nbsp;and&nbsp;medical&nbsp;devices,&nbsp;and&nbsp;cannot&nbsp;unilaterally</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;dose&nbsp;estimation.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substitute&nbsp;for&nbsp;biological&nbsp;testing.&nbsp;However,&nbsp;chemical&nbsp;characterization&nbsp;in&nbsp;combination&nbsp;with&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a02</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment&nbsp;can&nbsp;be&nbsp;a&nbsp;necessary&nbsp;part&nbsp;of&nbsp;judging&nbsp;chemical&nbsp;equivalence&nbsp;and&nbsp;assessing&nbsp;biocompatibility,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Assessment&nbsp;of&nbsp;toxicological&nbsp;risk&nbsp;typically&nbsp;involves&nbsp;close&nbsp;collaboration&nbsp;of&nbsp;experts&nbsp;in&nbsp;medical&nbsp;device</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;if&nbsp;appropriately&nbsp;conducted&nbsp;can&nbsp;be&nbsp;used&nbsp;in&nbsp;lieu&nbsp;of&nbsp;certain&nbsp;biological&nbsp;tests.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">manufacturing&nbsp;or&nbsp;clinical&nbsp;use&nbsp;or&nbsp;design,&nbsp;material&nbsp;science,&nbsp;analytical&nbsp;chemistry&nbsp;and&nbsp;toxicology.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;characterization&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;provides&nbsp;the&nbsp;necessary&nbsp;input&nbsp;into&nbsp;the&nbsp;device\u2019s&nbsp;biological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">This&nbsp;document&nbsp;shall&nbsp;not&nbsp;be&nbsp;used&nbsp;for&nbsp;commercially&nbsp;marketed&nbsp;medical&nbsp;devices&nbsp;to&nbsp;mandate&nbsp;a&nbsp;reassessment</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">evaluation&nbsp;and&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(see&nbsp;ISO\u00a010993-1&nbsp;and&nbsp;ISO\u00a010993-17).&nbsp;A&nbsp;flowchart&nbsp;describing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">of&nbsp;historical&nbsp;ISO&nbsp;10993-18&nbsp;chemical&nbsp;constituent&nbsp;data&nbsp;assessed&nbsp;previously&nbsp;using&nbsp;the&nbsp;appropriate&nbsp;edition</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;general&nbsp;chemical&nbsp;characterization&nbsp;process&nbsp;is&nbsp;given&nbsp;in&nbsp;Figure\u00a0&nbsp;1.&nbsp;This&nbsp;flowchart&nbsp;represents&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_add\">of&nbsp;this&nbsp;document&nbsp;at&nbsp;the&nbsp;time&nbsp;of&nbsp;the&nbsp;assessment.&nbsp;Compliance&nbsp;with&nbsp;this&nbsp;document&nbsp;(i.e.&nbsp;ISO&nbsp;10993-17:2023)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization&nbsp;portion&nbsp;of&nbsp;the&nbsp;overall&nbsp;biological&nbsp;evaluation&nbsp;flow&nbsp;as&nbsp;discussed&nbsp;in&nbsp;ISO\u00a010993-1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_add\">may&nbsp;be&nbsp;shown&nbsp;by&nbsp;providing&nbsp;a&nbsp;justification&nbsp;for&nbsp;the&nbsp;adequacy&nbsp;of&nbsp;the&nbsp;historical&nbsp;toxicological&nbsp;risk</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;is&nbsp;meant&nbsp;to&nbsp;illustrate&nbsp;the&nbsp;characterization&nbsp;process&nbsp;that&nbsp;is&nbsp;described&nbsp;in&nbsp;this&nbsp;clause.&nbsp;This&nbsp;general</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">assessment.&nbsp;This&nbsp;includes&nbsp;confirmation&nbsp;that&nbsp;none&nbsp;of&nbsp;the&nbsp;issues&nbsp;identified&nbsp;in&nbsp;ISO&nbsp;10993-1:2018,&nbsp;4.9&nbsp;have</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">flowchart&nbsp;is&nbsp;supplemented&nbsp;with&nbsp;additional&nbsp;flowcharts&nbsp;(see&nbsp;Figures\u00a02&nbsp;to&nbsp;4)&nbsp;that&nbsp;provide&nbsp;greater&nbsp;detail&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_add\">occurred;&nbsp;otherwise,&nbsp;a&nbsp;new&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;needed&nbsp;for&nbsp;any&nbsp;of&nbsp;the&nbsp;relevant&nbsp;endpoints&nbsp;in</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specific&nbsp;steps&nbsp;in&nbsp;the&nbsp;general&nbsp;process.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.1&nbsp;of&nbsp;this&nbsp;document.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5.1.2</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Hazard&nbsp;identification</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to16__1\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_add\">A&nbsp;hazard&nbsp;is&nbsp;identified&nbsp;when&nbsp;a&nbsp;medical&nbsp;device&nbsp;constituent&nbsp;that&nbsp;is&nbsp;capable&nbsp;of&nbsp;causing&nbsp;a&nbsp;harm&nbsp;that&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_add\">relevant&nbsp;to&nbsp;the&nbsp;circumstances&nbsp;of&nbsp;exposure&nbsp;to&nbsp;the&nbsp;medical&nbsp;device&nbsp;is&nbsp;found&nbsp;to&nbsp;be&nbsp;present&nbsp;in&nbsp;or&nbsp;on,&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_add\">released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_37\">37</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_43\">43</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to16__2\">n</a></td><td class=\"diff_header\" id=\"from16_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table&nbsp;1&nbsp;(continued)</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__2\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to16__2\"></td><td class=\"diff_header\" id=\"from16_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">7</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_44\">44</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_44\">44</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to16__3\">n</a></td><td class=\"diff_header\" id=\"from16_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__3\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;requirements&nbsp;and&nbsp;guidance&nbsp;for&nbsp;each&nbsp;step&nbsp;of&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;process&nbsp;are&nbsp;specified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in\u00a05.2&nbsp;to&nbsp;5.10.&nbsp;When&nbsp;specified&nbsp;in&nbsp;the&nbsp;applicable&nbsp;flowchart,&nbsp;knowledgeable&nbsp;and&nbsp;experienced&nbsp;individuals</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">shall&nbsp;compile&nbsp;existing&nbsp;information&nbsp;relevant&nbsp;to&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;(information&nbsp;gathering)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;assess&nbsp;its&nbsp;adequacy&nbsp;as&nbsp;the&nbsp;basis&nbsp;for&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;the&nbsp;material/medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;the&nbsp;existing&nbsp;information&nbsp;is&nbsp;insufficient&nbsp;to&nbsp;complete&nbsp;the&nbsp;assessment,&nbsp;additional&nbsp;information&nbsp;shall&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">gathered&nbsp;or&nbsp;produced&nbsp;by&nbsp;testing&nbsp;(information&nbsp;generation)&nbsp;to&nbsp;enable&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;procedure&nbsp;should&nbsp;consider&nbsp;each&nbsp;of&nbsp;the&nbsp;direct&nbsp;and&nbsp;indirect&nbsp;contact&nbsp;materials&nbsp;of&nbsp;construction&nbsp;used</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;a&nbsp;medical&nbsp;device&nbsp;in&nbsp;addition&nbsp;to&nbsp;the&nbsp;requirement&nbsp;for&nbsp;chemical&nbsp;characterization&nbsp;of&nbsp;the&nbsp;finished&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device.&nbsp;Since&nbsp;the&nbsp;chemical&nbsp;nature&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;can&nbsp;be&nbsp;affected&nbsp;by&nbsp;its&nbsp;processing&nbsp;during&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;(e.g.&nbsp;sterilization),&nbsp;the&nbsp;effect&nbsp;of&nbsp;this&nbsp;processing&nbsp;on&nbsp;the&nbsp;device&nbsp;shall&nbsp;be&nbsp;taken&nbsp;into&nbsp;account&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;design&nbsp;and&nbsp;interpretation&nbsp;of&nbsp;the&nbsp;chemical&nbsp;characterization.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">At&nbsp;each&nbsp;step&nbsp;of&nbsp;the&nbsp;characterization&nbsp;procedure,&nbsp;the&nbsp;adequacy&nbsp;of&nbsp;the&nbsp;available&nbsp;data&nbsp;as&nbsp;the&nbsp;basis&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">performing&nbsp;the&nbsp;risk&nbsp;assessment&nbsp;shall&nbsp;be&nbsp;established.&nbsp;The&nbsp;available&nbsp;data&nbsp;can&nbsp;be&nbsp;considered&nbsp;adequate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">if&nbsp;it&nbsp;reflects&nbsp;or&nbsp;exceeds&nbsp;the&nbsp;conditions&nbsp;of&nbsp;clinical&nbsp;use&nbsp;and&nbsp;a&nbsp;risk&nbsp;assessment&nbsp;based&nbsp;on&nbsp;the&nbsp;available&nbsp;data</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;completed.&nbsp;Inadequacies&nbsp;in&nbsp;the&nbsp;data&nbsp;can&nbsp;be&nbsp;addressed&nbsp;by&nbsp;filling&nbsp;gaps&nbsp;in&nbsp;such&nbsp;data&nbsp;(e.g.&nbsp;literature</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">review)&nbsp;and/or&nbsp;supplementing&nbsp;the&nbsp;data&nbsp;via&nbsp;analytical&nbsp;testing.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;flowcharts&nbsp;have&nbsp;the&nbsp;following&nbsp;types&nbsp;of&nbsp;process&nbsp;steps;&nbsp;start/stop,&nbsp;decision&nbsp;points,&nbsp;information</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">gathering&nbsp;and&nbsp;evaluation,&nbsp;and&nbsp;analytical&nbsp;testing.&nbsp;Each&nbsp;type&nbsp;of&nbsp;step&nbsp;is&nbsp;represented&nbsp;by&nbsp;a&nbsp;geometric&nbsp;shape.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Start/stop&nbsp;steps&nbsp;are&nbsp;identified&nbsp;as&nbsp;ovals,&nbsp;a&nbsp;decision&nbsp;step&nbsp;is&nbsp;identified&nbsp;as&nbsp;a&nbsp;diamond,&nbsp;an&nbsp;information</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">gathering/evaluation&nbsp;step&nbsp;is&nbsp;represented&nbsp;as&nbsp;a&nbsp;parallelogram,&nbsp;and&nbsp;a&nbsp;step&nbsp;that&nbsp;involves&nbsp;analytical&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;represented&nbsp;as&nbsp;a&nbsp;rectangle.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;steps&nbsp;and&nbsp;actions&nbsp;defined&nbsp;in&nbsp;5.4.2,&nbsp;5.7&nbsp;and&nbsp;5.9&nbsp;are&nbsp;part&nbsp;of&nbsp;the&nbsp;risk&nbsp;assessment&nbsp;process&nbsp;and&nbsp;represent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;points&nbsp;at&nbsp;which&nbsp;chemical&nbsp;information&nbsp;is&nbsp;provided&nbsp;for&nbsp;assessment.&nbsp;As&nbsp;such,&nbsp;they&nbsp;are&nbsp;for&nbsp;the&nbsp;most</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">part,&nbsp;outside&nbsp;the&nbsp;scope&nbsp;of&nbsp;chemical&nbsp;characterization,&nbsp;which&nbsp;is&nbsp;the&nbsp;focus&nbsp;of&nbsp;this&nbsp;document.&nbsp;These&nbsp;steps</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;included&nbsp;to&nbsp;indicate&nbsp;the&nbsp;important&nbsp;link&nbsp;between&nbsp;chemical&nbsp;characterization&nbsp;and&nbsp;risk&nbsp;assessment&nbsp;(see</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-1,&nbsp;ISO\u00a010993-17,&nbsp;and&nbsp;ISO\u00a014971).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;characterization&nbsp;procedure&nbsp;and&nbsp;its&nbsp;associated&nbsp;flowchart&nbsp;system&nbsp;is&nbsp;based&nbsp;on&nbsp;the&nbsp;principles&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a0&nbsp;10993-1;&nbsp;specifically,&nbsp;that&nbsp;the&nbsp;biological&nbsp;evaluation&nbsp;and&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;most&nbsp;efficient&nbsp;and&nbsp;effective&nbsp;if&nbsp;it&nbsp;is&nbsp;based&nbsp;on&nbsp;the&nbsp;appropriate&nbsp;(minimum)&nbsp;amount&nbsp;of&nbsp;acceptable&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">necessary&nbsp;chemical&nbsp;information&nbsp;that&nbsp;can&nbsp;establish&nbsp;that&nbsp;a&nbsp;medical&nbsp;device&nbsp;presents&nbsp;an&nbsp;acceptable&nbsp;health</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk.&nbsp;Thus,&nbsp;the&nbsp;first&nbsp;step&nbsp;of&nbsp;the&nbsp;procedure&nbsp;is&nbsp;to&nbsp;establish&nbsp;the&nbsp;configuration&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;composition&nbsp;of&nbsp;the&nbsp;device\u2019s&nbsp;materials&nbsp;of&nbsp;construction&nbsp;so&nbsp;that&nbsp;it&nbsp;can&nbsp;be&nbsp;compared&nbsp;to&nbsp;a&nbsp;clinically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">established&nbsp;device&nbsp;or&nbsp;assessed&nbsp;based&nbsp;on&nbsp;hypothetical&nbsp;worst-case&nbsp;chemical&nbsp;release&nbsp;(i.e.&nbsp;\u201cit&nbsp;all&nbsp;comes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">out\u201d).&nbsp;This&nbsp;assessment&nbsp;should&nbsp;include&nbsp;potential&nbsp;contaminants,&nbsp;degradants,&nbsp;processing&nbsp;aids&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additives&nbsp;which&nbsp;could&nbsp;be&nbsp;introduced&nbsp;by&nbsp;the&nbsp;manufacturing&nbsp;process.&nbsp;If&nbsp;an&nbsp;assessment&nbsp;based&nbsp;on&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">hypothetical&nbsp;worst-case&nbsp;chemical&nbsp;release&nbsp;leads&nbsp;to&nbsp;the&nbsp;conclusion&nbsp;that&nbsp;there&nbsp;is&nbsp;an&nbsp;acceptable&nbsp;risk,&nbsp;then</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;process&nbsp;can&nbsp;be&nbsp;completed&nbsp;with&nbsp;the&nbsp;collection&nbsp;or&nbsp;generation&nbsp;of&nbsp;a&nbsp;minimum&nbsp;amount&nbsp;of&nbsp;information.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">On&nbsp;the&nbsp;other&nbsp;hand,&nbsp;if&nbsp;the&nbsp;conclusion&nbsp;of&nbsp;acceptable&nbsp;health&nbsp;risk&nbsp;cannot&nbsp;be&nbsp;supported,&nbsp;then&nbsp;additional&nbsp;data</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">shall&nbsp;be&nbsp;collected,&nbsp;following&nbsp;a&nbsp;step-wise&nbsp;process&nbsp;from&nbsp;determining&nbsp;and&nbsp;evaluating&nbsp;the&nbsp;medical&nbsp;device\u2019s</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">hypothetical&nbsp;worst-case&nbsp;chemical&nbsp;release&nbsp;to&nbsp;the&nbsp;actual&nbsp;chemical&nbsp;release&nbsp;under&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;any&nbsp;and&nbsp;all&nbsp;cases,&nbsp;the&nbsp;information&nbsp;collected&nbsp;shall&nbsp;reflect&nbsp;(or&nbsp;exceed)&nbsp;and&nbsp;be&nbsp;assessed&nbsp;according&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;conditions&nbsp;of&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;using&nbsp;the&nbsp;flowcharts,&nbsp;it&nbsp;is&nbsp;not&nbsp;always&nbsp;necessary&nbsp;to&nbsp;complete&nbsp;all&nbsp;steps&nbsp;in&nbsp;the&nbsp;entire&nbsp;sequence;&nbsp;thus,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">flowchart&nbsp;system&nbsp;has&nbsp;multiple&nbsp;points&nbsp;of&nbsp;exit.&nbsp;For&nbsp;example,&nbsp;if&nbsp;one&nbsp;can&nbsp;demonstrate&nbsp;that&nbsp;a&nbsp;hypothetical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exposure&nbsp;to&nbsp;all&nbsp;of&nbsp;the&nbsp;chemical&nbsp;constituents&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;presents&nbsp;an&nbsp;acceptable&nbsp;health&nbsp;risk,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additional&nbsp;chemical&nbsp;testing&nbsp;is&nbsp;not&nbsp;necessary,&nbsp;the&nbsp;characterization&nbsp;is&nbsp;complete&nbsp;and&nbsp;the&nbsp;flowcharts&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exited&nbsp;and&nbsp;biological&nbsp;evaluation&nbsp;continued&nbsp;according&nbsp;to&nbsp;ISO\u00a010993-1.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">8\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;flowchart&nbsp;can&nbsp;be&nbsp;entered&nbsp;and&nbsp;exited&nbsp;at&nbsp;multiple&nbsp;points.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a01\u00a0\u2014&nbsp;General&nbsp;chemical&nbsp;characterization&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to16__3\"></td><td class=\"diff_header\" id=\"from16_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_106\">106</td><td nowrap=\"nowrap\">9</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_45\">45</td><td nowrap=\"nowrap\">9</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_107\">107</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_46\">46</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_108\">108</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_47\">47</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_109\">109</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_48\">48</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to16__4\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__4\">n</a></td><td class=\"diff_header\" id=\"to16_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;relevance&nbsp;of&nbsp;the&nbsp;harm&nbsp;shall&nbsp;be&nbsp;determined&nbsp;from&nbsp;information&nbsp;on&nbsp;the&nbsp;intended&nbsp;use&nbsp;of&nbsp;the&nbsp;medical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_add\">device,&nbsp;based&nbsp;on&nbsp;its&nbsp;categorization&nbsp;in&nbsp;accordance&nbsp;with&nbsp;ISO&nbsp;10993-1:2018,&nbsp;Clause\u00a0&nbsp;5&nbsp;and&nbsp;6.2,&nbsp;taking</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_add\">into&nbsp;account&nbsp;its&nbsp;exposure&nbsp;scenario&nbsp;(see&nbsp;6.2.1)&nbsp;and&nbsp;reasonably&nbsp;foreseeable&nbsp;sequences&nbsp;or&nbsp;combinations</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_add\">of&nbsp;events&nbsp;related&nbsp;to&nbsp;medical&nbsp;device&nbsp;use&nbsp;that&nbsp;can&nbsp;result&nbsp;in&nbsp;harm&nbsp;to&nbsp;health&nbsp;(refer&nbsp;to&nbsp;the&nbsp;applicable</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_add\">requirements&nbsp;in&nbsp;ISO&nbsp;14971).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Types&nbsp;of&nbsp;exposure&nbsp;or&nbsp;contact&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;topical,&nbsp;dermal,&nbsp;oral,&nbsp;gastrointestinal,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_add\">inhalation,&nbsp;respiratory,&nbsp;subcutaneous,&nbsp;intramuscular,&nbsp;bone,&nbsp;intravenous&nbsp;or&nbsp;blood,&nbsp;neural&nbsp;tissues.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Reasonably&nbsp;foreseeable&nbsp;means&nbsp;sequences&nbsp;or&nbsp;combinations&nbsp;of&nbsp;events&nbsp;related&nbsp;to&nbsp;medical&nbsp;device&nbsp;use&nbsp;that</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_add\">can&nbsp;result&nbsp;in&nbsp;harm&nbsp;to&nbsp;health&nbsp;(when&nbsp;TTC&nbsp;is&nbsp;applied).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_add\">If&nbsp;the&nbsp;harm&nbsp;is&nbsp;not&nbsp;relevant&nbsp;to&nbsp;the&nbsp;intended&nbsp;use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device,&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;is&nbsp;negligible,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_add\">and&nbsp;can&nbsp;be&nbsp;evaluated&nbsp;as&nbsp;acceptable.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5.1.3</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Risk&nbsp;estimation</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;toxicological&nbsp;risk&nbsp;shall&nbsp;be&nbsp;estimated&nbsp;when&nbsp;exposure&nbsp;to&nbsp;a&nbsp;constituent&nbsp;can&nbsp;exceed&nbsp;a&nbsp;pre-determined</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_add\">level&nbsp;that&nbsp;can&nbsp;result&nbsp;in&nbsp;a&nbsp;relevant&nbsp;harm&nbsp;under&nbsp;the&nbsp;anticipated&nbsp;worst-case&nbsp;conditions&nbsp;of&nbsp;medical&nbsp;device</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_add\">use.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;toxicological&nbsp;risk&nbsp;is&nbsp;negligible&nbsp;when&nbsp;the&nbsp;total&nbsp;quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;that&nbsp;is&nbsp;present&nbsp;in,&nbsp;on&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_add\">extracted&nbsp;from&nbsp;the&nbsp;medical&nbsp;device&nbsp;is&nbsp;at&nbsp;or&nbsp;below&nbsp;the&nbsp;toxicological&nbsp;screening&nbsp;limit&nbsp;(see&nbsp;6.2.2),&nbsp;or&nbsp;worst-</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_add\">case&nbsp;estimated&nbsp;exposure&nbsp;dose&nbsp;is&nbsp;below&nbsp;the&nbsp;applicable&nbsp;TTC&nbsp;value&nbsp;(see&nbsp;7.2),&nbsp;or&nbsp;the&nbsp;worst-case&nbsp;estimated</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;dose&nbsp;is&nbsp;below&nbsp;the&nbsp;tolerable&nbsp;contact&nbsp;level&nbsp;or&nbsp;tolerable&nbsp;intake&nbsp;(see&nbsp;Clauses\u00a08,&nbsp;9&nbsp;and\u00a010).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;risk&nbsp;estimation&nbsp;includes&nbsp;the&nbsp;following&nbsp;activities:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;constituent-specific&nbsp;TCL&nbsp;or&nbsp;TI&nbsp;is&nbsp;derived&nbsp;based&nbsp;on&nbsp;conservative&nbsp;assumptions&nbsp;(see&nbsp;7.1)&nbsp;or,&nbsp;if&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent-specific&nbsp;POD&nbsp;is&nbsp;not&nbsp;available,&nbsp;a&nbsp;TTC&nbsp;(if&nbsp;applicable)&nbsp;is&nbsp;applied&nbsp;(see&nbsp;7.2);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;worst-case&nbsp;estimated&nbsp;exposure&nbsp;dose&nbsp;for&nbsp;the&nbsp;constituent&nbsp;(see&nbsp;Clause\u00a08);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;MoS,&nbsp;where&nbsp;appropriate&nbsp;(see&nbsp;Clause\u00a09).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Risk&nbsp;estimation&nbsp;is&nbsp;a&nbsp;process&nbsp;used&nbsp;to&nbsp;assign&nbsp;values&nbsp;to&nbsp;the&nbsp;probability&nbsp;of&nbsp;occurrence&nbsp;of&nbsp;harm&nbsp;and&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_add\">severity&nbsp;of&nbsp;that&nbsp;harm&nbsp;(see&nbsp;ISO&nbsp;14971:2019,&nbsp;3.22&nbsp;and&nbsp;A.2.5.5).&nbsp;For&nbsp;medical&nbsp;devices&nbsp;for&nbsp;which&nbsp;any&nbsp;harm&nbsp;due&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicity&nbsp;is&nbsp;considered&nbsp;unacceptable,&nbsp;assigning&nbsp;a&nbsp;value&nbsp;for&nbsp;severity&nbsp;is&nbsp;not&nbsp;necessary.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Risk&nbsp;acceptability&nbsp;shall&nbsp;be&nbsp;based&nbsp;on&nbsp;pre-determined&nbsp;risk&nbsp;acceptability&nbsp;criteria&nbsp;in&nbsp;accordance&nbsp;with</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;14971:2019,&nbsp;4.4&nbsp;d)&nbsp;and&nbsp;ISO&nbsp;10993-1:2018,&nbsp;7&nbsp;b).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;MoS&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;evaluate&nbsp;whether&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;acceptability&nbsp;criteria&nbsp;are&nbsp;met&nbsp;(see</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Clause\u00a09&nbsp;and&nbsp;Clause\u00a010).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;exposure&nbsp;to&nbsp;a&nbsp;constituent&nbsp;does&nbsp;not&nbsp;meet&nbsp;the&nbsp;acceptability&nbsp;criteria,&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;shall&nbsp;be</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_add\">further&nbsp;addressed&nbsp;(see&nbsp;10.2).</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to16__4\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_110\">110</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_91\">91</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to16__top\">t</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to16__top\">t</a></td><td class=\"diff_header\" id=\"to16_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_add\">10</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_111\">111</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">8</span>:202<span class=\"diff_chg\">0</span>(E)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_96\">96</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">7</span>:202<span class=\"diff_chg\">3</span>(E)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;addition&nbsp;to&nbsp;multiple&nbsp;possible&nbsp;exit&nbsp;points,&nbsp;the&nbsp;flowchart&nbsp;system&nbsp;also&nbsp;has&nbsp;multiple&nbsp;points&nbsp;of&nbsp;entry.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Key</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">While&nbsp;the&nbsp;first&nbsp;actions&nbsp;taken&nbsp;in&nbsp;the&nbsp;flowcharts&nbsp;can&nbsp;facilitate&nbsp;the&nbsp;later&nbsp;actions&nbsp;in&nbsp;the&nbsp;flowcharts,&nbsp;they</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Tox.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;not&nbsp;necessarily&nbsp;prerequisites&nbsp;for&nbsp;those&nbsp;further&nbsp;actions.&nbsp;For&nbsp;example,&nbsp;although&nbsp;knowing&nbsp;a&nbsp;device\u2019s</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">configuration&nbsp;and&nbsp;material&nbsp;composition&nbsp;(including&nbsp;potential&nbsp;impurities)&nbsp;might&nbsp;facilitate&nbsp;establishing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">its&nbsp;leachables&nbsp;profile,&nbsp;the&nbsp;leachables&nbsp;profile&nbsp;can&nbsp;be&nbsp;delineated&nbsp;without&nbsp;configuration&nbsp;and&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL&nbsp;or&nbsp;TTC&nbsp;are&nbsp;not&nbsp;applicable&nbsp;to&nbsp;cohort&nbsp;of&nbsp;concern,&nbsp;excluded&nbsp;compounds,&nbsp;irritation&nbsp;or&nbsp;other&nbsp;endpoints&nbsp;(see</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information.&nbsp;Thus,&nbsp;if&nbsp;a&nbsp;sponsor&nbsp;has&nbsp;reason&nbsp;to&nbsp;believe&nbsp;that&nbsp;a&nbsp;leachables&nbsp;assessment&nbsp;will&nbsp;be&nbsp;necessary&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO/TS&nbsp;21726).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">most&nbsp;relevant&nbsp;(e.g.&nbsp;for&nbsp;certain&nbsp;indirect&nbsp;contact&nbsp;medical&nbsp;devices)&nbsp;to&nbsp;properly&nbsp;and&nbsp;completely&nbsp;establish</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;medical&nbsp;device\u2019s&nbsp;toxicological&nbsp;risk,&nbsp;then&nbsp;compositional&nbsp;profiling&nbsp;and&nbsp;extractables&nbsp;studies&nbsp;need&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Adequacy&nbsp;of&nbsp;constituent&nbsp;identity&nbsp;for&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;informed&nbsp;by&nbsp;the&nbsp;experts&nbsp;involved&nbsp;in&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;conducted.&nbsp;Likewise,&nbsp;available&nbsp;knowledge&nbsp;of&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;composition&nbsp;can&nbsp;make&nbsp;it&nbsp;clear&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;risk&nbsp;assessment.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;extractables&nbsp;study&nbsp;is&nbsp;likely&nbsp;to&nbsp;produce&nbsp;an&nbsp;extracted&nbsp;substance&nbsp;above&nbsp;an&nbsp;acceptable&nbsp;threshold;&nbsp;in&nbsp;this</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_add\">b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">case,&nbsp;it&nbsp;can&nbsp;be&nbsp;appropriate&nbsp;to&nbsp;skip&nbsp;the&nbsp;extractables&nbsp;study&nbsp;and&nbsp;proceed&nbsp;directly&nbsp;to&nbsp;a&nbsp;leachables&nbsp;study.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Harms&nbsp;specified&nbsp;in&nbsp;this&nbsp;document&nbsp;may&nbsp;be&nbsp;addressed&nbsp;by&nbsp;other&nbsp;approaches&nbsp;described&nbsp;in&nbsp;ISO\u00a010993-1&nbsp;and&nbsp;other</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;multiple&nbsp;entry&nbsp;and&nbsp;exit&nbsp;approach&nbsp;is&nbsp;proper&nbsp;and&nbsp;justifiable&nbsp;as&nbsp;the&nbsp;flowchart&nbsp;system&nbsp;is&nbsp;constructed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_add\">applicable&nbsp;parts&nbsp;of&nbsp;the&nbsp;ISO\u00a010993&nbsp;series.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;that&nbsp;each&nbsp;successive&nbsp;step&nbsp;gets&nbsp;closer&nbsp;to&nbsp;establishing&nbsp;the&nbsp;actual&nbsp;clinical&nbsp;exposure&nbsp;to&nbsp;leachables&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_125\">125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">thus&nbsp;gets&nbsp;closer&nbsp;to&nbsp;establishing&nbsp;the&nbsp;actual&nbsp;risk.&nbsp;Entering&nbsp;the&nbsp;process&nbsp;at&nbsp;an&nbsp;intermediate&nbsp;point&nbsp;can&nbsp;still</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_110\">110</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assure&nbsp;that&nbsp;the&nbsp;most&nbsp;accurate&nbsp;estimate&nbsp;of&nbsp;exposure&nbsp;is&nbsp;produced&nbsp;for&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;If&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">alternative&nbsp;entry&nbsp;to&nbsp;the&nbsp;flow&nbsp;chart&nbsp;(i.e.&nbsp;other&nbsp;than&nbsp;\u201cstart&nbsp;at&nbsp;the&nbsp;beginning\u201d)&nbsp;is&nbsp;taken,&nbsp;it&nbsp;shall&nbsp;be&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_add\">11</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from16_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additional&nbsp;general&nbsp;guidance&nbsp;on&nbsp;chemical&nbsp;characterization&nbsp;is&nbsp;provided&nbsp;in&nbsp;Annex\u00a0A.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_add\">c</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;identity&nbsp;of&nbsp;a&nbsp;reportable&nbsp;constituent&nbsp;cannot&nbsp;be&nbsp;adequately&nbsp;elucidated&nbsp;and&nbsp;its&nbsp;worst-case&nbsp;exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_add\">dose&nbsp;cannot&nbsp;be&nbsp;estimated,&nbsp;biological&nbsp;testing&nbsp;may&nbsp;be&nbsp;necessary&nbsp;to&nbsp;address&nbsp;the&nbsp;applicable&nbsp;biological&nbsp;risk(s).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_add\">d</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;determination&nbsp;that&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;criteria&nbsp;are&nbsp;met&nbsp;is&nbsp;specific&nbsp;to&nbsp;the&nbsp;constituent&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_add\">endpoint(s)&nbsp;addressed&nbsp;per&nbsp;this&nbsp;document&nbsp;and&nbsp;does&nbsp;not&nbsp;infer&nbsp;that&nbsp;all&nbsp;biological&nbsp;risks&nbsp;associated&nbsp;with&nbsp;a&nbsp;medical&nbsp;device</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_add\">are&nbsp;acceptable.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to16_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Figure\u00a01\u00a0\u2014&nbsp;Toxicological&nbsp;risk&nbsp;assessment&nbsp;within&nbsp;the&nbsp;biological&nbsp;evaluation&nbsp;process</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "5.10",
    "change_type": "deleted",
    "old_text": "5.10\tExiting the chemical characterization process\nIf the chemical characterization supports equivalence, or a toxicological risk assessment conclusion\n(per ISO\u00a010993-17) that constituents, extractables, or leachables present an acceptable health risk, then\nthe chemical characterization process has been completed and this outcome can be used to support\nbiological evaluation under ISO\u00a010993-1.\nIf the chemical characterization does not support a toxicological risk assessment conclusion (per\nISO\u00a0 10993-17) that constituents, extractables, or leachables present an acceptable health risk, the\nchemical characterization process has been completed but cannot be used to support biological\nevaluation. The need for further assessment (e.g. biological testing) or other mitigation activity should\nbe evaluated per ISO\u00a010993-1 and ISO\u00a010993-17.",
    "new_text": "",
    "change_text": "5.10\tExiting the chemical characterization process\nIf the chemical characterization supports equivalence, or a toxicological risk assessment conclusion\n(per ISO\u00a010993-17) that constituents, extractables, or leachables present an acceptable health risk, then\nthe chemical characterization process has been completed and this outcome can be used to support\nbiological evaluation under ISO\u00a010993-1.\nIf the chemical characterization does not support a toxicological risk assessment conclusion (per\nISO\u00a0 10993-17) that constituents, extractables, or leachables present an acceptable health risk, the\nchemical characterization process has been completed but cannot be used to support biological\nevaluation. The need for further assessment (e.g. biological testing) or other mitigation activity should\nbe evaluated per ISO\u00a010993-1 and ISO\u00a010993-17."
  },
  {
    "clause_id": "5.2",
    "change_type": "modified",
    "old_text": "5.2 Establish medical device configuration and material composition\n5.2.1\nGeneral\nA medical device\u2019s ability to interact with a potentially affected individual requires contact, as\nestablished in ISO 10993-1. For medical devices (or components) that do not have direct or indirect\ncontact with the body, chemical characterization is not necessary. The hypothetical worst-case\nchemical release is established by the configuration and composition of the medical device. Thus, the\nfirst step is to compile all required chemical information related to the configuration and composition\nof the medical device and its materials of construction. This information is secured either from an\nappropriate source (e.g. material\u2019s vendor) or via appropriate compositional testing.\nThe medical device shall be described and its configuration, its intended purpose, and its clinical use\nshall be documented. This shall include its individual materials of construction, the proportion of those\nmaterials (e.g. by surface area or weight) in the device, and its physical structure (including surface\nproperties such as topography and chemistry, where applicable). Providing the geometric distribution\nof the materials within the medical device (medical device configuration) is relevant as such a structural\ndescription establishes the nature of contact, if any, between individual materials of construction and\nthe potentially affected individual.\nOnce the medical device configuration has been established, each material of construction in direct or\nindirect contact should be compositionally described and its intended interaction with body tissues and\nfluids established. A documented, qualitative description of the known composition of each material of\nconstruction and known additives and processing residues from manufacturing activities is required.\nAdditional guidance on preparing a qualitative description can be found in ISO\u00a010993-1 and Annex\u00a0B.\nThe amount of detail in the qualitative and/or quantitative compositional data provided/required (e.g.\nthe levels of additives and residuals in the material) shall reflect the potential safety risk associated\nwith the medical device and its materials (see ISO\u00a010993-1:2018, 6.1). For example, long-term contact\ndevices need more detail than limited contact devices and implanted devices need more detail than\nsurface devices. The amount of and detail in the provided compositional data shall be justified. The\neffect of processing (including sterilization) of the materials and the medical device shall be considered.\nThe qualitative description of each material shall include details of trade name or specification number,\nsupplier name and material specification (e.g. formulation disclosure, certificate of analysis, technical\ndata sheet, safety data sheet) to the extent that such information can be secured and is relevant. The\nuse of a standardised material, e.g. ISO\u00a0 5832 series, in its intended use is considered to meet this\nrequirement.\n\ufeff\n10\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n5.2.2\nInformation gathering\nMedical device manufacturers should preferably obtain qualitative and quantitative compositional\ninformation about materials from the supplier of the starting material. Qualitative information about\nany additional processing additives, for example, mould release agents, should also be obtained from\nappropriate members of the manufacturing chain, including convertors and component suppliers. In\nthe absence of sufficient supplier information, such information should be obtained by chemical testing\n(e.g. compositional, extractables, or leachables testing). The information obtained can be sufficient to\nidentify all biological hazards arising from the chemical constituents of the material for inclusion in\nthe toxicological risk assessment (see ISO\u00a0 10993-1). Information on whether any constituents from\nthe cohort of concern (see E.6) are likely to be present is important if extractables testing with a TTC\napproach may be planned (see ISO/TS 21726).\nThe biological evaluation considers data from several datasets alongside those derived from chemical\ncharacterization. Thus, the inability to obtain such information from suppliers does not necessarily\nprevent the biological evaluation. However, when a toxicological hazard has been identified, information\ngaps that would prevent a toxicological risk assessment shall either be filled or otherwise addressed.\nThe composition of materials used in medical devices shall either be documented in accordance with\napplicable materials standards or shall be specified by the medical device manufacturer.\nNOTE\nThe supplier can be a useful source of appropriate material composition information. In the absence\nof any initial compositional data, a literature study to establish the likely nature of the starting material and any\nadditives is recommended.\n5.2.3\nInformation generation\nCompositional testing of the medical device and/or its materials of construction can be needed to\nsupplement any information gaps and to provide the necessary quantitative information on materials\nand chemical constituents.\nNOTE\nAs stated in ISO\u00a0 10993-1:2018, 6.1, \u201cThe extent of physical and/or chemical characterization\nrequired depends on what is known about the material formulation, what nonclinical and clinical safety and\ntoxicological data exist, and on the nature and duration of body contact with the medical device. At a minimum,\nthe characterization shall address the constituent chemicals of the medical device and possible residual process\naids or additives used in its manufacture.\u201d\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n11\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nFigure\u00a02\u00a0\u2014 Compositional profiling process",
    "new_text": "5.2\t Toxicological risk assessment process\nFigure\u00a02 shows in detail the toxicological risk assessment process that is shown in Figure\u00a01. Critical\ntoxicological risk assessment activities described in this document are illustrated in Figure\u00a02.\nThe toxicological risk assessment process requires that[12][13][14]:\na)\t The following information shall be provided (see Clause\u00a06), in accordance with ISO 10993-1 and\nISO 10993-18:\n\u2014\t a description of the device (e.g. an illustration of the device and identification of its materials of\nconstruction that contact the body);\n\u2014\t a description of the intended use of the medical device (e.g. indications, contraindications,\nclinical use conditions, route of exposure, patient population, duration and frequency of use),\nfrom which the worst-case intended clinical use scenario shall be determined;\n\u2014\t the identity and quantity of each reportable constituent (e.g. molecular structure or CAS RN)\nobtained in accordance with ISO 10993-18.\nb)\t The toxicity of each constituent shall be characterized (see 6.1 and 6.2), based on a systematic\nreview of available toxicological information that takes into account:\n\u2014\t the nature of the harm(s) to health;\n\u2014\t the relationship between exposure and harm (i.e. dose-response relationship and the influence\nof the route and duration of exposure).\nc)\nThe toxicological risk shall be assessed for each constituent by either:\n\u2014\t determining that the constituent is not capable of eliciting harm that is relevant to the intended\nuse of the medical device (see 6.2), or\n\u2014\t determining that the total quantity of a constituent is too low to elicit appreciable harm to\nhealth (see 6.2.1 or 6.2.2), or\n\u2014\t determining that the worst-case estimated exposure dose for each constituent present in, on, or\nreleased from the medical device is below its TCL or TI (see Clauses\u00a07, 8 and 9), or\n\u2014\t determining that the quantity of a constituent released is below the relevant TTC value (if\napplicable; see 7.2).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n12\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\na\nHarm relevant to a toxicological risk assessment of a constituent in, on or released from a medical\ndevice of a given categorization are determined in ISO 10993-1.\nb\nTSL or TTC are not applicable to the cohorts of concern, excluded compounds, irritation or other\nexcluded endpoints as described in ISO/TS\u00a021726:2019, 5.3.\nFigure\u00a02\u00a0\u2014 Critical toxicological risk assessment activities\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n13\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)",
    "change_text": "5.2\t Toxicological risk assessment process\nFigure\u00a02 shows in detail the toxicological risk assessment process that is shown in Figure\u00a01. Critical\ntoxicological risk assessment activities described in this document are illustrated in Figure\u00a02.\nThe toxicological risk assessment process requires that[12][13][14]:\na)\t The following information shall be provided (see Clause\u00a06), in accordance with ISO 10993-1 and\nISO 10993-18:\n\u2014\t a description of the device (e.g. an illustration of the device and identification of its materials of\nconstruction that contact the body);\n\u2014\t a description of the intended use of the medical device (e.g. indications, contraindications,\nclinical use conditions, route of exposure, patient population, duration and frequency of use),\nfrom which the worst-case intended clinical use scenario shall be determined;\n\u2014\t the identity and quantity of each reportable constituent (e.g. molecular structure or CAS RN)\nobtained in accordance with ISO 10993-18.\nb)\t The toxicity of each constituent shall be characterized (see 6.1 and 6.2), based on a systematic\nreview of available toxicological information that takes into account:\n\u2014\t the nature of the harm(s) to health;\n\u2014\t the relationship between exposure and harm (i.e. dose-response relationship and the influence\nof the route and duration of exposure).\nc)\nThe toxicological risk shall be assessed for each constituent by either:\n\u2014\t determining that the constituent is not capable of eliciting harm that is relevant to the intended\nuse of the medical device (see 6.2), or\n\u2014\t determining that the total quantity of a constituent is too low to elicit appreciable harm to\nhealth (see 6.2.1 or 6.2.2), or\n\u2014\t determining that the worst-case estimated exposure dose for each constituent present in, on, or\nreleased from the medical device is below its TCL or TI (see Clauses\u00a07, 8 and 9), or\n\u2014\t determining that the quantity of a constituent released is below the relevant TTC value (if\napplicable; see 7.2).\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n12\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\na\nHarm relevant to a toxicological risk assessment of a constituent in, on or released from a medical\ndevice of a given categorization are determined in ISO 10993-1.\nb\nTSL or TTC are not applicable to the cohorts of concern, excluded compounds, irritation or other\nexcluded endpoints as described in ISO/TS\u00a021726:2019, 5.3.\nFigure\u00a02\u00a0\u2014 Critical toxicological risk assessment activities\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n13\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to17__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__0\"><a href=\"#difflib_chg_to17__1\">n</a></td><td class=\"diff_header\" id=\"from17_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5.2&nbsp;Establish&nbsp;medical&nbsp;device&nbsp;configuration&nbsp;and&nbsp;material&nbsp;composition</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__1\">n</a></td><td class=\"diff_header\" id=\"to17_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Toxicological&nbsp;risk&nbsp;assessment&nbsp;process</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5.2.1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Figure\u00a02&nbsp;shows&nbsp;in&nbsp;detail&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;process&nbsp;that&nbsp;is&nbsp;shown&nbsp;in&nbsp;Figure\u00a01.&nbsp;Critical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxicological&nbsp;risk&nbsp;assessment&nbsp;activities&nbsp;described&nbsp;in&nbsp;this&nbsp;document&nbsp;are&nbsp;illustrated&nbsp;in&nbsp;Figure\u00a02.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A&nbsp;medical&nbsp;device\u2019s&nbsp;ability&nbsp;to&nbsp;interact&nbsp;with&nbsp;a&nbsp;potentially&nbsp;affected&nbsp;individual&nbsp;requires&nbsp;contact,&nbsp;as</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;process&nbsp;requires&nbsp;that[12][13][14]:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">established&nbsp;in&nbsp;ISO&nbsp;10993-1.&nbsp;For&nbsp;medical&nbsp;devices&nbsp;(or&nbsp;components)&nbsp;that&nbsp;do&nbsp;not&nbsp;have&nbsp;direct&nbsp;or&nbsp;indirect</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;following&nbsp;information&nbsp;shall&nbsp;be&nbsp;provided&nbsp;(see&nbsp;Clause\u00a06),&nbsp;in&nbsp;accordance&nbsp;with&nbsp;ISO&nbsp;10993-1&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contact&nbsp;with&nbsp;the&nbsp;body,&nbsp;chemical&nbsp;characterization&nbsp;is&nbsp;not&nbsp;necessary.&nbsp;The&nbsp;hypothetical&nbsp;worst-case</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-18:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;release&nbsp;is&nbsp;established&nbsp;by&nbsp;the&nbsp;configuration&nbsp;and&nbsp;composition&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.&nbsp;Thus,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;description&nbsp;of&nbsp;the&nbsp;device&nbsp;(e.g.&nbsp;an&nbsp;illustration&nbsp;of&nbsp;the&nbsp;device&nbsp;and&nbsp;identification&nbsp;of&nbsp;its&nbsp;materials&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">first&nbsp;step&nbsp;is&nbsp;to&nbsp;compile&nbsp;all&nbsp;required&nbsp;chemical&nbsp;information&nbsp;related&nbsp;to&nbsp;the&nbsp;configuration&nbsp;and&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">construction&nbsp;that&nbsp;contact&nbsp;the&nbsp;body);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction.&nbsp;This&nbsp;information&nbsp;is&nbsp;secured&nbsp;either&nbsp;from&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;description&nbsp;of&nbsp;the&nbsp;intended&nbsp;use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;(e.g.&nbsp;indications,&nbsp;contraindications,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;source&nbsp;(e.g.&nbsp;material\u2019s&nbsp;vendor)&nbsp;or&nbsp;via&nbsp;appropriate&nbsp;compositional&nbsp;testing.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">clinical&nbsp;use&nbsp;conditions,&nbsp;route&nbsp;of&nbsp;exposure,&nbsp;patient&nbsp;population,&nbsp;duration&nbsp;and&nbsp;frequency&nbsp;of&nbsp;use),</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;medical&nbsp;device&nbsp;shall&nbsp;be&nbsp;described&nbsp;and&nbsp;its&nbsp;configuration,&nbsp;its&nbsp;intended&nbsp;purpose,&nbsp;and&nbsp;its&nbsp;clinical&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">from&nbsp;which&nbsp;the&nbsp;worst-case&nbsp;intended&nbsp;clinical&nbsp;use&nbsp;scenario&nbsp;shall&nbsp;be&nbsp;determined;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">shall&nbsp;be&nbsp;documented.&nbsp;This&nbsp;shall&nbsp;include&nbsp;its&nbsp;individual&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;the&nbsp;proportion&nbsp;of&nbsp;those</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;identity&nbsp;and&nbsp;quantity&nbsp;of&nbsp;each&nbsp;reportable&nbsp;constituent&nbsp;(e.g.&nbsp;molecular&nbsp;structure&nbsp;or&nbsp;CAS&nbsp;RN)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">materials&nbsp;(e.g.&nbsp;by&nbsp;surface&nbsp;area&nbsp;or&nbsp;weight)&nbsp;in&nbsp;the&nbsp;device,&nbsp;and&nbsp;its&nbsp;physical&nbsp;structure&nbsp;(including&nbsp;surface</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">obtained&nbsp;in&nbsp;accordance&nbsp;with&nbsp;ISO&nbsp;10993-18.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">properties&nbsp;such&nbsp;as&nbsp;topography&nbsp;and&nbsp;chemistry,&nbsp;where&nbsp;applicable).&nbsp;Providing&nbsp;the&nbsp;geometric&nbsp;distribution</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;toxicity&nbsp;of&nbsp;each&nbsp;constituent&nbsp;shall&nbsp;be&nbsp;characterized&nbsp;(see&nbsp;6.1&nbsp;and&nbsp;6.2),&nbsp;based&nbsp;on&nbsp;a&nbsp;systematic</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;materials&nbsp;within&nbsp;the&nbsp;medical&nbsp;device&nbsp;(medical&nbsp;device&nbsp;configuration)&nbsp;is&nbsp;relevant&nbsp;as&nbsp;such&nbsp;a&nbsp;structural</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">review&nbsp;of&nbsp;available&nbsp;toxicological&nbsp;information&nbsp;that&nbsp;takes&nbsp;into&nbsp;account:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">description&nbsp;establishes&nbsp;the&nbsp;nature&nbsp;of&nbsp;contact,&nbsp;if&nbsp;any,&nbsp;between&nbsp;individual&nbsp;materials&nbsp;of&nbsp;construction&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;nature&nbsp;of&nbsp;the&nbsp;harm(s)&nbsp;to&nbsp;health;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;potentially&nbsp;affected&nbsp;individual.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;relationship&nbsp;between&nbsp;exposure&nbsp;and&nbsp;harm&nbsp;(i.e.&nbsp;dose-response&nbsp;relationship&nbsp;and&nbsp;the&nbsp;influence</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Once&nbsp;the&nbsp;medical&nbsp;device&nbsp;configuration&nbsp;has&nbsp;been&nbsp;established,&nbsp;each&nbsp;material&nbsp;of&nbsp;construction&nbsp;in&nbsp;direct&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">of&nbsp;the&nbsp;route&nbsp;and&nbsp;duration&nbsp;of&nbsp;exposure).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">indirect&nbsp;contact&nbsp;should&nbsp;be&nbsp;compositionally&nbsp;described&nbsp;and&nbsp;its&nbsp;intended&nbsp;interaction&nbsp;with&nbsp;body&nbsp;tissues&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">c)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">fluids&nbsp;established.&nbsp;A&nbsp;documented,&nbsp;qualitative&nbsp;description&nbsp;of&nbsp;the&nbsp;known&nbsp;composition&nbsp;of&nbsp;each&nbsp;material&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;toxicological&nbsp;risk&nbsp;shall&nbsp;be&nbsp;assessed&nbsp;for&nbsp;each&nbsp;constituent&nbsp;by&nbsp;either:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;and&nbsp;known&nbsp;additives&nbsp;and&nbsp;processing&nbsp;residues&nbsp;from&nbsp;manufacturing&nbsp;activities&nbsp;is&nbsp;required.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining&nbsp;that&nbsp;the&nbsp;constituent&nbsp;is&nbsp;not&nbsp;capable&nbsp;of&nbsp;eliciting&nbsp;harm&nbsp;that&nbsp;is&nbsp;relevant&nbsp;to&nbsp;the&nbsp;intended</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additional&nbsp;guidance&nbsp;on&nbsp;preparing&nbsp;a&nbsp;qualitative&nbsp;description&nbsp;can&nbsp;be&nbsp;found&nbsp;in&nbsp;ISO\u00a010993-1&nbsp;and&nbsp;Annex\u00a0B.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;(see&nbsp;6.2),&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;amount&nbsp;of&nbsp;detail&nbsp;in&nbsp;the&nbsp;qualitative&nbsp;and/or&nbsp;quantitative&nbsp;compositional&nbsp;data&nbsp;provided/required&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining&nbsp;that&nbsp;the&nbsp;total&nbsp;quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;is&nbsp;too&nbsp;low&nbsp;to&nbsp;elicit&nbsp;appreciable&nbsp;harm&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;levels&nbsp;of&nbsp;additives&nbsp;and&nbsp;residuals&nbsp;in&nbsp;the&nbsp;material)&nbsp;shall&nbsp;reflect&nbsp;the&nbsp;potential&nbsp;safety&nbsp;risk&nbsp;associated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">health&nbsp;(see&nbsp;6.2.1&nbsp;or&nbsp;6.2.2),&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;its&nbsp;materials&nbsp;(see&nbsp;ISO\u00a010993-1:2018,&nbsp;6.1).&nbsp;For&nbsp;example,&nbsp;long-term&nbsp;contact</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining&nbsp;that&nbsp;the&nbsp;worst-case&nbsp;estimated&nbsp;exposure&nbsp;dose&nbsp;for&nbsp;each&nbsp;constituent&nbsp;present&nbsp;in,&nbsp;on,&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices&nbsp;need&nbsp;more&nbsp;detail&nbsp;than&nbsp;limited&nbsp;contact&nbsp;devices&nbsp;and&nbsp;implanted&nbsp;devices&nbsp;need&nbsp;more&nbsp;detail&nbsp;than</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">released&nbsp;from&nbsp;the&nbsp;medical&nbsp;device&nbsp;is&nbsp;below&nbsp;its&nbsp;TCL&nbsp;or&nbsp;TI&nbsp;(see&nbsp;Clauses\u00a07,&nbsp;8&nbsp;and&nbsp;9),&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">surface&nbsp;devices.&nbsp;The&nbsp;amount&nbsp;of&nbsp;and&nbsp;detail&nbsp;in&nbsp;the&nbsp;provided&nbsp;compositional&nbsp;data&nbsp;shall&nbsp;be&nbsp;justified.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining&nbsp;that&nbsp;the&nbsp;quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;released&nbsp;is&nbsp;below&nbsp;the&nbsp;relevant&nbsp;TTC&nbsp;value&nbsp;(if</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">effect&nbsp;of&nbsp;processing&nbsp;(including&nbsp;sterilization)&nbsp;of&nbsp;the&nbsp;materials&nbsp;and&nbsp;the&nbsp;medical&nbsp;device&nbsp;shall&nbsp;be&nbsp;considered.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_add\">applicable;&nbsp;see&nbsp;7.2).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;qualitative&nbsp;description&nbsp;of&nbsp;each&nbsp;material&nbsp;shall&nbsp;include&nbsp;details&nbsp;of&nbsp;trade&nbsp;name&nbsp;or&nbsp;specification&nbsp;number,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__1\"></td><td class=\"diff_header\" id=\"from17_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">supplier&nbsp;name&nbsp;and&nbsp;material&nbsp;specification&nbsp;(e.g.&nbsp;formulation&nbsp;disclosure,&nbsp;certificate&nbsp;of&nbsp;analysis,&nbsp;technical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">data&nbsp;sheet,&nbsp;safety&nbsp;data&nbsp;sheet)&nbsp;to&nbsp;the&nbsp;extent&nbsp;that&nbsp;such&nbsp;information&nbsp;can&nbsp;be&nbsp;secured&nbsp;and&nbsp;is&nbsp;relevant.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;of&nbsp;a&nbsp;standardised&nbsp;material,&nbsp;e.g.&nbsp;ISO\u00a0&nbsp;5832&nbsp;series,&nbsp;in&nbsp;its&nbsp;intended&nbsp;use&nbsp;is&nbsp;considered&nbsp;to&nbsp;meet&nbsp;this</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">requirement.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_34\">34</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_33\">33</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__2\"><a href=\"#difflib_chg_to17__2\">n</a></td><td class=\"diff_header\" id=\"from17_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">10\b</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__2\">n</a></td><td class=\"diff_header\" id=\"to17_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">12</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_37\">37</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_35\">35</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_38\">38</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_36\">36</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_39\">39</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_37\">37</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to17__3\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__3\">n</a></td><td class=\"diff_header\" id=\"to17_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_add\">a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Harm&nbsp;relevant&nbsp;to&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;a&nbsp;constituent&nbsp;in,&nbsp;on&nbsp;or&nbsp;released&nbsp;from&nbsp;a&nbsp;medical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_add\">device&nbsp;of&nbsp;a&nbsp;given&nbsp;categorization&nbsp;are&nbsp;determined&nbsp;in&nbsp;ISO&nbsp;10993-1.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_add\">b</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__3\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL&nbsp;or&nbsp;TTC&nbsp;are&nbsp;not&nbsp;applicable&nbsp;to&nbsp;the&nbsp;cohorts&nbsp;of&nbsp;concern,&nbsp;excluded&nbsp;compounds,&nbsp;irritation&nbsp;or&nbsp;other</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_add\">excluded&nbsp;endpoints&nbsp;as&nbsp;described&nbsp;in&nbsp;ISO/TS\u00a021726:2019,&nbsp;5.3.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Figure\u00a02\u00a0\u2014&nbsp;Critical&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;activities</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_40\">40</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_47\">47</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to17__4\">n</a></td><td class=\"diff_header\" id=\"from17_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__4\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5.2.2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Information&nbsp;gathering</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Medical&nbsp;device&nbsp;manufacturers&nbsp;should&nbsp;preferably&nbsp;obtain&nbsp;qualitative&nbsp;and&nbsp;quantitative&nbsp;compositional</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;about&nbsp;materials&nbsp;from&nbsp;the&nbsp;supplier&nbsp;of&nbsp;the&nbsp;starting&nbsp;material.&nbsp;Qualitative&nbsp;information&nbsp;about</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">any&nbsp;additional&nbsp;processing&nbsp;additives,&nbsp;for&nbsp;example,&nbsp;mould&nbsp;release&nbsp;agents,&nbsp;should&nbsp;also&nbsp;be&nbsp;obtained&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;members&nbsp;of&nbsp;the&nbsp;manufacturing&nbsp;chain,&nbsp;including&nbsp;convertors&nbsp;and&nbsp;component&nbsp;suppliers.&nbsp;In</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;absence&nbsp;of&nbsp;sufficient&nbsp;supplier&nbsp;information,&nbsp;such&nbsp;information&nbsp;should&nbsp;be&nbsp;obtained&nbsp;by&nbsp;chemical&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(e.g.&nbsp;compositional,&nbsp;extractables,&nbsp;or&nbsp;leachables&nbsp;testing).&nbsp;The&nbsp;information&nbsp;obtained&nbsp;can&nbsp;be&nbsp;sufficient&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identify&nbsp;all&nbsp;biological&nbsp;hazards&nbsp;arising&nbsp;from&nbsp;the&nbsp;chemical&nbsp;constituents&nbsp;of&nbsp;the&nbsp;material&nbsp;for&nbsp;inclusion&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(see&nbsp;ISO\u00a0&nbsp;10993-1).&nbsp;Information&nbsp;on&nbsp;whether&nbsp;any&nbsp;constituents&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;cohort&nbsp;of&nbsp;concern&nbsp;(see&nbsp;E.6)&nbsp;are&nbsp;likely&nbsp;to&nbsp;be&nbsp;present&nbsp;is&nbsp;important&nbsp;if&nbsp;extractables&nbsp;testing&nbsp;with&nbsp;a&nbsp;TTC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">approach&nbsp;may&nbsp;be&nbsp;planned&nbsp;(see&nbsp;ISO/TS&nbsp;21726).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;biological&nbsp;evaluation&nbsp;considers&nbsp;data&nbsp;from&nbsp;several&nbsp;datasets&nbsp;alongside&nbsp;those&nbsp;derived&nbsp;from&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization.&nbsp;Thus,&nbsp;the&nbsp;inability&nbsp;to&nbsp;obtain&nbsp;such&nbsp;information&nbsp;from&nbsp;suppliers&nbsp;does&nbsp;not&nbsp;necessarily</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">prevent&nbsp;the&nbsp;biological&nbsp;evaluation.&nbsp;However,&nbsp;when&nbsp;a&nbsp;toxicological&nbsp;hazard&nbsp;has&nbsp;been&nbsp;identified,&nbsp;information</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">gaps&nbsp;that&nbsp;would&nbsp;prevent&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;shall&nbsp;either&nbsp;be&nbsp;filled&nbsp;or&nbsp;otherwise&nbsp;addressed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;composition&nbsp;of&nbsp;materials&nbsp;used&nbsp;in&nbsp;medical&nbsp;devices&nbsp;shall&nbsp;either&nbsp;be&nbsp;documented&nbsp;in&nbsp;accordance&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">applicable&nbsp;materials&nbsp;standards&nbsp;or&nbsp;shall&nbsp;be&nbsp;specified&nbsp;by&nbsp;the&nbsp;medical&nbsp;device&nbsp;manufacturer.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;supplier&nbsp;can&nbsp;be&nbsp;a&nbsp;useful&nbsp;source&nbsp;of&nbsp;appropriate&nbsp;material&nbsp;composition&nbsp;information.&nbsp;In&nbsp;the&nbsp;absence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;any&nbsp;initial&nbsp;compositional&nbsp;data,&nbsp;a&nbsp;literature&nbsp;study&nbsp;to&nbsp;establish&nbsp;the&nbsp;likely&nbsp;nature&nbsp;of&nbsp;the&nbsp;starting&nbsp;material&nbsp;and&nbsp;any</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additives&nbsp;is&nbsp;recommended.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5.2.3</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Information&nbsp;generation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Compositional&nbsp;testing&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and/or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction&nbsp;can&nbsp;be&nbsp;needed&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">supplement&nbsp;any&nbsp;information&nbsp;gaps&nbsp;and&nbsp;to&nbsp;provide&nbsp;the&nbsp;necessary&nbsp;quantitative&nbsp;information&nbsp;on&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;chemical&nbsp;constituents.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;stated&nbsp;in&nbsp;ISO\u00a0&nbsp;10993-1:2018,&nbsp;6.1,&nbsp;\u201cThe&nbsp;extent&nbsp;of&nbsp;physical&nbsp;and/or&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__4\"></td><td class=\"diff_header\" id=\"from17_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">required&nbsp;depends&nbsp;on&nbsp;what&nbsp;is&nbsp;known&nbsp;about&nbsp;the&nbsp;material&nbsp;formulation,&nbsp;what&nbsp;nonclinical&nbsp;and&nbsp;clinical&nbsp;safety&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">toxicological&nbsp;data&nbsp;exist,&nbsp;and&nbsp;on&nbsp;the&nbsp;nature&nbsp;and&nbsp;duration&nbsp;of&nbsp;body&nbsp;contact&nbsp;with&nbsp;the&nbsp;medical&nbsp;device.&nbsp;At&nbsp;a&nbsp;minimum,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;characterization&nbsp;shall&nbsp;address&nbsp;the&nbsp;constituent&nbsp;chemicals&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;possible&nbsp;residual&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">aids&nbsp;or&nbsp;additives&nbsp;used&nbsp;in&nbsp;its&nbsp;manufacture.\u201d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_75\">75</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_48\">48</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to17__5\"><a href=\"#difflib_chg_to17__5\">n</a></td><td class=\"diff_header\" id=\"from17_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__5\">n</a></td><td class=\"diff_header\" id=\"to17_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_add\">13</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">11</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_78\">78</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_50\">50</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_79\">79</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_51\">51</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_80\">80</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_52\">52</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to17__top\">t</a></td><td class=\"diff_header\" id=\"from17_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to17__top\">t</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_82\">82</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">8</span>:202<span class=\"diff_chg\">0</span>(E)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to17_53\">53</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">7</span>:202<span class=\"diff_chg\">3</span>(E)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from17_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a02\u00a0\u2014&nbsp;Compositional&nbsp;profiling&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "5.3",
    "change_type": "deleted",
    "old_text": "5.3 Assess material/chemical equivalence to a clinically established material or\nmedical device\nWhen specified in the flowcharts, the information compiled in 5.2 shall be used to compare the medical\ndevice under consideration to another device that has been clinically established. Specifically, the\n\ufeff\n12\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\ninformation is used to determine whether the medical device under consideration is equivalent, in\nconfiguration, composition, manufacturing, processing and intended use, to a clinically established\nmedical device. Annex\u00a0C and ISO\u00a010993-1 present principles for judging equivalence.\nIn some cases (e.g. change in the material supplier for a component), demonstration of material\nequivalence can be sufficient. Enough qualitative and quantitative information shall be obtained to\ndetermine whether a material under consideration is equivalent, in composition (including impurities),\nphysical and chemical properties, processing and use, to a clinically established material. If a device\nor material is determined to be equivalent to a clinically established device or material, then that\ndetermination shall be justified and documented.\nWhen an equivalent clinically established medical device can be identified and justified for the device\nunder consideration, then the chemical characterization process shall be deemed to have been completed.\nWhen a clinically established equivalent medical device cannot be established and justified, then other\nelements of a biological evaluation in accordance with ISO\u00a0 10993-1 should be considered, including\nadditional chemical characterization, as established by the additional steps in the flowchart system.\nMaterial equivalence can be based on either material composition or extractable profile data compared\nto a clinically established material, provided that the analytical methods used to generate the data are\njustified.\nPhysical, chemical, morphological and topographical characteristics (see ISO/TS\u00a0 10993-19 and\nISO/TR\u00a0 10993-22 as applicable) should be considered as appropriate when determining material\nequivalence.",
    "new_text": "",
    "change_text": "5.3 Assess material/chemical equivalence to a clinically established material or\nmedical device\nWhen specified in the flowcharts, the information compiled in 5.2 shall be used to compare the medical\ndevice under consideration to another device that has been clinically established. Specifically, the\n\ufeff\n12\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\ninformation is used to determine whether the medical device under consideration is equivalent, in\nconfiguration, composition, manufacturing, processing and intended use, to a clinically established\nmedical device. Annex\u00a0C and ISO\u00a010993-1 present principles for judging equivalence.\nIn some cases (e.g. change in the material supplier for a component), demonstration of material\nequivalence can be sufficient. Enough qualitative and quantitative information shall be obtained to\ndetermine whether a material under consideration is equivalent, in composition (including impurities),\nphysical and chemical properties, processing and use, to a clinically established material. If a device\nor material is determined to be equivalent to a clinically established device or material, then that\ndetermination shall be justified and documented.\nWhen an equivalent clinically established medical device can be identified and justified for the device\nunder consideration, then the chemical characterization process shall be deemed to have been completed.\nWhen a clinically established equivalent medical device cannot be established and justified, then other\nelements of a biological evaluation in accordance with ISO\u00a0 10993-1 should be considered, including\nadditional chemical characterization, as established by the additional steps in the flowchart system.\nMaterial equivalence can be based on either material composition or extractable profile data compared\nto a clinically established material, provided that the analytical methods used to generate the data are\njustified.\nPhysical, chemical, morphological and topographical characteristics (see ISO/TS\u00a0 10993-19 and\nISO/TR\u00a0 10993-22 as applicable) should be considered as appropriate when determining material\nequivalence."
  },
  {
    "clause_id": "5.4",
    "change_type": "deleted",
    "old_text": "5.4\t Assess the hypothetical worst-case chemical release based on total exposure to the\nmedical device\u2019s chemical constituents\n5.4.1\nEstablish the hypothetical worst-case chemical release\nThe greatest potential chemical impact of a medical device would be achieved if the device\u2019s entire\ncomposition were to transfer to the potentially affected individual during clinical use. This would be\naccomplished, for example, if an implantable medical device were to dissolve during clinical use or if\nan externally communicating device were to be completely leached during clinical use. Accordingly,\nthe qualitative and quantitative data collected in 5.2 regarding the material or medical device\nconfiguration, materials of construction, process residuals and supplier information can be used to\nestablish the hypothetical worst-case chemical release, even if it is unlikely that this worst-case would\nhappen under the clinical conditions of use. Additional factors shall be considered when establishing\nhypothetical worst-case chemical release, such as the medical device size and the possible clinical use\nof multiple devices.\n5.4.2\nAssess the hypothetical worst-case chemical release\nThe health impact of the medical device\u2019s individual chemical constituents is assessed by providing\nthe hypothetical worst-case chemical release, established in 5.4.1 to a risk assessor to establish the\npotential adverse impact that the chemical constituents could have on the health of a potentially\naffected individual according to ISO 10993-1 and ISO 10993-17.\nWhen exposure to a medical device\u2019s entire composition can be established as being acceptable (e.g. by\ncomparing the exposure to a safety threshold established in 5.5), then the chemical characterization\nprocess shall be deemed to have been completed. The biological evaluation can then be completed\naccording to ISO\u00a010993-1. When exposure to a medical device\u2019s entire composition is established to be\npotentially unacceptable, then the chemical characterization process can be continued by moving to the\nnext step (see 5.5, 5.6 and Figure\u00a03). Alternatively, it can be appropriate to return to ISO\u00a010993-1:2018\nto continue forward with biological endpoint evaluation, if characterization information is not likely to\nprovide further benefit.\nNOTE\u00a01\nIn some cases, theoretical compositional profiling might not be sufficient (e.g. if degradation products\nand unintended contaminants during manufacture are likely).\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n13\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nNOTE\u00a02\nIt can be possible to evaluate biological safety of devices with low risk exposure (e.g. intact skin)\nbased on qualitative information on material composition, if the device is made of widely used materials having\nextensive history of clinical use and manufactured using the same methods (e.g. ISO implant grade stainless steel\nand common passivation and post passivation processing). In these cases, chemical analysis and toxicological\nrisk assessment might not be necessary.",
    "new_text": "",
    "change_text": "5.4\t Assess the hypothetical worst-case chemical release based on total exposure to the\nmedical device\u2019s chemical constituents\n5.4.1\nEstablish the hypothetical worst-case chemical release\nThe greatest potential chemical impact of a medical device would be achieved if the device\u2019s entire\ncomposition were to transfer to the potentially affected individual during clinical use. This would be\naccomplished, for example, if an implantable medical device were to dissolve during clinical use or if\nan externally communicating device were to be completely leached during clinical use. Accordingly,\nthe qualitative and quantitative data collected in 5.2 regarding the material or medical device\nconfiguration, materials of construction, process residuals and supplier information can be used to\nestablish the hypothetical worst-case chemical release, even if it is unlikely that this worst-case would\nhappen under the clinical conditions of use. Additional factors shall be considered when establishing\nhypothetical worst-case chemical release, such as the medical device size and the possible clinical use\nof multiple devices.\n5.4.2\nAssess the hypothetical worst-case chemical release\nThe health impact of the medical device\u2019s individual chemical constituents is assessed by providing\nthe hypothetical worst-case chemical release, established in 5.4.1 to a risk assessor to establish the\npotential adverse impact that the chemical constituents could have on the health of a potentially\naffected individual according to ISO 10993-1 and ISO 10993-17.\nWhen exposure to a medical device\u2019s entire composition can be established as being acceptable (e.g. by\ncomparing the exposure to a safety threshold established in 5.5), then the chemical characterization\nprocess shall be deemed to have been completed. The biological evaluation can then be completed\naccording to ISO\u00a010993-1. When exposure to a medical device\u2019s entire composition is established to be\npotentially unacceptable, then the chemical characterization process can be continued by moving to the\nnext step (see 5.5, 5.6 and Figure\u00a03). Alternatively, it can be appropriate to return to ISO\u00a010993-1:2018\nto continue forward with biological endpoint evaluation, if characterization information is not likely to\nprovide further benefit.\nNOTE\u00a01\nIn some cases, theoretical compositional profiling might not be sufficient (e.g. if degradation products\nand unintended contaminants during manufacture are likely).\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n13\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nNOTE\u00a02\nIt can be possible to evaluate biological safety of devices with low risk exposure (e.g. intact skin)\nbased on qualitative information on material composition, if the device is made of widely used materials having\nextensive history of clinical use and manufactured using the same methods (e.g. ISO implant grade stainless steel\nand common passivation and post passivation processing). In these cases, chemical analysis and toxicological\nrisk assessment might not be necessary."
  },
  {
    "clause_id": "5.5",
    "change_type": "deleted",
    "old_text": "5.5\t Establish an analytical evaluation threshold\nAn AET shall be determined and justified (see Annex\u00a0E). The AET should preferably be derived from\na safety-based threshold (such as the TTC) but if this is not practically achievable, an analytical\nthreshold, such as the Limit of Quantification (LOQ) can be used as the reporting threshold. However,\nthe difference between the AET and the LOQ shall be considered in the toxicological risk assessment\nand the difference shall be justified.",
    "new_text": "",
    "change_text": "5.5\t Establish an analytical evaluation threshold\nAn AET shall be determined and justified (see Annex\u00a0E). The AET should preferably be derived from\na safety-based threshold (such as the TTC) but if this is not practically achievable, an analytical\nthreshold, such as the Limit of Quantification (LOQ) can be used as the reporting threshold. However,\nthe difference between the AET and the LOQ shall be considered in the toxicological risk assessment\nand the difference shall be justified."
  },
  {
    "clause_id": "5.6",
    "change_type": "deleted",
    "old_text": "5.6\t Estimate the chemical release; perform extraction study\nAn extraction study can be performed to identify and quantify extractables for toxicological risk\nassessment per ISO 10993-17. In some cases (e.g. with exhaustive extractions), information on the\nrelease kinetics of extracted chemicals can be helpful. The extraction conditions used; exhaustive,\nexaggerated or simulated use shall be documented and justified. Annex\u00a0 D provides guidance on\nprinciples of extractions.\nThe nature of use for some medical devices (e.g. indirect contact devices such as saline infusion bags)\ncan obviate the need for extractables testing, as the conditions of use associated with the maximum\nhuman exposure to leachables can be replicated and the clinical use solutions can be analysed in a\nstraightforward manner. In such cases, extractables testing could reasonably be replaced by leachables\ntesting.\nNOTE\u00a01\nExtractables can, in some cases (e.g. for well understood materials), be forecasted through sound\nscientific and computational methods, as well as determined empirically.\nNOTE\u00a02\nAs indicated in ISO\u00a010993-1, biological testing or additional analytical testing can be used to mitigate\nany potential concerns raised by chemical characterization.\nThe design of the extraction study should take into account the nature of contact (of the device) with\nthe potentially affected user; the influence of (or interaction with) other substances such as drugs in an\nadministration device may also need to be considered.\nTable\u00a02\u00a0\u2014 Recommended extraction conditions\nContact category\nRecommended extraction conditions\nCredible alternatives\nLimited contact devices\nSimulated use conditionsa\nExaggerated conditions\nProlonged contact devices\nExhaustive conditions\nExaggerated conditionsb,c\nLong-term contact devices\nExhaustive conditions\nExaggerated conditionsb,c,d\na\nNote that some legal authorities (e.g., U.S. FDA) can request exaggerated extraction, unless otherwise justified.\nb\nExamples of instances where exhaustive extraction would not typically be required include:\n\u2014\u00a0\u00a0\u00a0single use devices used for less than 24 h, where repeat use of a new device each day would result in categorization as\nprolonged or long-term contact;\n\u2014\u00a0\u00a0\u00a0single use devices used for several days, where repeat use of new devices would result in categorization as prolonged\nor long-term contact;\n\u2014\u00a0\u00a0\u00a0reusable devices, where a patient may be exposed to repeated use of the same device, resulting in categorization\nas prolonged or long-term contact; when an exaggerated extraction is used for a reusable device, the extraction should\nproperly account for the duration of each individual use.\nc\nExaggerated conditions can be appropriate for external communicating or non-absorbable surface contact devices,\nwith justification.\nd\nAn example is a device comprised entirely of non-absorbable metal (e.g. a vascular stent), because migration of\nconstituents from within the material is not possible, and the constituents of interest are related to the surface only and\nexaggerated extraction can be adequate to generate a complete extractables profile.\n\ufeff\n14\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nThe primary objective of the extraction is to produce an extractables profile that is at least as\ncomprehensive as a device\u2019s leachables' profile, meaning that the extractables profile includes all\nleachables as extractables and that the concentration of the extractables is at least as great as the\nconcentrations of leachables. An extractables' profile that overestimates the leachables' profile,\nspecifically by overestimating the extractables\u2019 concentrations versus leachables\u2019 concentrations,\nprovides an added margin for uncertainty in the toxicological risk assessment, and can be appropriate\nin many circumstances. However, care must be taken to limit the extent of overestimation, as overly\naggressive extractions conditions can lead to an altered extractables' profile.\nThe recommended extraction conditions in Table\u00a0 2 will, in many circumstances, provide such an\nappropriate overestimation. However, in certain circumstances, the overestimation provided by the\nrecommended exhaustive extraction conditions will be excessive and thus the recommended extraction\ncircumstances are not appropriate. For all device classifications, alternative credible extraction\nconditions can be considered and used if deemed appropriate. The use of alternative extraction\nconditions shall be documented and justified. Extractions done for specific purposes other than\nidentification and quantification of extractables (e.g. determining release kinetics) can be conducted\nusing other extraction conditions.\nConsidering replication of extractions, a single extraction replicate for each vehicle shall be sufficient\nin those circumstances where it can be established that the variation in the test article\u2019s composition\nand/or the variation in the extraction process is low, establishing that the single extraction is properly\nrepresentative of the test article and the extraction process. In cases where other information (e.g.\nengineering testing) indicates higher variability either within or across test article units or lots or\ninherent to the extraction process, multiple (e.g. duplicate or triplicate) extractions can be necessary.\nMultiple extractions should also be performed in those circumstances where the test article and/or\nextraction variability is unknown. Regardless of the number of replicate extractions performed, the\nnumber of extracts generated should be justified.\nNOTE\nMultiple (e.g. triplicate) extraction replicates per solvent could be important for:\n\u2014\t Absorbable devices, in situ polymerizing devices, and combination products which are physically and\nchemically combined. For these types of devices, there can be a higher potential for variability between\ndevices, and for small changes in chemistry at manufacture, over shelf life, or while in use.\n\u2014\t Devices with existing vertical standards or device-specific guidance which call for multiple extractions.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n15\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nFigure\u00a03\u00a0\u2014 Extractables profiling process\nThe extracts shall be analysed using sensitive and selective methods to screen the extracts for\nextractables, and the detected extractables above the analytical evaluation threshold, AET (5.5 and\nAnnex\u00a0 E), should be identified and quantified. Adequate chromatographic resolution is an example\nof how adequate selectivity can be demonstrated. The analytical methods shall be selected and the\nanalytical results reported consistent with the AET. Table\u00a03 establishes those analytical methods that\nare generally applicable to extractables studies.\nThe analytical process should be replicated by testing multiple aliquots of the extract, to account for\nanalytical variation. Although triplicates are recommended, a smaller number of replicates can be more\npractical, if justified.\n\ufeff\n16\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nThe information from this study will be used to determine the risk associated with the estimated\nchemical release. If a toxicological risk assessment determines that a chemical or chemicals could\nbe a risk to the potentially affected individual using the extractables data, a more clinically relevant\nextraction can be done to more precisely estimate the amount of the chemical or chemicals released\nfrom the medical device in clinical use (see 5.8). When a more clinically relevant extraction cannot be\njustified, other risk mitigation strategies can include targeted analysis, biological testing, reduction of\nthe chemical in the device, and in some cases, labelling as described in ISO\u00a014971, ISO\u00a010993-1 and\nISO\u00a010993-17.",
    "new_text": "",
    "change_text": "5.6\t Estimate the chemical release; perform extraction study\nAn extraction study can be performed to identify and quantify extractables for toxicological risk\nassessment per ISO 10993-17. In some cases (e.g. with exhaustive extractions), information on the\nrelease kinetics of extracted chemicals can be helpful. The extraction conditions used; exhaustive,\nexaggerated or simulated use shall be documented and justified. Annex\u00a0 D provides guidance on\nprinciples of extractions.\nThe nature of use for some medical devices (e.g. indirect contact devices such as saline infusion bags)\ncan obviate the need for extractables testing, as the conditions of use associated with the maximum\nhuman exposure to leachables can be replicated and the clinical use solutions can be analysed in a\nstraightforward manner. In such cases, extractables testing could reasonably be replaced by leachables\ntesting.\nNOTE\u00a01\nExtractables can, in some cases (e.g. for well understood materials), be forecasted through sound\nscientific and computational methods, as well as determined empirically.\nNOTE\u00a02\nAs indicated in ISO\u00a010993-1, biological testing or additional analytical testing can be used to mitigate\nany potential concerns raised by chemical characterization.\nThe design of the extraction study should take into account the nature of contact (of the device) with\nthe potentially affected user; the influence of (or interaction with) other substances such as drugs in an\nadministration device may also need to be considered.\nTable\u00a02\u00a0\u2014 Recommended extraction conditions\nContact category\nRecommended extraction conditions\nCredible alternatives\nLimited contact devices\nSimulated use conditionsa\nExaggerated conditions\nProlonged contact devices\nExhaustive conditions\nExaggerated conditionsb,c\nLong-term contact devices\nExhaustive conditions\nExaggerated conditionsb,c,d\na\nNote that some legal authorities (e.g., U.S. FDA) can request exaggerated extraction, unless otherwise justified.\nb\nExamples of instances where exhaustive extraction would not typically be required include:\n\u2014\u00a0\u00a0\u00a0single use devices used for less than 24 h, where repeat use of a new device each day would result in categorization as\nprolonged or long-term contact;\n\u2014\u00a0\u00a0\u00a0single use devices used for several days, where repeat use of new devices would result in categorization as prolonged\nor long-term contact;\n\u2014\u00a0\u00a0\u00a0reusable devices, where a patient may be exposed to repeated use of the same device, resulting in categorization\nas prolonged or long-term contact; when an exaggerated extraction is used for a reusable device, the extraction should\nproperly account for the duration of each individual use.\nc\nExaggerated conditions can be appropriate for external communicating or non-absorbable surface contact devices,\nwith justification.\nd\nAn example is a device comprised entirely of non-absorbable metal (e.g. a vascular stent), because migration of\nconstituents from within the material is not possible, and the constituents of interest are related to the surface only and\nexaggerated extraction can be adequate to generate a complete extractables profile.\n\ufeff\n14\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nThe primary objective of the extraction is to produce an extractables profile that is at least as\ncomprehensive as a device\u2019s leachables' profile, meaning that the extractables profile includes all\nleachables as extractables and that the concentration of the extractables is at least as great as the\nconcentrations of leachables. An extractables' profile that overestimates the leachables' profile,\nspecifically by overestimating the extractables\u2019 concentrations versus leachables\u2019 concentrations,\nprovides an added margin for uncertainty in the toxicological risk assessment, and can be appropriate\nin many circumstances. However, care must be taken to limit the extent of overestimation, as overly\naggressive extractions conditions can lead to an altered extractables' profile.\nThe recommended extraction conditions in Table\u00a0 2 will, in many circumstances, provide such an\nappropriate overestimation. However, in certain circumstances, the overestimation provided by the\nrecommended exhaustive extraction conditions will be excessive and thus the recommended extraction\ncircumstances are not appropriate. For all device classifications, alternative credible extraction\nconditions can be considered and used if deemed appropriate. The use of alternative extraction\nconditions shall be documented and justified. Extractions done for specific purposes other than\nidentification and quantification of extractables (e.g. determining release kinetics) can be conducted\nusing other extraction conditions.\nConsidering replication of extractions, a single extraction replicate for each vehicle shall be sufficient\nin those circumstances where it can be established that the variation in the test article\u2019s composition\nand/or the variation in the extraction process is low, establishing that the single extraction is properly\nrepresentative of the test article and the extraction process. In cases where other information (e.g.\nengineering testing) indicates higher variability either within or across test article units or lots or\ninherent to the extraction process, multiple (e.g. duplicate or triplicate) extractions can be necessary.\nMultiple extractions should also be performed in those circumstances where the test article and/or\nextraction variability is unknown. Regardless of the number of replicate extractions performed, the\nnumber of extracts generated should be justified.\nNOTE\nMultiple (e.g. triplicate) extraction replicates per solvent could be important for:\n\u2014\t Absorbable devices, in situ polymerizing devices, and combination products which are physically and\nchemically combined. For these types of devices, there can be a higher potential for variability between\ndevices, and for small changes in chemistry at manufacture, over shelf life, or while in use.\n\u2014\t Devices with existing vertical standards or device-specific guidance which call for multiple extractions.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n15\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nFigure\u00a03\u00a0\u2014 Extractables profiling process\nThe extracts shall be analysed using sensitive and selective methods to screen the extracts for\nextractables, and the detected extractables above the analytical evaluation threshold, AET (5.5 and\nAnnex\u00a0 E), should be identified and quantified. Adequate chromatographic resolution is an example\nof how adequate selectivity can be demonstrated. The analytical methods shall be selected and the\nanalytical results reported consistent with the AET. Table\u00a03 establishes those analytical methods that\nare generally applicable to extractables studies.\nThe analytical process should be replicated by testing multiple aliquots of the extract, to account for\nanalytical variation. Although triplicates are recommended, a smaller number of replicates can be more\npractical, if justified.\n\ufeff\n16\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nThe information from this study will be used to determine the risk associated with the estimated\nchemical release. If a toxicological risk assessment determines that a chemical or chemicals could\nbe a risk to the potentially affected individual using the extractables data, a more clinically relevant\nextraction can be done to more precisely estimate the amount of the chemical or chemicals released\nfrom the medical device in clinical use (see 5.8). When a more clinically relevant extraction cannot be\njustified, other risk mitigation strategies can include targeted analysis, biological testing, reduction of\nthe chemical in the device, and in some cases, labelling as described in ISO\u00a014971, ISO\u00a010993-1 and\nISO\u00a010993-17."
  },
  {
    "clause_id": "5.7",
    "change_type": "deleted",
    "old_text": "5.7 Assess the estimated chemical release (extractables profile)\nThe results of the extraction study shall be reported so that the risks attributable to each identified\nextractable can be assessed according to ISO\u00a010993-17, ISO 10993-1 and ISO\u00a014971.",
    "new_text": "",
    "change_text": "5.7 Assess the estimated chemical release (extractables profile)\nThe results of the extraction study shall be reported so that the risks attributable to each identified\nextractable can be assessed according to ISO\u00a010993-17, ISO 10993-1 and ISO\u00a014971."
  },
  {
    "clause_id": "5.8",
    "change_type": "deleted",
    "old_text": "5.8\t Determine the actual chemical release; perform leachables study\nWhen the quantity of any extractable released from the medical device presents a potential safety\nhazard in the light of its estimated clinical release, a more accurate estimate of actual exposure to, and\nactual case chemical release of, that chemical can be established by performing a leachables assessment\nof the device using actual or accelerated extraction conditions (e.g. using elevated temperature) as\npresented in Figure\u00a04. If a leachables study is performed because substances of concern were identified\nin an extractables study, the new study should target those substances of concern. Extractables which\ndo not present a potential toxicological concern in light of estimated clinical release have already been\nestablished to be safe and their further characterization is unnecessary. When it is anticipated that\nadditional leachables that were not revealed as extractables can be present, the leachables study should\ninclude screening for the additional leachables.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n17\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nFigure\u00a04\u00a0\u2014 Leachables profiling process\nAlternatively, a sponsor may decide to perform a leachables study without having previously performed\nother chemical characterizations processes (e.g. extractables profiling). For example, it can be possible\nto readily perform a leaching study with an analytically expedient contacting vehicle under the exact\nor accelerated clinical conditions of use (e.g. for a medical device that serves to deliver fluids). In such a\ncircumstance, the leaching vehicle shall be screened for leachables in a manner similar to, and with the\nsame requirements for, extractables screening as discussed in 5.6.\nLeachables studies include two actions; generation of the leachate and testing of the leachate. At this\nstage in the chemical assessment process, the leaching conditions should be either accelerated or actual\nclinical use. In either circumstance, the leaching conditions used to generate the leachate shall be\ndocumented and justified.\nThe leachate shall be analysed using sensitive and selective methods, and the levels of target or\nscreened leachables quantified. Table\u00a04 lists those analytical methods that are generally applicable to\nleachables quantification.\nAnalytical methods used to quantify leachables shall be qualified for that purpose (see 6.5 and Annex\u00a0F\nfor further information related to method qualification). Targeting leachables and use of qualified\nanalytical methods for their quantification will produce a more accurate assessment of a potentially\naffected individual\u2019s exposure than that obtained using extractables screening data.\n\ufeff\n18\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)",
    "new_text": "",
    "change_text": "5.8\t Determine the actual chemical release; perform leachables study\nWhen the quantity of any extractable released from the medical device presents a potential safety\nhazard in the light of its estimated clinical release, a more accurate estimate of actual exposure to, and\nactual case chemical release of, that chemical can be established by performing a leachables assessment\nof the device using actual or accelerated extraction conditions (e.g. using elevated temperature) as\npresented in Figure\u00a04. If a leachables study is performed because substances of concern were identified\nin an extractables study, the new study should target those substances of concern. Extractables which\ndo not present a potential toxicological concern in light of estimated clinical release have already been\nestablished to be safe and their further characterization is unnecessary. When it is anticipated that\nadditional leachables that were not revealed as extractables can be present, the leachables study should\ninclude screening for the additional leachables.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n17\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nFigure\u00a04\u00a0\u2014 Leachables profiling process\nAlternatively, a sponsor may decide to perform a leachables study without having previously performed\nother chemical characterizations processes (e.g. extractables profiling). For example, it can be possible\nto readily perform a leaching study with an analytically expedient contacting vehicle under the exact\nor accelerated clinical conditions of use (e.g. for a medical device that serves to deliver fluids). In such a\ncircumstance, the leaching vehicle shall be screened for leachables in a manner similar to, and with the\nsame requirements for, extractables screening as discussed in 5.6.\nLeachables studies include two actions; generation of the leachate and testing of the leachate. At this\nstage in the chemical assessment process, the leaching conditions should be either accelerated or actual\nclinical use. In either circumstance, the leaching conditions used to generate the leachate shall be\ndocumented and justified.\nThe leachate shall be analysed using sensitive and selective methods, and the levels of target or\nscreened leachables quantified. Table\u00a04 lists those analytical methods that are generally applicable to\nleachables quantification.\nAnalytical methods used to quantify leachables shall be qualified for that purpose (see 6.5 and Annex\u00a0F\nfor further information related to method qualification). Targeting leachables and use of qualified\nanalytical methods for their quantification will produce a more accurate assessment of a potentially\naffected individual\u2019s exposure than that obtained using extractables screening data.\n\ufeff\n18\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)"
  },
  {
    "clause_id": "5.9",
    "change_type": "deleted",
    "old_text": "5.9 Assess the actual chemical release (leachables profile)\nResults of leachables studies, including both targeted leachables and leachables revealed by screening\nat levels above the AET, shall be reported so that the potential risks attributable to each constituent\nreleased can be assessed according to ISO\u00a010993-17, ISO 10993-1 and ISO\u00a014971.",
    "new_text": "",
    "change_text": "5.9 Assess the actual chemical release (leachables profile)\nResults of leachables studies, including both targeted leachables and leachables revealed by screening\nat levels above the AET, shall be reported so that the potential risks attributable to each constituent\nreleased can be assessed according to ISO\u00a010993-17, ISO 10993-1 and ISO\u00a014971."
  },
  {
    "clause_id": "6",
    "change_type": "modified",
    "old_text": "6\t Chemical characterization parameters and methods",
    "new_text": "6 Constituent specific toxicological information",
    "change_text": "6 Constituent specific toxicological information",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to18__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to18__0\"><a href=\"#difflib_chg_to18__top\">t</a></td><td class=\"diff_header\" id=\"from18_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical&nbsp;characterization&nbsp;parameters&nbsp;and&nbsp;methods</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to18__top\">t</a></td><td class=\"diff_header\" id=\"to18_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6&nbsp;Constituent&nbsp;specific&nbsp;toxicological&nbsp;information</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "6.1",
    "change_type": "modified",
    "old_text": "6.1\t General\nClause\u00a05 describes the stepwise generation of qualitative and quantitative chemical characterization\ndata for use in the risk assessment. The characterization parameters to be used should be appropriate\nto the material or finished medical device. Due to the diversity of medical devices, it is recognized that\nnot all of the parameters identified for a material will be required for all/some medical device uses.\nAs noted previously, the extent of characterization required is determined by the invasiveness and\nduration of clinical exposure in the intended use (see ISO 10993-1:2018, 6.1). The type and amount of\ncharacterization data should be consistent with all of the parameters considered relevant to the risk\nassessment of the medical device and should consider the clinical application.\nChemical characterization data can be collected by information gathering from supplier information or\nliterature review, or produced by information generation through testing a medical device or material\ndirectly in its natural state (e.g. IR analysis of a film). However, it is often necessary to solubilize all or\npart of the test article prior to analysis. The type and extent of solubilization employed shall match the\nintent and purpose of the testing. For example, if the purpose is to:\n\u2014\t generate information on the composition of a material (e.g. additives, residuals), then the appropriate\nsolubilisation could involve complete dissolution or exhaustive extraction of the test article;\n\u2014\t establish the presence of elemental impurities in the material, then digestion of the material could\nbe appropriate;\n\u2014\t establish the test article\u2019s extractables profile, then complete dissolution is inappropriate, and\nexhaustive, exaggerated, accelerated or simulated-use extraction, is appropriate.\nAdditionally, the vehicles/media used for solubilisation should be considered in the context of the\nmethods chosen for testing those extracts, as the vehicles should be compatible with the test methods\nemployed to analyse the extracts. If visible particles or precipitates occur during extraction, and are\nnot solubilized, these should be analysed as well, using applicable methods.\nDue to the diversity of medical devices, their materials of construction and the conditions of their clinical\nuse, it is recognized that extraction conditions suitable for simulating, accelerating or exaggerating\nclinical use will vary greatly. Nevertheless, Annex\u00a0D provides considerations in determining extraction\nparameters for typical medical devices, including the choice of extraction vehicle, based on type of\ncontact and duration of exposure.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n19\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nConsidering analytical methods appropriate for relevant data, 6.2 and 6.3 provide examples of\nqualitative and quantitative parameters that can be relevant for assessing structural and composition\nof medical device materials, and also provide examples of specific methods which can be used.",
    "new_text": "6.1\t General\nAfter constituents have been identified, the next step in the toxicological risk assessment is\nunderstanding the inherent property of a constituent to elicit or induce harm in humans, as well as the\nconditions (e.g. route, duration, frequency, gender, age) necessary for the constituent to elicit the harm.\nKnowledge of the conditions that pertain to the clinical use of the device is recommended to determine\nwhether the harm is clinically relevant.\nNOTE\u00a01\nToxicity is an inherent property of a constituent\u2019s molecular structure and physicochemical\ncharacteristics that occurs under specified conditions (e.g. treatment dose, route, duration, frequency, sex, age).\nEXAMPLE\nClinical conditions include, but are not limited to, the number of medical devices per patient\nprocedure, nature and duration of body contact, and sensitivity of individuals.\nThe nature or types of harm to health that can be addressed by application of a TCL, TI, TSL or TTC (if\napplicable) include the following:\n\u2014\t irritation (TCL);\n\u2014\t systemic toxicity (i.e. acute, subacute, subchronic or chronic) (TSL, TI or TTC);\n\u2014\t genotoxicity (TSL, TI or TTC);\n\u2014\t carcinogenicity (TSL, TI or TTC);\n\u2014\t reproductive toxicity (TSL, TI or TTC);\n\u2014\t developmental toxicity (TSL, TI or TTC);\n\u2014\t other toxicity endpoints if relevant based on available toxicological data (i.e. TSL, TI or TTC do not\napply).\nWhen toxicological information for a constituent is obtained from the literature or other sources, the\ninformation shall be evaluated in accordance with 6.2.1, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010 and\nClause\u00a011.\nWhen toxicological information is not available or is inadequate to derive a TI for a constituent, the TTC\nconcept can be used according to 6.2.2 or 7.2.\nToxicological risk assessment of other harms (e.g. skin sensitization) shall be justified, based on\nadequacy of available constituent and harm specific toxicological data, and documented.\nNOTE\u00a02\nSkin sensitization is a delayed-type hypersensitivity reaction that comprises induction and elicitation.\nFor constituents that elicit an allergic response in hypersensitive individuals at very low concentrations, the\nrisk of elicitation of an allergic response in these individuals is typically controlled by avoiding exposure to that\nspecific constituent[15][16][17].",
    "change_text": "6.1\t General\nAfter constituents have been identified, the next step in the toxicological risk assessment is\nunderstanding the inherent property of a constituent to elicit or induce harm in humans, as well as the\nconditions (e.g. route, duration, frequency, gender, age) necessary for the constituent to elicit the harm.\nKnowledge of the conditions that pertain to the clinical use of the device is recommended to determine\nwhether the harm is clinically relevant.\nNOTE\u00a01\nToxicity is an inherent property of a constituent\u2019s molecular structure and physicochemical\ncharacteristics that occurs under specified conditions (e.g. treatment dose, route, duration, frequency, sex, age).\nEXAMPLE\nClinical conditions include, but are not limited to, the number of medical devices per patient\nprocedure, nature and duration of body contact, and sensitivity of individuals.\nThe nature or types of harm to health that can be addressed by application of a TCL, TI, TSL or TTC (if\napplicable) include the following:\n\u2014\t irritation (TCL);\n\u2014\t systemic toxicity (i.e. acute, subacute, subchronic or chronic) (TSL, TI or TTC);\n\u2014\t genotoxicity (TSL, TI or TTC);\n\u2014\t carcinogenicity (TSL, TI or TTC);\n\u2014\t reproductive toxicity (TSL, TI or TTC);\n\u2014\t developmental toxicity (TSL, TI or TTC);\n\u2014\t other toxicity endpoints if relevant based on available toxicological data (i.e. TSL, TI or TTC do not\napply).\nWhen toxicological information for a constituent is obtained from the literature or other sources, the\ninformation shall be evaluated in accordance with 6.2.1, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010 and\nClause\u00a011.\nWhen toxicological information is not available or is inadequate to derive a TI for a constituent, the TTC\nconcept can be used according to 6.2.2 or 7.2.\nToxicological risk assessment of other harms (e.g. skin sensitization) shall be justified, based on\nadequacy of available constituent and harm specific toxicological data, and documented.\nNOTE\u00a02\nSkin sensitization is a delayed-type hypersensitivity reaction that comprises induction and elicitation.\nFor constituents that elicit an allergic response in hypersensitive individuals at very low concentrations, the\nrisk of elicitation of an allergic response in these individuals is typically controlled by avoiding exposure to that\nspecific constituent[15][16][17].",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to19__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to19__0\"><a href=\"#difflib_chg_to19__0\">f</a></td><td class=\"diff_header\" id=\"from19_1\">1</td><td nowrap=\"nowrap\">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</td><td class=\"diff_next\"><a href=\"#difflib_chg_to19__0\">f</a></td><td class=\"diff_header\" id=\"to19_1\">1</td><td nowrap=\"nowrap\">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to19__top\">t</a></td><td class=\"diff_header\" id=\"from19_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Clause\u00a05&nbsp;describes&nbsp;the&nbsp;stepwise&nbsp;generation&nbsp;of&nbsp;qualitative&nbsp;and&nbsp;quantitative&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to19__top\">t</a></td><td class=\"diff_header\" id=\"to19_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">After&nbsp;constituents&nbsp;have&nbsp;been&nbsp;identified,&nbsp;the&nbsp;next&nbsp;step&nbsp;in&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">data&nbsp;for&nbsp;use&nbsp;in&nbsp;the&nbsp;risk&nbsp;assessment.&nbsp;The&nbsp;characterization&nbsp;parameters&nbsp;to&nbsp;be&nbsp;used&nbsp;should&nbsp;be&nbsp;appropriate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">understanding&nbsp;the&nbsp;inherent&nbsp;property&nbsp;of&nbsp;a&nbsp;constituent&nbsp;to&nbsp;elicit&nbsp;or&nbsp;induce&nbsp;harm&nbsp;in&nbsp;humans,&nbsp;as&nbsp;well&nbsp;as&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;the&nbsp;material&nbsp;or&nbsp;finished&nbsp;medical&nbsp;device.&nbsp;Due&nbsp;to&nbsp;the&nbsp;diversity&nbsp;of&nbsp;medical&nbsp;devices,&nbsp;it&nbsp;is&nbsp;recognized&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_add\">conditions&nbsp;(e.g.&nbsp;route,&nbsp;duration,&nbsp;frequency,&nbsp;gender,&nbsp;age)&nbsp;necessary&nbsp;for&nbsp;the&nbsp;constituent&nbsp;to&nbsp;elicit&nbsp;the&nbsp;harm.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">not&nbsp;all&nbsp;of&nbsp;the&nbsp;parameters&nbsp;identified&nbsp;for&nbsp;a&nbsp;material&nbsp;will&nbsp;be&nbsp;required&nbsp;for&nbsp;all/some&nbsp;medical&nbsp;device&nbsp;uses.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Knowledge&nbsp;of&nbsp;the&nbsp;conditions&nbsp;that&nbsp;pertain&nbsp;to&nbsp;the&nbsp;clinical&nbsp;use&nbsp;of&nbsp;the&nbsp;device&nbsp;is&nbsp;recommended&nbsp;to&nbsp;determine</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;noted&nbsp;previously,&nbsp;the&nbsp;extent&nbsp;of&nbsp;characterization&nbsp;required&nbsp;is&nbsp;determined&nbsp;by&nbsp;the&nbsp;invasiveness&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">whether&nbsp;the&nbsp;harm&nbsp;is&nbsp;clinically&nbsp;relevant.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">duration&nbsp;of&nbsp;clinical&nbsp;exposure&nbsp;in&nbsp;the&nbsp;intended&nbsp;use&nbsp;(see&nbsp;ISO&nbsp;10993-1:2018,&nbsp;6.1).&nbsp;The&nbsp;type&nbsp;and&nbsp;amount&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a01</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization&nbsp;data&nbsp;should&nbsp;be&nbsp;consistent&nbsp;with&nbsp;all&nbsp;of&nbsp;the&nbsp;parameters&nbsp;considered&nbsp;relevant&nbsp;to&nbsp;the&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicity&nbsp;is&nbsp;an&nbsp;inherent&nbsp;property&nbsp;of&nbsp;a&nbsp;constituent\u2019s&nbsp;molecular&nbsp;structure&nbsp;and&nbsp;physicochemical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;should&nbsp;consider&nbsp;the&nbsp;clinical&nbsp;application.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">characteristics&nbsp;that&nbsp;occurs&nbsp;under&nbsp;specified&nbsp;conditions&nbsp;(e.g.&nbsp;treatment&nbsp;dose,&nbsp;route,&nbsp;duration,&nbsp;frequency,&nbsp;sex,&nbsp;age).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;characterization&nbsp;data&nbsp;can&nbsp;be&nbsp;collected&nbsp;by&nbsp;information&nbsp;gathering&nbsp;from&nbsp;supplier&nbsp;information&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">literature&nbsp;review,&nbsp;or&nbsp;produced&nbsp;by&nbsp;information&nbsp;generation&nbsp;through&nbsp;testing&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Clinical&nbsp;conditions&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;the&nbsp;number&nbsp;of&nbsp;medical&nbsp;devices&nbsp;per&nbsp;patient</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">directly&nbsp;in&nbsp;its&nbsp;natural&nbsp;state&nbsp;(e.g.&nbsp;IR&nbsp;analysis&nbsp;of&nbsp;a&nbsp;film).&nbsp;However,&nbsp;it&nbsp;is&nbsp;often&nbsp;necessary&nbsp;to&nbsp;solubilize&nbsp;all&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">procedure,&nbsp;nature&nbsp;and&nbsp;duration&nbsp;of&nbsp;body&nbsp;contact,&nbsp;and&nbsp;sensitivity&nbsp;of&nbsp;individuals.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">part&nbsp;of&nbsp;the&nbsp;test&nbsp;article&nbsp;prior&nbsp;to&nbsp;analysis.&nbsp;The&nbsp;type&nbsp;and&nbsp;extent&nbsp;of&nbsp;solubilization&nbsp;employed&nbsp;shall&nbsp;match&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;nature&nbsp;or&nbsp;types&nbsp;of&nbsp;harm&nbsp;to&nbsp;health&nbsp;that&nbsp;can&nbsp;be&nbsp;addressed&nbsp;by&nbsp;application&nbsp;of&nbsp;a&nbsp;TCL,&nbsp;TI,&nbsp;TSL&nbsp;or&nbsp;TTC&nbsp;(if</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">intent&nbsp;and&nbsp;purpose&nbsp;of&nbsp;the&nbsp;testing.&nbsp;For&nbsp;example,&nbsp;if&nbsp;the&nbsp;purpose&nbsp;is&nbsp;to:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">applicable)&nbsp;include&nbsp;the&nbsp;following:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;generate&nbsp;information&nbsp;on&nbsp;the&nbsp;composition&nbsp;of&nbsp;a&nbsp;material&nbsp;(e.g.&nbsp;additives,&nbsp;residuals),&nbsp;then&nbsp;the&nbsp;appropriate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;irritation&nbsp;(TCL);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solubilisation&nbsp;could&nbsp;involve&nbsp;complete&nbsp;dissolution&nbsp;or&nbsp;exhaustive&nbsp;extraction&nbsp;of&nbsp;the&nbsp;test&nbsp;article;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;systemic&nbsp;toxicity&nbsp;(i.e.&nbsp;acute,&nbsp;subacute,&nbsp;subchronic&nbsp;or&nbsp;chronic)&nbsp;(TSL,&nbsp;TI&nbsp;or&nbsp;TTC);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establish&nbsp;the&nbsp;presence&nbsp;of&nbsp;elemental&nbsp;impurities&nbsp;in&nbsp;the&nbsp;material,&nbsp;then&nbsp;digestion&nbsp;of&nbsp;the&nbsp;material&nbsp;could</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;genotoxicity&nbsp;(TSL,&nbsp;TI&nbsp;or&nbsp;TTC);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;appropriate;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;carcinogenicity&nbsp;(TSL,&nbsp;TI&nbsp;or&nbsp;TTC);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establish&nbsp;the&nbsp;test&nbsp;article\u2019s&nbsp;extractables&nbsp;profile,&nbsp;then&nbsp;complete&nbsp;dissolution&nbsp;is&nbsp;inappropriate,&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reproductive&nbsp;toxicity&nbsp;(TSL,&nbsp;TI&nbsp;or&nbsp;TTC);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive,&nbsp;exaggerated,&nbsp;accelerated&nbsp;or&nbsp;simulated-use&nbsp;extraction,&nbsp;is&nbsp;appropriate.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;developmental&nbsp;toxicity&nbsp;(TSL,&nbsp;TI&nbsp;or&nbsp;TTC);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additionally,&nbsp;the&nbsp;vehicles/media&nbsp;used&nbsp;for&nbsp;solubilisation&nbsp;should&nbsp;be&nbsp;considered&nbsp;in&nbsp;the&nbsp;context&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other&nbsp;toxicity&nbsp;endpoints&nbsp;if&nbsp;relevant&nbsp;based&nbsp;on&nbsp;available&nbsp;toxicological&nbsp;data&nbsp;(i.e.&nbsp;TSL,&nbsp;TI&nbsp;or&nbsp;TTC&nbsp;do&nbsp;not</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">methods&nbsp;chosen&nbsp;for&nbsp;testing&nbsp;those&nbsp;extracts,&nbsp;as&nbsp;the&nbsp;vehicles&nbsp;should&nbsp;be&nbsp;compatible&nbsp;with&nbsp;the&nbsp;test&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">apply).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">employed&nbsp;to&nbsp;analyse&nbsp;the&nbsp;extracts.&nbsp;If&nbsp;visible&nbsp;particles&nbsp;or&nbsp;precipitates&nbsp;occur&nbsp;during&nbsp;extraction,&nbsp;and&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;toxicological&nbsp;information&nbsp;for&nbsp;a&nbsp;constituent&nbsp;is&nbsp;obtained&nbsp;from&nbsp;the&nbsp;literature&nbsp;or&nbsp;other&nbsp;sources,&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">not&nbsp;solubilized,&nbsp;these&nbsp;should&nbsp;be&nbsp;analysed&nbsp;as&nbsp;well,&nbsp;using&nbsp;applicable&nbsp;methods.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">information&nbsp;shall&nbsp;be&nbsp;evaluated&nbsp;in&nbsp;accordance&nbsp;with&nbsp;6.2.1,&nbsp;Clause\u00a07,&nbsp;Clause\u00a08,&nbsp;Clause\u00a09,&nbsp;Clause\u00a010&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Due&nbsp;to&nbsp;the&nbsp;diversity&nbsp;of&nbsp;medical&nbsp;devices,&nbsp;their&nbsp;materials&nbsp;of&nbsp;construction&nbsp;and&nbsp;the&nbsp;conditions&nbsp;of&nbsp;their&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Clause\u00a011.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use,&nbsp;it&nbsp;is&nbsp;recognized&nbsp;that&nbsp;extraction&nbsp;conditions&nbsp;suitable&nbsp;for&nbsp;simulating,&nbsp;accelerating&nbsp;or&nbsp;exaggerating</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;toxicological&nbsp;information&nbsp;is&nbsp;not&nbsp;available&nbsp;or&nbsp;is&nbsp;inadequate&nbsp;to&nbsp;derive&nbsp;a&nbsp;TI&nbsp;for&nbsp;a&nbsp;constituent,&nbsp;the&nbsp;TTC</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;use&nbsp;will&nbsp;vary&nbsp;greatly.&nbsp;Nevertheless,&nbsp;Annex\u00a0D&nbsp;provides&nbsp;considerations&nbsp;in&nbsp;determining&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">concept&nbsp;can&nbsp;be&nbsp;used&nbsp;according&nbsp;to&nbsp;6.2.2&nbsp;or&nbsp;7.2.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parameters&nbsp;for&nbsp;typical&nbsp;medical&nbsp;devices,&nbsp;including&nbsp;the&nbsp;choice&nbsp;of&nbsp;extraction&nbsp;vehicle,&nbsp;based&nbsp;on&nbsp;type&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;other&nbsp;harms&nbsp;(e.g.&nbsp;skin&nbsp;sensitization)&nbsp;shall&nbsp;be&nbsp;justified,&nbsp;based&nbsp;on</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contact&nbsp;and&nbsp;duration&nbsp;of&nbsp;exposure.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">adequacy&nbsp;of&nbsp;available&nbsp;constituent&nbsp;and&nbsp;harm&nbsp;specific&nbsp;toxicological&nbsp;data,&nbsp;and&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a02</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Skin&nbsp;sensitization&nbsp;is&nbsp;a&nbsp;delayed-type&nbsp;hypersensitivity&nbsp;reaction&nbsp;that&nbsp;comprises&nbsp;induction&nbsp;and&nbsp;elicitation.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">19</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_add\">For&nbsp;constituents&nbsp;that&nbsp;elicit&nbsp;an&nbsp;allergic&nbsp;response&nbsp;in&nbsp;hypersensitive&nbsp;individuals&nbsp;at&nbsp;very&nbsp;low&nbsp;concentrations,&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_add\">risk&nbsp;of&nbsp;elicitation&nbsp;of&nbsp;an&nbsp;allergic&nbsp;response&nbsp;in&nbsp;these&nbsp;individuals&nbsp;is&nbsp;typically&nbsp;controlled&nbsp;by&nbsp;avoiding&nbsp;exposure&nbsp;to&nbsp;that</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to19_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">specific&nbsp;constituent[15][16][17].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Considering&nbsp;analytical&nbsp;methods&nbsp;appropriate&nbsp;for&nbsp;relevant&nbsp;data,&nbsp;6.2&nbsp;and&nbsp;6.3&nbsp;provide&nbsp;examples&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualitative&nbsp;and&nbsp;quantitative&nbsp;parameters&nbsp;that&nbsp;can&nbsp;be&nbsp;relevant&nbsp;for&nbsp;assessing&nbsp;structural&nbsp;and&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from19_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;medical&nbsp;device&nbsp;materials,&nbsp;and&nbsp;also&nbsp;provide&nbsp;examples&nbsp;of&nbsp;specific&nbsp;methods&nbsp;which&nbsp;can&nbsp;be&nbsp;used.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "6.2",
    "change_type": "modified",
    "old_text": "6.2\t Material composition\nAs the material composition of a medical device is relevant to its biocompatibility, it is necessary to\ndetermine and consider device characteristics that establish the device\u2019s composition. Table\u00a0 3 lists\nsome of the characteristics which could be relevant, along with examples of appropriate analytical\napproaches.\n\ufeff\n20\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nTable\u00a03\u00a0\u2014 Test methods for establishing the material composition of medical device materials\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nResidual monomer\nGC, LC (*)\nX\nX\nSurface composition\nFTIR\nX\nXf\nXPS\nX\nX\nResidual catalyst, initiators Atomic spectroscopye (*)\nX\nX\nLC (*)\nX\nX\nSynthetic\nPolymers\nAdditives, process\nresidues, trace\nGC, LC, IC (*)\nX\nX\nX-ray diffraction\nX\n\u2014\nImpuritiesb\nResidue on ignition\nX\nXg\nX-ray fluorescence\nX\nX\nGC, LC, IC (*)\nX\nX\nChemical structure\nFTIR\nX\nXf\n13C and 1H NMR (*)\nX\nX\nX-ray fluorescence\nX\nXf\nEDX/SEM, XPS\nX\nXf\nCombustion analysis (C, S)\nX\nX\nAtomic spectroscopye (*)\nX\nX\nMaterial compositionc\nGas fusion (N, O, H)\nX\nX\nMetals and alloys\nTitrimetric\nX\nX\nGravimetric\n\nX\nElectrolytic\nX\nX\nColourimetric\nX\n\u2014\nElemental distribution\nbetween phases\nEDX/SEM, XPS\nX\nXf\nElectron microscopy\nX\nX\nPhase or surface\ncomposition\nEDX/SEM, XPS\nX\nX\nTrace substances,\nincluding additivesd\nX-ray fluorescence\nX\nXf\nAtomic spectroscopye (*)\nX\nX\nCeramics\nLC, GC (*)\nX\nX\nAnions\nIon chromatography (IC)\nX\nX\nMaterial composition\nX-ray diffraction\nX\n\u2014\na\nNot comprehensive or exclusive. Methods denoted with a (*) are methods that are most commonly employed for the\nindicated purpose. In certain situations, the other methods listed in this table can be used.\nb\nExamples can include lubricants, crosslinking agents, mould release and blowing agents, and catalysts.\nc\nMetals and alloys are frequently supplied with documented composition. When such information is already available,\nit is generally not necessary to repeat the analysis.\nd\nExamples of additives that should be considered include metal deactivators, light/heat stabilizers, plasticizers,\nlubricants, viscosity modifiers, impact modifiers, antistatic agents, antimicrobials, antioxidants, flame retardants,\nwhitening agents, fillers, sintering agents, mould release agents, binders, pigments, and coatings.\ne\nAtomic spectroscopy includes AA and inductively coupled plasma spectroscopy with either optical emission detection\n(ICP-AES) or mass spectrometric (ICP-MS) detection.\nf\nThe nature of these analyses is such that their quantitative measurements are characterized by either limited\nsensitivity or a relatively high degree of imprecision.\ng\nThis method quantifies total impurities but not individual impurities.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n21\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nColourimetric\nX\n\u2014\nIdentity\n2D PAGE (*)\nX\nX\nNatural\nmacro-molecules\nGPC/SEC\nX\nX\nAmino acid sequencing\nX\nX\nChemical structure\nFTIR\nX\nXf\n13C and 1H NMR (*)\nX\nX\na\nNot comprehensive or exclusive. Methods denoted with a (*) are methods that are most commonly employed for the\nindicated purpose. In certain situations, the other methods listed in this table can be used.\nb\nExamples can include lubricants, crosslinking agents, mould release and blowing agents, and catalysts.\nc\nMetals and alloys are frequently supplied with documented composition. When such information is already available,\nit is generally not necessary to repeat the analysis.\nd\nExamples of additives that should be considered include metal deactivators, light/heat stabilizers, plasticizers,\nlubricants, viscosity modifiers, impact modifiers, antistatic agents, antimicrobials, antioxidants, flame retardants,\nwhitening agents, fillers, sintering agents, mould release agents, binders, pigments, and coatings.\ne\nAtomic spectroscopy includes AA and inductively coupled plasma spectroscopy with either optical emission detection\n(ICP-AES) or mass spectrometric (ICP-MS) detection.\nf\nThe nature of these analyses is such that their quantitative measurements are characterized by either limited\nsensitivity or a relatively high degree of imprecision.\ng\nThis method quantifies total impurities but not individual impurities.",
    "new_text": "6.2 Identification of hazardous constituents\n6.2.1\nGeneral\nIdentification of hazardous constituents involves obtaining and evaluating toxicological information\nfor each constituent. Constituent specific toxicological information such as in vitro or in vivo toxicity\nstudies, as well as human epidemiological studies, clinical trials or case reports, can be obtained from\nprimary health effect data, supporting health effect data or secondary health effect sources (published\nreview articles, authoritative reports, databases, etc.).\nToxicological information shall be obtained from a systematic search in multiple information sources\nor databases in accordance with ISO\u00a010993-1:2018, C.2.3.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n14\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe selection of information sources and search criteria shall be documented and justified.\nNOTE\u00a01\nToxicological data are typically obtained experimentally or predicted based on a qualified or validated\nmodel, and are used to identify hazardous constituents. Examples of toxicological data include, but are not limited\nto, benchmark dose low, dose-response data, nature of the harm to health, harmful dose, primary health effect\ndata, lowest observed adverse effect level, minimally irritating level, non-irritating level, no observed adverse\neffect level, slope factor, supporting health effect data and systemic toxicity data.\nNOTE\u00a02\nPrimary health effect data are original reports of direct evidence, in vitro or in vivo, of the potential\ntoxic effect that a constituent does or does not elicit at a specified dose and route and duration of treatment.\nExamples of primary health effect data include original reports of irritation, systemic toxicity (acute, subacute,\nsubchronic or chronic), genotoxicity, carcinogenicity, or reproductive or developmental toxicity.\nNOTE\u00a03\nSupporting health effect data are indirect evidence, in vitro, in silico, in chemico, in vivo or clinical\ndata that a constituent does or does not have the potential to elicit harm to health at a specified dose, and\nroute and duration of the treatment. Examples of supporting evidence include, but are not limited to, chemical/\nphysical properties, toxicological structural alerts, toxicokinetics (i.e. absorption, distribution, metabolism, and\nexcretion), mechanism or mode of toxic action, animal studies, human epidemiological studies, clinical trials or\ncase reports.\nNOTE\u00a04\nA secondary health effect source is a document other than the original report (e.g. a review article\npublished in a scientific journal or a database that summarizes the toxicological findings in one or more original\nreports) that includes a description of constituent specific toxicological data (i.e. primary health effect or\nsupporting health effect data).\nThe adequacy and relevance of the obtained toxicological information shall be justified and documented\nin the context of the intended use conditions of the medical device.\nThe reliability and quality of the information shall be evaluated and documented in accordance with\nAnnex\u00a0A.\nWhen systematic review of constituent toxicity by an expert group addresses the availability and\nquality of toxicological data, the systematic review can be used as a secondary health effect source. The\napplicability, relevance and quality of such systematic reviews shall be justified and documented.\nNOTE\u00a05\nApplicability of a systematic review means the reported toxicological information is current and\nspecific to the constituent.\nWhen toxicological information for a constituent indicates that exposure does not result in harm\nrelevant to the intended use of the medical device, further toxicological risk assessment is not necessary\n(i.e. negligible toxicological risk).\nEXAMPLE 1\nAn example of negligible toxicological risk includes, but is not limited to, when physicochemical\ncharacteristics of a constituent indicates it will not absorb into, or interact with, the body (e.g. molecules with\nmolecular weight of\u00a0>500 Da having direct contact with intact skin)[18].\nFor constituents where toxicological information is available, the following information shall be\ndocumented (if available):\n\u2014\t animal model (species, breed/strain, age, male or female, and number);\n\u2014\t the route of administration;\n\u2014\t the dose range, administration frequency and duration;\n\u2014\t the nature of harm associated with a specified dose;\n\u2014\t the cell(s), tissue(s), organ(s) or systems that are evaluated and whether any harm is observed.\nNOTE\u00a06\nThe relationship between a constituent and its harm is established by demonstrating whether the\nbiological response is dose- and time-dependent, or that sufficient mechanistic information is available to\nestablish a cause-effect relationship.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n15\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nNOTE\u00a07\nIn silico analysis can be used to predict the nature of harm when a chemical specific POD is not\navailable.\nWhen nature of harm is not understood, a computer-based model (also known as in silico analysis) can\nbe used to predict the nature of the harm to health for the identified constituent. The validation of the\nselected in silico model shall be justified and documented.\nIf a quantitative mathematical model is used to predict the nature of the harm to health (e.g. quantitative\nstructure activity relationship), the model should be validated[18]to[21].\nNOTE\u00a08\nIn silico quantitative mathematical models establish a relationship between one or more quantitative\nparameters derived from constituent identity information to a measurable property or activity that relates to\nthe harm to health.\nRelevance of specific exposure scenarios that are applicable to the constituent and its harm to health\nshall be established[22].\nWhen constituent harm to health is dependent on a specific exposure scenario, the constituent\nexposure specific information and the relevance of the information to medical device intended use\nshall be documented.\nEXAMPLE 2\nFactors that define exposure specific scenarios include: duration (e.g. acute, subacute, subchronic,\nchronic), route (e.g. dermal, oral, inhalation, intravenous), tissue, organ or system (e.g. digestive, nervous, hepatic,\nrenal, cardiovascular, or respiratory), sex (i.e. male or female), age of the individuals (e.g. paediatric or geriatric),\nor species (i.e. human or non-human).\n6.2.2\nApplication of the toxicological screening limit\nThe toxicological screening limit can be used to establish whether the TQ of an identified constituent,\nwhich is present or extracted, is too low to elicit genotoxicity, cancer, systemic toxicity (e.g. acute,\nsubacute, subchronic, chronic), or reproductive or developmental toxicological risk (see Annex\u00a0B for\nadditional information). When the total quantity of a constituent to which an individual can be exposed\nfor a specified time period (i.e. a cumulative exposure dose) is below the specified TSL, the quantity\ncan be judged to be of negligible toxicological risk and no further risk evaluation is recommended\nfor these systemic harms; this is subject to the exclusions specified in Clause B.1, and conditions and\nrequirements specified in this subclause.\nWhen the toxicological screening limit approach is used for a constituent, the applicable TSL value shall\nbe compared to the TQmax to which an individual can be exposed.\nThe TQmax shall account for the duration that the medical device contacts the body, the number or\nquantity of devices extracted, and the number or quantity of medical devices that is in contact with the\nbody in accordance with Clause B.3.\nComparisons between TSL values and TQmax for each constituent shall be documented.\nWhen the TQmax of an identified constituent exceeds the applicable TSL, an exposure dose for the\nconstituent shall be estimated and evaluated as described in Clause\u00a07, Clause\u00a08, Clause\u00a09 and Clause\u00a010.\nNOTE\u00a01\nISO\u00a010993-18 describes methods to obtain the total quantity of a constituent present in or on, or that\ncan be extracted from the medical device (e.g. information gathering or generating chemical data by extracting a\nmedical device using exaggerated or exhaustive methods).\nNOTE\u00a02\nSuitability of the TQ of a constituent that can be extracted from a medical device for comparision to a\nTSL is dependent on extraction and analytical parameters, such as the number of medical devices used as the test\narticle, the method used in the preparation of the test article, the solvent type(s) and volume, the temperature,\nthe duration of extraction, the number of extraction cycles (i.e. one or more), and the reference standard used for\nquantification[23].\nWhen the TQ of a constituent that can be extracted is obtained by extraction and quantification\nmethods that are conservative relative to the medical device intended use, the TQ of each reportable\nconstituent may be assumed to represent a cumulative exposure dose suitable for comparing to a TSL.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n16\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nWhen the TQ of a reportable constituent that can be extracted does not represent a cumulative exposure\ndose based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed according to 6.2.3, 6.2.4, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010 and Clause\u00a011.\nWhen the TQ cannot be obtained, such as when the constituent cannot be identified or when the\namount of the constituent cannot be measured, the TSL approach shall not be applied and toxicological\nrisk assessment shall be conducted in accordance with the requirements of this document; otherwise,\nfurther biological evaluation is needed in accordance with ISO 10993-1.\n6.2.3\nIdentification of human carcinogens or suspected human carcinogens\nA human carcinogen or suspected human carcinogen is identified when human or non-human weight of\nevidence data that indicates the constituent is a human carcinogen or a suspected human carcinogen[24]\nto[29].\nCancer risk of a carcinogen shall be estimated, in accordance with Clause C.3, or controlled or managed\nin accordance with 10.2.\n6.2.4\nSelection of the point of departure\nWhen the constituent harm to health is relevant to the medical device\u2019s intended use and a constituent\nspecific POD is available, the selected POD and source (i.e. primary health effect data, supporting data\nor secondary health effect source) shall be documented.\nBased on the obtained toxicological information, the most critical (e.g. the lowest) clinically relevant\nPOD shall be selected.\nNOTE\u00a01\nGuidance on selection of a POD is given in 7.1. Guidance on evaluating toxicological data quality is\ngiven in Annex\u00a0A.\nWhen toxicological information is assessed to be inadequate or absent for an identified constituent, the\nuse of TTC or toxicological data from a structural analogue (also known as read-across approach), shall\nbe justified and documented[30]to[38].\nNOTE\u00a02\nTTC selection is described in ISO/TS 21726.\nThe following criteria are useful to identify an analogue:\n\u2014\t molecular structure (e.g. the type and arrangement, including bonding, configuration and optical\nrotation of elements in a specified order);\n\u2014\t physical properties (e.g. molecular weight, boiling point, vapour pressure, density, crystallinity or\nsolubility);\n\u2014\t chemical properties (e.g. reactivity, stability, acidity or alkalinity);\n\u2014\t biological properties (e.g. metabolism or metabolic pathways, lipophilicity or bioaccumulation) as\napplicable to the constituent and intended use of the medical device.\nNOTE\u00a03\nThe use of a similarity score (e.g. Tanimoto coefficient, Fingerprints) can be useful in combination\nwith physicochemical information for the selection of structural analogues[39][40].\nSelection of a structural analogue shall be justified and documented. Alternatively, TTC can be used to\naddress genotoxicity, carcinogenicity, systemic toxicity, or reproductive or developmental toxicity as\ndescribed in 7.2[41].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n17\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)",
    "change_text": "6.2 Identification of hazardous constituents\n6.2.1\nGeneral\nIdentification of hazardous constituents involves obtaining and evaluating toxicological information\nfor each constituent. Constituent specific toxicological information such as in vitro or in vivo toxicity\nstudies, as well as human epidemiological studies, clinical trials or case reports, can be obtained from\nprimary health effect data, supporting health effect data or secondary health effect sources (published\nreview articles, authoritative reports, databases, etc.).\nToxicological information shall be obtained from a systematic search in multiple information sources\nor databases in accordance with ISO\u00a010993-1:2018, C.2.3.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n14\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe selection of information sources and search criteria shall be documented and justified.\nNOTE\u00a01\nToxicological data are typically obtained experimentally or predicted based on a qualified or validated\nmodel, and are used to identify hazardous constituents. Examples of toxicological data include, but are not limited\nto, benchmark dose low, dose-response data, nature of the harm to health, harmful dose, primary health effect\ndata, lowest observed adverse effect level, minimally irritating level, non-irritating level, no observed adverse\neffect level, slope factor, supporting health effect data and systemic toxicity data.\nNOTE\u00a02\nPrimary health effect data are original reports of direct evidence, in vitro or in vivo, of the potential\ntoxic effect that a constituent does or does not elicit at a specified dose and route and duration of treatment.\nExamples of primary health effect data include original reports of irritation, systemic toxicity (acute, subacute,\nsubchronic or chronic), genotoxicity, carcinogenicity, or reproductive or developmental toxicity.\nNOTE\u00a03\nSupporting health effect data are indirect evidence, in vitro, in silico, in chemico, in vivo or clinical\ndata that a constituent does or does not have the potential to elicit harm to health at a specified dose, and\nroute and duration of the treatment. Examples of supporting evidence include, but are not limited to, chemical/\nphysical properties, toxicological structural alerts, toxicokinetics (i.e. absorption, distribution, metabolism, and\nexcretion), mechanism or mode of toxic action, animal studies, human epidemiological studies, clinical trials or\ncase reports.\nNOTE\u00a04\nA secondary health effect source is a document other than the original report (e.g. a review article\npublished in a scientific journal or a database that summarizes the toxicological findings in one or more original\nreports) that includes a description of constituent specific toxicological data (i.e. primary health effect or\nsupporting health effect data).\nThe adequacy and relevance of the obtained toxicological information shall be justified and documented\nin the context of the intended use conditions of the medical device.\nThe reliability and quality of the information shall be evaluated and documented in accordance with\nAnnex\u00a0A.\nWhen systematic review of constituent toxicity by an expert group addresses the availability and\nquality of toxicological data, the systematic review can be used as a secondary health effect source. The\napplicability, relevance and quality of such systematic reviews shall be justified and documented.\nNOTE\u00a05\nApplicability of a systematic review means the reported toxicological information is current and\nspecific to the constituent.\nWhen toxicological information for a constituent indicates that exposure does not result in harm\nrelevant to the intended use of the medical device, further toxicological risk assessment is not necessary\n(i.e. negligible toxicological risk).\nEXAMPLE 1\nAn example of negligible toxicological risk includes, but is not limited to, when physicochemical\ncharacteristics of a constituent indicates it will not absorb into, or interact with, the body (e.g. molecules with\nmolecular weight of\u00a0>500 Da having direct contact with intact skin)[18].\nFor constituents where toxicological information is available, the following information shall be\ndocumented (if available):\n\u2014\t animal model (species, breed/strain, age, male or female, and number);\n\u2014\t the route of administration;\n\u2014\t the dose range, administration frequency and duration;\n\u2014\t the nature of harm associated with a specified dose;\n\u2014\t the cell(s), tissue(s), organ(s) or systems that are evaluated and whether any harm is observed.\nNOTE\u00a06\nThe relationship between a constituent and its harm is established by demonstrating whether the\nbiological response is dose- and time-dependent, or that sufficient mechanistic information is available to\nestablish a cause-effect relationship.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n15\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nNOTE\u00a07\nIn silico analysis can be used to predict the nature of harm when a chemical specific POD is not\navailable.\nWhen nature of harm is not understood, a computer-based model (also known as in silico analysis) can\nbe used to predict the nature of the harm to health for the identified constituent. The validation of the\nselected in silico model shall be justified and documented.\nIf a quantitative mathematical model is used to predict the nature of the harm to health (e.g. quantitative\nstructure activity relationship), the model should be validated[18]to[21].\nNOTE\u00a08\nIn silico quantitative mathematical models establish a relationship between one or more quantitative\nparameters derived from constituent identity information to a measurable property or activity that relates to\nthe harm to health.\nRelevance of specific exposure scenarios that are applicable to the constituent and its harm to health\nshall be established[22].\nWhen constituent harm to health is dependent on a specific exposure scenario, the constituent\nexposure specific information and the relevance of the information to medical device intended use\nshall be documented.\nEXAMPLE 2\nFactors that define exposure specific scenarios include: duration (e.g. acute, subacute, subchronic,\nchronic), route (e.g. dermal, oral, inhalation, intravenous), tissue, organ or system (e.g. digestive, nervous, hepatic,\nrenal, cardiovascular, or respiratory), sex (i.e. male or female), age of the individuals (e.g. paediatric or geriatric),\nor species (i.e. human or non-human).\n6.2.2\nApplication of the toxicological screening limit\nThe toxicological screening limit can be used to establish whether the TQ of an identified constituent,\nwhich is present or extracted, is too low to elicit genotoxicity, cancer, systemic toxicity (e.g. acute,\nsubacute, subchronic, chronic), or reproductive or developmental toxicological risk (see Annex\u00a0B for\nadditional information). When the total quantity of a constituent to which an individual can be exposed\nfor a specified time period (i.e. a cumulative exposure dose) is below the specified TSL, the quantity\ncan be judged to be of negligible toxicological risk and no further risk evaluation is recommended\nfor these systemic harms; this is subject to the exclusions specified in Clause B.1, and conditions and\nrequirements specified in this subclause.\nWhen the toxicological screening limit approach is used for a constituent, the applicable TSL value shall\nbe compared to the TQmax to which an individual can be exposed.\nThe TQmax shall account for the duration that the medical device contacts the body, the number or\nquantity of devices extracted, and the number or quantity of medical devices that is in contact with the\nbody in accordance with Clause B.3.\nComparisons between TSL values and TQmax for each constituent shall be documented.\nWhen the TQmax of an identified constituent exceeds the applicable TSL, an exposure dose for the\nconstituent shall be estimated and evaluated as described in Clause\u00a07, Clause\u00a08, Clause\u00a09 and Clause\u00a010.\nNOTE\u00a01\nISO\u00a010993-18 describes methods to obtain the total quantity of a constituent present in or on, or that\ncan be extracted from the medical device (e.g. information gathering or generating chemical data by extracting a\nmedical device using exaggerated or exhaustive methods).\nNOTE\u00a02\nSuitability of the TQ of a constituent that can be extracted from a medical device for comparision to a\nTSL is dependent on extraction and analytical parameters, such as the number of medical devices used as the test\narticle, the method used in the preparation of the test article, the solvent type(s) and volume, the temperature,\nthe duration of extraction, the number of extraction cycles (i.e. one or more), and the reference standard used for\nquantification[23].\nWhen the TQ of a constituent that can be extracted is obtained by extraction and quantification\nmethods that are conservative relative to the medical device intended use, the TQ of each reportable\nconstituent may be assumed to represent a cumulative exposure dose suitable for comparing to a TSL.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n16\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nWhen the TQ of a reportable constituent that can be extracted does not represent a cumulative exposure\ndose based on the extraction and quantification methods used, the toxicological risk of a constituent\nshould be addressed according to 6.2.3, 6.2.4, Clause\u00a07, Clause\u00a08, Clause\u00a09, Clause\u00a010 and Clause\u00a011.\nWhen the TQ cannot be obtained, such as when the constituent cannot be identified or when the\namount of the constituent cannot be measured, the TSL approach shall not be applied and toxicological\nrisk assessment shall be conducted in accordance with the requirements of this document; otherwise,\nfurther biological evaluation is needed in accordance with ISO 10993-1.\n6.2.3\nIdentification of human carcinogens or suspected human carcinogens\nA human carcinogen or suspected human carcinogen is identified when human or non-human weight of\nevidence data that indicates the constituent is a human carcinogen or a suspected human carcinogen[24]\nto[29].\nCancer risk of a carcinogen shall be estimated, in accordance with Clause C.3, or controlled or managed\nin accordance with 10.2.\n6.2.4\nSelection of the point of departure\nWhen the constituent harm to health is relevant to the medical device\u2019s intended use and a constituent\nspecific POD is available, the selected POD and source (i.e. primary health effect data, supporting data\nor secondary health effect source) shall be documented.\nBased on the obtained toxicological information, the most critical (e.g. the lowest) clinically relevant\nPOD shall be selected.\nNOTE\u00a01\nGuidance on selection of a POD is given in 7.1. Guidance on evaluating toxicological data quality is\ngiven in Annex\u00a0A.\nWhen toxicological information is assessed to be inadequate or absent for an identified constituent, the\nuse of TTC or toxicological data from a structural analogue (also known as read-across approach), shall\nbe justified and documented[30]to[38].\nNOTE\u00a02\nTTC selection is described in ISO/TS 21726.\nThe following criteria are useful to identify an analogue:\n\u2014\t molecular structure (e.g. the type and arrangement, including bonding, configuration and optical\nrotation of elements in a specified order);\n\u2014\t physical properties (e.g. molecular weight, boiling point, vapour pressure, density, crystallinity or\nsolubility);\n\u2014\t chemical properties (e.g. reactivity, stability, acidity or alkalinity);\n\u2014\t biological properties (e.g. metabolism or metabolic pathways, lipophilicity or bioaccumulation) as\napplicable to the constituent and intended use of the medical device.\nNOTE\u00a03\nThe use of a similarity score (e.g. Tanimoto coefficient, Fingerprints) can be useful in combination\nwith physicochemical information for the selection of structural analogues[39][40].\nSelection of a structural analogue shall be justified and documented. Alternatively, TTC can be used to\naddress genotoxicity, carcinogenicity, systemic toxicity, or reproductive or developmental toxicity as\ndescribed in 7.2[41].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n17\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to20__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__0\"><a href=\"#difflib_chg_to20__1\">n</a></td><td class=\"diff_header\" id=\"from20_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Material&nbsp;composition</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__1\">n</a></td><td class=\"diff_header\" id=\"to20_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.2&nbsp;Identification&nbsp;of&nbsp;hazardous&nbsp;constituents</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;the&nbsp;material&nbsp;composition&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;is&nbsp;relevant&nbsp;to&nbsp;its&nbsp;biocompatibility,&nbsp;it&nbsp;is&nbsp;necessary&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.2.1</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">determine&nbsp;and&nbsp;consider&nbsp;device&nbsp;characteristics&nbsp;that&nbsp;establish&nbsp;the&nbsp;device\u2019s&nbsp;composition.&nbsp;Table\u00a0&nbsp;3&nbsp;lists</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_add\">General</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">some&nbsp;of&nbsp;the&nbsp;characteristics&nbsp;which&nbsp;could&nbsp;be&nbsp;relevant,&nbsp;along&nbsp;with&nbsp;examples&nbsp;of&nbsp;appropriate&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Identification&nbsp;of&nbsp;hazardous&nbsp;constituents&nbsp;involves&nbsp;obtaining&nbsp;and&nbsp;evaluating&nbsp;toxicological&nbsp;information</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">approaches.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_add\">for&nbsp;each&nbsp;constituent.&nbsp;Constituent&nbsp;specific&nbsp;toxicological&nbsp;information&nbsp;such&nbsp;as&nbsp;in&nbsp;vitro&nbsp;or&nbsp;in&nbsp;vivo&nbsp;toxicity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_add\">studies,&nbsp;as&nbsp;well&nbsp;as&nbsp;human&nbsp;epidemiological&nbsp;studies,&nbsp;clinical&nbsp;trials&nbsp;or&nbsp;case&nbsp;reports,&nbsp;can&nbsp;be&nbsp;obtained&nbsp;from</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_add\">primary&nbsp;health&nbsp;effect&nbsp;data,&nbsp;supporting&nbsp;health&nbsp;effect&nbsp;data&nbsp;or&nbsp;secondary&nbsp;health&nbsp;effect&nbsp;sources&nbsp;(published</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_add\">review&nbsp;articles,&nbsp;authoritative&nbsp;reports,&nbsp;databases,&nbsp;etc.).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;information&nbsp;shall&nbsp;be&nbsp;obtained&nbsp;from&nbsp;a&nbsp;systematic&nbsp;search&nbsp;in&nbsp;multiple&nbsp;information&nbsp;sources</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;databases&nbsp;in&nbsp;accordance&nbsp;with&nbsp;ISO\u00a010993-1:2018,&nbsp;C.2.3.</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__1\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_6\">6</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_15\">15</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__2\"><a href=\"#difflib_chg_to20__2\">n</a></td><td class=\"diff_header\" id=\"from20_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">20\b</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__2\">n</a></td><td class=\"diff_header\" id=\"to20_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_add\">14</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_9\">9</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_17\">17</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_10\">10</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_18\">18</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_11\">11</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_19\">19</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to20__3\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__3\">n</a></td><td class=\"diff_header\" id=\"to20_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;selection&nbsp;of&nbsp;information&nbsp;sources&nbsp;and&nbsp;search&nbsp;criteria&nbsp;shall&nbsp;be&nbsp;documented&nbsp;and&nbsp;justified.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a01</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Toxicological&nbsp;data&nbsp;are&nbsp;typically&nbsp;obtained&nbsp;experimentally&nbsp;or&nbsp;predicted&nbsp;based&nbsp;on&nbsp;a&nbsp;qualified&nbsp;or&nbsp;validated</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_add\">model,&nbsp;and&nbsp;are&nbsp;used&nbsp;to&nbsp;identify&nbsp;hazardous&nbsp;constituents.&nbsp;Examples&nbsp;of&nbsp;toxicological&nbsp;data&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_add\">to,&nbsp;benchmark&nbsp;dose&nbsp;low,&nbsp;dose-response&nbsp;data,&nbsp;nature&nbsp;of&nbsp;the&nbsp;harm&nbsp;to&nbsp;health,&nbsp;harmful&nbsp;dose,&nbsp;primary&nbsp;health&nbsp;effect</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_add\">data,&nbsp;lowest&nbsp;observed&nbsp;adverse&nbsp;effect&nbsp;level,&nbsp;minimally&nbsp;irritating&nbsp;level,&nbsp;non-irritating&nbsp;level,&nbsp;no&nbsp;observed&nbsp;adverse</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_add\">effect&nbsp;level,&nbsp;slope&nbsp;factor,&nbsp;supporting&nbsp;health&nbsp;effect&nbsp;data&nbsp;and&nbsp;systemic&nbsp;toxicity&nbsp;data.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a02</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Primary&nbsp;health&nbsp;effect&nbsp;data&nbsp;are&nbsp;original&nbsp;reports&nbsp;of&nbsp;direct&nbsp;evidence,&nbsp;in&nbsp;vitro&nbsp;or&nbsp;in&nbsp;vivo,&nbsp;of&nbsp;the&nbsp;potential</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_add\">toxic&nbsp;effect&nbsp;that&nbsp;a&nbsp;constituent&nbsp;does&nbsp;or&nbsp;does&nbsp;not&nbsp;elicit&nbsp;at&nbsp;a&nbsp;specified&nbsp;dose&nbsp;and&nbsp;route&nbsp;and&nbsp;duration&nbsp;of&nbsp;treatment.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Examples&nbsp;of&nbsp;primary&nbsp;health&nbsp;effect&nbsp;data&nbsp;include&nbsp;original&nbsp;reports&nbsp;of&nbsp;irritation,&nbsp;systemic&nbsp;toxicity&nbsp;(acute,&nbsp;subacute,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_add\">subchronic&nbsp;or&nbsp;chronic),&nbsp;genotoxicity,&nbsp;carcinogenicity,&nbsp;or&nbsp;reproductive&nbsp;or&nbsp;developmental&nbsp;toxicity.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a03</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Supporting&nbsp;health&nbsp;effect&nbsp;data&nbsp;are&nbsp;indirect&nbsp;evidence,&nbsp;in&nbsp;vitro,&nbsp;in&nbsp;silico,&nbsp;in&nbsp;chemico,&nbsp;in&nbsp;vivo&nbsp;or&nbsp;clinical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_add\">data&nbsp;that&nbsp;a&nbsp;constituent&nbsp;does&nbsp;or&nbsp;does&nbsp;not&nbsp;have&nbsp;the&nbsp;potential&nbsp;to&nbsp;elicit&nbsp;harm&nbsp;to&nbsp;health&nbsp;at&nbsp;a&nbsp;specified&nbsp;dose,&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_add\">route&nbsp;and&nbsp;duration&nbsp;of&nbsp;the&nbsp;treatment.&nbsp;Examples&nbsp;of&nbsp;supporting&nbsp;evidence&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to,&nbsp;chemical/</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_add\">physical&nbsp;properties,&nbsp;toxicological&nbsp;structural&nbsp;alerts,&nbsp;toxicokinetics&nbsp;(i.e.&nbsp;absorption,&nbsp;distribution,&nbsp;metabolism,&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_add\">excretion),&nbsp;mechanism&nbsp;or&nbsp;mode&nbsp;of&nbsp;toxic&nbsp;action,&nbsp;animal&nbsp;studies,&nbsp;human&nbsp;epidemiological&nbsp;studies,&nbsp;clinical&nbsp;trials&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_add\">case&nbsp;reports.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a04</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_add\">A&nbsp;secondary&nbsp;health&nbsp;effect&nbsp;source&nbsp;is&nbsp;a&nbsp;document&nbsp;other&nbsp;than&nbsp;the&nbsp;original&nbsp;report&nbsp;(e.g.&nbsp;a&nbsp;review&nbsp;article</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_add\">published&nbsp;in&nbsp;a&nbsp;scientific&nbsp;journal&nbsp;or&nbsp;a&nbsp;database&nbsp;that&nbsp;summarizes&nbsp;the&nbsp;toxicological&nbsp;findings&nbsp;in&nbsp;one&nbsp;or&nbsp;more&nbsp;original</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_add\">reports)&nbsp;that&nbsp;includes&nbsp;a&nbsp;description&nbsp;of&nbsp;constituent&nbsp;specific&nbsp;toxicological&nbsp;data&nbsp;(i.e.&nbsp;primary&nbsp;health&nbsp;effect&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_add\">supporting&nbsp;health&nbsp;effect&nbsp;data).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;adequacy&nbsp;and&nbsp;relevance&nbsp;of&nbsp;the&nbsp;obtained&nbsp;toxicological&nbsp;information&nbsp;shall&nbsp;be&nbsp;justified&nbsp;and&nbsp;documented</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_add\">in&nbsp;the&nbsp;context&nbsp;of&nbsp;the&nbsp;intended&nbsp;use&nbsp;conditions&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;reliability&nbsp;and&nbsp;quality&nbsp;of&nbsp;the&nbsp;information&nbsp;shall&nbsp;be&nbsp;evaluated&nbsp;and&nbsp;documented&nbsp;in&nbsp;accordance&nbsp;with</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Annex\u00a0A.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;systematic&nbsp;review&nbsp;of&nbsp;constituent&nbsp;toxicity&nbsp;by&nbsp;an&nbsp;expert&nbsp;group&nbsp;addresses&nbsp;the&nbsp;availability&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_add\">quality&nbsp;of&nbsp;toxicological&nbsp;data,&nbsp;the&nbsp;systematic&nbsp;review&nbsp;can&nbsp;be&nbsp;used&nbsp;as&nbsp;a&nbsp;secondary&nbsp;health&nbsp;effect&nbsp;source.&nbsp;The</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_add\">applicability,&nbsp;relevance&nbsp;and&nbsp;quality&nbsp;of&nbsp;such&nbsp;systematic&nbsp;reviews&nbsp;shall&nbsp;be&nbsp;justified&nbsp;and&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a05</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Applicability&nbsp;of&nbsp;a&nbsp;systematic&nbsp;review&nbsp;means&nbsp;the&nbsp;reported&nbsp;toxicological&nbsp;information&nbsp;is&nbsp;current&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_add\">specific&nbsp;to&nbsp;the&nbsp;constituent.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;toxicological&nbsp;information&nbsp;for&nbsp;a&nbsp;constituent&nbsp;indicates&nbsp;that&nbsp;exposure&nbsp;does&nbsp;not&nbsp;result&nbsp;in&nbsp;harm</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_add\">relevant&nbsp;to&nbsp;the&nbsp;intended&nbsp;use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device,&nbsp;further&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;not&nbsp;necessary</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_add\">(i.e.&nbsp;negligible&nbsp;toxicological&nbsp;risk).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE&nbsp;1</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_add\">An&nbsp;example&nbsp;of&nbsp;negligible&nbsp;toxicological&nbsp;risk&nbsp;includes,&nbsp;but&nbsp;is&nbsp;not&nbsp;limited&nbsp;to,&nbsp;when&nbsp;physicochemical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_add\">characteristics&nbsp;of&nbsp;a&nbsp;constituent&nbsp;indicates&nbsp;it&nbsp;will&nbsp;not&nbsp;absorb&nbsp;into,&nbsp;or&nbsp;interact&nbsp;with,&nbsp;the&nbsp;body&nbsp;(e.g.&nbsp;molecules&nbsp;with</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_add\">molecular&nbsp;weight&nbsp;of\u00a0&gt;500&nbsp;Da&nbsp;having&nbsp;direct&nbsp;contact&nbsp;with&nbsp;intact&nbsp;skin)[18].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_add\">For&nbsp;constituents&nbsp;where&nbsp;toxicological&nbsp;information&nbsp;is&nbsp;available,&nbsp;the&nbsp;following&nbsp;information&nbsp;shall&nbsp;be</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_add\">documented&nbsp;(if&nbsp;available):</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;animal&nbsp;model&nbsp;(species,&nbsp;breed/strain,&nbsp;age,&nbsp;male&nbsp;or&nbsp;female,&nbsp;and&nbsp;number);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;route&nbsp;of&nbsp;administration;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;dose&nbsp;range,&nbsp;administration&nbsp;frequency&nbsp;and&nbsp;duration;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;nature&nbsp;of&nbsp;harm&nbsp;associated&nbsp;with&nbsp;a&nbsp;specified&nbsp;dose;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;cell(s),&nbsp;tissue(s),&nbsp;organ(s)&nbsp;or&nbsp;systems&nbsp;that&nbsp;are&nbsp;evaluated&nbsp;and&nbsp;whether&nbsp;any&nbsp;harm&nbsp;is&nbsp;observed.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a06</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__3\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;relationship&nbsp;between&nbsp;a&nbsp;constituent&nbsp;and&nbsp;its&nbsp;harm&nbsp;is&nbsp;established&nbsp;by&nbsp;demonstrating&nbsp;whether&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_add\">biological&nbsp;response&nbsp;is&nbsp;dose-&nbsp;and&nbsp;time-dependent,&nbsp;or&nbsp;that&nbsp;sufficient&nbsp;mechanistic&nbsp;information&nbsp;is&nbsp;available&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_add\">establish&nbsp;a&nbsp;cause-effect&nbsp;relationship.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_12\">12</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_74\">74</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to20__4\">n</a></td><td class=\"diff_header\" id=\"from20_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__4\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a03\u00a0\u2014&nbsp;Test&nbsp;methods&nbsp;for&nbsp;establishing&nbsp;the&nbsp;material&nbsp;composition&nbsp;of&nbsp;medical&nbsp;device&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Material&nbsp;type</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Characteristic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Example&nbsp;methodsa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualitative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Quantitative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Residual&nbsp;monomer</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GC,&nbsp;LC&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Surface&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">FTIR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">XPS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Residual&nbsp;catalyst,&nbsp;initiators&nbsp;Atomic&nbsp;spectroscopye&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">LC&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Synthetic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polymers</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additives,&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">residues,&nbsp;trace</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GC,&nbsp;LC,&nbsp;IC&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;diffraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Impuritiesb</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Residue&nbsp;on&nbsp;ignition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xg</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;fluorescence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GC,&nbsp;LC,&nbsp;IC&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;structure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">FTIR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">13C&nbsp;and&nbsp;1H&nbsp;NMR&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;fluorescence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EDX/SEM,&nbsp;XPS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Combustion&nbsp;analysis&nbsp;(C,&nbsp;S)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Atomic&nbsp;spectroscopye&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Material&nbsp;compositionc</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gas&nbsp;fusion&nbsp;(N,&nbsp;O,&nbsp;H)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Metals&nbsp;and&nbsp;alloys</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Titrimetric</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gravimetric</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Electrolytic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Colourimetric</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Elemental&nbsp;distribution</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">between&nbsp;phases</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EDX/SEM,&nbsp;XPS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Electron&nbsp;microscopy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Phase&nbsp;or&nbsp;surface</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EDX/SEM,&nbsp;XPS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Trace&nbsp;substances,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">including&nbsp;additivesd</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;fluorescence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_110\">110</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Atomic&nbsp;spectroscopye&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ceramics</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">LC,&nbsp;GC&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Anions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ion&nbsp;chromatography&nbsp;(IC)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Material&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X-ray&nbsp;diffraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_125\">125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Not&nbsp;comprehensive&nbsp;or&nbsp;exclusive.&nbsp;Methods&nbsp;denoted&nbsp;with&nbsp;a&nbsp;(*)&nbsp;are&nbsp;methods&nbsp;that&nbsp;are&nbsp;most&nbsp;commonly&nbsp;employed&nbsp;for&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">indicated&nbsp;purpose.&nbsp;In&nbsp;certain&nbsp;situations,&nbsp;the&nbsp;other&nbsp;methods&nbsp;listed&nbsp;in&nbsp;this&nbsp;table&nbsp;can&nbsp;be&nbsp;used.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_129\">129</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_130\">130</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;can&nbsp;include&nbsp;lubricants,&nbsp;crosslinking&nbsp;agents,&nbsp;mould&nbsp;release&nbsp;and&nbsp;blowing&nbsp;agents,&nbsp;and&nbsp;catalysts.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_131\">131</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_132\">132</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Metals&nbsp;and&nbsp;alloys&nbsp;are&nbsp;frequently&nbsp;supplied&nbsp;with&nbsp;documented&nbsp;composition.&nbsp;When&nbsp;such&nbsp;information&nbsp;is&nbsp;already&nbsp;available,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_133\">133</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">it&nbsp;is&nbsp;generally&nbsp;not&nbsp;necessary&nbsp;to&nbsp;repeat&nbsp;the&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_134\">134</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_135\">135</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;of&nbsp;additives&nbsp;that&nbsp;should&nbsp;be&nbsp;considered&nbsp;include&nbsp;metal&nbsp;deactivators,&nbsp;light/heat&nbsp;stabilizers,&nbsp;plasticizers,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_136\">136</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">lubricants,&nbsp;viscosity&nbsp;modifiers,&nbsp;impact&nbsp;modifiers,&nbsp;antistatic&nbsp;agents,&nbsp;antimicrobials,&nbsp;antioxidants,&nbsp;flame&nbsp;retardants,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_137\">137</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">whitening&nbsp;agents,&nbsp;fillers,&nbsp;sintering&nbsp;agents,&nbsp;mould&nbsp;release&nbsp;agents,&nbsp;binders,&nbsp;pigments,&nbsp;and&nbsp;coatings.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_138\">138</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_139\">139</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Atomic&nbsp;spectroscopy&nbsp;includes&nbsp;AA&nbsp;and&nbsp;inductively&nbsp;coupled&nbsp;plasma&nbsp;spectroscopy&nbsp;with&nbsp;either&nbsp;optical&nbsp;emission&nbsp;detection</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_140\">140</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(ICP-AES)&nbsp;or&nbsp;mass&nbsp;spectrometric&nbsp;(ICP-MS)&nbsp;detection.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_141\">141</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__4\"></td><td class=\"diff_header\" id=\"from20_142\">142</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;nature&nbsp;of&nbsp;these&nbsp;analyses&nbsp;is&nbsp;such&nbsp;that&nbsp;their&nbsp;quantitative&nbsp;measurements&nbsp;are&nbsp;characterized&nbsp;by&nbsp;either&nbsp;limited</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_143\">143</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sensitivity&nbsp;or&nbsp;a&nbsp;relatively&nbsp;high&nbsp;degree&nbsp;of&nbsp;imprecision.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_144\">144</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">g</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_145\">145</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;method&nbsp;quantifies&nbsp;total&nbsp;impurities&nbsp;but&nbsp;not&nbsp;individual&nbsp;impurities.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_146\">146</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_75\">75</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__5\"><a href=\"#difflib_chg_to20__5\">n</a></td><td class=\"diff_header\" id=\"from20_147\">147</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__5\">n</a></td><td class=\"diff_header\" id=\"to20_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_add\">15</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_148\">148</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">21</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_149\">149</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_77\">77</td><td nowrap=\"nowrap\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_150\">150</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_78\">78</td><td nowrap=\"nowrap\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_151\">151</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_79\">79</td><td nowrap=\"nowrap\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to20__6\">n</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__6\">n</a></td><td class=\"diff_header\" id=\"to20_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a07</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_add\">In&nbsp;silico&nbsp;analysis&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;predict&nbsp;the&nbsp;nature&nbsp;of&nbsp;harm&nbsp;when&nbsp;a&nbsp;chemical&nbsp;specific&nbsp;POD&nbsp;is&nbsp;not</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_add\">available.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;nature&nbsp;of&nbsp;harm&nbsp;is&nbsp;not&nbsp;understood,&nbsp;a&nbsp;computer-based&nbsp;model&nbsp;(also&nbsp;known&nbsp;as&nbsp;in&nbsp;silico&nbsp;analysis)&nbsp;can</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_add\">be&nbsp;used&nbsp;to&nbsp;predict&nbsp;the&nbsp;nature&nbsp;of&nbsp;the&nbsp;harm&nbsp;to&nbsp;health&nbsp;for&nbsp;the&nbsp;identified&nbsp;constituent.&nbsp;The&nbsp;validation&nbsp;of&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_add\">selected&nbsp;in&nbsp;silico&nbsp;model&nbsp;shall&nbsp;be&nbsp;justified&nbsp;and&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_add\">If&nbsp;a&nbsp;quantitative&nbsp;mathematical&nbsp;model&nbsp;is&nbsp;used&nbsp;to&nbsp;predict&nbsp;the&nbsp;nature&nbsp;of&nbsp;the&nbsp;harm&nbsp;to&nbsp;health&nbsp;(e.g.&nbsp;quantitative</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_add\">structure&nbsp;activity&nbsp;relationship),&nbsp;the&nbsp;model&nbsp;should&nbsp;be&nbsp;validated[18]to[21].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a08</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_add\">In&nbsp;silico&nbsp;quantitative&nbsp;mathematical&nbsp;models&nbsp;establish&nbsp;a&nbsp;relationship&nbsp;between&nbsp;one&nbsp;or&nbsp;more&nbsp;quantitative</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_add\">parameters&nbsp;derived&nbsp;from&nbsp;constituent&nbsp;identity&nbsp;information&nbsp;to&nbsp;a&nbsp;measurable&nbsp;property&nbsp;or&nbsp;activity&nbsp;that&nbsp;relates&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;harm&nbsp;to&nbsp;health.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Relevance&nbsp;of&nbsp;specific&nbsp;exposure&nbsp;scenarios&nbsp;that&nbsp;are&nbsp;applicable&nbsp;to&nbsp;the&nbsp;constituent&nbsp;and&nbsp;its&nbsp;harm&nbsp;to&nbsp;health</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_add\">shall&nbsp;be&nbsp;established[22].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;constituent&nbsp;harm&nbsp;to&nbsp;health&nbsp;is&nbsp;dependent&nbsp;on&nbsp;a&nbsp;specific&nbsp;exposure&nbsp;scenario,&nbsp;the&nbsp;constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_add\">exposure&nbsp;specific&nbsp;information&nbsp;and&nbsp;the&nbsp;relevance&nbsp;of&nbsp;the&nbsp;information&nbsp;to&nbsp;medical&nbsp;device&nbsp;intended&nbsp;use</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_add\">shall&nbsp;be&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_add\">EXAMPLE&nbsp;2</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Factors&nbsp;that&nbsp;define&nbsp;exposure&nbsp;specific&nbsp;scenarios&nbsp;include:&nbsp;duration&nbsp;(e.g.&nbsp;acute,&nbsp;subacute,&nbsp;subchronic,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_add\">chronic),&nbsp;route&nbsp;(e.g.&nbsp;dermal,&nbsp;oral,&nbsp;inhalation,&nbsp;intravenous),&nbsp;tissue,&nbsp;organ&nbsp;or&nbsp;system&nbsp;(e.g.&nbsp;digestive,&nbsp;nervous,&nbsp;hepatic,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_add\">renal,&nbsp;cardiovascular,&nbsp;or&nbsp;respiratory),&nbsp;sex&nbsp;(i.e.&nbsp;male&nbsp;or&nbsp;female),&nbsp;age&nbsp;of&nbsp;the&nbsp;individuals&nbsp;(e.g.&nbsp;paediatric&nbsp;or&nbsp;geriatric),</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;species&nbsp;(i.e.&nbsp;human&nbsp;or&nbsp;non-human).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.2.2</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Application&nbsp;of&nbsp;the&nbsp;toxicological&nbsp;screening&nbsp;limit</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;toxicological&nbsp;screening&nbsp;limit&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;establish&nbsp;whether&nbsp;the&nbsp;TQ&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_add\">which&nbsp;is&nbsp;present&nbsp;or&nbsp;extracted,&nbsp;is&nbsp;too&nbsp;low&nbsp;to&nbsp;elicit&nbsp;genotoxicity,&nbsp;cancer,&nbsp;systemic&nbsp;toxicity&nbsp;(e.g.&nbsp;acute,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_add\">subacute,&nbsp;subchronic,&nbsp;chronic),&nbsp;or&nbsp;reproductive&nbsp;or&nbsp;developmental&nbsp;toxicological&nbsp;risk&nbsp;(see&nbsp;Annex\u00a0B&nbsp;for</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_add\">additional&nbsp;information).&nbsp;When&nbsp;the&nbsp;total&nbsp;quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;to&nbsp;which&nbsp;an&nbsp;individual&nbsp;can&nbsp;be&nbsp;exposed</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_add\">for&nbsp;a&nbsp;specified&nbsp;time&nbsp;period&nbsp;(i.e.&nbsp;a&nbsp;cumulative&nbsp;exposure&nbsp;dose)&nbsp;is&nbsp;below&nbsp;the&nbsp;specified&nbsp;TSL,&nbsp;the&nbsp;quantity</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_110\">110</td><td nowrap=\"nowrap\"><span class=\"diff_add\">can&nbsp;be&nbsp;judged&nbsp;to&nbsp;be&nbsp;of&nbsp;negligible&nbsp;toxicological&nbsp;risk&nbsp;and&nbsp;no&nbsp;further&nbsp;risk&nbsp;evaluation&nbsp;is&nbsp;recommended</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_add\">for&nbsp;these&nbsp;systemic&nbsp;harms;&nbsp;this&nbsp;is&nbsp;subject&nbsp;to&nbsp;the&nbsp;exclusions&nbsp;specified&nbsp;in&nbsp;Clause&nbsp;B.1,&nbsp;and&nbsp;conditions&nbsp;and</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_add\">requirements&nbsp;specified&nbsp;in&nbsp;this&nbsp;subclause.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;toxicological&nbsp;screening&nbsp;limit&nbsp;approach&nbsp;is&nbsp;used&nbsp;for&nbsp;a&nbsp;constituent,&nbsp;the&nbsp;applicable&nbsp;TSL&nbsp;value&nbsp;shall</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_add\">be&nbsp;compared&nbsp;to&nbsp;the&nbsp;TQmax&nbsp;to&nbsp;which&nbsp;an&nbsp;individual&nbsp;can&nbsp;be&nbsp;exposed.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;TQmax&nbsp;shall&nbsp;account&nbsp;for&nbsp;the&nbsp;duration&nbsp;that&nbsp;the&nbsp;medical&nbsp;device&nbsp;contacts&nbsp;the&nbsp;body,&nbsp;the&nbsp;number&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_add\">quantity&nbsp;of&nbsp;devices&nbsp;extracted,&nbsp;and&nbsp;the&nbsp;number&nbsp;or&nbsp;quantity&nbsp;of&nbsp;medical&nbsp;devices&nbsp;that&nbsp;is&nbsp;in&nbsp;contact&nbsp;with&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_add\">body&nbsp;in&nbsp;accordance&nbsp;with&nbsp;Clause&nbsp;B.3.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Comparisons&nbsp;between&nbsp;TSL&nbsp;values&nbsp;and&nbsp;TQmax&nbsp;for&nbsp;each&nbsp;constituent&nbsp;shall&nbsp;be&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;TQmax&nbsp;of&nbsp;an&nbsp;identified&nbsp;constituent&nbsp;exceeds&nbsp;the&nbsp;applicable&nbsp;TSL,&nbsp;an&nbsp;exposure&nbsp;dose&nbsp;for&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;shall&nbsp;be&nbsp;estimated&nbsp;and&nbsp;evaluated&nbsp;as&nbsp;described&nbsp;in&nbsp;Clause\u00a07,&nbsp;Clause\u00a08,&nbsp;Clause\u00a09&nbsp;and&nbsp;Clause\u00a010.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a01</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO\u00a010993-18&nbsp;describes&nbsp;methods&nbsp;to&nbsp;obtain&nbsp;the&nbsp;total&nbsp;quantity&nbsp;of&nbsp;a&nbsp;constituent&nbsp;present&nbsp;in&nbsp;or&nbsp;on,&nbsp;or&nbsp;that</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_add\">can&nbsp;be&nbsp;extracted&nbsp;from&nbsp;the&nbsp;medical&nbsp;device&nbsp;(e.g.&nbsp;information&nbsp;gathering&nbsp;or&nbsp;generating&nbsp;chemical&nbsp;data&nbsp;by&nbsp;extracting&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_add\">medical&nbsp;device&nbsp;using&nbsp;exaggerated&nbsp;or&nbsp;exhaustive&nbsp;methods).</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_125\">125</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a02</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Suitability&nbsp;of&nbsp;the&nbsp;TQ&nbsp;of&nbsp;a&nbsp;constituent&nbsp;that&nbsp;can&nbsp;be&nbsp;extracted&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;for&nbsp;comparision&nbsp;to&nbsp;a</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TSL&nbsp;is&nbsp;dependent&nbsp;on&nbsp;extraction&nbsp;and&nbsp;analytical&nbsp;parameters,&nbsp;such&nbsp;as&nbsp;the&nbsp;number&nbsp;of&nbsp;medical&nbsp;devices&nbsp;used&nbsp;as&nbsp;the&nbsp;test</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_add\">article,&nbsp;the&nbsp;method&nbsp;used&nbsp;in&nbsp;the&nbsp;preparation&nbsp;of&nbsp;the&nbsp;test&nbsp;article,&nbsp;the&nbsp;solvent&nbsp;type(s)&nbsp;and&nbsp;volume,&nbsp;the&nbsp;temperature,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_129\">129</td><td nowrap=\"nowrap\"><span class=\"diff_add\">the&nbsp;duration&nbsp;of&nbsp;extraction,&nbsp;the&nbsp;number&nbsp;of&nbsp;extraction&nbsp;cycles&nbsp;(i.e.&nbsp;one&nbsp;or&nbsp;more),&nbsp;and&nbsp;the&nbsp;reference&nbsp;standard&nbsp;used&nbsp;for</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_130\">130</td><td nowrap=\"nowrap\"><span class=\"diff_add\">quantification[23].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_131\">131</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;TQ&nbsp;of&nbsp;a&nbsp;constituent&nbsp;that&nbsp;can&nbsp;be&nbsp;extracted&nbsp;is&nbsp;obtained&nbsp;by&nbsp;extraction&nbsp;and&nbsp;quantification</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_132\">132</td><td nowrap=\"nowrap\"><span class=\"diff_add\">methods&nbsp;that&nbsp;are&nbsp;conservative&nbsp;relative&nbsp;to&nbsp;the&nbsp;medical&nbsp;device&nbsp;intended&nbsp;use,&nbsp;the&nbsp;TQ&nbsp;of&nbsp;each&nbsp;reportable</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_133\">133</td><td nowrap=\"nowrap\"><span class=\"diff_add\">constituent&nbsp;may&nbsp;be&nbsp;assumed&nbsp;to&nbsp;represent&nbsp;a&nbsp;cumulative&nbsp;exposure&nbsp;dose&nbsp;suitable&nbsp;for&nbsp;comparing&nbsp;to&nbsp;a&nbsp;TSL.</span></td></tr>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to20__6\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_134\">134</td><td nowrap=\"nowrap\"><span class=\"diff_add\">&nbsp;</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_135\">135</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_136\">136</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_137\">137</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\b</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_152\">152</td><td nowrap=\"nowrap\">\ufeff</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_138\">138</td><td nowrap=\"nowrap\">\ufeff</td></tr>\n            <tr><td class=\"diff_next\"><a href=\"#difflib_chg_to20__top\">t</a></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"><a href=\"#difflib_chg_to20__top\">t</a></td><td class=\"diff_header\" id=\"to20_139\">139</td><td nowrap=\"nowrap\"><span class=\"diff_add\">16</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_140\">140</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_141\">141</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_142\">142</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_153\">153</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">8</span>:202<span class=\"diff_chg\">0</span>(E)</td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_143\">143</td><td nowrap=\"nowrap\">ISO&nbsp;10993-1<span class=\"diff_chg\">7</span>:202<span class=\"diff_chg\">3</span>(E)</td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_154\">154</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Material&nbsp;type</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_144\">144</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;TQ&nbsp;of&nbsp;a&nbsp;reportable&nbsp;constituent&nbsp;that&nbsp;can&nbsp;be&nbsp;extracted&nbsp;does&nbsp;not&nbsp;represent&nbsp;a&nbsp;cumulative&nbsp;exposure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_155\">155</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Characteristic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_145\">145</td><td nowrap=\"nowrap\"><span class=\"diff_add\">dose&nbsp;based&nbsp;on&nbsp;the&nbsp;extraction&nbsp;and&nbsp;quantification&nbsp;methods&nbsp;used,&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;of&nbsp;a&nbsp;constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_156\">156</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Example&nbsp;methodsa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_146\">146</td><td nowrap=\"nowrap\"><span class=\"diff_add\">should&nbsp;be&nbsp;addressed&nbsp;according&nbsp;to&nbsp;6.2.3,&nbsp;6.2.4,&nbsp;Clause\u00a07,&nbsp;Clause\u00a08,&nbsp;Clause\u00a09,&nbsp;Clause\u00a010&nbsp;and&nbsp;Clause\u00a011.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_157\">157</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualitative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_147\">147</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;TQ&nbsp;cannot&nbsp;be&nbsp;obtained,&nbsp;such&nbsp;as&nbsp;when&nbsp;the&nbsp;constituent&nbsp;cannot&nbsp;be&nbsp;identified&nbsp;or&nbsp;when&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_158\">158</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Quantitative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_148\">148</td><td nowrap=\"nowrap\"><span class=\"diff_add\">amount&nbsp;of&nbsp;the&nbsp;constituent&nbsp;cannot&nbsp;be&nbsp;measured,&nbsp;the&nbsp;TSL&nbsp;approach&nbsp;shall&nbsp;not&nbsp;be&nbsp;applied&nbsp;and&nbsp;toxicological</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_159\">159</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Colourimetric</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_149\">149</td><td nowrap=\"nowrap\"><span class=\"diff_add\">risk&nbsp;assessment&nbsp;shall&nbsp;be&nbsp;conducted&nbsp;in&nbsp;accordance&nbsp;with&nbsp;the&nbsp;requirements&nbsp;of&nbsp;this&nbsp;document;&nbsp;otherwise,</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_160\">160</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_150\">150</td><td nowrap=\"nowrap\"><span class=\"diff_add\">further&nbsp;biological&nbsp;evaluation&nbsp;is&nbsp;needed&nbsp;in&nbsp;accordance&nbsp;with&nbsp;ISO&nbsp;10993-1.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_161\">161</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_151\">151</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.2.3</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_162\">162</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Identity</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_152\">152</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Identification&nbsp;of&nbsp;human&nbsp;carcinogens&nbsp;or&nbsp;suspected&nbsp;human&nbsp;carcinogens</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_163\">163</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2D&nbsp;PAGE&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_153\">153</td><td nowrap=\"nowrap\"><span class=\"diff_add\">A&nbsp;human&nbsp;carcinogen&nbsp;or&nbsp;suspected&nbsp;human&nbsp;carcinogen&nbsp;is&nbsp;identified&nbsp;when&nbsp;human&nbsp;or&nbsp;non-human&nbsp;weight&nbsp;of</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_164\">164</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_154\">154</td><td nowrap=\"nowrap\"><span class=\"diff_add\">evidence&nbsp;data&nbsp;that&nbsp;indicates&nbsp;the&nbsp;constituent&nbsp;is&nbsp;a&nbsp;human&nbsp;carcinogen&nbsp;or&nbsp;a&nbsp;suspected&nbsp;human&nbsp;carcinogen[24]</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_165\">165</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_155\">155</td><td nowrap=\"nowrap\"><span class=\"diff_add\">to[29].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_166\">166</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Natural</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_156\">156</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Cancer&nbsp;risk&nbsp;of&nbsp;a&nbsp;carcinogen&nbsp;shall&nbsp;be&nbsp;estimated,&nbsp;in&nbsp;accordance&nbsp;with&nbsp;Clause&nbsp;C.3,&nbsp;or&nbsp;controlled&nbsp;or&nbsp;managed</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_167\">167</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">macro-molecules</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_157\">157</td><td nowrap=\"nowrap\"><span class=\"diff_add\">in&nbsp;accordance&nbsp;with&nbsp;10.2.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_168\">168</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GPC/SEC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_158\">158</td><td nowrap=\"nowrap\"><span class=\"diff_add\">6.2.4</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_169\">169</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_159\">159</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Selection&nbsp;of&nbsp;the&nbsp;point&nbsp;of&nbsp;departure</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_170\">170</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_160\">160</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;the&nbsp;constituent&nbsp;harm&nbsp;to&nbsp;health&nbsp;is&nbsp;relevant&nbsp;to&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;intended&nbsp;use&nbsp;and&nbsp;a&nbsp;constituent</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_171\">171</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Amino&nbsp;acid&nbsp;sequencing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_161\">161</td><td nowrap=\"nowrap\"><span class=\"diff_add\">specific&nbsp;POD&nbsp;is&nbsp;available,&nbsp;the&nbsp;selected&nbsp;POD&nbsp;and&nbsp;source&nbsp;(i.e.&nbsp;primary&nbsp;health&nbsp;effect&nbsp;data,&nbsp;supporting&nbsp;data</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_172\">172</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_162\">162</td><td nowrap=\"nowrap\"><span class=\"diff_add\">or&nbsp;secondary&nbsp;health&nbsp;effect&nbsp;source)&nbsp;shall&nbsp;be&nbsp;documented.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_173\">173</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_163\">163</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Based&nbsp;on&nbsp;the&nbsp;obtained&nbsp;toxicological&nbsp;information,&nbsp;the&nbsp;most&nbsp;critical&nbsp;(e.g.&nbsp;the&nbsp;lowest)&nbsp;clinically&nbsp;relevant</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_174\">174</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;structure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_164\">164</td><td nowrap=\"nowrap\"><span class=\"diff_add\">POD&nbsp;shall&nbsp;be&nbsp;selected.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_175\">175</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">FTIR</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_165\">165</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a01</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_176\">176</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_166\">166</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Guidance&nbsp;on&nbsp;selection&nbsp;of&nbsp;a&nbsp;POD&nbsp;is&nbsp;given&nbsp;in&nbsp;7.1.&nbsp;Guidance&nbsp;on&nbsp;evaluating&nbsp;toxicological&nbsp;data&nbsp;quality&nbsp;is</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_177\">177</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_167\">167</td><td nowrap=\"nowrap\"><span class=\"diff_add\">given&nbsp;in&nbsp;Annex\u00a0A.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_178\">178</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">13C&nbsp;and&nbsp;1H&nbsp;NMR&nbsp;(*)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_168\">168</td><td nowrap=\"nowrap\"><span class=\"diff_add\">When&nbsp;toxicological&nbsp;information&nbsp;is&nbsp;assessed&nbsp;to&nbsp;be&nbsp;inadequate&nbsp;or&nbsp;absent&nbsp;for&nbsp;an&nbsp;identified&nbsp;constituent,&nbsp;the</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_179\">179</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_169\">169</td><td nowrap=\"nowrap\"><span class=\"diff_add\">use&nbsp;of&nbsp;TTC&nbsp;or&nbsp;toxicological&nbsp;data&nbsp;from&nbsp;a&nbsp;structural&nbsp;analogue&nbsp;(also&nbsp;known&nbsp;as&nbsp;read-across&nbsp;approach),&nbsp;shall</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_180\">180</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">X</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_170\">170</td><td nowrap=\"nowrap\"><span class=\"diff_add\">be&nbsp;justified&nbsp;and&nbsp;documented[30]to[38].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_181\">181</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_171\">171</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a02</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_182\">182</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Not&nbsp;comprehensive&nbsp;or&nbsp;exclusive.&nbsp;Methods&nbsp;denoted&nbsp;with&nbsp;a&nbsp;(*)&nbsp;are&nbsp;methods&nbsp;that&nbsp;are&nbsp;most&nbsp;commonly&nbsp;employed&nbsp;for&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_172\">172</td><td nowrap=\"nowrap\"><span class=\"diff_add\">TTC&nbsp;selection&nbsp;is&nbsp;described&nbsp;in&nbsp;ISO/TS&nbsp;21726.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_183\">183</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">indicated&nbsp;purpose.&nbsp;In&nbsp;certain&nbsp;situations,&nbsp;the&nbsp;other&nbsp;methods&nbsp;listed&nbsp;in&nbsp;this&nbsp;table&nbsp;can&nbsp;be&nbsp;used.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_173\">173</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;following&nbsp;criteria&nbsp;are&nbsp;useful&nbsp;to&nbsp;identify&nbsp;an&nbsp;analogue:</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_184\">184</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_174\">174</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;molecular&nbsp;structure&nbsp;(e.g.&nbsp;the&nbsp;type&nbsp;and&nbsp;arrangement,&nbsp;including&nbsp;bonding,&nbsp;configuration&nbsp;and&nbsp;optical</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_185\">185</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;can&nbsp;include&nbsp;lubricants,&nbsp;crosslinking&nbsp;agents,&nbsp;mould&nbsp;release&nbsp;and&nbsp;blowing&nbsp;agents,&nbsp;and&nbsp;catalysts.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_175\">175</td><td nowrap=\"nowrap\"><span class=\"diff_add\">rotation&nbsp;of&nbsp;elements&nbsp;in&nbsp;a&nbsp;specified&nbsp;order);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_186\">186</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_176\">176</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;physical&nbsp;properties&nbsp;(e.g.&nbsp;molecular&nbsp;weight,&nbsp;boiling&nbsp;point,&nbsp;vapour&nbsp;pressure,&nbsp;density,&nbsp;crystallinity&nbsp;or</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_187\">187</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Metals&nbsp;and&nbsp;alloys&nbsp;are&nbsp;frequently&nbsp;supplied&nbsp;with&nbsp;documented&nbsp;composition.&nbsp;When&nbsp;such&nbsp;information&nbsp;is&nbsp;already&nbsp;available,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_177\">177</td><td nowrap=\"nowrap\"><span class=\"diff_add\">solubility);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_188\">188</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">it&nbsp;is&nbsp;generally&nbsp;not&nbsp;necessary&nbsp;to&nbsp;repeat&nbsp;the&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_178\">178</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;chemical&nbsp;properties&nbsp;(e.g.&nbsp;reactivity,&nbsp;stability,&nbsp;acidity&nbsp;or&nbsp;alkalinity);</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_189\">189</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_179\">179</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;biological&nbsp;properties&nbsp;(e.g.&nbsp;metabolism&nbsp;or&nbsp;metabolic&nbsp;pathways,&nbsp;lipophilicity&nbsp;or&nbsp;bioaccumulation)&nbsp;as</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_190\">190</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;of&nbsp;additives&nbsp;that&nbsp;should&nbsp;be&nbsp;considered&nbsp;include&nbsp;metal&nbsp;deactivators,&nbsp;light/heat&nbsp;stabilizers,&nbsp;plasticizers,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_180\">180</td><td nowrap=\"nowrap\"><span class=\"diff_add\">applicable&nbsp;to&nbsp;the&nbsp;constituent&nbsp;and&nbsp;intended&nbsp;use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_191\">191</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">lubricants,&nbsp;viscosity&nbsp;modifiers,&nbsp;impact&nbsp;modifiers,&nbsp;antistatic&nbsp;agents,&nbsp;antimicrobials,&nbsp;antioxidants,&nbsp;flame&nbsp;retardants,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_181\">181</td><td nowrap=\"nowrap\"><span class=\"diff_add\">NOTE\u00a03</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_192\">192</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">whitening&nbsp;agents,&nbsp;fillers,&nbsp;sintering&nbsp;agents,&nbsp;mould&nbsp;release&nbsp;agents,&nbsp;binders,&nbsp;pigments,&nbsp;and&nbsp;coatings.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_182\">182</td><td nowrap=\"nowrap\"><span class=\"diff_add\">The&nbsp;use&nbsp;of&nbsp;a&nbsp;similarity&nbsp;score&nbsp;(e.g.&nbsp;Tanimoto&nbsp;coefficient,&nbsp;Fingerprints)&nbsp;can&nbsp;be&nbsp;useful&nbsp;in&nbsp;combination</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_193\">193</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_183\">183</td><td nowrap=\"nowrap\"><span class=\"diff_add\">with&nbsp;physicochemical&nbsp;information&nbsp;for&nbsp;the&nbsp;selection&nbsp;of&nbsp;structural&nbsp;analogues[39][40].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_194\">194</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Atomic&nbsp;spectroscopy&nbsp;includes&nbsp;AA&nbsp;and&nbsp;inductively&nbsp;coupled&nbsp;plasma&nbsp;spectroscopy&nbsp;with&nbsp;either&nbsp;optical&nbsp;emission&nbsp;detection</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_184\">184</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Selection&nbsp;of&nbsp;a&nbsp;structural&nbsp;analogue&nbsp;shall&nbsp;be&nbsp;justified&nbsp;and&nbsp;documented.&nbsp;Alternatively,&nbsp;TTC&nbsp;can&nbsp;be&nbsp;used&nbsp;to</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_195\">195</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(ICP-AES)&nbsp;or&nbsp;mass&nbsp;spectrometric&nbsp;(ICP-MS)&nbsp;detection.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_185\">185</td><td nowrap=\"nowrap\"><span class=\"diff_add\">address&nbsp;genotoxicity,&nbsp;carcinogenicity,&nbsp;systemic&nbsp;toxicity,&nbsp;or&nbsp;reproductive&nbsp;or&nbsp;developmental&nbsp;toxicity&nbsp;as</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_196\">196</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_186\">186</td><td nowrap=\"nowrap\"><span class=\"diff_add\">described&nbsp;in&nbsp;7.2[41].</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_197\">197</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;nature&nbsp;of&nbsp;these&nbsp;analyses&nbsp;is&nbsp;such&nbsp;that&nbsp;their&nbsp;quantitative&nbsp;measurements&nbsp;are&nbsp;characterized&nbsp;by&nbsp;either&nbsp;limited</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_187\">187</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\u00a9&nbsp;ISO&nbsp;2023&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_198\">198</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sensitivity&nbsp;or&nbsp;a&nbsp;relatively&nbsp;high&nbsp;degree&nbsp;of&nbsp;imprecision.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_188\">188</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_199\">199</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">g</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_189\">189</td><td nowrap=\"nowrap\"><span class=\"diff_add\">\ufeff</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from20_200\">200</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;method&nbsp;quantifies&nbsp;total&nbsp;impurities&nbsp;but&nbsp;not&nbsp;individual&nbsp;impurities.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_190\">190</td><td nowrap=\"nowrap\"><span class=\"diff_add\">17</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_191\">191</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_192\">192</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_193\">193</td><td nowrap=\"nowrap\"><span class=\"diff_add\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"to20_194\">194</td><td nowrap=\"nowrap\"><span class=\"diff_add\">ISO&nbsp;10993-17:2023(E)</span></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "6.3",
    "change_type": "deleted",
    "old_text": "6.3\t Extractables and leachables\nTest methodologies that can be used in extractables screening and leachables studies are listed in\nTable\u00a04.\nAnalysis of extracted (or leached) substances should consider both organic and inorganic entities.\nOrganic extractables can be qualitatively placed into three classes based on their volatility; VOC,\nSVOC and NVOC. The analytical techniques used to screen for these classes of organic extractables\nare different, though one chemical can often be detected using a variety of techniques; for example,\ngas chromatography with headspace sampling\u00a0 (HS-GC) is typically used to analyse VOCs, gas\nchromatography\u00a0 (GC) is typically used to analyse SVOCs and\u00a0 LC is used to analyse NVOCs. The\nchromatographic techniques used for screening are coupled with appropriate sensitive, broadly\napplicable, and information-rich detection methods to ascertain the extractables\u2019 identity and\nconcentration. As extracts usually contain mixtures of chemicals, chromatographic methods\nare typically coupled to multiple detectors. Thus, for example, GC separations may be coupled to\nflame ionization\u00a0(FID) and MS detectors and LC separations may be coupled to ultraviolet radiation\nabsorption\u00a0(UV) and MS detectors.\n\ufeff\nTable 3 (continued)\n22\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nTable\u00a04\u00a0\u2014 Test methodologies for extractables and leachables\nMaterial\ntype\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nOrganic extractables, VOC\nHS\u2013GC or GC with FID and/or MS*\nX\nX\nTotal organic carbon (TOC)b\n\u2014\nX\nHS-GC and GC, with FID and/or MS*\nX\nX\nOrganic extractables, SVOC\nHPLC, with UV, CAD, ELSD and/or MS*\n\n\nTotal organic carbon (TOC)b\n\u2014\nX\nAll\nNMR\nX\nX\nHPLC, with UV, CAD, ELSD and/or MS*\nX\nX\nOrganic extractables, NVOC\nNMR\nX\nX\nTotal organic carbon (TOC)b\n\u2014\nX\nNon-volatile residue*\n\u2014\nX\nElemental extractables\nICP-AES, ICP-MS*b\nX\nX\nAnions and cations\nIon chromatographyb\nX\nX\na\nNot comprehensive or exclusive. Methods denoted with a (*) are the most typically and commonly employed for the\nindicated purpose and are generally considered sufficient. The selection of the appropriate methods should be carried out\nby qualified personnel, in accordance with the composition of materials of construction and their manufacturing.\nb\nGenerally employed for aqueous extracting solvents (e.g. water, saline).\nAs an extract can contain compounds from all three classes (VOC, SVOC and NVOC), an appropriate\nstrategy for comprehensively screening an extract for organic extractables could involve application\nof all three chromatographic techniques and the various detection strategies. The exact combination\nof separation and detection strategies used to accomplish the screening depends on the nature of the\norganic extractable, as no single chromatographic method is applicable to the wide range of potential\norganic extractables.\nAlthough GC-MS and LC-MS methods are the primary tools used in screening for organic extractables,\nadditional methods can be applied as necessary and appropriate. For example, NMR can be applied to\nfacilitate the identification of organic extractables.\nWhile the chromatographic methods screen solutions for organic extracted compounds, atomic\nspectroscopic methods, including atomic absorption\u00a0(AA), inductively coupled plasma atomic emission\nspectroscopy (ICP-AES), and inductively coupled plasma mass spectrometry (ICP-MS) screen solutions\nfor extracted elements which may be associated with either organic or inorganic extractables. Note\nthat ICP analysis is not strictly limited to analysis of inorganic extractables, as several of the elements\ntypically included in ICP analysis can exist in both organic and inorganic forms (e.g. S, Si, Zn).\nA potential shortcoming in the ICP analysis is that it does not reveal the form in which the element\nexists. This could complicate the toxicological risk assessment of ICP data in certain (but not all)\ncircumstances. For example, sulphur can be extracted as elemental sulphur, as the sulphate ion or as a\npart of an organic extractable (such as mercaptobenzothiazole). The chemical form of sulphur detected\nin an ICP analysis can be necessary to perform the toxicological risk assessment, because the toxicology\nof sulphur can depend on its form.\nIC can be applied to extractables screening to address extracted inorganic anions (e.g. fluoride, chloride,\nsulphate) and low molecular weight organic acids (e.g. acetic and formic acids).\nGeneral methods such as NVR and TOC provide estimates of the total amount of extracted substances\nbut do not provide the identities of the extractables nor the concentrations of individual extractables.\nFurther discussions around the appropriate analytical strategies and methods for extractables and\npotentially leachables screening and profiling are found in References [34] and [48].\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n23\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nIn many circumstances, leachables profiling involves quantifying known and individually targeted\nleachables. In this situation, analytical methods suitable for this purpose shall be developed and\nqualified. In many cases, the same analytical methods used for screening extractables can be optimized\nfor the purpose of targeted leachables analysis.",
    "new_text": "",
    "change_text": "6.3\t Extractables and leachables\nTest methodologies that can be used in extractables screening and leachables studies are listed in\nTable\u00a04.\nAnalysis of extracted (or leached) substances should consider both organic and inorganic entities.\nOrganic extractables can be qualitatively placed into three classes based on their volatility; VOC,\nSVOC and NVOC. The analytical techniques used to screen for these classes of organic extractables\nare different, though one chemical can often be detected using a variety of techniques; for example,\ngas chromatography with headspace sampling\u00a0 (HS-GC) is typically used to analyse VOCs, gas\nchromatography\u00a0 (GC) is typically used to analyse SVOCs and\u00a0 LC is used to analyse NVOCs. The\nchromatographic techniques used for screening are coupled with appropriate sensitive, broadly\napplicable, and information-rich detection methods to ascertain the extractables\u2019 identity and\nconcentration. As extracts usually contain mixtures of chemicals, chromatographic methods\nare typically coupled to multiple detectors. Thus, for example, GC separations may be coupled to\nflame ionization\u00a0(FID) and MS detectors and LC separations may be coupled to ultraviolet radiation\nabsorption\u00a0(UV) and MS detectors.\n\ufeff\nTable 3 (continued)\n22\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nTable\u00a04\u00a0\u2014 Test methodologies for extractables and leachables\nMaterial\ntype\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nOrganic extractables, VOC\nHS\u2013GC or GC with FID and/or MS*\nX\nX\nTotal organic carbon (TOC)b\n\u2014\nX\nHS-GC and GC, with FID and/or MS*\nX\nX\nOrganic extractables, SVOC\nHPLC, with UV, CAD, ELSD and/or MS*\n\n\nTotal organic carbon (TOC)b\n\u2014\nX\nAll\nNMR\nX\nX\nHPLC, with UV, CAD, ELSD and/or MS*\nX\nX\nOrganic extractables, NVOC\nNMR\nX\nX\nTotal organic carbon (TOC)b\n\u2014\nX\nNon-volatile residue*\n\u2014\nX\nElemental extractables\nICP-AES, ICP-MS*b\nX\nX\nAnions and cations\nIon chromatographyb\nX\nX\na\nNot comprehensive or exclusive. Methods denoted with a (*) are the most typically and commonly employed for the\nindicated purpose and are generally considered sufficient. The selection of the appropriate methods should be carried out\nby qualified personnel, in accordance with the composition of materials of construction and their manufacturing.\nb\nGenerally employed for aqueous extracting solvents (e.g. water, saline).\nAs an extract can contain compounds from all three classes (VOC, SVOC and NVOC), an appropriate\nstrategy for comprehensively screening an extract for organic extractables could involve application\nof all three chromatographic techniques and the various detection strategies. The exact combination\nof separation and detection strategies used to accomplish the screening depends on the nature of the\norganic extractable, as no single chromatographic method is applicable to the wide range of potential\norganic extractables.\nAlthough GC-MS and LC-MS methods are the primary tools used in screening for organic extractables,\nadditional methods can be applied as necessary and appropriate. For example, NMR can be applied to\nfacilitate the identification of organic extractables.\nWhile the chromatographic methods screen solutions for organic extracted compounds, atomic\nspectroscopic methods, including atomic absorption\u00a0(AA), inductively coupled plasma atomic emission\nspectroscopy (ICP-AES), and inductively coupled plasma mass spectrometry (ICP-MS) screen solutions\nfor extracted elements which may be associated with either organic or inorganic extractables. Note\nthat ICP analysis is not strictly limited to analysis of inorganic extractables, as several of the elements\ntypically included in ICP analysis can exist in both organic and inorganic forms (e.g. S, Si, Zn).\nA potential shortcoming in the ICP analysis is that it does not reveal the form in which the element\nexists. This could complicate the toxicological risk assessment of ICP data in certain (but not all)\ncircumstances. For example, sulphur can be extracted as elemental sulphur, as the sulphate ion or as a\npart of an organic extractable (such as mercaptobenzothiazole). The chemical form of sulphur detected\nin an ICP analysis can be necessary to perform the toxicological risk assessment, because the toxicology\nof sulphur can depend on its form.\nIC can be applied to extractables screening to address extracted inorganic anions (e.g. fluoride, chloride,\nsulphate) and low molecular weight organic acids (e.g. acetic and formic acids).\nGeneral methods such as NVR and TOC provide estimates of the total amount of extracted substances\nbut do not provide the identities of the extractables nor the concentrations of individual extractables.\nFurther discussions around the appropriate analytical strategies and methods for extractables and\npotentially leachables screening and profiling are found in References [34] and [48].\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n23\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nIn many circumstances, leachables profiling involves quantifying known and individually targeted\nleachables. In this situation, analytical methods suitable for this purpose shall be developed and\nqualified. In many cases, the same analytical methods used for screening extractables can be optimized\nfor the purpose of targeted leachables analysis."
  },
  {
    "clause_id": "6.4",
    "change_type": "deleted",
    "old_text": "6.4 Structural composition or configuration\nAs the structural composition or configuration of a medical device material could be relevant to its\nbiocompatibility, especially in the case of establishing and justifying surrogate devices, it could be\nappropriate to establish these device characteristics. Table\u00a05 lists some of the characteristics which\ncould be relevant, along with examples of appropriate analytical approaches.\nTable\u00a05\u00a0\u2014 Possible test methodologies for assessing the structural composition of medical\ndevice materials\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\n\nConstituent structure\nFTIR, Raman Spectroscopy\nX\nX\n\nCrystallinity\nDSC, X-ray diffraction, Raman\nX\nX\n\nConfiguration, pendant\ngroup analysis\nTitration\n\u2014\nX\n\nSpectroscopy (NMR)\nX\nX\n\nConfiguration, presence of\ndouble bonds\nSpectroscopy (IR/UV)\nX\nX\n\nIodine number\n\u2014\nX\n\nConfiguration, copolymer\ncharacterization\nSpectroscopy (IR/NMR)\nX\nX\n\nChain configuration,\ntacticity\nSpectroscopy (13C NMR)\nX\nX\n\nDSC, TGA\nX\n\u2014\nSynthetic\nPolymer\nChain configuration,\npresence of cross links\nSol-gel extraction\nX\n\u2014\nDMTA\n\u2014\nX\n\nChain branching\nSpectroscopy (NMR)\nX\nX\n\nConfiguration\nRheology\nX\n\u2014\n\nGPC\n\u2014\nX\n\nEnd group analysis\n\u2014\nX\n\nMolecular mass and/or\nmolecular mass distribution\nOsmometry\n\u2014\nX\n\nStatic light scattering\n\u2014\nX\n\nSolution viscometry\n\u2014\nX\n\nSedimentation\n\u2014\nX\n\nMass spectrometry\nX\nX\na\nNot comprehensive or exclusive.\nNOTE\u00a0 1\u00a0 \u00a0 \u00a0 Natural macromolecules utilized in medical devices include but are not limited to proteins, glycoproteins,\npolysaccharides and ceramics. Examples include gelatin, collagen, elastin, fibrin, albumin, alginate, cellulose, fatty acids\n(such as stearic acid), heparin, chitosan, processed bone, coral and natural rubber. These materials could have been\nprocessed, purified and modified to different extents.\nNOTE\u00a0 2\u00a0 \u00a0 \u00a0 For natural macromolecules, it is essential that the source organism (species) and breed/strain be clearly\nidentified as a first step.\nNOTE\u00a03\u00a0\u00a0\u00a0The ISO\u00a022442 series covers the safe utilization of animal tissues and derivatives in the manufacture of medical\ndevices. EN\u00a0455-3 covers the assessment of risks associated with protein residues in natural rubber latex.\nNOTE\u00a04\u00a0\u00a0\u00a0Pharmacopoeial monographs (e.g. Ph. Eur./USP/JP) exist for many of these materials, and several ASTM\u00a0F04\nstandards also cover the characterization of these materials (see Bibliography).\nNOTE\u00a05\u00a0\u00a0\u00a0For characterization of nanomaterials, see ISO/TR\u00a010993-22.\n\ufeff\n24\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nMetals and alloys\nCrystallographic phases\nX-ray diffraction\nX\n\u2014\nElectron diffraction\nX\n\u2014\nMicro/Macro structure\nMetallography\nX\nX\nCeramics\nValency\nColourimetric analysis\nX\n\u2014\nPhases\nX-ray diffraction\nX\nX\nMicrostructure\nMicroscopy\n\u2014\nX\nConfiguration, pendant\ngroup analysis\nTitration\n\u2014\nX\nSpectroscopy\nX\nX\nChain configuration, tactic\u00ad\nity\nSpectroscopy (13C NMR)\nX\nX\nNatural\nmacromolecules\n(see NOTES)\nDSC\nX\n\u2014\nChain configuration, pres\u00ad\nence of crosslinks\nSol-gel extraction\nX\n\u2014\nDi-sulphide link analysis\n\u2014\nX\nChain configuration,\nbranching\nDMTA\n\u2014\nX\nSpectroscopy\nX\nX\na\nNot comprehensive or exclusive.\nNOTE\u00a0 1\u00a0 \u00a0 \u00a0 Natural macromolecules utilized in medical devices include but are not limited to proteins, glycoproteins,\npolysaccharides and ceramics. Examples include gelatin, collagen, elastin, fibrin, albumin, alginate, cellulose, fatty acids\n(such as stearic acid), heparin, chitosan, processed bone, coral and natural rubber. These materials could have been\nprocessed, purified and modified to different extents.\nNOTE\u00a0 2\u00a0 \u00a0 \u00a0 For natural macromolecules, it is essential that the source organism (species) and breed/strain be clearly\nidentified as a first step.\nNOTE\u00a03\u00a0\u00a0\u00a0The ISO\u00a022442 series covers the safe utilization of animal tissues and derivatives in the manufacture of medical\ndevices. EN\u00a0455-3 covers the assessment of risks associated with protein residues in natural rubber latex.\nNOTE\u00a04\u00a0\u00a0\u00a0Pharmacopoeial monographs (e.g. Ph. Eur./USP/JP) exist for many of these materials, and several ASTM\u00a0F04\nstandards also cover the characterization of these materials (see Bibliography).\nNOTE\u00a05\u00a0\u00a0\u00a0For characterization of nanomaterials, see ISO/TR\u00a010993-22.",
    "new_text": "",
    "change_text": "6.4 Structural composition or configuration\nAs the structural composition or configuration of a medical device material could be relevant to its\nbiocompatibility, especially in the case of establishing and justifying surrogate devices, it could be\nappropriate to establish these device characteristics. Table\u00a05 lists some of the characteristics which\ncould be relevant, along with examples of appropriate analytical approaches.\nTable\u00a05\u00a0\u2014 Possible test methodologies for assessing the structural composition of medical\ndevice materials\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\n\nConstituent structure\nFTIR, Raman Spectroscopy\nX\nX\n\nCrystallinity\nDSC, X-ray diffraction, Raman\nX\nX\n\nConfiguration, pendant\ngroup analysis\nTitration\n\u2014\nX\n\nSpectroscopy (NMR)\nX\nX\n\nConfiguration, presence of\ndouble bonds\nSpectroscopy (IR/UV)\nX\nX\n\nIodine number\n\u2014\nX\n\nConfiguration, copolymer\ncharacterization\nSpectroscopy (IR/NMR)\nX\nX\n\nChain configuration,\ntacticity\nSpectroscopy (13C NMR)\nX\nX\n\nDSC, TGA\nX\n\u2014\nSynthetic\nPolymer\nChain configuration,\npresence of cross links\nSol-gel extraction\nX\n\u2014\nDMTA\n\u2014\nX\n\nChain branching\nSpectroscopy (NMR)\nX\nX\n\nConfiguration\nRheology\nX\n\u2014\n\nGPC\n\u2014\nX\n\nEnd group analysis\n\u2014\nX\n\nMolecular mass and/or\nmolecular mass distribution\nOsmometry\n\u2014\nX\n\nStatic light scattering\n\u2014\nX\n\nSolution viscometry\n\u2014\nX\n\nSedimentation\n\u2014\nX\n\nMass spectrometry\nX\nX\na\nNot comprehensive or exclusive.\nNOTE\u00a0 1\u00a0 \u00a0 \u00a0 Natural macromolecules utilized in medical devices include but are not limited to proteins, glycoproteins,\npolysaccharides and ceramics. Examples include gelatin, collagen, elastin, fibrin, albumin, alginate, cellulose, fatty acids\n(such as stearic acid), heparin, chitosan, processed bone, coral and natural rubber. These materials could have been\nprocessed, purified and modified to different extents.\nNOTE\u00a0 2\u00a0 \u00a0 \u00a0 For natural macromolecules, it is essential that the source organism (species) and breed/strain be clearly\nidentified as a first step.\nNOTE\u00a03\u00a0\u00a0\u00a0The ISO\u00a022442 series covers the safe utilization of animal tissues and derivatives in the manufacture of medical\ndevices. EN\u00a0455-3 covers the assessment of risks associated with protein residues in natural rubber latex.\nNOTE\u00a04\u00a0\u00a0\u00a0Pharmacopoeial monographs (e.g. Ph. Eur./USP/JP) exist for many of these materials, and several ASTM\u00a0F04\nstandards also cover the characterization of these materials (see Bibliography).\nNOTE\u00a05\u00a0\u00a0\u00a0For characterization of nanomaterials, see ISO/TR\u00a010993-22.\n\ufeff\n24\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nMaterial type\nCharacteristic\nExample methodsa\nQualitative\nQuantitative\nMetals and alloys\nCrystallographic phases\nX-ray diffraction\nX\n\u2014\nElectron diffraction\nX\n\u2014\nMicro/Macro structure\nMetallography\nX\nX\nCeramics\nValency\nColourimetric analysis\nX\n\u2014\nPhases\nX-ray diffraction\nX\nX\nMicrostructure\nMicroscopy\n\u2014\nX\nConfiguration, pendant\ngroup analysis\nTitration\n\u2014\nX\nSpectroscopy\nX\nX\nChain configuration, tactic\u00ad\nity\nSpectroscopy (13C NMR)\nX\nX\nNatural\nmacromolecules\n(see NOTES)\nDSC\nX\n\u2014\nChain configuration, pres\u00ad\nence of crosslinks\nSol-gel extraction\nX\n\u2014\nDi-sulphide link analysis\n\u2014\nX\nChain configuration,\nbranching\nDMTA\n\u2014\nX\nSpectroscopy\nX\nX\na\nNot comprehensive or exclusive.\nNOTE\u00a0 1\u00a0 \u00a0 \u00a0 Natural macromolecules utilized in medical devices include but are not limited to proteins, glycoproteins,\npolysaccharides and ceramics. Examples include gelatin, collagen, elastin, fibrin, albumin, alginate, cellulose, fatty acids\n(such as stearic acid), heparin, chitosan, processed bone, coral and natural rubber. These materials could have been\nprocessed, purified and modified to different extents.\nNOTE\u00a0 2\u00a0 \u00a0 \u00a0 For natural macromolecules, it is essential that the source organism (species) and breed/strain be clearly\nidentified as a first step.\nNOTE\u00a03\u00a0\u00a0\u00a0The ISO\u00a022442 series covers the safe utilization of animal tissues and derivatives in the manufacture of medical\ndevices. EN\u00a0455-3 covers the assessment of risks associated with protein residues in natural rubber latex.\nNOTE\u00a04\u00a0\u00a0\u00a0Pharmacopoeial monographs (e.g. Ph. Eur./USP/JP) exist for many of these materials, and several ASTM\u00a0F04\nstandards also cover the characterization of these materials (see Bibliography).\nNOTE\u00a05\u00a0\u00a0\u00a0For characterization of nanomaterials, see ISO/TR\u00a010993-22."
  },
  {
    "clause_id": "6.5",
    "change_type": "deleted",
    "old_text": "6.5\t Analytical methods\nAnalytical methods used in chemical characterization generally serve one of two purposes: screening\nsamples for unspecified analytes and testing samples for specified (targeted) analytes. The purpose of\na screening analysis is to reveal analytes present in the sample above a relevant reporting threshold\n(e.g. AET), to estimate the concentration of such analytes, and to secure the identities of such analytes.\nThe purpose of a targeting analysis is to accurately and precisely establish the concentration of the\nspecified (targeted) and identified analytes in the sample.\nAppropriate analytical methods shall be developed and qualified for these purposes, where qualification\nis defined as the process by which a method is established to be suited for its intended use. Prior to new\nmethod development, existing standards, monographs, scientific articles or other relevant scientific\ndocuments should be consulted to check for existing appropriate test methods. Methods from the\nliterature could potentially need to be adapted and qualified before use. If suitable methods cannot be\nidentified, appropriate new methods shall be developed.\nAs it is generally the case that the potential population of analytes which is addressed by analytical\nscreening methods is large and diverse, a single method cannot be qualified for all potential analytes\nand it is not possible that a single method produces highly accurate and precise concentration estimates\nfor all potential analytes. Thus, analytical methods used for screening should be qualified, whenever\npossible, using a set of surrogate analytes representative of the entire population of possible analytes.\nFor example, when an analytical method is employed to screen an extract for extractables above the AET,\nthe method shall be qualified using a set of potential extractables as surrogate analytes. The rationale\nfor selecting surrogate analytes shall be documented. Potential factors in such a rationale could include\n\ufeff\nTable 5 (continued)\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n25\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nknowledge of expected substances from material composition, functional group information from MS\nor similarity in retention time(s).\nAlternatively, a method used to analyse a test sample to establish the levels of targeted analytes is\ngenerally optimized for this purpose and thus while it might sacrifice broadness in scope (which is\ncritical in screening methods), it does so in a manner that enhances other performance properties such\nas accuracy and precision. Because the targeting method targets a small and defined list of analytes,\nthe qualification of the method addresses the performance of the method specific to each and every\ntargeted analyte.\nThe qualification of an analytical method is discussed in Annex\u00a0F.",
    "new_text": "",
    "change_text": "6.5\t Analytical methods\nAnalytical methods used in chemical characterization generally serve one of two purposes: screening\nsamples for unspecified analytes and testing samples for specified (targeted) analytes. The purpose of\na screening analysis is to reveal analytes present in the sample above a relevant reporting threshold\n(e.g. AET), to estimate the concentration of such analytes, and to secure the identities of such analytes.\nThe purpose of a targeting analysis is to accurately and precisely establish the concentration of the\nspecified (targeted) and identified analytes in the sample.\nAppropriate analytical methods shall be developed and qualified for these purposes, where qualification\nis defined as the process by which a method is established to be suited for its intended use. Prior to new\nmethod development, existing standards, monographs, scientific articles or other relevant scientific\ndocuments should be consulted to check for existing appropriate test methods. Methods from the\nliterature could potentially need to be adapted and qualified before use. If suitable methods cannot be\nidentified, appropriate new methods shall be developed.\nAs it is generally the case that the potential population of analytes which is addressed by analytical\nscreening methods is large and diverse, a single method cannot be qualified for all potential analytes\nand it is not possible that a single method produces highly accurate and precise concentration estimates\nfor all potential analytes. Thus, analytical methods used for screening should be qualified, whenever\npossible, using a set of surrogate analytes representative of the entire population of possible analytes.\nFor example, when an analytical method is employed to screen an extract for extractables above the AET,\nthe method shall be qualified using a set of potential extractables as surrogate analytes. The rationale\nfor selecting surrogate analytes shall be documented. Potential factors in such a rationale could include\n\ufeff\nTable 5 (continued)\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n25\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nknowledge of expected substances from material composition, functional group information from MS\nor similarity in retention time(s).\nAlternatively, a method used to analyse a test sample to establish the levels of targeted analytes is\ngenerally optimized for this purpose and thus while it might sacrifice broadness in scope (which is\ncritical in screening methods), it does so in a manner that enhances other performance properties such\nas accuracy and precision. Because the targeting method targets a small and defined list of analytes,\nthe qualification of the method addresses the performance of the method specific to each and every\ntargeted analyte.\nThe qualification of an analytical method is discussed in Annex\u00a0F."
  },
  {
    "clause_id": "7",
    "change_type": "modified",
    "old_text": "7\t Reporting of the chemical characterization data\nThe purpose of a chemical assessment report is to provide information that enables the review of\nchemical characterization data and supports the toxicological risk assessment of this information.\nSuch reports shall clearly state the purpose and objectives of the chemical assessment that has been\nperformed and shall include description and justification for the following:\na)\t test article (material or medical device) description and details of sample preparation;\nb)\t analytical methods and extraction conditions (e.g. choice of extraction vehicles, extraction duration\nand cycles, extraction temperature, extraction/sample ratio, agitation method and speed during\nextraction);\nc)\ndocumentation of system suitability testing and its outcome;\nd)\t value for, and justification of, the reporting threshold (e.g. AET);\ne)\t qualitative data generated (e.g. extractables' identities, including a description of the identification\nprocedure);\nf)\nquantitative data generated (e.g. extractables\u2019 concentrations, including a description of the\nquantification procedures and providing the classification of the quantitative data as estimated\nquantitative analysis, semi-quantitative analysis or quantitative analysis);\ng)\t information necessary to estimate clinical exposure to chemicals (e.g. analyte amounts in \u00b5g/\ndevice).\nAs necessary and appropriate, identified substances in the test solutions could be grouped into\ncompound classes, based on structural or functional group similarities, to assist in any toxicological\nrisk assessment.\nChemical or compositional information or data that is obtained without the device\u2019s sponsor having to\nperform testing (e.g. data supplied by a material\u2019s vendor, data available from the chemical literature)\ncan be included in reports, as relevant and appropriate. Reporting requirements for data obtained from\nsuch additional sources include the same items noted above for sponsor-generated test data but in\naddition would include a discussion of its relevance to the toxicological risk assessment.\nIn addition to containing the necessary study design-related details and the relevant and appropriate\nchemical assessment data, thereby facilitating study review and toxicological risk assessment, a report\nshould contain sufficient information to establish the appropriateness of the analytical processes\nemployed. Such information would be relevant to establishing that the analytical procedures were\nsuitable for their intended use and implemented appropriately at their time of use.\nTypes of information that can be included in a report to facilitate the toxicological risk assessment and\nthe review of the analytical data and procedures are listed in Annex\u00a0G.\n\ufeff\n26\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0A\n(informative)\n\nGeneral principles of chemical characterization\nA.1\t The chemical characterization process\nChemical characterization is the process of obtaining chemical information about a medical device,\nrelevant to its biological evaluation and any toxicological risk assessment. Chemical characterization of\na medical device, its components, or its materials of construction involves multiple processes, including\ninformation gathering and generation, to:\n\u2014\t establish the device\u2019s material composition and configuration;\n\u2014\t identify and quantify extractables and/or leachables associated with the device.\nChemically characterizing a medical device and/or its components and materials of construction is a\nnecessary aspect in assessing the biological safety of that medical device.\nA.2\t The uses of chemical characterization\nChemical characterization can facilitate the biological safety assessment process in one of three ways\nby providing\n\u2014\t the chemical information that enables a comparison between the medical device in question and\nclinically established medical devices (establish equivalence),\n\u2014\t the chemical basis for comparing the medical device in question to a relevant material standard\n(confirm conformance), and\n\u2014\t the chemical information that serves as the basis for a toxicological risk assessment (enable\nassessment).\nIn certain circumstances, the toxicological implications associated with use of a medical device can be\nassessed by comparing the device in question to a clinically established device. In such circumstances,\nchemical characterization is important in establishing chemical equivalence between, for example,\n\u2014\t a proposed item (materials, component or device) and a clinically established item (see Annex\u00a0C),\n\u2014\t a finished and marketable medical device and a prototype device, and\n\u2014\t a material, component, or medical device after a process, material, application or manufacturing\nchange.\nStandards that include requirements for material composition exist for some medical device materials\n(e.g. the ISO\u00a0 5832 series). It is possible that a material complying with such a standard would not\nrequire further chemical characterization to support toxicological or biological evaluation. However,\nthe conversion of the material into the final form of the medical device can introduce contaminants or\nprocess residues. These can leach from the medical device and be of toxicological concern. Evaluation of\nthe finished medical device should consider and address such leachables. In addition, physical, chemical,\nmorphological, and topographical characteristics of a component manufactured with the material may\nneed to be assessed to determine the overall safety.\nLastly, and in other circumstances, most notably at its inception and in the absence of a relevant\nclinically established medical device, the toxicological implications associated with the use of a device,\nincluding its components or materials of construction, can be assessed using a chemical characterization\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n27\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\napproach. Such an approach can include data gathering, data generation (e.g. extractables or leachables\nprofiles), and data interpretation.\nAn overview of the chemical characterization procedure outlined in this document and its relationship\nto risk assessment is given in Clause\u00a05. The procedure is based on the following considerations.\na)\t The first step in chemical characterization is establishing contact according to ISO\u00a010993-1.\nb)\t The extent of chemical characterization (e.g. whether information gathering can be sufficient;\ndesign of extraction studies, if performed) should reflect:\n1)\t the nature and duration of the clinical exposure;\n2)\t the physical form of the materials used (e.g. liquids, gels, pastes, solids, or biologically sourced\nmaterial);\n3)\t the history of use of the materials.\nFurther, it should be sufficient to produce the data necessary to establish the biological safety of\nthe medical device.\nc)\nEstablishing the configuration of a medical device, by delineating its materials of construction, is the\nnecessary first step in establishing the device\u2019s biocompatibility as (a) use of appropriate materials\nof construction increases the likelihood a device will be biocompatible and (b) knowledge of the\nmaterials of construction could provide the starting point for establishing chemical equivalence to\na clinically established device.\nFor some medical devices, configuration and material composition information could be readily\navailable to the device manufacturer as part of the device specification, or it could be obtained\nthrough inquiry. In other circumstances, such information can be obtained by appropriate testing\nof the device. In any case, processing aids and additives (see Table\u00a03, footnotes b and d) should be\nincluded as part of this compositional information.\nd)\t Establishing the composition of a medical device\u2019s materials of construction is a necessary step\nin establishing a device\u2019s biocompatibility, as (a) the composition of the individual materials of\nconstruction can serve as the basis for establishing chemical equivalence to a clinically established\ndevice, and (b) the chemical entities contained in a material of construction can be sources of\nextractables and leachables.\n1)\t Compositional data include qualitative data, which describe the composition of a material and\nestablish which chemicals are present in the material, and quantitative data which establish\nthe concentrations of the material\u2019s chemical constituents. Quantitative information can\nbe necessary to assess biological safety, as the identity and amounts of the constituents of a\nmedical device\u2019s materials of construction enables the investigation of the intrinsic toxicity of\neach constituent. The data obtained are intended for use by the medical device manufacturer\nto support the biological evaluation of the medical device.\n2)\t For some materials, compositional information could be readily available as part of the material\nspecification. As materials such as polymers can have complex formulations, compositional\ndetails should be requested from the supplier of the material. Furthermore, some relevant\ninformation can be available in the published chemical literature (e.g. typical variability\nin composition or guidance on possible analytes of interest). In the absence of such details,\nappropriate analytical techniques can be applied to a material to obtain compositional data.\ne)\t Determining the medical device\u2019s potential to release chemical substances under clinical\nuse conditions can provide the basis for understanding and assessing the device\u2019s potential\nsafety impact. Although any of the substances in a material or additives used in the process of\nmanufacturing a medical device could be leached from the device and thereby become bio-available,\nit could potentially be necessary to obtain information demonstrating the extent to which the\nsubstances will be leached under the clinical use conditions of the finished product to estimate\nthe risk arising from them. This can be estimated by conducting extraction studies of the medical\n\ufeff\n28\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\ndevice. Appropriate extraction conditions should be established, justified and then used to ensure\nthat any substance which is likely to be released during finished product use will be released into\nthe extraction media (see also Annex\u00a0D). Extractions can be used to determine the total amount of\nextractable materials that is present in the medical device/material (exhaustive extraction) or the\ntotal available amount of extractable material (exaggerated or simulated use extraction) in order\nto complete the toxicological risk assessment. Exhaustive extractions are generally necessary\nto produce sufficient data for medical devices with prolonged or long-term contact; exaggerated\nextractions should only be used for long term contact devices if appropriately justified.\nRegardless of the means by which the extract is obtained, the extract is quantitatively analysed to\ngenerate the data for use in the toxicological risk assessment of the medical device (see ISO\u00a010993-17).\nDepending on the nature and sources of the chemical information to be assembled, the successful\ncompletion of the chemical characterization outlined in this document can require expertise in material\nscience or analytical chemistry to provide the necessary qualitative and quantitative data that a risk\nassessor can use to assess medical device safety. Toxicology expertise is valuable in understanding the\ntypes of compounds that might be of toxicological concern so that the materials and chemistry experts\ncan design appropriate experiments.\nThe chemical characterization outlined in this document is performed as part of the initial\nbiocompatibility assessment of the medical device. It is noted that the biological safety of the medical\ndevice is inferred over the medical device\u2019s time in market only so long as the device\u2019s materials of\nconstruction and manufacturing process remain unchanged. It is important that controls be introduced\nto prevent a material supplier from changing the composition of a material supplied under a specific\ncommercial trade name or supply agreement without prior notification to the medical device\nmanufacturer. The manufacturer should assess and document the consequences of any notified changes\non the biological safety of the product.\nA.3\t The analytical evaluation threshold\nAn important aspect of extractables/leachables analysis is the testing of a liquid sample (e.g. extract,\ndigest) to detect, identify, and quantify solubilized (extracted or leached) substances. For the purposes\nof toxicological assessment, the analytical test methods will be capable of detecting, identifying, and\nquantifying solubilized substances in the extract at the levels which could potentially have an effect\non the health of potentially affected individuals in contact with a medical device. However, in certain\ncircumstances some essential chemical characterization activities, such as identification, cannot be\nperformed. In the absence of reliable identification or sufficient toxicological information for identified\ncompounds, the probable risk can often be inferred via the application of toxicological threshold\nconcepts. Accordingly, substances lower than such a threshold do not require further chemical\ncharacterization, including identification and quantification. It is noted that these thresholds make\nexceptions for special case compounds of known high toxicity.\nIf a threshold is expressed in terms of dose, then it is not directly applicable to analytical\ncharacterization of a liquid test sample. However, these thresholds can be converted to a concentration\nvia the appropriate mathematical conversion, which takes into account the clinical use of the medical\ndevice and the experimental conditions used to derive the liquid sample. Such a concentration-based\nthreshold, termed the AET, becomes that threshold above which an analytical chemist should produce\nthat information (concentration and identity) which is necessary for toxicological risk assessment (e.g.\napplication of ISO\u00a010993-17). A substance that is present in a liquid sample at a concentration below the\nAET is established as having an acceptable toxicological risk without further assessment, meaning that\nthe substance does not have to be accurately quantified or identified.\nThe AET is not applicable to analytical targeting methods in which the specified analytes are compounds\nwith sufficient toxicological safety data to address using ISO\u00a010993-17.\nThe calculation and application of the AET is discussed in greater detail in Annex\u00a0E.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n29\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nA.4\t The role of chemical characterization in biological analysis\nThe primary objective of ISO\u00a010993 is the protection of humans from potential biological risks arising\nfrom the use of medical devices. This objective is achieved via the biological evaluation of medical\ndevices, which includes the means (testing procedures) for producing the biological data and the means\nof interpreting the biological data in the context of a risk assessment.\nGenerally, biocompatibility information can be obtained from two types of assessments: (1) chemical\ncharacterization coupled with relevant toxicology data, and (2) biological testing. Generally, risk\nassessment should include the proper mix of chemical and biological data, which can vary depending\nupon the circumstances. If information from both types of assessments address the same biological\nendpoint in a comparable manner, information from either type of assessment could be used to address\nthat endpoint. However, in vitro tests should be favoured as far as possible (see ISO\u00a010993-2). In the\nevent conflicting data is obtained, the biological test (given it has acceptable sensitivity) should be\ngiven greater weight due to its being directly applicable to biological systems.\nThe general category of biological evaluation can be further subdivided into two sub-categories: those\ntypes of testing that evaluate a systemic effect (i.e. one that depends on systemic distribution of extracts\nor leachates), and those that evaluate local effects (i.e. those that occur in the vicinity of the medical\ndevice). Tests that evaluate systemic effects, or endpoints (e.g. systemic toxicity) are more likely to be\nsuitably addressed by chemical characterization than are those tests for local effects (e.g. irritation and\nimplantation effects). Endpoints that have both local and systemic effects (e.g. sensitization) may be\naddressed through chemical characterization, if sufficient toxicology data exist.\nThe use of chemical characterization in place of biological testing should be documented and justified.\n\ufeff\n30\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0B\n(informative)\n\nInformation sources for chemical characterization\nB.1\t General\nKnowledge of a medical device\u2019s material composition is an essential input into a device\u2019s biological\nevaluation and toxicological risk assessment (see ISO\u00a0 10993-1 and ISO\u00a0 10993-17). As described in\nISO\u00a010993-1:2018, 6.1, the type and amount of characterization data should be consistent with all of\nthe parameters considered relevant to the risk assessment of the medical device and should consider\nthe clinical application. Gathering of chemical characterization data could require the use of multiple\nsources of information as described in B.2 to B.4 and could include a review of the available published\nchemical literature.\nB.2\t Information from the material supplier\nThe following information, where available, is useful to specify the material used (e.g. raw and basic\nstarting materials, processing aids), and the compositional information is particularly useful to aid\nquantitative risk assessment:\na)\t name of material manufacturer or supplier;\nb)\t generic material trade name;\nEXAMPLE\nSilastic\u00ae, Dacron\u00ae, Tetoron\u00ae, Pellethane\u00ae, Nylon, Teflon\u00ae1).\nc)\nchemical identifier (e.g. CAS number) or systematic name (IUPAC/USAN) (see B.5);\nd)\t product code and number;\nEXAMPLE\nPellethane 2393-80AE, methylvinylpolysiloxane 0215.\ne)\t material manufacturer's specification, including, for example, purity, impurity identities and levels,\nquality, molecular weight, molecular weight distribution, thermal properties, tensile strength,\nRockwell hardness, bending modulus, conduction of electricity, and others in addition to the\ngeneral parameters described in 5.2;\nf)\ndetails of material composition and formulation (see 5.2) such as Chemical Abstracts Service\u00a0(CAS)\nnumbers (see B.5.2), mass fraction in percent\u00a0(%) of each chemical in the formulation, function of\neach chemical constituent, and structure and formula of each chemical;\nNOTE\nFor medical grade components often used in medical devices, a detailed description can be\nfound in material standards [e.g. ASTM F136-13 Standard Specification for Wrought Titanium-6Aluminum-\n4Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications], and sometimes in\npharmacopoeias.\ng)\t certificates of compliance with regional compendia and relevant global regulations (e.g. REACH,\nindirect food additives).\n1)\t  Silastic\u00ae, Dacron\u00ae, Tetoron\u00ae, Pellethane\u00ae, Nylon, Teflon\u00ae are examples of suitable products available\ncommercially. This information is given for the convenience of users of this document and does not constitute an\nendorsement by ISO of these products.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n31\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nB.3\t Chemical analyses\nB.3.1\t General\nFurther to Clause\u00a06, several modes of chemical analyses are described in B.3.2 to B.3.5.\nB.3.2 Non-specific chemical analysis relevant to exposure assessment\nNon-specific chemical analyses have been included in some international standards and national\nguidelines or standards intended to ensure safety. These methods are generally usable for an imprecise,\nfirst pass estimation of the chemical hazards of medical devices, though their direct relationship to\nsafety is limited. Some examples are given below:\nEXAMPLE 1\nOECD Guidelines; Test No.\u00a0120[17].\nThis test protocol[17] describes the procedure for determining the solution/extraction behaviour of\npolymers in water at 20\u00a0\u00b0C at pH\u00a02 and pH\u00a09 and at 37\u00a0\u00b0C at pH\u00a07. Total organic carbon content\u00a0(TOC)\nanalysis is recommended for determining total polymeric species in aqueous phase. Other more specific\nmethods are also described.\nEXAMPLE 2\nJP\u00a0XVII[21], USP 41[22] or Ph. Eur. Ed.\u00a09[20].\nThe JP and Ph. Eur methods (see References\u00a0[21] and [20]) include test methods and specifications for\nresidue on ignition, heavy metals, extractable substances such as potassium permanganate-reducing\nsubstances and residue of evaporation. The USP methods (Reference\u00a0[22]) include test methods and\nspecifications for acidity/alkalinity, UV absorbance, total organic carbon\u00a0 (TOC), extractable metals,\npolymer additives and biocompatibility.\nB.3.3\t Qualitative analysis\nIf material composition and/or formulation is required but the available qualitative information is\njudged to be incomplete or not available, further chemical testing can be necessary. Depending on the\ninformation needs, qualitative or quantitative information might be required.\nMany of the analytical methods employed for chemical characterization are capable of both qualitative\nand quantitative analyses. However, the purpose of the qualitative analysis is to provide a list of\nidentified chemical constituents in a sample. Conversely, the aim of quantitative analysis is to establish\nthe level or amount of each individual chemical constituent in a sample, whether the constituent\nis identified or not. Since a toxicological risk assessment is typically based on both identity (which\nestablishes the constituent\u2019s toxic potential) and concentration (which establishes exposure), both\nqualitative and quantitative analyses are important and relevant.\nNOTE\nSemi-quantitative methods can be sufficient for an initial risk assessment, and quantitative methods\nmight be needed when a specific risk has been identified (i.e. an inadequate margin of safety found after semi-\nquantitative analysis).\nB.3.4 Quantitative analysis of specific toxic chemicals for exposure assessment\nIf qualitative analyses identify chemicals of toxicological concern, then quantitative and specific\nanalysis should be performed. The specificity, level of sensitivity and limit of quantification of the\nanalytical method should be sufficient for the required level of risk assessment.\nB.3.5\t Qualitative and quantitative analytical methods\nNMR, attenuated total reflectance/Fourier transform infrared spectroscopy (ATR/FT-IR) and pyrolysis\ngas chromatography/mass spectrometry are useful methods for compositional and formulation\nanalyses. Medical device or material extracts can be analysed by chromatographic methods combined\nwith appropriate detection techniques (e.g. GC and LC each combined with MS) to identify and\nquantify, as appropriate, extracted substances. Inductively coupled plasma\u00a0 (ICP) analysis is useful\nfor establishing the levels of elements present in extracts or digests of medical devices or materials,\n\ufeff\n32\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nalthough this method does not establish the chemical form of the element. Such analytical methods can\nbe employed so that gaps in material composition and/or formulation are adequately and appropriately\naddressed.\nB.4 National and international material and/or product standards\nMost material and/or product standards specify a quality of material in the standard in relation to the\npurpose of use. When the material used in the medical device meets such a standard and when the\ncategory and duration of contact of the device are comparable to those in the standard, giving the title\nand number of the standard can be sufficient for characterization of the material. Applicability of these\nstandards for chemical characterization depends on the following factors.\n\u2014\t Does the standard specify the medical device and its contact and duration?\n\u2014\t Does the standard specify the material (e.g. specific material, category of material)? If so, to\nwhat extent?\n\u2014\t Does the standard set any limits on the level of certain chemicals? Are such limits comprehensive,\nspecific, general, or total?\n\u2014\t Does the medical device or material standardized have a history of safe clinical use?\nThe extent to which these factors are addressed in the standard determines the extent to which their\nuse can fulfil chemical characterization needs.\nNOTE\nUse of material standards might not be sufficient to address the effects that manufacturing and\nprocessing can have on materials when incorporated into the final device. For example, the manufacturing\nprocess for medical devices manufactured out of metallic materials described in national and international\nmaterial or product standards can have a negative influence upon the overall biocompatibility, as residues of\ncutting oils used during the CNC cutting process can be insufficiently removed.\nB.5\t Reporting chemical descriptions of materials\nB.5.1\t Generic name of material\nThe generic name should be supplied with references to the specific chemical name.\nNOTE\nGeneric names can be misunderstood. For instance, \u201cpolyester\u201d refers to a class of polymers comprised\nof ester linkages, but is commonly used to refer specifically to poly(ethylene terephthalate).\nB.5.2\t Other nomenclatures and chemical descriptions of materials\nB.5.2.1\t General\nThere are several nomenclature systems that specify the materials more exactly.\nB.5.2.2\t IUPAC nomenclature and structure formulae of polymeric chemicals\nThe International Union of Pure and Applied Chemistry\u00a0 (IUPAC) Macromolecular Nomenclature\nCommission has published rules for naming polymers[37]. Naming and describing polymers according\nto the rules present some exact features of polymeric chemicals as defined. It does not give any\ninformation however about the commercially available polymers that often contain some additives.\nB.5.2.3 CAS Registry number, USAN, REACH and other registry name and/or number\nChemical Abstract Service\u00a0(CAS) and United States Adopted Names\u00a0(USAN) give a specific number and\nname respectively to newly developed polymeric chemicals such as contact lens materials. When the\nmaterial used has its given CAS No. and/or USAN name, it is easy to discriminate it from similar but not\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n33\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nidentical materials. Concise information on the chemical constituents/ingredients is possibly available\nfrom USAN.\nThough the REACH registration number is primarily to demonstrate REACH registration, it provides\na link to the ECHA database which can contain helpful information such as substance identification,\npurity, identity and levels of impurities.\nB.6\t Reporting general information concerning chemical nature of materials\nSeveral parameters are generally usable to specify the chemical nature of the material used. These\nparameters differ by category of materials. For synthetic polymers, examples of such parameters\nare molecular mass and its distribution, glass transition temperature, melting point, specific gravity,\nsolubility and swelling nature.\nNOTE\nThe OECD Guidelines, Section\u00a01, Test No.\u00a0118:1996 can be useful for synthetic polymers[16].\nB.7 Material master file\nWhen it can be secured, a master file may be used in the review of a pending application for marketing\nauthorization of a specific medical device. It often contains detailed information about a specific\nmaterial formulation, or its processing, which is used in a medical device. It is a reference source that\nallows a third party to submit information to a regulatory agency. A master file is useful for supporting\nequivalence of a material or suitability of a material for a specific category of use. Its contents are\nconsidered to be trade secret or commercially confidential information.\n\ufeff\n34\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0C\n(informative)\n\nPrinciples for establishing biological equivalence\nC.1\t General\nAs noted in 5.3, it can be appropriate to compare a new or modified medical device (or material) with\nan existing clinically established medical device (material). When the term medical device is used in\nthis annex, it is understood that the same concepts are applicable to materials as well. The purpose of\nsuch a comparison would be to establish whether the new or modified medical device is biologically\nequivalent to the existing medical device since if biological equivalence can be established then the\nexisting medical device\u2019s biocompatibility can be extended to the new or modified medical device.\nC.2\t Principles of biological equivalence\nThe concept of biological equivalence consists of the following elements (Figure\u00a0C.1):\n\u2014\t Chemical equivalence: situation where the chemical characteristics of two materials or medical\ndevices are sufficiently similar, such that the composition and processing do not result in additional\nor different toxicological concerns.\n\u2014\t Physical equivalence: situation where the physical characteristics of two materials or medical devices\nare sufficiently similar, such that the configuration, morphology, topography (per ISO/TS\u00a010993-19)\nand tribology do not result in additional or different biocompatibility concerns.\n\u2014\t Material equivalence: situation where two materials or medical devices demonstrate chemical and\nphysical equivalence.\n\u2014\t Contact equivalence: situation where the intended clinical use of two materials or medical devices\nis sufficiently similar that the endpoints of biological evaluation identified in ISO\u00a010993-1:2018, A.1\nare identical.\n\u2014\t Biological equivalence: situation where two materials or medical devices demonstrate material and\ncontact equivalence.\nFigure\u00a0C.1\u00a0\u2014 Biological equivalence relationship map\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n35\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nC.3\t Process for determining biological equivalence\nFigure\u00a0C.2 describes the process for determining biological equivalence between two medical devices.\nFigure\u00a0C.2\u00a0\u2014 Biological equivalence process map\nIf biological equivalence is established, this satisfactorily completes the biological risk assessment of a\nnew or modified medical device.\nIf biological equivalence cannot be established, the biocompatibility of a new or modified medical device\ncan only be established based on the medical device\u2019s own contact, chemical, physical, toxicological and\nbiological characteristics.\nC.4\t Examples of chemical equivalence\nThe following list of examples is provided to assist with establishing chemical equivalence (according\nto 5.3), where the requirements of chemical equivalence are met.\na)\t The composition or extractables profile of the proposed material is equivalent (i.e. same chemicals\nat the same or lower level and no new chemicals) to that of a clinically established material, and\n\ufeff\n36\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nthere are no significant differences in physical, chemical, morphological and topographical\ncharacteristics which could impact the biological safety of the medical device.\nNOTE\nIf there are slight increases in any chemicals, it can be reasonable to justify chemical equivalence\nwithin the statistical variability of the semi-quantitative methods being used. Use of calibration standards\nacross a range of chemistries and concentrations can be helpful to this approach.\nb)\t A material that is already clinically established in a more invasive exposure is proposed to be used\nin a comparable but less invasive application, where less invasive is understood in the context of\nISO 10993-1 as having a shorter duration of contact or a contact category calling for fewer endpoints\nto be addressed.\nc)\nA chemical constituent or residue in a clinically established material is replaced in the proposed\nmaterial with a chemical constituent or residue whose toxicological safety profile is no worse than\nthat of the constituent or residue that it is replacing, assuming similar exposure.\nd)\t The only difference between a proposed material and a clinically established material is that the\nproposed material has eliminated or reduced the level of an additive/contaminant/residue present\nin the clinically established material.\ne)\t The only difference between a proposed material and a clinically established material is that the\nproposed material is produced using processing conditions that either maintain or reduce the\nnumber and/or levels of extractables in the clinically established material.\nf)\nA material in a clinically established medical device is moved to a location in a proposed medical\ndevice where contact between a potentially affected individual and the material is lessened.\ng)\t Both the proposed material and the clinically established material meet relevant and rigorous\ncompositional specifications.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n37\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0D\n(informative)\n\nPrinciples of sample extraction\nD.1\t General\nInformation generation in the chemical characterization of a medical device and/or its materials of\nconstruction is typically a two-step process in which the medical device or material is extracted and\nthe extract is subsequently chemically analysed to establish the extracted substances. The goal of the\nextraction is to produce an extractables profile that equals or exceeds the leachables generated in clinical\nuse but does not cause deleterious effects to the materials (such as degradation) or the extractables\nprofile (such as chemical alteration of the extractables). Doing so may provide an extractables profile\nthat is at least as extensive as the medical device\u2019s leachables profile, meaning that the extractables\nprofile minimally accounts for the leachables and their levels. Under certain circumstances (e.g.\nexhaustive extractions), the extractables profile can greatly exaggerate the actual chemical release,\nmeaning that the extractables represent all possible leachables at their highest possible concentration.\nHowever, it should be noted that all leachables might not necessarily be present in the extractables\nprofile. Extractables studies which differ significantly from simulated use conditions in terms of solvent\nproperties and extraction method might not fully represent every leachable compound which would be\nobserved under simulated use conditions. This should be taken into account in design of extractables\nstudies and determination of when chemical characterization is complete (according to Figure\u00a01).\nAs chemical characterization is a general term that describes several individual activities with varying\nobjectives (e.g. compositional analysis, extractables profiling), it is clear that there are numerous\nmeans of performing an extraction, where the means of performing an extraction is closely linked to\nthe objective of the characterization. Thus, an extraction to support establishment of the composition\nof a medical device is necessarily and appropriately performed differently from an extraction done to\nsupport establishment of the medical device\u2019s extractables profile under the device\u2019s typical clinical use\nconditions.\nIn general, there can be four objectives of extractions for a chemical characterization:\n\u2014\t to establish the compositional aspects of the configuration of a medical device or the composition of\na material of construction (digestion, dissolution or exhaustive extraction);\n\u2014\t to establish the worst-case extractables profile of a medical device or material as either the total\npool of extractables in the medical device (exhaustive extraction) or the maximum amount that can\nbe extracted under defined experimental conditions that exaggerate a device\u2019s clinical conditions of\nuse (exaggerated or accelerated extraction);\n\u2014\t to establish the extractables profile of a medical device or material under its clinical conditions of\nuse (simulated extraction);\n\u2014\t to correlate chemical data to the results of biological testing performed as described elsewhere in\nISO\u00a010993.\nEach of these cases will be considered in greater detail in subsequent clauses with respect to\nestablishing appropriate extraction conditions that are consistent with the objectives of the case.\nRegardless of the type of extraction performed, extraction is a complex process influenced by aspects\nincluding time, temperature, surface area-to-volume ratio, extraction vehicle and the partitioning\nbehaviour of the substances in the test article relative to the extraction vehicle. In general, the\nextraction conditions should not alter the test article, unless justified, as alteration of the test article\ncould change the amount and/or type of extractables released from the test article. Thus, the material\u2019s\n\ufeff\n38\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nchemical properties might also need to be considered when selecting extraction vehicles, for example,\nto avoid or enhance (e.g. in dissolution studies) solubilisation of the base material.\nAs stated in ISO\u00a010993-12:2012, 3.8, extraction conditions are expected to be at least as aggressive\nas the conditions of clinical use. However, for extractables and leachables studies, avoid using\nextraction solvents that can cause significant swelling and/or compromise the integrity of the test\narticle. Significant swelling can cause reduction of free extraction solvent, which could impact the\nconcentration of extractables and lead to inaccurate analytical calculations. Regarding evaporative loss\nthat might occur during extraction, it is not recommended to compensate for solvent loss by adding\nadditional solvent after extraction is complete; rather, steps should be taken to reduce evaporative\nloss (e.g. by covering sample containers), or the final extract volume should be measured for later\ncalculations on extractables device. Measurement of solvent volumes in order to compensate for solvent\nloss due to swelling should be done cautiously, given that the amount of solvent that swells a test article\nmight be unknown and difficult to measure. In either case, the final extract volume should be measured\nand reported for later calculations on extractables per device. Furthermore, destructive swelling can\ninduce material/medical device disintegration and result in particulate debris, and extractables and\nleachables that would not otherwise be present; this could potentially interfere with analysis.\nAlthough choice of extraction vehicles will depend on the specific extraction objectives, it is generally\nappropriate for long-term implants that a minimum of two extraction solvents of differing polarity\nbe employed; for example, polar and non-polar vehicles consistent with ISO\u00a0 10993-12. For medical\ndevices with indirect contact, it can be appropriate to use a single extraction solvent that replicates the\nexpected contacting fluid. In any case, the choice of extraction vehicle(s) shall be justified.\nNOTE\nFor some regulatory regions, such as the U.S., three solvents (e.g. polar, non-polar, and semi-polar) are\nrecommended for long term implants, unless justified.\nExamples of possible extraction vehicles are presented in Table\u00a0 D.1. Inclusion of these solvents in\nTable\u00a0D.1 serves only as a starting point for solvent vehicles selection and does not constitute a complete\njustification for their use.\nSAFETY PRECAUTIONS \u2014 If hazardous solvents are used, occupational health requirements\nshould be observed.\nTable\u00a0D.1\u00a0\u2014 Parameters of solvents commonly used for extraction of polymeric medical\ndevices/materials\n\nSolventa\nPolarity index[50]\nBoiling point (\u00b0C)b\nPolar\nWaterc\n10,2\n100\nDimethyl sulfoxide\n7,2\n189\nAcetonitrile\n5,8\n82\nSemi Polar\nMethanol\n5,1\n65\nAcetone\n5,1\n56\nEthanold\n4,3\n78\nTetrahydrofuran\n4,0\n65\nn-Propyl alcohol\n4,0\n97\na\nThese solvents serve only as a starting point for solvent vehicle selection, and their inclusion here does not constitute a\ncomplete justification for their use.\nb\nNot consistently related to solvent polarity (e.g. Reference [49]), but of practical value when solvent is evaporated from\nan extract (e.g. in common approaches to NVR in exhaustive extraction).\nc\nPhysiological saline and aqueous buffer systems such as phosphate buffered saline (PBS) are also considered polar\nsolvents. Although specific values for their polarity index have not been developed, the presence of relatively small amounts\nof dissolved salts is not expected to markedly change their extracting power.\nd\nAqueous solutions of ethanol will have polarities between those of pure ethanol and water; their polarity indexes may\nbe estimated according to Formula\u00a0(D.1). For example, a 20\u00a0% ethanolaq solution will have an estimated polarity index of 9.0.\ne\nSee Reference\u00a0[32].\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n39\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n\nSolventa\nPolarity index[50]\nBoiling point (\u00b0C)b\ni-Propyl alcohol\n3,9\n82\nDichloromethane\n3,1\n41\nToluene\n2,4\n111\nNon-Polar\nCyclohexane\n0,2\n81\nHeptane\n0,1e\n98\nn-Hexane\n0,1\n69\na\nThese solvents serve only as a starting point for solvent vehicle selection, and their inclusion here does not constitute a\ncomplete justification for their use.\nb\nNot consistently related to solvent polarity (e.g. Reference [49]), but of practical value when solvent is evaporated from\nan extract (e.g. in common approaches to NVR in exhaustive extraction).\nc\nPhysiological saline and aqueous buffer systems such as phosphate buffered saline (PBS) are also considered polar\nsolvents. Although specific values for their polarity index have not been developed, the presence of relatively small amounts\nof dissolved salts is not expected to markedly change their extracting power.\nd\nAqueous solutions of ethanol will have polarities between those of pure ethanol and water; their polarity indexes may\nbe estimated according to Formula\u00a0(D.1). For example, a 20\u00a0% ethanolaq solution will have an estimated polarity index of 9.0.\ne\nSee Reference\u00a0[32].\nThe polarity index developed by Snyder was derived empirically from data on mixtures of solvents\ncommonly used in chromatography (GC stationary phases and LC mobile phases)[49]. Other\ncategorization schemes have been proposed for categorizing solvent extraction power. For example,\nHansen[35] has expanded the Hildebrand solubility parameter \u2018\u03b4\u2019[36], attempting to account for\nthe effects of dispersion forces, dipole moments, and hydrogen bonding. When Hansen solubility\nparameters are available for both material and solvents, they can provide an estimation of the degree of\ninteraction between materials and solvents; materials with similar solubility parameters can interact\nwith each other, resulting in solvation, miscibility or swelling. Either of these scales can contribute to\nthe rationale for selection of vehicles for extraction in chemical characterization. Stults, et al.[52] have\ncompiled some information on plastic and elastomer compatibility with several common solvents.\nThe polarity of binary mixtures can be estimated by taking into consideration the polarity\u00a0(P) and the\nmole fraction\u00a0(\u03a6) of each solvent of the mixture[49] and is calculated as in Formula\u00a0(D.1):\nP\nP\nP\nmix\nA\nA\nB\nB\n=\n\u00d7\n(\n)+\n\u00d7\n(\n)\n\u03a6\n\u03a6\n\n(D.1)\nwhere\n\n\u03a6A\nis the volume fraction of solvent\u00a0A;\n\nPA\nis the polarity of solvent\u00a0A;\n\n\u03a6B\nis the volume fraction of solvent\u00a0B;\n\nPB\nis the polarity of solvent B.\nD.2 Approaches to establishing the compositional aspects of the configuration of\na medical device or the composition of a material of construction\nThe terms composition applied to a material and configuration applied to a medical device address the\nsame concept in that they both establish what chemical entities are present in the test article and at\nwhat amounts they are present. Although certain non-destructive test methods exist for establishing\ncomposition and configuration, it is typically the case that both require test article solubilisation\nfollowed by chemical testing of the resulting solution. When solubilisation is used, it can be accomplished\nin several different manners including digestion or dissolution.\n\ufeff\nTable D.1 (continued)\n40\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nTo establish the elemental composition of a ceramic, metallic or polymeric test articles, digestion using\nan appropriate chemical (e.g. strong acid, base or enzyme) is recommended. In digesting the test article,\nthe chemical form of its constituents is largely disrupted and the constituents are typically converted\nto their elemental form. Although the use of digestion is generally not appropriate for assessment\nof extractables, it can facilitate the procurement of otherwise unavailable information on material\ncomposition and it establishes the absolute and maximum total pool of elemental entities present in a\ntest article.\nTo establish chemical formulation, dissolution is typically applied to polymeric or natural macromolecule\ntest articles via the use of an appropriate organic solvent and is typically performed to establish the\nintact organic and/or inorganic constituents in a test article. Once the test article is dissolved with\nan appropriate vehicle, analysis of the dissolution solution is performed. In many cases, the analysis\nis facilitated after the polymer itself has been re-precipitated with an antivehicle and filtered out.\nAlthough the use of dissolution is not appropriate for assessment of clinical exposure, unless the medical\ndevice or material being assessed dissolves in clinical use, it can facilitate the procurement of otherwise\nunavailable information on material composition and it establishes the absolute total and maximum\npool of constituents in a test article. If this step is undertaken, the possibility of co-precipitation of\nconstituents other than the base polymer should be considered.\nPossible solvent/anti-solvent combinations for common polymers are listed in Table\u00a0D.2 and can be\nfound in the literature[28][29][30][31][33][43].\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n41\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nTable\u00a0D.2\u00a0\u2014 Possible solvent/anti-solvent combinations for common polymers\nPolymer\nSolventsa\nAnti-solventsa\nPolyethylene (high density)\nXyleneb, Decalineb, TCBb\nAcetone, MeOH, ether\nPolyethylene (low density)\nToluene\nMeOH, ACN\nPolypropylene (general)\nToluene\nMeOH, ACN\nPolypropylene (atactic)\nGeneral hydrocarbons\nEA, iPrOH\nPolypropylene (isotactic)\nXyleneb, Decalineb, TCBb\nAcetone, MeOH, ether\nPolybutadiene\nHydrocarbons, benzene\nGasoline, alcohols, esters, ketones\nPolyisoprene\nBenzene\nGasoline, alcohols, esters, ketones\nPolyamides\nHFIP, Formic acid, DMF, m-cresol\nMeOH, ACN\nPolyurethanes\nDMF\nMeOH, ether\nPolyesters (except PET)\nToluene, chloroform, benzene\nMeOH, EtOH, iPrOH, ether\nPET\nTHF, m-Cresol, o-Chlorophenol\nMeOH, acetone\nPolycarbonate\nTHF, DCM\nMEOH, EtOH, ACN\nPoly(methyl methacrylate)\nToluene, chloroform, acetone, THF\nMeOH, EtOH, ACN, petroleum ether\nPoly(vinyl chloride)\nToluene, THF, DMF\nMeOH, EtOH, hexane, ACN\nPoly(vinylidene chloride)\nTHF, dioxane, ketones, butylacetate\nHydrocarbons, alcohols, phenols\nPoly(vinyl alcohol)\nWater, formamide\nGasoline, aromatic hydrocarbons,\nalcohols\nPolystyrene\nToluene, chloroform, cyclohex\u00ad\nanone, DCM\nMeOH, EtOH, can\nStyrenics (ABS)\nToluene, acetone\nMeOH, EtOH, can\nPolysulphone\nTHF\nTHF-water gradient\nRubbers\nToluene, chlorinated hydrocarbons\nMeOH, ACN, ketones, esters\nCellulose esters\nAcetone, esters\nAliphatic hydrocarbons\na\nABS\u00a0=\u00a0poly(acrylonitrile-butadiene-styrene);\nACN\u00a0=\u00a0acetonitrile;\nAE\u00a0=\u00a0ethyl acetate;\nDCM\u00a0=\u00a0dichloromethane;\nDMF\u00a0=\u00a0dimethylformamide;\nHFIP\u00a0=\u00a0hexafluoroisopropanol;\nPET\u00a0=\u00a0poly(ethylene terephthalate);\nTCB\u00a0=\u00a0trichlorobenzene;\nTHF\u00a0=\u00a0tetrahydrofuran;\nMeOH\u00a0=\u00a0methanol;\nEtOH\u00a0=\u00a0ethanol;\niPrOH\u00a0=\u00a0isopropyl alcohol.\nb\nPerformed at high temperature (>130\u00a0\u00b0C).\nOther than this general discussion, this annex provides no additional insights on performing dissolutions\nand digestions, as the approaches applied to accomplish dissolution or digestion vary significantly on a\ncase by case basis.\nThe concept of an exhaustive extraction is discussed in ISO\u00a010993-12:2012, Annex\u00a0D. An exhaustive\nextraction establishes the maximum amounts of extractables that can be removed (extracted) from the\nmedical device or material and thus defines the upper bound on the amount of leachables that could\npotentially be released by the device or material during clinical use/lifetime. In many circumstances,\n\ufeff\n42\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nan exhaustive extraction will accomplish the same outcome as digestion or dissolution, but without the\nsolubilisation of the medical device.\nFor long-term implanted medical devices, an exhaustive extraction is recommended. If an exaggerated\nextraction is used, then its use should be justified. It should also be recognized that if total extractables\nfrom an exhaustive (or justified exaggerated extraction) of a long-term implant medical device exceed\na permissible daily exposure, the extraction kinetics (e.g. to determine maximum daily release) might\nneed to be evaluated (e.g. by repeated analysis of a simulated extraction over time), or a leachables\nstudy performed, if possible. A toxicologist can be consulted to establish the specific data required to\nsupport risk assessment when there is a need to understand the kinetics of release.\nAs defined in 3.15, exhaustive extraction involves sequential extraction of the test article under\nrelevant extraction conditions and with a relevant extraction vehicle and is achieved when the level of\nextracted substance by gravimetric (or other analysis) in a subsequent extraction step is less than 10\u00a0%\nof the level of the same extracted substance in the initial extract. Achieving the required 10\u00a0% level for\neach individual extractable can be analytically and practically challenging (e.g. when the 10\u00a0% level is\nbelow the method\u2019s LOQ); thus, it might be necessary to establish that the 10\u00a0% level of extraction has\nbeen established by alternate means (e.g. total peak area, TOC, non-volatile residue). Such alternate\nmeans should be justified. In some cases, the 10\u00a0% level cannot be reached in a practical number of\nsequential extractions. In these cases, the analyst should consider an alternate extraction process (e.g.\nuse of an extraction vehicle with greater extraction power) so that the 10\u00a0% level can be achieved in\na reasonable number of sequential extractions. It can also be possible to estimate lifetime exposures\nfrom the sequential amounts extracted, even if the 10\u00a0% level is not achieved.\nAdditionally, ISO\u00a010993-12:2012, Annex\u00a0D, describes a set of extraction vehicles [methanol, acetone,\nisopropanol-hexane (50:50) and hexane] that can be used, as appropriate, in preliminary experiments\nwhose purpose is to optimize the extraction sequence and discusses the need to use extraction\nconditions and extraction vehicles (including those described above) that do not result in a chemical\nchange of either the test article or the extracted chemical entity. Regardless of the specific extraction\nparameters selected, each step of exhaustive extractions should use uniform extraction parameters.\nThe means by which the individual extraction steps in a sequential exhaustive extraction are\naccomplished are many and varied. Liquid extraction techniques for polymers span a century in terms\nof development and use and can be divided into two categories \u201ctraditional\u201d and \u201cmodern\u201d. Traditional\ntechniques, including Soxhlet extraction, boiling under reflux, shake flask extraction, and sonication\nare widely used even today and are more or less simple to implement using basic laboratory apparatus.\nAs the traditional techniques have been used for an extended period of time, their capabilities and\nperformance is well-known and well-documented. Nevertheless, they can have significant practical\nshortcomings including low extraction efficiencies, long extraction times, and the use of large\nquantities of environmentally inopportune extraction vehicles. Such shortcomings are addressed, to\na certain extent, by the more modern extraction techniques, including microwave-assisted extraction,\npressurized fluid extraction, and supercritical fluid extraction, which typically employ instrumental\nmeans to increase the heat and/or the pressure at which extraction occurs or the power of the extraction\nvehicle[26][51]. Nevertheless, the fact that the techniques are more \u201cmodern\u201d do not make them superior.\nThe use of any technique, \u201ctraditional\u201d or \u201cmodern\u201d, should carefully and fully consider their technical\nand practical limitations and relevance to the clinical use of medical devices.\nFrom a practical perspective, sequential extraction is facilitated when the extraction sequence consists\nof the fewest possible number of extraction steps while not degrading the additives and ingredients.\nAn exhaustive extraction reveals a test article\u2019s constituents and the levels of these constituents. The\nexhaustive extraction addresses extractables and leachables in the sense of a total leaching, meaning\nthat a profile of exhaustive extractables addresses the clinical use situation of \u201call constituents\n(extractables) are leached in their entirety\u201d. Although such an exhaustive extractables profile can be\nrelevant to the clinical use of certain medical devices (e.g., long term implants as noted previously), in\nmany cases the clinical leaching of the medical devices is not exhaustive and thus an alternate extraction\nprocess, such as exaggerated or simulated extraction, produces a more appropriate extractables profile\nfor the purpose of toxicological risk assessment. Furthermore, clinical use can, in certain circumstances\n(such as absorbable medical devices) promote the chemical conversion of constituents into related\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n43\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nsubstances such as degradation products or side products. If this same conversion does not occur during\nan extraction study (e.g. exhaustive extraction/dissolution), then the exhaustive extraction is not a\nfully accurate representation of a potentially affected individual\u2019s clinical exposure to the chemicals\npresent during the medical device use. In such cases, the knowledge of potential intermediate and final\nchemical products, including degradation products, in combination with chemical characterization data\nand implantation data might be needed to evaluate the safety of products. Knowledge of degradation\nprocess/products should be incorporated into any related toxicology risk assessment, even if the\ndegradants are not observed in extracts.\nD.3 Exaggerated extraction to estimate the worst-case extractables profile of\na\u00a0medical device or material\nAs stated in 3.16, extractables are defined as the substances that are released from a medical device or\nmaterial of construction using extraction vehicles and/or laboratory extraction conditions. However,\nit is clear that the extraction conditions used to establish configuration and composition are generally\nmuch more extreme than the medical device\u2019s clinical conditions of use, and thus that extractables\nrevealed in compositional studies are less likely to appear as leachables from the device under its\nclinical conditions of use. Nevertheless, as discussed in Clause\u00a0 5, the worst-case assessment of the\nleaching of a medical device considers the situation where all ingredients and additives leach from the\nmedical device in their entirety. Should a toxicological risk assessment of this worst-case establish that\nthe risk related to the total amount of ingredients and additives be acceptable, then the assessment is\nessentially complete and the medical device is accepted as being suitable for its intended use with no\nfurther chemical testing.\nHowever, if the toxicological risk assessment establishes that the worst-case provided by an exhaustive\nextraction could represent a safety issue, then a less extreme, more practical exaggerated estimate of\nthe medical device\u2019s leaching characteristics is necessary and appropriate. Such an estimate is obtained\nby using justified exaggerated extraction conditions that somewhat more closely reflect the clinical\nconditions of use. Of course, exaggerated extractions can be useful for other purposes as well, such as\naddressing limited and prolonged duration medical devices.\nThe purpose of an exaggerated extraction is to produce an extractables profile which is at least\nas complete and complex as the worst-case leachables profile. This means that the exaggerated\nextractables minimally include all leachables, and that the levels of the exaggerated extractables\nmeet or exceed the highest levels reached by leachables. An exaggerated extraction establishes in a\nsingle extraction the highest amount of extractables that most likely will be released by the medical\ndevice or material as leachables during clinical use. The exaggerated extraction is accomplished by\nusing extraction conditions that are, in one or more dimensions, exaggerated versus the conditions of\nclinical use. For example, an exaggerated extraction might be performed considering one or more of the\nconditions below:\n\u2014\t At a temperature that exceeds the clinical use temperature (typically referred to as an accelerated\nextraction, see D.4);\n\u2014\t With a duration that exceeds the duration of clinical use;\n\u2014\t With a vehicle whose extraction power exceeds that of the solution that mediates the clinical contact\nbetween the medical device and potentially affected individual;\n\u2014\t At a surface area/volume ratio that exceed clinical use exposure;\n\u2014\t Via the use of exhaustive (sequential) extraction for limited or prolonged contact medical devices.\nDevising and justifying exaggerated extraction conditions can be a technically challenging exercise and\ngreat care should be taken to ensure that the scientific basis for the exaggerated conditions is rigorous\nand sound. Although certain exaggerating conditions can be appropriate and justifiable for certain\nsituations, they might not be universally applicable to all situations.\n\ufeff\n44\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nIf an exaggerated extraction cannot be justified or experimentally verified, then its use for producing\nchemical information that is the basis of a toxicological risk assessment is not recommended.\nWhen an exaggerated extraction is employed, it is necessary to account for the exaggeration both in\ndesigning the extraction and in interpreting the result of the extraction study. One means of accounting\nfor the exaggeration is via an exaggeration factor (a numerical factor that estimates the degree to\nwhich an exaggerated extraction amplifies the clinical conditions of use), although other means can\nbe envisioned and employed. Regardless of the means, the degree of exaggeration is established by\na rigorous assessment of the extraction and clinical use conditions and knowledge of the degree of\nexaggeration may be used to adjust the results of the exaggerated extraction to allow for the toxicological\nrisk assessment of the extractables. Thus, for example, if quantity of extracted medical devices is\ndoubled over that used clinically, or the device contact surface area to contact solution volume ratio of\nthe extraction is doubled this degree of exaggeration should be taken into account when the extractables\ndata are reported for toxicological risk assessment. It should be noted that greatly exaggerated surface\narea/solution volume ratios may not produce proportionally exaggerated extractables profiles, making\nan accounting of the degree of exaggeration more challenging. Furthermore, any quantification of\ndegree of extraction exaggeration should address whether the extractables\u2019 concentrations have\nreached an equilibrium-based plateau (i.e. that sink conditions have been maintained).\nDue to the vast number of various medical devices and usage conditions within the scope of this\ndocument, it is unrealistic to provide specific guidance here. However, points to consider in establishing\nexaggerated conditions are outlined as follows.\nDimensions to consider when establishing and justifying an exaggerating extraction vehicle include\npH (for aqueous vehicles) and polarity (for organic or \u201corganic-like\u201d vehicles). Considering extraction\nvehicle pH, it is noted that pH is an exaggerating dimension only for acidic or basic extractables (that is,\nthe extraction of neutral or un-ionisable extractables is largely unaffected by the pH of the extraction\nvehicle). For acidic extractables (e.g. stearic acid), it is generally the case that an extraction vehicle with\na pH higher than that of the clinical contact solution will exaggerate extraction. For a basic extractable\n(e.g. dibenzylamine), it is generally the case that an extraction vehicle with a pH lower than that of the\nclinical contact solution will exaggerate extraction. A neutral extractable\u2019s accumulation level will be\nunaffected by pH unless that neutral compound is reactive as a function of pH.\nFor neutral extractables, extraction vehicle polarity can be an exaggerating dimension. For example,\nincreasing the alcohol content of an extraction vehicle versus the clinical contact solution will typically\nresult in an exaggerated extraction.\nThe use of temperature as an exaggerating dimension is addressed in D.4.\nExaggerated extraction conditions should not alter the extractables profile. For example, the use\nof extreme temperatures as a means of accomplishing the exaggeration might result in either the\ndecomposition of the extractables or the alteration of the medical device materials (e.g. curing, cross-\nlinking, or degradation of the device\u2019s polymeric materials of construction, physical state change over\nthe glass transition temperature), any of which could result in an altered extractables profile.\nWhen extraction is exaggerated using multiple dimensions (e.g. both temperature and surface area),\nthe combined effect of the multiple dimensions should be considered and justified, although doing so\ncan be scientifically challenging.\nAs altered extractables profiles can be obtained when greatly exaggerated extraction conditions are\nemployed, it is recommended that exaggerations be kept as small as is necessary, minimizing potential\ncomplicating effects such as degradation. As exaggeration is justified in the context of the circumstances\nin which it is employed, determining whether an exaggeration is appropriate or excessive is done on a\ncase by case basis and it is difficult to provide general guidelines in terms of when an exaggeration\nis no longer appropriate and becomes excessive. Nevertheless, highly exaggerated conditions can be\nsufficiently extreme that the exaggerated extractables profile becomes poorly correlated with the\nclinical use extractables profile. The justification of any exaggeration, but especially a significant\nexaggeration should consider the exaggerated extraction\u2019s propensity to chemically or physically alter\nthe test article and/or the extracted substances, as extractions that alter either the test article or the\nextracted substances are not permitted.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n45\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nRegardless of the means by which an exaggeration is accounted for, the use of exaggeration in\ntoxicological risk assessment should be rigorously justified and documented. While such a justification\ncould be derived from scientific first principles, it is always the case that the most definitive means of\njustifying an exaggeration is to verify the exaggeration with experimental data.\nAny exaggeration resulting from the extraction process or the testing of the extracts should be clearly\ndescribed to facilitate a proper and accurate safety risk assessment and to ensure\u00a0that the exaggeration\nis properly accounted for in the safety risk assessment.\nD.4\t Simulated or accelerated extractions to establish clinical use extractables\nprofiles\nThe exaggerated extraction produces a practical worst-case assessment of the leaching of a medical\ndevice. As discussed in Clause\u00a05, should a toxicological risk assessment of this practical worst-case\nestablish that the risk related to the extractables be acceptable, then the risk assessment is essentially\ncomplete and the medical device is accepted as being chemically suitable for its intended use with no\nfurther chemical testing.\nHowever, if the toxicological risk assessment establishes that the practical worst-case could represent\na risk, then a more realistic estimate of the medical device\u2019s leaching characteristics is necessary and\nappropriate. This more realistic estimate is obtained by using either simulated extraction conditions\nthat very closely reflect the clinical conditions of use or accelerated extraction conditions which use\ndurations that are shorter than clinical use.\nThe purpose of a simulated extraction is to produce an extractables profile which closely matches the\nclinical case leachables profile. A simulated-use extraction establishes the actual amount of extractables\nthat will be released as leachables by the medical device or material during clinical use/lifetime. The\nsimulated extraction is performed in those circumstances where either the clinical conditions of use\ncannot be achieved in the laboratory or when use of the clinical conditions produces a solution for\ntesting which cannot be analytically profiled for leached substances. If the clinical conditions of use can\nbe replicated in the laboratory and if the resulting solution can be analytically profiled for leachables,\nthen the value of performing a simulated extraction is lessened and it is reasonable to suggest that the\nsimulated extraction be replaced with an actual leachables study.\nThe simulated extraction is accomplished by using extraction conditions (i.e. temperature and duration)\nthat mimic the conditions of clinical use. Additionally and as appropriate, the simulated extraction\ncan be performed with a vehicle whose extraction power equals that of the solution that mediates the\nclinical contact between the medical device and potentially affected individual. The aspect of specifying\na simulating extraction vehicle has been discussed previously in considering exaggerated extractions\n(see D.3). Considering this aspect more specifically for simulating extractions, guidance can be provided\nfor certain medical device categories considering the nature of body contact and the application site.\nFor example, if the clinical application of the device:\n\u2014\t involves contact with blood, then a mixture of ethanol in water could be an appropriate simulating\nvehicle. If an ethanol/water mixture is used, it should be demonstrated to extract comparable levels\nof the target leachables with respect to blood (e.g. Reference\u00a0[38]). Other simulating vehicles can be\nused if justified;\n\u2014\t is such that the medical device communicates with the potentially affected individual via an\naqueous solution, then the appropriate simulating vehicle is either physiological saline, adjusted\nand buffered to a relevant pH, or an appropriate pH adjusted salt solution whose composition is\njustified. If the clinical application of the medical device involves contact with numerous solutions\nwith varying pH (e.g. solution administration sets), then the pH range should be properly bracketed\nby two simulating vehicles, one adjusted to a pH of 2 and the other adjusted and buffered to a pH of\n10 (see Reference\u00a0[40]). If the pH range of solutions encountered in clinical use is smaller than this\nrange, simulating extraction solutions bracketing the smaller range can be used;\n\u2014\t is such that the medical device communicates with the potentially affected individual via a solution\nwith lipophilic properties (e.g. lipid emulsions, drug products containing solubilizing agents such\n\ufeff\n46\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nas polysorbate 80) then an appropriate simulating vehicle should be identified and scientifically\njustified. In many situations, an alcohol/water mixture whose proportion of alcohol to water is\njustified, can serve as a suitable simulating vehicle. Reference\u00a0[38] contains information which could\nfacilitate the identification and justification of such proportions for certain \u201corganic-like\u201d solutions.\nInformation on solvents that may be used to simulate body fluids has been published[24][44][47].\nSimulating extraction vehicles relevant to either surface-contacting medical devices or devices which\ncontact tissue/bone/dentin are not specified in this document. Any simulating solvent use should be\nestablished and justified on a case-by-case basis.\nOther design parameters are typically matched between the simulated extraction and the clinical\nconditions of use. Thus, in a simulated extraction, the surface area/volume ratio that is used is the same\nratio that is experienced during clinical use, where possible. For example, for infusion systems, the\ndevice surface area and infusate volume could be used. In contrast, it will often be difficult to justify\na surface area/volume ratio for implanted devices, as it can be difficult to establish the volume of\nphysiologic fluid that contacts the device over its implantation time. Moreover, sequential extraction is\ngenerally not appropriate for simulated extractions, with the exception of reusable or multi-use medical\ndevices.\nIn certain circumstances (such as for medical devices with long term contact duration), a simulated\nextraction might be performed under accelerated conditions. For example, an accelerated extraction\nmight be performed at a temperature that exceeds the clinical use temperature and a duration that is\nshorter than clinical use. However, the accelerated extraction should be performed in such a manner\nthat the accelerated conditions and the clinical use conditions subject the device to the same heat\nexposure (i.e. the same transfer of thermal energy). Additionally, acceleration can be accomplished by\nagitation during extraction or use of recirculating or flowing extraction vehicles. However, the extent of\nacceleration by these approaches can be challenging to quantify.\nIn certain circumstances, such as when an accelerated extraction can be appropriate to simulate longer\nduration and greater invasiveness of contact, an analysis that provides information on the kinetics of\nextraction might be necessary to establish and justify the proper extraction procedure.\nConsidering the acceleration of extraction conditions, it makes little sense to accelerate limited contact\ndurations of less than 24\u00a0 h and in such cases the actual clinical conditions of use are used in the\nsimulated extraction. A similar logic applies to prolonged contact durations of 3\u00a0d or less. However,\nfor contact durations longer than 3\u00a0d and for all long-term contact durations, acceleration could be\ndesirable to facilitate appropriate extraction.\nAs was the case with exaggerated extraction discussed previously, accelerated extraction conditions\nshould be fully and rigorously justified. Although certain accelerated conditions might be justifiable in\ncertain circumstances, the same accelerated conditions or the same justification might not be applicable\nto other situations.\nIt is beyond the scope of this document and the current state of good science to provide specific\nguidance on how to devise and justify accelerated extractions and how to calculate appropriate and\njustifiable acceleration factors for all medical devices and their clinical conditions of use. Nevertheless,\ncareful review of the chemical literature may suggest means for performing such calculations and\njustifications.\nCare should be exercised in the selection of accelerating conditions and the effects of higher temperatures\nor other accelerating conditions on extraction kinetics and the identity of the extractables should be\nconsidered carefully if accelerated extraction is used. Proper accelerating conditions are those which\nreduce the extraction duration to a value shorter than the duration of clinical use but which do not\nresult in a chemical modification of the device itself or to the type and amount of extracted substances.\nAny model or concept used to establish acceleration or exaggeration factors shall be justified and\ndocumented.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n47\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nD.5\t Extractions performed for correlating chemical characterization with\nbiological testing\nGenerally, there are two reasons for correlating chemical characterization with biological testing:\n\u2014\t to elucidate the chemical cause of a particular biological test result;\n\u2014\t to establish the biological test outcome of a chemical or set of chemicals.\nWhen correlating chemical characterization, most likely extractables profiling, with biological\ntesting, it is clear that the best case is when the chemical testing and the biological testing occurs\non the same extract, as so doing will produce the closest and most rigorous correlation. The\nproper extraction methods for correlating chemical and biological testing are documented in\nISO\u00a010993-12:2012, specifically in Clause\u00a010 and Annex\u00a0C. Whenever possible, the exact conditions used\nto generate an extract for biological testing should also be used for generating the extract for chemical\ncharacterization. This recommendation is typically easier to achieve for extraction parameters such\nas surface area to volume, extraction time and extraction duration. However, it can be more difficult to\nfollow this recommendation when considering the extraction vehicle. As is noted in ISO\u00a010993-12:2012,\nC.7, \u201cthe vehicles selected as the extraction vehicle (for biological testing) should be suitable for use\nin the specific biological test systems\u201d. While such a recommendation most certainly facilitates\nbiological testing, in certain circumstances it confounds chemical testing, as an extraction vehicle that\nis appropriate for biological testing might not be amenable to chemical testing. In such circumstances,\neither a surrogate extraction vehicle should be found to facilitate the chemical testing or the extract for\nbiological testing should be manipulated to make it analytically viable. If a surrogate extraction vehicle\nis used, such a surrogate extraction vehicle should, in addition to being analytically viable, ideally\nhave similar extracting properties as the extraction vehicle used for biological testing. If a chemical\nmanipulation (e.g. derivatization) of the extract is used, care should be taken to avoid a chemical change\nof one or more extractables.\nISO\u00a010993-12:2012, 10.3.5, establishes extraction vehicles appropriate for biological testing, including:\n\u2014\t polar extraction vehicles such as water, physiological saline, culture media without serum;\n\u2014\t non-polar extraction vehicles such as freshly refined vegetable oil;\n\u2014\t additional extraction vehicles such as ethanol/water, ethanol/saline, polyethylene glycol\u00a0 400\n(diluted to a physiological osmotic pressure), dimethylsulphoxide and culture media with serum.\nSeveral of these extraction media are readily amenable to chemical testing and thus should be used for\nboth biological and chemical testing when a correlation between the two is desired. Such extraction\nmedia can include water, physiological saline, ethanol/water, ethanol/saline and dimethylsulphoxide.\nThe other extraction vehicles listed previously might or might not be analytically viable from a chemical\ncharacterization perspective. If it can be established that such an extraction vehicle is analytically\nviable from a chemical perspective, then the same vehicle should be used for both biological and\nchemical testing. If the vehicle is not analytically viable, then a surrogate vehicle should be used for\nchemical testing.\nAs the purpose of using the surrogate vehicle is to facilitate the discovery of the chemical agents\nresponsible for a biological test result, any surrogate vehicle that accomplishes this objective is an\nappropriate surrogate solvent. Potential surrogate extraction vehicles that can be employed for\nchemical testing and which meet the dual requirements of approximating extracting power and\nfacilitating analytical testing are given in Table\u00a0D.3. Although use of these surrogate vehicles does not\nensure that the chemical investigation will be successful, they represent a good starting point for such\nan investigation and their use will typically lead to the desired positive outcome. Justification for a\nchosen surrogate extraction vehicles should be provided. Justification should include biological testing\nthat confirms the indicted chemicals are actually causing the biological test failure. It can also be\npossible to confirm causality with information from the literature.\nIt is noted that these surrogate vehicle recommendations are relevant solely for the purpose of\ncorrelating biological and chemical test results and are not necessarily specified for the broader\n\ufeff\n48\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\npurpose of generating an extractables profile for the purpose of toxicological risk assessment. As\nthe appropriateness of surrogate vehicles can vary somewhat from situation to situation, surrogate\nvehicles other than those proposed above may be used if they meet the two criteria noted previously,\nthat they are amenable to the anticipated chemical testing and that their solvating properties have\nbeen established to be similar to those properties of the extraction vehicles that the surrogates would\nreplace.\nTable\u00a0D.3\u00a0\u2014 Potential surrogate extraction vehicles for correlating chemical to biological testing\nExtraction vehicle for biological testing\nPotential surrogate extraction vehicle for\nchemical testing\nWaterf\nWater\nPhysiological salinef\nPhysiological saline\nEthanol/waterf\nEthanol/water\nEthanol/salinef\nEthanol/saline\nDimethylsulphoxidef\nDimethylsulphoxide\nCulture medium without serum\n1/9 (v/v) ethanol/salinea\nVegetable oil\n1/1 (v/v) ethanol/waterb (Reference\u00a0[25])\nPolyethylene glycol\u00a0400e\n1/3 (v/v) ethanol/waterc (Reference\u00a0[38])\nCulture medium with serum\n2/3 (v/v) ethanol/salined (Reference\u00a0[38])\na\nIn general, culture media contain all the elements that most bacteria need for growth, including: a carbon source (such\nas glucose), water, various salts, and a source of amino acids and nitrogen (e.g. beef, yeast extract). To account for the salt\ncontent of the culture medium, saline is used in the surrogate vehicle. To account for the organic character of the culture\nmedium, a 10\u00a0% (by volume) portion of ethanol is used in the surrogate vehicle.\nb\nThis recommendation is based on surrogate extraction vehicles specified for, and widely used, with food packaging.\nThis surrogate extraction vehicle (1/1 ethanol/water) is acceptable for most polymers; however, for polyolefins complying\nwith 21\u00a0CFR\u00a0177.1520 and ethylene - vinyl acetate copolymers complying with 21\u00a0CFR\u00a0177.1350, a surrogate extraction\nvehicle of 95\u00a0% or absolute ethanol should be considered.\nc\nPublished research has noted that \u201cglycols (such as polyethylene glycol and propylene glycol) are weak solubilizing\nagents and can be simulated by ethanol/water mixtures containing 25\u00a0% ethanol or less\u201d. Thus, a 1/3 mixture of ethanol/\nwater is recommended as the appropriate simulating vehicle for polyethylene glycol\u00a0400.\nd\nBased on published research, 40\u00a0% (by volume) mixture of ethanol/water is considered an appropriate surrogate\nfor blood and blood related substances, which would include serum. Thus the 40\u00a0% (by volume) portion of the surrogate\nvehicle (ethanol) is used to account for the serum.\ne\nAnd its associated aqueous mixtures.\nf\nThese vehicles are analytically expedient and can readily be screened for extractables. Thus, surrogate vehicles are not\nwarranted.\nNOTE 1\u00a0\u00a0\u00a0It cannot be emphasized more strongly that the extraction vehicle examples provided in Table\u00a0D.3 are solely for\nthe purpose of correlating the results of biological and chemical testing. These examples are not meant to be applied to the\nselection and justification of extraction vehicles used for the purpose of extractables or leachables profiling, although in\ncertain situations these vehicles can be suitable for those purposes. Furthermore, it is noted that while these vehicles can\nbe applicable for a large population of medical devices, no leaching vehicle is applicable to every medical device and every\nclinical use circumstance. Thus, use of these or any other vehicles should be evaluated and justified on a case by case basis.\nNOTE 2\u00a0\u00a0\u00a0Inclusion of vehicles here does not fully justify their use in chemical-biological comparisons.\nISO 10993-12:2012, 10.3.5, Note\u00a01, states that \u201cother extraction vehicles appropriate to the nature and\nuse of the medical device or to the methods for hazard identification can also be used (for biological\ntesting) if their effects on the material and the biological system are known\u201d. If these other extraction\nvehicles are amenable to both biological and chemical testing then the vehicles should be used for both\nbiological and chemical testing. If these other extraction vehicles are not amenable to chemical testing,\nthen a surrogate vehicle should be identified and justified.\nGiven a potentially differing level of sensitivity for biological versus chemical testing, other extraction\nconditions, such as the extracted surface area to extraction solution volume ratio, might need to be\nadjusted to facilitate the generation of a useful correlation.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n49\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0E\n(informative)\n\nCalculation and application of the analytical evaluation\nthreshold (AET)\nE.1\t Discussion\nAnalytical methods used to screen an extract for extracted substances should perform four functions:\na)\t they should detect the extractables;\nb)\t they should distinguish between the extractables so that each extractable provides a unique\nresponse;\nc)\nthey should provide information with which the extractable's identity can be elucidated;\nd)\t they should provide information with which the extractable's concentration can be established.\nConsidering chromatographic methods used to screen extracts for organic extractables, the methods\ncould be more capable of detecting extractables than they are at correctly identifying or accurately\nquantifying extractables.\nWhen an extractable has been detected, it is necessary to consider the safety impact that extractable\nmight have as a leachable. However, if the extractable's identity cannot be established, a toxicological\nrisk assessment of this extractable, as described in ISO 10993-17, cannot be performed. Furthermore,\nif the extractable is inaccurately quantified, the outcome of any toxicological risk assessment can be\nincorrect.\nThe purpose of this annex is to address the quantitative aspect of extractables screening, specifically\nconsidering the issue of an AET.\nThresholds such as a TTC establish a dose of leachables (and other potentially toxic impurities) below\nwhich there is insufficient quantity present to elicit toxicity, irrespective of the substance\u2019s identity.\nIt is important to note that some highly toxic substances (i.e. cohorts of concern) are excluded from\na TTC approach and their presence should be ruled out (see ISO\u00a010993-17) before the AET is applied.\nAny specifically targeted analytes of concern for the specific medical device should also be assessed\nindividually, independent of the AET.\nLeachables present at levels below the TTC are deemed to be appropriately safe and not to require\nadditional assessment (identification and quantification). In essence, these thresholds (e.g. TTC) in\ncombination with an appropriate factor that addresses the uncertainty of the analytical method,\nbecome identification thresholds, as substances dosed at and above the threshold should be identified\nto allow for their safety assessment\u00a0 \u2014 while substances dosed below the threshold are deemed to\npresent an acceptably low toxicological safety risk without identification.\nThe threshold concept can be applied to extractables in the circumstance that extractables are used to\nproject the worst-case release of leachables from medical devices.\nThe application of the threshold concept requires that a dose-based threshold (TTC) be converted to\na concentration-based threshold (AET), as such a conversion would facilitate extractables assessment\ndecisions based on the concentration of the extractable in an extract.\nSuch an analytical threshold has been termed the AET. By definition, the AET establishes a threshold\nfor the toxicological risk assessment of extractables or leachables. Extractables whose concentrations\nare above the AET should be identified and quantified as a prerequisite for their toxicological risk\n\ufeff\n50\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nassessment, as there is a sufficient possibility that the extractables could be toxic. On the other hand,\nextractables whose concentrations are below the AET do not need to be identified or quantified for\ntoxicological risk assessment.\nAlthough PDEs for individual metals have been established[19], a dose based threshold (DBT) applicable\nto all metals has not been established. Thus, practically speaking, the AET is only applied to organic\nextractables or leachables.\nThe relationship between the AET and frequently encountered analytical limits, such as the limit of\ndetection\u00a0(LOD) and LOQ, is as follows. As the AET is a threshold that requires the compound responsible\nfor an analytical response to be identified and quantified, it is clear that the analytical response should\nbe discernible above the analytical noise (detected) before its source compound can be identified. Thus,\nthe AET should be greater than or equal to the LOD as an AET lower than the LOD would indicate that\nthe analytical method is incapable of producing analytical responses at the necessary concentration\nlevels for relevant compounds. Although the LOD might not be determinable for compounds detected\nduring the screening process, the LODs of one or more relevant surrogates or internal standards\ncan be used to represent the method\u2019s LOD for all compounds that the method is suited for. It is also\nclear that if one purpose of the analytical testing is quantification,\u00a0the AET should be higher than or\nequal to the LOQ. However, it is understood that semi-quantitative concentration estimates obtained\nin screening cannot meet the rigorous accuracy and precision expectations inherent in an LOQ and\nthus that there can be cases where screening studies provide concentration estimates when the AET is\nlower than the rigorously determined LOQ. Concentration estimates below a method\u2019s established LOQ\nmight not be sufficiently accurate to support a valid toxicological risk assessment. Lastly, it is observed\nthat the AET is also an identification threshold and that the process of identification requires that the\nresponse contain more complex and/or advanced information than does the process of quantification\n(i.e. quantification can typically be accomplished at concentrations lower than those required for\nidentification). This being the case, it is possible that the AET could be above the LOQ but it would still\nnot be possible to secure an identification for an analyte present in the sample at the AET.\nE.2\t Calculation of the AET\nThe conversion from a dose-based threshold (e.g. TTC) to a concentration-based threshold (AET)\nrequires inputs including:\n\u2014\t the frequency and duration of the medical device\u2019s clinical use;\n\u2014\t the various extraction conditions used to produce the extractables profile;\n\u2014\t the uncertainty of the analytical method.\nThe duration of the medical device\u2019s clinical use could dictate the actual value used for the dose-based\nthreshold (e.g. a staged TTC based on duration)[18] while the frequency of clinical use establishes the\nmagnitude of clinical exposure. The AET in \u00b5g/ml can be calculated as given in Formula\u00a0(E.1):\nAET\nUF\nDBT\nA\nBC\n=\n\u00d7\n\n(E.1)\nwhere\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n51\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n\nA\nis the number of medical devices that were extracted to generate the extract;\n\nB\nis the volume of the extract (measured in ml);\n\nC\nis the clinical exposure to the medical device (number of devices a user would be exposed to\nin a day under normal clinical practice);\n\nDBT is the dose-based threshold (e.g. TTC or SCT) in \u00b5g/d (a toxicologist should be consulted in\nselecting a specific threshold that can support risk assessment);\n\nUF\nis an uncertainty factor that could be applied to account for the analytical uncertainty of the\nscreening methods used to estimate extractables\u2019 concentrations in an extract (see E.3 for a\ndiscussion on how to determine the proper value to assign to UF).\nThe extract processing (e.g. any dilution or concentration steps) should be considered during analytical\nconcentration calculations and the calculation of the AET value adjusted accordingly.\nSeveral examples of AET determination are provided in E.4 to illustrate the process in various settings.\nThese examples use values for various inputs (e.g. UF) that were chosen for illustrative purposes\nand the choice is not meant to imply that the exact value used should be unilaterally applied in all\ncircumstances.\nNOTE\nThe application of Formula\u00a0(E.1) to long term implants could require knowledge and consideration of\nthe release kinetics of the constituents of interest.\nE.3\t Determination of the uncertainty factor\nQuantification in extractables profiling is achieved by various means which differ in the degree of\ncertainty in the estimated and reported concentration. The degree of uncertainty can vary significantly\ndepending on the quantification strategy employed. For example, quantification in some cases could\ninvolve the use of an internal standard to normalize the responses obtained for all relevant analytes\nand estimates the concentration of each analyte based on the simplifying assumption that all analytes\nrespond similarly, among themselves and with respect to the internal standard. Depending on the\nvalidity of this simplifying assumption, the concentration estimates thus obtained can have widely\ndiffering uncertainties and degrees of accuracy. If the simplifying assumption is true and response\nfactors are constant, then the resulting concentration estimates for all analytes will be highly\naccurate. If the simplifying assumption is false and the response factors vary widely, then the resulting\nconcentration estimates for the analytes will have widely varying accuracies.\nIn other cases, the degree of uncertainty can be low. For example, if quantification is achieved through\nthe use of authentic standards employed in qualified analytical methods, the concentration estimates\nobtained for the qualified analytes will be highly accurate. Considering quantification via an internal\nstandard, if the simplifying assumption noted previously is true and response factors are constant, then\nthe resulting concentration estimates for all analytes will also be sufficiently accurate for toxicological\nrisk assessment.\nOther quantification strategies could produce concentration estimates whose uncertainty is somewhere\nbetween these two extremes; lower uncertainty than use of an internal standard\u2019s response factor but\nhigher uncertainty then use of a calibration curve generated with an authentic reference standard. For\nexample, relative response factors can be obtained for extractables, were the relative response factor is\nthe ratio of the response of the extractable versus that of an internal standard at equal concentrations\nof extractable and internal standard. Use of relative response factors in quantification essentially\naccounts for differences in response factors, extractable versus internal standard.\nRecognizing that the accuracy of and uncertainty in concentration estimates obtained in extractables\nstudies can vary, an UF is added to the calculation of the AET to account for the analytical uncertainty\nthat arises due to the variable accuracy. Use of a UF is the same principle as calculation of a final AET\nfrom an estimated AET (e.g. see Reference [45]).\n\ufeff\n52\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nIn cases where the analytical uncertainty is known to be acceptably low, a UF value of 1 can be justified.\nExamples of these cases are methods with comparable response factors between expected extractables\nand applied internal standards in qualified methods for targeted extractables. Otherwise the value of\nthe uncertainty factor is based on an assessment of the analytical methodology to which the AET is\napplied. For example, a UF value of 2 has been proposed[39][45] as being appropriate, in certain situations,\nto the screening of extracts for semi-volatile extractables via GC-FID or GC-MS, as analytical FID or MS\nresponse factors for extractables are somewhat consistent, extractable to extractable. Alternatively,\nresponse factors for other analytical methods used for extractables screening, such as HPLC-UV and\nHPLC-MS (which are typically applied to non-volatile extractables), may be higher given the frequently\nwide variation in response factors among extractables by this methodology. At the current time, there\nis no available general guidance which recommends a specific value for the UF for these methods.\nA statistical approach to establishing and justifying a particular UF is statistical analysis of a database of\nresponse factors specific to the analytical method being considered and the population of extractables\nfor which that method is applicable. In one possible approach, the value of the UF would be linked to the\nrelative standard deviation of the response factors according to Formula\u00a0(E.2):\nmean\nstd\n/ 1\u2212t \u00d7\n(\n)\n\uf8ee\uf8f0\n\uf8f9\uf8fb\n(E.2)\nwhere\nmean\nis the mean response factor from the reference database;\nt\nis the desired degree of confidence;\nstd\nis the standard deviation in the response factor database.\nApplying commonly used statistics for normally distributed data, t = 1 would provide 68\u00a0% confidence,\nt\u00a0=\u00a01,65 would provide 90\u00a0% confidence, t = 2 would provide 95\u00a0% confidence, and t\u00a0=\u00a03 would provide\n99,7\u00a0% confidence. Note that when the mean response factor is 1 and t = 1, Formula\u00a0(E.2) simplifies to\nthat proposed by PQRI and Jordi (see References [41] and [46]). There are two implications of these\npoints. First, if the mean response factor is not 1, best practice would be to pick an internal standard\nthat makes it 1. This approach minimizes potential bias in this part of the analytical process. Second,\nuse of t\u00a0=\u00a01 is a reasonable option as it: 1) is consistent with previously published approaches[41][46]; 2)\nactually provides a 95\u00a0% level of confidence, because the distribution of interest is single tailed (i.e. of\nthe population outside of the confidence interval, only the half that would fall below the AET is a safety\nconcern).\nWhen the variation in responses factors is large relative to the mean response factor (e.g.\nstd\u00a0=\u00a00,9\u00a0X\u00a0mean), the variation in response factors is so large that although a UF can be calculated, its\nscientific validity becomes questionable. For example, while a UF > 10 can be calculated, the fact that\nthe UF is as large as 10 (or larger) suggests that the quantification method being used is inherently\ninaccurate and thus might not be appropriate for the purpose of toxicological safety risk assessment. In\nthis case, an adjusted AET should not be established and the concept of an AET should not be applied to\nthe method.\nIn cases where t \u00d7 std > 1, a UF cannot be calculated, as the result is either infinity or a negative number.\nClearly an analytical method with this much variation in response factors is not suitable for the purpose\nof toxicological safety risk assessment.\nIn any event, the use of the uncertainty factor, and the value of the uncertainty factor that is used,\nshould always be justified. In some cases where the variation in response factors among extractables\ncannot be established or where the variation is established to be large, the value of UF can be so large\n(e.g. UF values of 10 or greater) that the AET becomes so low that the AET concept has little practical\nvalue (e.g. the analytical method\u2019s LOD or LOQ are greater than the AET). In such circumstances, use of\nthe AET cannot be justified and thus the AET should not be applied. In such cases, it can be necessary to\nidentify and quantify all the compounds associated all observed analytical responses obtained by the\nscreening analyses.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n53\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nE.4\t AET determination examples\nEXAMPLE A\nConsider a limited contact medical device (e.g. a balloon catheter) in which a single device is used\nclinically and therapy is completed in less than 1 day. In the extraction study, a single device was\nextracted in 9,0\u00a0ml of extracting vehicle. The resulting extract was neither diluted nor concentrated.\nGC-FID was used as the analytical method; therefore, an uncertainty factor of 2 was considered\nappropriate. In this case, the value of the DBT was set to the ICH M7 TTC for potentially mutagenic\nimpurities[18], and DBT\u00a0=\u00a0TTC\u00a0=\u00a0120\u00a0\u03bcg/d (duration of treatment 24 h).\n\u2014\t A = 1 device\n\u2014\t B = 9,0 ml\n\u2014\t C = 1 device/d\n\u2014\t UF = 2\nand the AET is calculated as given by application of Formula\u00a0(E.1):\nAET (\u03bcg/mL) = {120 \u03bcg/d \u00d7 [1 device/(1 device/d \u00d7 9,0 ml)]} \u00f7 2\nAET (\u03bcg/mL) = 6,6 \u03bcg/ml\nEXAMPLE B\nConsider a medical device that is used in a therapy which is completed in 7\u00a0d. On each day of therapy,\n2\u00a0devices are required. In the extraction study, 4 devices were extracted in 100\u00a0ml of extracting vehicle.\nThe resulting extract was neither diluted nor concentrated. The analytical method was supported by\na response factor database which established that the response factors were acceptably consistent\nbetween extractables. In this case,\n\u2014\t DBT\u00a0 =\u00a0 TTC\u00a0 =\u00a0 120\u00a0 \u00b5g/d (M7 assessment for potentially mutagenic impurities, duration of\ntreatment\u00a0\u2264\u00a01\u00a0month),\n\u2014\t A\u00a0=\u00a04 medical devices,\n\u2014\t B\u00a0=\u00a0100\u00a0ml,\n\u2014\t C\u00a0=\u00a02 medical devices/d,\n\u2014\t UF\u00a0=\u00a01.\nand the AET is calculated as given by application of Formula\u00a0(E.1):\nAET (\u00b5g/ml)\u00a0=\u00a0{120\u00a0\u00b5g/d\u00a0\u00d7\u00a0[4\u00a0devices/(2\u00a0devices/d\u00a0\u00d7\u00a0100\u00a0ml)]}\u00a0\u00f7\u00a01\nAET (\u00b5g/ml)\u00a0=\u00a02,4\u00a0\u00b5g/ml\nEXAMPLE C.1\nConsider a medical device that is permanently implanted (e.g. a cardiovascular stent), and a single\ndevice is used. The circumstance that this is a permanent implant requires that the extraction study\nbe exhaustive. In the extraction study, 20 devices were extracted in 33,3\u00a0ml of extracting vehicle. The\nexhaustive extraction was accomplished in 2 sequential extracts, meaning that the levels of extractables\npresent in the second extract was less than 10\u00a0% of the levels present in the first extract. The resulting\nextract was neither diluted nor concentrated. The analytical method had a response factor database\nwhich established that the %RSD of response factors was 25\u00a0%, suggesting that a UF value of 2 is\nappropriate.\n\ufeff\n54\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nEXAMPLE C.2\nIn this case, the critical issue is establishing the proper DBT. Because the device is a permanent implant,\nthe most likely leaching scenario is that all extractables present in the medical device will leach out of\nthe device during the device/patient contact. This is why the proper extraction study for a permanent\nimplant is an exhaustive extraction. Considering potentially mutagenic extractables, a DBT of 120\u00a0\u00b5g/d\nis appropriate, regardless of leaching kinetics, as illustrated below.\nConsider a mutagenic substance, revealed after exhaustive extraction with a level of 120\u00a0\u00b5g/d, which\ncorresponds to 120 \u00b5g/device in the example above based on a single device.\n\u2014\t If the 120 \u00b5g/device is leached in 1 d, the amount leached is equal to 120\u00a0\u00b5g/day, which is the TTC\nfor this duration category per ICH M7.\n\u2014\t If the 120 \u00b5g/device is leached in 31 d (1 month), the amount leached is 120/31\u00a0=\u00a03,9\u00a0\u00b5g/d, which is\nlower than 20 \u00b5g/d, the TTC for this duration category per ICH M7.\n\u2014\t If the 120 \u00b5g/device is leached in 365 d (1 year), the amount leached is 120/365\u00a0=\u00a00,33\u00a0\u00b5g/d, which\nis lower than 10 \u00b5g/d, the TTC for this duration category per ICH M7.\n\u2014\t If the 120 \u00b5g/device is leached in 3\u00a0650 d (10 years), the amount leached is 120/3\u00a0650\u00a0=\u00a00,033\u00a0\u00b5g/\nday, which is lower than 1,5 \u00b5g/d, the TTC for this duration category per ICH M7.\nNote that 20 \u00b5g/d for 31 ds would be an exposure of 620 \u00b5g, 10 \u00b5g/d for 365 d would be an exposure of\n3,650 \u00b5g, and 1,5\u00a0\u00b5g/d for 3\u00a0650 d would be an exposure of 5,475\u00a0\u00b5g. Each of these theoretical extreme\napproaches would therefore be less conservative.\nIn this case, the calculation of the AET proceeds as follows:\n\u2014\t DBT\u00a0=\u00a0TTC\u00a0=\u00a0120 \u00b5g/day (Note, however, that this DBT is \u201cdistributed\u201d over both extraction steps;\nthus, the DBT for each extraction step is 120 \u00b5g/d \u00f7 2 extracts = 60 \u00b5g/d) A\u00a0=\u00a020\u00a0medical devices,\n\u2014\t B\u00a0=\u00a033,3\u00a0ml,\n\u2014\t C\u00a0=\u00a01 medical devices/d,\n\u2014\t UF\u00a0=\u00a02.\nand the AET is calculated as given by application of Formula\u00a0(E.1):\nAET (\u00b5g/ml)\u00a0=\u00a0{60\u00a0\u00b5g/d\u00a0\u00d7\u00a0[20\u00a0devices/(1\u00a0device/d\u00a0\u00d7\u00a033,3 ml)]}\u00a0\u00f7\u00a02\nAET (\u00b5g/ml)\u00a0=\u00a018\u00a0\u00b5g/ml\nEXAMPLE C.3\nBecause the device was exhaustively extracted to screen for toxic chemicals to which the patient\ncould be exposed, application of 1,5 \u00b5g/d without modification is the most conservative approach that\ncan be applied so that all toxic chemicals present in/on the device will be identified/quantified and\ntoxicological risk assessed. In this highly conservative approach, the expected DBT becomes the TTC of\n1,5\u00a0\u00b5g/d and the calculation of the AET proceeds as follows:\n\u2014\t DBT = TTC = 1,5 \u00b5g/d (Note, however, that this DBT is \u201cdistributed\u201d over both extraction steps.\nThus, the DBT for each extraction step is 1,5 \u00b5g/d \u00f7 2 extracts = 0,75 \u00b5g/d),\n\u2014\t A = 20 medical devices,\n\u2014\t B = 33,3 ml,\n\u2014\t C = 1 medical devices/d,\n\u2014\t UF = 2.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n55\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nand the AET is calculated as given by application of Formula\u00a0(E.1):\nAET (\u00b5g/ml) = {0,75 \u00b5g/d \u00d7 [20 devices/(1 device/d \u00d7 33,3 ml)]} \u00f7 2\nAET (\u00b5g/ml) = 0,23 \u00b5g/ml\nNOTE\nData establishing the actual release kinetics of leachables can be an essential input for establishing\nan appropriately conservative DBT. If the actual release kinetics of leachables establishes that the exposure\nto extractables is less than 10 years, then the kinetic data can potentially support a higher DBT value (see\nISO/TS\u00a021726).\nE.5\t Use of the AET\nThe conversion of the DBT to an AET enables an analytical chemist to address the question of whether\na specific extractable need be identified and quantified. However, analytical methods do not produce\nconcentrations directly but a response in units that should be converted to concentrations. For example,\nthe output of chromatographic analysis of a sample is a chromatogram in which extractables appear as\npeaks in the chromatogram (see Figure\u00a0E.1). In this case, peak A corresponds to an analyte present in\nthe test sample at a concentration equal to the AET. Thus, a horizontal AET line can be drawn across the\nchromatogram using the apex of A as the reference point. Peaks whose responses fall above such a line\n(e.g. peak\u00a0B) are present in the sample at levels above the AET and the substance responsible for peak\nB should be identified and reported for toxicological risk assessment. Peaks whose response fall below\nthe line (e.g. peak\u00a0C) are present in the sample at levels below the AET and do not need to be identified\nfor toxicological risk assessment.\nFigure\u00a0E.1\u00a0\u2014 Application of the AET in chromatographic analysis\nAlthough Figure\u00a0 E.1 illustrates the application of the AET in terms of peak height, peak area may\nalso be used to compare individual extractables peaks with the AET and can be more appropriate.\nFurthermore, while this example and illustration specifically relates to chromatographic analysis, the\nconcept of the AET is widely applicable to many analytical techniques.\nE.6\t Exclusions to the AET; cohorts of concern\nThe term \u201ccohorts of concern\u201d has been applied to those sets of compounds that possess structural\ngroups of such high potency that intakes even below the TTC would be associated with a potential for\n\ufeff\n56\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nsignificant patient safety risk, including, but not necessarily limited to, carcinogenic risk. Compound\nclasses that comprise the cohorts of concern are described in ISO/TS\u00a021726. Some colorants can also\nhave the potential to raise concern and should be considered for exclusion from the AET. See also\nReference\u00a0[42] and ISO\u00a010993-17.\nThe previously established convention that extractables below the AET are taken to be toxicologically\nsafe regardless of their identities is clearly not applicable for a cohort of concern, as by definition the\ncohort could pose a risk even at concentrations below the AET. Since the AET is both an identification\nand quantification threshold, the cohorts of concern present an analytical dilemma in the sense that it\nis impossible to know whether a compound whose concentration is less than the AET is from a cohort of\nconcern unless the compound is identified at the extent that its molecular structure can be established\nin sufficient detail to allow for a toxicological risk assessment. Although there are several options for\nreconciling the AET with potential cohorts of concern, some are not practical. For example, rejecting\nthe AET concept based on the possibility that there might be an extractable that is a cohort of concern\nis likely an excessively conservative response to a relatively low probability circumstance. Rather, the\ndecision is whether to accept the low risk of a cohort of concern and apply the AET to all the analytical\nresponses or to perform testing whose purpose is to establish whether one or more substances from a\ncohort of concern could be present. To facilitate the decision-making process, the following approach is\nrecommended.\n\u2014\t When there is experimental evidence or a compositional reason to suspect that a cohort of concern\ncould be present, then either the general absence of cohorts of concern should be established by\ninformation gathering and proper documentation, or the extracts should be screened for targeted\npotential substances from cohorts of concern. In the absence of cohorts of concern, the AET can\nbe applied to all analytical responses. If cohorts of concern are present, then the AET can only be\napplied to those analytical responses that are not attributable to cohorts of concern. Analytical\nresponses attributable to a cohort substance should be safety assessed based on the concentration\nof the cohort substance and its toxicological safety data.\n\u2014\t When there is no experimental evidence or a compositional reason that suggests that a cohort\nsubstance could be present, it can be concluded that it is unlikely that a cohort of concern is present\nand the AET can be applied to all analytical responses.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n57\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0F\n(informative)\n\nQualification of analytical methods used for extractables/\nleachables\nAn analytical method is qualified to establish that it is suited for its intended purpose. In extractables/\nleachables studies, analytical methods serve one of two purposes; screening samples for unspecified\nanalytes and testing samples for specified (targeted) analytes. As these purposes are quite different, it\nis reasonable to suspect that their qualification would differ.\nThe qualification of an analytical method is documented in a qualification protocol, which establishes the:\n\u2014\t relevant qualification parameters;\n\u2014\t experimental means by which the qualification parameters will be assessed;\n\u2014\t performance expectations for each parameter.\nQualification parameters that are specifically relevant to screening methods include:\n\u2014\t sensitivity, as it is expected that the method\u2019s LOQ be less than or equal to the reporting threshold\n(note that this expectation is discussed in greater detail in Annex\u00a0E);\nNOTE\u00a01\nIn cases of very low reporting thresholds, it might not be possible to achieve an LOQ which is\nless than or equal to the reporting threshold. In such cases, the lowest reasonably attainable LOQ should be\nused, and all analytes above this LOQ should be reported. If the LOQ is higher than the AET, this should be\nexplained and justified.\n\u2014\t specificity, which is ability to assess unequivocally the analyte in the presence of other constituents\nthat can be expected in the sample;\n\u2014\t accuracy, taken as the ability to produce a response that is comparable to the true value (e.g. a\nmeasured concentration in a spiked extract that is comparable to the spiked amount). Accuracy\nfor screening tests is typically accomplished using surrogate substances that are representative of\nextractables;\n\u2014\t precision, taken as the variation in replicate analyses of either the same extract or a standard\nsolution containing extractables or leachables;\n\u2014\t dynamic range, taken as the concentration range over which the response and the analyte\nconcentration producing that response are relatable by a simple mathematical function. Dynamic\nrange can be established by analysis of surrogate or standard solutions at various concentrations.\nNOTE\u00a02\nThe objectives of this parameter can be achieved within establishment of the LOQ along with\nsystem suitability results.\nNOTE\u00a03\nDilution might be needed if analytes of interest are clearly out of range.\nQualification parameters that are specifically relevant to targeting methods include:\n\u2014\t sensitivity, relevant in the circumstance that the method\u2019s range includes, or is near to, the LOQ;\n\u2014\t specificity, as described for screening methods;\n\u2014\t accuracy, as described for screening methods; however, as opposed to screening tests, accuracy in\ntargeting is accomplished with the actual substances being targeted;\n\ufeff\n58\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nNOTE\u00a04\nSpiking samples can help to determine the recovery.\n\u2014\t precision, as described for screening methods;\n\u2014\t dynamic range, taken as the concentration range over which the response and the analyte\nconcentration producing that response are relatable by a simple mathematical function. Dynamic\nrange can be established by analysis of standard solutions at various concentrations;\n\u2014\t goodness of fit, taken as the degree to which a simple mathematical function can express the\nrelationship between an analyte\u2019s concentration in a standard and the method response obtained\nwhen the standard is analysed. Although the desired mathematical function is generally a linear\nfunction, simple, non-linear functions can be used if they are able to meet the acceptance criteria for\ngoodness of fit.\nQualifying that a method is rugged is relevant for both screening and targeting methods.\nAdditional performance parameters can be included in a qualification at the discretion of the method\u2019s\nuser and with appropriate justification. These additional parameters could include: robustness,\nefficiency (for a chromatographic separation this might include resolution), matrix effects, sample and\nstandard stability.\nGiven their different purpose and function, the processes of qualifying a screening or targeting\nmethod will be different, even if the qualifying criteria are generally the same. For example, while both\nscreening and targeted methods are qualified for accuracy, the nature of the qualification activity is\ndifferent. While accuracy is established in a targeting method specifically for the analyte(s) of interest,\nin a screening method accuracy is established more generally by considering a group of surrogate\nanalytes. Additionally, as screening methods provide concentration estimates, the acceptance criterion\nfor accuracy is less rigorous than the acceptance criterion for accuracy in targeted analysis, where the\ncalculated concentration is expected to be highly quantitative.\nThe same concept is applicable to precision, as it is generally accepted that the precision expectations\nfor a targeting method are more rigorous than are the precision expectations for a screening method.\nSpecificity is important in a screening method as the identification of individual extractables is\nfacilitated if the chromatographic peak associated with an extractable is produced by only that\nextractable. In a targeting method, specificity for the targeted compound, meaning that the target\ncompound\u2019s chromatographic peak is pure, is necessary to provide the required degree of accuracy\nand precision. Because a targeted substance is established in advance of implementing the method,\nspecificity can be established up-front. However, since it is not possible to establish up-front what\nanalytes might be discovered in screening, specificity in screening methods is typically established\nat time of use. Thus, specificity could be measured and judged quite differently in screening versus\ntargeting.\nA method is considered to be qualified (that is, suited for its intended use) when\n\u2014\t it has been established that the method is able to routinely meet the performance expectations\ncontained in the qualification protocol, and\n\u2014\t appropriate system suitability has been established.\nIn addition to having documented performance capabilities, qualified analytical methods should have\nadditional controls that may include, but are not limited to:\n\u2014\t documentation of the method in the form of a standard operating procedure (SOP) which is\ncontrolled in a document change system;\n\u2014\t an approved and specified Scope, captured in the method\u2019s SOP;\n\u2014\t a detailed scientific description and justification of the method, establishing its suitability for the\nintended use;\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n59\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n\u2014\t a requirement that the qualified method is implemented by an appropriately qualified and\ntrained staff;\n\u2014\t a requirement that the qualified method is implemented on calibrated/qualified instrumentation.\nConsidering system suitability specifically, establishing system suitability is a time of use assessment\nthat addresses three performance aspects of the method:\na)\t the method has been set up and implemented properly;\nb)\t the method as set up is capable of performing at the same level it performed at during its\nqualification;\nc)\nthat the method has performed acceptably throughout its use.\nSystem suitability assessment should focus on that minimum number of performance characteristics\nwhich individually and in aggregate demonstrate that these three performance criteria were achieved.\nThe system suitability parameters to be assessed and their associated acceptance criteria should be\nrigorous enough to ensure that the method produces data of acceptable quality but not so rigorous\nthat potentially acceptable analytical runs are rejected on a frequent basis. Properly collected and\nstatistically evaluated system suitability data can provide diagnostic evidence of imminent method\nfailure.\nReference\u00a0[23] can provide helpful information when devising and implementing a method qualification\nprocess. The reporting of method qualification information is addressed, to a certain extent, in Annex\u00a0G.\n\ufeff\n60\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nAnnex\u00a0G\n(informative)\n\nReporting details for analytical methods and chemical data\nG.1\t General\nClause\u00a07 provided general guidelines in terms of the type of chemical and compositional information\nthat should be reported, facilitating the information\u2019s use in a toxicological risk assessment. Users\nshould recognize that additional details can be necessary for regulatory review of the analytical\nmethods and chemical data. Such information includes:\nG.2\t Reporting of analytical data to facilitate toxicological risk assessment\n\u2014\t Accounting of qualitative data generated (e.g. extractable\u2019s identities).\n\u2014\t Accounting of quantitative data generated (e.g. extractable\u2019s concentrations, including a discussion\nof the quantification approach and providing the classification of the quantitative data as estimated\nquantitative analysis, semi-quantitative analysis or quantitative analysis).\n\u2014\t A discussion and justification of the reporting threshold and its relevance to toxicological risk\nassessment (e.g. safety thresholds).\n\u2014\t List of chemical compounds above the reporting threshold. Such a list can be provided in a tabular\nformat and the table should contain the chemical compounds including their mass, proposed\nstructure, chemical formula, IUPAC chemical name, common chemical name(s) and abbreviation(s),\nCAS registry number, their identification status (e.g. confirmed, confident, tentative, speculative) and\ntheir measured levels in the relevant samples. Additional information, such as chemical structure,\nmay be provided in the document. When multiple candidate identifications are found (e.g. a class of\ncompounds such as is often reported in tentative identifications), all should be reported.\n\u2014\t Information about the device\u2019s clinical use which, when combined with the chemical data, allows for\nthe calculation of the worst-case amount of the chemical in appropriate units (e.g. \u00b5g/medical device)\nthat can be readily used in toxicological risk assessment (establishing human daily exposure).\n\u2014\t Appropriate figures, diagrams, etc. that illustrate the analytical data and/or facilitates data review\nand/or interpretation (e.g. labelled chromatograms, migration curves).\n\u2014\t Approach and rationale addressing cohorts of concern substances (see E.5).\nNote that the reporting of analytical data should facilitate the calculation of estimated clinical exposure\nto the reported chemicals, as this is an essential aspect of the toxicological risk assessment. It is not\nnecessary that the analytical reports themselves contain these estimated exposures.\nWhile the information outlined above is sufficient to enable toxicological risk assessment, it typically\nis not sufficient to fully specify and justify the experimental and analytical approaches that were\nused to perform a specific study to produce specific data and information. This critical information is\nused to establish the validity of the experimental design, the applicability of the analytical approach\nand the suitability of the specific analytical methods employed for their intended purpose, during,\nfor example, regulatory review. Thus, a report should include some of the following information to\nprovide the proper context with respect to the experimental design, the experimental approach and the\nexperimental methods.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n61\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nG.3\t Details of test article preparation (extraction)\n\u2014\t Appropriate and complete description of the test article, including relevant processing details (e.g.\nsterilization, rinsing), and parts removed, if applicable;\n\u2014\t Extraction method with justification (e.g. refluxing, sealed vessel);\n\u2014\t List of extraction vehicles with justification;\n\u2014\t Extraction vehicle/ sample ratio (e.g. extracted surface area to extraction solution volume ratio);\n\u2014\t Extraction time and temperature;\n\u2014\t Number of extraction cycles (e.g. single vs. exhaustive);\n\u2014\t Methods for determining when exhaustive extraction endpoints are reached (as appropriate);\n\u2014\t Description of changes to the vehicle or test article (e.g. medical device) post-extraction, to include\nphysical state, appearance, colour, clarity, or presence of particles;\n\u2014\t If particles are present in the extract, a description of how they were addressed, including, if\nperformed, the means by which they were separated from the extract prior to analysis and the\nmeans by which they were chemically characterized.\nG.4\t Extract preparation for analysis\n\u2014\t Description of any dilution, concentration and other significant processing steps (e.g. vehicle\nexchange).\n\u2014\t Justification for all significant processing steps.\n\u2014\t Description of any sample filtering/particle separation that was performed.\n\u2014\t Description of the storage conditions and duration of extracts, if stored prior to analysis.\nG.5\t Description of the analytical methods for testing prepared extracts (include\nall that apply)\n\u2014\t Justification for choice.\n\u2014\t Relevant operating conditions (e.g. chromatographic mobile phase, methods, flow rates, gradient\nrun time, column temperature).\n\u2014\t Analytical column; Dimensions and stationary phase used.\n\u2014\t Analytical instrumentation manufacturer, model, principal components.\n\u2014\t For methods using mass spectrometric detection:\n\u2014\t ionization technique (APCI, ESI),\n\u2014\t polarity mode (positive, negative),\n\u2014\t mass range (or specific masses analysed for ICP-MS data),\n\u2014\t nominal mass resolution.\n\u2014\t For methods using UV detection, detection wavelength.\n\u2014\t For other detection methods, key operational parameters.\n\ufeff\n62\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n\u2014\t Surrogate standard(s) used, with justification, and resulting response factor to be applied in semi-\nquantitative analysis.\n\u2014\t Quantification approach applied, with justification:\n\u2014\t which analytical endpoint is used for quantification (e.g. MS signal or UV response);\n\u2014\t description of how any surrogate and internal standards are applied for quantification of\nspecific analytes (e.g. closest retention time, similarity in chemistry between the reference\nstandard and the analyte, or use of \u201cworst case,\u201d meaning lowest response factor, or use of an\naveraged response factor).\n\u2014\t A description of how confidence in identifications was determined and assigned (e.g. definitions of\ncategorization terms or match scores), with justification;\n\u2014\t Means used to address unknowns (e.g. additional analytical testing to identify or risk mitigation per\nISO 10993-1);\n\u2014\t Determination, justification and application of reporting thresholds (such as the AET).\nG.6 Qualification metrics for the analytical methods:\nSystem suitability (per qualification protocol in Annex F) to include:\n\u2014\t LOD and LOQ (including how LOQ was established);\n\u2014\t Linearity [calibration curve(s)];\n\u2014\t Specificity;\n\u2014\t System suitability;\n\u2014\t Recovery (accuracy);\n\u2014\t Precision;\n\u2014\t Dynamic range;\n\u2014\t Other relevant parameters as appropriate.\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n63\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\nBibliography\nGenerally relevant references\n[1]\nISO\u00a0 5725-1, Accuracy (trueness and precision) of measurement methods and results \u2014 Part 1:\nGeneral principles and definitions\n[2]\nISO\u00a05832-1, Implants for surgery \u2014 Metallic materials \u2014 Part 1: Wrought stainless steel\n[3]\nISO\u00a010993-2, Biological evaluation of medical devices \u2014 Part 2: Animal welfare requirements\n[4]\nISO\u00a010993-9, Biological evaluation of medical devices\u00a0\u2014 Part\u00a09: Framework for identification and\nquantification of potential degradation products\n[5]\nISO\u00a010993-12:2012, Biological evaluation of medical devices \u2014 Part 12: Sample preparation and\nreference materials\n[6]\nISO\u00a010993-13, Biological evaluation of medical devices \u2014 Part 13: Identification and quantification\nof degradation products from polymeric medical devices\n[7]\nISO\u00a010993-14, Biological evaluation of medical devices \u2014 Part 14: Identification and quantification\nof degradation products from ceramics\n[8]\nISO\u00a010993-15, Biological evaluation of medical devices\u00a0\u2014 Part\u00a015: Identification and quantification\nof degradation products from metals and alloys\n[9]\nEN\u00a0455-3, Medical gloves for single use\u00a0\u2014 Part\u00a03: Requirements and testing for biological evaluation\n[10]\nISO\u00a022442-1, Medical devices utilizing animal tissues and their derivatives\u00a0\u2014 Part\u00a01: Application of\nrisk management\n[11]\nISO\u00a022442-2, Medical devices utilizing animal tissues and their derivatives\u00a0\u2014 Part\u00a02: Controls on\nsourcing, collection and handling\n[12]\nISO\u00a022442-3, Medical devices utilizing animal tissues and their derivatives \u2014 Part 3:  Validation of the\nelimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents\n[13]\nUSP 41, 2018, [1663] Assessment of Extractables Associated with Pharmaceutical Packaging/\nDelivery Systems\n[14]\nUSP 41, 2018, [1664] Assessment of Drug Product Leachables Associated with Pharmaceutical\nPackaging/Delivery Systems\n[15]\nUse of International Standard ISO\u00a0 10993-1, Biological evaluation of medical devices\u00a0 \u2014\nPart\u00a0 1: Evaluation and testing within a risk management process\u00a0 \u2014 Guidance for Industry\nand Food and Drug Administration Staff [viewed 2019-01-29]. Available from:\n\nhttps://\u200bwww\u200b.fda\u200b.gov/\u200bdownloads/\u200bmedicaldevices/\u200bdeviceregulationandguidance/\u200b\nguidancedocuments/ucm348890.pdf\nReferences cited in the document\n[16]\nOECD, 1996, Test No. 118: Determination of the Number-Average Molecular Weight and the\nMolecular Weight Distribution of Polymers using Gel Permeation Chromatography, OECD\nGuidelines for the Testing of Chemicals, Section\u00a01,  OECD Publishing,  Paris.\n[17]\nOECD, 2000, Test No. 120: Solution/Extraction Behaviour of Polymers in Water, OECD Guidelines\nfor the Testing of Chemicals, Section 1,  OECD Publishing,  Paris.\n\ufeff\n64\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n[18]\nICH Technical Requirements for Registration of Pharmaceutical for Human Use Draft\nConsensus Guideline, M7. Assessment and Control of DNA Reactive (Mutagenic) Impurities in\nPharmaceuticals to Limit Potential Carcinogenic Risk. Current Step\u00a02 version; 6 February 2013.\n[19]\nICH Guideline for Elemental Impurities [viewed 2019-01-29]. Available from: https://\u200bwww\u200b.ich\u200b\n.org/\u200bfileadmin/\u200bPublic\u200b_Web\u200b_Site/\u200bICH\u200b_Products/\u200bGuidelines/\u200bQuality/\u200bQ3D/\u200bQ3D\u200b_Step2b\u200b.pdf\n[20]\nEur  Ph., Ed. 9, 2016, Section 2.2.28, and Chapters 3.1 and 3.2.\n[21]\nJP XVII 2017 General tests/plastic containers\n[22]\nUSP 41, 2018, [661] Plastic packaging systems and their materials of construction\n[23]\nUSP 41, 2018, [1058] Analytical instrument qualification\n[24]\nASTM F2129\u201317b, Standard Test Method for Conducting Cyclic Potentiodynamic Polarization\nMeasurements to Determine the Corrosion Susceptibility of Small Implant Devices\n[25]\nGuidance for Industry: Preparation of Premarket Submissions for Food Contact Substances:\nChemistry Recommendations. U.S. Department of Health and Human Services, Food and Drug\nAdministration, Center for Food Safety and Applied Nutrition. April 2002; December 2007\n[26]\nArias  M., Penichet  I., Ysambertt  F. et al. , Fast supercritical fluid extraction of low-and high-\ndensity polyethylene additives: comparison with conventional reflux and automatic Soxhlet\nextraction. Journal of Supercritical Fluids. 2009;  50(1): 22-28\n[27]\nBall  D., Blanchard  J., Jacobson-Kram  D. et al. , Development of Safety Qualification\nThresholds and Their Use in Orally Inhaled and Nasal Drug Product Evaluation. Toxicological\nSciences. 2007;  97: 226\u2013236\n[28]\nBart  J.C.J., Additives in Polymers\u00a0\u2014 Industrial Analysis and Applications,  John Wiley & Sons,\nInc.,  New York, (2005). (ISBN 0-470-85062-0)\n[29]\nBataillard  P., Evangelista  L., Thomas  M., in Plastics Additive Handbook, Zweifel  E., (ed),\nHanser Publishers,  Munich pp. 1047-1083 (2000)\n[30]\nBrandrup  J, Immergut  E.H., Grulke  EA., (eds). Polymer Handbook,  John Wiley & Sons, Inc.,\nNew York, (1999)\n[31]\nBraun  D., Simple Methods for Identification of Plastics,  Hanser Publishers,  Munich (1996)\n[32]\nBurdick & Jackson Laboratories, Solvent guide.  Published by Burdick and Jackson Laboratories;\nMcGaw Park, IL (1986)\n[33]\nFreitag  W., in Kunststoff-Additive, Gachter  R.,  Muller  H., (eds),  Hanser Publishers,  Munich,\npp. 909-946 (1990)\n[34]\nGad-McDonald  S.,  Gad  C.S., Leachables and Extractables from Medical Devices, in Biomaterials,\nMedical Devices, and Combination Products, CRC Press: 419-468. (2015)\n[35]\nHansen  C.M., Hansen Solubility Parameters: A User\u2019s Handbook, 2nd edn. CRC Press, Taylor and\nFrancis Group, Boca Raton Florida (2007)\n[36]\nHildebrand  J.H.,  Scott  R.L., The solubility of nonelectrolytes.  New York:  Dover\nPublications (1964)\n[37]\nInternational Union of Pure and Applied Chemistry\u00a0\u2014 Macromolecular division\u00a0\u2014 Commission\non macromolecular nomenclature: compendium of macromolecular nomenclature, Prepared for\npublication by W. V. Metanomski,  Blackwell Scientific Publications Ltd.,  Oxford (1991)\n[38]\nJenke  D., Liu  N., Hua  Y. et al. , A means of establishing and justifying binary ethanol/water\nmixtures as simulating vehicles in extractables studies. PDA J Pharm Sci Technol. 2015;  69(3):\n366-382. Doi: 10.5731/pdajpst.2015.01046\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\b\n65\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n[39]\nJenke  D.,  Odufu  A., Utilization of internal standard response factors to estimate the\nconcentration of organic compounds leached from pharmaceutical packaging systems and\napplication of such estimated concentrations to safety assessment. J. Chromatogr. Sci. 2012;\n50:206-212\n[40]\nJenke  D., Establishing the proper pH of simulating solvents used in organic extractables\nassessments for packaging systems and their materials of construction used with aqueous\nparenteral drug products. Pharm Outsourcing. 2014;  15(4):20, 22, 24-27\n[41]\nJordi  M.A., Khera  S., Roland  K. et al. , Qualitative assessment of extractables from single-use\ncomponents and the impact of reference standard selection. J. Pharmaceutical and Biomedical\nAnalysis. 2018; 150:368-376\n[42]\nKoster  S. et al.  Food and Chem Tox. 2011; 49:1643\u20131660\n[43]\nKrause  A., Lange  A., Ezrin  M., Plastics Analysis Guide, Chemical and Instrumental Methods,\nHanser Publishers,  Munich (1983)\n[44]\nMarques  M.R.C., Loebenberg  R., Almukainzi  M., Simulated Biological Fluids with Possible.\nDissolution Technologies [Viewed 2019-01-29] Available from: http://\u200bwww\u200b.dissolutiontech\u200b\n.com/\u200bDTresour/\u200b201108Articles/\u200bDT201108\u200b_A02\u200b.pdf\n[45]\nMullis  J.O., Granger  A., Quin  C., Norwood  D.L., The analytical evaluation threshold (AET)\nconcept, sensitivity and analytical uncertainty. Conference Proceedings, Leachables and\nExtractables. Smithers Rapra, Dublin, Ireland, March, 2008\n[46]\nNorwood  D.L., Nagao  L.M., Stults  C.L.M, Perspectives on the PQRI Extractables and\nLeachables \u201cSafety Thresholds and Best Practices\u201d Recommendations for Inhalation Drug\nProducts, PDA J Pharm Sci and Tech 2013,  67 413-429\n[47]\nOyane  A., Kim  H-M., Furuya  T. et al. , Preparation and assessment of revised simulated body\n\ufb02uids, J Biomed Mater Res, 2003;  65A: 188 \u2013195\n[48]\nSafety Thresholds and Best Practices for Extractables and Leachables in Orally\nInhaled and Nasal Drug ProductsPQRI Leachables and Extractables Working Group,\nSeptember 9, 2006 [viewed 2019-01-29] Available from: http://\u200bpqri\u200b.org/\u200bwp\u200b-content/\u200buploads/\u200b\n2015/\u200b08/\u200bpdf/\u200bLE\u200b_Recommendations\u200b_to\u200b_FDA\u200b_09\u200b-29\u200b-06\u200b.pdf\n[49]\nSnyder  LR, Chapter 1 Theory of chromatography, Editor(s): E. Heftmann, In Journal of\nChromatography Library, Elsevier, Volume 51, Part A, 1992, Pages A1-A68\n[50]\nSnyder  LR, Classification of the solvent properties of common liquids. J Chromatogr Sci 1978:\n16;223-234\n[51]\nStrandberg  D.,  Albertsson  A.C., Chromatographic analysis of antioxidants in polymeric\nmaterials and their migration from plastics into solution. Adv Poly Sci. 2007;  211: 117-157\n[52]\nStults  C.L.M.,  Creasey  J.M., Development, optimization, and validation of methods for routine\ntesting, Editors: DJ Ball, DL Norwood, CLM Stults, LM Nagao in Leachables and Extractables\nHandbook, John Wiley & Sons, Pages 449-506(2012)\n[53]\nISO/TS\u00a0 10993-19, Biological evaluation of medical devices \u2014 Part 19: Physico-chemical,\nmorphological and topographical characterization of materials\n[54]\nISO/TR\u00a010993-22, Biological evaluation of medical devices \u2014 Part 22: Guidance on nanomaterials\n[55]\nISO/TS\u00a0 21726, Biological evaluation of medical devices \u2014 Application of the threshold of\ntoxicological concern (TTC) for assessing biocompatibility of medical device constituents\n\ufeff\n66\b\n\u00a9 ISO 2020 \u2013 All rights reserved\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\n\ufeff\nISO 10993-18:2020(E)\n\ufeff\n\u00a9 ISO 2020 \u2013 All rights reserved\nICS\u200211.100.20\nPrice based on 66 pages\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.",
    "new_text": "7\t Tolerable contact level, tolerable intake and threshold of toxicological concern",
    "change_text": "7\t Tolerable contact level, tolerable intake and threshold of toxicological concern",
    "diff_html": "\n    <table class=\"diff\" id=\"difflib_chg_to21__top\"\n           cellspacing=\"0\" cellpadding=\"0\" rules=\"groups\" >\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>\n        <thead><tr><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">Old Version</th><th class=\"diff_next\"><br /></th><th colspan=\"2\" class=\"diff_header\">New Version</th></tr></thead>\n        <tbody>\n            <tr><td class=\"diff_next\" id=\"difflib_chg_to21__0\"><a href=\"#difflib_chg_to21__top\">t</a></td><td class=\"diff_header\" id=\"from21_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reporting&nbsp;of&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;data</span></td><td class=\"diff_next\"><a href=\"#difflib_chg_to21__top\">t</a></td><td class=\"diff_header\" id=\"to21_1\">1</td><td nowrap=\"nowrap\"><span class=\"diff_add\">7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tolerable&nbsp;contact&nbsp;level,&nbsp;tolerable&nbsp;intake&nbsp;and&nbsp;threshold&nbsp;of&nbsp;toxicological&nbsp;concern</span></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2\">2</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;purpose&nbsp;of&nbsp;a&nbsp;chemical&nbsp;assessment&nbsp;report&nbsp;is&nbsp;to&nbsp;provide&nbsp;information&nbsp;that&nbsp;enables&nbsp;the&nbsp;review&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_3\">3</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization&nbsp;data&nbsp;and&nbsp;supports&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;this&nbsp;information.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_4\">4</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Such&nbsp;reports&nbsp;shall&nbsp;clearly&nbsp;state&nbsp;the&nbsp;purpose&nbsp;and&nbsp;objectives&nbsp;of&nbsp;the&nbsp;chemical&nbsp;assessment&nbsp;that&nbsp;has&nbsp;been</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_5\">5</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">performed&nbsp;and&nbsp;shall&nbsp;include&nbsp;description&nbsp;and&nbsp;justification&nbsp;for&nbsp;the&nbsp;following:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_6\">6</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;test&nbsp;article&nbsp;(material&nbsp;or&nbsp;medical&nbsp;device)&nbsp;description&nbsp;and&nbsp;details&nbsp;of&nbsp;sample&nbsp;preparation;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_7\">7</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;analytical&nbsp;methods&nbsp;and&nbsp;extraction&nbsp;conditions&nbsp;(e.g.&nbsp;choice&nbsp;of&nbsp;extraction&nbsp;vehicles,&nbsp;extraction&nbsp;duration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_8\">8</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;cycles,&nbsp;extraction&nbsp;temperature,&nbsp;extraction/sample&nbsp;ratio,&nbsp;agitation&nbsp;method&nbsp;and&nbsp;speed&nbsp;during</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_9\">9</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_10\">10</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_11\">11</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">documentation&nbsp;of&nbsp;system&nbsp;suitability&nbsp;testing&nbsp;and&nbsp;its&nbsp;outcome;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_12\">12</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;value&nbsp;for,&nbsp;and&nbsp;justification&nbsp;of,&nbsp;the&nbsp;reporting&nbsp;threshold&nbsp;(e.g.&nbsp;AET);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_13\">13</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;qualitative&nbsp;data&nbsp;generated&nbsp;(e.g.&nbsp;extractables'&nbsp;identities,&nbsp;including&nbsp;a&nbsp;description&nbsp;of&nbsp;the&nbsp;identification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_14\">14</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">procedure);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_15\">15</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_16\">16</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;data&nbsp;generated&nbsp;(e.g.&nbsp;extractables\u2019&nbsp;concentrations,&nbsp;including&nbsp;a&nbsp;description&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_17\">17</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantification&nbsp;procedures&nbsp;and&nbsp;providing&nbsp;the&nbsp;classification&nbsp;of&nbsp;the&nbsp;quantitative&nbsp;data&nbsp;as&nbsp;estimated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_18\">18</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;analysis,&nbsp;semi-quantitative&nbsp;analysis&nbsp;or&nbsp;quantitative&nbsp;analysis);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_19\">19</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;information&nbsp;necessary&nbsp;to&nbsp;estimate&nbsp;clinical&nbsp;exposure&nbsp;to&nbsp;chemicals&nbsp;(e.g.&nbsp;analyte&nbsp;amounts&nbsp;in&nbsp;\u00b5g/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_20\">20</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_21\">21</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;necessary&nbsp;and&nbsp;appropriate,&nbsp;identified&nbsp;substances&nbsp;in&nbsp;the&nbsp;test&nbsp;solutions&nbsp;could&nbsp;be&nbsp;grouped&nbsp;into</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_22\">22</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compound&nbsp;classes,&nbsp;based&nbsp;on&nbsp;structural&nbsp;or&nbsp;functional&nbsp;group&nbsp;similarities,&nbsp;to&nbsp;assist&nbsp;in&nbsp;any&nbsp;toxicological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_23\">23</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_24\">24</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;or&nbsp;compositional&nbsp;information&nbsp;or&nbsp;data&nbsp;that&nbsp;is&nbsp;obtained&nbsp;without&nbsp;the&nbsp;device\u2019s&nbsp;sponsor&nbsp;having&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_25\">25</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">perform&nbsp;testing&nbsp;(e.g.&nbsp;data&nbsp;supplied&nbsp;by&nbsp;a&nbsp;material\u2019s&nbsp;vendor,&nbsp;data&nbsp;available&nbsp;from&nbsp;the&nbsp;chemical&nbsp;literature)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_26\">26</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;included&nbsp;in&nbsp;reports,&nbsp;as&nbsp;relevant&nbsp;and&nbsp;appropriate.&nbsp;Reporting&nbsp;requirements&nbsp;for&nbsp;data&nbsp;obtained&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_27\">27</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;additional&nbsp;sources&nbsp;include&nbsp;the&nbsp;same&nbsp;items&nbsp;noted&nbsp;above&nbsp;for&nbsp;sponsor-generated&nbsp;test&nbsp;data&nbsp;but&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_28\">28</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">addition&nbsp;would&nbsp;include&nbsp;a&nbsp;discussion&nbsp;of&nbsp;its&nbsp;relevance&nbsp;to&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_29\">29</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;addition&nbsp;to&nbsp;containing&nbsp;the&nbsp;necessary&nbsp;study&nbsp;design-related&nbsp;details&nbsp;and&nbsp;the&nbsp;relevant&nbsp;and&nbsp;appropriate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_30\">30</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;assessment&nbsp;data,&nbsp;thereby&nbsp;facilitating&nbsp;study&nbsp;review&nbsp;and&nbsp;toxicological&nbsp;risk&nbsp;assessment,&nbsp;a&nbsp;report</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_31\">31</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">should&nbsp;contain&nbsp;sufficient&nbsp;information&nbsp;to&nbsp;establish&nbsp;the&nbsp;appropriateness&nbsp;of&nbsp;the&nbsp;analytical&nbsp;processes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_32\">32</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">employed.&nbsp;Such&nbsp;information&nbsp;would&nbsp;be&nbsp;relevant&nbsp;to&nbsp;establishing&nbsp;that&nbsp;the&nbsp;analytical&nbsp;procedures&nbsp;were</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_33\">33</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">suitable&nbsp;for&nbsp;their&nbsp;intended&nbsp;use&nbsp;and&nbsp;implemented&nbsp;appropriately&nbsp;at&nbsp;their&nbsp;time&nbsp;of&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_34\">34</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Types&nbsp;of&nbsp;information&nbsp;that&nbsp;can&nbsp;be&nbsp;included&nbsp;in&nbsp;a&nbsp;report&nbsp;to&nbsp;facilitate&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_35\">35</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;review&nbsp;of&nbsp;the&nbsp;analytical&nbsp;data&nbsp;and&nbsp;procedures&nbsp;are&nbsp;listed&nbsp;in&nbsp;Annex\u00a0G.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_36\">36</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_37\">37</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">26\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_38\">38</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_39\">39</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_40\">40</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_41\">41</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_42\">42</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_43\">43</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_44\">44</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_45\">45</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_46\">46</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_47\">47</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">General&nbsp;principles&nbsp;of&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_48\">48</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;chemical&nbsp;characterization&nbsp;process</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_49\">49</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;characterization&nbsp;is&nbsp;the&nbsp;process&nbsp;of&nbsp;obtaining&nbsp;chemical&nbsp;information&nbsp;about&nbsp;a&nbsp;medical&nbsp;device,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_50\">50</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relevant&nbsp;to&nbsp;its&nbsp;biological&nbsp;evaluation&nbsp;and&nbsp;any&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Chemical&nbsp;characterization&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_51\">51</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;medical&nbsp;device,&nbsp;its&nbsp;components,&nbsp;or&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction&nbsp;involves&nbsp;multiple&nbsp;processes,&nbsp;including</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_52\">52</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;gathering&nbsp;and&nbsp;generation,&nbsp;to:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_53\">53</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;establish&nbsp;the&nbsp;device\u2019s&nbsp;material&nbsp;composition&nbsp;and&nbsp;configuration;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_54\">54</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;identify&nbsp;and&nbsp;quantify&nbsp;extractables&nbsp;and/or&nbsp;leachables&nbsp;associated&nbsp;with&nbsp;the&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_55\">55</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemically&nbsp;characterizing&nbsp;a&nbsp;medical&nbsp;device&nbsp;and/or&nbsp;its&nbsp;components&nbsp;and&nbsp;materials&nbsp;of&nbsp;construction&nbsp;is&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_56\">56</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">necessary&nbsp;aspect&nbsp;in&nbsp;assessing&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of&nbsp;that&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_57\">57</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;uses&nbsp;of&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_58\">58</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;characterization&nbsp;can&nbsp;facilitate&nbsp;the&nbsp;biological&nbsp;safety&nbsp;assessment&nbsp;process&nbsp;in&nbsp;one&nbsp;of&nbsp;three&nbsp;ways</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_59\">59</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">by&nbsp;providing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_60\">60</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;chemical&nbsp;information&nbsp;that&nbsp;enables&nbsp;a&nbsp;comparison&nbsp;between&nbsp;the&nbsp;medical&nbsp;device&nbsp;in&nbsp;question&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_61\">61</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinically&nbsp;established&nbsp;medical&nbsp;devices&nbsp;(establish&nbsp;equivalence),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_62\">62</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;chemical&nbsp;basis&nbsp;for&nbsp;comparing&nbsp;the&nbsp;medical&nbsp;device&nbsp;in&nbsp;question&nbsp;to&nbsp;a&nbsp;relevant&nbsp;material&nbsp;standard</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_63\">63</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(confirm&nbsp;conformance),&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_64\">64</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;chemical&nbsp;information&nbsp;that&nbsp;serves&nbsp;as&nbsp;the&nbsp;basis&nbsp;for&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(enable</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_65\">65</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_66\">66</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;certain&nbsp;circumstances,&nbsp;the&nbsp;toxicological&nbsp;implications&nbsp;associated&nbsp;with&nbsp;use&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_67\">67</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessed&nbsp;by&nbsp;comparing&nbsp;the&nbsp;device&nbsp;in&nbsp;question&nbsp;to&nbsp;a&nbsp;clinically&nbsp;established&nbsp;device.&nbsp;In&nbsp;such&nbsp;circumstances,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_68\">68</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;characterization&nbsp;is&nbsp;important&nbsp;in&nbsp;establishing&nbsp;chemical&nbsp;equivalence&nbsp;between,&nbsp;for&nbsp;example,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_69\">69</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;proposed&nbsp;item&nbsp;(materials,&nbsp;component&nbsp;or&nbsp;device)&nbsp;and&nbsp;a&nbsp;clinically&nbsp;established&nbsp;item&nbsp;(see&nbsp;Annex\u00a0C),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_70\">70</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;finished&nbsp;and&nbsp;marketable&nbsp;medical&nbsp;device&nbsp;and&nbsp;a&nbsp;prototype&nbsp;device,&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_71\">71</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;material,&nbsp;component,&nbsp;or&nbsp;medical&nbsp;device&nbsp;after&nbsp;a&nbsp;process,&nbsp;material,&nbsp;application&nbsp;or&nbsp;manufacturing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_72\">72</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">change.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_73\">73</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Standards&nbsp;that&nbsp;include&nbsp;requirements&nbsp;for&nbsp;material&nbsp;composition&nbsp;exist&nbsp;for&nbsp;some&nbsp;medical&nbsp;device&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_74\">74</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(e.g.&nbsp;the&nbsp;ISO\u00a0&nbsp;5832&nbsp;series).&nbsp;It&nbsp;is&nbsp;possible&nbsp;that&nbsp;a&nbsp;material&nbsp;complying&nbsp;with&nbsp;such&nbsp;a&nbsp;standard&nbsp;would&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_75\">75</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">require&nbsp;further&nbsp;chemical&nbsp;characterization&nbsp;to&nbsp;support&nbsp;toxicological&nbsp;or&nbsp;biological&nbsp;evaluation.&nbsp;However,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_76\">76</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;conversion&nbsp;of&nbsp;the&nbsp;material&nbsp;into&nbsp;the&nbsp;final&nbsp;form&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;can&nbsp;introduce&nbsp;contaminants&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_77\">77</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;residues.&nbsp;These&nbsp;can&nbsp;leach&nbsp;from&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;be&nbsp;of&nbsp;toxicological&nbsp;concern.&nbsp;Evaluation&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_78\">78</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;finished&nbsp;medical&nbsp;device&nbsp;should&nbsp;consider&nbsp;and&nbsp;address&nbsp;such&nbsp;leachables.&nbsp;In&nbsp;addition,&nbsp;physical,&nbsp;chemical,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_79\">79</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">morphological,&nbsp;and&nbsp;topographical&nbsp;characteristics&nbsp;of&nbsp;a&nbsp;component&nbsp;manufactured&nbsp;with&nbsp;the&nbsp;material&nbsp;may</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_80\">80</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">need&nbsp;to&nbsp;be&nbsp;assessed&nbsp;to&nbsp;determine&nbsp;the&nbsp;overall&nbsp;safety.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_81\">81</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Lastly,&nbsp;and&nbsp;in&nbsp;other&nbsp;circumstances,&nbsp;most&nbsp;notably&nbsp;at&nbsp;its&nbsp;inception&nbsp;and&nbsp;in&nbsp;the&nbsp;absence&nbsp;of&nbsp;a&nbsp;relevant</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_82\">82</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinically&nbsp;established&nbsp;medical&nbsp;device,&nbsp;the&nbsp;toxicological&nbsp;implications&nbsp;associated&nbsp;with&nbsp;the&nbsp;use&nbsp;of&nbsp;a&nbsp;device,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_83\">83</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">including&nbsp;its&nbsp;components&nbsp;or&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;can&nbsp;be&nbsp;assessed&nbsp;using&nbsp;a&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_84\">84</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_85\">85</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_86\">86</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">27</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_87\">87</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_88\">88</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_89\">89</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_90\">90</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_91\">91</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_92\">92</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">approach.&nbsp;Such&nbsp;an&nbsp;approach&nbsp;can&nbsp;include&nbsp;data&nbsp;gathering,&nbsp;data&nbsp;generation&nbsp;(e.g.&nbsp;extractables&nbsp;or&nbsp;leachables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_93\">93</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">profiles),&nbsp;and&nbsp;data&nbsp;interpretation.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_94\">94</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">An&nbsp;overview&nbsp;of&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;procedure&nbsp;outlined&nbsp;in&nbsp;this&nbsp;document&nbsp;and&nbsp;its&nbsp;relationship</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_95\">95</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;given&nbsp;in&nbsp;Clause\u00a05.&nbsp;The&nbsp;procedure&nbsp;is&nbsp;based&nbsp;on&nbsp;the&nbsp;following&nbsp;considerations.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_96\">96</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;first&nbsp;step&nbsp;in&nbsp;chemical&nbsp;characterization&nbsp;is&nbsp;establishing&nbsp;contact&nbsp;according&nbsp;to&nbsp;ISO\u00a010993-1.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_97\">97</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;extent&nbsp;of&nbsp;chemical&nbsp;characterization&nbsp;(e.g.&nbsp;whether&nbsp;information&nbsp;gathering&nbsp;can&nbsp;be&nbsp;sufficient;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_98\">98</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">design&nbsp;of&nbsp;extraction&nbsp;studies,&nbsp;if&nbsp;performed)&nbsp;should&nbsp;reflect:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_99\">99</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;nature&nbsp;and&nbsp;duration&nbsp;of&nbsp;the&nbsp;clinical&nbsp;exposure;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_100\">100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;physical&nbsp;form&nbsp;of&nbsp;the&nbsp;materials&nbsp;used&nbsp;(e.g.&nbsp;liquids,&nbsp;gels,&nbsp;pastes,&nbsp;solids,&nbsp;or&nbsp;biologically&nbsp;sourced</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_101\">101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_102\">102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;history&nbsp;of&nbsp;use&nbsp;of&nbsp;the&nbsp;materials.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_103\">103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Further,&nbsp;it&nbsp;should&nbsp;be&nbsp;sufficient&nbsp;to&nbsp;produce&nbsp;the&nbsp;data&nbsp;necessary&nbsp;to&nbsp;establish&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_104\">104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_105\">105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_106\">106</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Establishing&nbsp;the&nbsp;configuration&nbsp;of&nbsp;a&nbsp;medical&nbsp;device,&nbsp;by&nbsp;delineating&nbsp;its&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;is&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_107\">107</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">necessary&nbsp;first&nbsp;step&nbsp;in&nbsp;establishing&nbsp;the&nbsp;device\u2019s&nbsp;biocompatibility&nbsp;as&nbsp;(a)&nbsp;use&nbsp;of&nbsp;appropriate&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_108\">108</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;construction&nbsp;increases&nbsp;the&nbsp;likelihood&nbsp;a&nbsp;device&nbsp;will&nbsp;be&nbsp;biocompatible&nbsp;and&nbsp;(b)&nbsp;knowledge&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_109\">109</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">materials&nbsp;of&nbsp;construction&nbsp;could&nbsp;provide&nbsp;the&nbsp;starting&nbsp;point&nbsp;for&nbsp;establishing&nbsp;chemical&nbsp;equivalence&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_110\">110</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;clinically&nbsp;established&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_111\">111</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;some&nbsp;medical&nbsp;devices,&nbsp;configuration&nbsp;and&nbsp;material&nbsp;composition&nbsp;information&nbsp;could&nbsp;be&nbsp;readily</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_112\">112</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">available&nbsp;to&nbsp;the&nbsp;device&nbsp;manufacturer&nbsp;as&nbsp;part&nbsp;of&nbsp;the&nbsp;device&nbsp;specification,&nbsp;or&nbsp;it&nbsp;could&nbsp;be&nbsp;obtained</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_113\">113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">through&nbsp;inquiry.&nbsp;In&nbsp;other&nbsp;circumstances,&nbsp;such&nbsp;information&nbsp;can&nbsp;be&nbsp;obtained&nbsp;by&nbsp;appropriate&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_114\">114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;device.&nbsp;In&nbsp;any&nbsp;case,&nbsp;processing&nbsp;aids&nbsp;and&nbsp;additives&nbsp;(see&nbsp;Table\u00a03,&nbsp;footnotes&nbsp;b&nbsp;and&nbsp;d)&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_115\">115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">included&nbsp;as&nbsp;part&nbsp;of&nbsp;this&nbsp;compositional&nbsp;information.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_116\">116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Establishing&nbsp;the&nbsp;composition&nbsp;of&nbsp;a&nbsp;medical&nbsp;device\u2019s&nbsp;materials&nbsp;of&nbsp;construction&nbsp;is&nbsp;a&nbsp;necessary&nbsp;step</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_117\">117</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;establishing&nbsp;a&nbsp;device\u2019s&nbsp;biocompatibility,&nbsp;as&nbsp;(a)&nbsp;the&nbsp;composition&nbsp;of&nbsp;the&nbsp;individual&nbsp;materials&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_118\">118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;can&nbsp;serve&nbsp;as&nbsp;the&nbsp;basis&nbsp;for&nbsp;establishing&nbsp;chemical&nbsp;equivalence&nbsp;to&nbsp;a&nbsp;clinically&nbsp;established</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_119\">119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device,&nbsp;and&nbsp;(b)&nbsp;the&nbsp;chemical&nbsp;entities&nbsp;contained&nbsp;in&nbsp;a&nbsp;material&nbsp;of&nbsp;construction&nbsp;can&nbsp;be&nbsp;sources&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_120\">120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractables&nbsp;and&nbsp;leachables.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_121\">121</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compositional&nbsp;data&nbsp;include&nbsp;qualitative&nbsp;data,&nbsp;which&nbsp;describe&nbsp;the&nbsp;composition&nbsp;of&nbsp;a&nbsp;material&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_122\">122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establish&nbsp;which&nbsp;chemicals&nbsp;are&nbsp;present&nbsp;in&nbsp;the&nbsp;material,&nbsp;and&nbsp;quantitative&nbsp;data&nbsp;which&nbsp;establish</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_123\">123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;concentrations&nbsp;of&nbsp;the&nbsp;material\u2019s&nbsp;chemical&nbsp;constituents.&nbsp;Quantitative&nbsp;information&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_124\">124</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;necessary&nbsp;to&nbsp;assess&nbsp;biological&nbsp;safety,&nbsp;as&nbsp;the&nbsp;identity&nbsp;and&nbsp;amounts&nbsp;of&nbsp;the&nbsp;constituents&nbsp;of&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_125\">125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medical&nbsp;device\u2019s&nbsp;materials&nbsp;of&nbsp;construction&nbsp;enables&nbsp;the&nbsp;investigation&nbsp;of&nbsp;the&nbsp;intrinsic&nbsp;toxicity&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_126\">126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">each&nbsp;constituent.&nbsp;The&nbsp;data&nbsp;obtained&nbsp;are&nbsp;intended&nbsp;for&nbsp;use&nbsp;by&nbsp;the&nbsp;medical&nbsp;device&nbsp;manufacturer</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_127\">127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;support&nbsp;the&nbsp;biological&nbsp;evaluation&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_128\">128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For&nbsp;some&nbsp;materials,&nbsp;compositional&nbsp;information&nbsp;could&nbsp;be&nbsp;readily&nbsp;available&nbsp;as&nbsp;part&nbsp;of&nbsp;the&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_129\">129</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specification.&nbsp;As&nbsp;materials&nbsp;such&nbsp;as&nbsp;polymers&nbsp;can&nbsp;have&nbsp;complex&nbsp;formulations,&nbsp;compositional</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_130\">130</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">details&nbsp;should&nbsp;be&nbsp;requested&nbsp;from&nbsp;the&nbsp;supplier&nbsp;of&nbsp;the&nbsp;material.&nbsp;Furthermore,&nbsp;some&nbsp;relevant</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_131\">131</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;can&nbsp;be&nbsp;available&nbsp;in&nbsp;the&nbsp;published&nbsp;chemical&nbsp;literature&nbsp;(e.g.&nbsp;typical&nbsp;variability</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_132\">132</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;composition&nbsp;or&nbsp;guidance&nbsp;on&nbsp;possible&nbsp;analytes&nbsp;of&nbsp;interest).&nbsp;In&nbsp;the&nbsp;absence&nbsp;of&nbsp;such&nbsp;details,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_133\">133</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;analytical&nbsp;techniques&nbsp;can&nbsp;be&nbsp;applied&nbsp;to&nbsp;a&nbsp;material&nbsp;to&nbsp;obtain&nbsp;compositional&nbsp;data.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_134\">134</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Determining&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;potential&nbsp;to&nbsp;release&nbsp;chemical&nbsp;substances&nbsp;under&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_135\">135</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;conditions&nbsp;can&nbsp;provide&nbsp;the&nbsp;basis&nbsp;for&nbsp;understanding&nbsp;and&nbsp;assessing&nbsp;the&nbsp;device\u2019s&nbsp;potential</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_136\">136</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">safety&nbsp;impact.&nbsp;Although&nbsp;any&nbsp;of&nbsp;the&nbsp;substances&nbsp;in&nbsp;a&nbsp;material&nbsp;or&nbsp;additives&nbsp;used&nbsp;in&nbsp;the&nbsp;process&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_137\">137</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manufacturing&nbsp;a&nbsp;medical&nbsp;device&nbsp;could&nbsp;be&nbsp;leached&nbsp;from&nbsp;the&nbsp;device&nbsp;and&nbsp;thereby&nbsp;become&nbsp;bio-available,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_138\">138</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">it&nbsp;could&nbsp;potentially&nbsp;be&nbsp;necessary&nbsp;to&nbsp;obtain&nbsp;information&nbsp;demonstrating&nbsp;the&nbsp;extent&nbsp;to&nbsp;which&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_139\">139</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substances&nbsp;will&nbsp;be&nbsp;leached&nbsp;under&nbsp;the&nbsp;clinical&nbsp;use&nbsp;conditions&nbsp;of&nbsp;the&nbsp;finished&nbsp;product&nbsp;to&nbsp;estimate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_140\">140</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;risk&nbsp;arising&nbsp;from&nbsp;them.&nbsp;This&nbsp;can&nbsp;be&nbsp;estimated&nbsp;by&nbsp;conducting&nbsp;extraction&nbsp;studies&nbsp;of&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_141\">141</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_142\">142</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">28\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_143\">143</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_144\">144</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_145\">145</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_146\">146</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_147\">147</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_148\">148</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_149\">149</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device.&nbsp;Appropriate&nbsp;extraction&nbsp;conditions&nbsp;should&nbsp;be&nbsp;established,&nbsp;justified&nbsp;and&nbsp;then&nbsp;used&nbsp;to&nbsp;ensure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_150\">150</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;any&nbsp;substance&nbsp;which&nbsp;is&nbsp;likely&nbsp;to&nbsp;be&nbsp;released&nbsp;during&nbsp;finished&nbsp;product&nbsp;use&nbsp;will&nbsp;be&nbsp;released&nbsp;into</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_151\">151</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;extraction&nbsp;media&nbsp;(see&nbsp;also&nbsp;Annex\u00a0D).&nbsp;Extractions&nbsp;can&nbsp;be&nbsp;used&nbsp;to&nbsp;determine&nbsp;the&nbsp;total&nbsp;amount&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_152\">152</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractable&nbsp;materials&nbsp;that&nbsp;is&nbsp;present&nbsp;in&nbsp;the&nbsp;medical&nbsp;device/material&nbsp;(exhaustive&nbsp;extraction)&nbsp;or&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_153\">153</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">total&nbsp;available&nbsp;amount&nbsp;of&nbsp;extractable&nbsp;material&nbsp;(exaggerated&nbsp;or&nbsp;simulated&nbsp;use&nbsp;extraction)&nbsp;in&nbsp;order</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_154\">154</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;complete&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Exhaustive&nbsp;extractions&nbsp;are&nbsp;generally&nbsp;necessary</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_155\">155</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;produce&nbsp;sufficient&nbsp;data&nbsp;for&nbsp;medical&nbsp;devices&nbsp;with&nbsp;prolonged&nbsp;or&nbsp;long-term&nbsp;contact;&nbsp;exaggerated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_156\">156</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractions&nbsp;should&nbsp;only&nbsp;be&nbsp;used&nbsp;for&nbsp;long&nbsp;term&nbsp;contact&nbsp;devices&nbsp;if&nbsp;appropriately&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_157\">157</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Regardless&nbsp;of&nbsp;the&nbsp;means&nbsp;by&nbsp;which&nbsp;the&nbsp;extract&nbsp;is&nbsp;obtained,&nbsp;the&nbsp;extract&nbsp;is&nbsp;quantitatively&nbsp;analysed&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_158\">158</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">generate&nbsp;the&nbsp;data&nbsp;for&nbsp;use&nbsp;in&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;(see&nbsp;ISO\u00a010993-17).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_159\">159</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Depending&nbsp;on&nbsp;the&nbsp;nature&nbsp;and&nbsp;sources&nbsp;of&nbsp;the&nbsp;chemical&nbsp;information&nbsp;to&nbsp;be&nbsp;assembled,&nbsp;the&nbsp;successful</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_160\">160</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">completion&nbsp;of&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;outlined&nbsp;in&nbsp;this&nbsp;document&nbsp;can&nbsp;require&nbsp;expertise&nbsp;in&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_161\">161</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">science&nbsp;or&nbsp;analytical&nbsp;chemistry&nbsp;to&nbsp;provide&nbsp;the&nbsp;necessary&nbsp;qualitative&nbsp;and&nbsp;quantitative&nbsp;data&nbsp;that&nbsp;a&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_162\">162</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessor&nbsp;can&nbsp;use&nbsp;to&nbsp;assess&nbsp;medical&nbsp;device&nbsp;safety.&nbsp;Toxicology&nbsp;expertise&nbsp;is&nbsp;valuable&nbsp;in&nbsp;understanding&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_163\">163</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">types&nbsp;of&nbsp;compounds&nbsp;that&nbsp;might&nbsp;be&nbsp;of&nbsp;toxicological&nbsp;concern&nbsp;so&nbsp;that&nbsp;the&nbsp;materials&nbsp;and&nbsp;chemistry&nbsp;experts</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_164\">164</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;design&nbsp;appropriate&nbsp;experiments.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_165\">165</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;chemical&nbsp;characterization&nbsp;outlined&nbsp;in&nbsp;this&nbsp;document&nbsp;is&nbsp;performed&nbsp;as&nbsp;part&nbsp;of&nbsp;the&nbsp;initial</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_166\">166</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biocompatibility&nbsp;assessment&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.&nbsp;It&nbsp;is&nbsp;noted&nbsp;that&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_167\">167</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;is&nbsp;inferred&nbsp;over&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;time&nbsp;in&nbsp;market&nbsp;only&nbsp;so&nbsp;long&nbsp;as&nbsp;the&nbsp;device\u2019s&nbsp;materials&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_168\">168</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;and&nbsp;manufacturing&nbsp;process&nbsp;remain&nbsp;unchanged.&nbsp;It&nbsp;is&nbsp;important&nbsp;that&nbsp;controls&nbsp;be&nbsp;introduced</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_169\">169</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;prevent&nbsp;a&nbsp;material&nbsp;supplier&nbsp;from&nbsp;changing&nbsp;the&nbsp;composition&nbsp;of&nbsp;a&nbsp;material&nbsp;supplied&nbsp;under&nbsp;a&nbsp;specific</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_170\">170</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">commercial&nbsp;trade&nbsp;name&nbsp;or&nbsp;supply&nbsp;agreement&nbsp;without&nbsp;prior&nbsp;notification&nbsp;to&nbsp;the&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_171\">171</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manufacturer.&nbsp;The&nbsp;manufacturer&nbsp;should&nbsp;assess&nbsp;and&nbsp;document&nbsp;the&nbsp;consequences&nbsp;of&nbsp;any&nbsp;notified&nbsp;changes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_172\">172</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">on&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of&nbsp;the&nbsp;product.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_173\">173</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;analytical&nbsp;evaluation&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_174\">174</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">An&nbsp;important&nbsp;aspect&nbsp;of&nbsp;extractables/leachables&nbsp;analysis&nbsp;is&nbsp;the&nbsp;testing&nbsp;of&nbsp;a&nbsp;liquid&nbsp;sample&nbsp;(e.g.&nbsp;extract,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_175\">175</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">digest)&nbsp;to&nbsp;detect,&nbsp;identify,&nbsp;and&nbsp;quantify&nbsp;solubilized&nbsp;(extracted&nbsp;or&nbsp;leached)&nbsp;substances.&nbsp;For&nbsp;the&nbsp;purposes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_176\">176</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;toxicological&nbsp;assessment,&nbsp;the&nbsp;analytical&nbsp;test&nbsp;methods&nbsp;will&nbsp;be&nbsp;capable&nbsp;of&nbsp;detecting,&nbsp;identifying,&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_177\">177</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantifying&nbsp;solubilized&nbsp;substances&nbsp;in&nbsp;the&nbsp;extract&nbsp;at&nbsp;the&nbsp;levels&nbsp;which&nbsp;could&nbsp;potentially&nbsp;have&nbsp;an&nbsp;effect</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_178\">178</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">on&nbsp;the&nbsp;health&nbsp;of&nbsp;potentially&nbsp;affected&nbsp;individuals&nbsp;in&nbsp;contact&nbsp;with&nbsp;a&nbsp;medical&nbsp;device.&nbsp;However,&nbsp;in&nbsp;certain</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_179\">179</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">circumstances&nbsp;some&nbsp;essential&nbsp;chemical&nbsp;characterization&nbsp;activities,&nbsp;such&nbsp;as&nbsp;identification,&nbsp;cannot&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_180\">180</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">performed.&nbsp;In&nbsp;the&nbsp;absence&nbsp;of&nbsp;reliable&nbsp;identification&nbsp;or&nbsp;sufficient&nbsp;toxicological&nbsp;information&nbsp;for&nbsp;identified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_181\">181</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compounds,&nbsp;the&nbsp;probable&nbsp;risk&nbsp;can&nbsp;often&nbsp;be&nbsp;inferred&nbsp;via&nbsp;the&nbsp;application&nbsp;of&nbsp;toxicological&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_182\">182</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concepts.&nbsp;Accordingly,&nbsp;substances&nbsp;lower&nbsp;than&nbsp;such&nbsp;a&nbsp;threshold&nbsp;do&nbsp;not&nbsp;require&nbsp;further&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_183\">183</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization,&nbsp;including&nbsp;identification&nbsp;and&nbsp;quantification.&nbsp;It&nbsp;is&nbsp;noted&nbsp;that&nbsp;these&nbsp;thresholds&nbsp;make</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_184\">184</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exceptions&nbsp;for&nbsp;special&nbsp;case&nbsp;compounds&nbsp;of&nbsp;known&nbsp;high&nbsp;toxicity.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_185\">185</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;a&nbsp;threshold&nbsp;is&nbsp;expressed&nbsp;in&nbsp;terms&nbsp;of&nbsp;dose,&nbsp;then&nbsp;it&nbsp;is&nbsp;not&nbsp;directly&nbsp;applicable&nbsp;to&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_186\">186</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization&nbsp;of&nbsp;a&nbsp;liquid&nbsp;test&nbsp;sample.&nbsp;However,&nbsp;these&nbsp;thresholds&nbsp;can&nbsp;be&nbsp;converted&nbsp;to&nbsp;a&nbsp;concentration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_187\">187</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">via&nbsp;the&nbsp;appropriate&nbsp;mathematical&nbsp;conversion,&nbsp;which&nbsp;takes&nbsp;into&nbsp;account&nbsp;the&nbsp;clinical&nbsp;use&nbsp;of&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_188\">188</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;and&nbsp;the&nbsp;experimental&nbsp;conditions&nbsp;used&nbsp;to&nbsp;derive&nbsp;the&nbsp;liquid&nbsp;sample.&nbsp;Such&nbsp;a&nbsp;concentration-based</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_189\">189</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">threshold,&nbsp;termed&nbsp;the&nbsp;AET,&nbsp;becomes&nbsp;that&nbsp;threshold&nbsp;above&nbsp;which&nbsp;an&nbsp;analytical&nbsp;chemist&nbsp;should&nbsp;produce</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_190\">190</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;information&nbsp;(concentration&nbsp;and&nbsp;identity)&nbsp;which&nbsp;is&nbsp;necessary&nbsp;for&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_191\">191</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">application&nbsp;of&nbsp;ISO\u00a010993-17).&nbsp;A&nbsp;substance&nbsp;that&nbsp;is&nbsp;present&nbsp;in&nbsp;a&nbsp;liquid&nbsp;sample&nbsp;at&nbsp;a&nbsp;concentration&nbsp;below&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_192\">192</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;is&nbsp;established&nbsp;as&nbsp;having&nbsp;an&nbsp;acceptable&nbsp;toxicological&nbsp;risk&nbsp;without&nbsp;further&nbsp;assessment,&nbsp;meaning&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_193\">193</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;substance&nbsp;does&nbsp;not&nbsp;have&nbsp;to&nbsp;be&nbsp;accurately&nbsp;quantified&nbsp;or&nbsp;identified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_194\">194</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;AET&nbsp;is&nbsp;not&nbsp;applicable&nbsp;to&nbsp;analytical&nbsp;targeting&nbsp;methods&nbsp;in&nbsp;which&nbsp;the&nbsp;specified&nbsp;analytes&nbsp;are&nbsp;compounds</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_195\">195</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;sufficient&nbsp;toxicological&nbsp;safety&nbsp;data&nbsp;to&nbsp;address&nbsp;using&nbsp;ISO\u00a010993-17.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_196\">196</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;calculation&nbsp;and&nbsp;application&nbsp;of&nbsp;the&nbsp;AET&nbsp;is&nbsp;discussed&nbsp;in&nbsp;greater&nbsp;detail&nbsp;in&nbsp;Annex\u00a0E.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_197\">197</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_198\">198</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_199\">199</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">29</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_200\">200</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_201\">201</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_202\">202</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_203\">203</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_204\">204</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_205\">205</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;role&nbsp;of&nbsp;chemical&nbsp;characterization&nbsp;in&nbsp;biological&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_206\">206</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;primary&nbsp;objective&nbsp;of&nbsp;ISO\u00a010993&nbsp;is&nbsp;the&nbsp;protection&nbsp;of&nbsp;humans&nbsp;from&nbsp;potential&nbsp;biological&nbsp;risks&nbsp;arising</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_207\">207</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;the&nbsp;use&nbsp;of&nbsp;medical&nbsp;devices.&nbsp;This&nbsp;objective&nbsp;is&nbsp;achieved&nbsp;via&nbsp;the&nbsp;biological&nbsp;evaluation&nbsp;of&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_208\">208</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices,&nbsp;which&nbsp;includes&nbsp;the&nbsp;means&nbsp;(testing&nbsp;procedures)&nbsp;for&nbsp;producing&nbsp;the&nbsp;biological&nbsp;data&nbsp;and&nbsp;the&nbsp;means</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_209\">209</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;interpreting&nbsp;the&nbsp;biological&nbsp;data&nbsp;in&nbsp;the&nbsp;context&nbsp;of&nbsp;a&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_210\">210</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Generally,&nbsp;biocompatibility&nbsp;information&nbsp;can&nbsp;be&nbsp;obtained&nbsp;from&nbsp;two&nbsp;types&nbsp;of&nbsp;assessments:&nbsp;(1)&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_211\">211</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization&nbsp;coupled&nbsp;with&nbsp;relevant&nbsp;toxicology&nbsp;data,&nbsp;and&nbsp;(2)&nbsp;biological&nbsp;testing.&nbsp;Generally,&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_212\">212</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment&nbsp;should&nbsp;include&nbsp;the&nbsp;proper&nbsp;mix&nbsp;of&nbsp;chemical&nbsp;and&nbsp;biological&nbsp;data,&nbsp;which&nbsp;can&nbsp;vary&nbsp;depending</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_213\">213</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">upon&nbsp;the&nbsp;circumstances.&nbsp;If&nbsp;information&nbsp;from&nbsp;both&nbsp;types&nbsp;of&nbsp;assessments&nbsp;address&nbsp;the&nbsp;same&nbsp;biological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_214\">214</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">endpoint&nbsp;in&nbsp;a&nbsp;comparable&nbsp;manner,&nbsp;information&nbsp;from&nbsp;either&nbsp;type&nbsp;of&nbsp;assessment&nbsp;could&nbsp;be&nbsp;used&nbsp;to&nbsp;address</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_215\">215</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;endpoint.&nbsp;However,&nbsp;in&nbsp;vitro&nbsp;tests&nbsp;should&nbsp;be&nbsp;favoured&nbsp;as&nbsp;far&nbsp;as&nbsp;possible&nbsp;(see&nbsp;ISO\u00a010993-2).&nbsp;In&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_216\">216</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">event&nbsp;conflicting&nbsp;data&nbsp;is&nbsp;obtained,&nbsp;the&nbsp;biological&nbsp;test&nbsp;(given&nbsp;it&nbsp;has&nbsp;acceptable&nbsp;sensitivity)&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_217\">217</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">given&nbsp;greater&nbsp;weight&nbsp;due&nbsp;to&nbsp;its&nbsp;being&nbsp;directly&nbsp;applicable&nbsp;to&nbsp;biological&nbsp;systems.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_218\">218</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;general&nbsp;category&nbsp;of&nbsp;biological&nbsp;evaluation&nbsp;can&nbsp;be&nbsp;further&nbsp;subdivided&nbsp;into&nbsp;two&nbsp;sub-categories:&nbsp;those</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_219\">219</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">types&nbsp;of&nbsp;testing&nbsp;that&nbsp;evaluate&nbsp;a&nbsp;systemic&nbsp;effect&nbsp;(i.e.&nbsp;one&nbsp;that&nbsp;depends&nbsp;on&nbsp;systemic&nbsp;distribution&nbsp;of&nbsp;extracts</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_220\">220</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">or&nbsp;leachates),&nbsp;and&nbsp;those&nbsp;that&nbsp;evaluate&nbsp;local&nbsp;effects&nbsp;(i.e.&nbsp;those&nbsp;that&nbsp;occur&nbsp;in&nbsp;the&nbsp;vicinity&nbsp;of&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_221\">221</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device).&nbsp;Tests&nbsp;that&nbsp;evaluate&nbsp;systemic&nbsp;effects,&nbsp;or&nbsp;endpoints&nbsp;(e.g.&nbsp;systemic&nbsp;toxicity)&nbsp;are&nbsp;more&nbsp;likely&nbsp;to&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_222\">222</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">suitably&nbsp;addressed&nbsp;by&nbsp;chemical&nbsp;characterization&nbsp;than&nbsp;are&nbsp;those&nbsp;tests&nbsp;for&nbsp;local&nbsp;effects&nbsp;(e.g.&nbsp;irritation&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_223\">223</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">implantation&nbsp;effects).&nbsp;Endpoints&nbsp;that&nbsp;have&nbsp;both&nbsp;local&nbsp;and&nbsp;systemic&nbsp;effects&nbsp;(e.g.&nbsp;sensitization)&nbsp;may&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_224\">224</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">addressed&nbsp;through&nbsp;chemical&nbsp;characterization,&nbsp;if&nbsp;sufficient&nbsp;toxicology&nbsp;data&nbsp;exist.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_225\">225</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;use&nbsp;of&nbsp;chemical&nbsp;characterization&nbsp;in&nbsp;place&nbsp;of&nbsp;biological&nbsp;testing&nbsp;should&nbsp;be&nbsp;documented&nbsp;and&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_226\">226</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_227\">227</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">30\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_228\">228</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_229\">229</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_230\">230</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_231\">231</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_232\">232</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_233\">233</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_234\">234</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_235\">235</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_236\">236</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_237\">237</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Information&nbsp;sources&nbsp;for&nbsp;chemical&nbsp;characterization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_238\">238</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_239\">239</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Knowledge&nbsp;of&nbsp;a&nbsp;medical&nbsp;device\u2019s&nbsp;material&nbsp;composition&nbsp;is&nbsp;an&nbsp;essential&nbsp;input&nbsp;into&nbsp;a&nbsp;device\u2019s&nbsp;biological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_240\">240</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">evaluation&nbsp;and&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(see&nbsp;ISO\u00a0&nbsp;10993-1&nbsp;and&nbsp;ISO\u00a0&nbsp;10993-17).&nbsp;As&nbsp;described&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_241\">241</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-1:2018,&nbsp;6.1,&nbsp;the&nbsp;type&nbsp;and&nbsp;amount&nbsp;of&nbsp;characterization&nbsp;data&nbsp;should&nbsp;be&nbsp;consistent&nbsp;with&nbsp;all&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_242\">242</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;parameters&nbsp;considered&nbsp;relevant&nbsp;to&nbsp;the&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;should&nbsp;consider</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_243\">243</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;clinical&nbsp;application.&nbsp;Gathering&nbsp;of&nbsp;chemical&nbsp;characterization&nbsp;data&nbsp;could&nbsp;require&nbsp;the&nbsp;use&nbsp;of&nbsp;multiple</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_244\">244</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sources&nbsp;of&nbsp;information&nbsp;as&nbsp;described&nbsp;in&nbsp;B.2&nbsp;to&nbsp;B.4&nbsp;and&nbsp;could&nbsp;include&nbsp;a&nbsp;review&nbsp;of&nbsp;the&nbsp;available&nbsp;published</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_245\">245</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;literature.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_246\">246</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information&nbsp;from&nbsp;the&nbsp;material&nbsp;supplier</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_247\">247</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;following&nbsp;information,&nbsp;where&nbsp;available,&nbsp;is&nbsp;useful&nbsp;to&nbsp;specify&nbsp;the&nbsp;material&nbsp;used&nbsp;(e.g.&nbsp;raw&nbsp;and&nbsp;basic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_248\">248</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">starting&nbsp;materials,&nbsp;processing&nbsp;aids),&nbsp;and&nbsp;the&nbsp;compositional&nbsp;information&nbsp;is&nbsp;particularly&nbsp;useful&nbsp;to&nbsp;aid</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_249\">249</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;risk&nbsp;assessment:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_250\">250</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;name&nbsp;of&nbsp;material&nbsp;manufacturer&nbsp;or&nbsp;supplier;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_251\">251</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;generic&nbsp;material&nbsp;trade&nbsp;name;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_252\">252</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_253\">253</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Silastic\u00ae,&nbsp;Dacron\u00ae,&nbsp;Tetoron\u00ae,&nbsp;Pellethane\u00ae,&nbsp;Nylon,&nbsp;Teflon\u00ae1).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_254\">254</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_255\">255</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;identifier&nbsp;(e.g.&nbsp;CAS&nbsp;number)&nbsp;or&nbsp;systematic&nbsp;name&nbsp;(IUPAC/USAN)&nbsp;(see&nbsp;B.5);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_256\">256</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;product&nbsp;code&nbsp;and&nbsp;number;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_257\">257</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_258\">258</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Pellethane&nbsp;2393-80AE,&nbsp;methylvinylpolysiloxane&nbsp;0215.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_259\">259</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;material&nbsp;manufacturer's&nbsp;specification,&nbsp;including,&nbsp;for&nbsp;example,&nbsp;purity,&nbsp;impurity&nbsp;identities&nbsp;and&nbsp;levels,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_260\">260</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quality,&nbsp;molecular&nbsp;weight,&nbsp;molecular&nbsp;weight&nbsp;distribution,&nbsp;thermal&nbsp;properties,&nbsp;tensile&nbsp;strength,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_261\">261</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Rockwell&nbsp;hardness,&nbsp;bending&nbsp;modulus,&nbsp;conduction&nbsp;of&nbsp;electricity,&nbsp;and&nbsp;others&nbsp;in&nbsp;addition&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_262\">262</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">general&nbsp;parameters&nbsp;described&nbsp;in&nbsp;5.2;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_263\">263</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_264\">264</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">details&nbsp;of&nbsp;material&nbsp;composition&nbsp;and&nbsp;formulation&nbsp;(see&nbsp;5.2)&nbsp;such&nbsp;as&nbsp;Chemical&nbsp;Abstracts&nbsp;Service\u00a0(CAS)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_265\">265</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">numbers&nbsp;(see&nbsp;B.5.2),&nbsp;mass&nbsp;fraction&nbsp;in&nbsp;percent\u00a0(%)&nbsp;of&nbsp;each&nbsp;chemical&nbsp;in&nbsp;the&nbsp;formulation,&nbsp;function&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_266\">266</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">each&nbsp;chemical&nbsp;constituent,&nbsp;and&nbsp;structure&nbsp;and&nbsp;formula&nbsp;of&nbsp;each&nbsp;chemical;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_267\">267</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_268\">268</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;medical&nbsp;grade&nbsp;components&nbsp;often&nbsp;used&nbsp;in&nbsp;medical&nbsp;devices,&nbsp;a&nbsp;detailed&nbsp;description&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_269\">269</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">found&nbsp;in&nbsp;material&nbsp;standards&nbsp;[e.g.&nbsp;ASTM&nbsp;F136-13&nbsp;Standard&nbsp;Specification&nbsp;for&nbsp;Wrought&nbsp;Titanium-6Aluminum-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_270\">270</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4Vanadium&nbsp;ELI&nbsp;(Extra&nbsp;Low&nbsp;Interstitial)&nbsp;Alloy&nbsp;for&nbsp;Surgical&nbsp;Implant&nbsp;Applications],&nbsp;and&nbsp;sometimes&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_271\">271</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pharmacopoeias.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_272\">272</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;certificates&nbsp;of&nbsp;compliance&nbsp;with&nbsp;regional&nbsp;compendia&nbsp;and&nbsp;relevant&nbsp;global&nbsp;regulations&nbsp;(e.g.&nbsp;REACH,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_273\">273</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">indirect&nbsp;food&nbsp;additives).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_274\">274</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Silastic\u00ae,&nbsp;Dacron\u00ae,&nbsp;Tetoron\u00ae,&nbsp;Pellethane\u00ae,&nbsp;Nylon,&nbsp;Teflon\u00ae&nbsp;are&nbsp;examples&nbsp;of&nbsp;suitable&nbsp;products&nbsp;available</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_275\">275</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">commercially.&nbsp;This&nbsp;information&nbsp;is&nbsp;given&nbsp;for&nbsp;the&nbsp;convenience&nbsp;of&nbsp;users&nbsp;of&nbsp;this&nbsp;document&nbsp;and&nbsp;does&nbsp;not&nbsp;constitute&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_276\">276</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">endorsement&nbsp;by&nbsp;ISO&nbsp;of&nbsp;these&nbsp;products.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_277\">277</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_278\">278</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_279\">279</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">31</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_280\">280</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_281\">281</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_282\">282</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_283\">283</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_284\">284</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_285\">285</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical&nbsp;analyses</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_286\">286</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3.1&nbsp;&nbsp;&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_287\">287</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Further&nbsp;to&nbsp;Clause\u00a06,&nbsp;several&nbsp;modes&nbsp;of&nbsp;chemical&nbsp;analyses&nbsp;are&nbsp;described&nbsp;in&nbsp;B.3.2&nbsp;to&nbsp;B.3.5.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_288\">288</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3.2&nbsp;Non-specific&nbsp;chemical&nbsp;analysis&nbsp;relevant&nbsp;to&nbsp;exposure&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_289\">289</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Non-specific&nbsp;chemical&nbsp;analyses&nbsp;have&nbsp;been&nbsp;included&nbsp;in&nbsp;some&nbsp;international&nbsp;standards&nbsp;and&nbsp;national</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_290\">290</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">guidelines&nbsp;or&nbsp;standards&nbsp;intended&nbsp;to&nbsp;ensure&nbsp;safety.&nbsp;These&nbsp;methods&nbsp;are&nbsp;generally&nbsp;usable&nbsp;for&nbsp;an&nbsp;imprecise,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_291\">291</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">first&nbsp;pass&nbsp;estimation&nbsp;of&nbsp;the&nbsp;chemical&nbsp;hazards&nbsp;of&nbsp;medical&nbsp;devices,&nbsp;though&nbsp;their&nbsp;direct&nbsp;relationship&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_292\">292</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">safety&nbsp;is&nbsp;limited.&nbsp;Some&nbsp;examples&nbsp;are&nbsp;given&nbsp;below:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_293\">293</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_294\">294</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">OECD&nbsp;Guidelines;&nbsp;Test&nbsp;No.\u00a0120[17].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_295\">295</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;test&nbsp;protocol[17]&nbsp;describes&nbsp;the&nbsp;procedure&nbsp;for&nbsp;determining&nbsp;the&nbsp;solution/extraction&nbsp;behaviour&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_296\">296</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">polymers&nbsp;in&nbsp;water&nbsp;at&nbsp;20\u00a0\u00b0C&nbsp;at&nbsp;pH\u00a02&nbsp;and&nbsp;pH\u00a09&nbsp;and&nbsp;at&nbsp;37\u00a0\u00b0C&nbsp;at&nbsp;pH\u00a07.&nbsp;Total&nbsp;organic&nbsp;carbon&nbsp;content\u00a0(TOC)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_297\">297</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analysis&nbsp;is&nbsp;recommended&nbsp;for&nbsp;determining&nbsp;total&nbsp;polymeric&nbsp;species&nbsp;in&nbsp;aqueous&nbsp;phase.&nbsp;Other&nbsp;more&nbsp;specific</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_298\">298</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">methods&nbsp;are&nbsp;also&nbsp;described.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_299\">299</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_300\">300</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">JP\u00a0XVII[21],&nbsp;USP&nbsp;41[22]&nbsp;or&nbsp;Ph.&nbsp;Eur.&nbsp;Ed.\u00a09[20].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_301\">301</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;JP&nbsp;and&nbsp;Ph.&nbsp;Eur&nbsp;methods&nbsp;(see&nbsp;References\u00a0[21]&nbsp;and&nbsp;[20])&nbsp;include&nbsp;test&nbsp;methods&nbsp;and&nbsp;specifications&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_302\">302</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">residue&nbsp;on&nbsp;ignition,&nbsp;heavy&nbsp;metals,&nbsp;extractable&nbsp;substances&nbsp;such&nbsp;as&nbsp;potassium&nbsp;permanganate-reducing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_303\">303</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substances&nbsp;and&nbsp;residue&nbsp;of&nbsp;evaporation.&nbsp;The&nbsp;USP&nbsp;methods&nbsp;(Reference\u00a0[22])&nbsp;include&nbsp;test&nbsp;methods&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_304\">304</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specifications&nbsp;for&nbsp;acidity/alkalinity,&nbsp;UV&nbsp;absorbance,&nbsp;total&nbsp;organic&nbsp;carbon\u00a0&nbsp;(TOC),&nbsp;extractable&nbsp;metals,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_305\">305</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">polymer&nbsp;additives&nbsp;and&nbsp;biocompatibility.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_306\">306</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3.3&nbsp;&nbsp;&nbsp;&nbsp;Qualitative&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_307\">307</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;material&nbsp;composition&nbsp;and/or&nbsp;formulation&nbsp;is&nbsp;required&nbsp;but&nbsp;the&nbsp;available&nbsp;qualitative&nbsp;information&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_308\">308</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">judged&nbsp;to&nbsp;be&nbsp;incomplete&nbsp;or&nbsp;not&nbsp;available,&nbsp;further&nbsp;chemical&nbsp;testing&nbsp;can&nbsp;be&nbsp;necessary.&nbsp;Depending&nbsp;on&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_309\">309</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;needs,&nbsp;qualitative&nbsp;or&nbsp;quantitative&nbsp;information&nbsp;might&nbsp;be&nbsp;required.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_310\">310</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Many&nbsp;of&nbsp;the&nbsp;analytical&nbsp;methods&nbsp;employed&nbsp;for&nbsp;chemical&nbsp;characterization&nbsp;are&nbsp;capable&nbsp;of&nbsp;both&nbsp;qualitative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_311\">311</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;quantitative&nbsp;analyses.&nbsp;However,&nbsp;the&nbsp;purpose&nbsp;of&nbsp;the&nbsp;qualitative&nbsp;analysis&nbsp;is&nbsp;to&nbsp;provide&nbsp;a&nbsp;list&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_312\">312</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identified&nbsp;chemical&nbsp;constituents&nbsp;in&nbsp;a&nbsp;sample.&nbsp;Conversely,&nbsp;the&nbsp;aim&nbsp;of&nbsp;quantitative&nbsp;analysis&nbsp;is&nbsp;to&nbsp;establish</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_313\">313</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;level&nbsp;or&nbsp;amount&nbsp;of&nbsp;each&nbsp;individual&nbsp;chemical&nbsp;constituent&nbsp;in&nbsp;a&nbsp;sample,&nbsp;whether&nbsp;the&nbsp;constituent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_314\">314</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;identified&nbsp;or&nbsp;not.&nbsp;Since&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;typically&nbsp;based&nbsp;on&nbsp;both&nbsp;identity&nbsp;(which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_315\">315</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establishes&nbsp;the&nbsp;constituent\u2019s&nbsp;toxic&nbsp;potential)&nbsp;and&nbsp;concentration&nbsp;(which&nbsp;establishes&nbsp;exposure),&nbsp;both</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_316\">316</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualitative&nbsp;and&nbsp;quantitative&nbsp;analyses&nbsp;are&nbsp;important&nbsp;and&nbsp;relevant.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_317\">317</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_318\">318</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Semi-quantitative&nbsp;methods&nbsp;can&nbsp;be&nbsp;sufficient&nbsp;for&nbsp;an&nbsp;initial&nbsp;risk&nbsp;assessment,&nbsp;and&nbsp;quantitative&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_319\">319</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">might&nbsp;be&nbsp;needed&nbsp;when&nbsp;a&nbsp;specific&nbsp;risk&nbsp;has&nbsp;been&nbsp;identified&nbsp;(i.e.&nbsp;an&nbsp;inadequate&nbsp;margin&nbsp;of&nbsp;safety&nbsp;found&nbsp;after&nbsp;semi-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_320\">320</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;analysis).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_321\">321</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3.4&nbsp;Quantitative&nbsp;analysis&nbsp;of&nbsp;specific&nbsp;toxic&nbsp;chemicals&nbsp;for&nbsp;exposure&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_322\">322</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;qualitative&nbsp;analyses&nbsp;identify&nbsp;chemicals&nbsp;of&nbsp;toxicological&nbsp;concern,&nbsp;then&nbsp;quantitative&nbsp;and&nbsp;specific</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_323\">323</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analysis&nbsp;should&nbsp;be&nbsp;performed.&nbsp;The&nbsp;specificity,&nbsp;level&nbsp;of&nbsp;sensitivity&nbsp;and&nbsp;limit&nbsp;of&nbsp;quantification&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_324\">324</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytical&nbsp;method&nbsp;should&nbsp;be&nbsp;sufficient&nbsp;for&nbsp;the&nbsp;required&nbsp;level&nbsp;of&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_325\">325</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.3.5&nbsp;&nbsp;&nbsp;&nbsp;Qualitative&nbsp;and&nbsp;quantitative&nbsp;analytical&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_326\">326</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NMR,&nbsp;attenuated&nbsp;total&nbsp;reflectance/Fourier&nbsp;transform&nbsp;infrared&nbsp;spectroscopy&nbsp;(ATR/FT-IR)&nbsp;and&nbsp;pyrolysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_327\">327</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">gas&nbsp;chromatography/mass&nbsp;spectrometry&nbsp;are&nbsp;useful&nbsp;methods&nbsp;for&nbsp;compositional&nbsp;and&nbsp;formulation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_328\">328</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analyses.&nbsp;Medical&nbsp;device&nbsp;or&nbsp;material&nbsp;extracts&nbsp;can&nbsp;be&nbsp;analysed&nbsp;by&nbsp;chromatographic&nbsp;methods&nbsp;combined</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_329\">329</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;appropriate&nbsp;detection&nbsp;techniques&nbsp;(e.g.&nbsp;GC&nbsp;and&nbsp;LC&nbsp;each&nbsp;combined&nbsp;with&nbsp;MS)&nbsp;to&nbsp;identify&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_330\">330</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantify,&nbsp;as&nbsp;appropriate,&nbsp;extracted&nbsp;substances.&nbsp;Inductively&nbsp;coupled&nbsp;plasma\u00a0&nbsp;(ICP)&nbsp;analysis&nbsp;is&nbsp;useful</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_331\">331</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;establishing&nbsp;the&nbsp;levels&nbsp;of&nbsp;elements&nbsp;present&nbsp;in&nbsp;extracts&nbsp;or&nbsp;digests&nbsp;of&nbsp;medical&nbsp;devices&nbsp;or&nbsp;materials,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_332\">332</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_333\">333</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">32\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_334\">334</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_335\">335</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_336\">336</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_337\">337</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_338\">338</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_339\">339</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_340\">340</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">although&nbsp;this&nbsp;method&nbsp;does&nbsp;not&nbsp;establish&nbsp;the&nbsp;chemical&nbsp;form&nbsp;of&nbsp;the&nbsp;element.&nbsp;Such&nbsp;analytical&nbsp;methods&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_341\">341</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;employed&nbsp;so&nbsp;that&nbsp;gaps&nbsp;in&nbsp;material&nbsp;composition&nbsp;and/or&nbsp;formulation&nbsp;are&nbsp;adequately&nbsp;and&nbsp;appropriately</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_342\">342</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">addressed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_343\">343</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.4&nbsp;National&nbsp;and&nbsp;international&nbsp;material&nbsp;and/or&nbsp;product&nbsp;standards</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_344\">344</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Most&nbsp;material&nbsp;and/or&nbsp;product&nbsp;standards&nbsp;specify&nbsp;a&nbsp;quality&nbsp;of&nbsp;material&nbsp;in&nbsp;the&nbsp;standard&nbsp;in&nbsp;relation&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_345\">345</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">purpose&nbsp;of&nbsp;use.&nbsp;When&nbsp;the&nbsp;material&nbsp;used&nbsp;in&nbsp;the&nbsp;medical&nbsp;device&nbsp;meets&nbsp;such&nbsp;a&nbsp;standard&nbsp;and&nbsp;when&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_346\">346</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">category&nbsp;and&nbsp;duration&nbsp;of&nbsp;contact&nbsp;of&nbsp;the&nbsp;device&nbsp;are&nbsp;comparable&nbsp;to&nbsp;those&nbsp;in&nbsp;the&nbsp;standard,&nbsp;giving&nbsp;the&nbsp;title</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_347\">347</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;number&nbsp;of&nbsp;the&nbsp;standard&nbsp;can&nbsp;be&nbsp;sufficient&nbsp;for&nbsp;characterization&nbsp;of&nbsp;the&nbsp;material.&nbsp;Applicability&nbsp;of&nbsp;these</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_348\">348</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">standards&nbsp;for&nbsp;chemical&nbsp;characterization&nbsp;depends&nbsp;on&nbsp;the&nbsp;following&nbsp;factors.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_349\">349</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Does&nbsp;the&nbsp;standard&nbsp;specify&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;its&nbsp;contact&nbsp;and&nbsp;duration?</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_350\">350</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Does&nbsp;the&nbsp;standard&nbsp;specify&nbsp;the&nbsp;material&nbsp;(e.g.&nbsp;specific&nbsp;material,&nbsp;category&nbsp;of&nbsp;material)?&nbsp;If&nbsp;so,&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_351\">351</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">what&nbsp;extent?</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_352\">352</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Does&nbsp;the&nbsp;standard&nbsp;set&nbsp;any&nbsp;limits&nbsp;on&nbsp;the&nbsp;level&nbsp;of&nbsp;certain&nbsp;chemicals?&nbsp;Are&nbsp;such&nbsp;limits&nbsp;comprehensive,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_353\">353</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specific,&nbsp;general,&nbsp;or&nbsp;total?</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_354\">354</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Does&nbsp;the&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;standardized&nbsp;have&nbsp;a&nbsp;history&nbsp;of&nbsp;safe&nbsp;clinical&nbsp;use?</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_355\">355</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;extent&nbsp;to&nbsp;which&nbsp;these&nbsp;factors&nbsp;are&nbsp;addressed&nbsp;in&nbsp;the&nbsp;standard&nbsp;determines&nbsp;the&nbsp;extent&nbsp;to&nbsp;which&nbsp;their</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_356\">356</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;can&nbsp;fulfil&nbsp;chemical&nbsp;characterization&nbsp;needs.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_357\">357</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_358\">358</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Use&nbsp;of&nbsp;material&nbsp;standards&nbsp;might&nbsp;not&nbsp;be&nbsp;sufficient&nbsp;to&nbsp;address&nbsp;the&nbsp;effects&nbsp;that&nbsp;manufacturing&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_359\">359</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">processing&nbsp;can&nbsp;have&nbsp;on&nbsp;materials&nbsp;when&nbsp;incorporated&nbsp;into&nbsp;the&nbsp;final&nbsp;device.&nbsp;For&nbsp;example,&nbsp;the&nbsp;manufacturing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_360\">360</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process&nbsp;for&nbsp;medical&nbsp;devices&nbsp;manufactured&nbsp;out&nbsp;of&nbsp;metallic&nbsp;materials&nbsp;described&nbsp;in&nbsp;national&nbsp;and&nbsp;international</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_361\">361</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;or&nbsp;product&nbsp;standards&nbsp;can&nbsp;have&nbsp;a&nbsp;negative&nbsp;influence&nbsp;upon&nbsp;the&nbsp;overall&nbsp;biocompatibility,&nbsp;as&nbsp;residues&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_362\">362</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">cutting&nbsp;oils&nbsp;used&nbsp;during&nbsp;the&nbsp;CNC&nbsp;cutting&nbsp;process&nbsp;can&nbsp;be&nbsp;insufficiently&nbsp;removed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_363\">363</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reporting&nbsp;chemical&nbsp;descriptions&nbsp;of&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_364\">364</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5.1&nbsp;&nbsp;&nbsp;&nbsp;Generic&nbsp;name&nbsp;of&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_365\">365</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;generic&nbsp;name&nbsp;should&nbsp;be&nbsp;supplied&nbsp;with&nbsp;references&nbsp;to&nbsp;the&nbsp;specific&nbsp;chemical&nbsp;name.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_366\">366</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_367\">367</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Generic&nbsp;names&nbsp;can&nbsp;be&nbsp;misunderstood.&nbsp;For&nbsp;instance,&nbsp;\u201cpolyester\u201d&nbsp;refers&nbsp;to&nbsp;a&nbsp;class&nbsp;of&nbsp;polymers&nbsp;comprised</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_368\">368</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;ester&nbsp;linkages,&nbsp;but&nbsp;is&nbsp;commonly&nbsp;used&nbsp;to&nbsp;refer&nbsp;specifically&nbsp;to&nbsp;poly(ethylene&nbsp;terephthalate).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_369\">369</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5.2&nbsp;&nbsp;&nbsp;&nbsp;Other&nbsp;nomenclatures&nbsp;and&nbsp;chemical&nbsp;descriptions&nbsp;of&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_370\">370</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5.2.1&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_371\">371</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">There&nbsp;are&nbsp;several&nbsp;nomenclature&nbsp;systems&nbsp;that&nbsp;specify&nbsp;the&nbsp;materials&nbsp;more&nbsp;exactly.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_372\">372</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5.2.2&nbsp;&nbsp;IUPAC&nbsp;nomenclature&nbsp;and&nbsp;structure&nbsp;formulae&nbsp;of&nbsp;polymeric&nbsp;chemicals</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_373\">373</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;International&nbsp;Union&nbsp;of&nbsp;Pure&nbsp;and&nbsp;Applied&nbsp;Chemistry\u00a0&nbsp;(IUPAC)&nbsp;Macromolecular&nbsp;Nomenclature</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_374\">374</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Commission&nbsp;has&nbsp;published&nbsp;rules&nbsp;for&nbsp;naming&nbsp;polymers[37].&nbsp;Naming&nbsp;and&nbsp;describing&nbsp;polymers&nbsp;according</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_375\">375</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;the&nbsp;rules&nbsp;present&nbsp;some&nbsp;exact&nbsp;features&nbsp;of&nbsp;polymeric&nbsp;chemicals&nbsp;as&nbsp;defined.&nbsp;It&nbsp;does&nbsp;not&nbsp;give&nbsp;any</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_376\">376</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;however&nbsp;about&nbsp;the&nbsp;commercially&nbsp;available&nbsp;polymers&nbsp;that&nbsp;often&nbsp;contain&nbsp;some&nbsp;additives.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_377\">377</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.5.2.3&nbsp;CAS&nbsp;Registry&nbsp;number,&nbsp;USAN,&nbsp;REACH&nbsp;and&nbsp;other&nbsp;registry&nbsp;name&nbsp;and/or&nbsp;number</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_378\">378</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemical&nbsp;Abstract&nbsp;Service\u00a0(CAS)&nbsp;and&nbsp;United&nbsp;States&nbsp;Adopted&nbsp;Names\u00a0(USAN)&nbsp;give&nbsp;a&nbsp;specific&nbsp;number&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_379\">379</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">name&nbsp;respectively&nbsp;to&nbsp;newly&nbsp;developed&nbsp;polymeric&nbsp;chemicals&nbsp;such&nbsp;as&nbsp;contact&nbsp;lens&nbsp;materials.&nbsp;When&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_380\">380</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;used&nbsp;has&nbsp;its&nbsp;given&nbsp;CAS&nbsp;No.&nbsp;and/or&nbsp;USAN&nbsp;name,&nbsp;it&nbsp;is&nbsp;easy&nbsp;to&nbsp;discriminate&nbsp;it&nbsp;from&nbsp;similar&nbsp;but&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_381\">381</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_382\">382</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_383\">383</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">33</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_384\">384</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_385\">385</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_386\">386</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_387\">387</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_388\">388</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_389\">389</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identical&nbsp;materials.&nbsp;Concise&nbsp;information&nbsp;on&nbsp;the&nbsp;chemical&nbsp;constituents/ingredients&nbsp;is&nbsp;possibly&nbsp;available</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_390\">390</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;USAN.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_391\">391</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Though&nbsp;the&nbsp;REACH&nbsp;registration&nbsp;number&nbsp;is&nbsp;primarily&nbsp;to&nbsp;demonstrate&nbsp;REACH&nbsp;registration,&nbsp;it&nbsp;provides</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_392\">392</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;link&nbsp;to&nbsp;the&nbsp;ECHA&nbsp;database&nbsp;which&nbsp;can&nbsp;contain&nbsp;helpful&nbsp;information&nbsp;such&nbsp;as&nbsp;substance&nbsp;identification,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_393\">393</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">purity,&nbsp;identity&nbsp;and&nbsp;levels&nbsp;of&nbsp;impurities.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_394\">394</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reporting&nbsp;general&nbsp;information&nbsp;concerning&nbsp;chemical&nbsp;nature&nbsp;of&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_395\">395</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Several&nbsp;parameters&nbsp;are&nbsp;generally&nbsp;usable&nbsp;to&nbsp;specify&nbsp;the&nbsp;chemical&nbsp;nature&nbsp;of&nbsp;the&nbsp;material&nbsp;used.&nbsp;These</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_396\">396</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parameters&nbsp;differ&nbsp;by&nbsp;category&nbsp;of&nbsp;materials.&nbsp;For&nbsp;synthetic&nbsp;polymers,&nbsp;examples&nbsp;of&nbsp;such&nbsp;parameters</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_397\">397</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;molecular&nbsp;mass&nbsp;and&nbsp;its&nbsp;distribution,&nbsp;glass&nbsp;transition&nbsp;temperature,&nbsp;melting&nbsp;point,&nbsp;specific&nbsp;gravity,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_398\">398</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solubility&nbsp;and&nbsp;swelling&nbsp;nature.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_399\">399</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_400\">400</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;OECD&nbsp;Guidelines,&nbsp;Section\u00a01,&nbsp;Test&nbsp;No.\u00a0118:1996&nbsp;can&nbsp;be&nbsp;useful&nbsp;for&nbsp;synthetic&nbsp;polymers[16].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_401\">401</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B.7&nbsp;Material&nbsp;master&nbsp;file</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_402\">402</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;it&nbsp;can&nbsp;be&nbsp;secured,&nbsp;a&nbsp;master&nbsp;file&nbsp;may&nbsp;be&nbsp;used&nbsp;in&nbsp;the&nbsp;review&nbsp;of&nbsp;a&nbsp;pending&nbsp;application&nbsp;for&nbsp;marketing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_403\">403</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">authorization&nbsp;of&nbsp;a&nbsp;specific&nbsp;medical&nbsp;device.&nbsp;It&nbsp;often&nbsp;contains&nbsp;detailed&nbsp;information&nbsp;about&nbsp;a&nbsp;specific</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_404\">404</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;formulation,&nbsp;or&nbsp;its&nbsp;processing,&nbsp;which&nbsp;is&nbsp;used&nbsp;in&nbsp;a&nbsp;medical&nbsp;device.&nbsp;It&nbsp;is&nbsp;a&nbsp;reference&nbsp;source&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_405\">405</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">allows&nbsp;a&nbsp;third&nbsp;party&nbsp;to&nbsp;submit&nbsp;information&nbsp;to&nbsp;a&nbsp;regulatory&nbsp;agency.&nbsp;A&nbsp;master&nbsp;file&nbsp;is&nbsp;useful&nbsp;for&nbsp;supporting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_406\">406</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">equivalence&nbsp;of&nbsp;a&nbsp;material&nbsp;or&nbsp;suitability&nbsp;of&nbsp;a&nbsp;material&nbsp;for&nbsp;a&nbsp;specific&nbsp;category&nbsp;of&nbsp;use.&nbsp;Its&nbsp;contents&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_407\">407</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">considered&nbsp;to&nbsp;be&nbsp;trade&nbsp;secret&nbsp;or&nbsp;commercially&nbsp;confidential&nbsp;information.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_408\">408</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_409\">409</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">34\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_410\">410</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_411\">411</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_412\">412</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_413\">413</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_414\">414</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_415\">415</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_416\">416</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0C</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_417\">417</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_418\">418</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_419\">419</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Principles&nbsp;for&nbsp;establishing&nbsp;biological&nbsp;equivalence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_420\">420</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_421\">421</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;noted&nbsp;in&nbsp;5.3,&nbsp;it&nbsp;can&nbsp;be&nbsp;appropriate&nbsp;to&nbsp;compare&nbsp;a&nbsp;new&nbsp;or&nbsp;modified&nbsp;medical&nbsp;device&nbsp;(or&nbsp;material)&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_422\">422</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;existing&nbsp;clinically&nbsp;established&nbsp;medical&nbsp;device&nbsp;(material).&nbsp;When&nbsp;the&nbsp;term&nbsp;medical&nbsp;device&nbsp;is&nbsp;used&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_423\">423</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">this&nbsp;annex,&nbsp;it&nbsp;is&nbsp;understood&nbsp;that&nbsp;the&nbsp;same&nbsp;concepts&nbsp;are&nbsp;applicable&nbsp;to&nbsp;materials&nbsp;as&nbsp;well.&nbsp;The&nbsp;purpose&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_424\">424</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">such&nbsp;a&nbsp;comparison&nbsp;would&nbsp;be&nbsp;to&nbsp;establish&nbsp;whether&nbsp;the&nbsp;new&nbsp;or&nbsp;modified&nbsp;medical&nbsp;device&nbsp;is&nbsp;biologically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_425\">425</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">equivalent&nbsp;to&nbsp;the&nbsp;existing&nbsp;medical&nbsp;device&nbsp;since&nbsp;if&nbsp;biological&nbsp;equivalence&nbsp;can&nbsp;be&nbsp;established&nbsp;then&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_426\">426</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">existing&nbsp;medical&nbsp;device\u2019s&nbsp;biocompatibility&nbsp;can&nbsp;be&nbsp;extended&nbsp;to&nbsp;the&nbsp;new&nbsp;or&nbsp;modified&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_427\">427</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Principles&nbsp;of&nbsp;biological&nbsp;equivalence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_428\">428</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;concept&nbsp;of&nbsp;biological&nbsp;equivalence&nbsp;consists&nbsp;of&nbsp;the&nbsp;following&nbsp;elements&nbsp;(Figure\u00a0C.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_429\">429</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chemical&nbsp;equivalence:&nbsp;situation&nbsp;where&nbsp;the&nbsp;chemical&nbsp;characteristics&nbsp;of&nbsp;two&nbsp;materials&nbsp;or&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_430\">430</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices&nbsp;are&nbsp;sufficiently&nbsp;similar,&nbsp;such&nbsp;that&nbsp;the&nbsp;composition&nbsp;and&nbsp;processing&nbsp;do&nbsp;not&nbsp;result&nbsp;in&nbsp;additional</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_431\">431</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">or&nbsp;different&nbsp;toxicological&nbsp;concerns.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_432\">432</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Physical&nbsp;equivalence:&nbsp;situation&nbsp;where&nbsp;the&nbsp;physical&nbsp;characteristics&nbsp;of&nbsp;two&nbsp;materials&nbsp;or&nbsp;medical&nbsp;devices</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_433\">433</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;sufficiently&nbsp;similar,&nbsp;such&nbsp;that&nbsp;the&nbsp;configuration,&nbsp;morphology,&nbsp;topography&nbsp;(per&nbsp;ISO/TS\u00a010993-19)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_434\">434</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;tribology&nbsp;do&nbsp;not&nbsp;result&nbsp;in&nbsp;additional&nbsp;or&nbsp;different&nbsp;biocompatibility&nbsp;concerns.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_435\">435</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Material&nbsp;equivalence:&nbsp;situation&nbsp;where&nbsp;two&nbsp;materials&nbsp;or&nbsp;medical&nbsp;devices&nbsp;demonstrate&nbsp;chemical&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_436\">436</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">physical&nbsp;equivalence.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_437\">437</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contact&nbsp;equivalence:&nbsp;situation&nbsp;where&nbsp;the&nbsp;intended&nbsp;clinical&nbsp;use&nbsp;of&nbsp;two&nbsp;materials&nbsp;or&nbsp;medical&nbsp;devices</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_438\">438</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;sufficiently&nbsp;similar&nbsp;that&nbsp;the&nbsp;endpoints&nbsp;of&nbsp;biological&nbsp;evaluation&nbsp;identified&nbsp;in&nbsp;ISO\u00a010993-1:2018,&nbsp;A.1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_439\">439</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;identical.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_440\">440</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biological&nbsp;equivalence:&nbsp;situation&nbsp;where&nbsp;two&nbsp;materials&nbsp;or&nbsp;medical&nbsp;devices&nbsp;demonstrate&nbsp;material&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_441\">441</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contact&nbsp;equivalence.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_442\">442</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a0C.1\u00a0\u2014&nbsp;Biological&nbsp;equivalence&nbsp;relationship&nbsp;map</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_443\">443</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_444\">444</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_445\">445</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">35</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_446\">446</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_447\">447</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_448\">448</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_449\">449</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_450\">450</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_451\">451</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Process&nbsp;for&nbsp;determining&nbsp;biological&nbsp;equivalence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_452\">452</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a0C.2&nbsp;describes&nbsp;the&nbsp;process&nbsp;for&nbsp;determining&nbsp;biological&nbsp;equivalence&nbsp;between&nbsp;two&nbsp;medical&nbsp;devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_453\">453</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a0C.2\u00a0\u2014&nbsp;Biological&nbsp;equivalence&nbsp;process&nbsp;map</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_454\">454</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;biological&nbsp;equivalence&nbsp;is&nbsp;established,&nbsp;this&nbsp;satisfactorily&nbsp;completes&nbsp;the&nbsp;biological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_455\">455</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">new&nbsp;or&nbsp;modified&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_456\">456</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;biological&nbsp;equivalence&nbsp;cannot&nbsp;be&nbsp;established,&nbsp;the&nbsp;biocompatibility&nbsp;of&nbsp;a&nbsp;new&nbsp;or&nbsp;modified&nbsp;medical&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_457\">457</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;only&nbsp;be&nbsp;established&nbsp;based&nbsp;on&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;own&nbsp;contact,&nbsp;chemical,&nbsp;physical,&nbsp;toxicological&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_458\">458</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biological&nbsp;characteristics.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_459\">459</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Examples&nbsp;of&nbsp;chemical&nbsp;equivalence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_460\">460</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;following&nbsp;list&nbsp;of&nbsp;examples&nbsp;is&nbsp;provided&nbsp;to&nbsp;assist&nbsp;with&nbsp;establishing&nbsp;chemical&nbsp;equivalence&nbsp;(according</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_461\">461</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;5.3),&nbsp;where&nbsp;the&nbsp;requirements&nbsp;of&nbsp;chemical&nbsp;equivalence&nbsp;are&nbsp;met.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_462\">462</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;composition&nbsp;or&nbsp;extractables&nbsp;profile&nbsp;of&nbsp;the&nbsp;proposed&nbsp;material&nbsp;is&nbsp;equivalent&nbsp;(i.e.&nbsp;same&nbsp;chemicals</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_463\">463</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">at&nbsp;the&nbsp;same&nbsp;or&nbsp;lower&nbsp;level&nbsp;and&nbsp;no&nbsp;new&nbsp;chemicals)&nbsp;to&nbsp;that&nbsp;of&nbsp;a&nbsp;clinically&nbsp;established&nbsp;material,&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_464\">464</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_465\">465</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">36\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_466\">466</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_467\">467</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_468\">468</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_469\">469</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_470\">470</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_471\">471</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_472\">472</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">there&nbsp;are&nbsp;no&nbsp;significant&nbsp;differences&nbsp;in&nbsp;physical,&nbsp;chemical,&nbsp;morphological&nbsp;and&nbsp;topographical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_473\">473</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characteristics&nbsp;which&nbsp;could&nbsp;impact&nbsp;the&nbsp;biological&nbsp;safety&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_474\">474</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_475\">475</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;there&nbsp;are&nbsp;slight&nbsp;increases&nbsp;in&nbsp;any&nbsp;chemicals,&nbsp;it&nbsp;can&nbsp;be&nbsp;reasonable&nbsp;to&nbsp;justify&nbsp;chemical&nbsp;equivalence</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_476\">476</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">within&nbsp;the&nbsp;statistical&nbsp;variability&nbsp;of&nbsp;the&nbsp;semi-quantitative&nbsp;methods&nbsp;being&nbsp;used.&nbsp;Use&nbsp;of&nbsp;calibration&nbsp;standards</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_477\">477</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">across&nbsp;a&nbsp;range&nbsp;of&nbsp;chemistries&nbsp;and&nbsp;concentrations&nbsp;can&nbsp;be&nbsp;helpful&nbsp;to&nbsp;this&nbsp;approach.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_478\">478</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A&nbsp;material&nbsp;that&nbsp;is&nbsp;already&nbsp;clinically&nbsp;established&nbsp;in&nbsp;a&nbsp;more&nbsp;invasive&nbsp;exposure&nbsp;is&nbsp;proposed&nbsp;to&nbsp;be&nbsp;used</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_479\">479</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;a&nbsp;comparable&nbsp;but&nbsp;less&nbsp;invasive&nbsp;application,&nbsp;where&nbsp;less&nbsp;invasive&nbsp;is&nbsp;understood&nbsp;in&nbsp;the&nbsp;context&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_480\">480</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-1&nbsp;as&nbsp;having&nbsp;a&nbsp;shorter&nbsp;duration&nbsp;of&nbsp;contact&nbsp;or&nbsp;a&nbsp;contact&nbsp;category&nbsp;calling&nbsp;for&nbsp;fewer&nbsp;endpoints</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_481\">481</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;be&nbsp;addressed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_482\">482</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_483\">483</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A&nbsp;chemical&nbsp;constituent&nbsp;or&nbsp;residue&nbsp;in&nbsp;a&nbsp;clinically&nbsp;established&nbsp;material&nbsp;is&nbsp;replaced&nbsp;in&nbsp;the&nbsp;proposed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_484\">484</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;with&nbsp;a&nbsp;chemical&nbsp;constituent&nbsp;or&nbsp;residue&nbsp;whose&nbsp;toxicological&nbsp;safety&nbsp;profile&nbsp;is&nbsp;no&nbsp;worse&nbsp;than</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_485\">485</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;of&nbsp;the&nbsp;constituent&nbsp;or&nbsp;residue&nbsp;that&nbsp;it&nbsp;is&nbsp;replacing,&nbsp;assuming&nbsp;similar&nbsp;exposure.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_486\">486</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;only&nbsp;difference&nbsp;between&nbsp;a&nbsp;proposed&nbsp;material&nbsp;and&nbsp;a&nbsp;clinically&nbsp;established&nbsp;material&nbsp;is&nbsp;that&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_487\">487</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">proposed&nbsp;material&nbsp;has&nbsp;eliminated&nbsp;or&nbsp;reduced&nbsp;the&nbsp;level&nbsp;of&nbsp;an&nbsp;additive/contaminant/residue&nbsp;present</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_488\">488</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;the&nbsp;clinically&nbsp;established&nbsp;material.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_489\">489</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;only&nbsp;difference&nbsp;between&nbsp;a&nbsp;proposed&nbsp;material&nbsp;and&nbsp;a&nbsp;clinically&nbsp;established&nbsp;material&nbsp;is&nbsp;that&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_490\">490</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">proposed&nbsp;material&nbsp;is&nbsp;produced&nbsp;using&nbsp;processing&nbsp;conditions&nbsp;that&nbsp;either&nbsp;maintain&nbsp;or&nbsp;reduce&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_491\">491</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">number&nbsp;and/or&nbsp;levels&nbsp;of&nbsp;extractables&nbsp;in&nbsp;the&nbsp;clinically&nbsp;established&nbsp;material.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_492\">492</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_493\">493</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A&nbsp;material&nbsp;in&nbsp;a&nbsp;clinically&nbsp;established&nbsp;medical&nbsp;device&nbsp;is&nbsp;moved&nbsp;to&nbsp;a&nbsp;location&nbsp;in&nbsp;a&nbsp;proposed&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_494\">494</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;where&nbsp;contact&nbsp;between&nbsp;a&nbsp;potentially&nbsp;affected&nbsp;individual&nbsp;and&nbsp;the&nbsp;material&nbsp;is&nbsp;lessened.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_495\">495</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Both&nbsp;the&nbsp;proposed&nbsp;material&nbsp;and&nbsp;the&nbsp;clinically&nbsp;established&nbsp;material&nbsp;meet&nbsp;relevant&nbsp;and&nbsp;rigorous</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_496\">496</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compositional&nbsp;specifications.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_497\">497</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_498\">498</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_499\">499</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">37</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_500\">500</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_501\">501</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_502\">502</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_503\">503</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_504\">504</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_505\">505</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0D</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_506\">506</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_507\">507</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_508\">508</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Principles&nbsp;of&nbsp;sample&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_509\">509</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">D.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_510\">510</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Information&nbsp;generation&nbsp;in&nbsp;the&nbsp;chemical&nbsp;characterization&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;and/or&nbsp;its&nbsp;materials&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_511\">511</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">construction&nbsp;is&nbsp;typically&nbsp;a&nbsp;two-step&nbsp;process&nbsp;in&nbsp;which&nbsp;the&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;is&nbsp;extracted&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_512\">512</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;extract&nbsp;is&nbsp;subsequently&nbsp;chemically&nbsp;analysed&nbsp;to&nbsp;establish&nbsp;the&nbsp;extracted&nbsp;substances.&nbsp;The&nbsp;goal&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_513\">513</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;is&nbsp;to&nbsp;produce&nbsp;an&nbsp;extractables&nbsp;profile&nbsp;that&nbsp;equals&nbsp;or&nbsp;exceeds&nbsp;the&nbsp;leachables&nbsp;generated&nbsp;in&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_514\">514</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;but&nbsp;does&nbsp;not&nbsp;cause&nbsp;deleterious&nbsp;effects&nbsp;to&nbsp;the&nbsp;materials&nbsp;(such&nbsp;as&nbsp;degradation)&nbsp;or&nbsp;the&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_515\">515</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">profile&nbsp;(such&nbsp;as&nbsp;chemical&nbsp;alteration&nbsp;of&nbsp;the&nbsp;extractables).&nbsp;Doing&nbsp;so&nbsp;may&nbsp;provide&nbsp;an&nbsp;extractables&nbsp;profile</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_516\">516</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;is&nbsp;at&nbsp;least&nbsp;as&nbsp;extensive&nbsp;as&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;leachables&nbsp;profile,&nbsp;meaning&nbsp;that&nbsp;the&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_517\">517</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">profile&nbsp;minimally&nbsp;accounts&nbsp;for&nbsp;the&nbsp;leachables&nbsp;and&nbsp;their&nbsp;levels.&nbsp;Under&nbsp;certain&nbsp;circumstances&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_518\">518</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive&nbsp;extractions),&nbsp;the&nbsp;extractables&nbsp;profile&nbsp;can&nbsp;greatly&nbsp;exaggerate&nbsp;the&nbsp;actual&nbsp;chemical&nbsp;release,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_519\">519</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">meaning&nbsp;that&nbsp;the&nbsp;extractables&nbsp;represent&nbsp;all&nbsp;possible&nbsp;leachables&nbsp;at&nbsp;their&nbsp;highest&nbsp;possible&nbsp;concentration.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_520\">520</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">However,&nbsp;it&nbsp;should&nbsp;be&nbsp;noted&nbsp;that&nbsp;all&nbsp;leachables&nbsp;might&nbsp;not&nbsp;necessarily&nbsp;be&nbsp;present&nbsp;in&nbsp;the&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_521\">521</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">profile.&nbsp;Extractables&nbsp;studies&nbsp;which&nbsp;differ&nbsp;significantly&nbsp;from&nbsp;simulated&nbsp;use&nbsp;conditions&nbsp;in&nbsp;terms&nbsp;of&nbsp;solvent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_522\">522</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">properties&nbsp;and&nbsp;extraction&nbsp;method&nbsp;might&nbsp;not&nbsp;fully&nbsp;represent&nbsp;every&nbsp;leachable&nbsp;compound&nbsp;which&nbsp;would&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_523\">523</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">observed&nbsp;under&nbsp;simulated&nbsp;use&nbsp;conditions.&nbsp;This&nbsp;should&nbsp;be&nbsp;taken&nbsp;into&nbsp;account&nbsp;in&nbsp;design&nbsp;of&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_524\">524</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">studies&nbsp;and&nbsp;determination&nbsp;of&nbsp;when&nbsp;chemical&nbsp;characterization&nbsp;is&nbsp;complete&nbsp;(according&nbsp;to&nbsp;Figure\u00a01).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_525\">525</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;chemical&nbsp;characterization&nbsp;is&nbsp;a&nbsp;general&nbsp;term&nbsp;that&nbsp;describes&nbsp;several&nbsp;individual&nbsp;activities&nbsp;with&nbsp;varying</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_526\">526</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">objectives&nbsp;(e.g.&nbsp;compositional&nbsp;analysis,&nbsp;extractables&nbsp;profiling),&nbsp;it&nbsp;is&nbsp;clear&nbsp;that&nbsp;there&nbsp;are&nbsp;numerous</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_527\">527</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">means&nbsp;of&nbsp;performing&nbsp;an&nbsp;extraction,&nbsp;where&nbsp;the&nbsp;means&nbsp;of&nbsp;performing&nbsp;an&nbsp;extraction&nbsp;is&nbsp;closely&nbsp;linked&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_528\">528</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;objective&nbsp;of&nbsp;the&nbsp;characterization.&nbsp;Thus,&nbsp;an&nbsp;extraction&nbsp;to&nbsp;support&nbsp;establishment&nbsp;of&nbsp;the&nbsp;composition</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_529\">529</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;a&nbsp;medical&nbsp;device&nbsp;is&nbsp;necessarily&nbsp;and&nbsp;appropriately&nbsp;performed&nbsp;differently&nbsp;from&nbsp;an&nbsp;extraction&nbsp;done&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_530\">530</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">support&nbsp;establishment&nbsp;of&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;extractables&nbsp;profile&nbsp;under&nbsp;the&nbsp;device\u2019s&nbsp;typical&nbsp;clinical&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_531\">531</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_532\">532</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;general,&nbsp;there&nbsp;can&nbsp;be&nbsp;four&nbsp;objectives&nbsp;of&nbsp;extractions&nbsp;for&nbsp;a&nbsp;chemical&nbsp;characterization:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_533\">533</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;establish&nbsp;the&nbsp;compositional&nbsp;aspects&nbsp;of&nbsp;the&nbsp;configuration&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;the&nbsp;composition&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_534\">534</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;material&nbsp;of&nbsp;construction&nbsp;(digestion,&nbsp;dissolution&nbsp;or&nbsp;exhaustive&nbsp;extraction);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_535\">535</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;establish&nbsp;the&nbsp;worst-case&nbsp;extractables&nbsp;profile&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;as&nbsp;either&nbsp;the&nbsp;total</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_536\">536</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pool&nbsp;of&nbsp;extractables&nbsp;in&nbsp;the&nbsp;medical&nbsp;device&nbsp;(exhaustive&nbsp;extraction)&nbsp;or&nbsp;the&nbsp;maximum&nbsp;amount&nbsp;that&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_537\">537</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;extracted&nbsp;under&nbsp;defined&nbsp;experimental&nbsp;conditions&nbsp;that&nbsp;exaggerate&nbsp;a&nbsp;device\u2019s&nbsp;clinical&nbsp;conditions&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_538\">538</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;(exaggerated&nbsp;or&nbsp;accelerated&nbsp;extraction);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_539\">539</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;establish&nbsp;the&nbsp;extractables&nbsp;profile&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;under&nbsp;its&nbsp;clinical&nbsp;conditions&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_540\">540</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;(simulated&nbsp;extraction);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_541\">541</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;correlate&nbsp;chemical&nbsp;data&nbsp;to&nbsp;the&nbsp;results&nbsp;of&nbsp;biological&nbsp;testing&nbsp;performed&nbsp;as&nbsp;described&nbsp;elsewhere&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_542\">542</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_543\">543</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Each&nbsp;of&nbsp;these&nbsp;cases&nbsp;will&nbsp;be&nbsp;considered&nbsp;in&nbsp;greater&nbsp;detail&nbsp;in&nbsp;subsequent&nbsp;clauses&nbsp;with&nbsp;respect&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_544\">544</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establishing&nbsp;appropriate&nbsp;extraction&nbsp;conditions&nbsp;that&nbsp;are&nbsp;consistent&nbsp;with&nbsp;the&nbsp;objectives&nbsp;of&nbsp;the&nbsp;case.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_545\">545</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Regardless&nbsp;of&nbsp;the&nbsp;type&nbsp;of&nbsp;extraction&nbsp;performed,&nbsp;extraction&nbsp;is&nbsp;a&nbsp;complex&nbsp;process&nbsp;influenced&nbsp;by&nbsp;aspects</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_546\">546</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">including&nbsp;time,&nbsp;temperature,&nbsp;surface&nbsp;area-to-volume&nbsp;ratio,&nbsp;extraction&nbsp;vehicle&nbsp;and&nbsp;the&nbsp;partitioning</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_547\">547</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">behaviour&nbsp;of&nbsp;the&nbsp;substances&nbsp;in&nbsp;the&nbsp;test&nbsp;article&nbsp;relative&nbsp;to&nbsp;the&nbsp;extraction&nbsp;vehicle.&nbsp;In&nbsp;general,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_548\">548</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;conditions&nbsp;should&nbsp;not&nbsp;alter&nbsp;the&nbsp;test&nbsp;article,&nbsp;unless&nbsp;justified,&nbsp;as&nbsp;alteration&nbsp;of&nbsp;the&nbsp;test&nbsp;article</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_549\">549</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">could&nbsp;change&nbsp;the&nbsp;amount&nbsp;and/or&nbsp;type&nbsp;of&nbsp;extractables&nbsp;released&nbsp;from&nbsp;the&nbsp;test&nbsp;article.&nbsp;Thus,&nbsp;the&nbsp;material\u2019s</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_550\">550</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_551\">551</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">38\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_552\">552</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_553\">553</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_554\">554</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_555\">555</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_556\">556</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_557\">557</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_558\">558</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;properties&nbsp;might&nbsp;also&nbsp;need&nbsp;to&nbsp;be&nbsp;considered&nbsp;when&nbsp;selecting&nbsp;extraction&nbsp;vehicles,&nbsp;for&nbsp;example,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_559\">559</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;avoid&nbsp;or&nbsp;enhance&nbsp;(e.g.&nbsp;in&nbsp;dissolution&nbsp;studies)&nbsp;solubilisation&nbsp;of&nbsp;the&nbsp;base&nbsp;material.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_560\">560</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;stated&nbsp;in&nbsp;ISO\u00a010993-12:2012,&nbsp;3.8,&nbsp;extraction&nbsp;conditions&nbsp;are&nbsp;expected&nbsp;to&nbsp;be&nbsp;at&nbsp;least&nbsp;as&nbsp;aggressive</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_561\">561</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">as&nbsp;the&nbsp;conditions&nbsp;of&nbsp;clinical&nbsp;use.&nbsp;However,&nbsp;for&nbsp;extractables&nbsp;and&nbsp;leachables&nbsp;studies,&nbsp;avoid&nbsp;using</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_562\">562</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;solvents&nbsp;that&nbsp;can&nbsp;cause&nbsp;significant&nbsp;swelling&nbsp;and/or&nbsp;compromise&nbsp;the&nbsp;integrity&nbsp;of&nbsp;the&nbsp;test</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_563\">563</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">article.&nbsp;Significant&nbsp;swelling&nbsp;can&nbsp;cause&nbsp;reduction&nbsp;of&nbsp;free&nbsp;extraction&nbsp;solvent,&nbsp;which&nbsp;could&nbsp;impact&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_564\">564</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;of&nbsp;extractables&nbsp;and&nbsp;lead&nbsp;to&nbsp;inaccurate&nbsp;analytical&nbsp;calculations.&nbsp;Regarding&nbsp;evaporative&nbsp;loss</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_565\">565</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;might&nbsp;occur&nbsp;during&nbsp;extraction,&nbsp;it&nbsp;is&nbsp;not&nbsp;recommended&nbsp;to&nbsp;compensate&nbsp;for&nbsp;solvent&nbsp;loss&nbsp;by&nbsp;adding</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_566\">566</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additional&nbsp;solvent&nbsp;after&nbsp;extraction&nbsp;is&nbsp;complete;&nbsp;rather,&nbsp;steps&nbsp;should&nbsp;be&nbsp;taken&nbsp;to&nbsp;reduce&nbsp;evaporative</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_567\">567</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">loss&nbsp;(e.g.&nbsp;by&nbsp;covering&nbsp;sample&nbsp;containers),&nbsp;or&nbsp;the&nbsp;final&nbsp;extract&nbsp;volume&nbsp;should&nbsp;be&nbsp;measured&nbsp;for&nbsp;later</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_568\">568</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">calculations&nbsp;on&nbsp;extractables&nbsp;device.&nbsp;Measurement&nbsp;of&nbsp;solvent&nbsp;volumes&nbsp;in&nbsp;order&nbsp;to&nbsp;compensate&nbsp;for&nbsp;solvent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_569\">569</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">loss&nbsp;due&nbsp;to&nbsp;swelling&nbsp;should&nbsp;be&nbsp;done&nbsp;cautiously,&nbsp;given&nbsp;that&nbsp;the&nbsp;amount&nbsp;of&nbsp;solvent&nbsp;that&nbsp;swells&nbsp;a&nbsp;test&nbsp;article</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_570\">570</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">might&nbsp;be&nbsp;unknown&nbsp;and&nbsp;difficult&nbsp;to&nbsp;measure.&nbsp;In&nbsp;either&nbsp;case,&nbsp;the&nbsp;final&nbsp;extract&nbsp;volume&nbsp;should&nbsp;be&nbsp;measured</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_571\">571</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;reported&nbsp;for&nbsp;later&nbsp;calculations&nbsp;on&nbsp;extractables&nbsp;per&nbsp;device.&nbsp;Furthermore,&nbsp;destructive&nbsp;swelling&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_572\">572</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">induce&nbsp;material/medical&nbsp;device&nbsp;disintegration&nbsp;and&nbsp;result&nbsp;in&nbsp;particulate&nbsp;debris,&nbsp;and&nbsp;extractables&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_573\">573</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachables&nbsp;that&nbsp;would&nbsp;not&nbsp;otherwise&nbsp;be&nbsp;present;&nbsp;this&nbsp;could&nbsp;potentially&nbsp;interfere&nbsp;with&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_574\">574</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Although&nbsp;choice&nbsp;of&nbsp;extraction&nbsp;vehicles&nbsp;will&nbsp;depend&nbsp;on&nbsp;the&nbsp;specific&nbsp;extraction&nbsp;objectives,&nbsp;it&nbsp;is&nbsp;generally</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_575\">575</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;for&nbsp;long-term&nbsp;implants&nbsp;that&nbsp;a&nbsp;minimum&nbsp;of&nbsp;two&nbsp;extraction&nbsp;solvents&nbsp;of&nbsp;differing&nbsp;polarity</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_576\">576</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;employed;&nbsp;for&nbsp;example,&nbsp;polar&nbsp;and&nbsp;non-polar&nbsp;vehicles&nbsp;consistent&nbsp;with&nbsp;ISO\u00a0&nbsp;10993-12.&nbsp;For&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_577\">577</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices&nbsp;with&nbsp;indirect&nbsp;contact,&nbsp;it&nbsp;can&nbsp;be&nbsp;appropriate&nbsp;to&nbsp;use&nbsp;a&nbsp;single&nbsp;extraction&nbsp;solvent&nbsp;that&nbsp;replicates&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_578\">578</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">expected&nbsp;contacting&nbsp;fluid.&nbsp;In&nbsp;any&nbsp;case,&nbsp;the&nbsp;choice&nbsp;of&nbsp;extraction&nbsp;vehicle(s)&nbsp;shall&nbsp;be&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_579\">579</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_580\">580</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;some&nbsp;regulatory&nbsp;regions,&nbsp;such&nbsp;as&nbsp;the&nbsp;U.S.,&nbsp;three&nbsp;solvents&nbsp;(e.g.&nbsp;polar,&nbsp;non-polar,&nbsp;and&nbsp;semi-polar)&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_581\">581</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">recommended&nbsp;for&nbsp;long&nbsp;term&nbsp;implants,&nbsp;unless&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_582\">582</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;of&nbsp;possible&nbsp;extraction&nbsp;vehicles&nbsp;are&nbsp;presented&nbsp;in&nbsp;Table\u00a0&nbsp;D.1.&nbsp;Inclusion&nbsp;of&nbsp;these&nbsp;solvents&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_583\">583</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a0D.1&nbsp;serves&nbsp;only&nbsp;as&nbsp;a&nbsp;starting&nbsp;point&nbsp;for&nbsp;solvent&nbsp;vehicles&nbsp;selection&nbsp;and&nbsp;does&nbsp;not&nbsp;constitute&nbsp;a&nbsp;complete</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_584\">584</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justification&nbsp;for&nbsp;their&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_585\">585</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">SAFETY&nbsp;PRECAUTIONS&nbsp;\u2014&nbsp;If&nbsp;hazardous&nbsp;solvents&nbsp;are&nbsp;used,&nbsp;occupational&nbsp;health&nbsp;requirements</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_586\">586</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">should&nbsp;be&nbsp;observed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_587\">587</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a0D.1\u00a0\u2014&nbsp;Parameters&nbsp;of&nbsp;solvents&nbsp;commonly&nbsp;used&nbsp;for&nbsp;extraction&nbsp;of&nbsp;polymeric&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_588\">588</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices/materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_589\">589</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_590\">590</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Solventa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_591\">591</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polarity&nbsp;index[50]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_592\">592</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Boiling&nbsp;point&nbsp;(\u00b0C)b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_593\">593</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polar</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_594\">594</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Waterc</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_595\">595</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">10,2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_596\">596</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">100</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_597\">597</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dimethyl&nbsp;sulfoxide</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_598\">598</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">7,2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_599\">599</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">189</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_600\">600</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Acetonitrile</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_601\">601</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5,8</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_602\">602</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">82</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_603\">603</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Semi&nbsp;Polar</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_604\">604</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Methanol</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_605\">605</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5,1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_606\">606</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">65</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_607\">607</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Acetone</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_608\">608</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">5,1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_609\">609</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">56</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_610\">610</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ethanold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_611\">611</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4,3</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_612\">612</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">78</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_613\">613</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Tetrahydrofuran</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_614\">614</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4,0</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_615\">615</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">65</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_616\">616</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">n-Propyl&nbsp;alcohol</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_617\">617</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">4,0</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_618\">618</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">97</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_619\">619</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_620\">620</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">These&nbsp;solvents&nbsp;serve&nbsp;only&nbsp;as&nbsp;a&nbsp;starting&nbsp;point&nbsp;for&nbsp;solvent&nbsp;vehicle&nbsp;selection,&nbsp;and&nbsp;their&nbsp;inclusion&nbsp;here&nbsp;does&nbsp;not&nbsp;constitute&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_621\">621</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">complete&nbsp;justification&nbsp;for&nbsp;their&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_622\">622</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_623\">623</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Not&nbsp;consistently&nbsp;related&nbsp;to&nbsp;solvent&nbsp;polarity&nbsp;(e.g.&nbsp;Reference&nbsp;[49]),&nbsp;but&nbsp;of&nbsp;practical&nbsp;value&nbsp;when&nbsp;solvent&nbsp;is&nbsp;evaporated&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_624\">624</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;extract&nbsp;(e.g.&nbsp;in&nbsp;common&nbsp;approaches&nbsp;to&nbsp;NVR&nbsp;in&nbsp;exhaustive&nbsp;extraction).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_625\">625</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_626\">626</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Physiological&nbsp;saline&nbsp;and&nbsp;aqueous&nbsp;buffer&nbsp;systems&nbsp;such&nbsp;as&nbsp;phosphate&nbsp;buffered&nbsp;saline&nbsp;(PBS)&nbsp;are&nbsp;also&nbsp;considered&nbsp;polar</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_627\">627</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solvents.&nbsp;Although&nbsp;specific&nbsp;values&nbsp;for&nbsp;their&nbsp;polarity&nbsp;index&nbsp;have&nbsp;not&nbsp;been&nbsp;developed,&nbsp;the&nbsp;presence&nbsp;of&nbsp;relatively&nbsp;small&nbsp;amounts</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_628\">628</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;dissolved&nbsp;salts&nbsp;is&nbsp;not&nbsp;expected&nbsp;to&nbsp;markedly&nbsp;change&nbsp;their&nbsp;extracting&nbsp;power.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_629\">629</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_630\">630</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Aqueous&nbsp;solutions&nbsp;of&nbsp;ethanol&nbsp;will&nbsp;have&nbsp;polarities&nbsp;between&nbsp;those&nbsp;of&nbsp;pure&nbsp;ethanol&nbsp;and&nbsp;water;&nbsp;their&nbsp;polarity&nbsp;indexes&nbsp;may</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_631\">631</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;estimated&nbsp;according&nbsp;to&nbsp;Formula\u00a0(D.1).&nbsp;For&nbsp;example,&nbsp;a&nbsp;20\u00a0%&nbsp;ethanolaq&nbsp;solution&nbsp;will&nbsp;have&nbsp;an&nbsp;estimated&nbsp;polarity&nbsp;index&nbsp;of&nbsp;9.0.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_632\">632</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_633\">633</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">See&nbsp;Reference\u00a0[32].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_634\">634</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_635\">635</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_636\">636</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">39</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_637\">637</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_638\">638</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_639\">639</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_640\">640</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_641\">641</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_642\">642</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_643\">643</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Solventa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_644\">644</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polarity&nbsp;index[50]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_645\">645</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Boiling&nbsp;point&nbsp;(\u00b0C)b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_646\">646</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">i-Propyl&nbsp;alcohol</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_647\">647</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3,9</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_648\">648</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">82</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_649\">649</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dichloromethane</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_650\">650</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3,1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_651\">651</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">41</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_652\">652</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_653\">653</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2,4</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_654\">654</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">111</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_655\">655</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Non-Polar</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_656\">656</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Cyclohexane</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_657\">657</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">0,2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_658\">658</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">81</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_659\">659</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Heptane</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_660\">660</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">0,1e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_661\">661</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">98</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_662\">662</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">n-Hexane</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_663\">663</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">0,1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_664\">664</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">69</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_665\">665</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_666\">666</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">These&nbsp;solvents&nbsp;serve&nbsp;only&nbsp;as&nbsp;a&nbsp;starting&nbsp;point&nbsp;for&nbsp;solvent&nbsp;vehicle&nbsp;selection,&nbsp;and&nbsp;their&nbsp;inclusion&nbsp;here&nbsp;does&nbsp;not&nbsp;constitute&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_667\">667</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">complete&nbsp;justification&nbsp;for&nbsp;their&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_668\">668</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_669\">669</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Not&nbsp;consistently&nbsp;related&nbsp;to&nbsp;solvent&nbsp;polarity&nbsp;(e.g.&nbsp;Reference&nbsp;[49]),&nbsp;but&nbsp;of&nbsp;practical&nbsp;value&nbsp;when&nbsp;solvent&nbsp;is&nbsp;evaporated&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_670\">670</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;extract&nbsp;(e.g.&nbsp;in&nbsp;common&nbsp;approaches&nbsp;to&nbsp;NVR&nbsp;in&nbsp;exhaustive&nbsp;extraction).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_671\">671</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_672\">672</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Physiological&nbsp;saline&nbsp;and&nbsp;aqueous&nbsp;buffer&nbsp;systems&nbsp;such&nbsp;as&nbsp;phosphate&nbsp;buffered&nbsp;saline&nbsp;(PBS)&nbsp;are&nbsp;also&nbsp;considered&nbsp;polar</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_673\">673</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solvents.&nbsp;Although&nbsp;specific&nbsp;values&nbsp;for&nbsp;their&nbsp;polarity&nbsp;index&nbsp;have&nbsp;not&nbsp;been&nbsp;developed,&nbsp;the&nbsp;presence&nbsp;of&nbsp;relatively&nbsp;small&nbsp;amounts</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_674\">674</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;dissolved&nbsp;salts&nbsp;is&nbsp;not&nbsp;expected&nbsp;to&nbsp;markedly&nbsp;change&nbsp;their&nbsp;extracting&nbsp;power.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_675\">675</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_676\">676</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Aqueous&nbsp;solutions&nbsp;of&nbsp;ethanol&nbsp;will&nbsp;have&nbsp;polarities&nbsp;between&nbsp;those&nbsp;of&nbsp;pure&nbsp;ethanol&nbsp;and&nbsp;water;&nbsp;their&nbsp;polarity&nbsp;indexes&nbsp;may</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_677\">677</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;estimated&nbsp;according&nbsp;to&nbsp;Formula\u00a0(D.1).&nbsp;For&nbsp;example,&nbsp;a&nbsp;20\u00a0%&nbsp;ethanolaq&nbsp;solution&nbsp;will&nbsp;have&nbsp;an&nbsp;estimated&nbsp;polarity&nbsp;index&nbsp;of&nbsp;9.0.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_678\">678</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_679\">679</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">See&nbsp;Reference\u00a0[32].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_680\">680</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;polarity&nbsp;index&nbsp;developed&nbsp;by&nbsp;Snyder&nbsp;was&nbsp;derived&nbsp;empirically&nbsp;from&nbsp;data&nbsp;on&nbsp;mixtures&nbsp;of&nbsp;solvents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_681\">681</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">commonly&nbsp;used&nbsp;in&nbsp;chromatography&nbsp;(GC&nbsp;stationary&nbsp;phases&nbsp;and&nbsp;LC&nbsp;mobile&nbsp;phases)[49].&nbsp;Other</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_682\">682</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">categorization&nbsp;schemes&nbsp;have&nbsp;been&nbsp;proposed&nbsp;for&nbsp;categorizing&nbsp;solvent&nbsp;extraction&nbsp;power.&nbsp;For&nbsp;example,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_683\">683</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hansen[35]&nbsp;has&nbsp;expanded&nbsp;the&nbsp;Hildebrand&nbsp;solubility&nbsp;parameter&nbsp;\u2018\u03b4\u2019[36],&nbsp;attempting&nbsp;to&nbsp;account&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_684\">684</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;effects&nbsp;of&nbsp;dispersion&nbsp;forces,&nbsp;dipole&nbsp;moments,&nbsp;and&nbsp;hydrogen&nbsp;bonding.&nbsp;When&nbsp;Hansen&nbsp;solubility</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_685\">685</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parameters&nbsp;are&nbsp;available&nbsp;for&nbsp;both&nbsp;material&nbsp;and&nbsp;solvents,&nbsp;they&nbsp;can&nbsp;provide&nbsp;an&nbsp;estimation&nbsp;of&nbsp;the&nbsp;degree&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_686\">686</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">interaction&nbsp;between&nbsp;materials&nbsp;and&nbsp;solvents;&nbsp;materials&nbsp;with&nbsp;similar&nbsp;solubility&nbsp;parameters&nbsp;can&nbsp;interact</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_687\">687</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;each&nbsp;other,&nbsp;resulting&nbsp;in&nbsp;solvation,&nbsp;miscibility&nbsp;or&nbsp;swelling.&nbsp;Either&nbsp;of&nbsp;these&nbsp;scales&nbsp;can&nbsp;contribute&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_688\">688</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;rationale&nbsp;for&nbsp;selection&nbsp;of&nbsp;vehicles&nbsp;for&nbsp;extraction&nbsp;in&nbsp;chemical&nbsp;characterization.&nbsp;Stults,&nbsp;et&nbsp;al.[52]&nbsp;have</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_689\">689</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compiled&nbsp;some&nbsp;information&nbsp;on&nbsp;plastic&nbsp;and&nbsp;elastomer&nbsp;compatibility&nbsp;with&nbsp;several&nbsp;common&nbsp;solvents.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_690\">690</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;polarity&nbsp;of&nbsp;binary&nbsp;mixtures&nbsp;can&nbsp;be&nbsp;estimated&nbsp;by&nbsp;taking&nbsp;into&nbsp;consideration&nbsp;the&nbsp;polarity\u00a0(P)&nbsp;and&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_691\">691</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">mole&nbsp;fraction\u00a0(\u03a6)&nbsp;of&nbsp;each&nbsp;solvent&nbsp;of&nbsp;the&nbsp;mixture[49]&nbsp;and&nbsp;is&nbsp;calculated&nbsp;as&nbsp;in&nbsp;Formula\u00a0(D.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_692\">692</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">P</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_693\">693</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">P</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_694\">694</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">P</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_695\">695</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">mix</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_696\">696</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_697\">697</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_698\">698</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_699\">699</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_700\">700</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">=</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_701\">701</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00d7</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_702\">702</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_703\">703</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">)+</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_704\">704</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00d7</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_705\">705</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_706\">706</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_707\">707</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u03a6</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_708\">708</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u03a6</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_709\">709</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_710\">710</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(D.1)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_711\">711</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">where</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_712\">712</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_713\">713</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u03a6A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_714\">714</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;volume&nbsp;fraction&nbsp;of&nbsp;solvent\u00a0A;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_715\">715</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_716\">716</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">PA</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_717\">717</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;polarity&nbsp;of&nbsp;solvent\u00a0A;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_718\">718</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_719\">719</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u03a6B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_720\">720</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;volume&nbsp;fraction&nbsp;of&nbsp;solvent\u00a0B;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_721\">721</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_722\">722</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">PB</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_723\">723</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;polarity&nbsp;of&nbsp;solvent&nbsp;B.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_724\">724</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">D.2&nbsp;Approaches&nbsp;to&nbsp;establishing&nbsp;the&nbsp;compositional&nbsp;aspects&nbsp;of&nbsp;the&nbsp;configuration&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_725\">725</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;medical&nbsp;device&nbsp;or&nbsp;the&nbsp;composition&nbsp;of&nbsp;a&nbsp;material&nbsp;of&nbsp;construction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_726\">726</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;terms&nbsp;composition&nbsp;applied&nbsp;to&nbsp;a&nbsp;material&nbsp;and&nbsp;configuration&nbsp;applied&nbsp;to&nbsp;a&nbsp;medical&nbsp;device&nbsp;address&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_727\">727</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">same&nbsp;concept&nbsp;in&nbsp;that&nbsp;they&nbsp;both&nbsp;establish&nbsp;what&nbsp;chemical&nbsp;entities&nbsp;are&nbsp;present&nbsp;in&nbsp;the&nbsp;test&nbsp;article&nbsp;and&nbsp;at</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_728\">728</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">what&nbsp;amounts&nbsp;they&nbsp;are&nbsp;present.&nbsp;Although&nbsp;certain&nbsp;non-destructive&nbsp;test&nbsp;methods&nbsp;exist&nbsp;for&nbsp;establishing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_729\">729</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">composition&nbsp;and&nbsp;configuration,&nbsp;it&nbsp;is&nbsp;typically&nbsp;the&nbsp;case&nbsp;that&nbsp;both&nbsp;require&nbsp;test&nbsp;article&nbsp;solubilisation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_730\">730</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">followed&nbsp;by&nbsp;chemical&nbsp;testing&nbsp;of&nbsp;the&nbsp;resulting&nbsp;solution.&nbsp;When&nbsp;solubilisation&nbsp;is&nbsp;used,&nbsp;it&nbsp;can&nbsp;be&nbsp;accomplished</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_731\">731</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;several&nbsp;different&nbsp;manners&nbsp;including&nbsp;digestion&nbsp;or&nbsp;dissolution.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_732\">732</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_733\">733</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table&nbsp;D.1&nbsp;(continued)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_734\">734</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">40\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_735\">735</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_736\">736</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_737\">737</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_738\">738</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_739\">739</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_740\">740</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_741\">741</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">To&nbsp;establish&nbsp;the&nbsp;elemental&nbsp;composition&nbsp;of&nbsp;a&nbsp;ceramic,&nbsp;metallic&nbsp;or&nbsp;polymeric&nbsp;test&nbsp;articles,&nbsp;digestion&nbsp;using</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_742\">742</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;appropriate&nbsp;chemical&nbsp;(e.g.&nbsp;strong&nbsp;acid,&nbsp;base&nbsp;or&nbsp;enzyme)&nbsp;is&nbsp;recommended.&nbsp;In&nbsp;digesting&nbsp;the&nbsp;test&nbsp;article,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_743\">743</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;chemical&nbsp;form&nbsp;of&nbsp;its&nbsp;constituents&nbsp;is&nbsp;largely&nbsp;disrupted&nbsp;and&nbsp;the&nbsp;constituents&nbsp;are&nbsp;typically&nbsp;converted</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_744\">744</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;their&nbsp;elemental&nbsp;form.&nbsp;Although&nbsp;the&nbsp;use&nbsp;of&nbsp;digestion&nbsp;is&nbsp;generally&nbsp;not&nbsp;appropriate&nbsp;for&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_745\">745</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;extractables,&nbsp;it&nbsp;can&nbsp;facilitate&nbsp;the&nbsp;procurement&nbsp;of&nbsp;otherwise&nbsp;unavailable&nbsp;information&nbsp;on&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_746\">746</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">composition&nbsp;and&nbsp;it&nbsp;establishes&nbsp;the&nbsp;absolute&nbsp;and&nbsp;maximum&nbsp;total&nbsp;pool&nbsp;of&nbsp;elemental&nbsp;entities&nbsp;present&nbsp;in&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_747\">747</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">test&nbsp;article.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_748\">748</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">To&nbsp;establish&nbsp;chemical&nbsp;formulation,&nbsp;dissolution&nbsp;is&nbsp;typically&nbsp;applied&nbsp;to&nbsp;polymeric&nbsp;or&nbsp;natural&nbsp;macromolecule</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_749\">749</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">test&nbsp;articles&nbsp;via&nbsp;the&nbsp;use&nbsp;of&nbsp;an&nbsp;appropriate&nbsp;organic&nbsp;solvent&nbsp;and&nbsp;is&nbsp;typically&nbsp;performed&nbsp;to&nbsp;establish&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_750\">750</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">intact&nbsp;organic&nbsp;and/or&nbsp;inorganic&nbsp;constituents&nbsp;in&nbsp;a&nbsp;test&nbsp;article.&nbsp;Once&nbsp;the&nbsp;test&nbsp;article&nbsp;is&nbsp;dissolved&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_751\">751</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;appropriate&nbsp;vehicle,&nbsp;analysis&nbsp;of&nbsp;the&nbsp;dissolution&nbsp;solution&nbsp;is&nbsp;performed.&nbsp;In&nbsp;many&nbsp;cases,&nbsp;the&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_752\">752</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;facilitated&nbsp;after&nbsp;the&nbsp;polymer&nbsp;itself&nbsp;has&nbsp;been&nbsp;re-precipitated&nbsp;with&nbsp;an&nbsp;antivehicle&nbsp;and&nbsp;filtered&nbsp;out.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_753\">753</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Although&nbsp;the&nbsp;use&nbsp;of&nbsp;dissolution&nbsp;is&nbsp;not&nbsp;appropriate&nbsp;for&nbsp;assessment&nbsp;of&nbsp;clinical&nbsp;exposure,&nbsp;unless&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_754\">754</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;or&nbsp;material&nbsp;being&nbsp;assessed&nbsp;dissolves&nbsp;in&nbsp;clinical&nbsp;use,&nbsp;it&nbsp;can&nbsp;facilitate&nbsp;the&nbsp;procurement&nbsp;of&nbsp;otherwise</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_755\">755</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">unavailable&nbsp;information&nbsp;on&nbsp;material&nbsp;composition&nbsp;and&nbsp;it&nbsp;establishes&nbsp;the&nbsp;absolute&nbsp;total&nbsp;and&nbsp;maximum</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_756\">756</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pool&nbsp;of&nbsp;constituents&nbsp;in&nbsp;a&nbsp;test&nbsp;article.&nbsp;If&nbsp;this&nbsp;step&nbsp;is&nbsp;undertaken,&nbsp;the&nbsp;possibility&nbsp;of&nbsp;co-precipitation&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_757\">757</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">constituents&nbsp;other&nbsp;than&nbsp;the&nbsp;base&nbsp;polymer&nbsp;should&nbsp;be&nbsp;considered.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_758\">758</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Possible&nbsp;solvent/anti-solvent&nbsp;combinations&nbsp;for&nbsp;common&nbsp;polymers&nbsp;are&nbsp;listed&nbsp;in&nbsp;Table\u00a0D.2&nbsp;and&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_759\">759</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">found&nbsp;in&nbsp;the&nbsp;literature[28][29][30][31][33][43].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_760\">760</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_761\">761</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_762\">762</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">41</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_763\">763</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_764\">764</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_765\">765</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_766\">766</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_767\">767</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_768\">768</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a0D.2\u00a0\u2014&nbsp;Possible&nbsp;solvent/anti-solvent&nbsp;combinations&nbsp;for&nbsp;common&nbsp;polymers</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_769\">769</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polymer</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_770\">770</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Solventsa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_771\">771</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Anti-solventsa</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_772\">772</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyethylene&nbsp;(high&nbsp;density)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_773\">773</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xyleneb,&nbsp;Decalineb,&nbsp;TCBb</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_774\">774</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Acetone,&nbsp;MeOH,&nbsp;ether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_775\">775</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyethylene&nbsp;(low&nbsp;density)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_776\">776</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_777\">777</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;ACN</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_778\">778</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polypropylene&nbsp;(general)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_779\">779</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_780\">780</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;ACN</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_781\">781</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polypropylene&nbsp;(atactic)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_782\">782</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">General&nbsp;hydrocarbons</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_783\">783</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EA,&nbsp;iPrOH</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_784\">784</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polypropylene&nbsp;(isotactic)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_785\">785</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Xyleneb,&nbsp;Decalineb,&nbsp;TCBb</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_786\">786</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Acetone,&nbsp;MeOH,&nbsp;ether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_787\">787</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polybutadiene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_788\">788</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hydrocarbons,&nbsp;benzene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_789\">789</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gasoline,&nbsp;alcohols,&nbsp;esters,&nbsp;ketones</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_790\">790</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyisoprene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_791\">791</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Benzene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_792\">792</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gasoline,&nbsp;alcohols,&nbsp;esters,&nbsp;ketones</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_793\">793</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyamides</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_794\">794</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">HFIP,&nbsp;Formic&nbsp;acid,&nbsp;DMF,&nbsp;m-cresol</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_795\">795</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;ACN</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_796\">796</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyurethanes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_797\">797</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DMF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_798\">798</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;ether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_799\">799</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyesters&nbsp;(except&nbsp;PET)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_800\">800</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;chloroform,&nbsp;benzene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_801\">801</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;EtOH,&nbsp;iPrOH,&nbsp;ether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_802\">802</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">PET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_803\">803</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF,&nbsp;m-Cresol,&nbsp;o-Chlorophenol</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_804\">804</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;acetone</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_805\">805</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polycarbonate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_806\">806</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF,&nbsp;DCM</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_807\">807</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MEOH,&nbsp;EtOH,&nbsp;ACN</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_808\">808</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Poly(methyl&nbsp;methacrylate)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_809\">809</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;chloroform,&nbsp;acetone,&nbsp;THF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_810\">810</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;EtOH,&nbsp;ACN,&nbsp;petroleum&nbsp;ether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_811\">811</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Poly(vinyl&nbsp;chloride)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_812\">812</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;THF,&nbsp;DMF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_813\">813</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;EtOH,&nbsp;hexane,&nbsp;ACN</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_814\">814</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Poly(vinylidene&nbsp;chloride)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_815\">815</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF,&nbsp;dioxane,&nbsp;ketones,&nbsp;butylacetate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_816\">816</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hydrocarbons,&nbsp;alcohols,&nbsp;phenols</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_817\">817</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Poly(vinyl&nbsp;alcohol)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_818\">818</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Water,&nbsp;formamide</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_819\">819</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gasoline,&nbsp;aromatic&nbsp;hydrocarbons,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_820\">820</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">alcohols</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_821\">821</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polystyrene</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_822\">822</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;chloroform,&nbsp;cyclohex\u00ad</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_823\">823</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">anone,&nbsp;DCM</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_824\">824</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;EtOH,&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_825\">825</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Styrenics&nbsp;(ABS)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_826\">826</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;acetone</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_827\">827</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;EtOH,&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_828\">828</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polysulphone</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_829\">829</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_830\">830</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF-water&nbsp;gradient</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_831\">831</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Rubbers</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_832\">832</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Toluene,&nbsp;chlorinated&nbsp;hydrocarbons</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_833\">833</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH,&nbsp;ACN,&nbsp;ketones,&nbsp;esters</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_834\">834</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Cellulose&nbsp;esters</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_835\">835</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Acetone,&nbsp;esters</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_836\">836</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Aliphatic&nbsp;hydrocarbons</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_837\">837</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_838\">838</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ABS\u00a0=\u00a0poly(acrylonitrile-butadiene-styrene);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_839\">839</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ACN\u00a0=\u00a0acetonitrile;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_840\">840</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AE\u00a0=\u00a0ethyl&nbsp;acetate;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_841\">841</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DCM\u00a0=\u00a0dichloromethane;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_842\">842</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DMF\u00a0=\u00a0dimethylformamide;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_843\">843</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">HFIP\u00a0=\u00a0hexafluoroisopropanol;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_844\">844</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">PET\u00a0=\u00a0poly(ethylene&nbsp;terephthalate);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_845\">845</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">TCB\u00a0=\u00a0trichlorobenzene;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_846\">846</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">THF\u00a0=\u00a0tetrahydrofuran;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_847\">847</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">MeOH\u00a0=\u00a0methanol;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_848\">848</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EtOH\u00a0=\u00a0ethanol;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_849\">849</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">iPrOH\u00a0=\u00a0isopropyl&nbsp;alcohol.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_850\">850</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_851\">851</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Performed&nbsp;at&nbsp;high&nbsp;temperature&nbsp;(&gt;130\u00a0\u00b0C).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_852\">852</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Other&nbsp;than&nbsp;this&nbsp;general&nbsp;discussion,&nbsp;this&nbsp;annex&nbsp;provides&nbsp;no&nbsp;additional&nbsp;insights&nbsp;on&nbsp;performing&nbsp;dissolutions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_853\">853</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;digestions,&nbsp;as&nbsp;the&nbsp;approaches&nbsp;applied&nbsp;to&nbsp;accomplish&nbsp;dissolution&nbsp;or&nbsp;digestion&nbsp;vary&nbsp;significantly&nbsp;on&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_854\">854</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">case&nbsp;by&nbsp;case&nbsp;basis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_855\">855</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;concept&nbsp;of&nbsp;an&nbsp;exhaustive&nbsp;extraction&nbsp;is&nbsp;discussed&nbsp;in&nbsp;ISO\u00a010993-12:2012,&nbsp;Annex\u00a0D.&nbsp;An&nbsp;exhaustive</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_856\">856</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;establishes&nbsp;the&nbsp;maximum&nbsp;amounts&nbsp;of&nbsp;extractables&nbsp;that&nbsp;can&nbsp;be&nbsp;removed&nbsp;(extracted)&nbsp;from&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_857\">857</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medical&nbsp;device&nbsp;or&nbsp;material&nbsp;and&nbsp;thus&nbsp;defines&nbsp;the&nbsp;upper&nbsp;bound&nbsp;on&nbsp;the&nbsp;amount&nbsp;of&nbsp;leachables&nbsp;that&nbsp;could</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_858\">858</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">potentially&nbsp;be&nbsp;released&nbsp;by&nbsp;the&nbsp;device&nbsp;or&nbsp;material&nbsp;during&nbsp;clinical&nbsp;use/lifetime.&nbsp;In&nbsp;many&nbsp;circumstances,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_859\">859</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_860\">860</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">42\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_861\">861</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_862\">862</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_863\">863</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_864\">864</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_865\">865</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_866\">866</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_867\">867</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;exhaustive&nbsp;extraction&nbsp;will&nbsp;accomplish&nbsp;the&nbsp;same&nbsp;outcome&nbsp;as&nbsp;digestion&nbsp;or&nbsp;dissolution,&nbsp;but&nbsp;without&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_868\">868</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solubilisation&nbsp;of&nbsp;the&nbsp;medical&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_869\">869</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;long-term&nbsp;implanted&nbsp;medical&nbsp;devices,&nbsp;an&nbsp;exhaustive&nbsp;extraction&nbsp;is&nbsp;recommended.&nbsp;If&nbsp;an&nbsp;exaggerated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_870\">870</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;is&nbsp;used,&nbsp;then&nbsp;its&nbsp;use&nbsp;should&nbsp;be&nbsp;justified.&nbsp;It&nbsp;should&nbsp;also&nbsp;be&nbsp;recognized&nbsp;that&nbsp;if&nbsp;total&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_871\">871</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;an&nbsp;exhaustive&nbsp;(or&nbsp;justified&nbsp;exaggerated&nbsp;extraction)&nbsp;of&nbsp;a&nbsp;long-term&nbsp;implant&nbsp;medical&nbsp;device&nbsp;exceed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_872\">872</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;permissible&nbsp;daily&nbsp;exposure,&nbsp;the&nbsp;extraction&nbsp;kinetics&nbsp;(e.g.&nbsp;to&nbsp;determine&nbsp;maximum&nbsp;daily&nbsp;release)&nbsp;might</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_873\">873</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">need&nbsp;to&nbsp;be&nbsp;evaluated&nbsp;(e.g.&nbsp;by&nbsp;repeated&nbsp;analysis&nbsp;of&nbsp;a&nbsp;simulated&nbsp;extraction&nbsp;over&nbsp;time),&nbsp;or&nbsp;a&nbsp;leachables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_874\">874</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">study&nbsp;performed,&nbsp;if&nbsp;possible.&nbsp;A&nbsp;toxicologist&nbsp;can&nbsp;be&nbsp;consulted&nbsp;to&nbsp;establish&nbsp;the&nbsp;specific&nbsp;data&nbsp;required&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_875\">875</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">support&nbsp;risk&nbsp;assessment&nbsp;when&nbsp;there&nbsp;is&nbsp;a&nbsp;need&nbsp;to&nbsp;understand&nbsp;the&nbsp;kinetics&nbsp;of&nbsp;release.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_876\">876</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;defined&nbsp;in&nbsp;3.15,&nbsp;exhaustive&nbsp;extraction&nbsp;involves&nbsp;sequential&nbsp;extraction&nbsp;of&nbsp;the&nbsp;test&nbsp;article&nbsp;under</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_877\">877</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relevant&nbsp;extraction&nbsp;conditions&nbsp;and&nbsp;with&nbsp;a&nbsp;relevant&nbsp;extraction&nbsp;vehicle&nbsp;and&nbsp;is&nbsp;achieved&nbsp;when&nbsp;the&nbsp;level&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_878\">878</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extracted&nbsp;substance&nbsp;by&nbsp;gravimetric&nbsp;(or&nbsp;other&nbsp;analysis)&nbsp;in&nbsp;a&nbsp;subsequent&nbsp;extraction&nbsp;step&nbsp;is&nbsp;less&nbsp;than&nbsp;10\u00a0%</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_879\">879</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;level&nbsp;of&nbsp;the&nbsp;same&nbsp;extracted&nbsp;substance&nbsp;in&nbsp;the&nbsp;initial&nbsp;extract.&nbsp;Achieving&nbsp;the&nbsp;required&nbsp;10\u00a0%&nbsp;level&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_880\">880</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">each&nbsp;individual&nbsp;extractable&nbsp;can&nbsp;be&nbsp;analytically&nbsp;and&nbsp;practically&nbsp;challenging&nbsp;(e.g.&nbsp;when&nbsp;the&nbsp;10\u00a0%&nbsp;level&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_881\">881</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">below&nbsp;the&nbsp;method\u2019s&nbsp;LOQ);&nbsp;thus,&nbsp;it&nbsp;might&nbsp;be&nbsp;necessary&nbsp;to&nbsp;establish&nbsp;that&nbsp;the&nbsp;10\u00a0%&nbsp;level&nbsp;of&nbsp;extraction&nbsp;has</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_882\">882</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">been&nbsp;established&nbsp;by&nbsp;alternate&nbsp;means&nbsp;(e.g.&nbsp;total&nbsp;peak&nbsp;area,&nbsp;TOC,&nbsp;non-volatile&nbsp;residue).&nbsp;Such&nbsp;alternate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_883\">883</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">means&nbsp;should&nbsp;be&nbsp;justified.&nbsp;In&nbsp;some&nbsp;cases,&nbsp;the&nbsp;10\u00a0%&nbsp;level&nbsp;cannot&nbsp;be&nbsp;reached&nbsp;in&nbsp;a&nbsp;practical&nbsp;number&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_884\">884</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sequential&nbsp;extractions.&nbsp;In&nbsp;these&nbsp;cases,&nbsp;the&nbsp;analyst&nbsp;should&nbsp;consider&nbsp;an&nbsp;alternate&nbsp;extraction&nbsp;process&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_885\">885</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;of&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;with&nbsp;greater&nbsp;extraction&nbsp;power)&nbsp;so&nbsp;that&nbsp;the&nbsp;10\u00a0%&nbsp;level&nbsp;can&nbsp;be&nbsp;achieved&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_886\">886</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;reasonable&nbsp;number&nbsp;of&nbsp;sequential&nbsp;extractions.&nbsp;It&nbsp;can&nbsp;also&nbsp;be&nbsp;possible&nbsp;to&nbsp;estimate&nbsp;lifetime&nbsp;exposures</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_887\">887</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;the&nbsp;sequential&nbsp;amounts&nbsp;extracted,&nbsp;even&nbsp;if&nbsp;the&nbsp;10\u00a0%&nbsp;level&nbsp;is&nbsp;not&nbsp;achieved.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_888\">888</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additionally,&nbsp;ISO\u00a010993-12:2012,&nbsp;Annex\u00a0D,&nbsp;describes&nbsp;a&nbsp;set&nbsp;of&nbsp;extraction&nbsp;vehicles&nbsp;[methanol,&nbsp;acetone,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_889\">889</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">isopropanol-hexane&nbsp;(50:50)&nbsp;and&nbsp;hexane]&nbsp;that&nbsp;can&nbsp;be&nbsp;used,&nbsp;as&nbsp;appropriate,&nbsp;in&nbsp;preliminary&nbsp;experiments</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_890\">890</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">whose&nbsp;purpose&nbsp;is&nbsp;to&nbsp;optimize&nbsp;the&nbsp;extraction&nbsp;sequence&nbsp;and&nbsp;discusses&nbsp;the&nbsp;need&nbsp;to&nbsp;use&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_891\">891</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions&nbsp;and&nbsp;extraction&nbsp;vehicles&nbsp;(including&nbsp;those&nbsp;described&nbsp;above)&nbsp;that&nbsp;do&nbsp;not&nbsp;result&nbsp;in&nbsp;a&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_892\">892</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">change&nbsp;of&nbsp;either&nbsp;the&nbsp;test&nbsp;article&nbsp;or&nbsp;the&nbsp;extracted&nbsp;chemical&nbsp;entity.&nbsp;Regardless&nbsp;of&nbsp;the&nbsp;specific&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_893\">893</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parameters&nbsp;selected,&nbsp;each&nbsp;step&nbsp;of&nbsp;exhaustive&nbsp;extractions&nbsp;should&nbsp;use&nbsp;uniform&nbsp;extraction&nbsp;parameters.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_894\">894</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;means&nbsp;by&nbsp;which&nbsp;the&nbsp;individual&nbsp;extraction&nbsp;steps&nbsp;in&nbsp;a&nbsp;sequential&nbsp;exhaustive&nbsp;extraction&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_895\">895</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">accomplished&nbsp;are&nbsp;many&nbsp;and&nbsp;varied.&nbsp;Liquid&nbsp;extraction&nbsp;techniques&nbsp;for&nbsp;polymers&nbsp;span&nbsp;a&nbsp;century&nbsp;in&nbsp;terms</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_896\">896</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;development&nbsp;and&nbsp;use&nbsp;and&nbsp;can&nbsp;be&nbsp;divided&nbsp;into&nbsp;two&nbsp;categories&nbsp;\u201ctraditional\u201d&nbsp;and&nbsp;\u201cmodern\u201d.&nbsp;Traditional</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_897\">897</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">techniques,&nbsp;including&nbsp;Soxhlet&nbsp;extraction,&nbsp;boiling&nbsp;under&nbsp;reflux,&nbsp;shake&nbsp;flask&nbsp;extraction,&nbsp;and&nbsp;sonication</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_898\">898</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;widely&nbsp;used&nbsp;even&nbsp;today&nbsp;and&nbsp;are&nbsp;more&nbsp;or&nbsp;less&nbsp;simple&nbsp;to&nbsp;implement&nbsp;using&nbsp;basic&nbsp;laboratory&nbsp;apparatus.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_899\">899</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;the&nbsp;traditional&nbsp;techniques&nbsp;have&nbsp;been&nbsp;used&nbsp;for&nbsp;an&nbsp;extended&nbsp;period&nbsp;of&nbsp;time,&nbsp;their&nbsp;capabilities&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_900\">900</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">performance&nbsp;is&nbsp;well-known&nbsp;and&nbsp;well-documented.&nbsp;Nevertheless,&nbsp;they&nbsp;can&nbsp;have&nbsp;significant&nbsp;practical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_901\">901</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">shortcomings&nbsp;including&nbsp;low&nbsp;extraction&nbsp;efficiencies,&nbsp;long&nbsp;extraction&nbsp;times,&nbsp;and&nbsp;the&nbsp;use&nbsp;of&nbsp;large</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_902\">902</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantities&nbsp;of&nbsp;environmentally&nbsp;inopportune&nbsp;extraction&nbsp;vehicles.&nbsp;Such&nbsp;shortcomings&nbsp;are&nbsp;addressed,&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_903\">903</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;certain&nbsp;extent,&nbsp;by&nbsp;the&nbsp;more&nbsp;modern&nbsp;extraction&nbsp;techniques,&nbsp;including&nbsp;microwave-assisted&nbsp;extraction,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_904\">904</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pressurized&nbsp;fluid&nbsp;extraction,&nbsp;and&nbsp;supercritical&nbsp;fluid&nbsp;extraction,&nbsp;which&nbsp;typically&nbsp;employ&nbsp;instrumental</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_905\">905</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">means&nbsp;to&nbsp;increase&nbsp;the&nbsp;heat&nbsp;and/or&nbsp;the&nbsp;pressure&nbsp;at&nbsp;which&nbsp;extraction&nbsp;occurs&nbsp;or&nbsp;the&nbsp;power&nbsp;of&nbsp;the&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_906\">906</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle[26][51].&nbsp;Nevertheless,&nbsp;the&nbsp;fact&nbsp;that&nbsp;the&nbsp;techniques&nbsp;are&nbsp;more&nbsp;\u201cmodern\u201d&nbsp;do&nbsp;not&nbsp;make&nbsp;them&nbsp;superior.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_907\">907</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;use&nbsp;of&nbsp;any&nbsp;technique,&nbsp;\u201ctraditional\u201d&nbsp;or&nbsp;\u201cmodern\u201d,&nbsp;should&nbsp;carefully&nbsp;and&nbsp;fully&nbsp;consider&nbsp;their&nbsp;technical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_908\">908</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;practical&nbsp;limitations&nbsp;and&nbsp;relevance&nbsp;to&nbsp;the&nbsp;clinical&nbsp;use&nbsp;of&nbsp;medical&nbsp;devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_909\">909</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">From&nbsp;a&nbsp;practical&nbsp;perspective,&nbsp;sequential&nbsp;extraction&nbsp;is&nbsp;facilitated&nbsp;when&nbsp;the&nbsp;extraction&nbsp;sequence&nbsp;consists</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_910\">910</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;fewest&nbsp;possible&nbsp;number&nbsp;of&nbsp;extraction&nbsp;steps&nbsp;while&nbsp;not&nbsp;degrading&nbsp;the&nbsp;additives&nbsp;and&nbsp;ingredients.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_911\">911</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">An&nbsp;exhaustive&nbsp;extraction&nbsp;reveals&nbsp;a&nbsp;test&nbsp;article\u2019s&nbsp;constituents&nbsp;and&nbsp;the&nbsp;levels&nbsp;of&nbsp;these&nbsp;constituents.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_912\">912</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive&nbsp;extraction&nbsp;addresses&nbsp;extractables&nbsp;and&nbsp;leachables&nbsp;in&nbsp;the&nbsp;sense&nbsp;of&nbsp;a&nbsp;total&nbsp;leaching,&nbsp;meaning</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_913\">913</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;a&nbsp;profile&nbsp;of&nbsp;exhaustive&nbsp;extractables&nbsp;addresses&nbsp;the&nbsp;clinical&nbsp;use&nbsp;situation&nbsp;of&nbsp;\u201call&nbsp;constituents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_914\">914</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(extractables)&nbsp;are&nbsp;leached&nbsp;in&nbsp;their&nbsp;entirety\u201d.&nbsp;Although&nbsp;such&nbsp;an&nbsp;exhaustive&nbsp;extractables&nbsp;profile&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_915\">915</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relevant&nbsp;to&nbsp;the&nbsp;clinical&nbsp;use&nbsp;of&nbsp;certain&nbsp;medical&nbsp;devices&nbsp;(e.g.,&nbsp;long&nbsp;term&nbsp;implants&nbsp;as&nbsp;noted&nbsp;previously),&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_916\">916</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">many&nbsp;cases&nbsp;the&nbsp;clinical&nbsp;leaching&nbsp;of&nbsp;the&nbsp;medical&nbsp;devices&nbsp;is&nbsp;not&nbsp;exhaustive&nbsp;and&nbsp;thus&nbsp;an&nbsp;alternate&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_917\">917</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process,&nbsp;such&nbsp;as&nbsp;exaggerated&nbsp;or&nbsp;simulated&nbsp;extraction,&nbsp;produces&nbsp;a&nbsp;more&nbsp;appropriate&nbsp;extractables&nbsp;profile</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_918\">918</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;the&nbsp;purpose&nbsp;of&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Furthermore,&nbsp;clinical&nbsp;use&nbsp;can,&nbsp;in&nbsp;certain&nbsp;circumstances</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_919\">919</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(such&nbsp;as&nbsp;absorbable&nbsp;medical&nbsp;devices)&nbsp;promote&nbsp;the&nbsp;chemical&nbsp;conversion&nbsp;of&nbsp;constituents&nbsp;into&nbsp;related</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_920\">920</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_921\">921</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_922\">922</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">43</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_923\">923</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_924\">924</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_925\">925</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_926\">926</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_927\">927</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_928\">928</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substances&nbsp;such&nbsp;as&nbsp;degradation&nbsp;products&nbsp;or&nbsp;side&nbsp;products.&nbsp;If&nbsp;this&nbsp;same&nbsp;conversion&nbsp;does&nbsp;not&nbsp;occur&nbsp;during</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_929\">929</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;extraction&nbsp;study&nbsp;(e.g.&nbsp;exhaustive&nbsp;extraction/dissolution),&nbsp;then&nbsp;the&nbsp;exhaustive&nbsp;extraction&nbsp;is&nbsp;not&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_930\">930</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">fully&nbsp;accurate&nbsp;representation&nbsp;of&nbsp;a&nbsp;potentially&nbsp;affected&nbsp;individual\u2019s&nbsp;clinical&nbsp;exposure&nbsp;to&nbsp;the&nbsp;chemicals</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_931\">931</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">present&nbsp;during&nbsp;the&nbsp;medical&nbsp;device&nbsp;use.&nbsp;In&nbsp;such&nbsp;cases,&nbsp;the&nbsp;knowledge&nbsp;of&nbsp;potential&nbsp;intermediate&nbsp;and&nbsp;final</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_932\">932</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;products,&nbsp;including&nbsp;degradation&nbsp;products,&nbsp;in&nbsp;combination&nbsp;with&nbsp;chemical&nbsp;characterization&nbsp;data</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_933\">933</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;implantation&nbsp;data&nbsp;might&nbsp;be&nbsp;needed&nbsp;to&nbsp;evaluate&nbsp;the&nbsp;safety&nbsp;of&nbsp;products.&nbsp;Knowledge&nbsp;of&nbsp;degradation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_934\">934</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process/products&nbsp;should&nbsp;be&nbsp;incorporated&nbsp;into&nbsp;any&nbsp;related&nbsp;toxicology&nbsp;risk&nbsp;assessment,&nbsp;even&nbsp;if&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_935\">935</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">degradants&nbsp;are&nbsp;not&nbsp;observed&nbsp;in&nbsp;extracts.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_936\">936</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">D.3&nbsp;Exaggerated&nbsp;extraction&nbsp;to&nbsp;estimate&nbsp;the&nbsp;worst-case&nbsp;extractables&nbsp;profile&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_937\">937</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a\u00a0medical&nbsp;device&nbsp;or&nbsp;material</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_938\">938</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;stated&nbsp;in&nbsp;3.16,&nbsp;extractables&nbsp;are&nbsp;defined&nbsp;as&nbsp;the&nbsp;substances&nbsp;that&nbsp;are&nbsp;released&nbsp;from&nbsp;a&nbsp;medical&nbsp;device&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_939\">939</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">material&nbsp;of&nbsp;construction&nbsp;using&nbsp;extraction&nbsp;vehicles&nbsp;and/or&nbsp;laboratory&nbsp;extraction&nbsp;conditions.&nbsp;However,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_940\">940</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">it&nbsp;is&nbsp;clear&nbsp;that&nbsp;the&nbsp;extraction&nbsp;conditions&nbsp;used&nbsp;to&nbsp;establish&nbsp;configuration&nbsp;and&nbsp;composition&nbsp;are&nbsp;generally</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_941\">941</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">much&nbsp;more&nbsp;extreme&nbsp;than&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use,&nbsp;and&nbsp;thus&nbsp;that&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_942\">942</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">revealed&nbsp;in&nbsp;compositional&nbsp;studies&nbsp;are&nbsp;less&nbsp;likely&nbsp;to&nbsp;appear&nbsp;as&nbsp;leachables&nbsp;from&nbsp;the&nbsp;device&nbsp;under&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_943\">943</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;conditions&nbsp;of&nbsp;use.&nbsp;Nevertheless,&nbsp;as&nbsp;discussed&nbsp;in&nbsp;Clause\u00a0&nbsp;5,&nbsp;the&nbsp;worst-case&nbsp;assessment&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_944\">944</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leaching&nbsp;of&nbsp;a&nbsp;medical&nbsp;device&nbsp;considers&nbsp;the&nbsp;situation&nbsp;where&nbsp;all&nbsp;ingredients&nbsp;and&nbsp;additives&nbsp;leach&nbsp;from&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_945\">945</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medical&nbsp;device&nbsp;in&nbsp;their&nbsp;entirety.&nbsp;Should&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;this&nbsp;worst-case&nbsp;establish&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_946\">946</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;risk&nbsp;related&nbsp;to&nbsp;the&nbsp;total&nbsp;amount&nbsp;of&nbsp;ingredients&nbsp;and&nbsp;additives&nbsp;be&nbsp;acceptable,&nbsp;then&nbsp;the&nbsp;assessment&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_947\">947</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">essentially&nbsp;complete&nbsp;and&nbsp;the&nbsp;medical&nbsp;device&nbsp;is&nbsp;accepted&nbsp;as&nbsp;being&nbsp;suitable&nbsp;for&nbsp;its&nbsp;intended&nbsp;use&nbsp;with&nbsp;no</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_948\">948</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">further&nbsp;chemical&nbsp;testing.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_949\">949</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">However,&nbsp;if&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;establishes&nbsp;that&nbsp;the&nbsp;worst-case&nbsp;provided&nbsp;by&nbsp;an&nbsp;exhaustive</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_950\">950</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;could&nbsp;represent&nbsp;a&nbsp;safety&nbsp;issue,&nbsp;then&nbsp;a&nbsp;less&nbsp;extreme,&nbsp;more&nbsp;practical&nbsp;exaggerated&nbsp;estimate&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_951\">951</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;medical&nbsp;device\u2019s&nbsp;leaching&nbsp;characteristics&nbsp;is&nbsp;necessary&nbsp;and&nbsp;appropriate.&nbsp;Such&nbsp;an&nbsp;estimate&nbsp;is&nbsp;obtained</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_952\">952</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">by&nbsp;using&nbsp;justified&nbsp;exaggerated&nbsp;extraction&nbsp;conditions&nbsp;that&nbsp;somewhat&nbsp;more&nbsp;closely&nbsp;reflect&nbsp;the&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_953\">953</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions&nbsp;of&nbsp;use.&nbsp;Of&nbsp;course,&nbsp;exaggerated&nbsp;extractions&nbsp;can&nbsp;be&nbsp;useful&nbsp;for&nbsp;other&nbsp;purposes&nbsp;as&nbsp;well,&nbsp;such&nbsp;as</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_954\">954</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">addressing&nbsp;limited&nbsp;and&nbsp;prolonged&nbsp;duration&nbsp;medical&nbsp;devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_955\">955</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;purpose&nbsp;of&nbsp;an&nbsp;exaggerated&nbsp;extraction&nbsp;is&nbsp;to&nbsp;produce&nbsp;an&nbsp;extractables&nbsp;profile&nbsp;which&nbsp;is&nbsp;at&nbsp;least</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_956\">956</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">as&nbsp;complete&nbsp;and&nbsp;complex&nbsp;as&nbsp;the&nbsp;worst-case&nbsp;leachables&nbsp;profile.&nbsp;This&nbsp;means&nbsp;that&nbsp;the&nbsp;exaggerated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_957\">957</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractables&nbsp;minimally&nbsp;include&nbsp;all&nbsp;leachables,&nbsp;and&nbsp;that&nbsp;the&nbsp;levels&nbsp;of&nbsp;the&nbsp;exaggerated&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_958\">958</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">meet&nbsp;or&nbsp;exceed&nbsp;the&nbsp;highest&nbsp;levels&nbsp;reached&nbsp;by&nbsp;leachables.&nbsp;An&nbsp;exaggerated&nbsp;extraction&nbsp;establishes&nbsp;in&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_959\">959</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">single&nbsp;extraction&nbsp;the&nbsp;highest&nbsp;amount&nbsp;of&nbsp;extractables&nbsp;that&nbsp;most&nbsp;likely&nbsp;will&nbsp;be&nbsp;released&nbsp;by&nbsp;the&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_960\">960</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;or&nbsp;material&nbsp;as&nbsp;leachables&nbsp;during&nbsp;clinical&nbsp;use.&nbsp;The&nbsp;exaggerated&nbsp;extraction&nbsp;is&nbsp;accomplished&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_961\">961</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">using&nbsp;extraction&nbsp;conditions&nbsp;that&nbsp;are,&nbsp;in&nbsp;one&nbsp;or&nbsp;more&nbsp;dimensions,&nbsp;exaggerated&nbsp;versus&nbsp;the&nbsp;conditions&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_962\">962</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;use.&nbsp;For&nbsp;example,&nbsp;an&nbsp;exaggerated&nbsp;extraction&nbsp;might&nbsp;be&nbsp;performed&nbsp;considering&nbsp;one&nbsp;or&nbsp;more&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_963\">963</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions&nbsp;below:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_964\">964</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At&nbsp;a&nbsp;temperature&nbsp;that&nbsp;exceeds&nbsp;the&nbsp;clinical&nbsp;use&nbsp;temperature&nbsp;(typically&nbsp;referred&nbsp;to&nbsp;as&nbsp;an&nbsp;accelerated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_965\">965</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction,&nbsp;see&nbsp;D.4);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_966\">966</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With&nbsp;a&nbsp;duration&nbsp;that&nbsp;exceeds&nbsp;the&nbsp;duration&nbsp;of&nbsp;clinical&nbsp;use;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_967\">967</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With&nbsp;a&nbsp;vehicle&nbsp;whose&nbsp;extraction&nbsp;power&nbsp;exceeds&nbsp;that&nbsp;of&nbsp;the&nbsp;solution&nbsp;that&nbsp;mediates&nbsp;the&nbsp;clinical&nbsp;contact</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_968\">968</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">between&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;potentially&nbsp;affected&nbsp;individual;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_969\">969</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At&nbsp;a&nbsp;surface&nbsp;area/volume&nbsp;ratio&nbsp;that&nbsp;exceed&nbsp;clinical&nbsp;use&nbsp;exposure;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_970\">970</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Via&nbsp;the&nbsp;use&nbsp;of&nbsp;exhaustive&nbsp;(sequential)&nbsp;extraction&nbsp;for&nbsp;limited&nbsp;or&nbsp;prolonged&nbsp;contact&nbsp;medical&nbsp;devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_971\">971</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Devising&nbsp;and&nbsp;justifying&nbsp;exaggerated&nbsp;extraction&nbsp;conditions&nbsp;can&nbsp;be&nbsp;a&nbsp;technically&nbsp;challenging&nbsp;exercise&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_972\">972</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">great&nbsp;care&nbsp;should&nbsp;be&nbsp;taken&nbsp;to&nbsp;ensure&nbsp;that&nbsp;the&nbsp;scientific&nbsp;basis&nbsp;for&nbsp;the&nbsp;exaggerated&nbsp;conditions&nbsp;is&nbsp;rigorous</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_973\">973</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;sound.&nbsp;Although&nbsp;certain&nbsp;exaggerating&nbsp;conditions&nbsp;can&nbsp;be&nbsp;appropriate&nbsp;and&nbsp;justifiable&nbsp;for&nbsp;certain</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_974\">974</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">situations,&nbsp;they&nbsp;might&nbsp;not&nbsp;be&nbsp;universally&nbsp;applicable&nbsp;to&nbsp;all&nbsp;situations.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_975\">975</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_976\">976</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">44\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_977\">977</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_978\">978</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_979\">979</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_980\">980</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_981\">981</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_982\">982</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_983\">983</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">If&nbsp;an&nbsp;exaggerated&nbsp;extraction&nbsp;cannot&nbsp;be&nbsp;justified&nbsp;or&nbsp;experimentally&nbsp;verified,&nbsp;then&nbsp;its&nbsp;use&nbsp;for&nbsp;producing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_984\">984</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;information&nbsp;that&nbsp;is&nbsp;the&nbsp;basis&nbsp;of&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;not&nbsp;recommended.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_985\">985</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;an&nbsp;exaggerated&nbsp;extraction&nbsp;is&nbsp;employed,&nbsp;it&nbsp;is&nbsp;necessary&nbsp;to&nbsp;account&nbsp;for&nbsp;the&nbsp;exaggeration&nbsp;both&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_986\">986</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">designing&nbsp;the&nbsp;extraction&nbsp;and&nbsp;in&nbsp;interpreting&nbsp;the&nbsp;result&nbsp;of&nbsp;the&nbsp;extraction&nbsp;study.&nbsp;One&nbsp;means&nbsp;of&nbsp;accounting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_987\">987</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;the&nbsp;exaggeration&nbsp;is&nbsp;via&nbsp;an&nbsp;exaggeration&nbsp;factor&nbsp;(a&nbsp;numerical&nbsp;factor&nbsp;that&nbsp;estimates&nbsp;the&nbsp;degree&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_988\">988</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">which&nbsp;an&nbsp;exaggerated&nbsp;extraction&nbsp;amplifies&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use),&nbsp;although&nbsp;other&nbsp;means&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_989\">989</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;envisioned&nbsp;and&nbsp;employed.&nbsp;Regardless&nbsp;of&nbsp;the&nbsp;means,&nbsp;the&nbsp;degree&nbsp;of&nbsp;exaggeration&nbsp;is&nbsp;established&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_990\">990</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;rigorous&nbsp;assessment&nbsp;of&nbsp;the&nbsp;extraction&nbsp;and&nbsp;clinical&nbsp;use&nbsp;conditions&nbsp;and&nbsp;knowledge&nbsp;of&nbsp;the&nbsp;degree&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_991\">991</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exaggeration&nbsp;may&nbsp;be&nbsp;used&nbsp;to&nbsp;adjust&nbsp;the&nbsp;results&nbsp;of&nbsp;the&nbsp;exaggerated&nbsp;extraction&nbsp;to&nbsp;allow&nbsp;for&nbsp;the&nbsp;toxicological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_992\">992</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk&nbsp;assessment&nbsp;of&nbsp;the&nbsp;extractables.&nbsp;Thus,&nbsp;for&nbsp;example,&nbsp;if&nbsp;quantity&nbsp;of&nbsp;extracted&nbsp;medical&nbsp;devices&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_993\">993</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">doubled&nbsp;over&nbsp;that&nbsp;used&nbsp;clinically,&nbsp;or&nbsp;the&nbsp;device&nbsp;contact&nbsp;surface&nbsp;area&nbsp;to&nbsp;contact&nbsp;solution&nbsp;volume&nbsp;ratio&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_994\">994</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;extraction&nbsp;is&nbsp;doubled&nbsp;this&nbsp;degree&nbsp;of&nbsp;exaggeration&nbsp;should&nbsp;be&nbsp;taken&nbsp;into&nbsp;account&nbsp;when&nbsp;the&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_995\">995</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">data&nbsp;are&nbsp;reported&nbsp;for&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;It&nbsp;should&nbsp;be&nbsp;noted&nbsp;that&nbsp;greatly&nbsp;exaggerated&nbsp;surface</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_996\">996</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">area/solution&nbsp;volume&nbsp;ratios&nbsp;may&nbsp;not&nbsp;produce&nbsp;proportionally&nbsp;exaggerated&nbsp;extractables&nbsp;profiles,&nbsp;making</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_997\">997</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;accounting&nbsp;of&nbsp;the&nbsp;degree&nbsp;of&nbsp;exaggeration&nbsp;more&nbsp;challenging.&nbsp;Furthermore,&nbsp;any&nbsp;quantification&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_998\">998</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">degree&nbsp;of&nbsp;extraction&nbsp;exaggeration&nbsp;should&nbsp;address&nbsp;whether&nbsp;the&nbsp;extractables\u2019&nbsp;concentrations&nbsp;have</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_999\">999</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">reached&nbsp;an&nbsp;equilibrium-based&nbsp;plateau&nbsp;(i.e.&nbsp;that&nbsp;sink&nbsp;conditions&nbsp;have&nbsp;been&nbsp;maintained).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1000\">1000</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Due&nbsp;to&nbsp;the&nbsp;vast&nbsp;number&nbsp;of&nbsp;various&nbsp;medical&nbsp;devices&nbsp;and&nbsp;usage&nbsp;conditions&nbsp;within&nbsp;the&nbsp;scope&nbsp;of&nbsp;this</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1001\">1001</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">document,&nbsp;it&nbsp;is&nbsp;unrealistic&nbsp;to&nbsp;provide&nbsp;specific&nbsp;guidance&nbsp;here.&nbsp;However,&nbsp;points&nbsp;to&nbsp;consider&nbsp;in&nbsp;establishing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1002\">1002</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exaggerated&nbsp;conditions&nbsp;are&nbsp;outlined&nbsp;as&nbsp;follows.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1003\">1003</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dimensions&nbsp;to&nbsp;consider&nbsp;when&nbsp;establishing&nbsp;and&nbsp;justifying&nbsp;an&nbsp;exaggerating&nbsp;extraction&nbsp;vehicle&nbsp;include</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1004\">1004</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pH&nbsp;(for&nbsp;aqueous&nbsp;vehicles)&nbsp;and&nbsp;polarity&nbsp;(for&nbsp;organic&nbsp;or&nbsp;\u201corganic-like\u201d&nbsp;vehicles).&nbsp;Considering&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1005\">1005</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle&nbsp;pH,&nbsp;it&nbsp;is&nbsp;noted&nbsp;that&nbsp;pH&nbsp;is&nbsp;an&nbsp;exaggerating&nbsp;dimension&nbsp;only&nbsp;for&nbsp;acidic&nbsp;or&nbsp;basic&nbsp;extractables&nbsp;(that&nbsp;is,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1006\">1006</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;extraction&nbsp;of&nbsp;neutral&nbsp;or&nbsp;un-ionisable&nbsp;extractables&nbsp;is&nbsp;largely&nbsp;unaffected&nbsp;by&nbsp;the&nbsp;pH&nbsp;of&nbsp;the&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1007\">1007</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle).&nbsp;For&nbsp;acidic&nbsp;extractables&nbsp;(e.g.&nbsp;stearic&nbsp;acid),&nbsp;it&nbsp;is&nbsp;generally&nbsp;the&nbsp;case&nbsp;that&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1008\">1008</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;pH&nbsp;higher&nbsp;than&nbsp;that&nbsp;of&nbsp;the&nbsp;clinical&nbsp;contact&nbsp;solution&nbsp;will&nbsp;exaggerate&nbsp;extraction.&nbsp;For&nbsp;a&nbsp;basic&nbsp;extractable</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1009\">1009</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(e.g.&nbsp;dibenzylamine),&nbsp;it&nbsp;is&nbsp;generally&nbsp;the&nbsp;case&nbsp;that&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;with&nbsp;a&nbsp;pH&nbsp;lower&nbsp;than&nbsp;that&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1010\">1010</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;contact&nbsp;solution&nbsp;will&nbsp;exaggerate&nbsp;extraction.&nbsp;A&nbsp;neutral&nbsp;extractable\u2019s&nbsp;accumulation&nbsp;level&nbsp;will&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1011\">1011</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">unaffected&nbsp;by&nbsp;pH&nbsp;unless&nbsp;that&nbsp;neutral&nbsp;compound&nbsp;is&nbsp;reactive&nbsp;as&nbsp;a&nbsp;function&nbsp;of&nbsp;pH.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1012\">1012</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;neutral&nbsp;extractables,&nbsp;extraction&nbsp;vehicle&nbsp;polarity&nbsp;can&nbsp;be&nbsp;an&nbsp;exaggerating&nbsp;dimension.&nbsp;For&nbsp;example,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1013\">1013</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">increasing&nbsp;the&nbsp;alcohol&nbsp;content&nbsp;of&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;versus&nbsp;the&nbsp;clinical&nbsp;contact&nbsp;solution&nbsp;will&nbsp;typically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1014\">1014</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">result&nbsp;in&nbsp;an&nbsp;exaggerated&nbsp;extraction.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1015\">1015</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;use&nbsp;of&nbsp;temperature&nbsp;as&nbsp;an&nbsp;exaggerating&nbsp;dimension&nbsp;is&nbsp;addressed&nbsp;in&nbsp;D.4.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1016\">1016</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Exaggerated&nbsp;extraction&nbsp;conditions&nbsp;should&nbsp;not&nbsp;alter&nbsp;the&nbsp;extractables&nbsp;profile.&nbsp;For&nbsp;example,&nbsp;the&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1017\">1017</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;extreme&nbsp;temperatures&nbsp;as&nbsp;a&nbsp;means&nbsp;of&nbsp;accomplishing&nbsp;the&nbsp;exaggeration&nbsp;might&nbsp;result&nbsp;in&nbsp;either&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1018\">1018</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">decomposition&nbsp;of&nbsp;the&nbsp;extractables&nbsp;or&nbsp;the&nbsp;alteration&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;materials&nbsp;(e.g.&nbsp;curing,&nbsp;cross-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1019\">1019</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">linking,&nbsp;or&nbsp;degradation&nbsp;of&nbsp;the&nbsp;device\u2019s&nbsp;polymeric&nbsp;materials&nbsp;of&nbsp;construction,&nbsp;physical&nbsp;state&nbsp;change&nbsp;over</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1020\">1020</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;glass&nbsp;transition&nbsp;temperature),&nbsp;any&nbsp;of&nbsp;which&nbsp;could&nbsp;result&nbsp;in&nbsp;an&nbsp;altered&nbsp;extractables&nbsp;profile.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1021\">1021</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;extraction&nbsp;is&nbsp;exaggerated&nbsp;using&nbsp;multiple&nbsp;dimensions&nbsp;(e.g.&nbsp;both&nbsp;temperature&nbsp;and&nbsp;surface&nbsp;area),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1022\">1022</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;combined&nbsp;effect&nbsp;of&nbsp;the&nbsp;multiple&nbsp;dimensions&nbsp;should&nbsp;be&nbsp;considered&nbsp;and&nbsp;justified,&nbsp;although&nbsp;doing&nbsp;so</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1023\">1023</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;scientifically&nbsp;challenging.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1024\">1024</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;altered&nbsp;extractables&nbsp;profiles&nbsp;can&nbsp;be&nbsp;obtained&nbsp;when&nbsp;greatly&nbsp;exaggerated&nbsp;extraction&nbsp;conditions&nbsp;are</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1025\">1025</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">employed,&nbsp;it&nbsp;is&nbsp;recommended&nbsp;that&nbsp;exaggerations&nbsp;be&nbsp;kept&nbsp;as&nbsp;small&nbsp;as&nbsp;is&nbsp;necessary,&nbsp;minimizing&nbsp;potential</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1026\">1026</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">complicating&nbsp;effects&nbsp;such&nbsp;as&nbsp;degradation.&nbsp;As&nbsp;exaggeration&nbsp;is&nbsp;justified&nbsp;in&nbsp;the&nbsp;context&nbsp;of&nbsp;the&nbsp;circumstances</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1027\">1027</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;which&nbsp;it&nbsp;is&nbsp;employed,&nbsp;determining&nbsp;whether&nbsp;an&nbsp;exaggeration&nbsp;is&nbsp;appropriate&nbsp;or&nbsp;excessive&nbsp;is&nbsp;done&nbsp;on&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1028\">1028</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">case&nbsp;by&nbsp;case&nbsp;basis&nbsp;and&nbsp;it&nbsp;is&nbsp;difficult&nbsp;to&nbsp;provide&nbsp;general&nbsp;guidelines&nbsp;in&nbsp;terms&nbsp;of&nbsp;when&nbsp;an&nbsp;exaggeration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1029\">1029</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;no&nbsp;longer&nbsp;appropriate&nbsp;and&nbsp;becomes&nbsp;excessive.&nbsp;Nevertheless,&nbsp;highly&nbsp;exaggerated&nbsp;conditions&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1030\">1030</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sufficiently&nbsp;extreme&nbsp;that&nbsp;the&nbsp;exaggerated&nbsp;extractables&nbsp;profile&nbsp;becomes&nbsp;poorly&nbsp;correlated&nbsp;with&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1031\">1031</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;use&nbsp;extractables&nbsp;profile.&nbsp;The&nbsp;justification&nbsp;of&nbsp;any&nbsp;exaggeration,&nbsp;but&nbsp;especially&nbsp;a&nbsp;significant</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1032\">1032</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exaggeration&nbsp;should&nbsp;consider&nbsp;the&nbsp;exaggerated&nbsp;extraction\u2019s&nbsp;propensity&nbsp;to&nbsp;chemically&nbsp;or&nbsp;physically&nbsp;alter</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1033\">1033</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;test&nbsp;article&nbsp;and/or&nbsp;the&nbsp;extracted&nbsp;substances,&nbsp;as&nbsp;extractions&nbsp;that&nbsp;alter&nbsp;either&nbsp;the&nbsp;test&nbsp;article&nbsp;or&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1034\">1034</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extracted&nbsp;substances&nbsp;are&nbsp;not&nbsp;permitted.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1035\">1035</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1036\">1036</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1037\">1037</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">45</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1038\">1038</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1039\">1039</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1040\">1040</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1041\">1041</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1042\">1042</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1043\">1043</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Regardless&nbsp;of&nbsp;the&nbsp;means&nbsp;by&nbsp;which&nbsp;an&nbsp;exaggeration&nbsp;is&nbsp;accounted&nbsp;for,&nbsp;the&nbsp;use&nbsp;of&nbsp;exaggeration&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1044\">1044</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">toxicological&nbsp;risk&nbsp;assessment&nbsp;should&nbsp;be&nbsp;rigorously&nbsp;justified&nbsp;and&nbsp;documented.&nbsp;While&nbsp;such&nbsp;a&nbsp;justification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1045\">1045</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">could&nbsp;be&nbsp;derived&nbsp;from&nbsp;scientific&nbsp;first&nbsp;principles,&nbsp;it&nbsp;is&nbsp;always&nbsp;the&nbsp;case&nbsp;that&nbsp;the&nbsp;most&nbsp;definitive&nbsp;means&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1046\">1046</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justifying&nbsp;an&nbsp;exaggeration&nbsp;is&nbsp;to&nbsp;verify&nbsp;the&nbsp;exaggeration&nbsp;with&nbsp;experimental&nbsp;data.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1047\">1047</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Any&nbsp;exaggeration&nbsp;resulting&nbsp;from&nbsp;the&nbsp;extraction&nbsp;process&nbsp;or&nbsp;the&nbsp;testing&nbsp;of&nbsp;the&nbsp;extracts&nbsp;should&nbsp;be&nbsp;clearly</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1048\">1048</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">described&nbsp;to&nbsp;facilitate&nbsp;a&nbsp;proper&nbsp;and&nbsp;accurate&nbsp;safety&nbsp;risk&nbsp;assessment&nbsp;and&nbsp;to&nbsp;ensure\u00a0that&nbsp;the&nbsp;exaggeration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1049\">1049</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;properly&nbsp;accounted&nbsp;for&nbsp;in&nbsp;the&nbsp;safety&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1050\">1050</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">D.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Simulated&nbsp;or&nbsp;accelerated&nbsp;extractions&nbsp;to&nbsp;establish&nbsp;clinical&nbsp;use&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1051\">1051</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">profiles</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1052\">1052</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;exaggerated&nbsp;extraction&nbsp;produces&nbsp;a&nbsp;practical&nbsp;worst-case&nbsp;assessment&nbsp;of&nbsp;the&nbsp;leaching&nbsp;of&nbsp;a&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1053\">1053</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device.&nbsp;As&nbsp;discussed&nbsp;in&nbsp;Clause\u00a05,&nbsp;should&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;this&nbsp;practical&nbsp;worst-case</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1054\">1054</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">establish&nbsp;that&nbsp;the&nbsp;risk&nbsp;related&nbsp;to&nbsp;the&nbsp;extractables&nbsp;be&nbsp;acceptable,&nbsp;then&nbsp;the&nbsp;risk&nbsp;assessment&nbsp;is&nbsp;essentially</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1055\">1055</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">complete&nbsp;and&nbsp;the&nbsp;medical&nbsp;device&nbsp;is&nbsp;accepted&nbsp;as&nbsp;being&nbsp;chemically&nbsp;suitable&nbsp;for&nbsp;its&nbsp;intended&nbsp;use&nbsp;with&nbsp;no</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1056\">1056</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">further&nbsp;chemical&nbsp;testing.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1057\">1057</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">However,&nbsp;if&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;establishes&nbsp;that&nbsp;the&nbsp;practical&nbsp;worst-case&nbsp;could&nbsp;represent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1058\">1058</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;risk,&nbsp;then&nbsp;a&nbsp;more&nbsp;realistic&nbsp;estimate&nbsp;of&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;leaching&nbsp;characteristics&nbsp;is&nbsp;necessary&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1059\">1059</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate.&nbsp;This&nbsp;more&nbsp;realistic&nbsp;estimate&nbsp;is&nbsp;obtained&nbsp;by&nbsp;using&nbsp;either&nbsp;simulated&nbsp;extraction&nbsp;conditions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1060\">1060</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;very&nbsp;closely&nbsp;reflect&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use&nbsp;or&nbsp;accelerated&nbsp;extraction&nbsp;conditions&nbsp;which&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1061\">1061</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">durations&nbsp;that&nbsp;are&nbsp;shorter&nbsp;than&nbsp;clinical&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1062\">1062</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;purpose&nbsp;of&nbsp;a&nbsp;simulated&nbsp;extraction&nbsp;is&nbsp;to&nbsp;produce&nbsp;an&nbsp;extractables&nbsp;profile&nbsp;which&nbsp;closely&nbsp;matches&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1063\">1063</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;case&nbsp;leachables&nbsp;profile.&nbsp;A&nbsp;simulated-use&nbsp;extraction&nbsp;establishes&nbsp;the&nbsp;actual&nbsp;amount&nbsp;of&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1064\">1064</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;will&nbsp;be&nbsp;released&nbsp;as&nbsp;leachables&nbsp;by&nbsp;the&nbsp;medical&nbsp;device&nbsp;or&nbsp;material&nbsp;during&nbsp;clinical&nbsp;use/lifetime.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1065\">1065</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">simulated&nbsp;extraction&nbsp;is&nbsp;performed&nbsp;in&nbsp;those&nbsp;circumstances&nbsp;where&nbsp;either&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1066\">1066</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">cannot&nbsp;be&nbsp;achieved&nbsp;in&nbsp;the&nbsp;laboratory&nbsp;or&nbsp;when&nbsp;use&nbsp;of&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;produces&nbsp;a&nbsp;solution&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1067\">1067</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">testing&nbsp;which&nbsp;cannot&nbsp;be&nbsp;analytically&nbsp;profiled&nbsp;for&nbsp;leached&nbsp;substances.&nbsp;If&nbsp;the&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1068\">1068</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;replicated&nbsp;in&nbsp;the&nbsp;laboratory&nbsp;and&nbsp;if&nbsp;the&nbsp;resulting&nbsp;solution&nbsp;can&nbsp;be&nbsp;analytically&nbsp;profiled&nbsp;for&nbsp;leachables,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1069\">1069</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">then&nbsp;the&nbsp;value&nbsp;of&nbsp;performing&nbsp;a&nbsp;simulated&nbsp;extraction&nbsp;is&nbsp;lessened&nbsp;and&nbsp;it&nbsp;is&nbsp;reasonable&nbsp;to&nbsp;suggest&nbsp;that&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1070\">1070</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">simulated&nbsp;extraction&nbsp;be&nbsp;replaced&nbsp;with&nbsp;an&nbsp;actual&nbsp;leachables&nbsp;study.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1071\">1071</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;simulated&nbsp;extraction&nbsp;is&nbsp;accomplished&nbsp;by&nbsp;using&nbsp;extraction&nbsp;conditions&nbsp;(i.e.&nbsp;temperature&nbsp;and&nbsp;duration)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1072\">1072</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;mimic&nbsp;the&nbsp;conditions&nbsp;of&nbsp;clinical&nbsp;use.&nbsp;Additionally&nbsp;and&nbsp;as&nbsp;appropriate,&nbsp;the&nbsp;simulated&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1073\">1073</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;performed&nbsp;with&nbsp;a&nbsp;vehicle&nbsp;whose&nbsp;extraction&nbsp;power&nbsp;equals&nbsp;that&nbsp;of&nbsp;the&nbsp;solution&nbsp;that&nbsp;mediates&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1074\">1074</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;contact&nbsp;between&nbsp;the&nbsp;medical&nbsp;device&nbsp;and&nbsp;potentially&nbsp;affected&nbsp;individual.&nbsp;The&nbsp;aspect&nbsp;of&nbsp;specifying</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1075\">1075</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;simulating&nbsp;extraction&nbsp;vehicle&nbsp;has&nbsp;been&nbsp;discussed&nbsp;previously&nbsp;in&nbsp;considering&nbsp;exaggerated&nbsp;extractions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1076\">1076</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(see&nbsp;D.3).&nbsp;Considering&nbsp;this&nbsp;aspect&nbsp;more&nbsp;specifically&nbsp;for&nbsp;simulating&nbsp;extractions,&nbsp;guidance&nbsp;can&nbsp;be&nbsp;provided</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1077\">1077</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;certain&nbsp;medical&nbsp;device&nbsp;categories&nbsp;considering&nbsp;the&nbsp;nature&nbsp;of&nbsp;body&nbsp;contact&nbsp;and&nbsp;the&nbsp;application&nbsp;site.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1078\">1078</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">For&nbsp;example,&nbsp;if&nbsp;the&nbsp;clinical&nbsp;application&nbsp;of&nbsp;the&nbsp;device:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1079\">1079</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;involves&nbsp;contact&nbsp;with&nbsp;blood,&nbsp;then&nbsp;a&nbsp;mixture&nbsp;of&nbsp;ethanol&nbsp;in&nbsp;water&nbsp;could&nbsp;be&nbsp;an&nbsp;appropriate&nbsp;simulating</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1080\">1080</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle.&nbsp;If&nbsp;an&nbsp;ethanol/water&nbsp;mixture&nbsp;is&nbsp;used,&nbsp;it&nbsp;should&nbsp;be&nbsp;demonstrated&nbsp;to&nbsp;extract&nbsp;comparable&nbsp;levels</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1081\">1081</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;target&nbsp;leachables&nbsp;with&nbsp;respect&nbsp;to&nbsp;blood&nbsp;(e.g.&nbsp;Reference\u00a0[38]).&nbsp;Other&nbsp;simulating&nbsp;vehicles&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1082\">1082</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">used&nbsp;if&nbsp;justified;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1083\">1083</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is&nbsp;such&nbsp;that&nbsp;the&nbsp;medical&nbsp;device&nbsp;communicates&nbsp;with&nbsp;the&nbsp;potentially&nbsp;affected&nbsp;individual&nbsp;via&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1084\">1084</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">aqueous&nbsp;solution,&nbsp;then&nbsp;the&nbsp;appropriate&nbsp;simulating&nbsp;vehicle&nbsp;is&nbsp;either&nbsp;physiological&nbsp;saline,&nbsp;adjusted</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1085\">1085</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;buffered&nbsp;to&nbsp;a&nbsp;relevant&nbsp;pH,&nbsp;or&nbsp;an&nbsp;appropriate&nbsp;pH&nbsp;adjusted&nbsp;salt&nbsp;solution&nbsp;whose&nbsp;composition&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1086\">1086</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justified.&nbsp;If&nbsp;the&nbsp;clinical&nbsp;application&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;involves&nbsp;contact&nbsp;with&nbsp;numerous&nbsp;solutions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1087\">1087</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;varying&nbsp;pH&nbsp;(e.g.&nbsp;solution&nbsp;administration&nbsp;sets),&nbsp;then&nbsp;the&nbsp;pH&nbsp;range&nbsp;should&nbsp;be&nbsp;properly&nbsp;bracketed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1088\">1088</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">by&nbsp;two&nbsp;simulating&nbsp;vehicles,&nbsp;one&nbsp;adjusted&nbsp;to&nbsp;a&nbsp;pH&nbsp;of&nbsp;2&nbsp;and&nbsp;the&nbsp;other&nbsp;adjusted&nbsp;and&nbsp;buffered&nbsp;to&nbsp;a&nbsp;pH&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1089\">1089</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">10&nbsp;(see&nbsp;Reference\u00a0[40]).&nbsp;If&nbsp;the&nbsp;pH&nbsp;range&nbsp;of&nbsp;solutions&nbsp;encountered&nbsp;in&nbsp;clinical&nbsp;use&nbsp;is&nbsp;smaller&nbsp;than&nbsp;this</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1090\">1090</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">range,&nbsp;simulating&nbsp;extraction&nbsp;solutions&nbsp;bracketing&nbsp;the&nbsp;smaller&nbsp;range&nbsp;can&nbsp;be&nbsp;used;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1091\">1091</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is&nbsp;such&nbsp;that&nbsp;the&nbsp;medical&nbsp;device&nbsp;communicates&nbsp;with&nbsp;the&nbsp;potentially&nbsp;affected&nbsp;individual&nbsp;via&nbsp;a&nbsp;solution</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1092\">1092</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;lipophilic&nbsp;properties&nbsp;(e.g.&nbsp;lipid&nbsp;emulsions,&nbsp;drug&nbsp;products&nbsp;containing&nbsp;solubilizing&nbsp;agents&nbsp;such</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1093\">1093</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1094\">1094</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">46\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1095\">1095</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1096\">1096</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1097\">1097</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1098\">1098</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1099\">1099</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1100\">1100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1101\">1101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">as&nbsp;polysorbate&nbsp;80)&nbsp;then&nbsp;an&nbsp;appropriate&nbsp;simulating&nbsp;vehicle&nbsp;should&nbsp;be&nbsp;identified&nbsp;and&nbsp;scientifically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1102\">1102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justified.&nbsp;In&nbsp;many&nbsp;situations,&nbsp;an&nbsp;alcohol/water&nbsp;mixture&nbsp;whose&nbsp;proportion&nbsp;of&nbsp;alcohol&nbsp;to&nbsp;water&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1103\">1103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justified,&nbsp;can&nbsp;serve&nbsp;as&nbsp;a&nbsp;suitable&nbsp;simulating&nbsp;vehicle.&nbsp;Reference\u00a0[38]&nbsp;contains&nbsp;information&nbsp;which&nbsp;could</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1104\">1104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">facilitate&nbsp;the&nbsp;identification&nbsp;and&nbsp;justification&nbsp;of&nbsp;such&nbsp;proportions&nbsp;for&nbsp;certain&nbsp;\u201corganic-like\u201d&nbsp;solutions.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1105\">1105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Information&nbsp;on&nbsp;solvents&nbsp;that&nbsp;may&nbsp;be&nbsp;used&nbsp;to&nbsp;simulate&nbsp;body&nbsp;fluids&nbsp;has&nbsp;been&nbsp;published[24][44][47].</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1106\">1106</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Simulating&nbsp;extraction&nbsp;vehicles&nbsp;relevant&nbsp;to&nbsp;either&nbsp;surface-contacting&nbsp;medical&nbsp;devices&nbsp;or&nbsp;devices&nbsp;which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1107\">1107</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contact&nbsp;tissue/bone/dentin&nbsp;are&nbsp;not&nbsp;specified&nbsp;in&nbsp;this&nbsp;document.&nbsp;Any&nbsp;simulating&nbsp;solvent&nbsp;use&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1108\">1108</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">established&nbsp;and&nbsp;justified&nbsp;on&nbsp;a&nbsp;case-by-case&nbsp;basis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1109\">1109</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Other&nbsp;design&nbsp;parameters&nbsp;are&nbsp;typically&nbsp;matched&nbsp;between&nbsp;the&nbsp;simulated&nbsp;extraction&nbsp;and&nbsp;the&nbsp;clinical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1110\">1110</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions&nbsp;of&nbsp;use.&nbsp;Thus,&nbsp;in&nbsp;a&nbsp;simulated&nbsp;extraction,&nbsp;the&nbsp;surface&nbsp;area/volume&nbsp;ratio&nbsp;that&nbsp;is&nbsp;used&nbsp;is&nbsp;the&nbsp;same</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1111\">1111</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ratio&nbsp;that&nbsp;is&nbsp;experienced&nbsp;during&nbsp;clinical&nbsp;use,&nbsp;where&nbsp;possible.&nbsp;For&nbsp;example,&nbsp;for&nbsp;infusion&nbsp;systems,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1112\">1112</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;surface&nbsp;area&nbsp;and&nbsp;infusate&nbsp;volume&nbsp;could&nbsp;be&nbsp;used.&nbsp;In&nbsp;contrast,&nbsp;it&nbsp;will&nbsp;often&nbsp;be&nbsp;difficult&nbsp;to&nbsp;justify</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1113\">1113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;surface&nbsp;area/volume&nbsp;ratio&nbsp;for&nbsp;implanted&nbsp;devices,&nbsp;as&nbsp;it&nbsp;can&nbsp;be&nbsp;difficult&nbsp;to&nbsp;establish&nbsp;the&nbsp;volume&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1114\">1114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">physiologic&nbsp;fluid&nbsp;that&nbsp;contacts&nbsp;the&nbsp;device&nbsp;over&nbsp;its&nbsp;implantation&nbsp;time.&nbsp;Moreover,&nbsp;sequential&nbsp;extraction&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1115\">1115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">generally&nbsp;not&nbsp;appropriate&nbsp;for&nbsp;simulated&nbsp;extractions,&nbsp;with&nbsp;the&nbsp;exception&nbsp;of&nbsp;reusable&nbsp;or&nbsp;multi-use&nbsp;medical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1116\">1116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1117\">1117</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;certain&nbsp;circumstances&nbsp;(such&nbsp;as&nbsp;for&nbsp;medical&nbsp;devices&nbsp;with&nbsp;long&nbsp;term&nbsp;contact&nbsp;duration),&nbsp;a&nbsp;simulated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1118\">1118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;might&nbsp;be&nbsp;performed&nbsp;under&nbsp;accelerated&nbsp;conditions.&nbsp;For&nbsp;example,&nbsp;an&nbsp;accelerated&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1119\">1119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">might&nbsp;be&nbsp;performed&nbsp;at&nbsp;a&nbsp;temperature&nbsp;that&nbsp;exceeds&nbsp;the&nbsp;clinical&nbsp;use&nbsp;temperature&nbsp;and&nbsp;a&nbsp;duration&nbsp;that&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1120\">1120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">shorter&nbsp;than&nbsp;clinical&nbsp;use.&nbsp;However,&nbsp;the&nbsp;accelerated&nbsp;extraction&nbsp;should&nbsp;be&nbsp;performed&nbsp;in&nbsp;such&nbsp;a&nbsp;manner</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1121\">1121</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;the&nbsp;accelerated&nbsp;conditions&nbsp;and&nbsp;the&nbsp;clinical&nbsp;use&nbsp;conditions&nbsp;subject&nbsp;the&nbsp;device&nbsp;to&nbsp;the&nbsp;same&nbsp;heat</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1122\">1122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exposure&nbsp;(i.e.&nbsp;the&nbsp;same&nbsp;transfer&nbsp;of&nbsp;thermal&nbsp;energy).&nbsp;Additionally,&nbsp;acceleration&nbsp;can&nbsp;be&nbsp;accomplished&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1123\">1123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">agitation&nbsp;during&nbsp;extraction&nbsp;or&nbsp;use&nbsp;of&nbsp;recirculating&nbsp;or&nbsp;flowing&nbsp;extraction&nbsp;vehicles.&nbsp;However,&nbsp;the&nbsp;extent&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1124\">1124</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">acceleration&nbsp;by&nbsp;these&nbsp;approaches&nbsp;can&nbsp;be&nbsp;challenging&nbsp;to&nbsp;quantify.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1125\">1125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;certain&nbsp;circumstances,&nbsp;such&nbsp;as&nbsp;when&nbsp;an&nbsp;accelerated&nbsp;extraction&nbsp;can&nbsp;be&nbsp;appropriate&nbsp;to&nbsp;simulate&nbsp;longer</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1126\">1126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">duration&nbsp;and&nbsp;greater&nbsp;invasiveness&nbsp;of&nbsp;contact,&nbsp;an&nbsp;analysis&nbsp;that&nbsp;provides&nbsp;information&nbsp;on&nbsp;the&nbsp;kinetics&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1127\">1127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction&nbsp;might&nbsp;be&nbsp;necessary&nbsp;to&nbsp;establish&nbsp;and&nbsp;justify&nbsp;the&nbsp;proper&nbsp;extraction&nbsp;procedure.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1128\">1128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Considering&nbsp;the&nbsp;acceleration&nbsp;of&nbsp;extraction&nbsp;conditions,&nbsp;it&nbsp;makes&nbsp;little&nbsp;sense&nbsp;to&nbsp;accelerate&nbsp;limited&nbsp;contact</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1129\">1129</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">durations&nbsp;of&nbsp;less&nbsp;than&nbsp;24\u00a0&nbsp;h&nbsp;and&nbsp;in&nbsp;such&nbsp;cases&nbsp;the&nbsp;actual&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use&nbsp;are&nbsp;used&nbsp;in&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1130\">1130</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">simulated&nbsp;extraction.&nbsp;A&nbsp;similar&nbsp;logic&nbsp;applies&nbsp;to&nbsp;prolonged&nbsp;contact&nbsp;durations&nbsp;of&nbsp;3\u00a0d&nbsp;or&nbsp;less.&nbsp;However,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1131\">1131</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;contact&nbsp;durations&nbsp;longer&nbsp;than&nbsp;3\u00a0d&nbsp;and&nbsp;for&nbsp;all&nbsp;long-term&nbsp;contact&nbsp;durations,&nbsp;acceleration&nbsp;could&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1132\">1132</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">desirable&nbsp;to&nbsp;facilitate&nbsp;appropriate&nbsp;extraction.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1133\">1133</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;was&nbsp;the&nbsp;case&nbsp;with&nbsp;exaggerated&nbsp;extraction&nbsp;discussed&nbsp;previously,&nbsp;accelerated&nbsp;extraction&nbsp;conditions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1134\">1134</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">should&nbsp;be&nbsp;fully&nbsp;and&nbsp;rigorously&nbsp;justified.&nbsp;Although&nbsp;certain&nbsp;accelerated&nbsp;conditions&nbsp;might&nbsp;be&nbsp;justifiable&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1135\">1135</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">certain&nbsp;circumstances,&nbsp;the&nbsp;same&nbsp;accelerated&nbsp;conditions&nbsp;or&nbsp;the&nbsp;same&nbsp;justification&nbsp;might&nbsp;not&nbsp;be&nbsp;applicable</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1136\">1136</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;other&nbsp;situations.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1137\">1137</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">It&nbsp;is&nbsp;beyond&nbsp;the&nbsp;scope&nbsp;of&nbsp;this&nbsp;document&nbsp;and&nbsp;the&nbsp;current&nbsp;state&nbsp;of&nbsp;good&nbsp;science&nbsp;to&nbsp;provide&nbsp;specific</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1138\">1138</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">guidance&nbsp;on&nbsp;how&nbsp;to&nbsp;devise&nbsp;and&nbsp;justify&nbsp;accelerated&nbsp;extractions&nbsp;and&nbsp;how&nbsp;to&nbsp;calculate&nbsp;appropriate&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1139\">1139</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justifiable&nbsp;acceleration&nbsp;factors&nbsp;for&nbsp;all&nbsp;medical&nbsp;devices&nbsp;and&nbsp;their&nbsp;clinical&nbsp;conditions&nbsp;of&nbsp;use.&nbsp;Nevertheless,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1140\">1140</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">careful&nbsp;review&nbsp;of&nbsp;the&nbsp;chemical&nbsp;literature&nbsp;may&nbsp;suggest&nbsp;means&nbsp;for&nbsp;performing&nbsp;such&nbsp;calculations&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1141\">1141</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">justifications.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1142\">1142</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Care&nbsp;should&nbsp;be&nbsp;exercised&nbsp;in&nbsp;the&nbsp;selection&nbsp;of&nbsp;accelerating&nbsp;conditions&nbsp;and&nbsp;the&nbsp;effects&nbsp;of&nbsp;higher&nbsp;temperatures</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1143\">1143</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">or&nbsp;other&nbsp;accelerating&nbsp;conditions&nbsp;on&nbsp;extraction&nbsp;kinetics&nbsp;and&nbsp;the&nbsp;identity&nbsp;of&nbsp;the&nbsp;extractables&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1144\">1144</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">considered&nbsp;carefully&nbsp;if&nbsp;accelerated&nbsp;extraction&nbsp;is&nbsp;used.&nbsp;Proper&nbsp;accelerating&nbsp;conditions&nbsp;are&nbsp;those&nbsp;which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1145\">1145</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">reduce&nbsp;the&nbsp;extraction&nbsp;duration&nbsp;to&nbsp;a&nbsp;value&nbsp;shorter&nbsp;than&nbsp;the&nbsp;duration&nbsp;of&nbsp;clinical&nbsp;use&nbsp;but&nbsp;which&nbsp;do&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1146\">1146</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">result&nbsp;in&nbsp;a&nbsp;chemical&nbsp;modification&nbsp;of&nbsp;the&nbsp;device&nbsp;itself&nbsp;or&nbsp;to&nbsp;the&nbsp;type&nbsp;and&nbsp;amount&nbsp;of&nbsp;extracted&nbsp;substances.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1147\">1147</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Any&nbsp;model&nbsp;or&nbsp;concept&nbsp;used&nbsp;to&nbsp;establish&nbsp;acceleration&nbsp;or&nbsp;exaggeration&nbsp;factors&nbsp;shall&nbsp;be&nbsp;justified&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1148\">1148</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">documented.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1149\">1149</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1150\">1150</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1151\">1151</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">47</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1152\">1152</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1153\">1153</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1154\">1154</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1155\">1155</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1156\">1156</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1157\">1157</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">D.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extractions&nbsp;performed&nbsp;for&nbsp;correlating&nbsp;chemical&nbsp;characterization&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1158\">1158</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biological&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1159\">1159</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Generally,&nbsp;there&nbsp;are&nbsp;two&nbsp;reasons&nbsp;for&nbsp;correlating&nbsp;chemical&nbsp;characterization&nbsp;with&nbsp;biological&nbsp;testing:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1160\">1160</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;elucidate&nbsp;the&nbsp;chemical&nbsp;cause&nbsp;of&nbsp;a&nbsp;particular&nbsp;biological&nbsp;test&nbsp;result;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1161\">1161</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;establish&nbsp;the&nbsp;biological&nbsp;test&nbsp;outcome&nbsp;of&nbsp;a&nbsp;chemical&nbsp;or&nbsp;set&nbsp;of&nbsp;chemicals.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1162\">1162</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;correlating&nbsp;chemical&nbsp;characterization,&nbsp;most&nbsp;likely&nbsp;extractables&nbsp;profiling,&nbsp;with&nbsp;biological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1163\">1163</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">testing,&nbsp;it&nbsp;is&nbsp;clear&nbsp;that&nbsp;the&nbsp;best&nbsp;case&nbsp;is&nbsp;when&nbsp;the&nbsp;chemical&nbsp;testing&nbsp;and&nbsp;the&nbsp;biological&nbsp;testing&nbsp;occurs</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1164\">1164</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">on&nbsp;the&nbsp;same&nbsp;extract,&nbsp;as&nbsp;so&nbsp;doing&nbsp;will&nbsp;produce&nbsp;the&nbsp;closest&nbsp;and&nbsp;most&nbsp;rigorous&nbsp;correlation.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1165\">1165</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">proper&nbsp;extraction&nbsp;methods&nbsp;for&nbsp;correlating&nbsp;chemical&nbsp;and&nbsp;biological&nbsp;testing&nbsp;are&nbsp;documented&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1166\">1166</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-12:2012,&nbsp;specifically&nbsp;in&nbsp;Clause\u00a010&nbsp;and&nbsp;Annex\u00a0C.&nbsp;Whenever&nbsp;possible,&nbsp;the&nbsp;exact&nbsp;conditions&nbsp;used</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1167\">1167</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;generate&nbsp;an&nbsp;extract&nbsp;for&nbsp;biological&nbsp;testing&nbsp;should&nbsp;also&nbsp;be&nbsp;used&nbsp;for&nbsp;generating&nbsp;the&nbsp;extract&nbsp;for&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1168\">1168</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization.&nbsp;This&nbsp;recommendation&nbsp;is&nbsp;typically&nbsp;easier&nbsp;to&nbsp;achieve&nbsp;for&nbsp;extraction&nbsp;parameters&nbsp;such</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1169\">1169</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">as&nbsp;surface&nbsp;area&nbsp;to&nbsp;volume,&nbsp;extraction&nbsp;time&nbsp;and&nbsp;extraction&nbsp;duration.&nbsp;However,&nbsp;it&nbsp;can&nbsp;be&nbsp;more&nbsp;difficult&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1170\">1170</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">follow&nbsp;this&nbsp;recommendation&nbsp;when&nbsp;considering&nbsp;the&nbsp;extraction&nbsp;vehicle.&nbsp;As&nbsp;is&nbsp;noted&nbsp;in&nbsp;ISO\u00a010993-12:2012,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1171\">1171</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C.7,&nbsp;\u201cthe&nbsp;vehicles&nbsp;selected&nbsp;as&nbsp;the&nbsp;extraction&nbsp;vehicle&nbsp;(for&nbsp;biological&nbsp;testing)&nbsp;should&nbsp;be&nbsp;suitable&nbsp;for&nbsp;use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1172\">1172</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;the&nbsp;specific&nbsp;biological&nbsp;test&nbsp;systems\u201d.&nbsp;While&nbsp;such&nbsp;a&nbsp;recommendation&nbsp;most&nbsp;certainly&nbsp;facilitates</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1173\">1173</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biological&nbsp;testing,&nbsp;in&nbsp;certain&nbsp;circumstances&nbsp;it&nbsp;confounds&nbsp;chemical&nbsp;testing,&nbsp;as&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1174\">1174</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;appropriate&nbsp;for&nbsp;biological&nbsp;testing&nbsp;might&nbsp;not&nbsp;be&nbsp;amenable&nbsp;to&nbsp;chemical&nbsp;testing.&nbsp;In&nbsp;such&nbsp;circumstances,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1175\">1175</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">either&nbsp;a&nbsp;surrogate&nbsp;extraction&nbsp;vehicle&nbsp;should&nbsp;be&nbsp;found&nbsp;to&nbsp;facilitate&nbsp;the&nbsp;chemical&nbsp;testing&nbsp;or&nbsp;the&nbsp;extract&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1176\">1176</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biological&nbsp;testing&nbsp;should&nbsp;be&nbsp;manipulated&nbsp;to&nbsp;make&nbsp;it&nbsp;analytically&nbsp;viable.&nbsp;If&nbsp;a&nbsp;surrogate&nbsp;extraction&nbsp;vehicle</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1177\">1177</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;used,&nbsp;such&nbsp;a&nbsp;surrogate&nbsp;extraction&nbsp;vehicle&nbsp;should,&nbsp;in&nbsp;addition&nbsp;to&nbsp;being&nbsp;analytically&nbsp;viable,&nbsp;ideally</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1178\">1178</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">have&nbsp;similar&nbsp;extracting&nbsp;properties&nbsp;as&nbsp;the&nbsp;extraction&nbsp;vehicle&nbsp;used&nbsp;for&nbsp;biological&nbsp;testing.&nbsp;If&nbsp;a&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1179\">1179</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">manipulation&nbsp;(e.g.&nbsp;derivatization)&nbsp;of&nbsp;the&nbsp;extract&nbsp;is&nbsp;used,&nbsp;care&nbsp;should&nbsp;be&nbsp;taken&nbsp;to&nbsp;avoid&nbsp;a&nbsp;chemical&nbsp;change</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1180\">1180</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;one&nbsp;or&nbsp;more&nbsp;extractables.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1181\">1181</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-12:2012,&nbsp;10.3.5,&nbsp;establishes&nbsp;extraction&nbsp;vehicles&nbsp;appropriate&nbsp;for&nbsp;biological&nbsp;testing,&nbsp;including:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1182\">1182</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;polar&nbsp;extraction&nbsp;vehicles&nbsp;such&nbsp;as&nbsp;water,&nbsp;physiological&nbsp;saline,&nbsp;culture&nbsp;media&nbsp;without&nbsp;serum;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1183\">1183</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;non-polar&nbsp;extraction&nbsp;vehicles&nbsp;such&nbsp;as&nbsp;freshly&nbsp;refined&nbsp;vegetable&nbsp;oil;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1184\">1184</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional&nbsp;extraction&nbsp;vehicles&nbsp;such&nbsp;as&nbsp;ethanol/water,&nbsp;ethanol/saline,&nbsp;polyethylene&nbsp;glycol\u00a0&nbsp;400</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1185\">1185</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(diluted&nbsp;to&nbsp;a&nbsp;physiological&nbsp;osmotic&nbsp;pressure),&nbsp;dimethylsulphoxide&nbsp;and&nbsp;culture&nbsp;media&nbsp;with&nbsp;serum.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1186\">1186</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Several&nbsp;of&nbsp;these&nbsp;extraction&nbsp;media&nbsp;are&nbsp;readily&nbsp;amenable&nbsp;to&nbsp;chemical&nbsp;testing&nbsp;and&nbsp;thus&nbsp;should&nbsp;be&nbsp;used&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1187\">1187</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">both&nbsp;biological&nbsp;and&nbsp;chemical&nbsp;testing&nbsp;when&nbsp;a&nbsp;correlation&nbsp;between&nbsp;the&nbsp;two&nbsp;is&nbsp;desired.&nbsp;Such&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1188\">1188</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">media&nbsp;can&nbsp;include&nbsp;water,&nbsp;physiological&nbsp;saline,&nbsp;ethanol/water,&nbsp;ethanol/saline&nbsp;and&nbsp;dimethylsulphoxide.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1189\">1189</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;other&nbsp;extraction&nbsp;vehicles&nbsp;listed&nbsp;previously&nbsp;might&nbsp;or&nbsp;might&nbsp;not&nbsp;be&nbsp;analytically&nbsp;viable&nbsp;from&nbsp;a&nbsp;chemical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1190\">1190</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">characterization&nbsp;perspective.&nbsp;If&nbsp;it&nbsp;can&nbsp;be&nbsp;established&nbsp;that&nbsp;such&nbsp;an&nbsp;extraction&nbsp;vehicle&nbsp;is&nbsp;analytically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1191\">1191</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">viable&nbsp;from&nbsp;a&nbsp;chemical&nbsp;perspective,&nbsp;then&nbsp;the&nbsp;same&nbsp;vehicle&nbsp;should&nbsp;be&nbsp;used&nbsp;for&nbsp;both&nbsp;biological&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1192\">1192</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;testing.&nbsp;If&nbsp;the&nbsp;vehicle&nbsp;is&nbsp;not&nbsp;analytically&nbsp;viable,&nbsp;then&nbsp;a&nbsp;surrogate&nbsp;vehicle&nbsp;should&nbsp;be&nbsp;used&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1193\">1193</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;testing.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1194\">1194</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">As&nbsp;the&nbsp;purpose&nbsp;of&nbsp;using&nbsp;the&nbsp;surrogate&nbsp;vehicle&nbsp;is&nbsp;to&nbsp;facilitate&nbsp;the&nbsp;discovery&nbsp;of&nbsp;the&nbsp;chemical&nbsp;agents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1195\">1195</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">responsible&nbsp;for&nbsp;a&nbsp;biological&nbsp;test&nbsp;result,&nbsp;any&nbsp;surrogate&nbsp;vehicle&nbsp;that&nbsp;accomplishes&nbsp;this&nbsp;objective&nbsp;is&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1196\">1196</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate&nbsp;surrogate&nbsp;solvent.&nbsp;Potential&nbsp;surrogate&nbsp;extraction&nbsp;vehicles&nbsp;that&nbsp;can&nbsp;be&nbsp;employed&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1197\">1197</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;testing&nbsp;and&nbsp;which&nbsp;meet&nbsp;the&nbsp;dual&nbsp;requirements&nbsp;of&nbsp;approximating&nbsp;extracting&nbsp;power&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1198\">1198</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">facilitating&nbsp;analytical&nbsp;testing&nbsp;are&nbsp;given&nbsp;in&nbsp;Table\u00a0D.3.&nbsp;Although&nbsp;use&nbsp;of&nbsp;these&nbsp;surrogate&nbsp;vehicles&nbsp;does&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1199\">1199</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ensure&nbsp;that&nbsp;the&nbsp;chemical&nbsp;investigation&nbsp;will&nbsp;be&nbsp;successful,&nbsp;they&nbsp;represent&nbsp;a&nbsp;good&nbsp;starting&nbsp;point&nbsp;for&nbsp;such</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1200\">1200</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;investigation&nbsp;and&nbsp;their&nbsp;use&nbsp;will&nbsp;typically&nbsp;lead&nbsp;to&nbsp;the&nbsp;desired&nbsp;positive&nbsp;outcome.&nbsp;Justification&nbsp;for&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1201\">1201</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chosen&nbsp;surrogate&nbsp;extraction&nbsp;vehicles&nbsp;should&nbsp;be&nbsp;provided.&nbsp;Justification&nbsp;should&nbsp;include&nbsp;biological&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1202\">1202</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;confirms&nbsp;the&nbsp;indicted&nbsp;chemicals&nbsp;are&nbsp;actually&nbsp;causing&nbsp;the&nbsp;biological&nbsp;test&nbsp;failure.&nbsp;It&nbsp;can&nbsp;also&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1203\">1203</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">possible&nbsp;to&nbsp;confirm&nbsp;causality&nbsp;with&nbsp;information&nbsp;from&nbsp;the&nbsp;literature.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1204\">1204</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">It&nbsp;is&nbsp;noted&nbsp;that&nbsp;these&nbsp;surrogate&nbsp;vehicle&nbsp;recommendations&nbsp;are&nbsp;relevant&nbsp;solely&nbsp;for&nbsp;the&nbsp;purpose&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1205\">1205</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">correlating&nbsp;biological&nbsp;and&nbsp;chemical&nbsp;test&nbsp;results&nbsp;and&nbsp;are&nbsp;not&nbsp;necessarily&nbsp;specified&nbsp;for&nbsp;the&nbsp;broader</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1206\">1206</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1207\">1207</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">48\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1208\">1208</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1209\">1209</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1210\">1210</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1211\">1211</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1212\">1212</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1213\">1213</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1214\">1214</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">purpose&nbsp;of&nbsp;generating&nbsp;an&nbsp;extractables&nbsp;profile&nbsp;for&nbsp;the&nbsp;purpose&nbsp;of&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;As</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1215\">1215</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;appropriateness&nbsp;of&nbsp;surrogate&nbsp;vehicles&nbsp;can&nbsp;vary&nbsp;somewhat&nbsp;from&nbsp;situation&nbsp;to&nbsp;situation,&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1216\">1216</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicles&nbsp;other&nbsp;than&nbsp;those&nbsp;proposed&nbsp;above&nbsp;may&nbsp;be&nbsp;used&nbsp;if&nbsp;they&nbsp;meet&nbsp;the&nbsp;two&nbsp;criteria&nbsp;noted&nbsp;previously,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1217\">1217</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;they&nbsp;are&nbsp;amenable&nbsp;to&nbsp;the&nbsp;anticipated&nbsp;chemical&nbsp;testing&nbsp;and&nbsp;that&nbsp;their&nbsp;solvating&nbsp;properties&nbsp;have</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1218\">1218</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">been&nbsp;established&nbsp;to&nbsp;be&nbsp;similar&nbsp;to&nbsp;those&nbsp;properties&nbsp;of&nbsp;the&nbsp;extraction&nbsp;vehicles&nbsp;that&nbsp;the&nbsp;surrogates&nbsp;would</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1219\">1219</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">replace.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1220\">1220</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Table\u00a0D.3\u00a0\u2014&nbsp;Potential&nbsp;surrogate&nbsp;extraction&nbsp;vehicles&nbsp;for&nbsp;correlating&nbsp;chemical&nbsp;to&nbsp;biological&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1221\">1221</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Extraction&nbsp;vehicle&nbsp;for&nbsp;biological&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1222\">1222</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Potential&nbsp;surrogate&nbsp;extraction&nbsp;vehicle&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1223\">1223</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chemical&nbsp;testing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1224\">1224</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Waterf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1225\">1225</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Water</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1226\">1226</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Physiological&nbsp;salinef</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1227\">1227</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Physiological&nbsp;saline</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1228\">1228</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ethanol/waterf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1229\">1229</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ethanol/water</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1230\">1230</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ethanol/salinef</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1231\">1231</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ethanol/saline</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1232\">1232</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dimethylsulphoxidef</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1233\">1233</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dimethylsulphoxide</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1234\">1234</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Culture&nbsp;medium&nbsp;without&nbsp;serum</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1235\">1235</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1/9&nbsp;(v/v)&nbsp;ethanol/salinea</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1236\">1236</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Vegetable&nbsp;oil</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1237\">1237</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1/1&nbsp;(v/v)&nbsp;ethanol/waterb&nbsp;(Reference\u00a0[25])</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1238\">1238</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Polyethylene&nbsp;glycol\u00a0400e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1239\">1239</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1/3&nbsp;(v/v)&nbsp;ethanol/waterc&nbsp;(Reference\u00a0[38])</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1240\">1240</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Culture&nbsp;medium&nbsp;with&nbsp;serum</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1241\">1241</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2/3&nbsp;(v/v)&nbsp;ethanol/salined&nbsp;(Reference\u00a0[38])</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1242\">1242</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1243\">1243</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;general,&nbsp;culture&nbsp;media&nbsp;contain&nbsp;all&nbsp;the&nbsp;elements&nbsp;that&nbsp;most&nbsp;bacteria&nbsp;need&nbsp;for&nbsp;growth,&nbsp;including:&nbsp;a&nbsp;carbon&nbsp;source&nbsp;(such</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1244\">1244</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">as&nbsp;glucose),&nbsp;water,&nbsp;various&nbsp;salts,&nbsp;and&nbsp;a&nbsp;source&nbsp;of&nbsp;amino&nbsp;acids&nbsp;and&nbsp;nitrogen&nbsp;(e.g.&nbsp;beef,&nbsp;yeast&nbsp;extract).&nbsp;To&nbsp;account&nbsp;for&nbsp;the&nbsp;salt</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1245\">1245</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">content&nbsp;of&nbsp;the&nbsp;culture&nbsp;medium,&nbsp;saline&nbsp;is&nbsp;used&nbsp;in&nbsp;the&nbsp;surrogate&nbsp;vehicle.&nbsp;To&nbsp;account&nbsp;for&nbsp;the&nbsp;organic&nbsp;character&nbsp;of&nbsp;the&nbsp;culture</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1246\">1246</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">medium,&nbsp;a&nbsp;10\u00a0%&nbsp;(by&nbsp;volume)&nbsp;portion&nbsp;of&nbsp;ethanol&nbsp;is&nbsp;used&nbsp;in&nbsp;the&nbsp;surrogate&nbsp;vehicle.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1247\">1247</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1248\">1248</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;recommendation&nbsp;is&nbsp;based&nbsp;on&nbsp;surrogate&nbsp;extraction&nbsp;vehicles&nbsp;specified&nbsp;for,&nbsp;and&nbsp;widely&nbsp;used,&nbsp;with&nbsp;food&nbsp;packaging.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1249\">1249</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">This&nbsp;surrogate&nbsp;extraction&nbsp;vehicle&nbsp;(1/1&nbsp;ethanol/water)&nbsp;is&nbsp;acceptable&nbsp;for&nbsp;most&nbsp;polymers;&nbsp;however,&nbsp;for&nbsp;polyolefins&nbsp;complying</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1250\">1250</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">with&nbsp;21\u00a0CFR\u00a0177.1520&nbsp;and&nbsp;ethylene&nbsp;-&nbsp;vinyl&nbsp;acetate&nbsp;copolymers&nbsp;complying&nbsp;with&nbsp;21\u00a0CFR\u00a0177.1350,&nbsp;a&nbsp;surrogate&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1251\">1251</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle&nbsp;of&nbsp;95\u00a0%&nbsp;or&nbsp;absolute&nbsp;ethanol&nbsp;should&nbsp;be&nbsp;considered.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1252\">1252</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1253\">1253</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Published&nbsp;research&nbsp;has&nbsp;noted&nbsp;that&nbsp;\u201cglycols&nbsp;(such&nbsp;as&nbsp;polyethylene&nbsp;glycol&nbsp;and&nbsp;propylene&nbsp;glycol)&nbsp;are&nbsp;weak&nbsp;solubilizing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1254\">1254</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">agents&nbsp;and&nbsp;can&nbsp;be&nbsp;simulated&nbsp;by&nbsp;ethanol/water&nbsp;mixtures&nbsp;containing&nbsp;25\u00a0%&nbsp;ethanol&nbsp;or&nbsp;less\u201d.&nbsp;Thus,&nbsp;a&nbsp;1/3&nbsp;mixture&nbsp;of&nbsp;ethanol/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1255\">1255</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">water&nbsp;is&nbsp;recommended&nbsp;as&nbsp;the&nbsp;appropriate&nbsp;simulating&nbsp;vehicle&nbsp;for&nbsp;polyethylene&nbsp;glycol\u00a0400.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1256\">1256</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1257\">1257</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Based&nbsp;on&nbsp;published&nbsp;research,&nbsp;40\u00a0%&nbsp;(by&nbsp;volume)&nbsp;mixture&nbsp;of&nbsp;ethanol/water&nbsp;is&nbsp;considered&nbsp;an&nbsp;appropriate&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1258\">1258</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;blood&nbsp;and&nbsp;blood&nbsp;related&nbsp;substances,&nbsp;which&nbsp;would&nbsp;include&nbsp;serum.&nbsp;Thus&nbsp;the&nbsp;40\u00a0%&nbsp;(by&nbsp;volume)&nbsp;portion&nbsp;of&nbsp;the&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1259\">1259</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicle&nbsp;(ethanol)&nbsp;is&nbsp;used&nbsp;to&nbsp;account&nbsp;for&nbsp;the&nbsp;serum.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1260\">1260</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">e</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1261\">1261</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">And&nbsp;its&nbsp;associated&nbsp;aqueous&nbsp;mixtures.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1262\">1262</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">f</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1263\">1263</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">These&nbsp;vehicles&nbsp;are&nbsp;analytically&nbsp;expedient&nbsp;and&nbsp;can&nbsp;readily&nbsp;be&nbsp;screened&nbsp;for&nbsp;extractables.&nbsp;Thus,&nbsp;surrogate&nbsp;vehicles&nbsp;are&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1264\">1264</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">warranted.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1265\">1265</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE&nbsp;1\u00a0\u00a0\u00a0It&nbsp;cannot&nbsp;be&nbsp;emphasized&nbsp;more&nbsp;strongly&nbsp;that&nbsp;the&nbsp;extraction&nbsp;vehicle&nbsp;examples&nbsp;provided&nbsp;in&nbsp;Table\u00a0D.3&nbsp;are&nbsp;solely&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1266\">1266</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;purpose&nbsp;of&nbsp;correlating&nbsp;the&nbsp;results&nbsp;of&nbsp;biological&nbsp;and&nbsp;chemical&nbsp;testing.&nbsp;These&nbsp;examples&nbsp;are&nbsp;not&nbsp;meant&nbsp;to&nbsp;be&nbsp;applied&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1267\">1267</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">selection&nbsp;and&nbsp;justification&nbsp;of&nbsp;extraction&nbsp;vehicles&nbsp;used&nbsp;for&nbsp;the&nbsp;purpose&nbsp;of&nbsp;extractables&nbsp;or&nbsp;leachables&nbsp;profiling,&nbsp;although&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1268\">1268</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">certain&nbsp;situations&nbsp;these&nbsp;vehicles&nbsp;can&nbsp;be&nbsp;suitable&nbsp;for&nbsp;those&nbsp;purposes.&nbsp;Furthermore,&nbsp;it&nbsp;is&nbsp;noted&nbsp;that&nbsp;while&nbsp;these&nbsp;vehicles&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1269\">1269</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;applicable&nbsp;for&nbsp;a&nbsp;large&nbsp;population&nbsp;of&nbsp;medical&nbsp;devices,&nbsp;no&nbsp;leaching&nbsp;vehicle&nbsp;is&nbsp;applicable&nbsp;to&nbsp;every&nbsp;medical&nbsp;device&nbsp;and&nbsp;every</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1270\">1270</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinical&nbsp;use&nbsp;circumstance.&nbsp;Thus,&nbsp;use&nbsp;of&nbsp;these&nbsp;or&nbsp;any&nbsp;other&nbsp;vehicles&nbsp;should&nbsp;be&nbsp;evaluated&nbsp;and&nbsp;justified&nbsp;on&nbsp;a&nbsp;case&nbsp;by&nbsp;case&nbsp;basis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1271\">1271</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE&nbsp;2\u00a0\u00a0\u00a0Inclusion&nbsp;of&nbsp;vehicles&nbsp;here&nbsp;does&nbsp;not&nbsp;fully&nbsp;justify&nbsp;their&nbsp;use&nbsp;in&nbsp;chemical-biological&nbsp;comparisons.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1272\">1272</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-12:2012,&nbsp;10.3.5,&nbsp;Note\u00a01,&nbsp;states&nbsp;that&nbsp;\u201cother&nbsp;extraction&nbsp;vehicles&nbsp;appropriate&nbsp;to&nbsp;the&nbsp;nature&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1273\">1273</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;of&nbsp;the&nbsp;medical&nbsp;device&nbsp;or&nbsp;to&nbsp;the&nbsp;methods&nbsp;for&nbsp;hazard&nbsp;identification&nbsp;can&nbsp;also&nbsp;be&nbsp;used&nbsp;(for&nbsp;biological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1274\">1274</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">testing)&nbsp;if&nbsp;their&nbsp;effects&nbsp;on&nbsp;the&nbsp;material&nbsp;and&nbsp;the&nbsp;biological&nbsp;system&nbsp;are&nbsp;known\u201d.&nbsp;If&nbsp;these&nbsp;other&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1275\">1275</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">vehicles&nbsp;are&nbsp;amenable&nbsp;to&nbsp;both&nbsp;biological&nbsp;and&nbsp;chemical&nbsp;testing&nbsp;then&nbsp;the&nbsp;vehicles&nbsp;should&nbsp;be&nbsp;used&nbsp;for&nbsp;both</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1276\">1276</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">biological&nbsp;and&nbsp;chemical&nbsp;testing.&nbsp;If&nbsp;these&nbsp;other&nbsp;extraction&nbsp;vehicles&nbsp;are&nbsp;not&nbsp;amenable&nbsp;to&nbsp;chemical&nbsp;testing,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1277\">1277</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">then&nbsp;a&nbsp;surrogate&nbsp;vehicle&nbsp;should&nbsp;be&nbsp;identified&nbsp;and&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1278\">1278</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Given&nbsp;a&nbsp;potentially&nbsp;differing&nbsp;level&nbsp;of&nbsp;sensitivity&nbsp;for&nbsp;biological&nbsp;versus&nbsp;chemical&nbsp;testing,&nbsp;other&nbsp;extraction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1279\">1279</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">conditions,&nbsp;such&nbsp;as&nbsp;the&nbsp;extracted&nbsp;surface&nbsp;area&nbsp;to&nbsp;extraction&nbsp;solution&nbsp;volume&nbsp;ratio,&nbsp;might&nbsp;need&nbsp;to&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1280\">1280</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">adjusted&nbsp;to&nbsp;facilitate&nbsp;the&nbsp;generation&nbsp;of&nbsp;a&nbsp;useful&nbsp;correlation.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1281\">1281</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1282\">1282</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1283\">1283</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">49</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1284\">1284</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1285\">1285</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1286\">1286</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1287\">1287</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1288\">1288</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1289\">1289</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0E</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1290\">1290</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1291\">1291</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1292\">1292</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Calculation&nbsp;and&nbsp;application&nbsp;of&nbsp;the&nbsp;analytical&nbsp;evaluation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1293\">1293</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">threshold&nbsp;(AET)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1294\">1294</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discussion</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1295\">1295</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Analytical&nbsp;methods&nbsp;used&nbsp;to&nbsp;screen&nbsp;an&nbsp;extract&nbsp;for&nbsp;extracted&nbsp;substances&nbsp;should&nbsp;perform&nbsp;four&nbsp;functions:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1296\">1296</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they&nbsp;should&nbsp;detect&nbsp;the&nbsp;extractables;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1297\">1297</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they&nbsp;should&nbsp;distinguish&nbsp;between&nbsp;the&nbsp;extractables&nbsp;so&nbsp;that&nbsp;each&nbsp;extractable&nbsp;provides&nbsp;a&nbsp;unique</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1298\">1298</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">response;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1299\">1299</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1300\">1300</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">they&nbsp;should&nbsp;provide&nbsp;information&nbsp;with&nbsp;which&nbsp;the&nbsp;extractable's&nbsp;identity&nbsp;can&nbsp;be&nbsp;elucidated;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1301\">1301</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;they&nbsp;should&nbsp;provide&nbsp;information&nbsp;with&nbsp;which&nbsp;the&nbsp;extractable's&nbsp;concentration&nbsp;can&nbsp;be&nbsp;established.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1302\">1302</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Considering&nbsp;chromatographic&nbsp;methods&nbsp;used&nbsp;to&nbsp;screen&nbsp;extracts&nbsp;for&nbsp;organic&nbsp;extractables,&nbsp;the&nbsp;methods</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1303\">1303</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">could&nbsp;be&nbsp;more&nbsp;capable&nbsp;of&nbsp;detecting&nbsp;extractables&nbsp;than&nbsp;they&nbsp;are&nbsp;at&nbsp;correctly&nbsp;identifying&nbsp;or&nbsp;accurately</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1304\">1304</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantifying&nbsp;extractables.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1305\">1305</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;an&nbsp;extractable&nbsp;has&nbsp;been&nbsp;detected,&nbsp;it&nbsp;is&nbsp;necessary&nbsp;to&nbsp;consider&nbsp;the&nbsp;safety&nbsp;impact&nbsp;that&nbsp;extractable</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1306\">1306</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">might&nbsp;have&nbsp;as&nbsp;a&nbsp;leachable.&nbsp;However,&nbsp;if&nbsp;the&nbsp;extractable's&nbsp;identity&nbsp;cannot&nbsp;be&nbsp;established,&nbsp;a&nbsp;toxicological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1307\">1307</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk&nbsp;assessment&nbsp;of&nbsp;this&nbsp;extractable,&nbsp;as&nbsp;described&nbsp;in&nbsp;ISO&nbsp;10993-17,&nbsp;cannot&nbsp;be&nbsp;performed.&nbsp;Furthermore,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1308\">1308</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">if&nbsp;the&nbsp;extractable&nbsp;is&nbsp;inaccurately&nbsp;quantified,&nbsp;the&nbsp;outcome&nbsp;of&nbsp;any&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;can&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1309\">1309</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">incorrect.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1310\">1310</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;purpose&nbsp;of&nbsp;this&nbsp;annex&nbsp;is&nbsp;to&nbsp;address&nbsp;the&nbsp;quantitative&nbsp;aspect&nbsp;of&nbsp;extractables&nbsp;screening,&nbsp;specifically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1311\">1311</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">considering&nbsp;the&nbsp;issue&nbsp;of&nbsp;an&nbsp;AET.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1312\">1312</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Thresholds&nbsp;such&nbsp;as&nbsp;a&nbsp;TTC&nbsp;establish&nbsp;a&nbsp;dose&nbsp;of&nbsp;leachables&nbsp;(and&nbsp;other&nbsp;potentially&nbsp;toxic&nbsp;impurities)&nbsp;below</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1313\">1313</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">which&nbsp;there&nbsp;is&nbsp;insufficient&nbsp;quantity&nbsp;present&nbsp;to&nbsp;elicit&nbsp;toxicity,&nbsp;irrespective&nbsp;of&nbsp;the&nbsp;substance\u2019s&nbsp;identity.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1314\">1314</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">It&nbsp;is&nbsp;important&nbsp;to&nbsp;note&nbsp;that&nbsp;some&nbsp;highly&nbsp;toxic&nbsp;substances&nbsp;(i.e.&nbsp;cohorts&nbsp;of&nbsp;concern)&nbsp;are&nbsp;excluded&nbsp;from</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1315\">1315</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;TTC&nbsp;approach&nbsp;and&nbsp;their&nbsp;presence&nbsp;should&nbsp;be&nbsp;ruled&nbsp;out&nbsp;(see&nbsp;ISO\u00a010993-17)&nbsp;before&nbsp;the&nbsp;AET&nbsp;is&nbsp;applied.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1316\">1316</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Any&nbsp;specifically&nbsp;targeted&nbsp;analytes&nbsp;of&nbsp;concern&nbsp;for&nbsp;the&nbsp;specific&nbsp;medical&nbsp;device&nbsp;should&nbsp;also&nbsp;be&nbsp;assessed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1317\">1317</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">individually,&nbsp;independent&nbsp;of&nbsp;the&nbsp;AET.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1318\">1318</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Leachables&nbsp;present&nbsp;at&nbsp;levels&nbsp;below&nbsp;the&nbsp;TTC&nbsp;are&nbsp;deemed&nbsp;to&nbsp;be&nbsp;appropriately&nbsp;safe&nbsp;and&nbsp;not&nbsp;to&nbsp;require</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1319\">1319</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additional&nbsp;assessment&nbsp;(identification&nbsp;and&nbsp;quantification).&nbsp;In&nbsp;essence,&nbsp;these&nbsp;thresholds&nbsp;(e.g.&nbsp;TTC)&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1320\">1320</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">combination&nbsp;with&nbsp;an&nbsp;appropriate&nbsp;factor&nbsp;that&nbsp;addresses&nbsp;the&nbsp;uncertainty&nbsp;of&nbsp;the&nbsp;analytical&nbsp;method,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1321\">1321</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">become&nbsp;identification&nbsp;thresholds,&nbsp;as&nbsp;substances&nbsp;dosed&nbsp;at&nbsp;and&nbsp;above&nbsp;the&nbsp;threshold&nbsp;should&nbsp;be&nbsp;identified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1322\">1322</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;allow&nbsp;for&nbsp;their&nbsp;safety&nbsp;assessment\u00a0&nbsp;\u2014&nbsp;while&nbsp;substances&nbsp;dosed&nbsp;below&nbsp;the&nbsp;threshold&nbsp;are&nbsp;deemed&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1323\">1323</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">present&nbsp;an&nbsp;acceptably&nbsp;low&nbsp;toxicological&nbsp;safety&nbsp;risk&nbsp;without&nbsp;identification.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1324\">1324</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;threshold&nbsp;concept&nbsp;can&nbsp;be&nbsp;applied&nbsp;to&nbsp;extractables&nbsp;in&nbsp;the&nbsp;circumstance&nbsp;that&nbsp;extractables&nbsp;are&nbsp;used&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1325\">1325</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">project&nbsp;the&nbsp;worst-case&nbsp;release&nbsp;of&nbsp;leachables&nbsp;from&nbsp;medical&nbsp;devices.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1326\">1326</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;application&nbsp;of&nbsp;the&nbsp;threshold&nbsp;concept&nbsp;requires&nbsp;that&nbsp;a&nbsp;dose-based&nbsp;threshold&nbsp;(TTC)&nbsp;be&nbsp;converted&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1327\">1327</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;concentration-based&nbsp;threshold&nbsp;(AET),&nbsp;as&nbsp;such&nbsp;a&nbsp;conversion&nbsp;would&nbsp;facilitate&nbsp;extractables&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1328\">1328</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">decisions&nbsp;based&nbsp;on&nbsp;the&nbsp;concentration&nbsp;of&nbsp;the&nbsp;extractable&nbsp;in&nbsp;an&nbsp;extract.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1329\">1329</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Such&nbsp;an&nbsp;analytical&nbsp;threshold&nbsp;has&nbsp;been&nbsp;termed&nbsp;the&nbsp;AET.&nbsp;By&nbsp;definition,&nbsp;the&nbsp;AET&nbsp;establishes&nbsp;a&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1330\">1330</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;of&nbsp;extractables&nbsp;or&nbsp;leachables.&nbsp;Extractables&nbsp;whose&nbsp;concentrations</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1331\">1331</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">are&nbsp;above&nbsp;the&nbsp;AET&nbsp;should&nbsp;be&nbsp;identified&nbsp;and&nbsp;quantified&nbsp;as&nbsp;a&nbsp;prerequisite&nbsp;for&nbsp;their&nbsp;toxicological&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1332\">1332</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1333\">1333</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">50\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1334\">1334</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1335\">1335</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1336\">1336</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1337\">1337</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1338\">1338</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1339\">1339</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1340\">1340</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment,&nbsp;as&nbsp;there&nbsp;is&nbsp;a&nbsp;sufficient&nbsp;possibility&nbsp;that&nbsp;the&nbsp;extractables&nbsp;could&nbsp;be&nbsp;toxic.&nbsp;On&nbsp;the&nbsp;other&nbsp;hand,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1341\">1341</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractables&nbsp;whose&nbsp;concentrations&nbsp;are&nbsp;below&nbsp;the&nbsp;AET&nbsp;do&nbsp;not&nbsp;need&nbsp;to&nbsp;be&nbsp;identified&nbsp;or&nbsp;quantified&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1342\">1342</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">toxicological&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1343\">1343</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Although&nbsp;PDEs&nbsp;for&nbsp;individual&nbsp;metals&nbsp;have&nbsp;been&nbsp;established[19],&nbsp;a&nbsp;dose&nbsp;based&nbsp;threshold&nbsp;(DBT)&nbsp;applicable</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1344\">1344</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;all&nbsp;metals&nbsp;has&nbsp;not&nbsp;been&nbsp;established.&nbsp;Thus,&nbsp;practically&nbsp;speaking,&nbsp;the&nbsp;AET&nbsp;is&nbsp;only&nbsp;applied&nbsp;to&nbsp;organic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1345\">1345</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractables&nbsp;or&nbsp;leachables.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1346\">1346</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;relationship&nbsp;between&nbsp;the&nbsp;AET&nbsp;and&nbsp;frequently&nbsp;encountered&nbsp;analytical&nbsp;limits,&nbsp;such&nbsp;as&nbsp;the&nbsp;limit&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1347\">1347</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">detection\u00a0(LOD)&nbsp;and&nbsp;LOQ,&nbsp;is&nbsp;as&nbsp;follows.&nbsp;As&nbsp;the&nbsp;AET&nbsp;is&nbsp;a&nbsp;threshold&nbsp;that&nbsp;requires&nbsp;the&nbsp;compound&nbsp;responsible</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1348\">1348</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;an&nbsp;analytical&nbsp;response&nbsp;to&nbsp;be&nbsp;identified&nbsp;and&nbsp;quantified,&nbsp;it&nbsp;is&nbsp;clear&nbsp;that&nbsp;the&nbsp;analytical&nbsp;response&nbsp;should</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1349\">1349</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;discernible&nbsp;above&nbsp;the&nbsp;analytical&nbsp;noise&nbsp;(detected)&nbsp;before&nbsp;its&nbsp;source&nbsp;compound&nbsp;can&nbsp;be&nbsp;identified.&nbsp;Thus,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1350\">1350</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;AET&nbsp;should&nbsp;be&nbsp;greater&nbsp;than&nbsp;or&nbsp;equal&nbsp;to&nbsp;the&nbsp;LOD&nbsp;as&nbsp;an&nbsp;AET&nbsp;lower&nbsp;than&nbsp;the&nbsp;LOD&nbsp;would&nbsp;indicate&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1351\">1351</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;analytical&nbsp;method&nbsp;is&nbsp;incapable&nbsp;of&nbsp;producing&nbsp;analytical&nbsp;responses&nbsp;at&nbsp;the&nbsp;necessary&nbsp;concentration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1352\">1352</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">levels&nbsp;for&nbsp;relevant&nbsp;compounds.&nbsp;Although&nbsp;the&nbsp;LOD&nbsp;might&nbsp;not&nbsp;be&nbsp;determinable&nbsp;for&nbsp;compounds&nbsp;detected</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1353\">1353</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">during&nbsp;the&nbsp;screening&nbsp;process,&nbsp;the&nbsp;LODs&nbsp;of&nbsp;one&nbsp;or&nbsp;more&nbsp;relevant&nbsp;surrogates&nbsp;or&nbsp;internal&nbsp;standards</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1354\">1354</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;used&nbsp;to&nbsp;represent&nbsp;the&nbsp;method\u2019s&nbsp;LOD&nbsp;for&nbsp;all&nbsp;compounds&nbsp;that&nbsp;the&nbsp;method&nbsp;is&nbsp;suited&nbsp;for.&nbsp;It&nbsp;is&nbsp;also</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1355\">1355</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clear&nbsp;that&nbsp;if&nbsp;one&nbsp;purpose&nbsp;of&nbsp;the&nbsp;analytical&nbsp;testing&nbsp;is&nbsp;quantification,\u00a0the&nbsp;AET&nbsp;should&nbsp;be&nbsp;higher&nbsp;than&nbsp;or</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1356\">1356</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">equal&nbsp;to&nbsp;the&nbsp;LOQ.&nbsp;However,&nbsp;it&nbsp;is&nbsp;understood&nbsp;that&nbsp;semi-quantitative&nbsp;concentration&nbsp;estimates&nbsp;obtained</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1357\">1357</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;screening&nbsp;cannot&nbsp;meet&nbsp;the&nbsp;rigorous&nbsp;accuracy&nbsp;and&nbsp;precision&nbsp;expectations&nbsp;inherent&nbsp;in&nbsp;an&nbsp;LOQ&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1358\">1358</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">thus&nbsp;that&nbsp;there&nbsp;can&nbsp;be&nbsp;cases&nbsp;where&nbsp;screening&nbsp;studies&nbsp;provide&nbsp;concentration&nbsp;estimates&nbsp;when&nbsp;the&nbsp;AET&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1359\">1359</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">lower&nbsp;than&nbsp;the&nbsp;rigorously&nbsp;determined&nbsp;LOQ.&nbsp;Concentration&nbsp;estimates&nbsp;below&nbsp;a&nbsp;method\u2019s&nbsp;established&nbsp;LOQ</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1360\">1360</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">might&nbsp;not&nbsp;be&nbsp;sufficiently&nbsp;accurate&nbsp;to&nbsp;support&nbsp;a&nbsp;valid&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Lastly,&nbsp;it&nbsp;is&nbsp;observed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1361\">1361</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;the&nbsp;AET&nbsp;is&nbsp;also&nbsp;an&nbsp;identification&nbsp;threshold&nbsp;and&nbsp;that&nbsp;the&nbsp;process&nbsp;of&nbsp;identification&nbsp;requires&nbsp;that&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1362\">1362</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">response&nbsp;contain&nbsp;more&nbsp;complex&nbsp;and/or&nbsp;advanced&nbsp;information&nbsp;than&nbsp;does&nbsp;the&nbsp;process&nbsp;of&nbsp;quantification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1363\">1363</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(i.e.&nbsp;quantification&nbsp;can&nbsp;typically&nbsp;be&nbsp;accomplished&nbsp;at&nbsp;concentrations&nbsp;lower&nbsp;than&nbsp;those&nbsp;required&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1364\">1364</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identification).&nbsp;This&nbsp;being&nbsp;the&nbsp;case,&nbsp;it&nbsp;is&nbsp;possible&nbsp;that&nbsp;the&nbsp;AET&nbsp;could&nbsp;be&nbsp;above&nbsp;the&nbsp;LOQ&nbsp;but&nbsp;it&nbsp;would&nbsp;still</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1365\">1365</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">not&nbsp;be&nbsp;possible&nbsp;to&nbsp;secure&nbsp;an&nbsp;identification&nbsp;for&nbsp;an&nbsp;analyte&nbsp;present&nbsp;in&nbsp;the&nbsp;sample&nbsp;at&nbsp;the&nbsp;AET.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1366\">1366</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Calculation&nbsp;of&nbsp;the&nbsp;AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1367\">1367</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;conversion&nbsp;from&nbsp;a&nbsp;dose-based&nbsp;threshold&nbsp;(e.g.&nbsp;TTC)&nbsp;to&nbsp;a&nbsp;concentration-based&nbsp;threshold&nbsp;(AET)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1368\">1368</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">requires&nbsp;inputs&nbsp;including:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1369\">1369</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;frequency&nbsp;and&nbsp;duration&nbsp;of&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;clinical&nbsp;use;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1370\">1370</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;various&nbsp;extraction&nbsp;conditions&nbsp;used&nbsp;to&nbsp;produce&nbsp;the&nbsp;extractables&nbsp;profile;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1371\">1371</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;uncertainty&nbsp;of&nbsp;the&nbsp;analytical&nbsp;method.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1372\">1372</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;duration&nbsp;of&nbsp;the&nbsp;medical&nbsp;device\u2019s&nbsp;clinical&nbsp;use&nbsp;could&nbsp;dictate&nbsp;the&nbsp;actual&nbsp;value&nbsp;used&nbsp;for&nbsp;the&nbsp;dose-based</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1373\">1373</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">threshold&nbsp;(e.g.&nbsp;a&nbsp;staged&nbsp;TTC&nbsp;based&nbsp;on&nbsp;duration)[18]&nbsp;while&nbsp;the&nbsp;frequency&nbsp;of&nbsp;clinical&nbsp;use&nbsp;establishes&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1374\">1374</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">magnitude&nbsp;of&nbsp;clinical&nbsp;exposure.&nbsp;The&nbsp;AET&nbsp;in&nbsp;\u00b5g/ml&nbsp;can&nbsp;be&nbsp;calculated&nbsp;as&nbsp;given&nbsp;in&nbsp;Formula\u00a0(E.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1375\">1375</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1376\">1376</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">UF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1377\">1377</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DBT</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1378\">1378</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1379\">1379</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">BC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1380\">1380</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">=</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1381\">1381</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00d7</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1382\">1382</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1383\">1383</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(E.1)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1384\">1384</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">where</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1385\">1385</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1386\">1386</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1387\">1387</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">51</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1388\">1388</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1389\">1389</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1390\">1390</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1391\">1391</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1392\">1392</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1393\">1393</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1394\">1394</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1395\">1395</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;number&nbsp;of&nbsp;medical&nbsp;devices&nbsp;that&nbsp;were&nbsp;extracted&nbsp;to&nbsp;generate&nbsp;the&nbsp;extract;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1396\">1396</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1397\">1397</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1398\">1398</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;volume&nbsp;of&nbsp;the&nbsp;extract&nbsp;(measured&nbsp;in&nbsp;ml);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1399\">1399</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1400\">1400</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">C</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1401\">1401</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;clinical&nbsp;exposure&nbsp;to&nbsp;the&nbsp;medical&nbsp;device&nbsp;(number&nbsp;of&nbsp;devices&nbsp;a&nbsp;user&nbsp;would&nbsp;be&nbsp;exposed&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1402\">1402</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;a&nbsp;day&nbsp;under&nbsp;normal&nbsp;clinical&nbsp;practice);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1403\">1403</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1404\">1404</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">DBT&nbsp;is&nbsp;the&nbsp;dose-based&nbsp;threshold&nbsp;(e.g.&nbsp;TTC&nbsp;or&nbsp;SCT)&nbsp;in&nbsp;\u00b5g/d&nbsp;(a&nbsp;toxicologist&nbsp;should&nbsp;be&nbsp;consulted&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1405\">1405</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">selecting&nbsp;a&nbsp;specific&nbsp;threshold&nbsp;that&nbsp;can&nbsp;support&nbsp;risk&nbsp;assessment);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1406\">1406</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1407\">1407</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">UF</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1408\">1408</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;an&nbsp;uncertainty&nbsp;factor&nbsp;that&nbsp;could&nbsp;be&nbsp;applied&nbsp;to&nbsp;account&nbsp;for&nbsp;the&nbsp;analytical&nbsp;uncertainty&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1409\">1409</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">screening&nbsp;methods&nbsp;used&nbsp;to&nbsp;estimate&nbsp;extractables\u2019&nbsp;concentrations&nbsp;in&nbsp;an&nbsp;extract&nbsp;(see&nbsp;E.3&nbsp;for&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1410\">1410</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">discussion&nbsp;on&nbsp;how&nbsp;to&nbsp;determine&nbsp;the&nbsp;proper&nbsp;value&nbsp;to&nbsp;assign&nbsp;to&nbsp;UF).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1411\">1411</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;extract&nbsp;processing&nbsp;(e.g.&nbsp;any&nbsp;dilution&nbsp;or&nbsp;concentration&nbsp;steps)&nbsp;should&nbsp;be&nbsp;considered&nbsp;during&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1412\">1412</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;calculations&nbsp;and&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;AET&nbsp;value&nbsp;adjusted&nbsp;accordingly.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1413\">1413</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Several&nbsp;examples&nbsp;of&nbsp;AET&nbsp;determination&nbsp;are&nbsp;provided&nbsp;in&nbsp;E.4&nbsp;to&nbsp;illustrate&nbsp;the&nbsp;process&nbsp;in&nbsp;various&nbsp;settings.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1414\">1414</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">These&nbsp;examples&nbsp;use&nbsp;values&nbsp;for&nbsp;various&nbsp;inputs&nbsp;(e.g.&nbsp;UF)&nbsp;that&nbsp;were&nbsp;chosen&nbsp;for&nbsp;illustrative&nbsp;purposes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1415\">1415</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;choice&nbsp;is&nbsp;not&nbsp;meant&nbsp;to&nbsp;imply&nbsp;that&nbsp;the&nbsp;exact&nbsp;value&nbsp;used&nbsp;should&nbsp;be&nbsp;unilaterally&nbsp;applied&nbsp;in&nbsp;all</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1416\">1416</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">circumstances.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1417\">1417</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1418\">1418</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;application&nbsp;of&nbsp;Formula\u00a0(E.1)&nbsp;to&nbsp;long&nbsp;term&nbsp;implants&nbsp;could&nbsp;require&nbsp;knowledge&nbsp;and&nbsp;consideration&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1419\">1419</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;release&nbsp;kinetics&nbsp;of&nbsp;the&nbsp;constituents&nbsp;of&nbsp;interest.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1420\">1420</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Determination&nbsp;of&nbsp;the&nbsp;uncertainty&nbsp;factor</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1421\">1421</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Quantification&nbsp;in&nbsp;extractables&nbsp;profiling&nbsp;is&nbsp;achieved&nbsp;by&nbsp;various&nbsp;means&nbsp;which&nbsp;differ&nbsp;in&nbsp;the&nbsp;degree&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1422\">1422</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">certainty&nbsp;in&nbsp;the&nbsp;estimated&nbsp;and&nbsp;reported&nbsp;concentration.&nbsp;The&nbsp;degree&nbsp;of&nbsp;uncertainty&nbsp;can&nbsp;vary&nbsp;significantly</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1423\">1423</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">depending&nbsp;on&nbsp;the&nbsp;quantification&nbsp;strategy&nbsp;employed.&nbsp;For&nbsp;example,&nbsp;quantification&nbsp;in&nbsp;some&nbsp;cases&nbsp;could</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1424\">1424</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">involve&nbsp;the&nbsp;use&nbsp;of&nbsp;an&nbsp;internal&nbsp;standard&nbsp;to&nbsp;normalize&nbsp;the&nbsp;responses&nbsp;obtained&nbsp;for&nbsp;all&nbsp;relevant&nbsp;analytes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1425\">1425</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;estimates&nbsp;the&nbsp;concentration&nbsp;of&nbsp;each&nbsp;analyte&nbsp;based&nbsp;on&nbsp;the&nbsp;simplifying&nbsp;assumption&nbsp;that&nbsp;all&nbsp;analytes</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1426\">1426</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">respond&nbsp;similarly,&nbsp;among&nbsp;themselves&nbsp;and&nbsp;with&nbsp;respect&nbsp;to&nbsp;the&nbsp;internal&nbsp;standard.&nbsp;Depending&nbsp;on&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1427\">1427</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">validity&nbsp;of&nbsp;this&nbsp;simplifying&nbsp;assumption,&nbsp;the&nbsp;concentration&nbsp;estimates&nbsp;thus&nbsp;obtained&nbsp;can&nbsp;have&nbsp;widely</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1428\">1428</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">differing&nbsp;uncertainties&nbsp;and&nbsp;degrees&nbsp;of&nbsp;accuracy.&nbsp;If&nbsp;the&nbsp;simplifying&nbsp;assumption&nbsp;is&nbsp;true&nbsp;and&nbsp;response</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1429\">1429</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">factors&nbsp;are&nbsp;constant,&nbsp;then&nbsp;the&nbsp;resulting&nbsp;concentration&nbsp;estimates&nbsp;for&nbsp;all&nbsp;analytes&nbsp;will&nbsp;be&nbsp;highly</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1430\">1430</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">accurate.&nbsp;If&nbsp;the&nbsp;simplifying&nbsp;assumption&nbsp;is&nbsp;false&nbsp;and&nbsp;the&nbsp;response&nbsp;factors&nbsp;vary&nbsp;widely,&nbsp;then&nbsp;the&nbsp;resulting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1431\">1431</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;estimates&nbsp;for&nbsp;the&nbsp;analytes&nbsp;will&nbsp;have&nbsp;widely&nbsp;varying&nbsp;accuracies.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1432\">1432</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;other&nbsp;cases,&nbsp;the&nbsp;degree&nbsp;of&nbsp;uncertainty&nbsp;can&nbsp;be&nbsp;low.&nbsp;For&nbsp;example,&nbsp;if&nbsp;quantification&nbsp;is&nbsp;achieved&nbsp;through</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1433\">1433</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;use&nbsp;of&nbsp;authentic&nbsp;standards&nbsp;employed&nbsp;in&nbsp;qualified&nbsp;analytical&nbsp;methods,&nbsp;the&nbsp;concentration&nbsp;estimates</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1434\">1434</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">obtained&nbsp;for&nbsp;the&nbsp;qualified&nbsp;analytes&nbsp;will&nbsp;be&nbsp;highly&nbsp;accurate.&nbsp;Considering&nbsp;quantification&nbsp;via&nbsp;an&nbsp;internal</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1435\">1435</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">standard,&nbsp;if&nbsp;the&nbsp;simplifying&nbsp;assumption&nbsp;noted&nbsp;previously&nbsp;is&nbsp;true&nbsp;and&nbsp;response&nbsp;factors&nbsp;are&nbsp;constant,&nbsp;then</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1436\">1436</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;resulting&nbsp;concentration&nbsp;estimates&nbsp;for&nbsp;all&nbsp;analytes&nbsp;will&nbsp;also&nbsp;be&nbsp;sufficiently&nbsp;accurate&nbsp;for&nbsp;toxicological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1437\">1437</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1438\">1438</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Other&nbsp;quantification&nbsp;strategies&nbsp;could&nbsp;produce&nbsp;concentration&nbsp;estimates&nbsp;whose&nbsp;uncertainty&nbsp;is&nbsp;somewhere</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1439\">1439</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">between&nbsp;these&nbsp;two&nbsp;extremes;&nbsp;lower&nbsp;uncertainty&nbsp;than&nbsp;use&nbsp;of&nbsp;an&nbsp;internal&nbsp;standard\u2019s&nbsp;response&nbsp;factor&nbsp;but</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1440\">1440</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">higher&nbsp;uncertainty&nbsp;then&nbsp;use&nbsp;of&nbsp;a&nbsp;calibration&nbsp;curve&nbsp;generated&nbsp;with&nbsp;an&nbsp;authentic&nbsp;reference&nbsp;standard.&nbsp;For</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1441\">1441</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">example,&nbsp;relative&nbsp;response&nbsp;factors&nbsp;can&nbsp;be&nbsp;obtained&nbsp;for&nbsp;extractables,&nbsp;were&nbsp;the&nbsp;relative&nbsp;response&nbsp;factor&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1442\">1442</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;ratio&nbsp;of&nbsp;the&nbsp;response&nbsp;of&nbsp;the&nbsp;extractable&nbsp;versus&nbsp;that&nbsp;of&nbsp;an&nbsp;internal&nbsp;standard&nbsp;at&nbsp;equal&nbsp;concentrations</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1443\">1443</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;extractable&nbsp;and&nbsp;internal&nbsp;standard.&nbsp;Use&nbsp;of&nbsp;relative&nbsp;response&nbsp;factors&nbsp;in&nbsp;quantification&nbsp;essentially</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1444\">1444</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">accounts&nbsp;for&nbsp;differences&nbsp;in&nbsp;response&nbsp;factors,&nbsp;extractable&nbsp;versus&nbsp;internal&nbsp;standard.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1445\">1445</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Recognizing&nbsp;that&nbsp;the&nbsp;accuracy&nbsp;of&nbsp;and&nbsp;uncertainty&nbsp;in&nbsp;concentration&nbsp;estimates&nbsp;obtained&nbsp;in&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1446\">1446</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">studies&nbsp;can&nbsp;vary,&nbsp;an&nbsp;UF&nbsp;is&nbsp;added&nbsp;to&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;AET&nbsp;to&nbsp;account&nbsp;for&nbsp;the&nbsp;analytical&nbsp;uncertainty</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1447\">1447</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;arises&nbsp;due&nbsp;to&nbsp;the&nbsp;variable&nbsp;accuracy.&nbsp;Use&nbsp;of&nbsp;a&nbsp;UF&nbsp;is&nbsp;the&nbsp;same&nbsp;principle&nbsp;as&nbsp;calculation&nbsp;of&nbsp;a&nbsp;final&nbsp;AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1448\">1448</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">from&nbsp;an&nbsp;estimated&nbsp;AET&nbsp;(e.g.&nbsp;see&nbsp;Reference&nbsp;[45]).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1449\">1449</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1450\">1450</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">52\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1451\">1451</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1452\">1452</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1453\">1453</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1454\">1454</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1455\">1455</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1456\">1456</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1457\">1457</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;cases&nbsp;where&nbsp;the&nbsp;analytical&nbsp;uncertainty&nbsp;is&nbsp;known&nbsp;to&nbsp;be&nbsp;acceptably&nbsp;low,&nbsp;a&nbsp;UF&nbsp;value&nbsp;of&nbsp;1&nbsp;can&nbsp;be&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1458\">1458</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Examples&nbsp;of&nbsp;these&nbsp;cases&nbsp;are&nbsp;methods&nbsp;with&nbsp;comparable&nbsp;response&nbsp;factors&nbsp;between&nbsp;expected&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1459\">1459</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;applied&nbsp;internal&nbsp;standards&nbsp;in&nbsp;qualified&nbsp;methods&nbsp;for&nbsp;targeted&nbsp;extractables.&nbsp;Otherwise&nbsp;the&nbsp;value&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1460\">1460</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;uncertainty&nbsp;factor&nbsp;is&nbsp;based&nbsp;on&nbsp;an&nbsp;assessment&nbsp;of&nbsp;the&nbsp;analytical&nbsp;methodology&nbsp;to&nbsp;which&nbsp;the&nbsp;AET&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1461\">1461</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">applied.&nbsp;For&nbsp;example,&nbsp;a&nbsp;UF&nbsp;value&nbsp;of&nbsp;2&nbsp;has&nbsp;been&nbsp;proposed[39][45]&nbsp;as&nbsp;being&nbsp;appropriate,&nbsp;in&nbsp;certain&nbsp;situations,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1462\">1462</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;the&nbsp;screening&nbsp;of&nbsp;extracts&nbsp;for&nbsp;semi-volatile&nbsp;extractables&nbsp;via&nbsp;GC-FID&nbsp;or&nbsp;GC-MS,&nbsp;as&nbsp;analytical&nbsp;FID&nbsp;or&nbsp;MS</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1463\">1463</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">response&nbsp;factors&nbsp;for&nbsp;extractables&nbsp;are&nbsp;somewhat&nbsp;consistent,&nbsp;extractable&nbsp;to&nbsp;extractable.&nbsp;Alternatively,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1464\">1464</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">response&nbsp;factors&nbsp;for&nbsp;other&nbsp;analytical&nbsp;methods&nbsp;used&nbsp;for&nbsp;extractables&nbsp;screening,&nbsp;such&nbsp;as&nbsp;HPLC-UV&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1465\">1465</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">HPLC-MS&nbsp;(which&nbsp;are&nbsp;typically&nbsp;applied&nbsp;to&nbsp;non-volatile&nbsp;extractables),&nbsp;may&nbsp;be&nbsp;higher&nbsp;given&nbsp;the&nbsp;frequently</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1466\">1466</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">wide&nbsp;variation&nbsp;in&nbsp;response&nbsp;factors&nbsp;among&nbsp;extractables&nbsp;by&nbsp;this&nbsp;methodology.&nbsp;At&nbsp;the&nbsp;current&nbsp;time,&nbsp;there</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1467\">1467</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;no&nbsp;available&nbsp;general&nbsp;guidance&nbsp;which&nbsp;recommends&nbsp;a&nbsp;specific&nbsp;value&nbsp;for&nbsp;the&nbsp;UF&nbsp;for&nbsp;these&nbsp;methods.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1468\">1468</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A&nbsp;statistical&nbsp;approach&nbsp;to&nbsp;establishing&nbsp;and&nbsp;justifying&nbsp;a&nbsp;particular&nbsp;UF&nbsp;is&nbsp;statistical&nbsp;analysis&nbsp;of&nbsp;a&nbsp;database&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1469\">1469</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">response&nbsp;factors&nbsp;specific&nbsp;to&nbsp;the&nbsp;analytical&nbsp;method&nbsp;being&nbsp;considered&nbsp;and&nbsp;the&nbsp;population&nbsp;of&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1470\">1470</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;which&nbsp;that&nbsp;method&nbsp;is&nbsp;applicable.&nbsp;In&nbsp;one&nbsp;possible&nbsp;approach,&nbsp;the&nbsp;value&nbsp;of&nbsp;the&nbsp;UF&nbsp;would&nbsp;be&nbsp;linked&nbsp;to&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1471\">1471</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relative&nbsp;standard&nbsp;deviation&nbsp;of&nbsp;the&nbsp;response&nbsp;factors&nbsp;according&nbsp;to&nbsp;Formula\u00a0(E.2):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1472\">1472</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">mean</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1473\">1473</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">std</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1474\">1474</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">/&nbsp;1\u2212t&nbsp;\u00d7</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1475\">1475</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1476\">1476</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1477\">1477</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\uf8ee\uf8f0</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1478\">1478</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\uf8f9\uf8fb</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1479\">1479</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(E.2)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1480\">1480</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">where</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1481\">1481</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">mean</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1482\">1482</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;mean&nbsp;response&nbsp;factor&nbsp;from&nbsp;the&nbsp;reference&nbsp;database;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1483\">1483</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">t</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1484\">1484</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;desired&nbsp;degree&nbsp;of&nbsp;confidence;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1485\">1485</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">std</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1486\">1486</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;the&nbsp;standard&nbsp;deviation&nbsp;in&nbsp;the&nbsp;response&nbsp;factor&nbsp;database.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1487\">1487</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Applying&nbsp;commonly&nbsp;used&nbsp;statistics&nbsp;for&nbsp;normally&nbsp;distributed&nbsp;data,&nbsp;t&nbsp;=&nbsp;1&nbsp;would&nbsp;provide&nbsp;68\u00a0%&nbsp;confidence,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1488\">1488</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">t\u00a0=\u00a01,65&nbsp;would&nbsp;provide&nbsp;90\u00a0%&nbsp;confidence,&nbsp;t&nbsp;=&nbsp;2&nbsp;would&nbsp;provide&nbsp;95\u00a0%&nbsp;confidence,&nbsp;and&nbsp;t\u00a0=\u00a03&nbsp;would&nbsp;provide</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1489\">1489</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">99,7\u00a0%&nbsp;confidence.&nbsp;Note&nbsp;that&nbsp;when&nbsp;the&nbsp;mean&nbsp;response&nbsp;factor&nbsp;is&nbsp;1&nbsp;and&nbsp;t&nbsp;=&nbsp;1,&nbsp;Formula\u00a0(E.2)&nbsp;simplifies&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1490\">1490</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;proposed&nbsp;by&nbsp;PQRI&nbsp;and&nbsp;Jordi&nbsp;(see&nbsp;References&nbsp;[41]&nbsp;and&nbsp;[46]).&nbsp;There&nbsp;are&nbsp;two&nbsp;implications&nbsp;of&nbsp;these</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1491\">1491</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">points.&nbsp;First,&nbsp;if&nbsp;the&nbsp;mean&nbsp;response&nbsp;factor&nbsp;is&nbsp;not&nbsp;1,&nbsp;best&nbsp;practice&nbsp;would&nbsp;be&nbsp;to&nbsp;pick&nbsp;an&nbsp;internal&nbsp;standard</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1492\">1492</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;makes&nbsp;it&nbsp;1.&nbsp;This&nbsp;approach&nbsp;minimizes&nbsp;potential&nbsp;bias&nbsp;in&nbsp;this&nbsp;part&nbsp;of&nbsp;the&nbsp;analytical&nbsp;process.&nbsp;Second,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1493\">1493</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">use&nbsp;of&nbsp;t\u00a0=\u00a01&nbsp;is&nbsp;a&nbsp;reasonable&nbsp;option&nbsp;as&nbsp;it:&nbsp;1)&nbsp;is&nbsp;consistent&nbsp;with&nbsp;previously&nbsp;published&nbsp;approaches[41][46];&nbsp;2)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1494\">1494</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">actually&nbsp;provides&nbsp;a&nbsp;95\u00a0%&nbsp;level&nbsp;of&nbsp;confidence,&nbsp;because&nbsp;the&nbsp;distribution&nbsp;of&nbsp;interest&nbsp;is&nbsp;single&nbsp;tailed&nbsp;(i.e.&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1495\">1495</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;population&nbsp;outside&nbsp;of&nbsp;the&nbsp;confidence&nbsp;interval,&nbsp;only&nbsp;the&nbsp;half&nbsp;that&nbsp;would&nbsp;fall&nbsp;below&nbsp;the&nbsp;AET&nbsp;is&nbsp;a&nbsp;safety</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1496\">1496</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concern).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1497\">1497</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">When&nbsp;the&nbsp;variation&nbsp;in&nbsp;responses&nbsp;factors&nbsp;is&nbsp;large&nbsp;relative&nbsp;to&nbsp;the&nbsp;mean&nbsp;response&nbsp;factor&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1498\">1498</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">std\u00a0=\u00a00,9\u00a0X\u00a0mean),&nbsp;the&nbsp;variation&nbsp;in&nbsp;response&nbsp;factors&nbsp;is&nbsp;so&nbsp;large&nbsp;that&nbsp;although&nbsp;a&nbsp;UF&nbsp;can&nbsp;be&nbsp;calculated,&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1499\">1499</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">scientific&nbsp;validity&nbsp;becomes&nbsp;questionable.&nbsp;For&nbsp;example,&nbsp;while&nbsp;a&nbsp;UF&nbsp;&gt;&nbsp;10&nbsp;can&nbsp;be&nbsp;calculated,&nbsp;the&nbsp;fact&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1500\">1500</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;UF&nbsp;is&nbsp;as&nbsp;large&nbsp;as&nbsp;10&nbsp;(or&nbsp;larger)&nbsp;suggests&nbsp;that&nbsp;the&nbsp;quantification&nbsp;method&nbsp;being&nbsp;used&nbsp;is&nbsp;inherently</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1501\">1501</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">inaccurate&nbsp;and&nbsp;thus&nbsp;might&nbsp;not&nbsp;be&nbsp;appropriate&nbsp;for&nbsp;the&nbsp;purpose&nbsp;of&nbsp;toxicological&nbsp;safety&nbsp;risk&nbsp;assessment.&nbsp;In</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1502\">1502</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">this&nbsp;case,&nbsp;an&nbsp;adjusted&nbsp;AET&nbsp;should&nbsp;not&nbsp;be&nbsp;established&nbsp;and&nbsp;the&nbsp;concept&nbsp;of&nbsp;an&nbsp;AET&nbsp;should&nbsp;not&nbsp;be&nbsp;applied&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1503\">1503</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;method.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1504\">1504</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;cases&nbsp;where&nbsp;t&nbsp;\u00d7&nbsp;std&nbsp;&gt;&nbsp;1,&nbsp;a&nbsp;UF&nbsp;cannot&nbsp;be&nbsp;calculated,&nbsp;as&nbsp;the&nbsp;result&nbsp;is&nbsp;either&nbsp;infinity&nbsp;or&nbsp;a&nbsp;negative&nbsp;number.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1505\">1505</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Clearly&nbsp;an&nbsp;analytical&nbsp;method&nbsp;with&nbsp;this&nbsp;much&nbsp;variation&nbsp;in&nbsp;response&nbsp;factors&nbsp;is&nbsp;not&nbsp;suitable&nbsp;for&nbsp;the&nbsp;purpose</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1506\">1506</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;toxicological&nbsp;safety&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1507\">1507</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;any&nbsp;event,&nbsp;the&nbsp;use&nbsp;of&nbsp;the&nbsp;uncertainty&nbsp;factor,&nbsp;and&nbsp;the&nbsp;value&nbsp;of&nbsp;the&nbsp;uncertainty&nbsp;factor&nbsp;that&nbsp;is&nbsp;used,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1508\">1508</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">should&nbsp;always&nbsp;be&nbsp;justified.&nbsp;In&nbsp;some&nbsp;cases&nbsp;where&nbsp;the&nbsp;variation&nbsp;in&nbsp;response&nbsp;factors&nbsp;among&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1509\">1509</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">cannot&nbsp;be&nbsp;established&nbsp;or&nbsp;where&nbsp;the&nbsp;variation&nbsp;is&nbsp;established&nbsp;to&nbsp;be&nbsp;large,&nbsp;the&nbsp;value&nbsp;of&nbsp;UF&nbsp;can&nbsp;be&nbsp;so&nbsp;large</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1510\">1510</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(e.g.&nbsp;UF&nbsp;values&nbsp;of&nbsp;10&nbsp;or&nbsp;greater)&nbsp;that&nbsp;the&nbsp;AET&nbsp;becomes&nbsp;so&nbsp;low&nbsp;that&nbsp;the&nbsp;AET&nbsp;concept&nbsp;has&nbsp;little&nbsp;practical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1511\">1511</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">value&nbsp;(e.g.&nbsp;the&nbsp;analytical&nbsp;method\u2019s&nbsp;LOD&nbsp;or&nbsp;LOQ&nbsp;are&nbsp;greater&nbsp;than&nbsp;the&nbsp;AET).&nbsp;In&nbsp;such&nbsp;circumstances,&nbsp;use&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1512\">1512</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;AET&nbsp;cannot&nbsp;be&nbsp;justified&nbsp;and&nbsp;thus&nbsp;the&nbsp;AET&nbsp;should&nbsp;not&nbsp;be&nbsp;applied.&nbsp;In&nbsp;such&nbsp;cases,&nbsp;it&nbsp;can&nbsp;be&nbsp;necessary&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1513\">1513</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">identify&nbsp;and&nbsp;quantify&nbsp;all&nbsp;the&nbsp;compounds&nbsp;associated&nbsp;all&nbsp;observed&nbsp;analytical&nbsp;responses&nbsp;obtained&nbsp;by&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1514\">1514</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">screening&nbsp;analyses.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1515\">1515</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1516\">1516</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1517\">1517</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">53</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1518\">1518</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1519\">1519</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1520\">1520</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1521\">1521</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1522\">1522</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1523\">1523</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AET&nbsp;determination&nbsp;examples</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1524\">1524</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;A</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1525\">1525</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Consider&nbsp;a&nbsp;limited&nbsp;contact&nbsp;medical&nbsp;device&nbsp;(e.g.&nbsp;a&nbsp;balloon&nbsp;catheter)&nbsp;in&nbsp;which&nbsp;a&nbsp;single&nbsp;device&nbsp;is&nbsp;used</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1526\">1526</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">clinically&nbsp;and&nbsp;therapy&nbsp;is&nbsp;completed&nbsp;in&nbsp;less&nbsp;than&nbsp;1&nbsp;day.&nbsp;In&nbsp;the&nbsp;extraction&nbsp;study,&nbsp;a&nbsp;single&nbsp;device&nbsp;was</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1527\">1527</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extracted&nbsp;in&nbsp;9,0\u00a0ml&nbsp;of&nbsp;extracting&nbsp;vehicle.&nbsp;The&nbsp;resulting&nbsp;extract&nbsp;was&nbsp;neither&nbsp;diluted&nbsp;nor&nbsp;concentrated.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1528\">1528</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">GC-FID&nbsp;was&nbsp;used&nbsp;as&nbsp;the&nbsp;analytical&nbsp;method;&nbsp;therefore,&nbsp;an&nbsp;uncertainty&nbsp;factor&nbsp;of&nbsp;2&nbsp;was&nbsp;considered</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1529\">1529</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate.&nbsp;In&nbsp;this&nbsp;case,&nbsp;the&nbsp;value&nbsp;of&nbsp;the&nbsp;DBT&nbsp;was&nbsp;set&nbsp;to&nbsp;the&nbsp;ICH&nbsp;M7&nbsp;TTC&nbsp;for&nbsp;potentially&nbsp;mutagenic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1530\">1530</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">impurities[18],&nbsp;and&nbsp;DBT\u00a0=\u00a0TTC\u00a0=\u00a0120\u00a0\u03bcg/d&nbsp;(duration&nbsp;of&nbsp;treatment&nbsp;24&nbsp;h).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1531\">1531</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A&nbsp;=&nbsp;1&nbsp;device</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1532\">1532</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B&nbsp;=&nbsp;9,0&nbsp;ml</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1533\">1533</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C&nbsp;=&nbsp;1&nbsp;device/d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1534\">1534</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UF&nbsp;=&nbsp;2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1535\">1535</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;AET&nbsp;is&nbsp;calculated&nbsp;as&nbsp;given&nbsp;by&nbsp;application&nbsp;of&nbsp;Formula\u00a0(E.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1536\">1536</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u03bcg/mL)&nbsp;=&nbsp;{120&nbsp;\u03bcg/d&nbsp;\u00d7&nbsp;[1&nbsp;device/(1&nbsp;device/d&nbsp;\u00d7&nbsp;9,0&nbsp;ml)]}&nbsp;\u00f7&nbsp;2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1537\">1537</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u03bcg/mL)&nbsp;=&nbsp;6,6&nbsp;\u03bcg/ml</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1538\">1538</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;B</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1539\">1539</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Consider&nbsp;a&nbsp;medical&nbsp;device&nbsp;that&nbsp;is&nbsp;used&nbsp;in&nbsp;a&nbsp;therapy&nbsp;which&nbsp;is&nbsp;completed&nbsp;in&nbsp;7\u00a0d.&nbsp;On&nbsp;each&nbsp;day&nbsp;of&nbsp;therapy,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1540\">1540</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2\u00a0devices&nbsp;are&nbsp;required.&nbsp;In&nbsp;the&nbsp;extraction&nbsp;study,&nbsp;4&nbsp;devices&nbsp;were&nbsp;extracted&nbsp;in&nbsp;100\u00a0ml&nbsp;of&nbsp;extracting&nbsp;vehicle.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1541\">1541</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;resulting&nbsp;extract&nbsp;was&nbsp;neither&nbsp;diluted&nbsp;nor&nbsp;concentrated.&nbsp;The&nbsp;analytical&nbsp;method&nbsp;was&nbsp;supported&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1542\">1542</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;response&nbsp;factor&nbsp;database&nbsp;which&nbsp;established&nbsp;that&nbsp;the&nbsp;response&nbsp;factors&nbsp;were&nbsp;acceptably&nbsp;consistent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1543\">1543</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">between&nbsp;extractables.&nbsp;In&nbsp;this&nbsp;case,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1544\">1544</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DBT\u00a0&nbsp;=\u00a0&nbsp;TTC\u00a0&nbsp;=\u00a0&nbsp;120\u00a0&nbsp;\u00b5g/d&nbsp;(M7&nbsp;assessment&nbsp;for&nbsp;potentially&nbsp;mutagenic&nbsp;impurities,&nbsp;duration&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1545\">1545</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">treatment\u00a0\u2264\u00a01\u00a0month),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1546\">1546</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A\u00a0=\u00a04&nbsp;medical&nbsp;devices,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1547\">1547</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B\u00a0=\u00a0100\u00a0ml,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1548\">1548</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C\u00a0=\u00a02&nbsp;medical&nbsp;devices/d,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1549\">1549</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UF\u00a0=\u00a01.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1550\">1550</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;AET&nbsp;is&nbsp;calculated&nbsp;as&nbsp;given&nbsp;by&nbsp;application&nbsp;of&nbsp;Formula\u00a0(E.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1551\">1551</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)\u00a0=\u00a0{120\u00a0\u00b5g/d\u00a0\u00d7\u00a0[4\u00a0devices/(2\u00a0devices/d\u00a0\u00d7\u00a0100\u00a0ml)]}\u00a0\u00f7\u00a01</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1552\">1552</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)\u00a0=\u00a02,4\u00a0\u00b5g/ml</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1553\">1553</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;C.1</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1554\">1554</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Consider&nbsp;a&nbsp;medical&nbsp;device&nbsp;that&nbsp;is&nbsp;permanently&nbsp;implanted&nbsp;(e.g.&nbsp;a&nbsp;cardiovascular&nbsp;stent),&nbsp;and&nbsp;a&nbsp;single</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1555\">1555</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">device&nbsp;is&nbsp;used.&nbsp;The&nbsp;circumstance&nbsp;that&nbsp;this&nbsp;is&nbsp;a&nbsp;permanent&nbsp;implant&nbsp;requires&nbsp;that&nbsp;the&nbsp;extraction&nbsp;study</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1556\">1556</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;exhaustive.&nbsp;In&nbsp;the&nbsp;extraction&nbsp;study,&nbsp;20&nbsp;devices&nbsp;were&nbsp;extracted&nbsp;in&nbsp;33,3\u00a0ml&nbsp;of&nbsp;extracting&nbsp;vehicle.&nbsp;The</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1557\">1557</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exhaustive&nbsp;extraction&nbsp;was&nbsp;accomplished&nbsp;in&nbsp;2&nbsp;sequential&nbsp;extracts,&nbsp;meaning&nbsp;that&nbsp;the&nbsp;levels&nbsp;of&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1558\">1558</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">present&nbsp;in&nbsp;the&nbsp;second&nbsp;extract&nbsp;was&nbsp;less&nbsp;than&nbsp;10\u00a0%&nbsp;of&nbsp;the&nbsp;levels&nbsp;present&nbsp;in&nbsp;the&nbsp;first&nbsp;extract.&nbsp;The&nbsp;resulting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1559\">1559</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extract&nbsp;was&nbsp;neither&nbsp;diluted&nbsp;nor&nbsp;concentrated.&nbsp;The&nbsp;analytical&nbsp;method&nbsp;had&nbsp;a&nbsp;response&nbsp;factor&nbsp;database</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1560\">1560</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">which&nbsp;established&nbsp;that&nbsp;the&nbsp;%RSD&nbsp;of&nbsp;response&nbsp;factors&nbsp;was&nbsp;25\u00a0%,&nbsp;suggesting&nbsp;that&nbsp;a&nbsp;UF&nbsp;value&nbsp;of&nbsp;2&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1561\">1561</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">appropriate.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1562\">1562</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1563\">1563</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">54\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1564\">1564</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1565\">1565</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1566\">1566</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1567\">1567</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1568\">1568</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1569\">1569</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1570\">1570</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;C.2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1571\">1571</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;this&nbsp;case,&nbsp;the&nbsp;critical&nbsp;issue&nbsp;is&nbsp;establishing&nbsp;the&nbsp;proper&nbsp;DBT.&nbsp;Because&nbsp;the&nbsp;device&nbsp;is&nbsp;a&nbsp;permanent&nbsp;implant,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1572\">1572</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;most&nbsp;likely&nbsp;leaching&nbsp;scenario&nbsp;is&nbsp;that&nbsp;all&nbsp;extractables&nbsp;present&nbsp;in&nbsp;the&nbsp;medical&nbsp;device&nbsp;will&nbsp;leach&nbsp;out&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1573\">1573</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;device&nbsp;during&nbsp;the&nbsp;device/patient&nbsp;contact.&nbsp;This&nbsp;is&nbsp;why&nbsp;the&nbsp;proper&nbsp;extraction&nbsp;study&nbsp;for&nbsp;a&nbsp;permanent</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1574\">1574</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">implant&nbsp;is&nbsp;an&nbsp;exhaustive&nbsp;extraction.&nbsp;Considering&nbsp;potentially&nbsp;mutagenic&nbsp;extractables,&nbsp;a&nbsp;DBT&nbsp;of&nbsp;120\u00a0\u00b5g/d</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1575\">1575</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;appropriate,&nbsp;regardless&nbsp;of&nbsp;leaching&nbsp;kinetics,&nbsp;as&nbsp;illustrated&nbsp;below.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1576\">1576</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Consider&nbsp;a&nbsp;mutagenic&nbsp;substance,&nbsp;revealed&nbsp;after&nbsp;exhaustive&nbsp;extraction&nbsp;with&nbsp;a&nbsp;level&nbsp;of&nbsp;120\u00a0\u00b5g/d,&nbsp;which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1577\">1577</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">corresponds&nbsp;to&nbsp;120&nbsp;\u00b5g/device&nbsp;in&nbsp;the&nbsp;example&nbsp;above&nbsp;based&nbsp;on&nbsp;a&nbsp;single&nbsp;device.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1578\">1578</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If&nbsp;the&nbsp;120&nbsp;\u00b5g/device&nbsp;is&nbsp;leached&nbsp;in&nbsp;1&nbsp;d,&nbsp;the&nbsp;amount&nbsp;leached&nbsp;is&nbsp;equal&nbsp;to&nbsp;120\u00a0\u00b5g/day,&nbsp;which&nbsp;is&nbsp;the&nbsp;TTC</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1579\">1579</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;this&nbsp;duration&nbsp;category&nbsp;per&nbsp;ICH&nbsp;M7.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1580\">1580</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If&nbsp;the&nbsp;120&nbsp;\u00b5g/device&nbsp;is&nbsp;leached&nbsp;in&nbsp;31&nbsp;d&nbsp;(1&nbsp;month),&nbsp;the&nbsp;amount&nbsp;leached&nbsp;is&nbsp;120/31\u00a0=\u00a03,9\u00a0\u00b5g/d,&nbsp;which&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1581\">1581</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">lower&nbsp;than&nbsp;20&nbsp;\u00b5g/d,&nbsp;the&nbsp;TTC&nbsp;for&nbsp;this&nbsp;duration&nbsp;category&nbsp;per&nbsp;ICH&nbsp;M7.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1582\">1582</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If&nbsp;the&nbsp;120&nbsp;\u00b5g/device&nbsp;is&nbsp;leached&nbsp;in&nbsp;365&nbsp;d&nbsp;(1&nbsp;year),&nbsp;the&nbsp;amount&nbsp;leached&nbsp;is&nbsp;120/365\u00a0=\u00a00,33\u00a0\u00b5g/d,&nbsp;which</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1583\">1583</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;lower&nbsp;than&nbsp;10&nbsp;\u00b5g/d,&nbsp;the&nbsp;TTC&nbsp;for&nbsp;this&nbsp;duration&nbsp;category&nbsp;per&nbsp;ICH&nbsp;M7.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1584\">1584</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If&nbsp;the&nbsp;120&nbsp;\u00b5g/device&nbsp;is&nbsp;leached&nbsp;in&nbsp;3\u00a0650&nbsp;d&nbsp;(10&nbsp;years),&nbsp;the&nbsp;amount&nbsp;leached&nbsp;is&nbsp;120/3\u00a0650\u00a0=\u00a00,033\u00a0\u00b5g/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1585\">1585</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">day,&nbsp;which&nbsp;is&nbsp;lower&nbsp;than&nbsp;1,5&nbsp;\u00b5g/d,&nbsp;the&nbsp;TTC&nbsp;for&nbsp;this&nbsp;duration&nbsp;category&nbsp;per&nbsp;ICH&nbsp;M7.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1586\">1586</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note&nbsp;that&nbsp;20&nbsp;\u00b5g/d&nbsp;for&nbsp;31&nbsp;ds&nbsp;would&nbsp;be&nbsp;an&nbsp;exposure&nbsp;of&nbsp;620&nbsp;\u00b5g,&nbsp;10&nbsp;\u00b5g/d&nbsp;for&nbsp;365&nbsp;d&nbsp;would&nbsp;be&nbsp;an&nbsp;exposure&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1587\">1587</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">3,650&nbsp;\u00b5g,&nbsp;and&nbsp;1,5\u00a0\u00b5g/d&nbsp;for&nbsp;3\u00a0650&nbsp;d&nbsp;would&nbsp;be&nbsp;an&nbsp;exposure&nbsp;of&nbsp;5,475\u00a0\u00b5g.&nbsp;Each&nbsp;of&nbsp;these&nbsp;theoretical&nbsp;extreme</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1588\">1588</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">approaches&nbsp;would&nbsp;therefore&nbsp;be&nbsp;less&nbsp;conservative.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1589\">1589</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;this&nbsp;case,&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;AET&nbsp;proceeds&nbsp;as&nbsp;follows:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1590\">1590</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DBT\u00a0=\u00a0TTC\u00a0=\u00a0120&nbsp;\u00b5g/day&nbsp;(Note,&nbsp;however,&nbsp;that&nbsp;this&nbsp;DBT&nbsp;is&nbsp;\u201cdistributed\u201d&nbsp;over&nbsp;both&nbsp;extraction&nbsp;steps;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1591\">1591</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">thus,&nbsp;the&nbsp;DBT&nbsp;for&nbsp;each&nbsp;extraction&nbsp;step&nbsp;is&nbsp;120&nbsp;\u00b5g/d&nbsp;\u00f7&nbsp;2&nbsp;extracts&nbsp;=&nbsp;60&nbsp;\u00b5g/d)&nbsp;A\u00a0=\u00a020\u00a0medical&nbsp;devices,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1592\">1592</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B\u00a0=\u00a033,3\u00a0ml,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1593\">1593</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C\u00a0=\u00a01&nbsp;medical&nbsp;devices/d,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1594\">1594</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UF\u00a0=\u00a02.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1595\">1595</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;AET&nbsp;is&nbsp;calculated&nbsp;as&nbsp;given&nbsp;by&nbsp;application&nbsp;of&nbsp;Formula\u00a0(E.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1596\">1596</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)\u00a0=\u00a0{60\u00a0\u00b5g/d\u00a0\u00d7\u00a0[20\u00a0devices/(1\u00a0device/d\u00a0\u00d7\u00a033,3&nbsp;ml)]}\u00a0\u00f7\u00a02</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1597\">1597</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)\u00a0=\u00a018\u00a0\u00b5g/ml</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1598\">1598</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EXAMPLE&nbsp;C.3</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1599\">1599</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Because&nbsp;the&nbsp;device&nbsp;was&nbsp;exhaustively&nbsp;extracted&nbsp;to&nbsp;screen&nbsp;for&nbsp;toxic&nbsp;chemicals&nbsp;to&nbsp;which&nbsp;the&nbsp;patient</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1600\">1600</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">could&nbsp;be&nbsp;exposed,&nbsp;application&nbsp;of&nbsp;1,5&nbsp;\u00b5g/d&nbsp;without&nbsp;modification&nbsp;is&nbsp;the&nbsp;most&nbsp;conservative&nbsp;approach&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1601\">1601</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">can&nbsp;be&nbsp;applied&nbsp;so&nbsp;that&nbsp;all&nbsp;toxic&nbsp;chemicals&nbsp;present&nbsp;in/on&nbsp;the&nbsp;device&nbsp;will&nbsp;be&nbsp;identified/quantified&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1602\">1602</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">toxicological&nbsp;risk&nbsp;assessed.&nbsp;In&nbsp;this&nbsp;highly&nbsp;conservative&nbsp;approach,&nbsp;the&nbsp;expected&nbsp;DBT&nbsp;becomes&nbsp;the&nbsp;TTC&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1603\">1603</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">1,5\u00a0\u00b5g/d&nbsp;and&nbsp;the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;AET&nbsp;proceeds&nbsp;as&nbsp;follows:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1604\">1604</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DBT&nbsp;=&nbsp;TTC&nbsp;=&nbsp;1,5&nbsp;\u00b5g/d&nbsp;(Note,&nbsp;however,&nbsp;that&nbsp;this&nbsp;DBT&nbsp;is&nbsp;\u201cdistributed\u201d&nbsp;over&nbsp;both&nbsp;extraction&nbsp;steps.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1605\">1605</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Thus,&nbsp;the&nbsp;DBT&nbsp;for&nbsp;each&nbsp;extraction&nbsp;step&nbsp;is&nbsp;1,5&nbsp;\u00b5g/d&nbsp;\u00f7&nbsp;2&nbsp;extracts&nbsp;=&nbsp;0,75&nbsp;\u00b5g/d),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1606\">1606</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A&nbsp;=&nbsp;20&nbsp;medical&nbsp;devices,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1607\">1607</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B&nbsp;=&nbsp;33,3&nbsp;ml,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1608\">1608</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C&nbsp;=&nbsp;1&nbsp;medical&nbsp;devices/d,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1609\">1609</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UF&nbsp;=&nbsp;2.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1610\">1610</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1611\">1611</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1612\">1612</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">55</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1613\">1613</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1614\">1614</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1615\">1615</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1616\">1616</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1617\">1617</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1618\">1618</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;AET&nbsp;is&nbsp;calculated&nbsp;as&nbsp;given&nbsp;by&nbsp;application&nbsp;of&nbsp;Formula\u00a0(E.1):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1619\">1619</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)&nbsp;=&nbsp;{0,75&nbsp;\u00b5g/d&nbsp;\u00d7&nbsp;[20&nbsp;devices/(1&nbsp;device/d&nbsp;\u00d7&nbsp;33,3&nbsp;ml)]}&nbsp;\u00f7&nbsp;2</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1620\">1620</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">AET&nbsp;(\u00b5g/ml)&nbsp;=&nbsp;0,23&nbsp;\u00b5g/ml</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1621\">1621</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1622\">1622</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Data&nbsp;establishing&nbsp;the&nbsp;actual&nbsp;release&nbsp;kinetics&nbsp;of&nbsp;leachables&nbsp;can&nbsp;be&nbsp;an&nbsp;essential&nbsp;input&nbsp;for&nbsp;establishing</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1623\">1623</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">an&nbsp;appropriately&nbsp;conservative&nbsp;DBT.&nbsp;If&nbsp;the&nbsp;actual&nbsp;release&nbsp;kinetics&nbsp;of&nbsp;leachables&nbsp;establishes&nbsp;that&nbsp;the&nbsp;exposure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1624\">1624</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;extractables&nbsp;is&nbsp;less&nbsp;than&nbsp;10&nbsp;years,&nbsp;then&nbsp;the&nbsp;kinetic&nbsp;data&nbsp;can&nbsp;potentially&nbsp;support&nbsp;a&nbsp;higher&nbsp;DBT&nbsp;value&nbsp;(see</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1625\">1625</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO/TS\u00a021726).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1626\">1626</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use&nbsp;of&nbsp;the&nbsp;AET</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1627\">1627</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;conversion&nbsp;of&nbsp;the&nbsp;DBT&nbsp;to&nbsp;an&nbsp;AET&nbsp;enables&nbsp;an&nbsp;analytical&nbsp;chemist&nbsp;to&nbsp;address&nbsp;the&nbsp;question&nbsp;of&nbsp;whether</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1628\">1628</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a&nbsp;specific&nbsp;extractable&nbsp;need&nbsp;be&nbsp;identified&nbsp;and&nbsp;quantified.&nbsp;However,&nbsp;analytical&nbsp;methods&nbsp;do&nbsp;not&nbsp;produce</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1629\">1629</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentrations&nbsp;directly&nbsp;but&nbsp;a&nbsp;response&nbsp;in&nbsp;units&nbsp;that&nbsp;should&nbsp;be&nbsp;converted&nbsp;to&nbsp;concentrations.&nbsp;For&nbsp;example,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1630\">1630</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;output&nbsp;of&nbsp;chromatographic&nbsp;analysis&nbsp;of&nbsp;a&nbsp;sample&nbsp;is&nbsp;a&nbsp;chromatogram&nbsp;in&nbsp;which&nbsp;extractables&nbsp;appear&nbsp;as</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1631\">1631</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">peaks&nbsp;in&nbsp;the&nbsp;chromatogram&nbsp;(see&nbsp;Figure\u00a0E.1).&nbsp;In&nbsp;this&nbsp;case,&nbsp;peak&nbsp;A&nbsp;corresponds&nbsp;to&nbsp;an&nbsp;analyte&nbsp;present&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1632\">1632</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;test&nbsp;sample&nbsp;at&nbsp;a&nbsp;concentration&nbsp;equal&nbsp;to&nbsp;the&nbsp;AET.&nbsp;Thus,&nbsp;a&nbsp;horizontal&nbsp;AET&nbsp;line&nbsp;can&nbsp;be&nbsp;drawn&nbsp;across&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1633\">1633</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">chromatogram&nbsp;using&nbsp;the&nbsp;apex&nbsp;of&nbsp;A&nbsp;as&nbsp;the&nbsp;reference&nbsp;point.&nbsp;Peaks&nbsp;whose&nbsp;responses&nbsp;fall&nbsp;above&nbsp;such&nbsp;a&nbsp;line</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1634\">1634</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(e.g.&nbsp;peak\u00a0B)&nbsp;are&nbsp;present&nbsp;in&nbsp;the&nbsp;sample&nbsp;at&nbsp;levels&nbsp;above&nbsp;the&nbsp;AET&nbsp;and&nbsp;the&nbsp;substance&nbsp;responsible&nbsp;for&nbsp;peak</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1635\">1635</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">B&nbsp;should&nbsp;be&nbsp;identified&nbsp;and&nbsp;reported&nbsp;for&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Peaks&nbsp;whose&nbsp;response&nbsp;fall&nbsp;below</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1636\">1636</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;line&nbsp;(e.g.&nbsp;peak\u00a0C)&nbsp;are&nbsp;present&nbsp;in&nbsp;the&nbsp;sample&nbsp;at&nbsp;levels&nbsp;below&nbsp;the&nbsp;AET&nbsp;and&nbsp;do&nbsp;not&nbsp;need&nbsp;to&nbsp;be&nbsp;identified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1637\">1637</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;toxicological&nbsp;risk&nbsp;assessment.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1638\">1638</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Figure\u00a0E.1\u00a0\u2014&nbsp;Application&nbsp;of&nbsp;the&nbsp;AET&nbsp;in&nbsp;chromatographic&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1639\">1639</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Although&nbsp;Figure\u00a0&nbsp;E.1&nbsp;illustrates&nbsp;the&nbsp;application&nbsp;of&nbsp;the&nbsp;AET&nbsp;in&nbsp;terms&nbsp;of&nbsp;peak&nbsp;height,&nbsp;peak&nbsp;area&nbsp;may</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1640\">1640</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">also&nbsp;be&nbsp;used&nbsp;to&nbsp;compare&nbsp;individual&nbsp;extractables&nbsp;peaks&nbsp;with&nbsp;the&nbsp;AET&nbsp;and&nbsp;can&nbsp;be&nbsp;more&nbsp;appropriate.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1641\">1641</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Furthermore,&nbsp;while&nbsp;this&nbsp;example&nbsp;and&nbsp;illustration&nbsp;specifically&nbsp;relates&nbsp;to&nbsp;chromatographic&nbsp;analysis,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1642\">1642</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concept&nbsp;of&nbsp;the&nbsp;AET&nbsp;is&nbsp;widely&nbsp;applicable&nbsp;to&nbsp;many&nbsp;analytical&nbsp;techniques.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1643\">1643</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">E.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exclusions&nbsp;to&nbsp;the&nbsp;AET;&nbsp;cohorts&nbsp;of&nbsp;concern</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1644\">1644</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;term&nbsp;\u201ccohorts&nbsp;of&nbsp;concern\u201d&nbsp;has&nbsp;been&nbsp;applied&nbsp;to&nbsp;those&nbsp;sets&nbsp;of&nbsp;compounds&nbsp;that&nbsp;possess&nbsp;structural</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1645\">1645</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">groups&nbsp;of&nbsp;such&nbsp;high&nbsp;potency&nbsp;that&nbsp;intakes&nbsp;even&nbsp;below&nbsp;the&nbsp;TTC&nbsp;would&nbsp;be&nbsp;associated&nbsp;with&nbsp;a&nbsp;potential&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1646\">1646</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1647\">1647</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">56\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1648\">1648</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1649\">1649</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1650\">1650</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1651\">1651</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1652\">1652</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1653\">1653</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1654\">1654</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">significant&nbsp;patient&nbsp;safety&nbsp;risk,&nbsp;including,&nbsp;but&nbsp;not&nbsp;necessarily&nbsp;limited&nbsp;to,&nbsp;carcinogenic&nbsp;risk.&nbsp;Compound</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1655\">1655</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">classes&nbsp;that&nbsp;comprise&nbsp;the&nbsp;cohorts&nbsp;of&nbsp;concern&nbsp;are&nbsp;described&nbsp;in&nbsp;ISO/TS\u00a021726.&nbsp;Some&nbsp;colorants&nbsp;can&nbsp;also</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1656\">1656</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">have&nbsp;the&nbsp;potential&nbsp;to&nbsp;raise&nbsp;concern&nbsp;and&nbsp;should&nbsp;be&nbsp;considered&nbsp;for&nbsp;exclusion&nbsp;from&nbsp;the&nbsp;AET.&nbsp;See&nbsp;also</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1657\">1657</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Reference\u00a0[42]&nbsp;and&nbsp;ISO\u00a010993-17.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1658\">1658</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;previously&nbsp;established&nbsp;convention&nbsp;that&nbsp;extractables&nbsp;below&nbsp;the&nbsp;AET&nbsp;are&nbsp;taken&nbsp;to&nbsp;be&nbsp;toxicologically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1659\">1659</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">safe&nbsp;regardless&nbsp;of&nbsp;their&nbsp;identities&nbsp;is&nbsp;clearly&nbsp;not&nbsp;applicable&nbsp;for&nbsp;a&nbsp;cohort&nbsp;of&nbsp;concern,&nbsp;as&nbsp;by&nbsp;definition&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1660\">1660</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">cohort&nbsp;could&nbsp;pose&nbsp;a&nbsp;risk&nbsp;even&nbsp;at&nbsp;concentrations&nbsp;below&nbsp;the&nbsp;AET.&nbsp;Since&nbsp;the&nbsp;AET&nbsp;is&nbsp;both&nbsp;an&nbsp;identification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1661\">1661</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;quantification&nbsp;threshold,&nbsp;the&nbsp;cohorts&nbsp;of&nbsp;concern&nbsp;present&nbsp;an&nbsp;analytical&nbsp;dilemma&nbsp;in&nbsp;the&nbsp;sense&nbsp;that&nbsp;it</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1662\">1662</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;impossible&nbsp;to&nbsp;know&nbsp;whether&nbsp;a&nbsp;compound&nbsp;whose&nbsp;concentration&nbsp;is&nbsp;less&nbsp;than&nbsp;the&nbsp;AET&nbsp;is&nbsp;from&nbsp;a&nbsp;cohort&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1663\">1663</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concern&nbsp;unless&nbsp;the&nbsp;compound&nbsp;is&nbsp;identified&nbsp;at&nbsp;the&nbsp;extent&nbsp;that&nbsp;its&nbsp;molecular&nbsp;structure&nbsp;can&nbsp;be&nbsp;established</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1664\">1664</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;sufficient&nbsp;detail&nbsp;to&nbsp;allow&nbsp;for&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Although&nbsp;there&nbsp;are&nbsp;several&nbsp;options&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1665\">1665</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">reconciling&nbsp;the&nbsp;AET&nbsp;with&nbsp;potential&nbsp;cohorts&nbsp;of&nbsp;concern,&nbsp;some&nbsp;are&nbsp;not&nbsp;practical.&nbsp;For&nbsp;example,&nbsp;rejecting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1666\">1666</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;AET&nbsp;concept&nbsp;based&nbsp;on&nbsp;the&nbsp;possibility&nbsp;that&nbsp;there&nbsp;might&nbsp;be&nbsp;an&nbsp;extractable&nbsp;that&nbsp;is&nbsp;a&nbsp;cohort&nbsp;of&nbsp;concern</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1667\">1667</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;likely&nbsp;an&nbsp;excessively&nbsp;conservative&nbsp;response&nbsp;to&nbsp;a&nbsp;relatively&nbsp;low&nbsp;probability&nbsp;circumstance.&nbsp;Rather,&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1668\">1668</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">decision&nbsp;is&nbsp;whether&nbsp;to&nbsp;accept&nbsp;the&nbsp;low&nbsp;risk&nbsp;of&nbsp;a&nbsp;cohort&nbsp;of&nbsp;concern&nbsp;and&nbsp;apply&nbsp;the&nbsp;AET&nbsp;to&nbsp;all&nbsp;the&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1669\">1669</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">responses&nbsp;or&nbsp;to&nbsp;perform&nbsp;testing&nbsp;whose&nbsp;purpose&nbsp;is&nbsp;to&nbsp;establish&nbsp;whether&nbsp;one&nbsp;or&nbsp;more&nbsp;substances&nbsp;from&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1670\">1670</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">cohort&nbsp;of&nbsp;concern&nbsp;could&nbsp;be&nbsp;present.&nbsp;To&nbsp;facilitate&nbsp;the&nbsp;decision-making&nbsp;process,&nbsp;the&nbsp;following&nbsp;approach&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1671\">1671</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">recommended.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1672\">1672</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When&nbsp;there&nbsp;is&nbsp;experimental&nbsp;evidence&nbsp;or&nbsp;a&nbsp;compositional&nbsp;reason&nbsp;to&nbsp;suspect&nbsp;that&nbsp;a&nbsp;cohort&nbsp;of&nbsp;concern</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1673\">1673</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">could&nbsp;be&nbsp;present,&nbsp;then&nbsp;either&nbsp;the&nbsp;general&nbsp;absence&nbsp;of&nbsp;cohorts&nbsp;of&nbsp;concern&nbsp;should&nbsp;be&nbsp;established&nbsp;by</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1674\">1674</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">information&nbsp;gathering&nbsp;and&nbsp;proper&nbsp;documentation,&nbsp;or&nbsp;the&nbsp;extracts&nbsp;should&nbsp;be&nbsp;screened&nbsp;for&nbsp;targeted</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1675\">1675</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">potential&nbsp;substances&nbsp;from&nbsp;cohorts&nbsp;of&nbsp;concern.&nbsp;In&nbsp;the&nbsp;absence&nbsp;of&nbsp;cohorts&nbsp;of&nbsp;concern,&nbsp;the&nbsp;AET&nbsp;can</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1676\">1676</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">be&nbsp;applied&nbsp;to&nbsp;all&nbsp;analytical&nbsp;responses.&nbsp;If&nbsp;cohorts&nbsp;of&nbsp;concern&nbsp;are&nbsp;present,&nbsp;then&nbsp;the&nbsp;AET&nbsp;can&nbsp;only&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1677\">1677</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">applied&nbsp;to&nbsp;those&nbsp;analytical&nbsp;responses&nbsp;that&nbsp;are&nbsp;not&nbsp;attributable&nbsp;to&nbsp;cohorts&nbsp;of&nbsp;concern.&nbsp;Analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1678\">1678</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">responses&nbsp;attributable&nbsp;to&nbsp;a&nbsp;cohort&nbsp;substance&nbsp;should&nbsp;be&nbsp;safety&nbsp;assessed&nbsp;based&nbsp;on&nbsp;the&nbsp;concentration</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1679\">1679</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;cohort&nbsp;substance&nbsp;and&nbsp;its&nbsp;toxicological&nbsp;safety&nbsp;data.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1680\">1680</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When&nbsp;there&nbsp;is&nbsp;no&nbsp;experimental&nbsp;evidence&nbsp;or&nbsp;a&nbsp;compositional&nbsp;reason&nbsp;that&nbsp;suggests&nbsp;that&nbsp;a&nbsp;cohort</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1681\">1681</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">substance&nbsp;could&nbsp;be&nbsp;present,&nbsp;it&nbsp;can&nbsp;be&nbsp;concluded&nbsp;that&nbsp;it&nbsp;is&nbsp;unlikely&nbsp;that&nbsp;a&nbsp;cohort&nbsp;of&nbsp;concern&nbsp;is&nbsp;present</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1682\">1682</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;AET&nbsp;can&nbsp;be&nbsp;applied&nbsp;to&nbsp;all&nbsp;analytical&nbsp;responses.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1683\">1683</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1684\">1684</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1685\">1685</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">57</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1686\">1686</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1687\">1687</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1688\">1688</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1689\">1689</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1690\">1690</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1691\">1691</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0F</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1692\">1692</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1693\">1693</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1694\">1694</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualification&nbsp;of&nbsp;analytical&nbsp;methods&nbsp;used&nbsp;for&nbsp;extractables/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1695\">1695</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1696\">1696</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">An&nbsp;analytical&nbsp;method&nbsp;is&nbsp;qualified&nbsp;to&nbsp;establish&nbsp;that&nbsp;it&nbsp;is&nbsp;suited&nbsp;for&nbsp;its&nbsp;intended&nbsp;purpose.&nbsp;In&nbsp;extractables/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1697\">1697</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">leachables&nbsp;studies,&nbsp;analytical&nbsp;methods&nbsp;serve&nbsp;one&nbsp;of&nbsp;two&nbsp;purposes;&nbsp;screening&nbsp;samples&nbsp;for&nbsp;unspecified</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1698\">1698</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytes&nbsp;and&nbsp;testing&nbsp;samples&nbsp;for&nbsp;specified&nbsp;(targeted)&nbsp;analytes.&nbsp;As&nbsp;these&nbsp;purposes&nbsp;are&nbsp;quite&nbsp;different,&nbsp;it</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1699\">1699</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;reasonable&nbsp;to&nbsp;suspect&nbsp;that&nbsp;their&nbsp;qualification&nbsp;would&nbsp;differ.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1700\">1700</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;qualification&nbsp;of&nbsp;an&nbsp;analytical&nbsp;method&nbsp;is&nbsp;documented&nbsp;in&nbsp;a&nbsp;qualification&nbsp;protocol,&nbsp;which&nbsp;establishes&nbsp;the:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1701\">1701</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;relevant&nbsp;qualification&nbsp;parameters;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1702\">1702</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;experimental&nbsp;means&nbsp;by&nbsp;which&nbsp;the&nbsp;qualification&nbsp;parameters&nbsp;will&nbsp;be&nbsp;assessed;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1703\">1703</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;performance&nbsp;expectations&nbsp;for&nbsp;each&nbsp;parameter.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1704\">1704</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualification&nbsp;parameters&nbsp;that&nbsp;are&nbsp;specifically&nbsp;relevant&nbsp;to&nbsp;screening&nbsp;methods&nbsp;include:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1705\">1705</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sensitivity,&nbsp;as&nbsp;it&nbsp;is&nbsp;expected&nbsp;that&nbsp;the&nbsp;method\u2019s&nbsp;LOQ&nbsp;be&nbsp;less&nbsp;than&nbsp;or&nbsp;equal&nbsp;to&nbsp;the&nbsp;reporting&nbsp;threshold</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1706\">1706</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(note&nbsp;that&nbsp;this&nbsp;expectation&nbsp;is&nbsp;discussed&nbsp;in&nbsp;greater&nbsp;detail&nbsp;in&nbsp;Annex\u00a0E);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1707\">1707</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE\u00a01</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1708\">1708</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;cases&nbsp;of&nbsp;very&nbsp;low&nbsp;reporting&nbsp;thresholds,&nbsp;it&nbsp;might&nbsp;not&nbsp;be&nbsp;possible&nbsp;to&nbsp;achieve&nbsp;an&nbsp;LOQ&nbsp;which&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1709\">1709</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">less&nbsp;than&nbsp;or&nbsp;equal&nbsp;to&nbsp;the&nbsp;reporting&nbsp;threshold.&nbsp;In&nbsp;such&nbsp;cases,&nbsp;the&nbsp;lowest&nbsp;reasonably&nbsp;attainable&nbsp;LOQ&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1710\">1710</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">used,&nbsp;and&nbsp;all&nbsp;analytes&nbsp;above&nbsp;this&nbsp;LOQ&nbsp;should&nbsp;be&nbsp;reported.&nbsp;If&nbsp;the&nbsp;LOQ&nbsp;is&nbsp;higher&nbsp;than&nbsp;the&nbsp;AET,&nbsp;this&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1711\">1711</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">explained&nbsp;and&nbsp;justified.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1712\">1712</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;specificity,&nbsp;which&nbsp;is&nbsp;ability&nbsp;to&nbsp;assess&nbsp;unequivocally&nbsp;the&nbsp;analyte&nbsp;in&nbsp;the&nbsp;presence&nbsp;of&nbsp;other&nbsp;constituents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1713\">1713</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;can&nbsp;be&nbsp;expected&nbsp;in&nbsp;the&nbsp;sample;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1714\">1714</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;accuracy,&nbsp;taken&nbsp;as&nbsp;the&nbsp;ability&nbsp;to&nbsp;produce&nbsp;a&nbsp;response&nbsp;that&nbsp;is&nbsp;comparable&nbsp;to&nbsp;the&nbsp;true&nbsp;value&nbsp;(e.g.&nbsp;a</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1715\">1715</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">measured&nbsp;concentration&nbsp;in&nbsp;a&nbsp;spiked&nbsp;extract&nbsp;that&nbsp;is&nbsp;comparable&nbsp;to&nbsp;the&nbsp;spiked&nbsp;amount).&nbsp;Accuracy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1716\">1716</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;screening&nbsp;tests&nbsp;is&nbsp;typically&nbsp;accomplished&nbsp;using&nbsp;surrogate&nbsp;substances&nbsp;that&nbsp;are&nbsp;representative&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1717\">1717</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractables;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1718\">1718</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;precision,&nbsp;taken&nbsp;as&nbsp;the&nbsp;variation&nbsp;in&nbsp;replicate&nbsp;analyses&nbsp;of&nbsp;either&nbsp;the&nbsp;same&nbsp;extract&nbsp;or&nbsp;a&nbsp;standard</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1719\">1719</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">solution&nbsp;containing&nbsp;extractables&nbsp;or&nbsp;leachables;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1720\">1720</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dynamic&nbsp;range,&nbsp;taken&nbsp;as&nbsp;the&nbsp;concentration&nbsp;range&nbsp;over&nbsp;which&nbsp;the&nbsp;response&nbsp;and&nbsp;the&nbsp;analyte</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1721\">1721</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;producing&nbsp;that&nbsp;response&nbsp;are&nbsp;relatable&nbsp;by&nbsp;a&nbsp;simple&nbsp;mathematical&nbsp;function.&nbsp;Dynamic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1722\">1722</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">range&nbsp;can&nbsp;be&nbsp;established&nbsp;by&nbsp;analysis&nbsp;of&nbsp;surrogate&nbsp;or&nbsp;standard&nbsp;solutions&nbsp;at&nbsp;various&nbsp;concentrations.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1723\">1723</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE\u00a02</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1724\">1724</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;objectives&nbsp;of&nbsp;this&nbsp;parameter&nbsp;can&nbsp;be&nbsp;achieved&nbsp;within&nbsp;establishment&nbsp;of&nbsp;the&nbsp;LOQ&nbsp;along&nbsp;with</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1725\">1725</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">system&nbsp;suitability&nbsp;results.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1726\">1726</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE\u00a03</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1727\">1727</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dilution&nbsp;might&nbsp;be&nbsp;needed&nbsp;if&nbsp;analytes&nbsp;of&nbsp;interest&nbsp;are&nbsp;clearly&nbsp;out&nbsp;of&nbsp;range.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1728\">1728</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualification&nbsp;parameters&nbsp;that&nbsp;are&nbsp;specifically&nbsp;relevant&nbsp;to&nbsp;targeting&nbsp;methods&nbsp;include:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1729\">1729</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sensitivity,&nbsp;relevant&nbsp;in&nbsp;the&nbsp;circumstance&nbsp;that&nbsp;the&nbsp;method\u2019s&nbsp;range&nbsp;includes,&nbsp;or&nbsp;is&nbsp;near&nbsp;to,&nbsp;the&nbsp;LOQ;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1730\">1730</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;specificity,&nbsp;as&nbsp;described&nbsp;for&nbsp;screening&nbsp;methods;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1731\">1731</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;accuracy,&nbsp;as&nbsp;described&nbsp;for&nbsp;screening&nbsp;methods;&nbsp;however,&nbsp;as&nbsp;opposed&nbsp;to&nbsp;screening&nbsp;tests,&nbsp;accuracy&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1732\">1732</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">targeting&nbsp;is&nbsp;accomplished&nbsp;with&nbsp;the&nbsp;actual&nbsp;substances&nbsp;being&nbsp;targeted;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1733\">1733</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1734\">1734</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">58\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1735\">1735</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1736\">1736</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1737\">1737</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1738\">1738</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1739\">1739</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1740\">1740</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1741\">1741</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">NOTE\u00a04</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1742\">1742</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Spiking&nbsp;samples&nbsp;can&nbsp;help&nbsp;to&nbsp;determine&nbsp;the&nbsp;recovery.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1743\">1743</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;precision,&nbsp;as&nbsp;described&nbsp;for&nbsp;screening&nbsp;methods;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1744\">1744</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dynamic&nbsp;range,&nbsp;taken&nbsp;as&nbsp;the&nbsp;concentration&nbsp;range&nbsp;over&nbsp;which&nbsp;the&nbsp;response&nbsp;and&nbsp;the&nbsp;analyte</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1745\">1745</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;producing&nbsp;that&nbsp;response&nbsp;are&nbsp;relatable&nbsp;by&nbsp;a&nbsp;simple&nbsp;mathematical&nbsp;function.&nbsp;Dynamic</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1746\">1746</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">range&nbsp;can&nbsp;be&nbsp;established&nbsp;by&nbsp;analysis&nbsp;of&nbsp;standard&nbsp;solutions&nbsp;at&nbsp;various&nbsp;concentrations;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1747\">1747</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;goodness&nbsp;of&nbsp;fit,&nbsp;taken&nbsp;as&nbsp;the&nbsp;degree&nbsp;to&nbsp;which&nbsp;a&nbsp;simple&nbsp;mathematical&nbsp;function&nbsp;can&nbsp;express&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1748\">1748</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">relationship&nbsp;between&nbsp;an&nbsp;analyte\u2019s&nbsp;concentration&nbsp;in&nbsp;a&nbsp;standard&nbsp;and&nbsp;the&nbsp;method&nbsp;response&nbsp;obtained</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1749\">1749</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">when&nbsp;the&nbsp;standard&nbsp;is&nbsp;analysed.&nbsp;Although&nbsp;the&nbsp;desired&nbsp;mathematical&nbsp;function&nbsp;is&nbsp;generally&nbsp;a&nbsp;linear</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1750\">1750</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">function,&nbsp;simple,&nbsp;non-linear&nbsp;functions&nbsp;can&nbsp;be&nbsp;used&nbsp;if&nbsp;they&nbsp;are&nbsp;able&nbsp;to&nbsp;meet&nbsp;the&nbsp;acceptance&nbsp;criteria&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1751\">1751</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">goodness&nbsp;of&nbsp;fit.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1752\">1752</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Qualifying&nbsp;that&nbsp;a&nbsp;method&nbsp;is&nbsp;rugged&nbsp;is&nbsp;relevant&nbsp;for&nbsp;both&nbsp;screening&nbsp;and&nbsp;targeting&nbsp;methods.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1753\">1753</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Additional&nbsp;performance&nbsp;parameters&nbsp;can&nbsp;be&nbsp;included&nbsp;in&nbsp;a&nbsp;qualification&nbsp;at&nbsp;the&nbsp;discretion&nbsp;of&nbsp;the&nbsp;method\u2019s</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1754\">1754</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">user&nbsp;and&nbsp;with&nbsp;appropriate&nbsp;justification.&nbsp;These&nbsp;additional&nbsp;parameters&nbsp;could&nbsp;include:&nbsp;robustness,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1755\">1755</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">efficiency&nbsp;(for&nbsp;a&nbsp;chromatographic&nbsp;separation&nbsp;this&nbsp;might&nbsp;include&nbsp;resolution),&nbsp;matrix&nbsp;effects,&nbsp;sample&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1756\">1756</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">standard&nbsp;stability.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1757\">1757</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Given&nbsp;their&nbsp;different&nbsp;purpose&nbsp;and&nbsp;function,&nbsp;the&nbsp;processes&nbsp;of&nbsp;qualifying&nbsp;a&nbsp;screening&nbsp;or&nbsp;targeting</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1758\">1758</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">method&nbsp;will&nbsp;be&nbsp;different,&nbsp;even&nbsp;if&nbsp;the&nbsp;qualifying&nbsp;criteria&nbsp;are&nbsp;generally&nbsp;the&nbsp;same.&nbsp;For&nbsp;example,&nbsp;while&nbsp;both</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1759\">1759</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">screening&nbsp;and&nbsp;targeted&nbsp;methods&nbsp;are&nbsp;qualified&nbsp;for&nbsp;accuracy,&nbsp;the&nbsp;nature&nbsp;of&nbsp;the&nbsp;qualification&nbsp;activity&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1760\">1760</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">different.&nbsp;While&nbsp;accuracy&nbsp;is&nbsp;established&nbsp;in&nbsp;a&nbsp;targeting&nbsp;method&nbsp;specifically&nbsp;for&nbsp;the&nbsp;analyte(s)&nbsp;of&nbsp;interest,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1761\">1761</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">in&nbsp;a&nbsp;screening&nbsp;method&nbsp;accuracy&nbsp;is&nbsp;established&nbsp;more&nbsp;generally&nbsp;by&nbsp;considering&nbsp;a&nbsp;group&nbsp;of&nbsp;surrogate</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1762\">1762</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytes.&nbsp;Additionally,&nbsp;as&nbsp;screening&nbsp;methods&nbsp;provide&nbsp;concentration&nbsp;estimates,&nbsp;the&nbsp;acceptance&nbsp;criterion</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1763\">1763</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;accuracy&nbsp;is&nbsp;less&nbsp;rigorous&nbsp;than&nbsp;the&nbsp;acceptance&nbsp;criterion&nbsp;for&nbsp;accuracy&nbsp;in&nbsp;targeted&nbsp;analysis,&nbsp;where&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1764\">1764</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">calculated&nbsp;concentration&nbsp;is&nbsp;expected&nbsp;to&nbsp;be&nbsp;highly&nbsp;quantitative.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1765\">1765</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;same&nbsp;concept&nbsp;is&nbsp;applicable&nbsp;to&nbsp;precision,&nbsp;as&nbsp;it&nbsp;is&nbsp;generally&nbsp;accepted&nbsp;that&nbsp;the&nbsp;precision&nbsp;expectations</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1766\">1766</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;a&nbsp;targeting&nbsp;method&nbsp;are&nbsp;more&nbsp;rigorous&nbsp;than&nbsp;are&nbsp;the&nbsp;precision&nbsp;expectations&nbsp;for&nbsp;a&nbsp;screening&nbsp;method.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1767\">1767</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Specificity&nbsp;is&nbsp;important&nbsp;in&nbsp;a&nbsp;screening&nbsp;method&nbsp;as&nbsp;the&nbsp;identification&nbsp;of&nbsp;individual&nbsp;extractables&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1768\">1768</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">facilitated&nbsp;if&nbsp;the&nbsp;chromatographic&nbsp;peak&nbsp;associated&nbsp;with&nbsp;an&nbsp;extractable&nbsp;is&nbsp;produced&nbsp;by&nbsp;only&nbsp;that</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1769\">1769</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extractable.&nbsp;In&nbsp;a&nbsp;targeting&nbsp;method,&nbsp;specificity&nbsp;for&nbsp;the&nbsp;targeted&nbsp;compound,&nbsp;meaning&nbsp;that&nbsp;the&nbsp;target</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1770\">1770</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compound\u2019s&nbsp;chromatographic&nbsp;peak&nbsp;is&nbsp;pure,&nbsp;is&nbsp;necessary&nbsp;to&nbsp;provide&nbsp;the&nbsp;required&nbsp;degree&nbsp;of&nbsp;accuracy</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1771\">1771</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;precision.&nbsp;Because&nbsp;a&nbsp;targeted&nbsp;substance&nbsp;is&nbsp;established&nbsp;in&nbsp;advance&nbsp;of&nbsp;implementing&nbsp;the&nbsp;method,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1772\">1772</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specificity&nbsp;can&nbsp;be&nbsp;established&nbsp;up-front.&nbsp;However,&nbsp;since&nbsp;it&nbsp;is&nbsp;not&nbsp;possible&nbsp;to&nbsp;establish&nbsp;up-front&nbsp;what</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1773\">1773</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">analytes&nbsp;might&nbsp;be&nbsp;discovered&nbsp;in&nbsp;screening,&nbsp;specificity&nbsp;in&nbsp;screening&nbsp;methods&nbsp;is&nbsp;typically&nbsp;established</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1774\">1774</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">at&nbsp;time&nbsp;of&nbsp;use.&nbsp;Thus,&nbsp;specificity&nbsp;could&nbsp;be&nbsp;measured&nbsp;and&nbsp;judged&nbsp;quite&nbsp;differently&nbsp;in&nbsp;screening&nbsp;versus</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1775\">1775</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">targeting.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1776\">1776</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">A&nbsp;method&nbsp;is&nbsp;considered&nbsp;to&nbsp;be&nbsp;qualified&nbsp;(that&nbsp;is,&nbsp;suited&nbsp;for&nbsp;its&nbsp;intended&nbsp;use)&nbsp;when</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1777\">1777</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;it&nbsp;has&nbsp;been&nbsp;established&nbsp;that&nbsp;the&nbsp;method&nbsp;is&nbsp;able&nbsp;to&nbsp;routinely&nbsp;meet&nbsp;the&nbsp;performance&nbsp;expectations</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1778\">1778</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">contained&nbsp;in&nbsp;the&nbsp;qualification&nbsp;protocol,&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1779\">1779</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;appropriate&nbsp;system&nbsp;suitability&nbsp;has&nbsp;been&nbsp;established.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1780\">1780</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">In&nbsp;addition&nbsp;to&nbsp;having&nbsp;documented&nbsp;performance&nbsp;capabilities,&nbsp;qualified&nbsp;analytical&nbsp;methods&nbsp;should&nbsp;have</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1781\">1781</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">additional&nbsp;controls&nbsp;that&nbsp;may&nbsp;include,&nbsp;but&nbsp;are&nbsp;not&nbsp;limited&nbsp;to:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1782\">1782</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;documentation&nbsp;of&nbsp;the&nbsp;method&nbsp;in&nbsp;the&nbsp;form&nbsp;of&nbsp;a&nbsp;standard&nbsp;operating&nbsp;procedure&nbsp;(SOP)&nbsp;which&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1783\">1783</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">controlled&nbsp;in&nbsp;a&nbsp;document&nbsp;change&nbsp;system;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1784\">1784</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an&nbsp;approved&nbsp;and&nbsp;specified&nbsp;Scope,&nbsp;captured&nbsp;in&nbsp;the&nbsp;method\u2019s&nbsp;SOP;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1785\">1785</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;detailed&nbsp;scientific&nbsp;description&nbsp;and&nbsp;justification&nbsp;of&nbsp;the&nbsp;method,&nbsp;establishing&nbsp;its&nbsp;suitability&nbsp;for&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1786\">1786</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">intended&nbsp;use;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1787\">1787</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1788\">1788</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1789\">1789</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">59</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1790\">1790</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1791\">1791</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1792\">1792</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1793\">1793</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1794\">1794</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1795\">1795</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;requirement&nbsp;that&nbsp;the&nbsp;qualified&nbsp;method&nbsp;is&nbsp;implemented&nbsp;by&nbsp;an&nbsp;appropriately&nbsp;qualified&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1796\">1796</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">trained&nbsp;staff;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1797\">1797</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;requirement&nbsp;that&nbsp;the&nbsp;qualified&nbsp;method&nbsp;is&nbsp;implemented&nbsp;on&nbsp;calibrated/qualified&nbsp;instrumentation.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1798\">1798</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Considering&nbsp;system&nbsp;suitability&nbsp;specifically,&nbsp;establishing&nbsp;system&nbsp;suitability&nbsp;is&nbsp;a&nbsp;time&nbsp;of&nbsp;use&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1799\">1799</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;addresses&nbsp;three&nbsp;performance&nbsp;aspects&nbsp;of&nbsp;the&nbsp;method:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1800\">1800</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;method&nbsp;has&nbsp;been&nbsp;set&nbsp;up&nbsp;and&nbsp;implemented&nbsp;properly;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1801\">1801</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the&nbsp;method&nbsp;as&nbsp;set&nbsp;up&nbsp;is&nbsp;capable&nbsp;of&nbsp;performing&nbsp;at&nbsp;the&nbsp;same&nbsp;level&nbsp;it&nbsp;performed&nbsp;at&nbsp;during&nbsp;its</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1802\">1802</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">qualification;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1803\">1803</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">c)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1804\">1804</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;the&nbsp;method&nbsp;has&nbsp;performed&nbsp;acceptably&nbsp;throughout&nbsp;its&nbsp;use.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1805\">1805</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">System&nbsp;suitability&nbsp;assessment&nbsp;should&nbsp;focus&nbsp;on&nbsp;that&nbsp;minimum&nbsp;number&nbsp;of&nbsp;performance&nbsp;characteristics</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1806\">1806</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">which&nbsp;individually&nbsp;and&nbsp;in&nbsp;aggregate&nbsp;demonstrate&nbsp;that&nbsp;these&nbsp;three&nbsp;performance&nbsp;criteria&nbsp;were&nbsp;achieved.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1807\">1807</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">The&nbsp;system&nbsp;suitability&nbsp;parameters&nbsp;to&nbsp;be&nbsp;assessed&nbsp;and&nbsp;their&nbsp;associated&nbsp;acceptance&nbsp;criteria&nbsp;should&nbsp;be</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1808\">1808</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">rigorous&nbsp;enough&nbsp;to&nbsp;ensure&nbsp;that&nbsp;the&nbsp;method&nbsp;produces&nbsp;data&nbsp;of&nbsp;acceptable&nbsp;quality&nbsp;but&nbsp;not&nbsp;so&nbsp;rigorous</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1809\">1809</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;potentially&nbsp;acceptable&nbsp;analytical&nbsp;runs&nbsp;are&nbsp;rejected&nbsp;on&nbsp;a&nbsp;frequent&nbsp;basis.&nbsp;Properly&nbsp;collected&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1810\">1810</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">statistically&nbsp;evaluated&nbsp;system&nbsp;suitability&nbsp;data&nbsp;can&nbsp;provide&nbsp;diagnostic&nbsp;evidence&nbsp;of&nbsp;imminent&nbsp;method</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1811\">1811</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">failure.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1812\">1812</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Reference\u00a0[23]&nbsp;can&nbsp;provide&nbsp;helpful&nbsp;information&nbsp;when&nbsp;devising&nbsp;and&nbsp;implementing&nbsp;a&nbsp;method&nbsp;qualification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1813\">1813</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">process.&nbsp;The&nbsp;reporting&nbsp;of&nbsp;method&nbsp;qualification&nbsp;information&nbsp;is&nbsp;addressed,&nbsp;to&nbsp;a&nbsp;certain&nbsp;extent,&nbsp;in&nbsp;Annex\u00a0G.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1814\">1814</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1815\">1815</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">60\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1816\">1816</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1817\">1817</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1818\">1818</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1819\">1819</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1820\">1820</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1821\">1821</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1822\">1822</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Annex\u00a0G</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1823\">1823</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">(informative)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1824\">1824</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1825\">1825</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Reporting&nbsp;details&nbsp;for&nbsp;analytical&nbsp;methods&nbsp;and&nbsp;chemical&nbsp;data</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1826\">1826</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1827\">1827</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Clause\u00a07&nbsp;provided&nbsp;general&nbsp;guidelines&nbsp;in&nbsp;terms&nbsp;of&nbsp;the&nbsp;type&nbsp;of&nbsp;chemical&nbsp;and&nbsp;compositional&nbsp;information</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1828\">1828</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;should&nbsp;be&nbsp;reported,&nbsp;facilitating&nbsp;the&nbsp;information\u2019s&nbsp;use&nbsp;in&nbsp;a&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;Users</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1829\">1829</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">should&nbsp;recognize&nbsp;that&nbsp;additional&nbsp;details&nbsp;can&nbsp;be&nbsp;necessary&nbsp;for&nbsp;regulatory&nbsp;review&nbsp;of&nbsp;the&nbsp;analytical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1830\">1830</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">methods&nbsp;and&nbsp;chemical&nbsp;data.&nbsp;Such&nbsp;information&nbsp;includes:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1831\">1831</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reporting&nbsp;of&nbsp;analytical&nbsp;data&nbsp;to&nbsp;facilitate&nbsp;toxicological&nbsp;risk&nbsp;assessment</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1832\">1832</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounting&nbsp;of&nbsp;qualitative&nbsp;data&nbsp;generated&nbsp;(e.g.&nbsp;extractable\u2019s&nbsp;identities).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1833\">1833</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounting&nbsp;of&nbsp;quantitative&nbsp;data&nbsp;generated&nbsp;(e.g.&nbsp;extractable\u2019s&nbsp;concentrations,&nbsp;including&nbsp;a&nbsp;discussion</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1834\">1834</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;the&nbsp;quantification&nbsp;approach&nbsp;and&nbsp;providing&nbsp;the&nbsp;classification&nbsp;of&nbsp;the&nbsp;quantitative&nbsp;data&nbsp;as&nbsp;estimated</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1835\">1835</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;analysis,&nbsp;semi-quantitative&nbsp;analysis&nbsp;or&nbsp;quantitative&nbsp;analysis).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1836\">1836</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A&nbsp;discussion&nbsp;and&nbsp;justification&nbsp;of&nbsp;the&nbsp;reporting&nbsp;threshold&nbsp;and&nbsp;its&nbsp;relevance&nbsp;to&nbsp;toxicological&nbsp;risk</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1837\">1837</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessment&nbsp;(e.g.&nbsp;safety&nbsp;thresholds).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1838\">1838</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;List&nbsp;of&nbsp;chemical&nbsp;compounds&nbsp;above&nbsp;the&nbsp;reporting&nbsp;threshold.&nbsp;Such&nbsp;a&nbsp;list&nbsp;can&nbsp;be&nbsp;provided&nbsp;in&nbsp;a&nbsp;tabular</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1839\">1839</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">format&nbsp;and&nbsp;the&nbsp;table&nbsp;should&nbsp;contain&nbsp;the&nbsp;chemical&nbsp;compounds&nbsp;including&nbsp;their&nbsp;mass,&nbsp;proposed</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1840\">1840</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">structure,&nbsp;chemical&nbsp;formula,&nbsp;IUPAC&nbsp;chemical&nbsp;name,&nbsp;common&nbsp;chemical&nbsp;name(s)&nbsp;and&nbsp;abbreviation(s),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1841\">1841</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">CAS&nbsp;registry&nbsp;number,&nbsp;their&nbsp;identification&nbsp;status&nbsp;(e.g.&nbsp;confirmed,&nbsp;confident,&nbsp;tentative,&nbsp;speculative)&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1842\">1842</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">their&nbsp;measured&nbsp;levels&nbsp;in&nbsp;the&nbsp;relevant&nbsp;samples.&nbsp;Additional&nbsp;information,&nbsp;such&nbsp;as&nbsp;chemical&nbsp;structure,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1843\">1843</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">may&nbsp;be&nbsp;provided&nbsp;in&nbsp;the&nbsp;document.&nbsp;When&nbsp;multiple&nbsp;candidate&nbsp;identifications&nbsp;are&nbsp;found&nbsp;(e.g.&nbsp;a&nbsp;class&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1844\">1844</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">compounds&nbsp;such&nbsp;as&nbsp;is&nbsp;often&nbsp;reported&nbsp;in&nbsp;tentative&nbsp;identifications),&nbsp;all&nbsp;should&nbsp;be&nbsp;reported.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1845\">1845</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Information&nbsp;about&nbsp;the&nbsp;device\u2019s&nbsp;clinical&nbsp;use&nbsp;which,&nbsp;when&nbsp;combined&nbsp;with&nbsp;the&nbsp;chemical&nbsp;data,&nbsp;allows&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1846\">1846</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">the&nbsp;calculation&nbsp;of&nbsp;the&nbsp;worst-case&nbsp;amount&nbsp;of&nbsp;the&nbsp;chemical&nbsp;in&nbsp;appropriate&nbsp;units&nbsp;(e.g.&nbsp;\u00b5g/medical&nbsp;device)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1847\">1847</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">that&nbsp;can&nbsp;be&nbsp;readily&nbsp;used&nbsp;in&nbsp;toxicological&nbsp;risk&nbsp;assessment&nbsp;(establishing&nbsp;human&nbsp;daily&nbsp;exposure).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1848\">1848</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appropriate&nbsp;figures,&nbsp;diagrams,&nbsp;etc.&nbsp;that&nbsp;illustrate&nbsp;the&nbsp;analytical&nbsp;data&nbsp;and/or&nbsp;facilitates&nbsp;data&nbsp;review</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1849\">1849</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and/or&nbsp;interpretation&nbsp;(e.g.&nbsp;labelled&nbsp;chromatograms,&nbsp;migration&nbsp;curves).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1850\">1850</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approach&nbsp;and&nbsp;rationale&nbsp;addressing&nbsp;cohorts&nbsp;of&nbsp;concern&nbsp;substances&nbsp;(see&nbsp;E.5).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1851\">1851</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Note&nbsp;that&nbsp;the&nbsp;reporting&nbsp;of&nbsp;analytical&nbsp;data&nbsp;should&nbsp;facilitate&nbsp;the&nbsp;calculation&nbsp;of&nbsp;estimated&nbsp;clinical&nbsp;exposure</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1852\">1852</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">to&nbsp;the&nbsp;reported&nbsp;chemicals,&nbsp;as&nbsp;this&nbsp;is&nbsp;an&nbsp;essential&nbsp;aspect&nbsp;of&nbsp;the&nbsp;toxicological&nbsp;risk&nbsp;assessment.&nbsp;It&nbsp;is&nbsp;not</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1853\">1853</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">necessary&nbsp;that&nbsp;the&nbsp;analytical&nbsp;reports&nbsp;themselves&nbsp;contain&nbsp;these&nbsp;estimated&nbsp;exposures.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1854\">1854</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">While&nbsp;the&nbsp;information&nbsp;outlined&nbsp;above&nbsp;is&nbsp;sufficient&nbsp;to&nbsp;enable&nbsp;toxicological&nbsp;risk&nbsp;assessment,&nbsp;it&nbsp;typically</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1855\">1855</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">is&nbsp;not&nbsp;sufficient&nbsp;to&nbsp;fully&nbsp;specify&nbsp;and&nbsp;justify&nbsp;the&nbsp;experimental&nbsp;and&nbsp;analytical&nbsp;approaches&nbsp;that&nbsp;were</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1856\">1856</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">used&nbsp;to&nbsp;perform&nbsp;a&nbsp;specific&nbsp;study&nbsp;to&nbsp;produce&nbsp;specific&nbsp;data&nbsp;and&nbsp;information.&nbsp;This&nbsp;critical&nbsp;information&nbsp;is</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1857\">1857</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">used&nbsp;to&nbsp;establish&nbsp;the&nbsp;validity&nbsp;of&nbsp;the&nbsp;experimental&nbsp;design,&nbsp;the&nbsp;applicability&nbsp;of&nbsp;the&nbsp;analytical&nbsp;approach</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1858\">1858</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;the&nbsp;suitability&nbsp;of&nbsp;the&nbsp;specific&nbsp;analytical&nbsp;methods&nbsp;employed&nbsp;for&nbsp;their&nbsp;intended&nbsp;purpose,&nbsp;during,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1859\">1859</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;example,&nbsp;regulatory&nbsp;review.&nbsp;Thus,&nbsp;a&nbsp;report&nbsp;should&nbsp;include&nbsp;some&nbsp;of&nbsp;the&nbsp;following&nbsp;information&nbsp;to</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1860\">1860</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">provide&nbsp;the&nbsp;proper&nbsp;context&nbsp;with&nbsp;respect&nbsp;to&nbsp;the&nbsp;experimental&nbsp;design,&nbsp;the&nbsp;experimental&nbsp;approach&nbsp;and&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1861\">1861</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">experimental&nbsp;methods.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1862\">1862</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1863\">1863</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1864\">1864</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">61</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1865\">1865</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1866\">1866</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1867\">1867</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1868\">1868</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1869\">1869</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1870\">1870</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Details&nbsp;of&nbsp;test&nbsp;article&nbsp;preparation&nbsp;(extraction)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1871\">1871</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Appropriate&nbsp;and&nbsp;complete&nbsp;description&nbsp;of&nbsp;the&nbsp;test&nbsp;article,&nbsp;including&nbsp;relevant&nbsp;processing&nbsp;details&nbsp;(e.g.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1872\">1872</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sterilization,&nbsp;rinsing),&nbsp;and&nbsp;parts&nbsp;removed,&nbsp;if&nbsp;applicable;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1873\">1873</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extraction&nbsp;method&nbsp;with&nbsp;justification&nbsp;(e.g.&nbsp;refluxing,&nbsp;sealed&nbsp;vessel);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1874\">1874</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;List&nbsp;of&nbsp;extraction&nbsp;vehicles&nbsp;with&nbsp;justification;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1875\">1875</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extraction&nbsp;vehicle/&nbsp;sample&nbsp;ratio&nbsp;(e.g.&nbsp;extracted&nbsp;surface&nbsp;area&nbsp;to&nbsp;extraction&nbsp;solution&nbsp;volume&nbsp;ratio);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1876\">1876</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extraction&nbsp;time&nbsp;and&nbsp;temperature;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1877\">1877</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Number&nbsp;of&nbsp;extraction&nbsp;cycles&nbsp;(e.g.&nbsp;single&nbsp;vs.&nbsp;exhaustive);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1878\">1878</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Methods&nbsp;for&nbsp;determining&nbsp;when&nbsp;exhaustive&nbsp;extraction&nbsp;endpoints&nbsp;are&nbsp;reached&nbsp;(as&nbsp;appropriate);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1879\">1879</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;of&nbsp;changes&nbsp;to&nbsp;the&nbsp;vehicle&nbsp;or&nbsp;test&nbsp;article&nbsp;(e.g.&nbsp;medical&nbsp;device)&nbsp;post-extraction,&nbsp;to&nbsp;include</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1880\">1880</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">physical&nbsp;state,&nbsp;appearance,&nbsp;colour,&nbsp;clarity,&nbsp;or&nbsp;presence&nbsp;of&nbsp;particles;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1881\">1881</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If&nbsp;particles&nbsp;are&nbsp;present&nbsp;in&nbsp;the&nbsp;extract,&nbsp;a&nbsp;description&nbsp;of&nbsp;how&nbsp;they&nbsp;were&nbsp;addressed,&nbsp;including,&nbsp;if</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1882\">1882</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">performed,&nbsp;the&nbsp;means&nbsp;by&nbsp;which&nbsp;they&nbsp;were&nbsp;separated&nbsp;from&nbsp;the&nbsp;extract&nbsp;prior&nbsp;to&nbsp;analysis&nbsp;and&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1883\">1883</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">means&nbsp;by&nbsp;which&nbsp;they&nbsp;were&nbsp;chemically&nbsp;characterized.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1884\">1884</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Extract&nbsp;preparation&nbsp;for&nbsp;analysis</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1885\">1885</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;of&nbsp;any&nbsp;dilution,&nbsp;concentration&nbsp;and&nbsp;other&nbsp;significant&nbsp;processing&nbsp;steps&nbsp;(e.g.&nbsp;vehicle</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1886\">1886</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">exchange).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1887\">1887</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Justification&nbsp;for&nbsp;all&nbsp;significant&nbsp;processing&nbsp;steps.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1888\">1888</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;of&nbsp;any&nbsp;sample&nbsp;filtering/particle&nbsp;separation&nbsp;that&nbsp;was&nbsp;performed.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1889\">1889</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;of&nbsp;the&nbsp;storage&nbsp;conditions&nbsp;and&nbsp;duration&nbsp;of&nbsp;extracts,&nbsp;if&nbsp;stored&nbsp;prior&nbsp;to&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1890\">1890</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;of&nbsp;the&nbsp;analytical&nbsp;methods&nbsp;for&nbsp;testing&nbsp;prepared&nbsp;extracts&nbsp;(include</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1891\">1891</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">all&nbsp;that&nbsp;apply)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1892\">1892</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Justification&nbsp;for&nbsp;choice.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1893\">1893</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Relevant&nbsp;operating&nbsp;conditions&nbsp;(e.g.&nbsp;chromatographic&nbsp;mobile&nbsp;phase,&nbsp;methods,&nbsp;flow&nbsp;rates,&nbsp;gradient</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1894\">1894</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">run&nbsp;time,&nbsp;column&nbsp;temperature).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1895\">1895</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Analytical&nbsp;column;&nbsp;Dimensions&nbsp;and&nbsp;stationary&nbsp;phase&nbsp;used.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1896\">1896</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Analytical&nbsp;instrumentation&nbsp;manufacturer,&nbsp;model,&nbsp;principal&nbsp;components.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1897\">1897</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For&nbsp;methods&nbsp;using&nbsp;mass&nbsp;spectrometric&nbsp;detection:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1898\">1898</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ionization&nbsp;technique&nbsp;(APCI,&nbsp;ESI),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1899\">1899</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;polarity&nbsp;mode&nbsp;(positive,&nbsp;negative),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1900\">1900</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mass&nbsp;range&nbsp;(or&nbsp;specific&nbsp;masses&nbsp;analysed&nbsp;for&nbsp;ICP-MS&nbsp;data),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1901\">1901</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nominal&nbsp;mass&nbsp;resolution.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1902\">1902</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For&nbsp;methods&nbsp;using&nbsp;UV&nbsp;detection,&nbsp;detection&nbsp;wavelength.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1903\">1903</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For&nbsp;other&nbsp;detection&nbsp;methods,&nbsp;key&nbsp;operational&nbsp;parameters.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1904\">1904</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1905\">1905</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">62\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1906\">1906</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1907\">1907</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1908\">1908</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1909\">1909</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1910\">1910</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1911\">1911</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1912\">1912</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Surrogate&nbsp;standard(s)&nbsp;used,&nbsp;with&nbsp;justification,&nbsp;and&nbsp;resulting&nbsp;response&nbsp;factor&nbsp;to&nbsp;be&nbsp;applied&nbsp;in&nbsp;semi-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1913\">1913</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantitative&nbsp;analysis.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1914\">1914</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Quantification&nbsp;approach&nbsp;applied,&nbsp;with&nbsp;justification:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1915\">1915</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;which&nbsp;analytical&nbsp;endpoint&nbsp;is&nbsp;used&nbsp;for&nbsp;quantification&nbsp;(e.g.&nbsp;MS&nbsp;signal&nbsp;or&nbsp;UV&nbsp;response);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1916\">1916</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;description&nbsp;of&nbsp;how&nbsp;any&nbsp;surrogate&nbsp;and&nbsp;internal&nbsp;standards&nbsp;are&nbsp;applied&nbsp;for&nbsp;quantification&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1917\">1917</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">specific&nbsp;analytes&nbsp;(e.g.&nbsp;closest&nbsp;retention&nbsp;time,&nbsp;similarity&nbsp;in&nbsp;chemistry&nbsp;between&nbsp;the&nbsp;reference</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1918\">1918</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">standard&nbsp;and&nbsp;the&nbsp;analyte,&nbsp;or&nbsp;use&nbsp;of&nbsp;\u201cworst&nbsp;case,\u201d&nbsp;meaning&nbsp;lowest&nbsp;response&nbsp;factor,&nbsp;or&nbsp;use&nbsp;of&nbsp;an</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1919\">1919</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">averaged&nbsp;response&nbsp;factor).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1920\">1920</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A&nbsp;description&nbsp;of&nbsp;how&nbsp;confidence&nbsp;in&nbsp;identifications&nbsp;was&nbsp;determined&nbsp;and&nbsp;assigned&nbsp;(e.g.&nbsp;definitions&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1921\">1921</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">categorization&nbsp;terms&nbsp;or&nbsp;match&nbsp;scores),&nbsp;with&nbsp;justification;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1922\">1922</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Means&nbsp;used&nbsp;to&nbsp;address&nbsp;unknowns&nbsp;(e.g.&nbsp;additional&nbsp;analytical&nbsp;testing&nbsp;to&nbsp;identify&nbsp;or&nbsp;risk&nbsp;mitigation&nbsp;per</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1923\">1923</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-1);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1924\">1924</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Determination,&nbsp;justification&nbsp;and&nbsp;application&nbsp;of&nbsp;reporting&nbsp;thresholds&nbsp;(such&nbsp;as&nbsp;the&nbsp;AET).</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1925\">1925</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">G.6&nbsp;Qualification&nbsp;metrics&nbsp;for&nbsp;the&nbsp;analytical&nbsp;methods:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1926\">1926</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">System&nbsp;suitability&nbsp;(per&nbsp;qualification&nbsp;protocol&nbsp;in&nbsp;Annex&nbsp;F)&nbsp;to&nbsp;include:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1927\">1927</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LOD&nbsp;and&nbsp;LOQ&nbsp;(including&nbsp;how&nbsp;LOQ&nbsp;was&nbsp;established);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1928\">1928</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Linearity&nbsp;[calibration&nbsp;curve(s)];</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1929\">1929</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Specificity;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1930\">1930</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;System&nbsp;suitability;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1931\">1931</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recovery&nbsp;(accuracy);</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1932\">1932</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Precision;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1933\">1933</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dynamic&nbsp;range;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1934\">1934</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other&nbsp;relevant&nbsp;parameters&nbsp;as&nbsp;appropriate.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1935\">1935</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1936\">1936</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1937\">1937</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">63</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1938\">1938</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1939\">1939</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1940\">1940</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1941\">1941</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1942\">1942</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1943\">1943</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Bibliography</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1944\">1944</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Generally&nbsp;relevant&nbsp;references</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1945\">1945</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[1]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1946\">1946</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a0&nbsp;5725-1,&nbsp;Accuracy&nbsp;(trueness&nbsp;and&nbsp;precision)&nbsp;of&nbsp;measurement&nbsp;methods&nbsp;and&nbsp;results&nbsp;\u2014&nbsp;Part&nbsp;1:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1947\">1947</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">General&nbsp;principles&nbsp;and&nbsp;definitions</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1948\">1948</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[2]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1949\">1949</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a05832-1,&nbsp;Implants&nbsp;for&nbsp;surgery&nbsp;\u2014&nbsp;Metallic&nbsp;materials&nbsp;\u2014&nbsp;Part&nbsp;1:&nbsp;Wrought&nbsp;stainless&nbsp;steel</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1950\">1950</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[3]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1951\">1951</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-2,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;2:&nbsp;Animal&nbsp;welfare&nbsp;requirements</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1952\">1952</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[4]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1953\">1953</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-9,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices\u00a0\u2014&nbsp;Part\u00a09:&nbsp;Framework&nbsp;for&nbsp;identification&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1954\">1954</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">quantification&nbsp;of&nbsp;potential&nbsp;degradation&nbsp;products</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1955\">1955</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[5]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1956\">1956</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-12:2012,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;12:&nbsp;Sample&nbsp;preparation&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1957\">1957</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">reference&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1958\">1958</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[6]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1959\">1959</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-13,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;13:&nbsp;Identification&nbsp;and&nbsp;quantification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1960\">1960</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;degradation&nbsp;products&nbsp;from&nbsp;polymeric&nbsp;medical&nbsp;devices</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1961\">1961</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[7]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1962\">1962</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-14,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;14:&nbsp;Identification&nbsp;and&nbsp;quantification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1963\">1963</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;degradation&nbsp;products&nbsp;from&nbsp;ceramics</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1964\">1964</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[8]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1965\">1965</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a010993-15,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices\u00a0\u2014&nbsp;Part\u00a015:&nbsp;Identification&nbsp;and&nbsp;quantification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1966\">1966</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">of&nbsp;degradation&nbsp;products&nbsp;from&nbsp;metals&nbsp;and&nbsp;alloys</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1967\">1967</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[9]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1968\">1968</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">EN\u00a0455-3,&nbsp;Medical&nbsp;gloves&nbsp;for&nbsp;single&nbsp;use\u00a0\u2014&nbsp;Part\u00a03:&nbsp;Requirements&nbsp;and&nbsp;testing&nbsp;for&nbsp;biological&nbsp;evaluation</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1969\">1969</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[10]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1970\">1970</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a022442-1,&nbsp;Medical&nbsp;devices&nbsp;utilizing&nbsp;animal&nbsp;tissues&nbsp;and&nbsp;their&nbsp;derivatives\u00a0\u2014&nbsp;Part\u00a01:&nbsp;Application&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1971\">1971</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">risk&nbsp;management</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1972\">1972</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[11]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1973\">1973</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a022442-2,&nbsp;Medical&nbsp;devices&nbsp;utilizing&nbsp;animal&nbsp;tissues&nbsp;and&nbsp;their&nbsp;derivatives\u00a0\u2014&nbsp;Part\u00a02:&nbsp;Controls&nbsp;on</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1974\">1974</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">sourcing,&nbsp;collection&nbsp;and&nbsp;handling</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1975\">1975</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[12]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1976\">1976</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO\u00a022442-3,&nbsp;Medical&nbsp;devices&nbsp;utilizing&nbsp;animal&nbsp;tissues&nbsp;and&nbsp;their&nbsp;derivatives&nbsp;\u2014&nbsp;Part&nbsp;3:&nbsp;&nbsp;Validation&nbsp;of&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1977\">1977</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">elimination&nbsp;and/or&nbsp;inactivation&nbsp;of&nbsp;viruses&nbsp;and&nbsp;transmissible&nbsp;spongiform&nbsp;encephalopathy&nbsp;(TSE)&nbsp;agents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1978\">1978</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[13]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1979\">1979</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">USP&nbsp;41,&nbsp;2018,&nbsp;[1663]&nbsp;Assessment&nbsp;of&nbsp;Extractables&nbsp;Associated&nbsp;with&nbsp;Pharmaceutical&nbsp;Packaging/</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1980\">1980</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Delivery&nbsp;Systems</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1981\">1981</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[14]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1982\">1982</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">USP&nbsp;41,&nbsp;2018,&nbsp;[1664]&nbsp;Assessment&nbsp;of&nbsp;Drug&nbsp;Product&nbsp;Leachables&nbsp;Associated&nbsp;with&nbsp;Pharmaceutical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1983\">1983</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Packaging/Delivery&nbsp;Systems</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1984\">1984</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[15]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1985\">1985</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Use&nbsp;of&nbsp;International&nbsp;Standard&nbsp;ISO\u00a0&nbsp;10993-1,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices\u00a0&nbsp;\u2014</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1986\">1986</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Part\u00a0&nbsp;1:&nbsp;Evaluation&nbsp;and&nbsp;testing&nbsp;within&nbsp;a&nbsp;risk&nbsp;management&nbsp;process\u00a0&nbsp;\u2014&nbsp;Guidance&nbsp;for&nbsp;Industry</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1987\">1987</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">and&nbsp;Food&nbsp;and&nbsp;Drug&nbsp;Administration&nbsp;Staff&nbsp;[viewed&nbsp;2019-01-29].&nbsp;Available&nbsp;from:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1988\">1988</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">&nbsp;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1989\">1989</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">https://\u200bwww\u200b.fda\u200b.gov/\u200bdownloads/\u200bmedicaldevices/\u200bdeviceregulationandguidance/\u200b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1990\">1990</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">guidancedocuments/ucm348890.pdf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1991\">1991</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">References&nbsp;cited&nbsp;in&nbsp;the&nbsp;document</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1992\">1992</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[16]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1993\">1993</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">OECD,&nbsp;1996,&nbsp;Test&nbsp;No.&nbsp;118:&nbsp;Determination&nbsp;of&nbsp;the&nbsp;Number-Average&nbsp;Molecular&nbsp;Weight&nbsp;and&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1994\">1994</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Molecular&nbsp;Weight&nbsp;Distribution&nbsp;of&nbsp;Polymers&nbsp;using&nbsp;Gel&nbsp;Permeation&nbsp;Chromatography,&nbsp;OECD</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1995\">1995</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Guidelines&nbsp;for&nbsp;the&nbsp;Testing&nbsp;of&nbsp;Chemicals,&nbsp;Section\u00a01,&nbsp;&nbsp;OECD&nbsp;Publishing,&nbsp;&nbsp;Paris.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1996\">1996</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[17]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1997\">1997</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">OECD,&nbsp;2000,&nbsp;Test&nbsp;No.&nbsp;120:&nbsp;Solution/Extraction&nbsp;Behaviour&nbsp;of&nbsp;Polymers&nbsp;in&nbsp;Water,&nbsp;OECD&nbsp;Guidelines</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1998\">1998</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">for&nbsp;the&nbsp;Testing&nbsp;of&nbsp;Chemicals,&nbsp;Section&nbsp;1,&nbsp;&nbsp;OECD&nbsp;Publishing,&nbsp;&nbsp;Paris.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_1999\">1999</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2000\">2000</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">64\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2001\">2001</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2002\">2002</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2003\">2003</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2004\">2004</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2005\">2005</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2006\">2006</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2007\">2007</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[18]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2008\">2008</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ICH&nbsp;Technical&nbsp;Requirements&nbsp;for&nbsp;Registration&nbsp;of&nbsp;Pharmaceutical&nbsp;for&nbsp;Human&nbsp;Use&nbsp;Draft</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2009\">2009</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Consensus&nbsp;Guideline,&nbsp;M7.&nbsp;Assessment&nbsp;and&nbsp;Control&nbsp;of&nbsp;DNA&nbsp;Reactive&nbsp;(Mutagenic)&nbsp;Impurities&nbsp;in</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2010\">2010</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Pharmaceuticals&nbsp;to&nbsp;Limit&nbsp;Potential&nbsp;Carcinogenic&nbsp;Risk.&nbsp;Current&nbsp;Step\u00a02&nbsp;version;&nbsp;6&nbsp;February&nbsp;2013.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2011\">2011</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[19]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2012\">2012</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ICH&nbsp;Guideline&nbsp;for&nbsp;Elemental&nbsp;Impurities&nbsp;[viewed&nbsp;2019-01-29].&nbsp;Available&nbsp;from:&nbsp;https://\u200bwww\u200b.ich\u200b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2013\">2013</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">.org/\u200bfileadmin/\u200bPublic\u200b_Web\u200b_Site/\u200bICH\u200b_Products/\u200bGuidelines/\u200bQuality/\u200bQ3D/\u200bQ3D\u200b_Step2b\u200b.pdf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2014\">2014</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[20]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2015\">2015</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Eur&nbsp;&nbsp;Ph.,&nbsp;Ed.&nbsp;9,&nbsp;2016,&nbsp;Section&nbsp;2.2.28,&nbsp;and&nbsp;Chapters&nbsp;3.1&nbsp;and&nbsp;3.2.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2016\">2016</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[21]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2017\">2017</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">JP&nbsp;XVII&nbsp;2017&nbsp;General&nbsp;tests/plastic&nbsp;containers</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2018\">2018</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[22]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2019\">2019</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">USP&nbsp;41,&nbsp;2018,&nbsp;[661]&nbsp;Plastic&nbsp;packaging&nbsp;systems&nbsp;and&nbsp;their&nbsp;materials&nbsp;of&nbsp;construction</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2020\">2020</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[23]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2021\">2021</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">USP&nbsp;41,&nbsp;2018,&nbsp;[1058]&nbsp;Analytical&nbsp;instrument&nbsp;qualification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2022\">2022</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[24]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2023\">2023</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ASTM&nbsp;F2129\u201317b,&nbsp;Standard&nbsp;Test&nbsp;Method&nbsp;for&nbsp;Conducting&nbsp;Cyclic&nbsp;Potentiodynamic&nbsp;Polarization</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2024\">2024</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Measurements&nbsp;to&nbsp;Determine&nbsp;the&nbsp;Corrosion&nbsp;Susceptibility&nbsp;of&nbsp;Small&nbsp;Implant&nbsp;Devices</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2025\">2025</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[25]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2026\">2026</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Guidance&nbsp;for&nbsp;Industry:&nbsp;Preparation&nbsp;of&nbsp;Premarket&nbsp;Submissions&nbsp;for&nbsp;Food&nbsp;Contact&nbsp;Substances:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2027\">2027</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chemistry&nbsp;Recommendations.&nbsp;U.S.&nbsp;Department&nbsp;of&nbsp;Health&nbsp;and&nbsp;Human&nbsp;Services,&nbsp;Food&nbsp;and&nbsp;Drug</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2028\">2028</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Administration,&nbsp;Center&nbsp;for&nbsp;Food&nbsp;Safety&nbsp;and&nbsp;Applied&nbsp;Nutrition.&nbsp;April&nbsp;2002;&nbsp;December&nbsp;2007</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2029\">2029</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[26]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2030\">2030</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Arias&nbsp;&nbsp;M.,&nbsp;Penichet&nbsp;&nbsp;I.,&nbsp;Ysambertt&nbsp;&nbsp;F.&nbsp;et&nbsp;al.&nbsp;,&nbsp;Fast&nbsp;supercritical&nbsp;fluid&nbsp;extraction&nbsp;of&nbsp;low-and&nbsp;high-</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2031\">2031</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">density&nbsp;polyethylene&nbsp;additives:&nbsp;comparison&nbsp;with&nbsp;conventional&nbsp;reflux&nbsp;and&nbsp;automatic&nbsp;Soxhlet</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2032\">2032</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">extraction.&nbsp;Journal&nbsp;of&nbsp;Supercritical&nbsp;Fluids.&nbsp;2009;&nbsp;&nbsp;50(1):&nbsp;22-28</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2033\">2033</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[27]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2034\">2034</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Ball&nbsp;&nbsp;D.,&nbsp;Blanchard&nbsp;&nbsp;J.,&nbsp;Jacobson-Kram&nbsp;&nbsp;D.&nbsp;et&nbsp;al.&nbsp;,&nbsp;Development&nbsp;of&nbsp;Safety&nbsp;Qualification</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2035\">2035</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Thresholds&nbsp;and&nbsp;Their&nbsp;Use&nbsp;in&nbsp;Orally&nbsp;Inhaled&nbsp;and&nbsp;Nasal&nbsp;Drug&nbsp;Product&nbsp;Evaluation.&nbsp;Toxicological</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2036\">2036</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Sciences.&nbsp;2007;&nbsp;&nbsp;97:&nbsp;226\u2013236</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2037\">2037</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[28]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2038\">2038</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Bart&nbsp;&nbsp;J.C.J.,&nbsp;Additives&nbsp;in&nbsp;Polymers\u00a0\u2014&nbsp;Industrial&nbsp;Analysis&nbsp;and&nbsp;Applications,&nbsp;&nbsp;John&nbsp;Wiley&nbsp;&amp;&nbsp;Sons,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2039\">2039</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Inc.,&nbsp;&nbsp;New&nbsp;York,&nbsp;(2005).&nbsp;(ISBN&nbsp;0-470-85062-0)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2040\">2040</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[29]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2041\">2041</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Bataillard&nbsp;&nbsp;P.,&nbsp;Evangelista&nbsp;&nbsp;L.,&nbsp;Thomas&nbsp;&nbsp;M.,&nbsp;in&nbsp;Plastics&nbsp;Additive&nbsp;Handbook,&nbsp;Zweifel&nbsp;&nbsp;E.,&nbsp;(ed),</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2042\">2042</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hanser&nbsp;Publishers,&nbsp;&nbsp;Munich&nbsp;pp.&nbsp;1047-1083&nbsp;(2000)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2043\">2043</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[30]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2044\">2044</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Brandrup&nbsp;&nbsp;J,&nbsp;Immergut&nbsp;&nbsp;E.H.,&nbsp;Grulke&nbsp;&nbsp;EA.,&nbsp;(eds).&nbsp;Polymer&nbsp;Handbook,&nbsp;&nbsp;John&nbsp;Wiley&nbsp;&amp;&nbsp;Sons,&nbsp;Inc.,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2045\">2045</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">New&nbsp;York,&nbsp;(1999)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2046\">2046</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[31]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2047\">2047</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Braun&nbsp;&nbsp;D.,&nbsp;Simple&nbsp;Methods&nbsp;for&nbsp;Identification&nbsp;of&nbsp;Plastics,&nbsp;&nbsp;Hanser&nbsp;Publishers,&nbsp;&nbsp;Munich&nbsp;(1996)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2048\">2048</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[32]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2049\">2049</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Burdick&nbsp;&amp;&nbsp;Jackson&nbsp;Laboratories,&nbsp;Solvent&nbsp;guide.&nbsp;&nbsp;Published&nbsp;by&nbsp;Burdick&nbsp;and&nbsp;Jackson&nbsp;Laboratories;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2050\">2050</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">McGaw&nbsp;Park,&nbsp;IL&nbsp;(1986)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2051\">2051</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[33]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2052\">2052</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Freitag&nbsp;&nbsp;W.,&nbsp;in&nbsp;Kunststoff-Additive,&nbsp;Gachter&nbsp;&nbsp;R.,&nbsp;&nbsp;Muller&nbsp;&nbsp;H.,&nbsp;(eds),&nbsp;&nbsp;Hanser&nbsp;Publishers,&nbsp;&nbsp;Munich,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2053\">2053</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">pp.&nbsp;909-946&nbsp;(1990)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2054\">2054</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[34]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2055\">2055</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Gad-McDonald&nbsp;&nbsp;S.,&nbsp;&nbsp;Gad&nbsp;&nbsp;C.S.,&nbsp;Leachables&nbsp;and&nbsp;Extractables&nbsp;from&nbsp;Medical&nbsp;Devices,&nbsp;in&nbsp;Biomaterials,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2056\">2056</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Medical&nbsp;Devices,&nbsp;and&nbsp;Combination&nbsp;Products,&nbsp;CRC&nbsp;Press:&nbsp;419-468.&nbsp;(2015)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2057\">2057</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[35]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2058\">2058</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hansen&nbsp;&nbsp;C.M.,&nbsp;Hansen&nbsp;Solubility&nbsp;Parameters:&nbsp;A&nbsp;User\u2019s&nbsp;Handbook,&nbsp;2nd&nbsp;edn.&nbsp;CRC&nbsp;Press,&nbsp;Taylor&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2059\">2059</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Francis&nbsp;Group,&nbsp;Boca&nbsp;Raton&nbsp;Florida&nbsp;(2007)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2060\">2060</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[36]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2061\">2061</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hildebrand&nbsp;&nbsp;J.H.,&nbsp;&nbsp;Scott&nbsp;&nbsp;R.L.,&nbsp;The&nbsp;solubility&nbsp;of&nbsp;nonelectrolytes.&nbsp;&nbsp;New&nbsp;York:&nbsp;&nbsp;Dover</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2062\">2062</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Publications&nbsp;(1964)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2063\">2063</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[37]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2064\">2064</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">International&nbsp;Union&nbsp;of&nbsp;Pure&nbsp;and&nbsp;Applied&nbsp;Chemistry\u00a0\u2014&nbsp;Macromolecular&nbsp;division\u00a0\u2014&nbsp;Commission</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2065\">2065</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">on&nbsp;macromolecular&nbsp;nomenclature:&nbsp;compendium&nbsp;of&nbsp;macromolecular&nbsp;nomenclature,&nbsp;Prepared&nbsp;for</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2066\">2066</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">publication&nbsp;by&nbsp;W.&nbsp;V.&nbsp;Metanomski,&nbsp;&nbsp;Blackwell&nbsp;Scientific&nbsp;Publications&nbsp;Ltd.,&nbsp;&nbsp;Oxford&nbsp;(1991)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2067\">2067</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[38]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2068\">2068</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Jenke&nbsp;&nbsp;D.,&nbsp;Liu&nbsp;&nbsp;N.,&nbsp;Hua&nbsp;&nbsp;Y.&nbsp;et&nbsp;al.&nbsp;,&nbsp;A&nbsp;means&nbsp;of&nbsp;establishing&nbsp;and&nbsp;justifying&nbsp;binary&nbsp;ethanol/water</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2069\">2069</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">mixtures&nbsp;as&nbsp;simulating&nbsp;vehicles&nbsp;in&nbsp;extractables&nbsp;studies.&nbsp;PDA&nbsp;J&nbsp;Pharm&nbsp;Sci&nbsp;Technol.&nbsp;2015;&nbsp;&nbsp;69(3):</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2070\">2070</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">366-382.&nbsp;Doi:&nbsp;10.5731/pdajpst.2015.01046</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2071\">2071</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2072\">2072</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2073\">2073</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">65</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2074\">2074</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2075\">2075</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2076\">2076</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2077\">2077</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2078\">2078</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2079\">2079</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[39]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2080\">2080</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Jenke&nbsp;&nbsp;D.,&nbsp;&nbsp;Odufu&nbsp;&nbsp;A.,&nbsp;Utilization&nbsp;of&nbsp;internal&nbsp;standard&nbsp;response&nbsp;factors&nbsp;to&nbsp;estimate&nbsp;the</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2081\">2081</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concentration&nbsp;of&nbsp;organic&nbsp;compounds&nbsp;leached&nbsp;from&nbsp;pharmaceutical&nbsp;packaging&nbsp;systems&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2082\">2082</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">application&nbsp;of&nbsp;such&nbsp;estimated&nbsp;concentrations&nbsp;to&nbsp;safety&nbsp;assessment.&nbsp;J.&nbsp;Chromatogr.&nbsp;Sci.&nbsp;2012;</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2083\">2083</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">50:206-212</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2084\">2084</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[40]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2085\">2085</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Jenke&nbsp;&nbsp;D.,&nbsp;Establishing&nbsp;the&nbsp;proper&nbsp;pH&nbsp;of&nbsp;simulating&nbsp;solvents&nbsp;used&nbsp;in&nbsp;organic&nbsp;extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2086\">2086</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">assessments&nbsp;for&nbsp;packaging&nbsp;systems&nbsp;and&nbsp;their&nbsp;materials&nbsp;of&nbsp;construction&nbsp;used&nbsp;with&nbsp;aqueous</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2087\">2087</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">parenteral&nbsp;drug&nbsp;products.&nbsp;Pharm&nbsp;Outsourcing.&nbsp;2014;&nbsp;&nbsp;15(4):20,&nbsp;22,&nbsp;24-27</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2088\">2088</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[41]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2089\">2089</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Jordi&nbsp;&nbsp;M.A.,&nbsp;Khera&nbsp;&nbsp;S.,&nbsp;Roland&nbsp;&nbsp;K.&nbsp;et&nbsp;al.&nbsp;,&nbsp;Qualitative&nbsp;assessment&nbsp;of&nbsp;extractables&nbsp;from&nbsp;single-use</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2090\">2090</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">components&nbsp;and&nbsp;the&nbsp;impact&nbsp;of&nbsp;reference&nbsp;standard&nbsp;selection.&nbsp;J.&nbsp;Pharmaceutical&nbsp;and&nbsp;Biomedical</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2091\">2091</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Analysis.&nbsp;2018;&nbsp;150:368-376</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2092\">2092</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[42]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2093\">2093</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Koster&nbsp;&nbsp;S.&nbsp;et&nbsp;al.&nbsp;&nbsp;Food&nbsp;and&nbsp;Chem&nbsp;Tox.&nbsp;2011;&nbsp;49:1643\u20131660</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2094\">2094</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[43]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2095\">2095</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Krause&nbsp;&nbsp;A.,&nbsp;Lange&nbsp;&nbsp;A.,&nbsp;Ezrin&nbsp;&nbsp;M.,&nbsp;Plastics&nbsp;Analysis&nbsp;Guide,&nbsp;Chemical&nbsp;and&nbsp;Instrumental&nbsp;Methods,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2096\">2096</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Hanser&nbsp;Publishers,&nbsp;&nbsp;Munich&nbsp;(1983)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2097\">2097</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[44]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2098\">2098</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Marques&nbsp;&nbsp;M.R.C.,&nbsp;Loebenberg&nbsp;&nbsp;R.,&nbsp;Almukainzi&nbsp;&nbsp;M.,&nbsp;Simulated&nbsp;Biological&nbsp;Fluids&nbsp;with&nbsp;Possible.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2099\">2099</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Dissolution&nbsp;Technologies&nbsp;[Viewed&nbsp;2019-01-29]&nbsp;Available&nbsp;from:&nbsp;http://\u200bwww\u200b.dissolutiontech\u200b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2100\">2100</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">.com/\u200bDTresour/\u200b201108Articles/\u200bDT201108\u200b_A02\u200b.pdf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2101\">2101</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[45]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2102\">2102</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Mullis&nbsp;&nbsp;J.O.,&nbsp;Granger&nbsp;&nbsp;A.,&nbsp;Quin&nbsp;&nbsp;C.,&nbsp;Norwood&nbsp;&nbsp;D.L.,&nbsp;The&nbsp;analytical&nbsp;evaluation&nbsp;threshold&nbsp;(AET)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2103\">2103</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">concept,&nbsp;sensitivity&nbsp;and&nbsp;analytical&nbsp;uncertainty.&nbsp;Conference&nbsp;Proceedings,&nbsp;Leachables&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2104\">2104</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Extractables.&nbsp;Smithers&nbsp;Rapra,&nbsp;Dublin,&nbsp;Ireland,&nbsp;March,&nbsp;2008</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2105\">2105</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[46]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2106\">2106</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Norwood&nbsp;&nbsp;D.L.,&nbsp;Nagao&nbsp;&nbsp;L.M.,&nbsp;Stults&nbsp;&nbsp;C.L.M,&nbsp;Perspectives&nbsp;on&nbsp;the&nbsp;PQRI&nbsp;Extractables&nbsp;and</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2107\">2107</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Leachables&nbsp;\u201cSafety&nbsp;Thresholds&nbsp;and&nbsp;Best&nbsp;Practices\u201d&nbsp;Recommendations&nbsp;for&nbsp;Inhalation&nbsp;Drug</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2108\">2108</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Products,&nbsp;PDA&nbsp;J&nbsp;Pharm&nbsp;Sci&nbsp;and&nbsp;Tech&nbsp;2013,&nbsp;&nbsp;67&nbsp;413-429</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2109\">2109</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[47]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2110\">2110</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Oyane&nbsp;&nbsp;A.,&nbsp;Kim&nbsp;&nbsp;H-M.,&nbsp;Furuya&nbsp;&nbsp;T.&nbsp;et&nbsp;al.&nbsp;,&nbsp;Preparation&nbsp;and&nbsp;assessment&nbsp;of&nbsp;revised&nbsp;simulated&nbsp;body</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2111\">2111</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufb02uids,&nbsp;J&nbsp;Biomed&nbsp;Mater&nbsp;Res,&nbsp;2003;&nbsp;&nbsp;65A:&nbsp;188&nbsp;\u2013195</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2112\">2112</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[48]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2113\">2113</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Safety&nbsp;Thresholds&nbsp;and&nbsp;Best&nbsp;Practices&nbsp;for&nbsp;Extractables&nbsp;and&nbsp;Leachables&nbsp;in&nbsp;Orally</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2114\">2114</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Inhaled&nbsp;and&nbsp;Nasal&nbsp;Drug&nbsp;ProductsPQRI&nbsp;Leachables&nbsp;and&nbsp;Extractables&nbsp;Working&nbsp;Group,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2115\">2115</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">September&nbsp;9,&nbsp;2006&nbsp;[viewed&nbsp;2019-01-29]&nbsp;Available&nbsp;from:&nbsp;http://\u200bpqri\u200b.org/\u200bwp\u200b-content/\u200buploads/\u200b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2116\">2116</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">2015/\u200b08/\u200bpdf/\u200bLE\u200b_Recommendations\u200b_to\u200b_FDA\u200b_09\u200b-29\u200b-06\u200b.pdf</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2117\">2117</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[49]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2118\">2118</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Snyder&nbsp;&nbsp;LR,&nbsp;Chapter&nbsp;1&nbsp;Theory&nbsp;of&nbsp;chromatography,&nbsp;Editor(s):&nbsp;E.&nbsp;Heftmann,&nbsp;In&nbsp;Journal&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2119\">2119</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Chromatography&nbsp;Library,&nbsp;Elsevier,&nbsp;Volume&nbsp;51,&nbsp;Part&nbsp;A,&nbsp;1992,&nbsp;Pages&nbsp;A1-A68</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2120\">2120</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[50]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2121\">2121</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Snyder&nbsp;&nbsp;LR,&nbsp;Classification&nbsp;of&nbsp;the&nbsp;solvent&nbsp;properties&nbsp;of&nbsp;common&nbsp;liquids.&nbsp;J&nbsp;Chromatogr&nbsp;Sci&nbsp;1978:</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2122\">2122</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">16;223-234</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2123\">2123</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[51]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2124\">2124</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Strandberg&nbsp;&nbsp;D.,&nbsp;&nbsp;Albertsson&nbsp;&nbsp;A.C.,&nbsp;Chromatographic&nbsp;analysis&nbsp;of&nbsp;antioxidants&nbsp;in&nbsp;polymeric</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2125\">2125</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">materials&nbsp;and&nbsp;their&nbsp;migration&nbsp;from&nbsp;plastics&nbsp;into&nbsp;solution.&nbsp;Adv&nbsp;Poly&nbsp;Sci.&nbsp;2007;&nbsp;&nbsp;211:&nbsp;117-157</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2126\">2126</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[52]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2127\">2127</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Stults&nbsp;&nbsp;C.L.M.,&nbsp;&nbsp;Creasey&nbsp;&nbsp;J.M.,&nbsp;Development,&nbsp;optimization,&nbsp;and&nbsp;validation&nbsp;of&nbsp;methods&nbsp;for&nbsp;routine</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2128\">2128</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">testing,&nbsp;Editors:&nbsp;DJ&nbsp;Ball,&nbsp;DL&nbsp;Norwood,&nbsp;CLM&nbsp;Stults,&nbsp;LM&nbsp;Nagao&nbsp;in&nbsp;Leachables&nbsp;and&nbsp;Extractables</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2129\">2129</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Handbook,&nbsp;John&nbsp;Wiley&nbsp;&amp;&nbsp;Sons,&nbsp;Pages&nbsp;449-506(2012)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2130\">2130</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[53]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2131\">2131</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO/TS\u00a0&nbsp;10993-19,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;19:&nbsp;Physico-chemical,</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2132\">2132</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">morphological&nbsp;and&nbsp;topographical&nbsp;characterization&nbsp;of&nbsp;materials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2133\">2133</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[54]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2134\">2134</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO/TR\u00a010993-22,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Part&nbsp;22:&nbsp;Guidance&nbsp;on&nbsp;nanomaterials</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2135\">2135</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">[55]</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2136\">2136</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO/TS\u00a0&nbsp;21726,&nbsp;Biological&nbsp;evaluation&nbsp;of&nbsp;medical&nbsp;devices&nbsp;\u2014&nbsp;Application&nbsp;of&nbsp;the&nbsp;threshold&nbsp;of</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2137\">2137</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">toxicological&nbsp;concern&nbsp;(TTC)&nbsp;for&nbsp;assessing&nbsp;biocompatibility&nbsp;of&nbsp;medical&nbsp;device&nbsp;constituents</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2138\">2138</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2139\">2139</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">66\b</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2140\">2140</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2141\">2141</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2142\">2142</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2143\">2143</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2144\">2144</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2145\">2145</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2146\">2146</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2147\">2147</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2148\">2148</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;10993-18:2020(E)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2149\">2149</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\ufeff</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2150\">2150</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">\u00a9&nbsp;ISO&nbsp;2020&nbsp;\u2013&nbsp;All&nbsp;rights&nbsp;reserved</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2151\">2151</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ICS\u200211.100.20</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2152\">2152</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Price&nbsp;based&nbsp;on&nbsp;66&nbsp;pages</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2153\">2153</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Licensed&nbsp;to&nbsp;Tulip&nbsp;Medical&nbsp;/&nbsp;Marc&nbsp;Pilkington&nbsp;(marc@tulipmedical.com)</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2154\">2154</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">ISO&nbsp;Store&nbsp;Order:&nbsp;OP-781942&nbsp;license&nbsp;#1/&nbsp;Downloaded:&nbsp;2024-05-09</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n            <tr><td class=\"diff_next\"></td><td class=\"diff_header\" id=\"from21_2155\">2155</td><td nowrap=\"nowrap\"><span class=\"diff_sub\">Single&nbsp;user&nbsp;licence&nbsp;only,&nbsp;copying&nbsp;and&nbsp;networking&nbsp;prohibited.</span></td><td class=\"diff_next\"></td><td class=\"diff_header\"></td><td nowrap=\"nowrap\"></td></tr>\n        </tbody>\n    </table>"
  },
  {
    "clause_id": "7.1",
    "change_type": "added",
    "old_text": "",
    "new_text": "7.1\t Derivation of TCL and TI\nPrior to deriving a constituent specific TCL (i.e. for irritation) or TI (i.e. for genotoxicity, systemic\ntoxicity, carcinogenicity, or reproductive or developmental toxicity), availability of a specific and\nrelevant POD for a medical device\u2019s intended use shall be determined.\nWhen available, a constituent\u2019s POD is used to derive a TCL or TI value for each constituent. The TCL\n(i.e. for irritation) or TI (i.e. for genotoxicity, systemic toxicity, carcinogenicity, or reproductive or\ndevelopmental toxicity) used shall account for the duration for which constituent exposure is assessed.\nNOTE\u00a01\nThe underlying objective in selecting the highest NOAEL when multiple NOAELs are available for the\nsame type of harm and same clinically relevant exposure scenario is to prevent over estimation of toxicological\nrisk of the constituent. The underlying objective in selecting the lowest POD for chemicals that induce more than\none type of harm is to prevent other clinically relevant harms that can occur at higher doses.\nWhen multiple NILs or NOAELs are available that apply to the same harm and same clinically relevant\nexposure scenario, the highest NIL or NOAEL can be used to derive the TCL or TI, respectively. When\ntoxicological data are of mixed quality, the TCL or TI shall be based on the study with the highest quality\ndata (see applicable requirements in Annex\u00a0A).\nWhen different types of PODs (e.g. NIL versus MIL; NOAEL versus LOAEL), or same type of POD for\ndifferent types of harms, are available for the same constituent and same study quality (see Annex\u00a0A for\nadditional information), the lowest POD shall be used.\nNOTE\u00a02\nDerivation of a TCL or TI for select harms is described in Annex\u00a0C and Annex\u00a0D.\nWhen a threshold for a constituent is available for use in other applications besides medical device\nuse (e.g. pharmaceutical product, food product, occupational, environmental), the applicability of the\nthreshold for the duration and type of medical device body contact shall be justified and documented.\nIn these situations, additional uncertainty factor(s) should be applied when the approach used to\nderive the threshold does not address all of the sources of uncertainty that reflect the circumstances of\nexposure applicable to the intended use of the medical device (see Clause C.2).\nNOTE\u00a03\nThe application of additional uncertainty factors to a TCL or TI not originally intended for medical\ndevice use apply when all of the uncertainties applicable to clinical use of the medical device are not addressed,\ne.g. differences in exposure route or sensitivity of the individual exposed.",
    "change_text": "7.1\t Derivation of TCL and TI\nPrior to deriving a constituent specific TCL (i.e. for irritation) or TI (i.e. for genotoxicity, systemic\ntoxicity, carcinogenicity, or reproductive or developmental toxicity), availability of a specific and\nrelevant POD for a medical device\u2019s intended use shall be determined.\nWhen available, a constituent\u2019s POD is used to derive a TCL or TI value for each constituent. The TCL\n(i.e. for irritation) or TI (i.e. for genotoxicity, systemic toxicity, carcinogenicity, or reproductive or\ndevelopmental toxicity) used shall account for the duration for which constituent exposure is assessed.\nNOTE\u00a01\nThe underlying objective in selecting the highest NOAEL when multiple NOAELs are available for the\nsame type of harm and same clinically relevant exposure scenario is to prevent over estimation of toxicological\nrisk of the constituent. The underlying objective in selecting the lowest POD for chemicals that induce more than\none type of harm is to prevent other clinically relevant harms that can occur at higher doses.\nWhen multiple NILs or NOAELs are available that apply to the same harm and same clinically relevant\nexposure scenario, the highest NIL or NOAEL can be used to derive the TCL or TI, respectively. When\ntoxicological data are of mixed quality, the TCL or TI shall be based on the study with the highest quality\ndata (see applicable requirements in Annex\u00a0A).\nWhen different types of PODs (e.g. NIL versus MIL; NOAEL versus LOAEL), or same type of POD for\ndifferent types of harms, are available for the same constituent and same study quality (see Annex\u00a0A for\nadditional information), the lowest POD shall be used.\nNOTE\u00a02\nDerivation of a TCL or TI for select harms is described in Annex\u00a0C and Annex\u00a0D.\nWhen a threshold for a constituent is available for use in other applications besides medical device\nuse (e.g. pharmaceutical product, food product, occupational, environmental), the applicability of the\nthreshold for the duration and type of medical device body contact shall be justified and documented.\nIn these situations, additional uncertainty factor(s) should be applied when the approach used to\nderive the threshold does not address all of the sources of uncertainty that reflect the circumstances of\nexposure applicable to the intended use of the medical device (see Clause C.2).\nNOTE\u00a03\nThe application of additional uncertainty factors to a TCL or TI not originally intended for medical\ndevice use apply when all of the uncertainties applicable to clinical use of the medical device are not addressed,\ne.g. differences in exposure route or sensitivity of the individual exposed."
  },
  {
    "clause_id": "7.2",
    "change_type": "added",
    "old_text": "",
    "new_text": "7.2\t Application of TTC\nWhen the result of the application of 7.1 is the determination that constituent specific toxicological\ninformation is not adequate to derive a TI, the TTC approach shall be applied in accordance with this\nclause to address the following endpoints: genotoxicity, carcinogenicity, systemic toxicity (i.e. acute,\nsubacute, subchronic and chronic), or reproductive or developmental toxicity.\nTTC values shall not be used to assess the toxicological risk of cohorts of concern, excluded compounds,\nor other biological endpoints in accordance with ISO/TS 21726.\nNOTE\u00a01\nTypes and examples of cohort of concern and excluded compounds are described in ISO/TS 21726.\nWhen the worst-case estimated exposure dose is conservative and below the corresponding TTC, the\nrelease can be judged to be of negligible toxicological risk.\nNOTE\u00a02\nConservative means the estimation of worst-case estimated exposure dose is deliberately higher than\nthe probable true exposure.\nWhen negligible toxicological risk cannot be determined (e.g. underestimation or overestimation of\nthe quantity released), the toxicological risk shall be addressed by other means in accordance with\nISO 10993-1 and ISO 14971. Outcomes of further risk analysis or risk evaluation or risk control shall be\ndocumented in accordance with ISO 10993-1 and ISO 14971.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n18\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nOutcomes of the comparison shall be documented (see Clause\u00a011).\nNOTE\u00a03\nISO/TS 21726 includes TTC values applicable to constituents that leach from medical devices (except\nfor gas pathway devices).\nNOTE\u00a04\nThe application of TTC for VOCs and SVOCs present or released from a gas pathway device is described\nin the ISO\u00a018562 series.",
    "change_text": "7.2\t Application of TTC\nWhen the result of the application of 7.1 is the determination that constituent specific toxicological\ninformation is not adequate to derive a TI, the TTC approach shall be applied in accordance with this\nclause to address the following endpoints: genotoxicity, carcinogenicity, systemic toxicity (i.e. acute,\nsubacute, subchronic and chronic), or reproductive or developmental toxicity.\nTTC values shall not be used to assess the toxicological risk of cohorts of concern, excluded compounds,\nor other biological endpoints in accordance with ISO/TS 21726.\nNOTE\u00a01\nTypes and examples of cohort of concern and excluded compounds are described in ISO/TS 21726.\nWhen the worst-case estimated exposure dose is conservative and below the corresponding TTC, the\nrelease can be judged to be of negligible toxicological risk.\nNOTE\u00a02\nConservative means the estimation of worst-case estimated exposure dose is deliberately higher than\nthe probable true exposure.\nWhen negligible toxicological risk cannot be determined (e.g. underestimation or overestimation of\nthe quantity released), the toxicological risk shall be addressed by other means in accordance with\nISO 10993-1 and ISO 14971. Outcomes of further risk analysis or risk evaluation or risk control shall be\ndocumented in accordance with ISO 10993-1 and ISO 14971.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n18\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nOutcomes of the comparison shall be documented (see Clause\u00a011).\nNOTE\u00a03\nISO/TS 21726 includes TTC values applicable to constituents that leach from medical devices (except\nfor gas pathway devices).\nNOTE\u00a04\nThe application of TTC for VOCs and SVOCs present or released from a gas pathway device is described\nin the ISO\u00a018562 series."
  },
  {
    "clause_id": "8",
    "change_type": "added",
    "old_text": "",
    "new_text": "8\t Exposure dose estimation\nThe EEDmax of a constituent that contacts or enters the body per day shall be estimated. The process to\ndetermine the quantity of a constituent that contacts or enters the body is described in Figure\u00a03.\nNOTE\u00a01\nPer day exposure is time-based and occurs on a single day or on multiple days.\nFigure\u00a03\u00a0\u2014 Exposure dose estimation\nThe worst-case exposure dose shall be estimated based on worst-case conditions of the use of the\nmedical device.\nThe following worst-case medical device use assumptions shall be applied:\n\u2014\t the type of chemical exposure information relevant to the medical device intended use (see\nClause E.1);\n\u2014\t the largest possible number or quantity of the medical device to which an individual can be exposed\nin accordance with the medical device intended use, unless otherwise justified (see Clauses E.2 and\nE.3);\n\u2014\t the lowest body mass of individuals who can be exposed to the constituent (see D.2.1 and Clauses E.2\nand E.3).\nNOTE\u00a02\nISO 10993-18:2020, Clause\u00a05 includes chemical characterization approaches that vary in relevance to\nmedical device intended use. Information gathering and extraction studies establish the hypothetical worst-case\nestimated exposure dose based on the total quantity of each chemical constituent released from the medical\ndevice, see ISO 10993-18:2020, 5.4. The determination of actual exposure is described in ISO 10993-18:2020, 5.8.\nWhen toxicological risk assessment applies to individuals with unique susceptibilities (see C.2.2.2),\nadditional exposure dose estimates, based on body mass specific to these individuals (see D.2.1) shall\nbe used in the exposure calculation as specified in Annex\u00a0E, unless justified with supporting evidence.\nWhen accounted for in the reporting of chemical characterization data per ISO 10993-18, the maximum\nnumber and quantity of medical devices that simultaneously contact the body shall be accounted for in\nthe calculation of the worst-case estimated exposure dose of each constituent to which an individual\ncan be exposed.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n19\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe specific medical device use assumptions that are used to calculate an exposure dose shall be\njustified and documented.\nThe method used to calculate an exposure dose shall be in accordance with Annex\u00a0E. The application of\nadditional assumptions and calculations used in the calculation shall be justified and documented.\nNOTE\u00a03\nThe exposure dose is expressed in the same unit as the TI (i.e. as \u00b5g/kg/d) or TCL (i.e. \u00b5g/cm2).\nNOTE\u00a04\nExposure on a day can occur intermittently, continuously for a portion of the day or continuously for\nthe entire day. In all these cases, the exposure dose is reported on a per day basis.\nNOTE\u00a05\nWhen available, toxicokinetics data can be useful to estimate an internal dose.",
    "change_text": "8\t Exposure dose estimation\nThe EEDmax of a constituent that contacts or enters the body per day shall be estimated. The process to\ndetermine the quantity of a constituent that contacts or enters the body is described in Figure\u00a03.\nNOTE\u00a01\nPer day exposure is time-based and occurs on a single day or on multiple days.\nFigure\u00a03\u00a0\u2014 Exposure dose estimation\nThe worst-case exposure dose shall be estimated based on worst-case conditions of the use of the\nmedical device.\nThe following worst-case medical device use assumptions shall be applied:\n\u2014\t the type of chemical exposure information relevant to the medical device intended use (see\nClause E.1);\n\u2014\t the largest possible number or quantity of the medical device to which an individual can be exposed\nin accordance with the medical device intended use, unless otherwise justified (see Clauses E.2 and\nE.3);\n\u2014\t the lowest body mass of individuals who can be exposed to the constituent (see D.2.1 and Clauses E.2\nand E.3).\nNOTE\u00a02\nISO 10993-18:2020, Clause\u00a05 includes chemical characterization approaches that vary in relevance to\nmedical device intended use. Information gathering and extraction studies establish the hypothetical worst-case\nestimated exposure dose based on the total quantity of each chemical constituent released from the medical\ndevice, see ISO 10993-18:2020, 5.4. The determination of actual exposure is described in ISO 10993-18:2020, 5.8.\nWhen toxicological risk assessment applies to individuals with unique susceptibilities (see C.2.2.2),\nadditional exposure dose estimates, based on body mass specific to these individuals (see D.2.1) shall\nbe used in the exposure calculation as specified in Annex\u00a0E, unless justified with supporting evidence.\nWhen accounted for in the reporting of chemical characterization data per ISO 10993-18, the maximum\nnumber and quantity of medical devices that simultaneously contact the body shall be accounted for in\nthe calculation of the worst-case estimated exposure dose of each constituent to which an individual\ncan be exposed.\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n19\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nThe specific medical device use assumptions that are used to calculate an exposure dose shall be\njustified and documented.\nThe method used to calculate an exposure dose shall be in accordance with Annex\u00a0E. The application of\nadditional assumptions and calculations used in the calculation shall be justified and documented.\nNOTE\u00a03\nThe exposure dose is expressed in the same unit as the TI (i.e. as \u00b5g/kg/d) or TCL (i.e. \u00b5g/cm2).\nNOTE\u00a04\nExposure on a day can occur intermittently, continuously for a portion of the day or continuously for\nthe entire day. In all these cases, the exposure dose is reported on a per day basis.\nNOTE\u00a05\nWhen available, toxicokinetics data can be useful to estimate an internal dose."
  },
  {
    "clause_id": "9",
    "change_type": "added",
    "old_text": "",
    "new_text": "9\t Margin of safety",
    "change_text": "9\t Margin of safety"
  },
  {
    "clause_id": "9.1",
    "change_type": "added",
    "old_text": "",
    "new_text": "9.1\t General\nFor each constituent, the estimated exposure dose shall be assessed to be either\n\u2014\t without appreciable harm to health, or\n\u2014\t a harmful dose.\nFor this toxicological assessment process, a MoS approach shall be used as described in 9.2.\nNOTE\u00a01\nAn estimated exposure dose can be a harmful dose when the TCL or TI or EEDmax are not conservative,\nsee 10.1.\nNOTE\u00a02\nMoS does not apply to biological risks associated with physical interactions of the medical device with\nthe body (i.e. application of mechanical forces, energy, or surface morphology, etc.), provided that the chemical\nexposure is not changed.",
    "change_text": "9.1\t General\nFor each constituent, the estimated exposure dose shall be assessed to be either\n\u2014\t without appreciable harm to health, or\n\u2014\t a harmful dose.\nFor this toxicological assessment process, a MoS approach shall be used as described in 9.2.\nNOTE\u00a01\nAn estimated exposure dose can be a harmful dose when the TCL or TI or EEDmax are not conservative,\nsee 10.1.\nNOTE\u00a02\nMoS does not apply to biological risks associated with physical interactions of the medical device with\nthe body (i.e. application of mechanical forces, energy, or surface morphology, etc.), provided that the chemical\nexposure is not changed."
  },
  {
    "clause_id": "9.2",
    "change_type": "added",
    "old_text": "",
    "new_text": "9.2\t Calculating the margin of safety\n9.2.1\nGeneral\nThe MoS shall be based on the following:\n\u2014\t constituent TI or TCL, in accordance with Clause\u00a07;\n\u2014\t worst-case estimated exposure dose, EEDmax, in accordance with 3.32 and Clause\u00a08.\nThe MoS is the ratio of the chemical specific TI or TCL and the worst-case estimated exposure dose (i.e.\nEEDmax in \u00b5g/kg/d or \u00b5g/cm2), and calculated by Formula\u00a0(1):\nMOS\nTI\nEED\n=\nmax\n\nor\nMOS\nTCL\nEED\n=\nmax\n\n(1)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n20\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\nEEDmax is the exposure dose that is a maximum value for a specified intended clinical-use scenario,\nin \u00b5g/kg/d or \u00b5g/cm2;\nTI\nis the estimated daily exposure of an identified constituent over a specified time period\n(e.g. acute, subacute, subchronic or chronic), on the basis of body mass in \u00b5g/kg/d, that is\nconsidered to be without appreciable harm to health.\n\nTCL\nis the estimated the daily tissue surface-contact exposure to an identified constituent at the\ncontact site over a specified time period that is without appreciable irritation, in \u00b5g/cm2;\nNOTE\u00a01\nTolerable contact level applies to irritation. Tolerable intake applies to systemic toxicity (acute,\nsubacute, subchronic or chronic), genotoxicity, carcinogenicity or reproductive/developmental toxicity.\nNOTE\u00a02\nMoS is unitless (i.e. units for EEDmax are the same as those used for TCL or TI).\nThe toxicological risk assessment shall address the quantity as a function of duration of exposure to\nthe constituent and associated risks. For example, the ratio of a worst-case estimated exposure dose to\na life-time TI is generally protective for acute, subacute, subchronic and chronic systemic toxic effects.\nWhen release kinetics data are available, then the worst-case estimated exposure dose, as described in\nClause\u00a0E.2, shall be used in the derivation of the MoS.\nWhen release kinetics data are not available, acute, subacute, subchronic or chronic exposure can\nbe assumed to occur based on the fewest number of exposure days as described in\u00a0Clause\u00a0E.3 [e.g.\nFormula\u00a0(E.3)]. MoS values that correspond to acute, subacute, subchronic, and chronic exposure shall\nbe calculated (see Table\u00a01) based on a worst-case exposure for each of these exposure periods (see\nTable\u00a0E.4) and compared to the TI or TCL value, unless the approach used is in accordance with E.3.2.\nTable\u00a01\u00a0\u2014 MoS values to consider when constituent release kinetics data are not available\nPeriod of assumed\nexposure to the\nconstituent\nCalculation of MoS value for toxicological endpoints to be addressedd\nAcutec\nSubacutec\nSubchronicc\nChronicc\n\u22641\u00a0da\nX\nNot applicable\nNot applicable\nNot applicable\n2 d to 30\u00a0dab\nX\nX\nNot applicable\nNot applicable\n31 to\u00a0365\u00a0dab\nX\nX\nX\nNot applicable\n\u2265366\u00a0dab\nX\nX\nX\nX\nX indicates toxicological endpoint shall be addressed unless otherwise justified (see Clause E.1).\na\nThis applies when Formula\u00a0(E.1) is used to estimate an exposure dose.\nb\nThis applies when Formula\u00a0(E.3) is used to estimate the worst-case estimated exposure dose for assumed exposure\nperiods.\nc\nAcute, subacute, subchronic and chronic refer to the duration of exposure for which the TCL or TI is protective (see",
    "change_text": "9.2\t Calculating the margin of safety\n9.2.1\nGeneral\nThe MoS shall be based on the following:\n\u2014\t constituent TI or TCL, in accordance with Clause\u00a07;\n\u2014\t worst-case estimated exposure dose, EEDmax, in accordance with 3.32 and Clause\u00a08.\nThe MoS is the ratio of the chemical specific TI or TCL and the worst-case estimated exposure dose (i.e.\nEEDmax in \u00b5g/kg/d or \u00b5g/cm2), and calculated by Formula\u00a0(1):\nMOS\nTI\nEED\n=\nmax\n\nor\nMOS\nTCL\nEED\n=\nmax\n\n(1)\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n20\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nwhere\n\nEEDmax is the exposure dose that is a maximum value for a specified intended clinical-use scenario,\nin \u00b5g/kg/d or \u00b5g/cm2;\nTI\nis the estimated daily exposure of an identified constituent over a specified time period\n(e.g. acute, subacute, subchronic or chronic), on the basis of body mass in \u00b5g/kg/d, that is\nconsidered to be without appreciable harm to health.\n\nTCL\nis the estimated the daily tissue surface-contact exposure to an identified constituent at the\ncontact site over a specified time period that is without appreciable irritation, in \u00b5g/cm2;\nNOTE\u00a01\nTolerable contact level applies to irritation. Tolerable intake applies to systemic toxicity (acute,\nsubacute, subchronic or chronic), genotoxicity, carcinogenicity or reproductive/developmental toxicity.\nNOTE\u00a02\nMoS is unitless (i.e. units for EEDmax are the same as those used for TCL or TI).\nThe toxicological risk assessment shall address the quantity as a function of duration of exposure to\nthe constituent and associated risks. For example, the ratio of a worst-case estimated exposure dose to\na life-time TI is generally protective for acute, subacute, subchronic and chronic systemic toxic effects.\nWhen release kinetics data are available, then the worst-case estimated exposure dose, as described in\nClause\u00a0E.2, shall be used in the derivation of the MoS.\nWhen release kinetics data are not available, acute, subacute, subchronic or chronic exposure can\nbe assumed to occur based on the fewest number of exposure days as described in\u00a0Clause\u00a0E.3 [e.g.\nFormula\u00a0(E.3)]. MoS values that correspond to acute, subacute, subchronic, and chronic exposure shall\nbe calculated (see Table\u00a01) based on a worst-case exposure for each of these exposure periods (see\nTable\u00a0E.4) and compared to the TI or TCL value, unless the approach used is in accordance with E.3.2.\nTable\u00a01\u00a0\u2014 MoS values to consider when constituent release kinetics data are not available\nPeriod of assumed\nexposure to the\nconstituent\nCalculation of MoS value for toxicological endpoints to be addressedd\nAcutec\nSubacutec\nSubchronicc\nChronicc\n\u22641\u00a0da\nX\nNot applicable\nNot applicable\nNot applicable\n2 d to 30\u00a0dab\nX\nX\nNot applicable\nNot applicable\n31 to\u00a0365\u00a0dab\nX\nX\nX\nNot applicable\n\u2265366\u00a0dab\nX\nX\nX\nX\nX indicates toxicological endpoint shall be addressed unless otherwise justified (see Clause E.1).\na\nThis applies when Formula\u00a0(E.1) is used to estimate an exposure dose.\nb\nThis applies when Formula\u00a0(E.3) is used to estimate the worst-case estimated exposure dose for assumed exposure\nperiods.\nc\nAcute, subacute, subchronic and chronic refer to the duration of exposure for which the TCL or TI is protective (see"
  },
  {
    "clause_id": "9.2.1",
    "change_type": "added",
    "old_text": "",
    "new_text": "9.2.1 NOTE\u00a01).\nd\nSee 6.1 for toxicological endpoints to be addressed.\nNOTE\u00a03\nWhen a POD is unavailable to derive a TI for limited or prolonged exposure (i.e. acute or subacute\nexposure), a TI that applies to long-term exposure (i.e. subchronic and chronic exposure) can be used to address\nlimited or prolonged exposure duration, also see example in 9.2.1.\nEXAMPLE\nAn example of the calculation of a MoS for a medical device constituent is as follows: an assumed\nworst-case estimated exposure dose is applied to constituent data obtained by exhaustively extracting the\nmedical device using analytically expedient solvents, see ISO 10993-18:2020, 5.4.\nIn this example, the medical device intended is an implant in long-term contact with tissue/bone. Worst-case\nestimated exposure from Clause E.4 and Table\u00a0E.5 are used in the calculation of the applicable MoS values and\ntwo constituent specific TI values are available [i.e. 60 \u00b5g/kg/d and 10\u00a0\u00b5g/kg/d for harm that can occur from\nlimited or prolonged (\u226430\u00a0d), and long-term (>30\u00a0d) exposures].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n21\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a02\u00a0\u2014 Calculation example of MoS based on assumed release for a long-term implant and\ntwo TI values\nTime period\nd\nTIa\n\u00b5g/kg/d\nEEDmaxb\n\u00b5g/kg/d\nMoS\nFormula\u00a0(1)\n\u22641\n60\n500\n0,12\n0,12\u00a0=\u00a060 /\u00a0500\n2 to\u00a030\n60\n250\n0,24\n0,24\u00a0=\u00a060\u00a0/\u00a0250\n31 to\u00a0365\n10\n16\n0,625\n0,625\u00a0=\u00a010\u00a0/\u00a016\n\u2265366\n10\n1,4\n7,14\n7,14\u00a0=\u00a010\u00a0/\u00a01,4\na\nTI values of 60\u00a0\u00b5g/kg/d and 10\u00a0\u00b5g/kg/d are derived based on a NOAEL obtained from a constituent specific subacute\nand chronic, respectively, systemic toxicity studies. Because constituent specific POD data from acute (<1\u00a0d) and subchronic\n(90\u00a0d) systemic toxicity studies are unavailable, the TI value applicable to the longer time periods is used (i.e. subacute TI\nfor\u00a02 d to 30\u00a0d and chronic TI for\u00a0>366\u00a0d of assumed exposure, respectively).\nb\nEEDmax values are based on the assumed worst-case estimated exposure from Annex\u00a0E.\nThe MoS values in Table\u00a02 are evaluated according to Clause\u00a010.\n9.2.2\nCombining MoS values to address additivity of harm\nMoS values, MoSi, of two or more constituents shall be combined when the following apply:\n\u2014\t exposure to each constituent can occur simultaneously (e.g. constituents are present in or on, or\nreleased from the same medical device);\n\u2014\t the constituents elicit the same harm in the same target organ or system and the same mode of\naction applies.\nThe combined MoS value, MoScom, shall be derived in accordance with Formula\u00a0(2).\nMOS\nMOS\ni\nn\ni\ncom =\n=\u2211\n1\n1\n1\n/\n\n(2)\nwhere\n\nMoScom is the result from the summation of reciprocal MoSi (unitless) values;\n\nMoSi\nis the MoS for each (i.e. individual) constituent that results from Formula\u00a0(1).\nWhen the constituent\u2019s critical adverse health effect is not known, then combining MoS values is not\nrequired and the MoS value for each constituent is calculated and used individually for toxicological\nrisk assessment.\nNOTE\u00a01\nCombining MoS values applies to the constituent\u2019s critical adverse health effect. The critical adverse\nhealth effect is the harm that occurs at the lowest administered POD dose.\nNOTE\u00a02\nCombining MoS values addresses the harm that can occur in an additive fashion, as well as the harm\nthat occurs by the same or different exposure routes. Formula\u00a0(2) is adapted from hazard index of mixtures for\nmedical device constituents[42]to[50].\nNOTE\u00a03\nIn some studies, a distinct toxicological mode of action is not always evident, particularly for minor\nadaptive effects such as small changes in organ mass or reversible changes in blood chemistry, and in such cases,\nrisks are not always additive for a target organ.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n22\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)",
    "change_text": "9.2.1 NOTE\u00a01).\nd\nSee 6.1 for toxicological endpoints to be addressed.\nNOTE\u00a03\nWhen a POD is unavailable to derive a TI for limited or prolonged exposure (i.e. acute or subacute\nexposure), a TI that applies to long-term exposure (i.e. subchronic and chronic exposure) can be used to address\nlimited or prolonged exposure duration, also see example in 9.2.1.\nEXAMPLE\nAn example of the calculation of a MoS for a medical device constituent is as follows: an assumed\nworst-case estimated exposure dose is applied to constituent data obtained by exhaustively extracting the\nmedical device using analytically expedient solvents, see ISO 10993-18:2020, 5.4.\nIn this example, the medical device intended is an implant in long-term contact with tissue/bone. Worst-case\nestimated exposure from Clause E.4 and Table\u00a0E.5 are used in the calculation of the applicable MoS values and\ntwo constituent specific TI values are available [i.e. 60 \u00b5g/kg/d and 10\u00a0\u00b5g/kg/d for harm that can occur from\nlimited or prolonged (\u226430\u00a0d), and long-term (>30\u00a0d) exposures].\n\u00a9 ISO 2023 \u2013 All rights reserved\n\ufeff\n\ufeff\n21\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)\nTable\u00a02\u00a0\u2014 Calculation example of MoS based on assumed release for a long-term implant and\ntwo TI values\nTime period\nd\nTIa\n\u00b5g/kg/d\nEEDmaxb\n\u00b5g/kg/d\nMoS\nFormula\u00a0(1)\n\u22641\n60\n500\n0,12\n0,12\u00a0=\u00a060 /\u00a0500\n2 to\u00a030\n60\n250\n0,24\n0,24\u00a0=\u00a060\u00a0/\u00a0250\n31 to\u00a0365\n10\n16\n0,625\n0,625\u00a0=\u00a010\u00a0/\u00a016\n\u2265366\n10\n1,4\n7,14\n7,14\u00a0=\u00a010\u00a0/\u00a01,4\na\nTI values of 60\u00a0\u00b5g/kg/d and 10\u00a0\u00b5g/kg/d are derived based on a NOAEL obtained from a constituent specific subacute\nand chronic, respectively, systemic toxicity studies. Because constituent specific POD data from acute (<1\u00a0d) and subchronic\n(90\u00a0d) systemic toxicity studies are unavailable, the TI value applicable to the longer time periods is used (i.e. subacute TI\nfor\u00a02 d to 30\u00a0d and chronic TI for\u00a0>366\u00a0d of assumed exposure, respectively).\nb\nEEDmax values are based on the assumed worst-case estimated exposure from Annex\u00a0E.\nThe MoS values in Table\u00a02 are evaluated according to Clause\u00a010.\n9.2.2\nCombining MoS values to address additivity of harm\nMoS values, MoSi, of two or more constituents shall be combined when the following apply:\n\u2014\t exposure to each constituent can occur simultaneously (e.g. constituents are present in or on, or\nreleased from the same medical device);\n\u2014\t the constituents elicit the same harm in the same target organ or system and the same mode of\naction applies.\nThe combined MoS value, MoScom, shall be derived in accordance with Formula\u00a0(2).\nMOS\nMOS\ni\nn\ni\ncom =\n=\u2211\n1\n1\n1\n/\n\n(2)\nwhere\n\nMoScom is the result from the summation of reciprocal MoSi (unitless) values;\n\nMoSi\nis the MoS for each (i.e. individual) constituent that results from Formula\u00a0(1).\nWhen the constituent\u2019s critical adverse health effect is not known, then combining MoS values is not\nrequired and the MoS value for each constituent is calculated and used individually for toxicological\nrisk assessment.\nNOTE\u00a01\nCombining MoS values applies to the constituent\u2019s critical adverse health effect. The critical adverse\nhealth effect is the harm that occurs at the lowest administered POD dose.\nNOTE\u00a02\nCombining MoS values addresses the harm that can occur in an additive fashion, as well as the harm\nthat occurs by the same or different exposure routes. Formula\u00a0(2) is adapted from hazard index of mixtures for\nmedical device constituents[42]to[50].\nNOTE\u00a03\nIn some studies, a distinct toxicological mode of action is not always evident, particularly for minor\nadaptive effects such as small changes in organ mass or reversible changes in blood chemistry, and in such cases,\nrisks are not always additive for a target organ.\n\n\ufeff\b\n\u00a9 ISO 2023 \u2013 All rights reserved\n\b\n\ufeff\n22\nLicensed to Tulip Medical / Marc Pilkington (marc@tulipmedical.com)\nISO Store Order: OP-781942 license #1/ Downloaded: 2024-05-09\nSingle user licence only, copying and networking prohibited.\nISO 10993-17:2023(E)"
  }
]